<SEC-DOCUMENT>0001193125-21-131534.txt : 20210426
<SEC-HEADER>0001193125-21-131534.hdr.sgml : 20210426
<ACCEPTANCE-DATETIME>20210426162201
ACCESSION NUMBER:		0001193125-21-131534
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		7
CONFORMED PERIOD OF REPORT:	20210519
FILED AS OF DATE:		20210426
DATE AS OF CHANGE:		20210426

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			DBV Technologies S.A.
		CENTRAL INDEX KEY:			0001613780
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			I0
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36697
		FILM NUMBER:		21854113

	BUSINESS ADDRESS:	
		STREET 1:		177-181 AVENUE PIERRE BROSSOLETTE
		CITY:			MONTROUGE
		STATE:			I0
		ZIP:			92120
		BUSINESS PHONE:		33(0)155427878

	MAIL ADDRESS:	
		STREET 1:		177-181 AVENUE PIERRE BROSSOLETTE
		CITY:			MONTROUGE
		STATE:			I0
		ZIP:			92120
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>d140648ddef14a.htm
<DESCRIPTION>DEF 14A
<TEXT>
<HTML><HEAD>
<TITLE>DEF 14A</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>WASHINGTON, D.C. 20549 </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SCHEDULE 14A
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Proxy Statement Pursuant to Section&nbsp;14(a) of the </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Securities Exchange Act of 1934 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>(Amendment No.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ) </B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Filed by the Registrant &#9746;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Filed by a Party other than the Registrant &#9744; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="95%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Preliminary Proxy Statement</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>Confidential, for Use of the Commission Only (as permitted by Rule <FONT STYLE="white-space:nowrap">14a-6(e)(2))</FONT></B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">&#9746;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Definitive Proxy Statement</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Definitive Additional Materials</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Soliciting Material Under Rule <FONT STYLE="white-space:nowrap">14a-12</FONT></TD></TR></TABLE>
<P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:22pt; font-family:Times New Roman" ALIGN="center"><B>DBV Technologies S.A. </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Name of
Registrant as Specified In Its Charter) </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Name of Person(s) Filing Proxy Statement, if other than the Registrant) </B></P>
<P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Payment of Filing Fee (Check the appropriate box): </P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="90%"></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&#9746;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3" NOWRAP>No fee required.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&#9744;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3" NOWRAP>Fee computed on table below per Exchange Act Rules <FONT STYLE="white-space:nowrap">14a-6(i)(1)</FONT> and <FONT STYLE="white-space:nowrap">0-11.</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">1)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Title of each class of securities to which transaction
applies:</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">2)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Aggregate number of securities to which transaction applies:</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">3)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule
<FONT STYLE="white-space:nowrap">0-11</FONT> (set forth the amount on which the filing fee is calculated and state how it was determined):</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">4)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Proposed maximum aggregate value of transaction:</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">5)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Total fee paid:</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&#9744;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Fee paid previously with preliminary materials.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&#9744;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Check box if any part of the fee is offset as provided by Exchange Act Rule <FONT STYLE="white-space:nowrap">0-11(a)(2)</FONT> and identify the filing for which the offsetting fee was paid previously. Identify the
previous filing by registration statement number, or the Form or Schedule and the date of its filing:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">1)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Amount previously paid:</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">2)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Form, Schedule or Registration Statement No:</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">3)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Filing party:</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">4)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Date Filed:</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dear Fellow Shareholders, </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">DBV Technologies was founded on the belief that children with food allergies, their families, and the allergists who treat them, need and deserve multiple
treatment options. We believe that our lead product candidate, Viaskin Peanut, has a profile that is important to many families and allergists, and our primary goal is its potential approval in the United States and European Union. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The first half of 2020 was a challenging time for us as we navigated the U.S. regulatory pathway for Viaskin Peanut. When we began the year in January, the
Biologic License Application (BLA) for Viaskin Peanut, which we had submitted and filed in 2019, was under review with the Food and Drug Administration (FDA). On March&nbsp;16, 2020, the FDA contacted DBV to inform us that it was cancelling the
Advisory Committee for Viaskin Peanut and that, during its ongoing review of the BLA, it had identified questions regarding efficacy, including the impact of patch-site adhesion. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">By May 2020, DBV was facing an uncertain regulatory path for Viaskin Peanut and operating in an industry and world upended by the global <FONT
STYLE="white-space:nowrap">COVID-19</FONT> pandemic. Although DBV had provided adhesion data to the FDA to potentially supplement the Viaskin Peanut BLA, and our FDA target action date of August&nbsp;5, 2020 remained unchanged, we began to plan for
scenarios other than a timely Viaskin Peanut approval. We considered all realistic alternative regulatory scenarios and each one resulted in a significant delay to the transformation of DBV from a clinical-stage biotechnology company to a
commercial-stage one with healthy product revenues. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Chief Executive Officer Daniel Tass&eacute; recognized that DBV would likely encounter significant
financial pressure in the near-term with limited ability to responsibly raise the additional capital necessary for DBV to remain a competitive and viable clinical-stage company. In June, and after several meetings, Daniel and the Board of Directors
made the very difficult and necessary decision to reduce the size of DBV and the scope of its operations to maximize the length of time that DBV&#146;s cash could support its operations. On June&nbsp;26, 2020, DBV initiated a global cost-containment
program that included pausing several programs, suspending several activities, shifting selected functions to external business partners, and reducing the workforce. A corporate restructuring is always a difficult and complex process. However, DBV
emerged a leaner organization with greater financial flexibility, all critical functions retained, high quality teams, and a cash position that is expected to support DBV operations into the second half of 2022. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On August&nbsp;3, 2020, DBV received a Complete Response Letter from the FDA regarding the BLA for Viaskin Peanut. The FDA indicated it could not approve the
Viaskin Peanut BLA in its current form and identified several issues, including their concern regarding the impact of patch-site adhesion on efficacy. The DBV executive management team, supported by a comprehensive working group of internal and
external experts, immediately began crafting a plan to address the FDA&#146;s concerns and clarify a clinical and regulatory path forward for Viaskin Peanut in the United States. We submitted the plan to the FDA in the fourth quarter of 2020, and in
January 2021, the FDA provided clear guidance on a well-defined path forward for a modified Viaskin Peanut. I am very pleased to report that DBV continues to make significant progress, in dialogue with the FDA, in advancing the clinical and
regulatory development plan for a modified Viaskin Peanut. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">I am also pleased to report that the European Medicines Agency (EMA) review of the Marketing
Authorization Application (MAA) for Viaskin Peanut is progressing according to our expectations and consistent with our <FONT STYLE="white-space:nowrap">pre-filing</FONT> exchanges with the EMA. In the fourth quarter of 2020, DBV submitted the MAA,
and the EMA confirmed the application was sufficiently complete to begin their review. We expect to provide further updates as the EMA&#146;s review progresses. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Looking ahead to 2021 and beyond, I believe DBV is strongly positioned for the future. We remain steadfast in our commitment to bring Viaskin Peanut to
potential approval in the United States and European Union, and we are driven every day by our foundational belief that children with food allergies, their families, and the allergists who treat them, need and deserve multiple treatment options.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Sincerely, </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">/s/ Michel de Rosen </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Michel de Rosen </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">April 26, 2021 </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>DBV Technologies S.A. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><FONT STYLE="white-space:nowrap">177-181</FONT> Avenue Pierre Brossolette </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>92120 Montrouge France </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTICE OF ANNUAL COMBINED GENERAL MEETING OF SHAREHOLDERS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>To Be Held at 2:00 p.m. Paris Time on Wednesday, May&nbsp;19, 2021 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To Shareholders of DBV Technologies S.A.: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
2021 Annual Combined General Meeting of Shareholders (the &#147;Annual General Meeting&#148;) of DBV Technologies S.A. (the &#147;Company&#148;), a French <I>soci&eacute;t&eacute; anonyme</I>, will be held on Wednesday, May&nbsp;19, 2021 at 2:00
p.m. Paris time at the Company&#146;s headquarters located at <FONT STYLE="white-space:nowrap">177-181</FONT> Avenue Pierre Brossolette, 92120 Montrouge, France* in closed session without the physical presence of shareholders and other persons
entitled to attend in accordance notably with Article 4 of Order <FONT STYLE="white-space:nowrap">No.&nbsp;2020-321</FONT> of March&nbsp;25, 2020 (as amended and extended by Order No.&nbsp;2020-1497 of 2&nbsp;December 2020 and Decree no. <FONT
STYLE="white-space:nowrap">2021-255</FONT> of 9&nbsp;March 2021) to consider the following actions, as more fully described in the accompanying proxy statement: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Within the authority of the Ordinary Shareholders&#146; Meeting:</U> </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Approval of the annual financial statements for the year ended on December&nbsp;31, 2020,
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Approval of the consolidated financial statements for the year ended on December&nbsp;31, 2020,
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Allocation of income for the year ended on December&nbsp;31, 2020, </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">4.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Allocation of the accumulated deficit to the &#147;Additional <FONT STYLE="white-space:nowrap">paid-in</FONT>
capital&#148;, </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">5.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Statutory auditors&#146; special report on regulated agreements and acknowledgement of the absence of new
regulated agreements, </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">6.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Renewal of the term of office of Julie O&#146;Neill as director, </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">7.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Renewal of the term of office of Viviane Monges as director, </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">8.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Appointment of Ms.&nbsp;Adora Ndu to replace Mr.&nbsp;Torbj&ouml;rn Bjerke as director, </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">9.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Appointment of Mr.&nbsp;Ravi Rao as director, </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">10.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Ratification of the provisional appointment of Timothy E. Morris as director, </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">11.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Determination of the annual fixed sum to be allocated to the members of the Board of Directors,
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">12.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Approval of the compensation policy for the Chairman of the Board of Directors and for the Board members,<B><SUP
STYLE="font-size:85%; vertical-align:top"> </SUP></B> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">13.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Approval of the compensation policy for the Chief Executive Officer and/or any other executive corporate
officer, </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">14.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Advisory opinion on the compensation of named executive officers other than the Chief Executive Officer,
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">15.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Advisory opinion on the opportunity to consult shareholders each year on the compensation paid by the Company
to named executive officers other than the Chief Executive Officer, </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">16.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Advisory opinion on the opportunity to consult shareholders every two years on the compensation paid by the
Company to named executive officers other than the Chief Executive Officer, </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">17.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Advisory opinion on the opportunity to consult shareholders every three years on the compensation paid by the
Company to named executive officers other than the Chief Executive Officer, </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">18.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Approval of the information set out in section I of Article <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">L.22-10-9</FONT></FONT> of the French Commercial Code,<B><SUP STYLE="font-size:85%; vertical-align:top"> </SUP></B> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">19.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Approval of the fixed, variable and <FONT STYLE="white-space:nowrap">non-recurring</FONT> components of overall
compensation and benefits of all types paid or assigned during the year ended to Michel de Rosen, Chairman of the Board of Directors, </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">20.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Approval of the fixed, variable and <FONT STYLE="white-space:nowrap">non-recurring</FONT> components of overall
compensation and benefits of all types paid or assigned during the year ended to Daniel Tass&eacute;, Chief Executive Officer, </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">21.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Approval of the fixed, variable and <FONT STYLE="white-space:nowrap">non-recurring</FONT> components of overall
compensation and benefits of all types paid or assigned during the year ended to Marie-Catherine Th&eacute;r&eacute;n&eacute;, Deputy Chief Executive Officer until September&nbsp;17, 2020, </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">22.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Authorization to be granted to the Board of Directors to buy back company shares on the Company&#146;s behalf
pursuant to Article L. <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">22-10-62</FONT></FONT> of the French Commercial Code, length of authorization, purpose, terms, and maximum amount, suspension during a public offering period,
</P></TD></TR></TABLE> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Within the authority of the Extraordinary Shareholders&#146; Meeting:</U> </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">23.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Authorization to be granted to the Board of Directors for the company to cancel the shares bought back pursuant
to Article L. <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">22-10-62</FONT></FONT> of the French Commercial Code, length of authorization, maximum amount, suspension during a public offering period, </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">24.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Delegation of powers to the Board of Directors to issue ordinary shares, giving, as necessary, access to
ordinary shares or to the allocation of debt securities (of the Company or of a Group company) and/or securities giving access to ordinary shares (of the Company or of a Group company) with <FONT STYLE="white-space:nowrap">pre-emptive</FONT> rights,
suspension during a public offering period, </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">25.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Delegation of powers to be granted to the Board of Directors to issue ordinary shares giving access, as the
case may be, to ordinary shares or to the allocation of debt securities (of the Company or a group company), and/or securities giving access to ordinary shares (of the Company or a group company), without
<FONT STYLE="white-space:nowrap">pre-emptive</FONT> rights, by means of a public offer (excluding the offers set out in section 1 of Article <FONT STYLE="white-space:nowrap">L.411-2</FONT> of the French Monetary and Financial Code), and/or as
consideration for securities in the context of a public exchange offer, suspension during a public offering period, </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">26.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Delegation of powers to be granted to the Board of Directors to issue ordinary shares giving access, as the
case may be, to ordinary shares or to the allocation of debt securities (of the Company or a group company), and/or securities giving access to ordinary shares (of the Company or a group company), without
<FONT STYLE="white-space:nowrap">pre-emptive</FONT> rights, by means of a public offer referred to in paragraph 1 of Article <FONT STYLE="white-space:nowrap">L.411-2</FONT> of the French Monetary and Financial Code, suspension during a public
offering period, </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">27.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Authorization, in the event of an issue without <FONT STYLE="white-space:nowrap">pre-emptive</FONT> rights, to
set the issue price according to the terms set by the General Meeting, within a limit of 10% of the capital per year, </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">28.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Delegation of powers to be granted to the Board of Directors to issue ordinary shares, giving, if applicable,
access to ordinary shares or the allocation of debt securities (of the Company or a group company) and/or securities giving access to ordinary shares (of the Company or a group company), with <FONT STYLE="white-space:nowrap">pre-emptive</FONT>
subscription rights waived in favor of categories of persons with certain characteristics, suspension during a public offering period, </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">29.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Authorization to increase the total amount of issues, </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">30.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Delegation of powers to be granted to the Board of Directors for the purpose of deciding on any
merger-absorption, demerger, or partial contribution of assets, </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">31.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Delegation of powers to be granted to the Board of Directors to issue ordinary shares giving access to ordinary
shares or to the allocation of debt securities (of the Company or of a Group company), and/or securities giving access to ordinary shares (of the Company or of a Group company), in the context of a merger, demerger or partial contribution of assets
decided by the Board of Directors pursuant to the delegation referred to in the thirtieth resolution, suspension during a public offering period, </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">32.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Overall limit on the maximum authorized amounts set under the
25<SUP STYLE="font-size:85%; vertical-align:top">th</SUP>, 26<SUP STYLE="font-size:85%; vertical-align:top">th</SUP>, 28<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> and 31<SUP STYLE="font-size:85%; vertical-align:top">st</SUP> resolutions
of this Meeting and the 28<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> resolution of the General Meeting of April&nbsp;20, 2020, </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">33.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Delegation of powers to the Board of Directors to issue stock warrants (BSA), subscription and/or acquisition
</P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
of new and/or existing stock warrants (BSAANE) and/or subscription and/or acquisition of new and/or existing redeemable stock warrants (BSAAR) with cancellation of preferential subscription
rights, reserved for a category of persons, suspension during a public offering period, </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">34.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Delegation of powers to be granted to the Board of Directors to increase the share capital by means of the
issue of ordinary shares and/or securities giving access to capital, with <FONT STYLE="white-space:nowrap">pre-emptive</FONT> subscription rights waived in favor of members of a company savings plan pursuant to
<FONT STYLE="white-space:nowrap">Articles&nbsp;L.3332-18</FONT> et seq. of the French Labor Code, </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">35.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Authorization to be granted to the Board of Directors to allocate free existing and/or future shares to members
of staff and/or certain corporate officers of the Company or related companies or economic interest groups, with shareholders waiving their <FONT STYLE="white-space:nowrap">pre-emptive</FONT> rights, length of authorization, maximum amount, duration
of vesting periods specifically in respect of disability and, if applicable, holding periods, </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">36.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Authorization to be granted to the Board of Directors to grant share subscription and/or purchase options
(stock options) to members of staff and/or certain corporate officers of the company or related companies or economic interest groups, with shareholders waiving their <FONT STYLE="white-space:nowrap">pre-emptive</FONT> rights, length of
authorization, maximum amount, strike price, maximum term of the option, </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">37.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Amendment of Article&nbsp;13 of the <FONT STYLE="white-space:nowrap">by-laws</FONT> in order to set the age
limit for the Chairman of the Board of Directors at 75 years of age, and, </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">38.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Powers to complete formalities. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In accordance notably with Article&nbsp;4 of Order <FONT STYLE="white-space:nowrap">No.&nbsp;2020-321</FONT> of 25&nbsp;March 2020 adapting the rules for
meetings and deliberations of meetings and governing bodies of legal persons and entities without legal personality under private law due to the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic, as amended and extended, among others, by
Order No.&nbsp;2020-1497 of 2&nbsp;December 2020 extending and amending Order <FONT STYLE="white-space:nowrap">No.&nbsp;2020-321</FONT> of 25&nbsp;March 2020 and by Decree no. <FONT STYLE="white-space:nowrap">2021-255</FONT> of 9&nbsp;March 2021
extending the period of application of Order <FONT STYLE="white-space:nowrap">No.&nbsp;2020-321</FONT> of 25&nbsp;March 2020, Decree no. <FONT STYLE="white-space:nowrap">2020-418</FONT> of 10&nbsp;April 2020 and Decree no. <FONT
STYLE="white-space:nowrap">2020-629</FONT> of 25&nbsp;May 2020, the Annual General Meeting will be held in closed session without the physical presence of shareholders and other persons entitled to attend. On May&nbsp;19, 2021, starting at
2:00&nbsp;p.m. Paris time, the Annual General Meeting will be webcast with live audio on our website <I><FONT STYLE="white-space:nowrap">https://www.dbv-technologies.com/fr/</FONT></I> in the Events and Presentations section. The recorded webcast of
the General Meeting will remain accessible on the Company&#146;s website for two years following the date of the General Meeting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Therefore, we invite
you to participate in this meeting by giving a proxy to the chairman of the Annual General Meeting, granting your voting proxy to another shareholder, your spouse or your partner with whom you have entered into a civil union,, voting by electronic
mail via the secure platform Votaccess or voting by using your proxy card as described below. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">These proxy materials will be mailed by Citibank, N.A.
(the &#147;Depositary&#148;) on or about April&nbsp;28, 2021 to all holders of the Company&#146;s American Depositary Shares (&#147;ADSs&#148;), each representing <FONT STYLE="white-space:nowrap">one-half</FONT> of one ordinary share of the Company,
having a nominal value of &#128;0.10 per share (the &#147;Ordinary Shares&#148; or &#147;Shares&#148;). Our registrar, Soci&eacute;t&eacute; G&eacute;n&eacute;rale Securities Services, will commence mailing proxy materials to all holders of the
Company&#146;s Ordinary Shares on or about May&nbsp;3, 2021, in accordance with French law and requirements. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In accordance with Article R. <FONT
STYLE="white-space:nowrap">225-85</FONT> of the French Commercial Code, if you are holder of Ordinary Shares that are registered in your name or in the name of an intermediary duly registered on your behalf as of Monday, May&nbsp;17, 2021 at
midnight Paris time, which is the second business day prior to the meeting (the &#147;Ordinary Share Record Date&#148;), either in the registered share accounts or in the bearer share accounts held by their authorized intermediary, you will be
eligible to vote your Ordinary Shares. You may (i)&nbsp;grant your voting proxy directly to the chairman of the Annual General Meeting (ii)&nbsp;grant your voting proxy to another shareholder, your spouse, or your partner with whom you have entered
into a civil union, (iii)&nbsp;vote by submitting your proxy card by mail or (iv)&nbsp;vote by electronic mail via the secure platform Votaccess. If you vote in advance of the Annual General Meeting, you may change your vote provided that your
request is received by the Company within the applicable time limits described in this proxy statement. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If you hold ADSs, you may instruct the Depositary, either directly or through your broker,
bank or other nominee, how to vote the Ordinary Shares underlying your ADSs. Please note that only holders of Ordinary Shares, and not ADS holders, are entitled to vote directly at the Annual General Meeting. The Depositary has fixed a record date
for the determination of holders of ADSs who shall be entitled to give such voting instructions. We have been informed by the Depositary that it has set the ADS record date for the Annual General Meeting as April&nbsp;21, 2021 (the &#147;ADS Record
Date&#148;). If you wish to have your votes cast at the meeting, you must obtain, complete and timely return at or prior to 10:00 a.m. Eastern Time on May&nbsp;12, 2021 a voting instruction form from the Depositary, if you are a registered holder of
ADSs, or from your broker, bank or other nominee in accordance with any instructions provided therefrom. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>YOUR VOTE IS IMPORTANT.
Please read the proxy statement and the accompanying materials. No matter how many Ordinary Shares or ADSs you own, please submit your proxy card or voting instruction form, as applicable, in accordance with the procedures described above. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We appreciate your continued support of DBV Technologies&nbsp;S.A. and look forward to receiving your vote. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>  <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="99%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">By order of the board of directors,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Daniel Tass&eacute;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Daniel Tass&eacute;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Chief Executive Officer</TD></TR>
</TABLE></DIV>  <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>* We are monitoring the situation regarding the ongoing <FONT STYLE="white-space:nowrap">COVID-19</FONT>
pandemic closely and we will monitor the need to potentially alter the date, time or organization of the Annual General Meeting. If we take any additional steps in light of the ongoing <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic, we
will announce the relevant changes in advance by a press release and the filing of additional proxy materials with the Securities and Exchange Commission. Please monitor our website
at</B><B><I><FONT STYLE="white-space:nowrap">&nbsp;https://www.dbv-technologies.com/investor-relations/</FONT> </I></B><B>for updated information and if you intend to view the webcast of the Annual General Meeting, please check the website in
advance of the meeting. </B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U><A NAME="toc"></A>TABLE OF CONTENTS </U></B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="94%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B><U>PAGE</U></B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc140648_1">IMPORTANT INFORMATION ABOUT THE ANNUAL MEETING AND VOTING</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc140648_2">BOARD OF DIRECTORS AND CORPORATE GOVERNANCE</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc140648_3">REPORT OF AUDIT COMMITTEE</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc140648_4">INFORMATION ABOUT OUR EXECUTIVE OFFICERS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc140648_5">EXECUTIVE OFFICER COMPENSATION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc140648_6">SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND
MANAGEMENT</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc140648_7">SECTION 16(a) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">39</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc140648_8">CERTAIN RELATIONSHIPS AND RELATED PERSON TRANSACTIONS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">40</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc140648_9_1">PROPOSAL NOS. 1 TO 4: APPROVAL OF THE ANNUAL FINANCIAL STATEMENTS, APPROVAL
 OF THE CONSOLIDATED FINANCIAL STATEMENTS, ALLOCATION OF INCOME AND ALLOCATION OFF ACCUMULATED DEFICIT</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">46</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc140648_9_2">PROPOSAL NO. 5 STATUTORY AUDITORS&#146; SPECIAL REPORT ON REGULATED AGREEMENTS
 AND ACKNOWLEDGMENT OF THE ABSENCE OF THE NEW REGULATED AGREEMENTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">48</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc140648_9_3">PROPOSAL NOS. 6 TO 10 RENEWAL OF TERM OF JULIE O&#146;NEILL, RENEWAL OF TERM
 OF VIVIANE MONGES, APPOINTMENT OF ADORA NDU, APPOINTMENT OF RAVI RAO AND RATIFICATION OF PROVISIONAL APPOINTMENT OF TIMOTHY E. MORRIS AS DIRECTORS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">49</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc140648_9_4">PROPOSAL NOS. 11 TO 13: DETERMINATION OF THE ANNUAL FIXED AMOUNT TO BE ALLOCATED
TO THE MEMBERS OF THE BOARD OF DIRECTORS, APPROVAL OF THE COMPENSATION POLICY FOR THE CHAIRMAN OF THE BOARD OF DIRECTORS AND FOR THE DIRECTORS AND APPROVAL OF THE COMPENSATION POLICY FOR THE CHIEF EXECUTIVE OFFICER AND/OR ANY OTHER EXECUTIVE
CORPORATE OFFICER</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">51</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc140648_9_5">PROPOSAL NO. 14: ADVISORY OPINION ON THE COMPENSATION OF NAMED EXECUTIVE
 OFFICERS OTHER THAN THE CHIEF EXECUTIVE OFFICER</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">52</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc140648_9_6">PROPOSAL NOS. 15 TO 17: ADVISORY VOTE ON THE FREQUENCY OF FUTURE ADVISORY
 VOTES ON NAMED EXECUTIVE OFFICER COMPENSATION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">53</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc140648_9_7">PROPOSAL NO. 18: APPROVAL OF THE INFORMATION SET OUT IN SECTION I OF THE
 ARTICLE L.22-10-9 OF THE FRENCH COMMERCIAL CODE</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">54</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc140648_9_8">PROPOSAL NO. 19: APPROVAL OF THE FIXED, VARIABLE AND NON-RECURRING COMPONENTS
 OF OVERALL COMPENSATION AND BENEFITS OF ALL TYPES PAID OR ASSIGNED DURING THE YEAR ENDED TO MICHEL DE ROSEN, CHAIRMAN OF THE BOARD OF DIRECTORS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">55</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc140648_9_9">PROPOSAL NO. 20: APPROVAL OF THE FIXED, VARIABLE AND NON-RECURRING COMPONENTS
 OF OVERALL COMPENSATION AND BENEFITS OF ALL TYPES PAID OR ASSIGNED DURING THE YEAR ENDED TO DANIEL TASS&#201;, CHIEF EXECUTIVE OFFICER</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">56</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc140648_9_10">PROPOSAL NO. 21: APPROVAL OF THE FIXED, VARIABLE AND NON-RECURRING COMPONENTS
 OF OVERALL COMPENSATION AND BENEFITS OF ALL TYPES PAID OR ASSIGNED DURING THE YEAR ENDED TO CATHERINE TH&#201;R&#201;N&#201;, DEPUTY CHIEF EXECUTIVE OFFICER</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">57</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc140648_9_11">PROPOSAL NO. 22 AUTHORIZATION TO BUY BACK COMPANY SHARES</A></P></TD>

<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">58</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc140648_9_12">PROPOSAL NO. 23: AUTHORIZATION TO THE BOARD OF DIRECTORS FOR THE COMPANY
 TO CANCEL THE SHARES BOUGHT BACK PURSUANT TO ARTICLE L. 22-10-62 OF THE FRENCH COMMERCIAL CODE SUSPENSION DURING A PUBLIC OFFERING PERIOD</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">60</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">i </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="94%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B><U>PAGE</U></B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc140648_9_13">PROPOSALS 24-29: FINANCIAL AUTHORIZATIONS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">61</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc140648_9_14">PROPOSAL NO. 25: DELEGATION OF POWERS TO BE GRANTED TO THE BOARD OF DIRECTORS
 TO ISSUE ORDINARY SHARES GIVING ACCESS, AS THE CASE MAY BE, TO ORDINARY SHARES OR TO THE ALLOCATION OF DEBT SECURITIES (OF THE COMPANY OR A GROUP COMPANY), AND/OR SECURITIES GIVING ACCESS TO ORDINARY SHARES (OF THE COMPANY OR A GROUP COMPANY),
WITHOUT PRE-EMPTIVE RIGHTS, BY MEANS OF A PUBLIC OFFER (EXCLUDING THE OFFERS SET OUT IN SECTION 1 OF ARTICLE L.411-2 OF THE FRENCH MONETARY AND FINANCIAL CODE), AND/OR AS CONSIDERATION FOR SECURITIES IN THE CONTEXT OF A PUBLIC EXCHANGE OFFER
SUSPENSION DURING A PUBLIC OFFERING PERIOD</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc140648_9_15">PROPOSAL NO. 26: DELEGATION OF POWERS TO BE GRANTED TO THE BOARD OF DIRECTORS
 TO ISSUE ORDINARY SHARES GIVING ACCESS, AS THE CASE MAY BE, TO ORDINARY SHARES OR TO THE ALLOCATION OF DEBT SECURITIES (OF THE COMPANY OR A GROUP COMPANY), AND/OR SECURITIES GIVING ACCESS TO ORDINARY SHARES (OF THE COMPANY OR A GROUP COMPANY),
WITHOUT PRE-EMPTIVE RIGHTS, BY MEANS OF A PUBLIC OFFER REFERRED TO IN PARAGRAPH 1 OF ARTICLE L.411-2 OF THE FRENCH MONETARY AND FINANCIAL CODE SUSPENSION DURING A PUBLIC OFFERING PERIOD</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">67</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc140648_9_16">PROPOSAL NO. 27: AUTHORIZATION, IN THE EVENT OF AN ISSUE WITHOUT PRE-EMPTIVE
 RIGHTS, TO SET THE ISSUE PRICE ACCORDING TO THE TERMS SET BY THE GENERAL MEETING, WITHIN A LIMIT OF 10% OF THE CAPITAL PER YEAR</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">68</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc140648_9_17">PROPOSAL NO. 28: DELEGATION OF POWERS TO BE GRANTED TO THE BOARD OF DIRECTORS
 TO ISSUE ORDINARY SHARES, GIVING, IF APPLICABLE, ACCESS TO ORDINARY SHARES OR THE ALLOCATION OF DEBT SECURITIES (OF THE COMPANY OR A GROUP COMPANY) AND/OR SECURITIES GIVING ACCESS TO ORDINARY SHARES (OF THE COMPANY OR A GROUP COMPANY), WITH
PRE-EMPTIVE SUBSCRIPTION RIGHTS WAIVED IN FAVOR OF CATEGORIES OF PERSONS WITH CERTAIN CHARACTERISTICS, SUSPENSION DURING A PUBLIC OFFERING PERIOD</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">69</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc140648_9_18">PROPOSAL NO. 29: AUTHORIZATION TO INCREASE THE TOTAL AMOUNT OF
ISSUES</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">71</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc140648_9_19">PROPOSAL NO. 30: DELEGATION OF POWERS TO BE GRANTED TO THE BOARD OF DIRECTORS
 FOR THE PURPOSE OF DECIDING ON ANY MERGER-ABSORPTION, DEMERGER, OR PARTIAL CONTRIBUTION OF ASSETS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">72</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc140648_9_20">PROPOSAL NO. 31: DELEGATION OF POWERS TO BE GRANTED TO THE BOARD OF DIRECTORS
 TO ISSUE ORDINARY SHARES GIVING ACCESS TO ORDINARY SHARES OR TO THE ALLOCATION OF DEBT SECURITIES (OF THE COMPANY OR OF A GROUP COMPANY), AND/OR SECURITIES GIVING ACCESS TO ORDINARY SHARES (OF THE COMPANY OR OF A GROUP COMPANY), IN THE CONTEXT OF A
MERGER, DEMERGER OR PARTIAL CONTRIBUTION OF ASSETS DECIDED BY THE BOARD OF DIRECTORS PURSUANT TO THE DELEGATION REFERRED TO IN THE TWENTY-SEVENTH RESOLUTION, SUSPENSION DURING A PUBLIC OFFERING PERIOD</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">73</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc140648_9_21">PROPOSAL NO. 32 OVERALL LIMIT ON THE MAXIMUM AUTHORIZED AMOUNTS SET UNDER
 THE 25<SUP STYLE="font-size:85%; vertical-align:top">TH</SUP>, 26<SUP STYLE="font-size:85%; vertical-align:top">TH</SUP>, 28<SUP STYLE="font-size:85%; vertical-align:top">TH</SUP> AND 31<SUP STYLE="font-size:85%; vertical-align:top">ST</SUP>
RESOLUTIONS OF THIS GENERAL MEETING AND THE 28<SUP STYLE="font-size:85%; vertical-align:top">TH</SUP> RESOLUTION OF THE GENERAL MEETING OF APRIL 20, 2020</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">75</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc140648_9_22">RESOLUTIONS 33 TO 36: EQUITY RESOLUTIONS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">76</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc140648_9_23">PROPOSAL NO. 33 DELEGATION OF POWERS TO THE BOARD OF DIRECTORS TO ISSUE
 STOCK WARRANTS (BSA), SUBSCRIPTION AND/OR ACQUISITION OF NEW AND/OR EXISTING STOCK WARRANTS (BSAANE) AND/OR SUBSCRIPTION AND/OR ACQUISITION OF NEW AND/OR EXISTING REDEEMABLE STOCK WARRANTS (BSAAR) WITH CANCELLATION OF PREFERENTIAL SUBSCRIPTION
RIGHTS, RESERVED FOR CATEGORIES OF PERSONS, SUSPENSION DURING A PUBLIC OFFERING PERIOD</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">77</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ii </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="94%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B><U>PAGE</U></B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc140648_9_24">PROPOSAL NO. 34: DELEGATION OF POWERS TO BE GRANTED TO THE BOARD OF DIRECTORS
 TO INCREASE THE SHARE CAPITAL BY THE ISSUE OF ORDINARY SHARES AND/OR SECURITIES GRANTING ACCESS TO THE CAPITAL, WITH PRE-EMPTIVE SUBSCRIPTION RIGHTS WAIVED IN FAVOR OF THE MEMBERS OF A COMPANY SAVINGS PLAN PURSUANT TO ARTICLES L. 3332-18 ET SEQ. OF
THE FRENCH LABOR CODE</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">80</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc140648_9_25">PROPOSAL NO. 35: AUTHORIZATION TO BE GRANTED TO THE BOARD OF DIRECTORS TO
 ALLOCATE FREE SHARES TO MEMBERS OF STAFF AND/OR CERTAIN CORPORATE OFFICERS.</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">81</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc140648_9_26">PROPOSAL NO. 36: AUTHORIZATION TO BE GRANTED TO THE BOARD OF DIRECTORS TO
 GRANT SHARE SUBSCRIPTION AND/OR PURCHASE OPTIONS (STOCK OPTIONS) TO MEMBERS OF STAFF (AND/OR CERTAIN CORPORATE OFFICERS)</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">84</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc140648_9_27">PROPOSAL NO. 37: AMENDMENT OF ARTICLE 13 OF THE BY-LAWS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">88</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc140648_9_28">PROPOSAL NO. 38: POWERS TO COMPLETE FORMALITIES</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">89</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc140648_10">CODE OF BUSINESS CONDUCT AND ETHICS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">90</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc140648_11">OTHER MATTERS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">90</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc140648_12">SHAREHOLDER PROPOSALS AND NOMINATIONS FOR DIRECTOR</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">90</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc140648_13">ANNEX A: ENGLISH TRANSLATION OF FULL TEXT OF RESOLUTIONS TO BE VOTED ON AT
THE ANNUAL GENERAL MEETING</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">91</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc140648_14">ANNEX B: COMPENSATION POLICY FOR CORPORATE OFFICERS (SAY ON PAY EX ANTE)
</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">113</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc140648_14a">ANNEX C &#150; Part 1: APPROVAL OF INFORMATION REFERRED TO IN ARTICLE <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">L.22-10-9</FONT></FONT> OF THE FRENCH COMMERCIAL CODE </A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">121</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc140648_15">ANNEX C &#150; Part 2: APPROVAL OF FIXED, VARIABLE AND EXCEPTIONAL ITEMS COMPRISING
 THE TOTAL COMPENSATION AND BENEFITS OF ANY KIND PAID DURING THE PREVIOUS FINANCIAL YEAR OR AWARDED FOR SAID FINANCIAL YEAR TO THE CORPORATE OFFICERS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">122</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc140648_16">ANNEX D: ACHIEVEMENT AGAINST ANNUAL CORPORATE OBJECTIVES</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">125</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">iii </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>DBV Technologies S.A. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><FONT STYLE="white-space:nowrap">177-181</FONT> Avenue Pierre Brossolette </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>92120 Montrouge France </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PROXY STATEMENT </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FOR THE
2021 ANNUAL COMBINED GENERAL MEETING OF SHAREHOLDERS </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>To Be Held at 2:00 p.m. Paris Time on Wednesday, May&nbsp;19, 2021 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This proxy statement and the enclosed form of proxy are furnished to holders of Ordinary Shares and ADSs in connection with the solicitation of proxies by our
board of directors for use at the 2021 Annual Combined General Meeting of shareholders of DBV Technologies S.A. (the &#147;Company&#148;), a French <I>soci&eacute;t&eacute; anonyme</I>, and any postponements, adjournments or continuations thereof
(the &#147;Annual General Meeting&#148;). The Annual General Meeting will be held on Wednesday, May&nbsp;19, 2021 at 2:00 p.m. Paris time at <FONT STYLE="white-space:nowrap">177-181</FONT> Avenue Pierre Brossolette, 92120 Montrouge, France. In
accordance notably with Article 4 of Order <FONT STYLE="white-space:nowrap">No.&nbsp;2020-321</FONT> of 25&nbsp;March 2020 adapting the rules for meetings and deliberations of meetings and governing bodies of legal persons and entities without legal
personality under private law due to the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic, as amended and extended, among others, by notably Order No.&nbsp;2020-1497 of 2&nbsp;December 2020 extending and amending Order <FONT
STYLE="white-space:nowrap">No.&nbsp;2020-321</FONT> of 25&nbsp;March 2020, and by Decree no. <FONT STYLE="white-space:nowrap">2021-255</FONT> of 9&nbsp;March 2021 extending the period of application of Order
<FONT STYLE="white-space:nowrap">No.&nbsp;2020-321</FONT> of 25&nbsp;March 2020, Decree no. <FONT STYLE="white-space:nowrap">2020-418</FONT> of 10&nbsp;April 2020 and Decree no. <FONT STYLE="white-space:nowrap">2020-629</FONT> of 25&nbsp;May 2020,
the Annual General Meeting will be held in closed session without the physical presence of shareholders and other persons entitled to attend. On May&nbsp;19, 2021, starting at 2:00 p.m. Paris time, the Annual General Meeting will be webcast with
live audio on our website <FONT STYLE="white-space:nowrap">https://www.dbv-technologies.com/fr/</FONT> in the Events and Presentations section. Shareholders will also be able to access the recorded webcast of the General Meeting on the
Company&#146;s website for two years following the date of the General Meeting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If we take any additional steps in light of the <FONT
STYLE="white-space:nowrap">COVID-19</FONT> pandemic, we will announce the relevant changes in advance by a press release and the filing of additional proxy materials with the Securities and Exchange Commission (&#147;SEC&#148;). Please monitor our
website at <I><FONT STYLE="white-space:nowrap">https://https://www.dbv-technologies.com/investor-relations/</FONT></I> for updated information and if you intend to view the webcast of the meeting, please check the website in advance of the meeting.
In this proxy statement references to &#147;DBV,&#148; &#147;the company,&#148; &#147;our company,&#148; &#147;we,&#148; &#147;us&#148; and &#147;our&#148; refer to DBV Technologies S.A. and our consolidated subsidiaries. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Important Notice Regarding the Availability of Proxy Materials for the </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Shareholder Meeting to be Held on May&nbsp;19, 2021: </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I>The proxy statement and annual report are available at:
<FONT STYLE="white-space:nowrap">https://www.dbv-technologies.com/investor-relations/financial-information/annual-reports/</FONT> </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">You may also request paper copies of materials by contacting: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">DBV Technologies&nbsp;S.A. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT
STYLE="white-space:nowrap">177-181</FONT> avenue Pierre Brossolette </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">92120 Montrouge, France </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Attention: Legal Department </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Email: <FONT STYLE="white-space:nowrap">investors@dbv-technologies.com</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Citibank, N.A., as the depositary (the &#147;Depositary&#148;), or a broker, bank or other nominee, will provide the proxy materials to
holders of American Depositary Shares, each representing <FONT STYLE="white-space:nowrap">one-half</FONT> of one Ordinary Share (&#147;ADSs&#148;). We expect the Depositary will mail the proxy materials to ADS holders on or about April&nbsp;28,
2021. Our registrar, Soci&eacute;t&eacute; G&eacute;n&eacute;rale Securities Services, will commence mailing of proxy materials to all holders of our ordinary shares, nominal value &#128;0.10 per shares (&#147;Ordinary Shares&#148;), on or about May
3, 2021, in accordance with French law and requirements. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Although not part of this proxy statement, we are also sending, along with this proxy
statement, our 2020 Annual Report on Form <FONT STYLE="white-space:nowrap">10-K,</FONT> which includes our financial statements prepared in accordance with U.S. GAAP for the fiscal year ended December&nbsp;31, 2020. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc140648_1"></A>IMPORTANT INFORMATION ABOUT THE ANNUAL MEETING AND VOTING
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The information provided in the &#147;question and answer&#148; format below is for your convenience only and is merely a summary of
the information contained in this proxy statement. You should read this entire proxy statement carefully. Information contained on, or that can be accessed through, our website is not intended to be incorporated by reference into this proxy
statement and references to our website address in this proxy statement are inactive textual references only. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>What matters will be voted at the Annual
General Meeting? </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">There are 38 proposed resolutions (the &#147;Proposals&#148;) scheduled to be considered and voted on at the Annual
General Meeting: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Within the authority of the Ordinary Shareholders&#146; Meeting:</U> </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Approval of the annual financial statements for the year ended on December&nbsp;31, 2020,
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Approval of the consolidated financial statements for the year ended on December&nbsp;31, 2020,
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Allocation of income for the year ended on December&nbsp;31, 2020, </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">4.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Allocation of the accumulated deficit to the &#147;Additional <FONT STYLE="white-space:nowrap">paid-in</FONT>
capital&#148;, </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">5.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Statutory auditors&#146; special report on regulated agreements and acknowledgement of the absence of new
regulated agreements, </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">6.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Renewal of the term of office of Julie O&#146;Neill as director, </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">7.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Renewal of the term of office of Viviane Monges as director, </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">8.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Appointment of Ms.&nbsp;Adora Ndu to replace Mr.&nbsp;Torbjorn Bjerke as director, </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">9.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Appointment of Mr.&nbsp;Ravi Rao as director, </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">10.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Ratification of the provisional appointment of Timothy E. Morris as director, </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">11.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Determination of the annual fixed sum to be allocated to the members of the Board of Directors,
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">12.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Approval of the compensation policy for the Chairman of the Board of Directors and for the Board members,<B><SUP
STYLE="font-size:85%; vertical-align:top"> </SUP></B> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">13.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Approval of the compensation policy for the Chief Executive Officer and/or any other executive corporate
officer, </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">14.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Advisory opinion on the compensation of named executive officers other than the Chief Executive Officer,
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">15.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Advisory opinion on the opportunity to consult shareholders each year on the compensation paid by the Company
to named executive officers other than the Chief Executive Officer, </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">16.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Advisory opinion on the opportunity to consult shareholders every two years on the compensation paid by the
Company to named executive officers other than the Chief Executive Officer, </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">17.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Advisory opinion on the opportunity to consult shareholders every three years on the compensation paid by the
Company to named executive officers other than the Chief Executive Officer, </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">18.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Approval of the information set out in section I of Article <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">L.22-10-9</FONT></FONT> of the French Commercial Code,<B><SUP STYLE="font-size:85%; vertical-align:top"> </SUP></B> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">19.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Approval of the fixed, variable and <FONT STYLE="white-space:nowrap">non-recurring</FONT> components of overall
compensation and benefits of all types paid or assigned during the year ended to Michel de Rosen, Chairman of the Board of Directors, </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">20.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Approval of the fixed, variable and <FONT STYLE="white-space:nowrap">non-recurring</FONT> components of overall
compensation and benefits of all types paid or assigned during the year ended to Daniel Tass&eacute;, Chief Executive Officer, </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">21.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Approval of the fixed, variable and <FONT STYLE="white-space:nowrap">non-recurring</FONT> components of overall
compensation and benefits of all types paid or assigned during the year ended to Marie-Catherine Th&eacute;r&eacute;n&eacute;, Deputy Chief Executive Officer until September&nbsp;17, 2020, </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">22.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Authorization to be granted to the Board of Directors to buy back company shares on the Company&#146;s behalf
pursuant to Article L. <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">22-10-62</FONT></FONT> of the French Commercial Code, length of authorization, purpose, terms, and maximum amount, suspension during a public offering period,
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>Within the authority of the Extraordinary Shareholders&#146; Meeting:</U> </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">23.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Authorization to be granted to the Board of Directors for the company to cancel the shares bought back pursuant
to Article L. <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">22-10-62</FONT></FONT> of the French Commercial Code, length of authorization, maximum amount, suspension during a public offering period, </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">24.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Delegation of powers to the Board of Directors to issue ordinary shares, giving, as necessary, access to
ordinary shares or to the allocation of debt securities (of the Company or of a Group company) and/or securities giving access to ordinary shares (of the Company or of a Group company) with <FONT STYLE="white-space:nowrap">pre-emptive</FONT> rights,
suspension during a public offering period, </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">25.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Delegation of powers to be granted to the Board of Directors to issue ordinary shares giving access, as the
case may be, to ordinary shares or to the allocation of debt securities (of the Company or a group company), and/or securities giving access to ordinary shares (of the Company or a group company), without
<FONT STYLE="white-space:nowrap">pre-emptive</FONT> rights, by means of a public offer (excluding the offers set out in section 1 of Article <FONT STYLE="white-space:nowrap">L.411-2</FONT> of the French Monetary and Financial Code), and/or as
consideration for securities in the context of a public exchange offer, suspension during a public offering period, </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">26.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Delegation of powers to be granted to the Board of Directors to issue ordinary shares giving access, as the
case may be, to ordinary shares or to the allocation of debt securities (of the Company or a group company), and/or securities giving access to ordinary shares (of the Company or a group company), without
<FONT STYLE="white-space:nowrap">pre-emptive</FONT> rights, by means of a public offer referred to in paragraph 1 of Article <FONT STYLE="white-space:nowrap">L.411-2</FONT> of the French Monetary and Financial Code, suspension during a public
offering period, </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">27.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Authorization, in the event of an issue without <FONT STYLE="white-space:nowrap">pre-emptive</FONT> rights, to
set the issue price according to the terms set by the General Meeting, within a limit of 10% of the capital per year, </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">28.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Delegation of powers to be granted to the Board of Directors to issue ordinary shares, giving, if applicable,
access to ordinary shares or the allocation of debt securities (of the Company or a group company) and/or securities giving access to ordinary shares (of the Company or a group company), with <FONT STYLE="white-space:nowrap">pre-emptive</FONT>
subscription rights waived in favor of categories of persons with certain characteristics, suspension during a public offering period, </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">29.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Authorization to increase the total amount of issues, </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">30.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Delegation of powers to be granted to the Board of Directors for the purpose of deciding on any
merger-absorption, demerger, or partial contribution of assets, </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">31.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Delegation of powers to be granted to the Board of Directors to issue ordinary shares giving access to ordinary
shares or to the allocation of debt securities (of the Company or of a Group company), and/or securities giving access to ordinary shares (of the Company or of a Group company), in the context of a merger, demerger or partial contribution of assets
decided by the Board of Directors pursuant to the delegation referred to in the thirtieth resolution, suspension during a public offering period, </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">32.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Overall limit on the maximum authorized amounts set under the
25<SUP STYLE="font-size:85%; vertical-align:top">th</SUP>, 26<SUP STYLE="font-size:85%; vertical-align:top">th</SUP>, 28<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> and 31<SUP STYLE="font-size:85%; vertical-align:top">st</SUP> resolutions
of this Meeting and the 28<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> resolution of the General Meeting of April&nbsp;20, 2020, </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">33.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Delegation of powers to the Board of Directors to issue stock warrants (BSA), subscription and/or acquisition
of new and/or existing stock warrants (BSAANE) and/or subscription and/or acquisition of new and/or existing redeemable stock warrants (BSAAR) with cancellation of preferential subscription rights, reserved for a category of persons, suspension
during a public offering period, </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">34.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Delegation of powers to be granted to the Board of Directors to increase the share capital by means of the
issue of ordinary shares and/or securities giving access to capital, with <FONT STYLE="white-space:nowrap">pre-emptive</FONT> subscription rights waived in favor of members of a company savings plan pursuant to Articles <FONT
STYLE="white-space:nowrap">L.3332-18</FONT> et seq. of the French Labor Code, </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">35.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Authorization to be granted to the Board of Directors to allocate free existing and/or future shares to members
of staff and/or certain corporate officers of the Company or related companies or economic interest groups, with shareholders waiving their <FONT STYLE="white-space:nowrap">pre-emptive</FONT> rights, length of authorization, maximum amount, duration
of vesting periods specifically in respect of disability and, if applicable, holding periods, </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">36.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Authorization to be granted to the Board of Directors to grant share subscription and/or purchase options
(stock options) to members of staff and/or certain corporate officers of the company or related companies or economic interest groups, with shareholders waiving their <FONT STYLE="white-space:nowrap">pre-emptive</FONT> rights, length of
authorization, maximum amount, strike price, maximum term of the option. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">37.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Amendment of Article 13 of the <FONT STYLE="white-space:nowrap">by-laws</FONT> in order to set the age limit
for the Chairman of the Board of Directors at 75 years of age, and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">38.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Powers to complete formalities. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>What if another matter is properly brought before the meeting? </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At this time, the board of directors is unaware of any matters to be presented at the Annual General Meeting, other than as set forth above and
the possible additional shareholder resolutions that may properly be submitted before the Annual General Meeting in accordance with applicable French law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Holders of Ordinary Shares</I>: To address the possibility of another matter being presented at the Annual General Meeting, holders of
Ordinary Shares may use their proxy card to (i)&nbsp;abstain from voting on such matters, (ii)&nbsp;vote &#147;AGAINST&#148; on such matters, or (iii)&nbsp;grant a proxy to the chairman of the Annual General Meeting to vote on any new matters that
are proposed during the meeting, or (iv)&nbsp;grant a voting proxy to another shareholder, your spouse, or your partner with whom you have entered into a civil union. If no instructions are given with respect to matters about which we are currently
unaware, your Ordinary Shares will not be voted on such matters. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If a holder of Ordinary Shares chooses to grant a proxy to the chairman
of the Annual General Meeting, with respect to either all matters or only any additional matters not disclosed in this proxy statement, the chairman of the Annual General Meeting shall issue a vote in favor of adopting such undisclosed resolutions
submitted or approved by the board of directors and a vote against adopting any other such undisclosed resolutions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Holders of
ADSs</I>: Ordinary Shares underlying ADSs will not be voted on any matter not disclosed in the proxy statement. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Why is the Company soliciting my
proxy? </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our board of directors is soliciting your proxy to vote at the 2021 annual meeting of shareholders to be held at the
Company&#146;s headquarters located at <FONT STYLE="white-space:nowrap">177-181</FONT> Avenue Pierre Brossolette &#150; 92120 Montrouge, France, on Wednesday, May&nbsp;19, 2021, at 2:00 p.m. Paris time in closed session without the physical presence
of the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
shareholders and any adjournments or postponements of the meeting, which we refer to as the annual meeting. This proxy statement, along with the accompanying Notice of Annual Meeting of
Shareholders, summarizes the purposes of the meeting and the information you need to know to vote at the annual meeting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have sent you
this proxy statement, the Notice of Annual Meeting of Shareholders, the proxy card and a copy of our Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended December&nbsp;31, 2020 because you owned our ordinary
shares or ADSs on April&nbsp;21, 2021. We intend to commence distribution of the proxy materials to shareholders on or about May 3, 2021, in accordance with French law and requirements. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Who may vote? </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Ordinary
shareholders of record and bearer shareholders </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In accordance with article R. <FONT STYLE="white-space:nowrap">225-85</FONT> of the
French Commercial Code, only those holders of ordinary shares who can prove their status by having their shares registered in their name, or in the name of an intermediary duly registered on their behalf, on the second business day prior to the
meeting, i.e. Monday, May&nbsp;17, 2021 at midnight Paris time (the &#147;Ordinary Share Record Date&#148;), either in the registered share accounts or in the bearer share accounts held by their authorized intermediary, will be eligible to vote.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For registered shareholders, this registration in the registered share accounts on the Ordinary Share Record Date is sufficient to enable
them to vote their Shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For bearer shareholders, it is the authorized intermediaries who maintain the bearer share accounts who
directly prove their clients&#146; status as shareholders to Soci&eacute;t&eacute; G&eacute;n&eacute;rale Securities Services (the centralizing institution for the meeting mandated by DBV Technologies) by producing a certificate of participation
which they attach to the single postal voting or proxy form drawn up in the name of the shareholder or on behalf of the shareholder represented by the registered intermediary. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Holders of American Depositary Shares </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If you are a registered holder of ADSs on the books of Citibank, N.A. on April&nbsp;21, 2021 (the &#147;ADS Record Date&#148;), then at or
prior to 10:00 a.m. Eastern Time on May&nbsp;12, 2021, you may provide instructions to the Depositary as to how to vote the Ordinary Shares underlying your ADSs on the issues set forth in this proxy statement. The Depositary will mail you a voting
instruction card if you hold ADSs in your own name on the Depositary&#146;s share register (&#147;Registered Holders&#148;). If, however, on the ADS Record Date you held your ADSs through a bank, broker, custodian or other nominee/agent
(&#147;Beneficial Holders&#148;), it is anticipated that such bank, broker, custodian or nominee/agent will forward voting instruction forms to you. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Registered holders</I>. Registered holders of ADSs must complete, sign and return a Voting Instruction Form to
be actually received by the Depositary on or prior to 10:00 a.m. Eastern Time on May&nbsp;12, 2021. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Street Name holders</I>. If our ADSs are held on your behalf in a stock brokerage account or by a bank or
other nominee, you are considered the beneficial owner of those ADSs held in &#147;street name,&#148; and this proxy statement was forwarded to you by your broker or nominee. A holder of ADSs held through a broker, bank or other nominee (a
&#147;beneficial holder of ADSs&#148;) should follow the instructions that its broker, bank or other nominee provides to vote the Ordinary Shares underlying its ADSs. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>How many votes do I have? </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each share of
our<B> </B>ordinary shares that you own entitles you to one vote. Each American Depositary Share represents <FONT STYLE="white-space:nowrap">one-half</FONT> of one ordinary share. Voting instructions with respect to ADSs may be given only in respect
of a number of ADSs representing an integral number of ordinary shares. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>How will my Ordinary Shares be voted if I do not vote? </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If you hold Ordinary Shares and do not&nbsp;(i) grant your voting proxy directly to the chairman of the Annual General Meeting, (ii)&nbsp;grant
your voting proxy to another shareholder, your spouse, or your partner with whom you have entered into a civil union, (iii)&nbsp;vote by submitting your proxy card by mail or (iv)&nbsp;vote electronically via Votaccess, your Ordinary Shares will not
be counted as votes cast and will have no effect on the outcome of the vote with respect to any matter. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If you hold Ordinary Shares and
grant your voting proxy directly to the chairman of the Annual General Meeting without specifying how you wish to vote with respect to a particular matter, your Ordinary Shares will be voted in accordance with the board of directors&#146;
recommendations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If you own Ordinary Shares in &#147;street name&#148; through a broker, bank or other nominee and you do not direct your
broker how to vote your shares on the proposals, your shares will not be voted on any proposal on which the broker does not have discretionary authority to vote. This is referred to as a broker <FONT STYLE="white-space:nowrap">non-vote.</FONT> We
believe that all of our proposals are <FONT STYLE="white-space:nowrap">non-routine</FONT> matters and your broker cannot vote your shares for which you have not provided voting instructions. Broker <FONT STYLE="white-space:nowrap">non-votes</FONT>
on a particular proposal will not be counted as votes cast and will have no effect on the outcome of the vote with respect to such matter. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>How will
the Ordinary Shares underlying my ADSs be voted if I do not provide voting instructions to the Depositary or my broker, bank or other nominee? </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">With respect to Ordinary Shares represented by ADSs for which no timely voting instructions are received by the Depositary from a holder of
ADSs, the Depositary shall not vote such Ordinary Shares. The Depositary will not itself exercise any voting discretion in respect of any Ordinary Shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If you own ADSs in &#147;street name&#148; through a broker, bank or other nominee and you do not direct your broker how to instruct the
Depositary how to vote the Ordinary Shares represented by your ADSs on the proposals, your shares will not be voted on any proposal on which the broker does not have discretionary authority to provide voting instructions to the Depositary. This is
referred to as a broker <FONT STYLE="white-space:nowrap">non-vote.</FONT> We believe that all of our proposals are <FONT STYLE="white-space:nowrap">non-routine</FONT> matters and your broker cannot provide voting instructions to the Depositary with
respect to how to vote the Ordinary Shares represented by your ADSs for which you have not provided voting instructions. Broker <FONT STYLE="white-space:nowrap">non-votes</FONT> on a particular proposal will not be counted as votes cast and will
have no effect on the outcome of the vote with respect to such matter. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>How will my Ordinary Shares be voted if I grant my proxy to the chairman of the
Annual General Meeting? </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If you are a holder of Ordinary Shares and you grant your proxy to the chairman of the Annual General Meeting,
the chairman of the Annual General Meeting will vote your Ordinary Shares in accordance with the board of directors&#146; recommendations. As a result, your Ordinary Shares would be voted &#147;FOR&#148; the nominees of the board of directors in
Proposal Nos.&nbsp;6 to 10 and &#147;FOR&#148; each of Proposal Nos.&nbsp;1 to 5, 11 to 15, and 18 to 38 and &#147;AGAINST&#148; each of Proposal Nos. 16 and 17. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>How many votes are needed for approval of each proposed resolution? </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Proposal Nos.</I><I></I><I>&nbsp;1 to 22:</I>&nbsp;The affirmative vote of a majority of the total number of
votes cast is required for the election of each director nominee in Proposal Nos.&nbsp;6 to 10 and for the approval of each matter described in Proposal Nos.&nbsp;1 to 5 and 11 to 23. Under French law, this means that the votes cast &#147;FOR&#148;
a nominee must exceed the aggregate of the votes cast &#147;AGAINST&#148; that nominee, and the votes cast &#147;FOR&#148; a resolution must exceed the aggregate of the votes cast &#147;AGAINST&#148; that resolution. </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Proposal Nos.</I><I></I><I>&nbsp;23 to 38:</I>&nbsp;For approval of Proposal Nos.&nbsp;23 through 38, the
affirmative vote of <FONT STYLE="white-space:nowrap">two-thirds</FONT> of the total number of votes cast is required. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>What is an &#147;abstention&#148; and how would it affect the vote? </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">With respect to Ordinary Shares, an &#147;abstention&#148; occurs when a shareholder votes by mail with instructions to abstain from voting
regarding a particular matter or without making a selection with respect to a particular matter. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">With respect to ADSs, an abstention
occurs when a holder of ADSs sends proxy instructions to the Depositary to abstain from voting regarding a particular matter or without making a selection with respect to a particular matter. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Abstentions by holders of Ordinary Shares or by holders of ADSs will not be counted toward a quorum and will not be counted as votes cast and
will have no effect on the outcome of the vote on matters on which a holder has abstained. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Who will count the votes at the Annual General Meeting?
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Representatives of Soci&eacute;t&eacute; G&eacute;n&eacute;rale Securities Services will tabulate the votes and act as inspectors of
election. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>What Constitutes a Quorum for the Annual Meeting? </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Consistent with French law, our <FONT STYLE="white-space:nowrap">by-laws</FONT> provide that a quorum requires the presence of shareholders
having at least (1) 20% of the shares entitled to vote in the case of an ordinary shareholders&#146; general meeting or at an extraordinary shareholders&#146; general meeting where shareholders are voting on a capital increase by capitalization of
reserves, profits or share premium, or (2) 25% of the shares entitled to vote in the case of any other extraordinary shareholders&#146; general meeting. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>How can I vote my ordinary shares? </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Due to the <FONT
STYLE="white-space:nowrap">COVID-19</FONT> pandemic, the Annual General Meeting will be held in closed session without the physical presence of shareholders and other persons entitled to attend, in accordance with Article 4 of Order <FONT
STYLE="white-space:nowrap">No.&nbsp;2020-321</FONT> of 25&nbsp;March 2020 adapting the rules for meetings and deliberations of meetings and governing bodies of legal persons and entities without legal personality under private law due to the <FONT
STYLE="white-space:nowrap">COVID-19</FONT> pandemic, as amended and extended, among others, by Order No.&nbsp;2020-1497 of 2&nbsp;December 2020 extending and amending Order <FONT STYLE="white-space:nowrap">No.&nbsp;2020-321</FONT> of 25&nbsp;March
2020 and by Decree no. <FONT STYLE="white-space:nowrap">2021-255</FONT> of 9&nbsp;March 2021 extending the period of application of Order <FONT STYLE="white-space:nowrap">No.&nbsp;2020-321</FONT> of 25&nbsp;March 2020, Decree no. <FONT
STYLE="white-space:nowrap">2020-418</FONT> of 10&nbsp;April 2020 and Decree no. <FONT STYLE="white-space:nowrap">2020-629</FONT> of 25&nbsp;May 2020, Therefore, we urge you to vote by proxy as you may not attend the meeting in person. All shares
represented by valid proxies that we receive through this solicitation, and that are not revoked, will be voted in accordance with your instructions on the proxy card or as instructed via the Internet or telephone. You may specify whether your
shares should be voted for, against or abstain with respect to each proposal. If you properly submit a proxy without giving specific voting instructions, your shares will be voted in accordance with our board of directors&#146; recommendations as
noted below. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In order to facilitate their participation in the Annual General Meeting, the Company offers its holders of ordinary shares
the possibility of voting via Votaccess. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Votaccess website will be open from Monday, May&nbsp;3, 2021 at 9:00 a.m. Paris time to
Tuesday, May&nbsp;18, 2021 at 3:00 p.m. Paris time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In order to avoid any possible bottleneck on the Votaccess platform, shareholders are
strongly recommended not to wait until the end of the opening period of Votaccess to enter their instructions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Only holders of bearer
shares whose account-holding institution has subscribed to the Votaccess system and offers them this service for this general meeting will be able to access it. The securities account holder of the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
bearer shareholder, who does not subscribe to Votaccess or who makes access to the site subject to conditions of use, will indicate to the shareholder how to proceed. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Shareholders wishing to participate in the Annual General Meeting may choose one of the following options: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">give proxy to the chairman of the general meeting grant your voting proxy to another shareholder, your spouse, or
your partner with whom you have entered into a civil union; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">vote by mail or via Votaccess; </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Shareholders who have chosen to vote by mail or to give aproxy to the Chairman or to grant a voting proxy to another shareholder, your spouse,
or your partner with whom you have entered into a civil union, using the single form may: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">If you are a registered shareholder: by mail, return the single form for voting by mail or by proxy that will be
sent to you with the notice of meeting using the enclosed T envelope no later than Saturday, May&nbsp;15, 2021, 11:59 p.m., Paris Time; or by Internet, log on to www.sharinbox.societegenerale.com no later than 3:00 p.m., Paris Time, Tuesday,
May&nbsp;18, 2021; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">in the case of bearer shareholders: by post, request this form from the financial intermediary with which their
shares are registered, as of the date of the meeting, which request must be received at least six days prior to the date of the meeting, at the following address Soci&eacute;t&eacute; G&eacute;n&eacute;rale, Service des Assembl&eacute;es (CS
30812&#151;44308 Nantes Cedex 3) no later than Saturday, May&nbsp;15, 2021, 11:59 p.m., Paris Time; or via Internet, log on to the portal of its securities account holder to access the Votaccess site in accordance with the terms and conditions set
out below, no later than 3:00 p.m., Paris Time, Tuesday, May&nbsp;18, 2021, Paris time. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Postal votes cast by paper
means will only be taken into account if the duly completed and signed forms (and accompanied by the certificate of participation for bearer shares) reach the aforementioned Meetings Department of Soci&eacute;t&eacute; G&eacute;n&eacute;rale at
least three days before the date of the general meeting, i.e. no later than Saturday, May&nbsp;15, 2021, 11:59 p.m. Paris time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In
addition, if you give a proxy vote to another shareholder, to your spouse or to your partner with whom you have entered into a civil union, the voting proxy needs to address its voting instructions to Soci&eacute;t&eacute; G&eacute;n&eacute;rale for
the exercise of its mandates in the form of a scanned copy of the single form, by <FONT STYLE="white-space:nowrap">e-mail</FONT> to the following address: assemblees.generales@sgss.socgen.com. The form must bear the surname, first name and address
of the person being named as proxy, the words &#147;In the capacity of proxy&#148;, and must be dated and signed. The direction of the vote must be indicated in the &#147;I vote by mail&#148; box of the form. The proxy must attach a copy of his or
her identity card and, if applicable, a power of attorney from the legal entity he/she represents. To be taken into account, the electronic message must be received by Soci&eacute;t&eacute; G&eacute;n&eacute;rale no later than the fourth day prior
to the date of the meeting, which is Saturday, May 15, 2021. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In accordance with the provisions of Article R. <FONT
STYLE="white-space:nowrap">225-79</FONT> of the French Commercial Code, notification of the appointment and revocation of a proxy to the Chairman may also be made in the following manner: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">by post, using the voting form sent either directly for registered shareholders, using the prepaid reply envelope
attached to the notice of meeting, or by the holder of the share account for bearer shareholders and received by the Soci&eacute;t&eacute; G&eacute;n&eacute;rale, Service des Assembl&eacute;es (CS 30812&nbsp;-&nbsp;44 308 Nantes&nbsp;Cedex 3) no
later than Saturday, May&nbsp;15, 2021, 11:59 p.m. Paris Time; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">by electronic means, by connecting, for registered shareholders to the www.sharinbox.societegenerale.com website,
for bearer shareholders to the portal of their securities account holder to access the Votaccess website, in accordance with the terms and conditions described below, no later than Tuesday, May&nbsp;18, 2021 at 3:00p.m., Paris time.
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As an exception to Section III of Article R. <FONT STYLE="white-space:nowrap">225-85</FONT>
of the French Commercial Code and in accordance Article 7 of Decree <FONT STYLE="white-space:nowrap">No.&nbsp;2020-418</FONT> of April&nbsp;10, 2020 adapting the rules of meeting and deliberation of the assemblies and governing bodies of legal
persons and entities without legal personality under private law due to the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic, a shareholder who has already voted by mail, or sent a proxy to the Chairman may choose another means of
participating in the meeting, provided that his/her/it instructions to this effect reaches the Company within the time required for the new mode of participation chosen. However, if a transfer of ownership occurs before the Ordinary Share Record
Date, the Company shall invalidate or modify, as the case may be, the vote cast by mail, the proxy or the certificate of participation, as the case may be. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To this end, the authorized intermediary holding the account shall notify the Company or its agent of the transfer of ownership and provide it
with the necessary information. No transfer of ownership made after Ordinary Share Record Date, regardless of the means used, shall be notified by the authorized intermediary holding the account or taken into consideration by the Company,
notwithstanding any agreement to the contrary. It should be noted that for any proxy given by a shareholder without indication of a proxy holder, the chairman of the Annual General Meeting shall cast a vote in favor of the adoption of draft
resolutions presented or approved by the Board of Directors, and a vote against the adoption of all other draft resolutions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Please also
note that shareholders who wish to ask questions may submit these in writing, accompanied by the shareholder&#146;s certificate of registration, to<I> <FONT STYLE="white-space:nowrap">investors@dbv-technologies.com</FONT></I>. Questions must be
received by Monday, May&nbsp;17, 2021 at 11:59 p.m., Paris time. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>How does the board of directors recommend that I vote on the proposals? </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our board of directors recommends that you vote FOR&#148; the nominees to the board of directors in Proposal Nos.&nbsp;6 to 10 and
&#147;FOR&#148; each of Proposal Nos.&nbsp;1 to 5, 11 to 15, and 18 to 38 and &#147;AGAINST&#148; each of Proposal Nos. 16 and 17. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>What if I receive
more than one proxy card? </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You may receive more than one proxy card if you hold shares in more than one account, which may be in
registered form or held in street name. Please vote in the manner described above under &#147;How Can I Vote my Ordinary Shares or ADSs?&#148; for each account to ensure that all of your shares are voted. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Is voting confidential? </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will keep all
the proxies, ballots and voting tabulations private. We only let our Inspector of Election <I></I>examine these documents. Management will not know how you voted on a specific proposal unless it is necessary to meet legal requirements. We will,
however, forward to management any written comments you make on the proxy card or that you otherwise provide. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Where can I find the voting results of
the Annual General Meeting? </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The preliminary voting results will be announced at the annual meeting, and we will publish preliminary
results, or final results if available, in a Current Report on Form <FONT STYLE="white-space:nowrap">8-K</FONT> within four business days of the annual meeting. If final results are unavailable at the time we file the Form <FONT
STYLE="white-space:nowrap">8-K,</FONT> then we will file an amended Current Report on Form <FONT STYLE="white-space:nowrap">8-K</FONT> to disclose the final voting results within four business days after the final voting results are
known.<B>&nbsp;</B> </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>What Are the Costs of Soliciting These Proxies? </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will pay all of the costs of soliciting these proxies. Our directors and employees may solicit proxies in person or by telephone, fax or
email. We will pay these employees and directors no additional compensation for </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
these services. We will ask banks, brokers and other institutions, nominees and fiduciaries to forward these proxy materials to their principals and to obtain authority to execute proxies. We
will then reimburse them for their expenses. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Where is the Annual General Meeting? </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The annual meeting will be held at 2:00 p.m. Paris time on Wednesday, May&nbsp;19, 2021 at the Company&#146;s headquarters located at <FONT
STYLE="white-space:nowrap">177-181</FONT> Avenue Pierre Brossolette &#150; 92120 Montrouge, France. However, due to the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic the Annual General Meeting will be held in closed session without the
physical presence of shareholders and other persons entitled to attend, in accordance with Article 4 of Order <FONT STYLE="white-space:nowrap">No.&nbsp;2020-321</FONT> of 25&nbsp;March 2020 adapting the rules for meetings and deliberations of
meetings and governing bodies of legal persons and entities without legal personality under private law due to the <FONT STYLE="white-space:nowrap">Covid-19</FONT> pandemic, as amended and extended, among others, by Order No.&nbsp;2020-1497 of
2&nbsp;December 2020 extending and amending Order <FONT STYLE="white-space:nowrap">No.&nbsp;2020-321</FONT> of 25&nbsp;March 2020 and by Decree no. <FONT STYLE="white-space:nowrap">2021-255</FONT> of 9&nbsp;March 2021 extending the period of
application of Order <FONT STYLE="white-space:nowrap">No.&nbsp;2020-321</FONT> of 25&nbsp;March 2020, Decree no. <FONT STYLE="white-space:nowrap">2020-418</FONT> of 10&nbsp;April 2020 and Decree no. <FONT STYLE="white-space:nowrap">2020-629</FONT>
of 25&nbsp;May 2020. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On May&nbsp;19, 2021, starting at 2:00 p.m. Paris time, the Annual General Meeting will be webcast with live audio
on the Company&#146;s website <I><FONT STYLE="white-space:nowrap">http://www.dbv-technologies.com/fr/</FONT></I> in the Events and Presentations section, including the presentation of the results of the votes on the resolutions received by
Soci&eacute;t&eacute; G&eacute;n&eacute;rale Securities Services. Shareholders will also be able to access the recorded webcast of the Annual General Meeting on the Company&#146;s website for two years. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>I share an address with another holder of ADSs, and we received only one paper copy of the proxy materials. How may I obtain an additional copy of the
proxy materials? </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SEC rules concerning the delivery of annual disclosure documents allow us or your broker to send a single set of our
proxy materials to any household at which two or more of our ADS holders of record reside, if we or your broker believe that the ADS holders of record are members of the same family. This practice, referred to as &#147;householding,&#148; benefits
both you and us. It reduces the volume of duplicate information received at your household and helps to reduce our expenses. The rule applies to our annual reports, proxy statements and information statements. Once you receive notice from your
broker or from us that communications to your address will be &#147;householded,&#148; the practice will continue until you are otherwise notified or until you revoke your consent to the practice. ADS holders who participate in householding will
continue to have access to and utilize separate proxy voting instructions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If a broker or other nominee holds your ADSs and (1)&nbsp;your
household received a single set of proxy materials this year, but you would prefer to receive your own copy or you do not wish to participate in householding and would like to receive your own set of our proxy materials in future years or
(2)&nbsp;you share an address with another ADS holder and together both of you would like to receive only a single set of proxy materials, please contact the broker or other nominee directly and inform them of your request. Be sure to include your
name, the name of your brokerage firm and your account number. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Can I receive Company shareholder communications by electronic delivery? </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Most shareholders can elect to view or receive copies of future proxy materials over the Internet instead of receiving paper copies in the
mail. You can choose this option and save us the cost of producing and mailing these documents by following the instructions provided on your proxy card or by following the instructions provided when you vote over the Internet. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Where can I find documents referenced in this proxy statement? </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">An English translation of the full text of the resolutions to be submitted to shareholders at the Annual General Meeting is included in
Annex&nbsp;A of this proxy statement and this proxy statement will be accompanied </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
by the Company&#146;s Annual Report on <FONT STYLE="white-space:nowrap">Form&nbsp;10-K,</FONT> which includes the consolidated financial statements of the Company for the fiscal year ended
December&nbsp;31, 2020 presented in accordance with generally accepted accounting principles in the United States. The Company&#146;s Annual Report on <FONT STYLE="white-space:nowrap">Form&nbsp;10-K</FONT> was filed with the SEC on March&nbsp;17,
2021 and is available on our website at<I><FONT STYLE="white-space:nowrap">&nbsp;https://www.dbv-technologies.com</FONT></I>. In addition, once available, the following documents will be posted on our website
at<I><FONT STYLE="white-space:nowrap">&nbsp;https://www.dbv-technologies</FONT></I>: (i)&nbsp;an English translation of the statutory financial statements of the Company for the fiscal year ended December&nbsp;31, 2020 prepared in accordance with
generally accepted accounting principles as applied to companies in France; (ii)&nbsp;an English translation of the consolidated financial statements of the Company for the fiscal year ended December&nbsp;31, 2020 prepared in accordance with
International Financial Reporting Standards as adopted by the European Union; (iii)&nbsp;an English translation of the report of the board of directors and the management report; and (iv)&nbsp;an English translation of the report of the statutory
auditors concerning the statutory and consolidated financial statements of the Company for the fiscal year ended December&nbsp;31, 2020, as well as an English translation of the special report of the statutory auditors concerning the regulated
agreements and acknowledgement of the absence of new related party transactions being presented to shareholders for approval in Proposal No.&nbsp;5. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You may obtain additional information, which we make available in accordance with French law, by contacting the Company at DBV
Technologies&nbsp;S.A., <FONT STYLE="white-space:nowrap">177-181</FONT> avenue Pierre Brossolette, 92120 Montrouge, France, or by emailing <I><FONT STYLE="white-space:nowrap">investors@dbv-technologies.com</FONT></I>. Such additional information
includes, but is not limited to, the statutory auditors&#146; reports referenced in the resolutions described below. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>What is the deadline to propose
actions for consideration at next year&#146;s Annual General Meeting of shareholders or to nominate individuals to serve as directors? </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Shareholder
Proposals </I></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any holder of ADSs and/or Ordinary Shares desiring to present a resolution for inclusion in the Company&#146;s proxy
statement for the 2022 Annual General Meeting of shareholders must deliver such resolution to the board of directors at the address below no later than December&nbsp;29, 2021. Only those resolutions that comply with the requirements of <FONT
STYLE="white-space:nowrap">Rule&nbsp;14a-8</FONT> under the Securities Exchange Act of 1934, as amended (the &#147;Exchange Act&#148;), will be included in the Company&#146;s proxy statement for the 2022 Annual General Meeting of shareholders. </P>
 <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, under French law, holders of Ordinary Shares are permitted to submit a resolution for consideration so long as such matter
is received by the Company no later than 25&nbsp;days prior to the date of the meeting. Holders of Ordinary Shares wishing to present resolutions at the 2022 Annual General Meeting of shareholders made outside of
<FONT STYLE="white-space:nowrap">Rule&nbsp;14a-8</FONT> under the Exchange Act must comply with the procedures specified under French law. A shareholder who meets the requirements set forth in Articles&nbsp;L.
<FONT STYLE="white-space:nowrap">225-105</FONT> and R. <FONT STYLE="white-space:nowrap">225-71</FONT> of the French Commercial Code may submit a resolution by sending such resolution to the address below by registered letter with acknowledgment of
receipt or via <FONT STYLE="white-space:nowrap">e-mail.</FONT> The resolution must include the text of the proposed resolution, a brief explanation of the reason for such resolution and an affidavit to evidence the shareholder&#146;s holdings. Any
holder of Ordinary Shares who meets the requirements set forth in Articles&nbsp;L. <FONT STYLE="white-space:nowrap">225-105</FONT> and R. <FONT STYLE="white-space:nowrap">225-71</FONT> of the French Commercial Code also may submit a director
nomination to be considered by the nomination and corporate governance committee for nomination by following the same process outlined above and including the information regarding the director as set forth in Article&nbsp;R. <FONT
STYLE="white-space:nowrap">225-83</FONT> 5<SUP STYLE="font-size:85%; vertical-align:top">o</SUP>&nbsp;of the French Commercial Code in their submission. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All submissions to the Company should be made to: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">DBV Technologies&nbsp;S.A. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT
STYLE="white-space:nowrap">177-181</FONT> avenue Pierre Brossolette </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">92120 Montrouge, France </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Attention: Legal Department </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Email: <FONT STYLE="white-space:nowrap">investors@dbv-technologies.com</FONT> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Nomination of Director Candidates </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Shareholders may recommend director candidates for consideration by our nominating and corporate governance committee. For additional
information regarding our policy regarding shareholder recommendations for director candidates, see &#147;Board of Directors and Corporate Governance&#151;Shareholder Recommendations for Nominations to the Board of Directors.&#148; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc140648_2"></A>BOARD OF DIRECTORS AND CORPORATE GOVERNANCE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Board of Directors </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our business affairs
are managed under the direction of our board of directors, which is currently composed of nine members. Seven of our directors are independent within the meaning of the listing standards of the Nasdaq Stock Market. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth the names, ages as of April&nbsp;21, 2021, and certain other information for each of the nominees for director,
each of the provisionally appointed directors subject to shareholder ratification, and for each of the continuing members of our board of directors: </P>  <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="31%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD WIDTH="50%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Age</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Position</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Term&nbsp;Expires</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><I>Nominees for Director</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Adora Ndu</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="center">39</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Director Nominee</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">n/a</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Ravi Rao</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">53</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Director Nominee</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">n/a</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Viviane Monges (1)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">57</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Director</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Julie O&#146;Neill</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">55</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Director</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><I>Provisionally&nbsp;Appointed<BR>Directors Subject to Shareholder Ratification</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Timothy&nbsp;E.&nbsp;Morris&nbsp;(1)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">59</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Director</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">2022</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><I>Continuing Directors</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Daniel Tass&eacute;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">61</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Chief Executive Officer and Director</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">2023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Michel de Rosen (3)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">70</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><FONT STYLE="white-space:nowrap">Non-Executive</FONT> Chairman of the Board of Directors</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">2022</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Ma&iuml;lys&nbsp;Ferr&egrave;re&nbsp;(2)(3)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">58</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Director</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">2023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Michael J. Goller (2)(3)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">46</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Director</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">2023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Daniel Soland (1)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">62</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Director</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">2022</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><I>Director Whose Term Expires Immediately Following Annual General Meeting</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dr.&nbsp;Torbj&ouml;rn Bjerke (2)(3)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">58</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Director</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Member of our audit committee. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Member of our compensation committee. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Member of our nominating and corporate governance committee. </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Daniel Tass&eacute;</I></B>&nbsp;has served as Chief Executive Officer since November 2018 and as a member of our board of directors
since March 2019. From March 2016 to November 2018, Mr.&nbsp;Tass&eacute; served as the Chairman and Chief Executive Officer of Alcresta Therapeutics, Inc., a pediatric-focused rare disease biotechnology company. From January 2008 to April 2015,
Mr.&nbsp;Tass&eacute; served as the Chairman and Chief Executive Officer of Ikaria, Inc., which develops drugs and devices for critically ill patients. In April 2015, Ikaria was acquired by Mallinckrodt Pharmaceuticals. Mr.&nbsp;Tass&eacute; holds a
B.Sc. in Biochemistry from Universit&eacute; de Montr&eacute;al. The board of directors believes that Mr.&nbsp;Tass&eacute;&#146;s leadership and extensive experience in the pharmaceutical industry will allow him to drive us to the success of our
objectives. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Michel de Rosen </I></B>has served as a member of our board of directors since May 2018 and as <FONT
STYLE="white-space:nowrap">Non-Executive</FONT> Chairman of our board of directors since March 2019. Mr.&nbsp;de Rosen also serves on the board of directors of Faurecia and Pharnext. Mr.&nbsp;de Rosen served as Chairman and Chief Executive Officer
of Eutelsat from 2009 until his retirement in November 2017, Chairman and Chief Executive Officer of ViroPharma from 2000 to 2008, and Chairman and Chief Executive Officer of Rhone-Poulenc Sant&eacute; from 1993 to 1999. He has also held numerous
positions at the French Ministries of Finance, Defense, Industry and Telecommunication. Mr.&nbsp;de Rosen holds an M.B.A. from HEC and an M.B.A. from Ecole Nationale d&#146;Administration. The board of directors
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
believes that Mr.&nbsp;de Rosen&#146;s extensive business experience in the biopharmaceutical industry and over 15 years&#146; experience in the United States will be instrumental to the success
of our objectives. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Dr.</I></B><B><I></I></B><B><I>&nbsp;Torbj&ouml;rn Bjerke </I></B>has served as a member of our board of
directors since 2006. Dr.&nbsp;Bjerke has served as the portfolio manager of Arctic Aurora LifeScience since January 2016 and as a director of TXP Pharma GmbH since 2014 and SynAct Pharma since April 2016. He previously served as the Chief Executive
Officer of Karolinska Development AB from 2011 to 2014. Prior to then, Dr.&nbsp;Bjerke was the President and Chief Executive Officer of Orexo AB, a position he held from 2007 until January 2011, President and Chief Executive Officer of Biolipox AB
and Director of Pharmacology at AstraZeneca. Dr.&nbsp;Bjerke holds a Ph.D. in Medicine from Aarhus Universitet. The board of directors believes that Dr.&nbsp;Bjerke&#146;s experience in the pharmaceutical industry, particularly his extensive
experience in allergy treatment field, and his years of business and leadership experience allow him to make valuable contributions to the board of directors. Dr.&nbsp;Bjerke&#146;s term as a director will terminate immediately following the Annual
Meeting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Ma&iuml;lys Ferr&egrave;re</I></B><B><I></I></B>&nbsp;has served as a member of our board of directors since June 2016 and
previously served as a <FONT STYLE="white-space:nowrap">non-voting</FONT> observer of our board of directors since our initial public offering on Euronext Paris in March 2012. Ms.&nbsp;Ferr&egrave;re has served as a Director, Head of the Large
Venture Investment Activity at Bpifrance, France&#146;s public investment bank, since October 2013 and is affiliated with one of our significant shareholders. She graduated from Institut d&#146;Etudes Politiques Paris, and began her career with the
General Inspectorate of Soci&eacute;t&eacute; G&eacute;n&eacute;rale before working for multiple French banks in the equity capital markets origination department. The board of directors believes that Ms.&nbsp;Ferr&egrave;re&#146;s experience in the
banking industry and her knowledge of capital markets allow her to make valuable contributions to the board of directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Michael
J. Goller </I></B>has served as a member of our board of directors since October 2015. Mr.&nbsp;Goller serves as a Partner of Baker Brothers Investments, a fund management company focused on long-term investments in life-sciences companies. Prior to
joining Baker Brothers in 2005, Mr.&nbsp;Goller was an associate of JPMorgan Partners, LLC where he focused on venture investments in the life sciences sector from 1999 to 2003. Mr.&nbsp;Goller began his career as an investment banker with Merrill
Lynch and Co. from 1997 to 1999. Mr.&nbsp;Goller holds a B.S. in Molecular and Cell Biology from The Pennsylvania State University, and a Masters in both Biotechnology and Business Administration from the University of Pennsylvania. The board of
directors believes that Mr.&nbsp;Goller&#146;s experience in the life sciences industry and his knowledge of corporate development matters allow him to make valuable contributions to the board of directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Viviane Monges</I></B><B><I></I></B>&nbsp;has served as a member of our board of directors since May 2019. Ms.&nbsp;Monges also serves
on the board of directors of Novo Holdings, Chimique Belge (UCB), Idorsia Pharmaceuticals and Voluntis. Ms.&nbsp;Monges has served as a strategic advisor to NeoMedLight since January 2014. Ms.&nbsp;Monges served as Vice President of
Finance&nbsp;&amp; Control &#150; Nestl&eacute; Business Excellence at Nestl&eacute; S.A. from February 2015 to May 2017, Group Chief Financial Officer at Nestl&eacute; Skin Health from October 2010 to February 2015 and Global Chief Financial
Officer &#150; OTC Division at Novartis from June 2008 to September 2010. Ms.&nbsp;Monges received an M.B.A. from ESCP Business School. The board of directors believes that Ms.&nbsp;Monges&#146; extensive business experience in the biopharmaceutical
industry allows her to make valuable contributions to the board of directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Timothy E. Morris</I></B><I> </I>has served as a
member of our board of directors since March 2021. Mr.&nbsp;Morris has served as the Chief Operating Officer and Chief Financial Officer of Humanigen, Inc. since August 2020. He previously served as the Chief Financial Officer of Iovance
Biotherapeutics, Inc. from August 2017 to June 2020 and as the Chief Financial Officer and Head of Business Development of AcelRx Pharmaceuticals, Inc. from March 2014 to June 2017. Mr.&nbsp;Morris previously served as a member of the board of
directors of Humanigen, Inc. from June 2016 to August 2020. Mr.&nbsp;Morris received his BS in Business with an emphasis in Accounting from California State University, Chico, and is a Certified Public Accountant (Inactive).&nbsp;The board of
directors believes that Mr.&nbsp;Morris&#146; extensive operational experience with public companies in the biopharmaceutical industry, particularly in the areas of finance and corporate development, allows him to make valuable contributions to the
board of directors. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Adora Ndu</I></B> is a nominee for our board of directors. Dr.&nbsp;Ndu has served as
the Group Vice President, Worldwide Research&nbsp;&amp; Development, Strategy, Scientific Collaborations and Policy at BioMarin Pharmaceutical, Inc. since January 2021. She previously served in positions of increasing responsibility at BioMarin, as
the Vice President, Regulatory Affairs, Policy, Research, Engagement&nbsp;&amp; International from August 2019 to January 2021, Executive Director from September 2017 to July 2019 and Senior Director from February 2017 to September 2019. Prior to
joining BioMarin, Dr.&nbsp;Ndu was an adjunct faculty member at the University of Maryland University College from 2016 to 2019 and served in various roles at the U.S. Food and Drug Administration from 2008 to 2016, most recently as a Division
Director in the Division of Medical Policy Development. Dr.&nbsp;Ndu received a Doctor of Pharmacy from Howard University and a Juris Doctor from the University of Maryland Francis King Carey School of Law. The board of directors believes that
Dr.&nbsp;Ndu&#146;s extensive experience in the biopharmaceutical industry will allow her to make valuable contributions to the board of directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Julie O&#146;Neill</I></B> has served as a member of our board of directors since June 2017. From January 2015 to September 2018,
Ms.&nbsp;O&#146;Neill was served as the Executive Vice President, Global Operations for Alexion Pharmaceuticals Inc. From 2014 to 2015, Ms.&nbsp;O&#146;Neill was Senior Vice President of Global Manufacturing Operations and General Manager of Alexion
Pharma International Trading. Prior to joining Alexion, Ms.&nbsp;O&#146;Neill served in various leadership positions at Gilead Sciences from 1997 to 2014 including Vice President of Operations and General Manager of Ireland from 2011 to 2014. Prior
to Gilead Sciences, Ms.&nbsp;O&#146;Neill held leadership positions at Burnil Pharmacies and Helsinn Birex Pharmaceuticals. She is the Chairperson for the National Standards Authority of Ireland and is a member of the Boards of the National
Institute for Bioprocessing Research&nbsp;&amp; Training and the American Chamber of Commerce, Ireland. From January 2019 to October 2019, Ms.&nbsp;O&#146;Neill was engaged by us to serve as a consultant to support CMC activities, including our BLA
resubmission for ViaskinTM Peanut. Ms.&nbsp;O&#146;Neill received a Bachelor of Science in Pharmacy from University of Dublin, Trinity College and a Masters of Business Administration from University College Dublin (Smurfit School of Business). The
board of directors believes that Ms.&nbsp;O&#146;Neill&#146;s experience in the life sciences industry and her knowledge of corporate development matters allow her to make valuable contributions to the board of directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Ravi Rao </I></B>is a nominee for our board of directors. He has served as the Chief Medical Officer of Swedish Orphan Biovitrum, a
global biopharmaceutical specialty company, since August 2020. From October 2019 to August 2020, Dr.&nbsp;Rao served as Chief Medical Officer of Aeglea Biotherapeutics, a clincal-stage company developing enzyme therapies for rare metabolic disease.
Prior to that, from 2012 to October 2019, Dr.&nbsp;Rao was a Vice President at GlaxoSmithKline plc, a British multinational pharmaceutical company. Dr.&nbsp;Rao received a Bachelor of Arts with Honors from the University of Cambridge, Gonville and
Caius College; an MB.BChir from the University of Cambridge; a MRCP from the Royal College of Physicians, London; a CCST in Rheumatology from the General Medical Council; and a Ph.D. from Imperial College London. The board of directors believes that
Dr.&nbsp;Rao&#146;s experience in clinical development and medical affairs will allow him to make valuable contributions to the board of directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Daniel Soland</I></B> has served as a member of our board of directors since March 2015. Mr.&nbsp;Soland most recently served as Senior
Vice President and Chief Operating Officer of Viropharma from March 2008 to December 2014, and currently serves on the board of directors of Acadia Pharmaceuticals Inc. and Kalvista Pharmaceuticals, Inc. In addition to his role at Viropharma, where
he helped build the organizational and commercial infrastructure that resulted in an <FONT STYLE="white-space:nowrap">11-fold</FONT> increase in Viropharma&#146;s share price during his tenure, Mr.&nbsp;Soland previously served as President of
Chiron Vaccines, and helped engineer a turnaround that contributed to Chiron&#146;s acquisition by Novartis. Prior to then, he served as President and Chief Executive Officer of Epigenesis Pharmaceuticals. At GlaxoSmithKline Biologicals,
Mr.&nbsp;Soland served as Vice President and Director, Worldwide Marketing Operations. Earlier in his career, Mr.&nbsp;Soland held positions of increasing responsibility in sales and product management at Pasteur-Merieux&#146;s Connaught
Laboratories. He holds a B.S. in Pharmacy from the University of Iowa. The board of directors believes that Mr.&nbsp;Soland&#146;s extensive executive and management </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
experience in the pharmaceutical industry worldwide, notably at various senior commercial operations positions, allow him to make valuable contributions to the board of directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">There are no family relationships between or among any of our continuing directors, provisionally appointed directors or director nominees.
The principal occupation and employment during the past five years of each of our directors and nominee was carried on, in each case except as specifically identified above, with a corporation or organization that is not a parent, subsidiary or
other affiliate of us. There is no arrangement or understanding between any of our directors or nominee and any other person or persons pursuant to which he or she is to be selected as a director or nominee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">There are no legal proceedings to which any of our directors is a party adverse to us or any of our subsidiaries or in which any such person
has a material interest adverse to us or any of our subsidiaries. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Director Compensation </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On December&nbsp;9, 2016, upon recommendation of our compensation committee, our board of directors approved an amendment to our <FONT
STYLE="white-space:nowrap">non-executive</FONT> director compensation policy to set attendance fees for our <FONT STYLE="white-space:nowrap">non-employee</FONT> directors at a fixed annual retainer of &#128;70,000 per year, regardless of whether or
not the director is independent. Under the policy, the chairman of the audit committee will be entitled to an additional retainer of &#128;20,000 per year, the chairman of the compensation committee will be entitled to an additional retainer of
&#128;10,000 per year, and the other members of our audit committee and compensation committee, regardless of whether or not the director is independent, will each be entitled to an additional retainer of &#128;5,000 per year. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On June&nbsp;15, 2017, our shareholders at our ordinary shareholders&#146; general meeting set the total annual attendance fees to be
distributed among <FONT STYLE="white-space:nowrap">non-employee</FONT> directors at &#128;600,000, which is then distributed according to the amended <FONT STYLE="white-space:nowrap">non-executive</FONT> director compensation policy. Shareholder
authorization for total attendance fees is automatically renewed each year, unless otherwise decided by our shareholders at an ordinary shareholders&#146; general meeting. See Proposal 11. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth information regarding the compensation earned by our <FONT
STYLE="white-space:nowrap">non-employee</FONT> directors for 2020. These amounts were earned in Euro per the above policy and paid in Euro. The amounts below were converted using an exchange rate of &#128;1.00=$1.1422 for Mr.&nbsp;Michel de Rosen
and &#128;1.00=$1.2143 for all other <FONT STYLE="white-space:nowrap">non-employee</FONT> directors, which represent respectively the average exchange rate for the year ended December&nbsp;31, 2020 and the exchange rates on the date of payment.
Mr.&nbsp;Tass&eacute;, our Chief Executive Officer, and Ms.&nbsp;Ferr&eacute;re are each directors but do not receive any additional compensation for their services as a director. Ms.&nbsp;Giraut resigned from our board of directors effective
March&nbsp;22, 2021, and Dr.&nbsp;Bjerke&#146;s service as a director will terminate immediately following the Annual General Meeting. </P>  <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="72%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Fees<BR>earned<BR>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total ($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Michel de Rosen</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">177,040</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">177,040</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Torbj&ouml;rn Bjerke</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">103,215</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">103,215</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Michael Goller</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">103,215</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">103,215</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Ma&iuml;lys Ferr&eacute;re&nbsp;(2)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Claire Giraut&nbsp;(1)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">109,287</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">109,287</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Viviane Monges</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 91,072</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 91,072</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Julie O&#146;Neill</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 85,001</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 85,001</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Daniel Soland</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 97,144</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 97,144</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Ms.&nbsp;Giraut served as a director and a member of our Audit Committee until her resignation in March 2021.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Ms. Ma&iuml;lys Ferr&eacute;re accepted no remuneration as a
<FONT STYLE="white-space:nowrap">non-executive</FONT> director as representative of BPI France. </P></TD></TR></TABLE>  <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table sets forth
information regarding the aggregate number of <FONT STYLE="white-space:nowrap">non-employee</FONT> warrant awards held by our <FONT STYLE="white-space:nowrap">non-employee</FONT> directors as of December&nbsp;31, 2020. None of our <FONT
STYLE="white-space:nowrap">non-employee</FONT> directors were granted warrants during the financial year ended December&nbsp;31, 2020. None of our <FONT STYLE="white-space:nowrap">non-employee</FONT> directors held stock awards or options as of
December&nbsp;31, 2020. </P>  <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="79%"></TD>

<TD VALIGN="bottom" WIDTH="12%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B><FONT STYLE="white-space:nowrap">Non-employee</FONT><BR>warrants<BR>awards (#)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Michel de Rosen</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Torbj&ouml;rn Bjerke</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Michael Goller</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">21,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Ma&iuml;lys Ferr&eacute;re</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Claire Giraut</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">17,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Viviane Monges</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Julie O&#146;Neill</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Daniel Soland</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">31,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Corporate Governance </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Board Independence </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As required under the Nasdaq listing standards, a majority of the members of a listed company&#146;s Board must qualify as
&#147;independent,&#148; as affirmatively determined by the Board. The Board consults with our counsel to ensure that the Board&#146;s determinations are consistent with relevant securities and other laws and regulations regarding the definition of
&#147;independent,&#148; including those set forth in pertinent listing standards of Nasdaq, as in effect from time to time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Consistent
with these considerations, after review of all relevant identified transactions or relationships between each director, or any of his or her family members, and us, our senior management and our independent auditors, the Board has affirmatively
determined all of our directors, other than Mr.&nbsp;Tass&eacute; and Ms.&nbsp;O&#146;Neill, are </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
independent directors within the meaning of the applicable Nasdaq listing standards. In accordance with the Nasdaq Listing Rules, a director shall be considered independent if she/he does not
have any relationship which, in the opinion of the board, would interfere with the exercise of independent judgment in carrying out the responsibilities of a director. In addition, in accordance with Nasdaq Listing Rules, to be considered
independent, a director shall not be subject to any of the mandatory bars to independence set forth in Rule 5605(a) of the Nasdaq Listing Rules. However, pursuant to French law requirements, only Timothy E. Morris, Torbj&ouml;rn Bjerke, Michel de
Rosen, Viviane Monges, and Daniel Soland are considered to be &#147;independent directors.&#148; If elected by the shareholders, Adora Ndu and Ravi Rao will also be independent directors under both the Nasdaq Listing Rules and French law
requirements. In making such determination, our board of directors considered the relationships that each <FONT STYLE="white-space:nowrap">non-employee</FONT> director has with us and all other facts and circumstances our board of directors deemed
relevant in determining the director&#146;s independence, including the number of ordinary shares beneficially owned by the director and his or her affiliated entities (if any). </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Board Structure and Director Election </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We currently have nine directors, a majority of whom are citizens or residents of the United States. Under French law and our <FONT
STYLE="white-space:nowrap">by-laws,</FONT> our board of directors must be composed of between three and 18 members. Within this limit, the number of directors is determined by our shareholders. Since January&nbsp;1, 2017, the number of directors of
each gender may not be less than 40%. Any appointment made in violation of this limit that is not remedied will be null and void. Directors are elected, <FONT STYLE="white-space:nowrap">re-elected</FONT> and may be removed at a shareholders&#146;
general meeting with a simple majority vote of our shareholders. Pursuant to our <FONT STYLE="white-space:nowrap">by-laws,</FONT> the term of a director is three years, subject to a lesser period which could either be one or two year(s) for the
purpose of a staggered board. In accordance with French law, our <FONT STYLE="white-space:nowrap">by-laws</FONT> also provide that our directors may be removed with or without cause by the affirmative vote of the holders of at least a majority of
the votes of the shareholders present, represented by a proxy or voting by mail at the relevant ordinary shareholders&#146; meeting, and that any vacancy on our board of directors resulting from the death or resignation of a director, provided there
are at least three directors remaining, may be filled by vote of a majority of our directors then in office provided that there has been no shareholders meeting since such death or resignation. Directors chosen or appointed to fill a vacancy shall
be elected by the board of directors for the remaining duration of the current term of the replaced director. The appointment must then be ratified at the next shareholders&#146; general meeting. In the event the board of directors would be composed
of less than three directors as a result of a vacancy, the remaining directors shall immediately convene a shareholders&#146; general meeting to elect one or several new directors so there are at least three directors serving on the board of
directors, in accordance with French law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We believe that the structure of our board of directors and its committees provides strong
overall governance of our Company. The Chairman of our board of directors monitors the content, quality and timeliness of information sent to our board of directors and is available for consultation with our board of directors regarding the
oversight of our business affairs. Mr.&nbsp;de Rosen has served as Chairman of the board of directors since March&nbsp;4, 2019. He is an independent director under the listing standards of the Nasdaq Stock Market. Our board of directors believes
that, given his perspective and experience in matters of the board and his ability to liaison between our <FONT STYLE="white-space:nowrap">non-independent</FONT> directors and our independent directors, Mr.&nbsp;de Rosen&#146;s service as our
chairman is appropriate and is in the best interests of our board of directors, our Company and our shareholders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Board Meetings
and Committees </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During our fiscal year ended December&nbsp;31, 2020, the board of directors held 18 meetings (including regularly
scheduled and special meetings), and each director attended at least 75% of the aggregate of (i)&nbsp;the total number of meetings of our board of directors held during the period for which he or she has been a director and (ii)&nbsp;the total
number of meetings held by all committees of our board of directors on which he or she served during the periods that he or she served as required under the charter of our board of directors. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We encourage, but do not require, members of our board of directors to attend our Annual
General Meetings of shareholders. None of our directors attended our 2020 Annual General Meeting given applicable <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">COVID-19-related</FONT></FONT> public health measures that restricted
<FONT STYLE="white-space:nowrap">in-person</FONT> attendance at such meeting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our board of directors has established an audit committee,
a compensation committee and a nominating and corporate governance committee. The composition and functioning of all of our committees complies with all applicable requirements of the French Commercial Code, the Exchange Act, and Nasdaq and SEC
rules and regulations. In accordance with French law, committees of our board of directors only have an advisory role on matters requiring approval of the board of directors under French law and can only make recommendations to our board of
directors on such matters. As a result, decisions are made by our board of directors taking into account <FONT STYLE="white-space:nowrap">non-binding</FONT> recommendations of the relevant board committee. The composition and responsibilities of
each of the committees of our board of directors is described below. Members will serve on these committees until their resignation or until as otherwise determined by our board of directors. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Role of the Board in Risk Oversight </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our board of directors is primarily responsible for the oversight of our risk management activities and has delegated to the audit committee
the responsibility to assist our board in this task. While our board oversees our risk management, our management is responsible for <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">day-to-day</FONT></FONT> risk management
processes. Our board of directors expects our management to consider risk and risk management in each business decision, to proactively develop and monitor risk management strategies and processes for <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">day-to-day</FONT></FONT> activities and to effectively implement risk management strategies adopted by the board of directors. We believe this division of responsibilities is the most effective approach for addressing the
risks we face. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Committees of the Board of Directors </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The board of directors has established an audit committee, a nominating and corporate governance committee and a compensation committee, each
of which operate pursuant to a written charter adopted by our board of directors that satisfies the applicable rules and regulation of the SEC and the listing standards of the Nasdaq Stock Market. The composition and functioning of all of our
committees complies with all applicable requirements of the French Commercial Code, the Exchange Act, Nasdaq, and SEC rules and regulations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to the following paragraph concerning the audit committee, in accordance with French law, committees of our board of directors only
have an advisory role on matters requiring approval of the board of directors under French law and can only make recommendations to our board of directors on such matters. As a result, decisions are made by our board of directors taking into account
<FONT STYLE="white-space:nowrap">non-binding</FONT> recommendations of the relevant board committee. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="61%"></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Audit</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Compensation</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Nominating<BR>and&nbsp;Corporate<BR>Governance</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Daniel Tass&eacute;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Michel de Rosen</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dr.&nbsp;Torbj&ouml;rn Bjerke</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="center">Chair</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Ma&iuml;lys Ferr&egrave;re</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Timothy E. Morris</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Michael J. Goller</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="center">Chair</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Viviane Monges</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="center">Chair</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Julie O&#146;Neill</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Daniel Soland</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="center">X</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Below is a description of each committee of the Board. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I><U>Audit Committee</U></I></B>. In accordance with French law, the Audit Committee
has the following responsibilities: (i) it monitors the process of preparing the financial information and, where appropriate, makes recommendations to ensure its integrity, (ii)&nbsp;it monitors the efficiency of risk management and internal
control systems, as well as that of internal audits if applicable, with regard to the preparation and processing of financial and accounting information, without prejudice to its independence, (iii)&nbsp;it issues a recommendation on the statutory
auditors proposed for appointment by the general meeting, (iv)&nbsp;it monitors implementation by the statutory auditors of their mission, (v)&nbsp;it ensures that the statutory auditors comply with independence criteria, (vi)&nbsp;it approves the
provision of services other than the auditing of accounts referred to in Article <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">L.822-11-2</FONT></FONT> of the French Commercial Code, (vii)&nbsp;it reports regularly to the Board
on the performance of its tasks. It also reports on the outcome of the accounts auditing task, how this task contributed to the integrity of the financial information, and the role it played in that process. It immediately informs the Board about
any difficulties encountered. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Audit Committee is composed entirely of independent directors in accordance with applicable law,
including the Code and Nasdaq Listing Rules. All members of the Audit Committee shall be able to read and understand fundamental financial statements, including the Company&#146;s balance sheet, income statement and cash flow statement. In addition,
at least one (1)&nbsp;of the directors who is independent must qualify as an &#147;audit committee financial expert,&#148; as defined in Item 407(d)(5)(ii) of Regulation <FONT STYLE="white-space:nowrap">S-K</FONT> under the U.S. Securities Act of
1933, as amended, and shall be a member of the Audit Committee as described below. A person who satisfies the definition of &#147;audit committee financial expert&#148; will also be presumed to have financial sophistication. In order to comply with
article <FONT STYLE="white-space:nowrap">L.823-19</FONT> of the French Commercial Code, such person shall also have an outstanding knowledge in the field of finance, accounting and audit of accounts (<I>comp&eacute;tences particuli&egrave;res en
mati&egrave;re financi&egrave;re, comptable ou de contr&ocirc;le des comptes</I>). </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Ms.&nbsp;Monges, Mr.&nbsp;Timothy&nbsp;E. Morris
and Mr.&nbsp;Soland currently serve on our audit committee. Ms.&nbsp;Monges is the chairperson of our audit committee since March&nbsp;23, 2021. Our board has determined that each of Ms.&nbsp;Monges, Mr.&nbsp;Timothy&nbsp;E. Morris and
Mr.&nbsp;Soland is independent within the meaning of the applicable listing rules and the independence requirements contemplated by Rule <FONT STYLE="white-space:nowrap">10A-3</FONT> under the Exchange Act. Our board of directors has further
determined that Ms.&nbsp;Monges is an &#147;audit committee financial expert&#148; as defined by SEC rules and regulations and that each of Mr.&nbsp;Morris and Mr.&nbsp;Soland qualifies as financially sophisticated under the applicable exchange
listing rules. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our audit committee has the following responsibilities: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">monitoring the process of preparing the financial information and, where appropriate, make recommendations to
ensure its integrity; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">monitoring the efficiency of risk management and internal control systems, as well as that of internal audits if
applicable, with regard to the preparation and processing of financial and accounting information, without prejudice to its independence; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">issuing a recommendation on the statutory auditors proposed for appointment by the general meeting. This
recommendation to our board of directors is prepared in accordance with the provisions of Article 16 of (EU) Regulation no. 537/2014; it also issues a recommendation to this body when the renewal of the mandate of the auditor(s) is considered.
</P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Except for renewal, the recommendation must be justified and contain at least two choices while stating a reasoned
preference. This recommendation is prepared following a selection procedure led by our audit committee. The recommendations and preferences of our audit committee are presented at our general meeting held to determine the appointment of the
statutory auditor; </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">monitoring implementation by the statutory auditors of their mission and taking account of any findings and
conclusions made by the French High Council of Statutory Auditors following controls carried out pursuant to Articles L. <FONT STYLE="white-space:nowrap">821-9</FONT> et seq. of the French Commercial Code; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">ensuring that the statutory auditors comply with independence criteria; where applicable, our audit committee
takes the required measures for application of the provisions relating to financial </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
independence set out in Article 4 section 3 of (EU) Regulation no. 537/2014 and ensures compliance with the conditions specified in Article 6 of the same regulation; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">approving the provision of services other than the auditing of accounts referred to in Article L. <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">822-11-2</FONT></FONT> of the French Commercial Code; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">regularly reporting to our board of directors on the performance of its tasks. Our audit committee also reports
on the outcome of the accounts auditing task, how this task contributed to the integrity of the financial information and the role it played in that process. Our audit committee immediately informs our board of directors about any difficulties
encountered. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition to the functions referred to above, our board of directors entrusts the following specific
missions to our audit committee: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">With regard to our financial statements: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to examine and verify our draft budgets and draft annual and interim financial statements before they are sent to
the board of director; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to examine the draft comments, announcements and financial communication concerning our financial statements; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to provide a timely opinion to our administrative and financial management upon the latter&#146;s request.
</P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">With regard to our cash flow: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to examine and verify our general cash flow policy (investments and loans, risk hedging tools) and our cash flow
situation. </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">With regard to risk management: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to establish and oversee procedures for the treatment of complaints or submissions identifying concerns regarding
accounting, internal accounting controls or auditing matters; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to examine the state of significant disputes; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to examine <FONT STYLE="white-space:nowrap">off-balance</FONT> sheet risks and commitments;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to examine the relevance of risk monitoring procedures; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to review and oversee all related-party transactions in accordance with our Person Transaction Policy. In
addition, the audit committee&#146;s mission is to provide its opinion on the repayment of the costs incurred by the members of the board of directors on our behalf and to prepare mapping of the legal risks of any kind to which we are exposed.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our audit committee operates under a written charter that satisfies the applicable rules and regulations of the SEC and
the listing standards of the Nasdaq Stock Market. A copy of the charter of our audit committee is available on the Corporate Governance section of our website at<I><FONT STYLE="white-space:nowrap">&nbsp;https://dbv-technologies.com</FONT></I>.
During our fiscal year ended December&nbsp;31, 2020, our audit committee held 12 meetings. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Nasdaq rules require that the audit committee
have the specific audit committee responsibilities and authority necessary to comply with <FONT STYLE="white-space:nowrap">Rule&nbsp;10A-3(b)(2),</FONT> (3), (4)&nbsp;and (5)&nbsp;under the Exchange Act, which requires, among other things, that the
audit committee have direct responsibility for the appointment, compensation, retention and oversight of our auditors. However, <FONT STYLE="white-space:nowrap">Rule&nbsp;10A-3</FONT> provides that if the laws of a company&#146;s home country
prohibit the full board of directors from delegating such responsibilities to the audit committee, the audit committee&#146;s powers with respect to such matters may instead be advisory. As indicated above, under French law, our audit committee may
only have an advisory role on matters requiring approval of the board of directors under French law and can only make recommendations to our board of directors on such matters. Moreover, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
<FONT STYLE="white-space:nowrap">Rule&nbsp;10A-3</FONT> also provides that its audit committee requirements do not conflict with any laws of a company&#146;s home country that require shareholder
approval of such matters. Under French law, our shareholders must appoint, or renew the appointment of, the statutory auditors once every six fiscal years. In accordance with the applicable requirements of the French Commercial Code, we have two
statutory auditors. Our shareholders appointed KPMG&nbsp;S.A. as one of our independent registered public accounting firms at the 2020 Annual General Meeting for a term of six years ending on the date of the 2026 Annual General Meeting, and the term
of office of Deloitte et Associ&eacute;s, our other independent registered public accounting firm, shall expire at the 2023 Annual General Meeting. KPMG&nbsp;S.A. and Deloitte et Associ&eacute;s will remain our statutory auditors for purposes of
complying with legal requirements and consistent with the <FONT STYLE="white-space:nowrap">six-year</FONT> term, it being specified that KPMG S.A. was elected to by our shareholders at the 2020 Annual General Meeting of shareholders and Deloitte et
Associ&eacute;s was elected by our shareholders at the 2017 Annual General Meeting of shareholders.</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I><U>Compensation
Committee</U></I></B><I>.</I> Our compensation committee assists our board of directors in reviewing and making recommendations to our board of directors with respect to the compensation of our executive officers and directors. Dr.&nbsp;Bjerke,
Ms.&nbsp;Ferr&egrave;re and Messrs. Goller and Soland currently serve on the compensation committee. Dr.&nbsp;Bjerke is the chairperson of our compensation committee. Following the termination of Dr.&nbsp;Bjerke&#146;s service as a director
immediately following the Annual General Meeting, the board of directors will appoint a new chairperson of the compensation committee. The principal duties and responsibilities of our compensation committee include: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">proposing all elements of the total compensation, including retirement and provident plans, supplemental
retirement plans, benefits in kind, and miscellaneous equity compensation for our executive officers and members of our executive committee; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">being informed by the company on a regular basis of the recruitment of the principal members of the management of
the company other than the Chief Executive Officer, as well as review of the initial offer of and all subsequent changes to the elements of management&#146;s proposed compensation; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">providing its opinion on the company&#146;s broad strategy in terms of compensation policies;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">as applicable, proposing directors&#146; attendance fees to be submitted to the general shareholders&#146;
meeting, as well as their appropriate distribution among board members; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">providing its opinion on the principles set by us with regard to profit sharing and shareholding; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">providing its opinion on funds allocated to board members elected by the employees, if applicable.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our compensation committee operates under a written charter that satisfies the applicable rules and regulations of the
SEC and the listing standards of the Nasdaq Stock Market. A copy of the charter of our compensation committee is available on the Corporate Governance section of our website at
<I><FONT STYLE="white-space:nowrap">https://www.dbv-technologies.com</FONT></I>. During our fiscal year ended December&nbsp;31, 2020, our compensation committee held 9 meetings. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I><U>Nominating and Corporate Governance Committee</U></I></B><I>.</I><SUP STYLE="font-size:85%; vertical-align:top"> </SUP>The principal
responsibilities of our nominating and governance committee include (i)&nbsp;preparing proposals for the renewal, replacement or appointment of new directors, in consultation with the Chairman of our board of directors, (ii)&nbsp;providing an
opinion, with the support of the Chairman of our board of directors, on the appointment or replacement of the Chief Executive Officer and/or the Executive Vice Presidents, as the case may be, as well as the members of the Executive Committee and
(iii)&nbsp;establishing, when appropriate, with the agreement of the Chairman of our board of directors, a succession plan for executive corporate officers. Dr.&nbsp;Bjerke, Ms.&nbsp;Ferr&egrave;re and Messrs. Goller and de Rosen currently serve on
the nominating and governance committee. Ms.&nbsp;Goller is the chairperson of this committee. Dr.&nbsp;Bjerke will cease service on the Nominating and Corporate Governance Committee upon the termination of his service as a director immediately
following the Annual General Meeting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our nominating and corporate governance committee operates under a written charter that satisfies
the applicable rules and regulations of the SEC and the listing standards of the Nasdaq Stock Market. A copy of the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
charter of our nominating and corporate governance committee is available on the Corporate Governance section of our website
at<I><FONT STYLE="white-space:nowrap">&nbsp;https://dbv-technologies.com</FONT></I>. During our fiscal year ended December&nbsp;31, 2020, our nominating and corporate governance committee held 3 meetings. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Code of Business Conduct and Ethics </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have adopted a Code of Business Conduct and Ethics applicable to all of our directors, officers and employees. The Code of Business Conduct
and Ethics is available on our website at <I><FONT STYLE="white-space:nowrap">https://www.dbv-technologies.com/.</FONT></I> We expect that any amendments to this code or any waivers of its requirements will be disclosed on our website. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Compensation Committee Interlocks and Insider Participation </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">None of the members of our compensation committee is or has been an officer or employee of our Company. None of our executive officers
currently serves, or in the past year has served, as a member of the board of directors or compensation committee (or other board committee performing equivalent functions or, in the absence of any such committee, the entire board) of any entity
that has one or more of its executive officers serving on our board of directors or compensation committee. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Considerations in
Evaluating Director Nominees </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As set out in the charter of the board of directors, the nominating and corporate governance
committee works with the board of directors to determine periodically, as appropriate, to the extent permitted or required under applicable laws, the qualifications, expertise and characteristics of the board of directors, including such factors as
business experience and diversity of gender, race, ethnicity, nationality, differences in professional background, education, skill, and other individual qualities and attributes that contribute to the total mix of viewpoints and experience
represented on the board of directors. The nominating and corporate governance committee and the board of directors evaluate each individual in the context of the membership of the board of directors as a group, with the objective of having a board
that can best perpetuate the success of the business and represent shareholder interests through the exercise of sound judgment using its diversity of background and experience across various areas. Each director should be an individual of high
character and integrity. In determining whether to recommend a director for <FONT STYLE="white-space:nowrap">re-election,</FONT> the nominating and corporate governance committee also considers the director&#146;s past attendance at meetings,
participation in and contributions to the activities of the board of directors and the Company and other relevant qualifications and characteristics. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each director must ensure that other existing and anticipated future commitments do not materially interfere with the members&#146; service as
a director. Any employee director must submit his or her offer of resignation from the board of directors in writing to the Chairperson of the nominating and corporate governance committee upon termination of employment with the Company. Upon change
of his or her principal employer, any <FONT STYLE="white-space:nowrap">non-employee</FONT> director must submit his or her offer of resignation from the board of directors in writing to the Chairperson of the nominating and corporate governance
committee. The board of directors, through the nominating and corporate governance committee, will determine whether to accept or reject such resignation and will make a recommendation to the board of directors as to whether to accept or reject the
offer of resignation, or whether other action should be taken. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Shareholder Communication with the Board </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Generally, shareholders who have questions or concerns should contact our Investor Relations department at +1 <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">857-529-2363.</FONT></FONT> However, any shareholders who wish to address questions regarding our business directly with our board of directors, or any individual director, should direct his or her questions in writing to
the chairman of our board of directors <FONT STYLE="white-space:nowrap">177-181</FONT> Avenue Pierre Brossolette &#150; 92120 Montrouge, France. Communications will be distributed to our board of directors, or to any individual director or directors
as appropriate, depending on the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
facts and circumstances outlined in the communications. Items that are unrelated to the duties and responsibilities of our board of directors may be excluded, such as: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">junk mail and mass mailings; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">resumes and other forms of job inquiries; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">surveys; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">solicitations or advertisements. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, any material that is unduly hostile, threatening, or illegal in nature may be excluded, in which case it will be made available to any outside
director upon request. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc140648_3"></A>REPORT OF AUDIT COMMITTEE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The audit committee of our board of directors, which consists entirely of directors who meet the independence and experience requirements of
the Nasdaq Stock Market, has furnished the following report: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The audit committee assists our board of directors in overseeing and
monitoring the integrity of our financial reporting process, compliance with legal and regulatory requirements and the quality of internal and external audit processes. This committee&#146;s role and responsibilities are set forth in our charter
adopted by our board of directors, which is available on our website at <FONT STYLE="white-space:nowrap">www.dbv-technologies.com.</FONT> This committee reviews and reassesses our charter annually and recommends any changes to our board of directors
for approval. The audit committee is responsible for overseeing our overall financial reporting process, and for recommending the appointment, compensation, retention, and oversight of the work of KPMG S.A. and Deloitte&nbsp;&amp; Associ&eacute;s,
which is ultimately determined by, respectively, the board of directors or the shareholders. In fulfilling its responsibilities for the DBV Technologies financial statements for the fiscal year ended December&nbsp;31, 2020, the audit committee of
DBV Technologies took the following actions: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Reviewed and discussed the audited financial statements for the fiscal year ended December&nbsp;31, 2020 with
management and KPMG S.A. and Deloitte&nbsp;&amp; Associ&eacute;s, our independent registered public accounting firms; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Discussed with KPMG S.A. and Deloitte&nbsp;&amp; Associ&eacute;s the matters required to be discussed in
accordance with Auditing Standard No.&nbsp;1301 &#150; <I>Communications with Audit committees</I>; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Received written disclosures and the letter from KPMG S.A. and Deloitte&nbsp;&amp; Associ&eacute;s regarding
their independence as required by applicable requirements of the Public Company Accounting Oversight Board regarding KPMG S.A. and Deloitte&nbsp;&amp; Associ&eacute;s&#146; communications with the audit committee and the audit committee further
discussed with KPMG S.A. and Deloitte&nbsp;&amp; Associ&eacute;s LLP their independence. The audit committee also considered the status of pending litigation, taxation matters and other areas of oversight relating to the financial reporting and
audit process that the committee determined appropriate. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Based on the audit committee&#146;s review of the audited
financial statements and discussions with management and KPMG S.A. and Deloitte&nbsp;&amp; Associ&eacute;s, the audit committee recommended to the Company&#146;s board of directors that the audited financial statements be included in the DBV
Technologies Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended December&nbsp;31, 2020 for filing with the SEC. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:47%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Members of the DBV Technologies S.A. Audit Committee </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:47%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Claire Giraut<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:47%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Viviane Monges </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:47%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Daniel Soland </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><SUP
STYLE="font-size:85%; vertical-align:top">(1)</SUP></B>Ms.&nbsp;Giraut resigned from our board of directors and the Audit Committee subsequent to approving the inclusion of audited financial statements in the Annual Report on Form <FONT
STYLE="white-space:nowrap">10-K.</FONT><B> </B> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>The material in this report is not &#147;soliciting material,&#148; is not deemed &#147;filed&#148;
with the SEC and is not to be incorporated by reference in any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof and irrespective of any general incorporation
language in any such filing. </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc140648_4"></A>INFORMATION ABOUT OUR EXECUTIVE OFFICERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Below is a list of our executive officers and their ages as of April&nbsp;21, 2021. Officers are elected by our board of directors to hold
office until their successors are elected and qualified. There is no arrangement or understanding between any executive officer and any other person pursuant to which the executive officer was selected. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="48%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="44%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">Name</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center">Age</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">Position</P></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Daniel Tass&eacute;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">61</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Chief Executive Officer and Director</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">S&eacute;bastien Robitaille</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">51</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Chief Financial Officer</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dr.&nbsp;Pharis Mohideen</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">56</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Chief Medical Officer</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>S&eacute;bastien Robitaille </I></B>has served as our Chief Financial Officer since October 2020. He
oversees Finance and Information Systems at the Group level and is a member of the Executive Committee. From July 2019 to October 2020 he served as our Chief of Staff responsible for leading our evolution from a development-stage biotechnology
company to a potential commercial organization. From December 2017 to December 2019, he served as our Deputy Chief Financial Officer and oversaw the Finance and Information Systems operations. Mr.&nbsp;Robitaille joined us in September 2015 as
Senior Vice President, Group Controller&nbsp;&amp; Information Systems. Prior to joining us, Mr.&nbsp;Robitaille worked at Ipsen for 15 years, where he held various roles of increasing. Mr.&nbsp;Robitaille holds a Bachelor&#146;s Degree in Business
Administration-Finance from Paris School of Business. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Dr.</I></B><B><I></I></B><B><I>&nbsp;Pharis Mohideen</I></B> has served as
our Chief Medical Officer since July 2019 and is responsible for continuing development efforts of our pipeline and bringing potentially innovative new treatments to patients, if approved. Dr.&nbsp;Mohideen is a member of our Executive Committee.
Prior to joining us, from October 2014 to July 2019, Dr.&nbsp;Mohideen served as Chief Medical Officer for Millendo Therapeutics, Inc. From June 2012 to October 2014, he served as Vice President of Clinical Development at Shionogi Inc.
Dr.&nbsp;Mohideen received his M.D., M.S. in human physiology and B.A. in biology from the University of Hawaii, as well as his M.S. in clinical investigation from Vanderbilt University. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Mr.&nbsp;Tass&eacute;&#146;s biography is set forth above under &#147;Board Of Directors and Corporate Governance &#150; Board Of
Directors.&#148; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Family Relationships </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">There are no family relationships among any of our executive officers or directors. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc140648_5"></A>EXECUTIVE COMPENSATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Summary Compensation Table </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following
table sets forth information for each of the last two completed fiscal years regarding compensation awarded to or earned by (i)&nbsp;our Chief Executive Officer (principal&nbsp;executive officer, PEO), (ii) two most highly compensated&nbsp;executive
officers&nbsp;other than the PEO who were serving as&nbsp;executive officers&nbsp;at the end of the last completed&nbsp;fiscal year and (iii)&nbsp;one additional former executive officers who would have been among the two most highly compensated
executive officers of the Company other than the PEO had he continued to serve as of December&nbsp;31, 2020, or collectively, the named executive officers. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the year ended December&nbsp;31, 2020, our named executive officers were: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Daniel Tass&eacute;, our Chief Executive Officer and Director; </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">S&eacute;bastien Robitaille, our Chief Financial Officer; </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dr.&nbsp;Pharis Mohideen, our Chief Medical Officer; and </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ramzi
Benamar, our former Chief Financial Officer, who left the Company on October&nbsp;2, 2020. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" ALIGN="center">


<TR>

<TD WIDTH="31%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><B>Name and</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Principal Position</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Salary</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Bonus</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Stock<BR>Awards&nbsp;(1)</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option<BR>Awards&nbsp;(1)<BR>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B><FONT STYLE="white-space:nowrap">Non-Equity</FONT><BR>Incentive Plan<BR>Compensation</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>All Other<BR>Compensation</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total&nbsp;(2)</B><br><B>$</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Daniel Tass&eacute;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">600,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">959,123</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">396,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">107,012</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;(3)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,062,135</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman"><I>Chief Executive Officer and Director</I></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">2019</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">600,000</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">1,693,381</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">780,000</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">88,071</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">3,161,452</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">S&eacute;bastien Robitaille</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">234,150</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">39,438</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">178,523</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">55,282</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,385</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;(4)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">509,778</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman"><I>Chief Financial Officer</I></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2019</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">211,265</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">362,400</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">146,637</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,102</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">724,403</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Pharis Mohideen</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">440,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">73,649</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">333,943</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">99,704</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">85,556</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;(5)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,032,851</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman"><I>Chief Medical Officer</I></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2019</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">195,824</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;(6)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">937,045</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">364,678</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">38,135</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,535,682</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Ramzi Benamar</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman"><I>Former Chief Financial Officer</I></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">2020</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">288,493</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">1,086,825</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">116,000</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">525,638</TD>
<TD NOWRAP VALIGN="top"><SUP STYLE="font-size:85%; vertical-align:top">(7)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">2,016,956</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The amounts reported in the &#147;Stock Awards&#148; and &#147;Option Awards&#148; columns reflect the
aggregate grant date fair value of each award computed in accordance with ASC Topic 718. For information regarding the assumptions used in determining the fair value of an award, please refer to Note 14 of our Annual Report on Form <FONT
STYLE="white-space:nowrap">10-K</FONT> as filed with the SEC on March&nbsp;17, 2021. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Amounts relating to compensation in 2020 have been converted from euros to U.S. dollars at a rate of
&#128;1.00&nbsp;= $1.1422, which represents the average exchange rate for the year ended December&nbsp;31, 2020, and amounts relating to compensation in 2019 have been converted from euros to U.S. dollars at a rate of &#128;1.00&nbsp;= $1.1195,
which represents the average exchange rate for the year ended December&nbsp;31, 2019. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Includes $6,750 in Company contributions to benefit plans, $41,546 in life insurance premiums, $40,905 in tax <FONT
STYLE="white-space:nowrap">gross-up</FONT> payments or reimbursements, and $17,811 in commuting expenses. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Includes $2,385 in commuting expenses. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Includes $26,000 in Company contributions to benefit plans, $41,546 in life insurance premiums, and $18,009 in
commuting expenses. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(6)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Dr.&nbsp;Mohideen joined the Company on July&nbsp;22, 2019. Represents the
<FONT STYLE="white-space:nowrap">pro-rated</FONT> portion of an annual base salary of $453,200. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(7)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Includes $19,500 of Company contributions to benefit plans, $37,722 in life insurance premiums, $13,416 in
commuting expenses, $65,000 in housing allocations, and $390,000 in severance payments. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Outstanding Equity Awards at Fiscal Year End 2020 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="18" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option Awards</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Stock Awards</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:7pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Grant<BR>Date</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of<BR>securities<BR>underlying<BR>unexercised<BR>options</B><br><B>(#)<BR>exercisable</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number
of<BR>securities<BR>underlying<BR>unexercised<BR>options</B><br><B>(#)<BR>unexercisable<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Equity<BR>incentive<BR>plan&nbsp;awards:<BR>Number of<BR>securities<BR>underlying<BR>unexercised<BR>unearned<BR>options (#)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option<BR>exercise<BR>price<BR>(&#128;)&nbsp;<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option<BR>expiration<BR>date</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number<BR>of<BR>shares<BR>or units<BR>of stock<BR>that<BR>have<BR>not<BR>vested<BR>(#)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Market<BR>value of<BR>shares<BR>of units<BR>of stock<BR>that<BR>have not<BR>vested<BR>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Equity<BR>incentive<BR>plan&nbsp;awards:<BR>Number of<BR>unearned<BR>shares, units<BR>or other<BR>rights that<BR>have not<BR>vested (#)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Equity<BR>incentive<BR>plan&nbsp;awards:<BR>Market or<BR>payout value<BR>of unearned<BR>shares, units<BR>or other<BR>rights that<BR>have not<BR>vested
($)&nbsp;(3)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman"><B>Daniel Tass&eacute;</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11/29/18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">350,000</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&#128;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">30.02</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11/29/28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">05/24/19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">150,000</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&#128;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16.99</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">05/24/29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11/24/20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">274,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&#128;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4.16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11/24/30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"><B>S&eacute;bastien&nbsp;Robitaille</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">06/22/18</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">15,000</TD>
<TD NOWRAP VALIGN="top"><SUP STYLE="font-size:85%; vertical-align:top">(5)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">$</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">79,811</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">05/10/19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20,000</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(5)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">106,414</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12/20/19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(6)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">532</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11/24/20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">51,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&#128;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4.16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11/24/30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8,300</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(7)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">44,162</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"><B>Pharis Mohideen</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">07/22/19</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">75,000</TD>
<TD NOWRAP VALIGN="top"><SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&#128;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">17.90</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">07/22/29</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11/24/20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">95,400</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&#128;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4.16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11/24/30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15,500</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(7)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">82,471</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">25% of the shares subject to each option vest 12 months after grant, with the remaining shares vesting in six
equal semi-annual installments thereafter, subject to each optionholder&#146;s continued service through each such vesting date. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Exercise prices, grant date share fair values and fair value per equity instruments are provided in euros, as
the Company is incorporated in France and the euro is the currency used for the grants. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Determined by reference to &#128;4.34, the closing price per ordinary share on Euronext Paris on
December&nbsp;31, 2020 and an applicable exchange rate of &#128;1.00 = $1.2271, which represents the exchange rate as of December 31, 2020. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">In addition to the vesting schedule in footnote (1), vesting of these options are subject to the achievement of
performance conditions. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The service conditions have been met as of December 31, 2020 for the awards granted on June&nbsp;22, 2018 and
May 10, 2019. The release of free shares is subject to the achievement of performance conditions. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(6)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">This award vests on December 19, 2021. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(7)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">25% of these RSUs vest on November 24, 2021, and the remaining RSUs vest in six equal semi-annual installments
thereafter, subject to the holder&#146;s continued service through each such vesting date. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mr.&nbsp;Benamar held no outstanding equity
awards at fiscal year end as a result of his departure from the Company in October 2020. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Narrative Disclosure to Summary Compensation Table </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Compensation Philosophy and Strategy </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are a clinical-stage biopharmaceutical company dedicated to developing and commercializing safe, effective, and convenient therapies for
patients with food allergies and other immunological conditions. Our therapeutic approach is based on epicutaneous immunotherapy, or EPIT<SUP STYLE="font-size:85%; vertical-align:top">&#153;</SUP>, our proprietary method of delivering biologically
active compounds to the immune system through intact skin using Viaskin<SUP STYLE="font-size:85%; vertical-align:top">&#153;</SUP>, an epicutaneous patch (i.e., a skin patch). We have generated significant data demonstrating that the mechanism of
action of Viaskin is novel and differentiated, as it targets specific antigen-presenting immune cells in the skin called Langerhans cells. Langerhans cells capture the antigen and migrate to the lymph node to activate the immune system without
allowing passage of the antigen into the bloodstream, minimizing systemic exposure in the body. We are advancing this unique technology to address areas of unmet medical need, including food allergies. Safety is paramount to children with food
allergies and their families because the introduction of the offending allergen into an allergic child&#146;s bloodstream can cause severe and life-threatening allergic reactions, such as anaphylactic shock. We believe Viaskin may offer a
convenient, <FONT STYLE="white-space:nowrap">self-administered,&nbsp;non-invasive&nbsp;immunotherapy</FONT> to patients. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our most
advanced product candidate is Viaskin Peanut, which has been evaluated in nine clinical studies, including four Phase II studies and two Phase III studies, as a potential therapy for children ages four to eleven with peanut allergy. We also have an
ongoing Phase III study of Viaskin Peanut in children ages one to three with peanut allergy. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have two earlier-stage food allergy
programs: Viaskin Milk, which is in Phase II of clinical development, and Viaskin Egg, which is in preclinical development. We are also exploring potential applications of our Viaskin platform in vaccines and other immune diseases such as
Eosinophilic Esophagitis, or EoE. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As a global biopharmaceutical company, we structure our compensation program to attract global talent.
The overall objectives of our executive compensation policies and programs are to: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">attract, retain and motivate superior executive talent; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">provide incentives that reward the achievement of performance goals that directly correlate to the enhancement of
stockholder value, as well as to facilitate executive retention; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">align our executives&#146; interests with those of our stockholders; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">link pay to company performance; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">offer pay opportunities that are competitive with the biopharmaceutical market in which we compete in order to
recruit and retain top talent, while maintaining reasonable cost and dilution to our shareholders. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In establishing
specific compensation levels for our executive officers, we considering benchmarking information provided from our independent compensation consultant. For 2020, we considered the following companies to be in our peer group for benchmarking
purposes: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV STYLE="position:relative;float:left; width:48%;padding-right:0%;padding-bottom:8pt;overflow:hidden;padding-top:3pt">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:20pt; font-size:10pt; font-family:Times New Roman">Aimmune Therapeutics </P>
<P STYLE="margin-top:4pt; margin-bottom:0pt; margin-left:20pt; font-size:10pt; font-family:Times New Roman">Apellis Pharmaceuticals Inc. </P>
<P STYLE="margin-top:4pt; margin-bottom:0pt; margin-left:20pt; font-size:10pt; font-family:Times New Roman">Aurinia Pharmaceuticals Inc. </P>
<P STYLE="margin-top:4pt; margin-bottom:0pt; margin-left:20pt; font-size:10pt; font-family:Times New Roman">Esperion Therapeutics, Inc. </P>
<P STYLE="margin-top:4pt; margin-bottom:0pt; margin-left:20pt; font-size:10pt; font-family:Times New Roman">Intercept Pharmaceuticals Inc. </P>
<P STYLE="margin-top:4pt; margin-bottom:0pt; margin-left:20pt; font-size:10pt; font-family:Times New Roman">Intra-Cellular Therapies, Inc. </P>
<P STYLE="margin-top:4pt; margin-bottom:0pt; margin-left:20pt; font-size:10pt; font-family:Times New Roman">Mesoblast Ltd.
</P></DIV><DIV STYLE="position:relative;float:left; margin-left:3%; width:49%;padding-right:0%;padding-bottom:8pt;overflow:hidden;padding-top:3pt">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:20pt; font-size:10pt; font-family:Times New Roman">Myovant Sciences Ltd. </P>
<P STYLE="margin-top:4pt; margin-bottom:0pt; margin-left:20pt; font-size:10pt; font-family:Times New Roman">Revance Therapeutics Inc. </P>
<P STYLE="margin-top:4pt; margin-bottom:0pt; margin-left:20pt; font-size:10pt; font-family:Times New Roman">Rhythm Pharmaceuticals Inc. </P>
<P STYLE="margin-top:4pt; margin-bottom:0pt; margin-left:20pt; font-size:10pt; font-family:Times New Roman">Tricida Inc. </P> <P STYLE="margin-top:4pt; margin-bottom:0pt; margin-left:20pt; font-size:10pt; font-family:Times New Roman">Viela Bio, Inc.
(subsequently acquired by Horizon Therapeutics plc) </P> <P STYLE="margin-top:4pt; margin-bottom:0pt; margin-left:20pt; font-size:10pt; font-family:Times New Roman">Zealand Pharma A/S </P>
<P STYLE="margin-top:4pt; margin-bottom:0pt; margin-left:20pt; font-size:10pt; font-family:Times New Roman">Zogenix, Inc. </P></div><div style="clear:both; height:0pt; font-size:0pt">&nbsp;</div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">30 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our executive compensation program generally consists of, and is intended to strike a
balance among, the following three principal components: base salary, annual performance-based incentives and long-term incentive compensation.&nbsp;Our compensation philosophy with respect to these elements is as follows: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><U>Base salary (fixed cash)</U></B>: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Target market median in the French or U.S., depending on job location. <B> </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Provides financial stability and security through a fixed amount of cash for performing job responsibilities.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Generally reviewed annually by the compensation committee based on a number of factors (including individual
performance, internal equity, retention, expected cost of living increases and the overall performance of our company) and by reference to market data provided by our independent compensation consultant). </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><B>&#149;</B></TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><U>Annual non-equity performance incentive plan (at risk cash)</U>: </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Motivates and rewards for attaining rigorous annual corporate performance goals that relate to our key business
objectives and individual contributions. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Target bonus amounts are generally reviewed annually by the compensation committee, including by reference to
market data provided by our independent compensation consultant. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Bonus opportunities are dependent on the achievement of specific corporate objectives established at the
beginning of the year by the board of directors and individual performance objectives that relate to the officer&#146;s role and expected contribution toward reaching our corporate goals. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Actual bonus amounts earned are determined after the end of the year, based on achievement of the designated
corporate performance objectives (which allow for 0% to 150% achievement) and, where applicable, individual performance objectives. Any corporate achievement of less than 50% results in no annual incentive compensation for our executive officers.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">For 2020, the compensation committee determined that our company had achieved 55% of the corporate objectives
established by the board. See <I>Annex D</I> for further information on our achievement of corporate objectives. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Long-term incentives</B> <B><FONT STYLE="white-space:nowrap">(at-risk</FONT> equity)</B>:
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Long-term incentives, or LTIs, represent the bulk of our executive compensation. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Motivates and rewards for long-term Company performance; aligns executives&#146; interests with stockholder
interests and changes in stockholder value. Attracts highly qualified executives and encourages their continued employment over the long-term. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Includes a mix of Stock-Options (SOs) and Restricted Stock Units (RSUs). The relative ratio of SOs to RSUs
increases as a function of organizational seniority, such that our executive officers receive upwards of 80% of their LTIs as SOs, which we believe is consistent with our peer companies and particularly our U.S. peer companies.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Annual equity opportunities are generally reviewed and determined annually or as appropriate during the year for
new hires, promotions, or other special circumstances, such as to encourage retention, or as an incentive for significant achievement. Individual grants are determined based on a number of factors, including current corporate and individual
performance, outstanding equity holdings and their retention value and total ownership, historical value of our stock, internal equity among executives and market data provided by our independent compensation consultant. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">We focus on time-vesting awards. Time based vesting over four years (25&nbsp;% at month 12, and 12.5% every 6
months afterwards) allows for retention that is aligned to the biotechnology </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">31 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
industry&#146;s longer time horizon for value creation and is competitive with market practices. Further, our focus on time-vesting awards allow us to most optimally allocate our resources by
enabling us to shift resources towards the most promising opportunities for shareholder value creation. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
compensation committee aims to structure a significant portion of the named executive officers&#146; total target compensation to be comprised of performance-based bonus opportunities and LTIs, in order to align the executive officers&#146;
incentives with the interests of our stockholders and our corporate objectives. In evaluating our executive compensation policies and programs, as well as the short-term and long-term value of our executive compensation plans, we consider both the
performance and skills of each of our executives, as well as the compensation paid to executives at similar companies with similar responsibilities. We focus on providing a competitive compensation package which provides significant short-term and
long-term incentives for the achievement of measurable corporate objectives. We believe this approach provides an appropriate blend of short-term and long-term incentives to maximize stockholder value. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Chief Executive Officer Compensation </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In 2020, the elements of our chief executive officer&#146;s compensation were: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Base salary</B>: Mr.&nbsp;Tass&eacute;&#146;s annual base salary has remained at $600,000 since joining our
company in November 2018. This amount is between the 50<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> and 75<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> percentile of the market data compiled by our independent compensation
consultant, in order to remain competitive with the companies with whom we compete. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Annual incentive award</B>: For 2020, in addition to determining that the company had achieved 55% of the
corporate objectives established by the board, the board approved a supplemental incentive award to Mr.&nbsp;Tass&eacute; equal to 11% of his base salary for his work in reorganizing our company and significantly reducing our expenses while
advancing our Viaskin Peanut program and other core capabilities. In total, Mr.&nbsp;Tass&eacute;&#146;s annual incentive award equaled 66% of his base salary in 2020, as compared to 130% in 2019. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>LTIs</B>: In 2020, the board granted Mr.&nbsp;Tass&eacute; a SO to purchase 274,000 ordinary shares, which
represented approximately 0,50% of our outstanding capital, which aligned to market practice of 0.45 to 0.55% at the median of our comparable companies. Such SOs have a four-year vesting schedule (25% at month 12, and 12.5% every 6 months
afterwards) and a <FONT STYLE="white-space:nowrap">10-year</FONT> exercise window, subject to Mr.&nbsp;Tass&eacute;&#146;s continued service at our company. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Executive Compensation Arrangements </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For a discussion of our employment arrangements with our executive officers, see &#147;Related Party Transactions&nbsp;&#150;Arrangements with Our Directors
and Executive Officers.&#148; Except the arrangements described in &#147;Related Party Transactions&#151;Arrangements with Our Directors and Executive Officers,&#148; there are no arrangements or understanding between us and any of our other
executive officers providing for benefits upon termination of their employment, other than as required by applicable law. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>French <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">&#147;Say-on-Pay&#148;</FONT></FONT> Requirements Related to Executive Compensation </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>French legal background on <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">say-on-pay</FONT></FONT> requirements
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">French laws applicable our company requires that all type of compensation to be granted or that have been granted to certain
corporate officers (Chairman of the Board, directors, chief executive officers, deputy chief executive officers, if any) be presented and approved shareholders at our annual shareholders &#146;general meeting, as regards on one hand compensation
policy applicable these corporate officers for the coming year (Ex Ante Vote) and on the other hand the compensation that was granted to these executive officers for the past year (Ex Post Vote). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">32 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">No compensation component, of any nature whatsoever, may be determined, allocated or paid by
our company, nor any commitment made by our company if it is not in accordance with the approved compensation policy or, in its absence, with the compensation or practices existing within our company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The determination, review and implementation of the compensation policy for each of the corporate officers is carried out by the Board on the
recommendation of the Compensation Committee. When the Board decides on a compensation component or a commitment in favor of the Chairman of the Board or the Chief Executive Officer, the interested party may not take part in the deliberations or
vote on the component or commitment concerned. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Ex Ante Vote </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Board of Directors shall draw up a remuneration policy that is made in accordance with our corporate purposes, that shall contribute to our
company&#146;s sustainability and that shall be part of our company&#146;s business strategy. It shall comprise all type of remunerations to be granted to corporate officers (whether fixed, variable or exceptional) and shall explain how it has been
determined and how it is implemented by our company. Such compensation policy shall be approved by our shareholders at our annual shareholders&#146; meeting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As part of the decision-making process followed for the determination and review of the compensation policy, the conditions of compensation
and employment of our company&#146;s employees were taken into account by the Compensation Committee and the Board. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In proposing the
structure of this compensation, the Compensation Committee also relies on studies indicating market practices for comparable companies. These studies are based on a sample of companies with common characteristics in terms of size, workforce, market
capitalization, clinical stage or geographic footprint. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Compensation Committee ensures that none of the components of remuneration is
disproportionate and analyses the remuneration as a whole, taking into account all of its components. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event of a change in
governance, the compensation policy will be applied our new executive officers, with necessary adjustments where applicable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Such
compensation policy is described in our annual corporate governance report, a portion of which, translated to English, is included as Annex B to this Proxy Statement and which was incorporated in Section&nbsp;4 of our 2021 Universal Registration
Document (URD) filed with the French Market Authority on March&nbsp;17, 2021 under number <FONT STYLE="white-space:nowrap">D.21-0141.</FONT> </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Ex Post vote </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
annual ordinary shareholders&#146; meeting must decide each year on the remuneration awarded or paid during the financial year to the corporate officers. This <FONT STYLE="white-space:nowrap">&#147;ex-post&#148;</FONT> vote concerns two sets of
resolutions, one concerning all corporate officers, the other concerning only some of them. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our annual shareholders&#146; meeting shall
then approve fixed, variable and exceptional items comprising the total compensation and benefits of any kind paid during the previous financial year or awarded for said financial year to the corporate officers. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">With regard to the vote on the information concerning all corporate officers, and in the event that the proposed resolution is rejected, the
Board of Directors must submit a revised remuneration policy for approval at the next general meeting; the payment of sums allocated for the current financial year to the directors as remuneration for their activity is suspended until this approval.
A further negative vote on the resolution on the new remuneration policy will result in a permanent ban on the payment of the suspended remuneration. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">33 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A description of our corporate officers&#146; compensation for the previous financial year
is included in Annex C, Part 1 and Part 2 to this proxy statement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As regards the vote on the fixed, variable, and exceptional components
of the total compensation and benefits of any kind paid or granted during the past financial year to the Chairman of the Board of Directors, the chief executive officer and the deputy chief executive officer, and if the proposed resolution is
rejected by the general meeting, the remuneration components remain in place, but the variable and exceptional remuneration components may not be paid to the said corporate officer </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A description of the compensation paid to Mr.&nbsp;Michel de Rosen, Mr.&nbsp;Daniel Tass&eacute; and Ms.&nbsp;Marie-Catherine
Th&eacute;r&eacute;n&eacute; for the previous financial year is included in Annex C, Part 2 to this proxy statement. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Limitations on Liability and
Indemnifications Matters </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under French law, provisions of <FONT STYLE="white-space:nowrap">by-laws</FONT> that limit the liability of
directors are prohibited. However, French law allows <I>soci&eacute;t&eacute;s anonymes</I> to contract for and maintain liability insurance against civil liabilities incurred by any of their directors and officers involved in a third-party action,
provided that they acted in good faith and within their capacities as directors or officers of the company. Criminal liability cannot be indemnified under French law, whether directly by the company or through liability insurance. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We maintain liability insurance for our directors and officers, including insurance against liability under the Securities Act and we intend
to enter into agreements with our directors and executive officers to provide contractual indemnification. With certain exceptions and subject to limitations on indemnification under French law, these agreements will provide for indemnification for
damages and expenses including, among other things, attorneys&#146; fees, judgments, fines and settlement amounts incurred by any of these individuals in any action or proceeding arising out of his or her actions in that capacity. We believe that
this insurance and these agreements are necessary to attract qualified directors and executive officers. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">These agreements may discourage
shareholders from bringing a lawsuit against our directors and executive officers for breach of their fiduciary duty. These provisions also may have the effect of reducing the likelihood of derivative litigation against directors and executive
officers, even though such an action, if successful, might otherwise benefit us and our shareholders. Furthermore, a shareholder&#146;s investment may be adversely affected to the extent we pay the costs of settlement and damage awards against
directors and officers pursuant to these insurance agreements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Certain of our <FONT STYLE="white-space:nowrap">non-employee</FONT>
directors may, through their relationships with their employers or partnerships, be insured against certain liabilities in their capacity as members of our board of directors. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">34 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Equity Compensation Plan Information </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I><U>Shares Authorized for Delivery under Equity Compensation Plans&#151; </U></I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table provides information about our Ordinary Shares that may be issued (or transferred) under our equity compensation plans at
December&nbsp;31,&nbsp;2020: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="56%"></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" ROWSPAN="2" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Plan Category</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of<BR>securities&nbsp;to&nbsp;be<BR>issued upon<BR>exercise of<BR>outstanding<BR>options,<BR>warrants and<BR>rights</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B><FONT STYLE="white-space:nowrap">Weighted-average</FONT><BR>exercise price of<BR>outstanding<BR>options, warrants<BR>and rights&nbsp;(11)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of securities<BR>remaining&nbsp;available&nbsp;for<BR>issuance under equity<BR>compensation plans<BR>(excluding securities<BR>reflected in column
(a)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>(a)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>(b)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>(c)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Equity compensation plans approved by security holders:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-Employee</FONT> Warrants (BSA)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">218,008</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&#128;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">52.78</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Employee Warrants (BSPCE)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">82,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&#128;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5.13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock options (OSA)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,610,510</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&#128;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">18.78</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,904,052</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Restricted Stock Units</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,118,745</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">N/A</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">623,734</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Equity compensation plans not approved by security holders:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">None</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(11)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Exercise prices, grant date share fair values and fair value per equity instruments are provided in Euros, as
the Company is incorporated in France and the Euro is the currency used for the grants. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">35 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc140648_6"></A>SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth certain information with respect to the beneficial ownership of ordinary shares as of March&nbsp;31,
2021 for: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">each beneficial owner of more than 5% of our ordinary shares; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">each of our named executive officers and directors; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">all of our executive officers and directors as a group </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Beneficial ownership is determined in accordance with the rules and regulations of the SEC. Under these rules, beneficial ownership includes
any shares as to which a person has sole or shared voting power or investment power. In computing the number of ordinary shares beneficially owned by a person and the percentage ownership of that person, ordinary shares subject to options, or other
rights held by such person that are currently exercisable or will become exercisable within 60 days of March&nbsp;31, 2021 are considered outstanding. These ordinary shares, however, are not included in the computation percentage ownership of any
other person. Applicable percentage ownership is based on 54,936,687 ordinary shares outstanding as of March&nbsp;31, 2021. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless
otherwise indicated, the address for each of the shareholders listed in the table below is c/o DBV Technologies S.A., <FONT STYLE="white-space:nowrap">177-181</FONT> Avenue Pierre Brossolette &#150; 92120 Montrouge, France. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="79%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of<BR>Shares<BR>Beneficially<BR>Owned</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Percentage<BR>of Shares<BR>Beneficially<BR>Owned</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>5% Shareholders</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Entities affiliated with Caisse de D&eacute;p&ocirc;ts et Consignations (1)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,668,702</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8.5</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Entities affiliated with Baker Bros. Advisors LP (2)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11,614,670</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">21.1</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Entities affiliated with Boxer Capital, LLC (3)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,767,299</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6.9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Entities affiliated with Perceptive Advisors (4)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,422,123.5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8.1</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Morgan Stanley (5)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,855,825</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5.2</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Named Executive Officers, Directors and Director Nominees</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Daniel Tass&eacute;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">250,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">S&eacute;bastien Robitaille</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Pharis Mohideen</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11,250</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Ramzi Benamar</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Michel de Rosen (6)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">32,570</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dr.&nbsp;Torbj&ouml;rn Bjerke (7)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">42,925</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Ma&iuml;lys Ferr&egrave;re</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Michael J. Goller (8)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">21,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Viviane Monges (9)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">600</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Timothy E. Morris</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Adora Ndu</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Julie O&#146;Neill (10)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Ravi Rao</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Daniel Soland (11)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">36,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">All current directors and current executive officers as a group (11 persons) (12)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">425,745</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Represents beneficial ownership of less than 1% of our outstanding ordinary shares. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The information shown is based, in part, on an declaration Schedule 13D/A filed jointly by (i)&nbsp;Bpifrance
Participations S.A., a soci&eacute;t&eacute; anonyme incorporated under the laws of the Republic of France (&#147;BpiP&#148;), (ii) Innobio FPCI, a fonds professionnel de capital investissement (&#147;Innobio&#148;), (iii) Bpifrance Investissement
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">36 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
S.A.S., a French management company (soci&eacute;t&eacute; de gestion) (&#147;BpiI&#148;), (iv) CDC Croissance S.A., a soci&eacute;t&eacute; anonyme incorporated under the laws of the Republic of
France (&#147;CDCC&#148;), (v) the Caisse des D&eacute;p&ocirc;ts, a French special public entity (&eacute;tablissement sp&eacute;cial) (&#147;CDC&#148;), (vi) EPIC Bpifrance, a French public institution of industrial and commercial nature
(&#147;EPIC&#148;), and (vii)&nbsp;Bpifrance S.A. (&#147;BPI&#148;), a soci&eacute;t&eacute; anonyme incorporated under the laws of the Republic of France, on February&nbsp;12, 2021. Consists of 4,442,569 ordinary shares directly held by BpiP and
226,133 ordinary shares directly held by Innobio. BpiP is a subsidiary owned at 99.99% by BPI. CDC and EPIC each hold 49.2% of the share capital of BPI and jointly control BPI. Innobio is managed by BpiI. BpiI is a wholly-owned, indirect subsidiary
of BpiP. Neither BPI, EPIC nor BpiI hold any ordinary shares directly. BpiI may be deemed to be the beneficial owner of 226,133 ordinary shares, through its management of Innobio. BPI may be deemed to be the beneficial owner of 4,442,569 ordinary
shares held by BpiP, indirectly through its 99.99% ownership of BpiP. CDC and EPIC may be deemed to be the beneficial owners of 4,442,569 ordinary shares held by BpiP, indirectly through their joint ownership and control of BPI. The principal
address for CDC Croissance is 209, rue de l&#146;Universit&eacute;, 75007 Paris. The principal address for CDC is 56, rue de Lille, 75007 Paris, France. The principal address for Bpifrance Participations, Innobio, Bpifrance Investissement, EPIC and
Bpifrance is <FONT STYLE="white-space:nowrap">27-31,</FONT> avenue du G&eacute;n&eacute;ral Leclerc, 94710 Maisons-Alfort Cedex, France. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Based on information provided in a Form 3 filed by Baker Bros. Advisors LP on January&nbsp;11, 2021. Consists
of (a) 4,286,038 ordinary shares held in the aggregate by 667, L.P. , Baker Brothers Life Sciences Capital, L.P. and Baker Brothers Life Sciences, L.P. (collectively, the &#147;Baker Bros. Holders&#148;), (b) 14,614,264 ADSs representing 7,307,132
ordinary shares held by the Baker Bros. Holders and (c) 21,500 ordinary shares issuable upon the exercise of warrants (the &#147;Baker Bros. Warrants&#148;) that are immediately exercisable or exercisable within 60 days of March&nbsp;31, 2021,
subject to French law. As a result of their ownership interest in (i)&nbsp;Baker Biotech Capital, L.P. and (ii) 667, Julian C. Baker and Felix J. Baker each may be deemed to have an indirect pecuniary interest in Ordinary Shares or ADS, as
applicable, directly held by 667, a limited partnership of which the sole general partner is Baker Biotech Capital, L.P., a limited partnership of which the sole general partner is Baker Biotech Capital (GP), LLC, due to their interest in 667 and
Baker Biotech Capital, L.P.&#146;s right to receive an allocation of a portion of the profits from 667. As a result of their ownership interest in (i)&nbsp;Baker Brothers Life Sciences Capital, L.P. and (ii)&nbsp;Baker Brothers Life Sciences, L.P,
(&#147;Life Sciences&#148;, and together with 667, the &#147;Funds&#148;), Julian C. Baker and Felix J. Baker may be deemed to have an indirect pecuniary interest in Ordinary Shares or ADS, as applicable, directly held by Life Sciences, a limited
partnership of which the sole general partner is Baker Brothers Life Sciences Capital, L.P., a limited partnership of which the sole general partner is Baker Brothers Life Sciences Capital (GP), LLC, due to their interest in Life Sciences and Baker
Brothers Life Sciences Capital, L.P.&#146;s right to receive an allocation of a portion of the profits from Life Sciences. Baker Bros. Advisors LP (the &#147;Adviser&#148;) serves as the investment adviser to the Funds. In connection with the
services provided by the Adviser, the Adviser receives an asset-based management fee that does not confer any pecuniary interest in the securities held by the Funds. Baker Bros. Advisors (GP) LLC (the &#147;Adviser GP&#148;) is the Adviser&#146;s
sole general partner. Julian C. Baker and Felix J. Baker are managing members of the Adviser GP. The Adviser has complete and unlimited discretion and authority with respect to the investment and voting power of the securities held by the Funds. The
general partners of the Funds relinquished to the Adviser all discretion and authority with respect to the investment and voting power of the securities held by the Funds. Julian C. Baker, Felix J. Baker, the Adviser GP and the Adviser disclaim
beneficial ownership of the securities held directly by the Funds except to the extent of their pecuniary interest therein. Michael Goller, a full-time employee of the Adviser currently serves on DBV&#146;s Board of directors as a representative of
the Funds. The policy of the Funds and the Adviser does not permit full-time employees of the Adviser to receive compensation for serving as directors of the Issuer, and the Funds are instead entitled to the pecuniary interest in the Baker Bros.
Warrants. Michael Goller has no voting or dispositive power and no pecuniary interest in the Baker Bros. Other than through their control of the Adviser, Felix J. Baker and Julian C. Baker have neither voting nor dispositive power and have no direct
pecuniary interest in the Baker Bros. Warrants held by Michael Goller. The Funds are instead entitled to the pecuniary interest in the Baker Bros. Warrants held by Michael Goller. The Adviser has voting and investment power over the Baker Bros.
Warrants held by Michael </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">37 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
Goller. The address for each of these entities is 860 Washington Street, 3rd Floor, New York, New York 10014. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">This information is based solely on a Schedule 13G filed by Boxer Capital, LLC, or Boxer Capital, Boxer Asset
Management Inc., or Boxer Management, Joe Lewis, MVA Investors and Aaron Davis on February&nbsp;16, 2021. Comprised of ordinary shares held through American Depositary Shares. Boxer Management is the managing member and majority owner of Boxer
Capital. Joe Lewis is the sole indirect beneficial owner of and controls Boxer Management. The principal business address for Boxer Capital, MVA Investors and Aaron Davis is 11682 El Camino Real, Suite 320, San Diego, CA 92130. The principal
business address for Boxer Management and Joe Lewis is Cay House, EP Taylor Drive N7776, Lyford Cay, New Providence, Bahamas. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">This information is based solely on a Schedule 13G/A filed by Perceptive Advisors LLC, or Perceptive Advisors,
Joseph Edelman and Perceptive Life Sciences Master Fund, Ltd., or the Master Fund, on February&nbsp;16, 2021. The Master Fund directly holds 1,124,371 Ordinary Shares of Common Stock and 6,595,505 American Depositary Shares, each representing <FONT
STYLE="white-space:nowrap">one-half</FONT> of one Ordinary Share. Perceptive Advisors serves as the investment manager to the Master Fund and may be deemed to beneficially own the securities directly held by the Master Fund. Mr.&nbsp;Edelman is the
managing member of Perceptive Advisors and may be deemed to beneficially own the securities directly held by the Master Fund. The principal business address for Perceptive Advisors is 51 Astor Place, 10th Floor, New York, New York 10003.
</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Based on information provided in a Schedule 13G filed by Morgan Stanley on January&nbsp;25, 2021. The principal
business address for Morgan Stanley is 1585 Broadway, New York, New York 10036. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(6)<B></B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>Consists of (a) 23,570 shares and (b) 9,000 shares issuable upon the exercise of warrants that are
immediately exercisable or exercisable within 60 days of March&nbsp;31, 2021, subject to French law </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(7)<B></B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>Consists of (a) 35,925 shares and (b) 7,000 shares issuable upon the exercise of warrants that are
immediately exercisable or exercisable within 60 days of March&nbsp;31, 2021, subject to French law. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(8)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Consists of shares issuable upon the exercise of warrants that are immediately exercisable or exercisable
within 60 days of March&nbsp;31, 2021, subject to French law. Mr.&nbsp;Goller has neither voting nor dispositive power and has no direct pecuniary interest in these securities. He has entered into an agreement with Baker Bros. Advisors LP related to
his beneficial ownership of our securities, as disclosed in a Schedule 13D/A filed by Baker Bros. Advisors LP, Baker Bros. Advisors (GP) LLC, Felix J. Baker and Julian C. Baker on June&nbsp;26, 2018. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(9)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Consists of shares that are immediately exercisable or exercisable within 60 days of March&nbsp;31, 2021,
subject to French law. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(10)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Consists of shares issuable upon the exercise of warrants that are immediately exercisable or exercisable
within 60 days of March&nbsp;31, 2021, subject to French law. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(11)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Consists of shares issuable upon the exercise of warrants that are immediately exercisable or exercisable
within 60 days of March&nbsp;31, 2021, subject to French law. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(12)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Consists of (a) 80,095 shares and (b) 346,250 shares issuable upon the exercise of options and warrants that
are immediately exercisable or exercisable within 60 days of March&nbsp;31, 2021, subject to French law. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">38 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc140648_7"></A>SECTION 16(a) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;16(a) of the Securities Exchange Act of 1934, as amended, or the Exchange Act, requires our directors and executive officers, and
persons who own more than ten percent of a registered class of our equity securities, to file with the SEC initial reports of ownership and reports of changes in ownership of our common stock and other equity securities. Officers, directors and
greater than ten percent shareholders are required by SEC regulations to furnish us with copies of all Section&nbsp;16(a) forms they file. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Because we were, prior to January&nbsp;1, 2021, a foreign private issuer, our officers, directors and greater than ten percent shareholders
were not required to make any filings pursuant to Section&nbsp;16(a) in the year ended December&nbsp;31, 2020. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">39 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc140648_8"></A>CERTAIN RELATIONSHIPS AND RELATED PERSON TRANSACTIONS </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Policies and Procedures for Related Person Transactions </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have adopted a related-party transaction policy that sets forth our procedures for the identification, review, consideration and approval or
ratification of related-party transactions. For purposes of our policy only, a related-party transaction is a transaction, arrangement or relationship, or any series of similar transactions, arrangements or relationships, in which we and any related
parties are, were or will be participants, which are not (1)&nbsp;in the ordinary course of business, (2)&nbsp;at arms&#146; length and (3)&nbsp;in which the amount involved exceeds $120,000. Transactions involving compensation for services provided
to us as an employee or director are not covered by this policy. For purposes of this policy, a related party is any executive officer, director (or nominee for director) or beneficial owner of more than five percent (5%) of any class of our voting
securities, including any of their immediate family members and any entity owned or controlled by such persons. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the policy, if a
transaction has been identified as a related-party transaction, including any transaction that was not a related-party transaction when originally consummated or any transaction that was not initially identified as a related-party transaction prior
to consummation, our management must present information regarding the related-party transaction to our board of directors for review, consideration and approval. The presentation must include a description of, among other things, the material
facts, the interests, direct and indirect, of the related parties, the benefits to us of the transaction and whether the transaction is on terms that are comparable to the terms available to or from, as the case may be, an unrelated third-party or
to or from employees generally. Under the policy, we will collect information that we deem reasonably necessary from each director, executive officer and, to the extent feasible, significant shareholder to enable us to identify any existing or
potential related-party transactions and to effectuate the terms of the policy. In addition, under our Code of Business Conduct and Ethics, our employees and directors have an affirmative responsibility to disclose any transaction or relationship
that reasonably could be expected to give rise to a conflict of interest. In considering related-party transactions, our board, or to the extent permitted by applicable law an independent body of our board, will take into account the relevant
available facts and circumstances including, but not limited to: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the risks, costs and benefits to us; </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the impact on a director&#146;s independence in the event that the related-party is a director, immediate family
member of a director or an entity with which a director is affiliated; </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the availability of other sources for comparable services or products; and </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the terms available to or from, as the case may be, unrelated third parties or to or from employees generally.
The policy requires that, in determining whether to approve, ratify or reject a related-party transaction, our board of directors, or if permitted by applicable law an independent body of our board of directors, must consider, in light of known
circumstances, whether the transaction is in, or is not inconsistent with, our best interests and those of our shareholders, as our board of directors, or if permitted by applicable law an independent body of our board of directors, determines in
the good faith exercise of its discretion. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Related Party Transactions </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Since January&nbsp;1, 2019, we have engaged in the following transactions with our directors, executive officers and holders of more than five
percent (5%) of our outstanding voting securities and their affiliates, which we refer to as our related-parties. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Participation in
April 2019 Underwritten Global Offering </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As part of our April 2019 underwritten global offering, certain of our holders of more
than 5% of our outstanding voting securities and their affiliates purchased an aggregate of 3,099,772 ordinary shares at the public offering price of &#128;12.02 per ordinary share. The following table sets forth the aggregate number of
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">40 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
ordinary shares that certain of our holders of more than 5% of our outstanding voting securities and their affiliates purchased: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="76%"></TD>

<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman"><B>Related Party</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of<BR>Ordinary&nbsp;Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Baker Brothers Life Sciences, L.P.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,851,852</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Bpifrance Participations S.A.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,247,920</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Participation in October 2019 Underwritten Global Offering </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As part of our October 2019 underwritten global offering, one of our holders of more than 5% of our outstanding voting securities and their
affiliates purchased an aggregate of 9,104,704 ADSs at the public offering price of $6.59 per ADS. The following table sets forth the aggregate number of ADSs that one of our holders of more than 5% of our outstanding voting securities and their
affiliates purchased: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman"><B>Related Party</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of<BR>ADSs</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Entities affiliated with Baker Bros. Advisors LP&nbsp;(1)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9,104,704</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Consists of 8,351,123 ADSs issued to Baker Brothers Life Sciences, L.P. and 753,581 ADSs issued to 667, L.P.
</P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Participation in February 2020 Underwritten Global Offering </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As part of our February 2020 underwritten global offering, two of our holders of more than 5% of our outstanding voting securities and their
affiliates purchased an aggregate of 664,419 ordinary shares at the public offering price of &#128;18.63 per ordinary share. The following table sets forth the aggregate number of ordinary shares that two of our holders of more than 5% of our
outstanding voting securities and their affiliates purchased: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="76%"></TD>

<TD VALIGN="bottom" WIDTH="13%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman"><B>Related Party</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number&nbsp;of<BR>Ordinary&nbsp;Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Entities affiliated with Baker Bros. Advisors LP&nbsp;(1)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">450,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Bpifrance Participations S.A.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">214,419</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Consists of 450,000 ordinary shares issued to Baker Brothers Life Sciences, L.P. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Registration Rights </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In March 2018, we entered into a registration rights agreement, or the Registration Rights Agreement, with entities affiliated with Baker Bros.
Advisors LP, or Baker Brothers, pursuant to which Baker Brothers is entitled to rights with respect to the registration under the Securities Act of ordinary shares and ADSs, including ordinary shares or ADSs issuable upon the exercise or conversion
of any other securities (whether equity, debt or otherwise) owned or subsequently acquired by Baker Brothers. These rights include demand registration rights and piggyback registration rights. All fees, costs and expenses of underwritten
registrations will be borne by us and all selling expenses, including underwriting commissions, will be borne by Baker Brothers. Under the terms of the Registration Rights Agreement, we are required, upon the request of Baker Brothers, to file a
registration statement covering, and use our reasonable best efforts to effect, the registration of the ordinary shares, including in the form of ADSs, requested to be registered for public resale. In addition, if we register our securities either
for our own account or for the account of other security holders under certain circumstances more than six months following the completion of our March 2018 underwritten global offering, Baker Brothers is entitled to include its ordinary shares or
ADSs in such registration. Subject to certain exceptions, we and the underwriters may limit the number of ordinary shares or ADSs included in an underwritten offering conducted pursuant to the terms of the Registration Rights Agreement if the
underwriters believe that including such securities would adversely affect the offering. The registration rights granted under the Registration Rights Agreement will terminate ten years after the date of the Registration Rights Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">41 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Agreements with Our Directors and Executive Officers </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Employment and Consulting Arrangements </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Daniel Tass&eacute;. </I></B>In November 2018, we entered into an executive agreement (as French &#147;mandataire social&#148;) with
Mr.&nbsp;Daniel Tass&eacute;, our current Chief Executive Officer. He is entitled to an annual base salary. Mr.&nbsp;Tass&eacute; is also eligible to receive equity grants as our board of directors may determine and to participate in our bonus plan.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In December 2018, our board of directors fixed the performance criteria in the event of termination of Mr.&nbsp;Daniel
Tass&eacute;&#146;s duties as our Chief Executive Officer. He will benefit from a severance package if all the following objectives are achieved: (i)&nbsp;Viaskin Peanut is approved in a major market; (ii)&nbsp;build an EPIT pipeline with three
ongoing clinical trials; (iii)&nbsp;six months cash runway as defined by the last quarter of spend on the day of severance. Compliance with these performance conditions will be established by our board of directors prior to any payment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event of termination &#147;without cause&#148; or for &#147;good reason&#148;, we will pay an amount equal to the sum of: (i) 18 months
of Mr.&nbsp;Tass&eacute;&#146;s base salary and (ii)&nbsp;the target bonus at a 100% achievement level. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In case of termination without
&#147;cause&#148; or for &#147;good reason&#148; outside of a change of control, the severance benefits will get paid out over a <FONT STYLE="white-space:nowrap">12-month</FONT> period. In case of termination without &#147;cause&#148; or for
&#147;good reason&#148; in connection with a change of control, those same amounts get paid in a lump sum. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>S&eacute;bastien
Robitaille. </I></B>In September 2015, we entered into an employment agreement with Mr.&nbsp;Robitaille, our then Senior Vice President, Group Controller&nbsp;&amp; Information Systems and current Chief of Staff. Mr.&nbsp;Robitaille is entitled to
an annual base salary. Mr.&nbsp;Robitaille is also eligible to receive equity grants as our board may determine and to participate in our bonus plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Dr.</I></B><B><I></I></B><B><I>&nbsp;Pharis Mohideen. </I></B>In July 2019, we entered into an employment agreement with
Mr.&nbsp;Mohideen, our Chief Medical Officer. Mr.&nbsp;Mohideen is entitled to an annual base salary. Mr.&nbsp;Mohideen is also eligible to receive equity grants as our board may determine and to participate in our bonus plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Ramzi Benamar</I></B><B>.</B> In January 2020, we entered into an employment agreement with Mr.&nbsp;Benamar, our then-Chief Financial
Officer. Mr.&nbsp;Benamar was entitled to an annual base salary. Mr.&nbsp;Benamar was also eligible to receive equity grants as our board determined from time to time and to participate in our bonus plan. Mr.&nbsp;Benamar&#146;s service as our Chief
Financial Officer ceased in October 2020. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Julie O&#146;Neill. </I></B>In December 2018, we entered into a consulting agreement with
Julie O&#146;Neill, a member of our board of directors, pursuant to which she agreed to provide chemistry, manufacturing and controls advice. Upon our request, she: (i)&nbsp;examined and remedied the shortcomings identified by the FDA;
(ii)&nbsp;examined and provided answers on all aspects of the technical operations, including, by way of <FONT STYLE="white-space:nowrap">non-exclusive</FONT> example, process development, analytical development, manufacture, engineering, the
procurement chain, quality control and quality assurance and (iii)&nbsp;advised our Chief Executive Officer and our internal services at the request of our Chief Executive Officer. The term of the agreement was for one year. Ms.&nbsp;O&#146;Neill
received &#128;45,000 per month and was eligible to receive certain success fees allocated as follows: (i)&nbsp;a maximum of &#128;200,000 for the resubmission of the BLA to the FDA for the treatment of peanut allergy in children four to 11 of age
and; (ii)&nbsp;an additional amount of up to &#128;250,000 if and when the FDA has approved the Viaskin Peanut BLA. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Director and
Executive Officer Compensation </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">See &#147;Board of Directors and Corporate Governance&#148; and &#147;Executive Compensation&#148; for
information regarding compensation of directors and executive officers. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">42 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Equity Awards </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Since January&nbsp;1, 2019, we have issued the following equity awards to our related parties: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">On January 15, 2019, we issued an aggregate of 9,500 options shares to new U.S. employees. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">On March 20, 2019, we issued an aggregate of 547,100 option shares to U.S. employees, of which 187,500 were to
certain of our executive officers. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">On May 10, 2019, we issued an aggregate of 100,000 free shares to certain of our French employees and French
executive officers. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">On May 15, 2019, we issued an aggregate of 7,200 option shares to new U.S. employees. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">On May 24, 2019, we issued an aggregate of 150,000 option shares to our CEO. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">On June 17, 2019, we issued an aggregate of 7,200 option shares to new U.S. employees. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">On July 1, 2019, we issued an aggregate of 403,400 option shares to U.S. employees. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">On July 22, 2019, we issued an aggregate of 75,000 option shares to certain of our executive officers.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">On July 31, 2019, we issued an aggregate of 23,750 free shares to certain of our French employees.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">On August 11, 2019, we issued an aggregate of 40,000 free shares to certain of our French employees and French
executive officers. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">On September 16, 2019, we issued an aggregate of 34,000 option shares to new U.S. employees.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">On October 16, 2019, we issued an aggregate of 3,500 option shares to new U.S. employees. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">On December 16, 2019, we issued an aggregate of 53,100 option shares to new U.S. employees.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">On December 19, 2019, we issued an aggregate of 23,600 free shares to all French employees.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">On January 15, 2020, we issued an aggregate of 85,200 option shares to certain US employees and executive
officers. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">On March 16, 2020, we issued an aggregate of 5,000 free shares to certain French employees.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">On April 29, 2020, we issued an aggregate of 20,000 free shares to certain French employees.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">On November 24, 2020, we issued an aggregate of 475,000 free shares 1,216,200 option shares to US&nbsp;&amp;
French employees and executive officers. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">See &#147;Board of Directors and Corporate Governance&#148; and
&#147;Executive Compensation&#148; for further information regarding equity awards to directors and executive officers. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Bonus Plans
</I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All our executive officers are entitled to a bonus ranging between 50% and 150% based on yearly objectives determined by our board of
directors upon recommendation of our compensation committee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Indemnification Agreements </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We intend to enter into indemnification agreements with each of our directors and executive officers. See &#147;Limitations on Liability and
Indemnification Matters&#148; above. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Insofar as indemnification for liabilities arising under the Securities Act may be permitted to
directors, officers or persons controlling us pursuant to the foregoing provisions, we have been informed that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act and is therefore unenforceable.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">43 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AUDIT FEES AND SERVICES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following tables presents fees for professional audit services rendered by KPMG S.A. and Deloitte&nbsp;&amp; Associ&eacute;s for the audit
of the Company&#146;s annual financial statements for the years ended December&nbsp;31, 2019 and December&nbsp;31, 2020 as well as fees billed for other services rendered by KPMG S.A. and Deloitte&nbsp;&amp; Associ&eacute;s during those periods.</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The amounts relating to audit fees and services in 2020 have been converted from euros to U.S. dollars at a rate of &#128;1.00 = $1.1422,
which represents the average exchange rate for the year ended December&nbsp;31, 2020, and those relating to audit fees and services in 2019 have been converted from euros to U.S. dollars at a rate of &#128;1.00 = $1.1195, which represents the
average exchange rate for the year ended December&nbsp;31, 2019. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table presents aggregate fees billed to the Company for
the fiscal years ended December&nbsp;31, 2020 and December&nbsp;31, 2019 by Deloitte&nbsp;&amp; Associ&eacute;s: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="72%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Fiscal Year Ended</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="bottom" ALIGN="center"><B>(in thousands of dollars)</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Audit Fees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">639,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">816,100</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Audit-related Fees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tax Fees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">All Other Fees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total Fees</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">639,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">816,100</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table presents aggregate fees billed to the Company for the fiscal years ended December&nbsp;31, 2020 and
December&nbsp;31, 2019 by KPMG S.A. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="77%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Fiscal Year Ended</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" ALIGN="center"><B>(in thousands of dollars)</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Audit Fees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">434,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Audit-related Fees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tax Fees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">All Other Fees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total Fees</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">434,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">There were no &#147;Audit Related Fees&#148; or &#147;Tax Fees&#148; or billed or paid during 2019 or 2020.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Audit and <FONT STYLE="white-space:nowrap">Non-Audit</FONT> Services <FONT STYLE="white-space:nowrap">Pre-Approval</FONT> Policy </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The audit committee has responsibility for appointing, setting compensation of and overseeing the work of the independent registered public
accounting firm. In recognition of this responsibility, the audit committee has adopted a policy governing the <FONT STYLE="white-space:nowrap">pre-approval</FONT> of all audit and permitted <FONT STYLE="white-space:nowrap">non-audit</FONT> services
performed by our independent registered public accounting firm to ensure that the provision of such services does not impair the independent registered public accounting firm&#146;s independence from us and our management. Unless a type of service
to be provided by our independent registered public accounting firm has received general <FONT STYLE="white-space:nowrap">pre-approval</FONT> from the audit committee, it requires specific <FONT STYLE="white-space:nowrap">pre-approval</FONT> by the
audit committee. The payment for any proposed services in excess of <FONT STYLE="white-space:nowrap">pre-approved</FONT> cost levels requires specific <FONT STYLE="white-space:nowrap">pre-approval</FONT> by the audit committee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to its <FONT STYLE="white-space:nowrap">pre-approval</FONT> policy, the audit committee may delegate its authority to <FONT
STYLE="white-space:nowrap">pre-approve</FONT> services to the chairperson of the audit committee. The decisions of the chairperson to grant <FONT STYLE="white-space:nowrap">pre-approvals</FONT> must be presented to the full audit committee at its
next scheduled meeting. The audit committee may not delegate its responsibilities to <FONT STYLE="white-space:nowrap">pre-approve</FONT> services to the management. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">44 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The audit committee has considered the <FONT STYLE="white-space:nowrap">non-audit</FONT>
services provided by KPMG and Deloitte as described above and believes that they are compatible with maintaining KPMG&#146;s and Deloitte&#146;s independence as our independent registered public accounting firm. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">45 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc140648_9_1"></A>PROPOSAL NOS. 1 TO 4: </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>APPROVAL OF THE ANNUAL FINANCIAL STATEMENTS, APPROVAL OF THE CONSOLIDATED FINANCIAL STATEMENTS, ALLOCATION OF INCOME AND ALLOCATION OFF
ACCUMULATED DEFICIT </B></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Proposal No.&nbsp;1 </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In accordance with French Law, our Board is required to present our annual statutory financial statements for the year ended December&nbsp;31,
2020 to the shareholders at the General Meeting. Shareholders who raise questions in relation to the statutory financial statements can submit questions for the Board in advance of the General Meeting to
<FONT STYLE="white-space:nowrap">investors@dbv-technologies.com.</FONT> The Board will endeavor, where appropriate, to answer such questions by publishing responses on our website as soon as practical after the General Meeting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In accordance with best practice, we are proposing an ordinary resolution to receive and adopt the statutory financial statements for the year
ended December&nbsp;31, 2020. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The 2020 statutory financial statements may be found in the Annual Reports and General Meetings section of
our website at <I><FONT STYLE="white-space:nowrap">https://www.dbv-technologies.com/investor-relations/financial-information/annual-reports/</FONT></I>. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Proposal No.&nbsp;2 </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In accordance with
French Law, our Board is required to present our consolidated statutory financial statements for the year ended December&nbsp;31, 2020 to the shareholders at the General Meeting. Shareholders who raise questions in relation to the consolidated
statutory financial statements can submit questions for the Board in advance of the General Meeting to <FONT STYLE="white-space:nowrap">investors@dbv-technologies.com.</FONT> The Board will endeavor, where appropriate, to answer such questions by
publishing responses on our website as soon as practical after the General Meeting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In accordance with best practice, we are proposing an
ordinary resolution to receive and adopt the consolidated statutory financial statements for the year ended December&nbsp;31, 2020. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
2020 consolidated statutory financial statements may be found in the General Meeting section of our website at <I><FONT STYLE="white-space:nowrap">https://www.dbv-technologies.com/investor-relations/financial-information/annual-reports/</FONT></I>.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Proposal No.&nbsp;3 </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In accordance
with French Law, our Board is required to present the proposed allocation of income for financial year ended December&nbsp;31, 2020 to the shareholders at the General Meeting. The Board proposes to fully allocate the whole of the loss for the
financial year ended December&nbsp;31, 2020, totaling &#128;(139,397,433.28), to the &#147;losses brought forward&#148; line, which would consequently change from a negative balance of &#128;(556,177,697.08) to a negative balance of
&#128;(696,575,130.36). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">No distribution of dividends or income has occurred in the past three financial years. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Proposal No.&nbsp;4 </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board proposes
to charge the whole of the retained earnings account for the financial year ended December&nbsp;31, 2020, totaling &#128;(695,575,130.36), to the &#147;share premium&#148; account, which would consequently change from a credit balance of
&#128;860,890,979.55 to a balance of &#128;165,315,849.19. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The retained earnings account would be completely cleared. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the full text of Proposal Nos. 1 to 4, please see Annex A. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">46 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Vote Required </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Proposal Nos.&nbsp;1 to 4 require the affirmative vote of a majority of the votes cast by the shareholders present in person, represented by
proxy, or voting by mail at the Annual General Meeting and entitled to vote thereon. The votes cast will not include those attached to shares for which the shareholder did not participate in the vote, abstained or voted blank or void. Abstentions
will not be counted as votes cast and will have no effect on the outcome of the votes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>THE BOARD OF DIRECTORS RECOMMENDS A VOTE
&#147;FOR&#148; </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EACH OF THE PROPOSAL NOS. 1 TO 4 </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">47 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc140648_9_2"></A>PROPOSAL NO. 5 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>STATUTORY AUDITORS&#146; SPECIAL REPORT ON REGULATED AGREEMENTS AND ACKNOWLEDGMENT OF THE ABSENCE OF THE NEW REGULATED AGREEMENTS </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In accordance with French law, our Board is required to present to the Annual General Meeting the annual report of our statutory auditors on new related party
transactions entered into either during the last financial year or at the beginning of the current financial year, it being specified that no new agreements referred to in Article L. <FONT STYLE="white-space:nowrap">225-38</FONT> of the French
Commercial Code were entered into in 2020 and early 2021. By approving Proposal No.&nbsp;5, shareholders will acknowledge that there were no related person transactions within the meaning of Articles L. <FONT STYLE="white-space:nowrap">225-3</FONT>
et seq. of the French Commercial Code entered into during 2020. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the full text of Proposal No.&nbsp;5, please see Annex A. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Vote Required </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Proposal No.&nbsp;5
requires the affirmative vote of a majority of the votes cast by the shareholders present in person, represented by proxy, or voting by mail at the Annual General Meeting and entitled to vote thereon. The votes cast will not include those attached
to shares for which the shareholder did not participate in the vote, abstained or voted blank or void. Abstentions will not be counted as votes cast and will have no effect on the outcome of the votes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>THE BOARD OF DIRECTORS RECOMMENDS A VOTE &#147;FOR&#148; </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PROPOSAL 5. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">48 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc140648_9_3"></A>PROPOSAL NOS. 6 TO 10 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>RENEWAL OF TERM OF JULIE O&#146;NEILL, RENEWAL OF TERM OF VIVIANE MONGES, APPOINTMENT OF ADORA NDU, APPOINTMENT OF RAVI RAO AND RATIFICATION
OF PROVISIONAL APPOINTMENT OF TIMOTHY E. MORRIS AS DIRECTORS </B></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Proposal 6 </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Ms.&nbsp;Julie O&#146;Neill is currently a member of our Board and has been nominated for <FONT STYLE="white-space:nowrap">re-election</FONT>
as director. If <FONT STYLE="white-space:nowrap">re-elected,</FONT> she will hold office from the date of her <FONT STYLE="white-space:nowrap">re-election</FONT> for a period of three years, to expire at the end of General Meeting occurring in 2024,
where she must retire by rotation and offer herself for <FONT STYLE="white-space:nowrap">re-election,</FONT> or until her earlier death, resignation, or removal. Ms.&nbsp;O&#146;Neill has agreed to serve if
<FONT STYLE="white-space:nowrap">re-elected,</FONT> and we have no reason to believe that she will be unable to serve. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Ms.&nbsp;O&#146;Neill&#146;s biography is provided above under &#147;Board of Directors and Corporate Governance &#150; Board of
Directors.&#148; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Proposal 7 </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Ms.&nbsp;Viviane Monges is currently a member of our Board and has been nominated for <FONT STYLE="white-space:nowrap">re-election</FONT> as
director. If <FONT STYLE="white-space:nowrap">re-elected,</FONT> she will hold office from the date of her <FONT STYLE="white-space:nowrap">re-election</FONT> for a period of three years, to expire at the end of General Meeting occurring in 2024,
where she must retire by rotation and offer herself for <FONT STYLE="white-space:nowrap">re-election,</FONT> or until her earlier death, resignation, or removal. Ms.&nbsp;Monges has agreed to serve if
<FONT STYLE="white-space:nowrap">re-elected,</FONT> and we have no reason to believe that she will be unable to serve. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Ms.&nbsp;Monges&#146; biography is provided above under &#147;Board of Directors and Corporate Governance &#150; Board of Directors.&#148;
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Proposal 8 </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If appointed, Mrs.&nbsp;Ndu will hold
office from the date of her appointment for a period of three years, to expire at the end of General Meeting occurring in 2024 where she must retire by rotation and offer herself for <FONT STYLE="white-space:nowrap">re-election,</FONT> or until her
earlier death, resignation, or removal. Mrs.&nbsp;Ndu has agreed to serve if elected, and we have no reason to believe that she will be unable to serve. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Ms.&nbsp;Ndu&#146;s biography is provided above under &#147;Board of Directors and Corporate Governance &#150; Board of Directors.&#148; </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Proposal 9 </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If appointed, Mr.&nbsp;Rao
will hold office from the date of his appointment for a period of three years, to expire at the end of General Meeting occurring in 2024, where he must retire by rotation and offer himself for <FONT STYLE="white-space:nowrap">re-election,</FONT> or
until her earlier death, resignation, or removal. Mr.&nbsp;Rao has agreed to serve if elected, and we have no reason to believe that he will be unable to serve. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Mr.&nbsp;Rao&#146;s biography is provided above under &#147;Board of Directors and Corporate Governance &#150; Board of Directors.&#148; </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Proposal 10 </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Mr.&nbsp;Morris was
provisionally appointed to the Board to replace Mrs.&nbsp;Claire Giraut following her resignation. If his provisional appointment is ratified, Mr.&nbsp;Rao will hold office until the expiration of the term of appointment of his predecessor, namely,
until the annual meeting of shareholders to be held in 2022. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">49 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Mr.&nbsp;Morris&#146;s biography is provided above under &#147;Board of Directors and
Corporate Governance &#150; Board of Directors.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the full text of Proposal Nos. 6 to 10, please see Annex A. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Vote Required </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Proposal Nos.&nbsp;6 to 10
require the affirmative vote of a majority of the votes cast by the shareholders present in person, represented by proxy, or voting by mail at the Annual General Meeting and entitled to vote thereon. Under French law, this means that the votes cast
&#147;FOR&#148; a nominee must exceed the aggregate of the votes cast &#147;AGAINST&#148; that nominee, and the votes cast &#147;FOR&#148; a resolution must exceed the aggregate of the votes cast &#147;AGAINST&#148; that resolution. The votes cast
will not include those attached to shares for which the shareholder did not participate in the vote, abstained or voted blank or void. Abstentions will not be counted as votes cast and will have no effect on the outcome of the votes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>THE BOARD OF DIRECTORS RECOMMENDS A VOTE &#147;FOR&#148; </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EACH OF THE PROPOSAL NOS. 6 TO 10 </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">50 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc140648_9_4"></A>PROPOSAL NOS. 11 TO 13: </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>DETERMINATION OF THE ANNUAL FIXED AMOUNT TO BE ALLOCATED TO THE MEMBERS OF THE BOARD OF DIRECTORS, APPROVAL OF THE COMPENSATION POLICY FOR
THE CHAIRMAN OF THE BOARD OF DIRECTORS AND FOR THE DIRECTORS AND APPROVAL OF THE COMPENSATION POLICY FOR THE CHIEF EXECUTIVE OFFICER AND/OR ANY OTHER EXECUTIVE CORPORATE OFFICER </B></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Proposal 11 </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In accordance with French
law, our Board is required to present to shareholders the proposed compensation to be allocated to the Board of Directors for their approval at the General Meeting. The Board proposes an increase in the total annual amount of the Board members&#146;
fees to be allocated to the Board of Directors from &#128;600,000 to &#128;800,000 for the current financial year and for future financial years until otherwise decided by a new General Meeting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As a global company listed on both Euronext Paris and the Nasdaq Global Market, it is critical that our compensation program attract global
talent. This proposal is intended to modify our <FONT STYLE="white-space:nowrap">non-employee</FONT> director compensation program to better align such program with U.S. director compensation programs based on a market assessment conducted by our
independent compensation consultant, including to enable us to award directors with long-term equity incentive compensation intended to motivate and reward our <FONT STYLE="white-space:nowrap">non-employee</FONT> directors for long-term company
performance and better align our <FONT STYLE="white-space:nowrap">non-employee</FONT> directors&#146; interests with shareholder interests and long-term shareholder value. In addition, this proposal would enable us to increase annual cash
compensation to our <FONT STYLE="white-space:nowrap">non-employee</FONT> directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We believe that this resolution is in
shareholders&#146; best interest by allowing us to diversify and enrich our Board to provide appropriate governance and inform strategy. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Proposal 12
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In accordance with Article L. <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">22-10-8</FONT></FONT> of the French
Commercial Code, our Board is required to present to shareholders the proposed compensation policy to be allocated to the Chairman of the Board of Directors for their approval at the General Meeting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For reference, an English translation of our proposed compensation policy is set forth in Annex B. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Proposal 13 </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In accordance with Article
L. <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">22-10-8</FONT></FONT> of the French Commercial Code, our Board is required to present to shareholders the proposed compensation policy to be allocated to the Chief Executive
Officer and any other executive corporate officer for their approval at the General Meeting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For reference, an English translation of our
proposed compensation policy is set forth in Annex B. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the full text of Proposal Nos. 11 to 13, please see Annex A. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Vote Required </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Proposal Nos.&nbsp;11 to
13 require the affirmative vote of a majority of the votes cast by the shareholders present in person, represented by proxy, or voting by mail at the Annual General Meeting and entitled to vote thereon. The votes cast will not include those attached
to shares for which the shareholder did not participate in the vote, abstained or voted blank or void. Abstentions will not be counted as votes cast and will have no effect on the outcome of the votes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>THE BOARD OF DIRECTORS RECOMMENDS A VOTE &#147;FOR&#148; </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EACH OF THE PROPOSAL NOS. 11 TO 13 </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">51 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc140648_9_5"></A>PROPOSAL NO. 14: </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ADVISORY OPINION ON THE COMPENSATION OF NAMED EXECUTIVE OFFICERS OTHER THAN THE CHIEF EXECUTIVE OFFICER </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In accordance with the requirements of Section&nbsp;14A of the Exchange Act, we are including in this proxy statement a resolution, subject to
shareholder vote, to approve, on a non-binding advisory basis, the compensation of our named executive officers other than the Chief Executive Officer (as disclosed under &#147;Executive Compensation&#148; and the tables that follow). Shareholder
approval of the compensation of our Chief Executive Officer is required as a matter of French law and is addressed by Proposal No.&nbsp;13. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We believe that our compensation programs for our named executive officers have been effective at promoting the achievement of positive
results, appropriately aligning pay and performance and enabling us to attract and retain very talented executives within our industry, while at the same time avoiding the encouragement of unnecessary or excessive risk-taking. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are asking our shareholders to indicate their support for the compensation of our named executive officers as described in this proxy
statement. This resolution, commonly known as a &#147;say-on-pay&#148; proposal, gives you as a shareholder the opportunity to express your views on our 2020 compensation for our named executive officers. This vote is not intended to address any
specific item of compensation; rather, the vote relates to the overall compensation of our named executive officers as described in this proxy statement in accordance with the compensation disclosure rules of the SEC. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Although this is an advisory vote which will not be binding on our compensation committee or board of directors, our compensation committee
and board of directors will carefully review the results of the shareholder vote. Our compensation committee and board of directors will consider potential shareholders&#146; concerns and take them into account in future determinations concerning
compensation of our named executive officers. Our board of directors therefore recommends that you indicate your support for the compensation of our named executive officers in 2019 as outlined in this proxy statement, by voting &#147;FOR&#148;
Resolution 14. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the full text of Resolution 14, please see Annex A. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Vote Required </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Proposal No.&nbsp;14
requires the affirmative vote of a majority of the votes cast by the shareholders present in person, represented by proxy, or voting by mail at the Annual General Meeting and entitled to vote thereon. The votes cast will not include those attached
to shares for which the shareholder did not participate in the vote, abstained or voted blank or void. Abstentions will not be counted as votes cast and will have no effect on the outcome of the votes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>THE BOARD OF DIRECTORS RECOMMENDS A VOTE &#147;FOR&#148; </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PROPOSAL NO. 14 </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">52 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc140648_9_6"></A>PROPOSAL NOS. 15 TO 17: </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ADVISORY VOTE ON THE FREQUENCY OF FUTURE ADVISORY VOTES ON NAMED EXECUTIVE OFFICER COMPENSATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Dodd-Frank Act and Section&nbsp;14A of the Exchange Act also enable our shareholders to indicate their preference at least once every six
years regarding how frequently we should solicit an advisory vote on the compensation of our named executive officers as disclosed in our proxy statement. Accordingly, we are asking our shareholders to indicate whether they would prefer an advisory
vote every one, two or three years. Alternatively, shareholders may abstain from casting a vote. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To comply with this requirement and the
limitations of French law, which permits shareholders to only vote &#147;FOR,&#148; &#147;AGAINST&#148; or &#147;ABSTAIN&#148; on any particular matter, we are presenting three <FONT STYLE="white-space:nowrap">non-binding</FONT> resolutions asking
our shareholders whether they prefer to cast future advisory votes on our Named Executive Officers&#146; compensation every year, once every two years, or once every three years, respectively. Shareholders have the option to vote &#147;FOR,&#148;
&#147;AGAINST&#148; or abstain on each of the three resolutions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our board of directors recommends that future advisory votes to approve
the compensation of our named executive officers take place every year. After careful consideration, the board of directors has determined that an advisory vote to approve executive compensation that occurs annually is the most appropriate
alternative for the Company, as it will allow shareholders to provide us with regular, direct input on our compensation philosophy, policies and practices as disclosed in the proxy statement every year. Additionally, an annual advisory vote to
approve executive compensation is consistent with our policy of seeking input from, and engaging in discussions with, our shareholders on corporate governance matters and our executive compensation philosophy, policies and practices. We will
continue to engage with our shareholders regarding our executive pay programs between shareholder advisory votes as part of our governance process. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company recognizes that shareholders may have different views as to the best approach for the Company and, therefore, the Company and our
board of directors encourage shareholders to express their preferences as to the appropriate frequency of the advisory vote to approve our named executive officers&#146; compensation<B>&nbsp;by voting &#147;FOR&#148; one (and only one) of Proposal
Nos.</B><B></B><B>&nbsp;15 through 17 and voting &#147;AGAINST&#148; the remaining two such proposals</B>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Vote Required </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The board of directors and the compensation committee will take into account the outcome of the vote on Proposal Nos.&nbsp;15 through 17 when
determining how often we will ask our shareholders to submit an advisory vote to approve our named executive officers&#146; compensation. If a majority of the votes cast are in favor of more than one of Proposal Nos.&nbsp;15 through 17 or if all
three such resolutions fail to receive a majority of the votes cast, the Company will consider the resolution with the highest percentage of &#147;FOR&#148; votes to be the recommendation of the shareholders. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the full text of Proposal Nos.&nbsp;15 to 17, please see Annex&nbsp;A. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>THE BOARD OF DIRECTORS RECOMMENDS THAT YOU VOTE &#147;FOR&#148; </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PROPOSAL 15 AND &#147;AGAINST&#148; PROPOSAL NOS. 16 AND 17. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">53 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc140648_9_7"></A>PROPOSAL NO. 18: </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>APPROVAL OF THE INFORMATION SET OUT IN SECTION I OF THE ARTICLE
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">L.22-10-9</FONT></FONT> OF THE FRENCH COMMERCIAL CODE </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In accordance
with Article <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">L.22-10-34</FONT></FONT> of the French Commercial Code, our Board is required to present to shareholders the information referred to in I of article <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">L.22-10-9</FONT></FONT> of the French Commercial Code mentioned in the corporate governance report included in the 2020 universal registration document filed with the AMF on March&nbsp;17,
2021 . </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For a description of such information referred to in I of article
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">L.22-10-9</FONT></FONT> of the French Commercial Code, please refer to Annex C, Part 1 and Part 2. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the full text of Proposal No.&nbsp;18, please see Annex A. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Vote Required </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Proposal No.&nbsp;18
requires the affirmative vote of a majority of the votes cast by the shareholders present in person, represented by proxy, or voting by mail at the Annual General Meeting and entitled to vote thereon. The votes cast will not include those attached
to shares for which the shareholder did not participate in the vote, abstained or voted blank or void. Abstentions will not be counted as votes cast and will have no effect on the outcome of the votes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>THE BOARD OF DIRECTORS RECOMMENDS A VOTE &#147;FOR&#148; </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PROPOSAL 18. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">54 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc140648_9_8"></A>PROPOSAL NO. 19: </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>APPROVAL OF THE FIXED, VARIABLE AND <FONT STYLE="white-space:nowrap">NON-RECURRING</FONT> COMPONENTS OF OVERALL COMPENSATION AND BENEFITS OF
ALL TYPES PAID OR ASSIGNED DURING THE YEAR ENDED TO MICHEL DE ROSEN, CHAIRMAN OF THE BOARD OF DIRECTORS </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In accordance with Article L. <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">22-10-34</FONT></FONT> II of the French Commercial Code, our Board is required to present to shareholders the fixed, variable and <FONT STYLE="white-space:nowrap">non-recurring</FONT>
components of overall compensation and benefits of all types paid or assigned during the year ended to Michel de Rosen, Chairman of the Board of Directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>FOR A DESCRIPTION OF SUCH INFORMATION RELATING TO MICHEL DE ROSEN, PLEASE REFER TO ANNEX C, PART 2. </B>For the full text of Proposal
No.&nbsp;19, please see Annex A. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Vote Required </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Proposal No.&nbsp;19 requires the affirmative vote of a majority of the votes cast by the shareholders present in person, represented by proxy,
or voting by mail at the Annual General Meeting and entitled to vote thereon. The votes cast will not include those attached to shares for which the shareholder did not participate in the vote, abstained or voted blank or void. Abstentions will not
be counted as votes cast and will have no effect on the outcome of the votes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>THE BOARD OF DIRECTORS RECOMMENDS A VOTE &#147;FOR&#148;
</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PROPOSAL 19. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">55 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc140648_9_9"></A>PROPOSAL NO. 20: </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>APPROVAL OF THE FIXED, VARIABLE AND <FONT STYLE="white-space:nowrap">NON-RECURRING</FONT> COMPONENTS OF OVERALL COMPENSATION AND BENEFITS OF
ALL TYPES PAID OR ASSIGNED DURING THE YEAR ENDED TO DANIEL TASS&Eacute;, CHIEF EXECUTIVE OFFICER </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In accordance with Article L. <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">22-10-34</FONT></FONT> II of the French Commercial Code, our Board is required to present to shareholders the fixed, variable and <FONT STYLE="white-space:nowrap">non-recurring</FONT>
components of overall compensation and benefits of all types paid or assigned during the year ended to Daniel Tass&eacute;, Chief Executive Officer. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For
a description of such information relating to Daniel Tass&eacute;, please refer to Annex C, Part 2. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the full text of Proposal
No.&nbsp;20, please see Annex A. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Vote Required </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Proposal No.&nbsp;20 requires the affirmative vote of a majority of the votes cast by the shareholders present in person, represented by proxy,
or voting by mail at the Annual General Meeting and entitled to vote thereon. The votes cast will not include those attached to shares for which the shareholder did not participate in the vote, abstained or voted blank or void. Abstentions will not
be counted as votes cast and will have no effect on the outcome of the votes. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>THE BOARD OF DIRECTORS RECOMMENDS A VOTE &#147;FOR&#148;
</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PROPOSAL 20. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">56 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc140648_9_10"></A>PROPOSAL NO. 21: </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>APPROVAL OF THE FIXED, VARIABLE AND <FONT STYLE="white-space:nowrap">NON-RECURRING</FONT> COMPONENTS OF OVERALL COMPENSATION AND BENEFITS OF
ALL TYPES PAID OR ASSIGNED DURING THE YEAR ENDED TO CATHERINE TH&Eacute;R&Eacute;N&Eacute;, DEPUTY CHIEF EXECUTIVE OFFICER </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In
accordance with Article L. <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">22-10-34</FONT></FONT> II of the French Commercial Code, our Board is required to present to shareholders the fixed, variable and <FONT
STYLE="white-space:nowrap">non-recurring</FONT> components of overall compensation and benefits of all types paid or assigned during the year ended to Marie-Catherine Th&eacute;r&eacute;n&eacute;, Deputy Chief Executive Officer. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For a description of such information relating to Marie-Catherine Th&eacute;r&eacute;n&eacute;, please refer to Annex C, Part 2. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the full text of Proposal No.&nbsp;21, please see Annex A. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Vote Required </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Proposal No.&nbsp;21
requires the affirmative vote of a majority of the votes cast by the shareholders present in person, represented by proxy, or voting by mail at the Annual General Meeting and entitled to vote thereon. The votes cast will not include those attached
to shares for which the shareholder did not participate in the vote, abstained or voted blank or void. Abstentions will not be counted as votes cast and will have no effect on the outcome of the votes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>THE BOARD OF DIRECTORS RECOMMENDS A VOTE &#147;FOR&#148; </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PROPOSAL 21. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">57 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc140648_9_11"></A>PROPOSAL NO.&nbsp;22 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AUTHORIZATION TO BUY BACK COMPANY SHARES </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the following resolution, shareholders are asked to approve a delegation of authority to buy back the Company&#146;s shares to use
as acquisition consideration and/or to underlie incentive instruments granted to the employees and executive officers of the Company and its subsidiaries. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board proposes the shareholders authorize it, for a period of eighteen months, pursuant to Articles L.
<FONT STYLE="white-space:nowrap">225-209</FONT> et seq. of the French Commercial Code, to buy back, on one or more occasions and at the times of its choosing, company shares up to the limit of 5% of the number of shares comprising the share capital,
adjusted, if necessary, to take into account any increase or reduction in capital that may have taken place during the course of the program. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If approved, this authorization would cancel the authorization granted to the Board of Directors under the twenty-first ordinary resolution of
the General Meeting of April&nbsp;20, 2020. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The shares may be bought back in order to: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">support the secondary market for or the liquidity of the Company&#146;s shares through a liquidity agreement with
an investment service provider, in accordance with the standard practice accepted by the regulations, in which context, the number of shares taken into account for the calculation of the aforementioned limit corresponds to the number of shares
purchased, after deduction of the number of shares resold; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">hold the purchased shares and ultimately return them for future exchange or as payment under external growth
transactions; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">provide coverage to meet obligations arising from stock option plans and/or free share allocation plans (or
similar plans) for the group&#146;s employees and/or corporate officers, as well as all share allocations arising under company or group employee savings plans (or similar plans), employee profit-sharing plans and/or any other form of share
allocation arrangement for the group&#146;s employees and/or corporate officers; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">hedge the securities giving access to the company&#146;s shares, pursuant to current regulations;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">where applicable, cancel the shares acquired, subject to the authorization granted under the nineteenth
resolution of this General Meeting . </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The acquisition, sale, exchange or transfer of these shares may be executed by any means,
including through the purchase of share blocks, at the time deemed appropriate by the Board of Directors. The Board may not, without the prior authorization of the Shareholders&#146; Meeting, use this authorization during a public offer period
initiated by a third party for the shares of the Company until the end of the offer period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The company does not intend to use options or derivatives.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The maximum purchase price is set at &#128;100 per share (excluding charges). In the event of a capital transaction, in particular a stock split or
reverse split, or the allocation of free shares to shareholders, the abovementioned amount will be adjusted in the same proportions (multiplier coefficient equal to the ratio between the number of shares comprising the capital before the transaction
and the number of shares after the transaction). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The maximum transaction amount is set at &#128;150,000,000 (excluding charges). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The General Meeting hereby authorizes the Board of Directors to carry out these transactions, set the terms and methods thereof, finalize all agreements and
complete all formalities when necessary. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the full text of Proposal No.&nbsp;22, please see Annex A. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">58 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Vote Required </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Proposal No.&nbsp;22 requires the affirmative vote of a majority of the votes cast by the shareholders present in person, represented by proxy,
or voting by mail at the Annual General Meeting and entitled to vote thereon. The votes cast will not include those attached to shares for which the shareholder did not participate in the vote, abstained or voted blank or void. Abstentions will not
be counted as votes cast and will have no effect on the outcome of the votes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>THE BOARD OF DIRECTORS RECOMMENDS A VOTE &#147;FOR&#148;
</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PROPOSAL 22. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">59 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc140648_9_12"></A>PROPOSAL NO. 23: </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AUTHORIZATION TO THE BOARD OF DIRECTORS FOR THE COMPANY TO CANCEL THE SHARES BOUGHT BACK PURSUANT TO ARTICLE L. <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">22-10-62</FONT></FONT> OF THE FRENCH COMMERCIAL CODE SUSPENSION DURING A PUBLIC OFFERING PERIOD </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The shareholders are asked to grant all powers to the board of directors for the purpose of canceling, on one or more occasions, all or part of the Company
shares acquired as a result of the share repurchases authorized by the shareholders pursuant to Resolution&nbsp;22. The shares to be canceled pursuant to this authorization shall not exceed 5% of our share capital in any <FONT
STYLE="white-space:nowrap">24-month</FONT> period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Board proposes the shareholders authorize the Board of Directors to, for a period of eighteen
months, pursuant to Article L. <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">22-10-62</FONT></FONT> of the French Commercial Code: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">cancel, at its discretion, on one or more occasions, up to 5% of the capital calculated on the date of the
decision to cancel, less any shares canceled during the last 24 months, shares the company holds or may hold following <FONT STYLE="white-space:nowrap">buy-backs</FONT> performed pursuant to Article L. <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">22-10-62</FONT></FONT> of the French Commercial Code and to reduce the share capital accordingly in compliance with legal and regulatory provisions in force;<B> </B>and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">carry out all necessary operations to perform such cancellations and the resulting reductions of the share
capital, accordingly amending the company&#146;s Bylaws and fulfilling all formalities required.</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the full text of
Proposal No.&nbsp;23, please see Annex A. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Vote Required </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Proposal No.&nbsp;23 requires the affirmative vote of 2/3 majority of the votes cast by the shareholders present in person, represented by
proxy, or voting by mail at the Annual General Meeting and entitled to vote thereon. The votes cast will not include those attached to shares for which the shareholder did not participate in the vote, abstained or voted blank or void. Abstentions
will not be counted as votes cast and will have no effect on the outcome of the votes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>THE BOARD OF DIRECTORS RECOMMENDS A VOTE
&#147;FOR&#148; </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PROPOSAL 23. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">60 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc140648_9_13"></A>PROPOSALS <FONT STYLE="white-space:nowrap">24-29:</FONT>
</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FINANCIAL AUTHORIZATIONS </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are a biotech company with modest revenues, from a development partnership with Nestl&eacute; and research and development credits from the
French government. Drug development and product launches are expensive, and biotech companies need continued access to capital to fund product development. More capital will likely be required to bring Viaskin Peanut to approval and to fund other
research and development programs until we achieve profitability and can self-fund our future development. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As our capital needs evolve,
we need the ability to access capital through the various means and tools that are available, tools that are constantly created, evolving or changing. Moreover, our company requires flexibility to secure capital while minimizing risk or dilution for
our shareholders given the dynamic, complex and risky nature of drug development. We may also need to secure capital to accelerate development of a promising new product candidate, to expand the geographical reach of our commercialization, or to
pursue a promising business development opportunity. That is why we ask for an applicable discount of up to 15% and a total ceiling set at 65% dilution. We understand the need to be good stewards of our investors&#146; money and will continue to
seek financing with a reasonable risk profile and attention to investor dilution. A range of financing options are available in the marketplace and we wish to be able to pursue the most appropriate financing for our company. We also need to have
resolutions that ensure consistency between U.S. (SEC) and French (AMF) market practices and regulatory standards. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are therefore
seeking approval at the Annual General Meeting of the following resolutions that would allow raising capital even in adverse situations, to best ensure the continuity of our operations. These resolutions will be suspended in case of a hostile
takeover attempt. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Resolutions&nbsp;24&nbsp;to&nbsp;29&nbsp;seek the delegation of financial authorizations. The goal of these resolutions
is to allow us to swiftly&nbsp;raise the funds and have the financial flexibility necessary to enable us to execute our strategic objectives, including, but not limited to, with respect to external growth. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unlike most companies incorporated under U.S. state law, which traditionally have a specified amount of authorized shares available for
issuance with limited restriction on the purpose of such issuance, in accordance with French law, in order for our board of directors to increase our share capital,&nbsp;it must have a specific delegation of authority authorizing it to increase the
share capital for each specific purpose. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At the&nbsp;2020&nbsp;Annual General Meeting on&nbsp;April 20, 2020, the shareholders approved
certain financial authorizations. <FONT STYLE="white-space:nowrap">Re-approving</FONT> our board of directors&#146; financial authorizations will allow the Company to&nbsp;maintain equal footing with U.S. companies and to increase our financial
flexibility by quickly raising capital and taking advantage of potential business opportunities.&nbsp;Although always important, we believe this flexibility is particularly necessary in light of the current worldwide economic challenges driven by
the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As a result, we are seeking approval at the Annual General Meeting of the
following financial resolution from Resolution 24 to Resolution 29. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, at the Annual General Meeting, shareholders are being
asked to approve the maximum global nominal amount of the share capital increases which may be completed pursuant to Resolutions&nbsp;25, 26, 28 and 31 as well as Resolution 28 of the 2020 Annual General Meeting, as well as the maximum global
nominal amount of the debt securities that may be issued pursuant to the delegations granted in Resolutions&nbsp;25, 26, 28 and 31. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
proposed financial authorizations would provide our board of directors with additional flexibility to&nbsp;respond quickly to changes in market conditions and thereby be able to obtain financing under the best possible conditions. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">61 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The financial delegations of authority presented for your approval at the General Meeting
are subject to the following important limitations: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the aggregate amount of share capital increases pursuant to Resolution&nbsp;24&nbsp;cannot exceed 40% of our
share capital on the date of the decision to increase the share capital by the Board of Directors, it being provided that Resolution 24 aims at raising capital by calling on the Company&#146;s shareholders; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the aggregate amount of share capital increases pursuant to Resolution&nbsp;25 cannot exceed 30% of our share
capital on the date of the decision to increase the share capital by the Board of Directors; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the aggregate amount of share capital increases pursuant to Resolution&nbsp;26&nbsp;cannot exceed 20% of our
share capital on the date of the decision to increase the share capital by the Board of Directors; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the aggregate amount of share capital increases pursuant to Resolution&nbsp;28&nbsp;cannot exceed 30% of our
share capital on the date of the decision to increase the share capital by the Board of Directors; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any share capital increase pursuant to Resolution 29, which grants a customary over-allotment option for any
issuance pursuant to Resolutions&nbsp;24, 25, 26 and 28, would be at the same price as, and limited to a maximum of 15% of, the initial issuance; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the maximum global nominal amount of the share capital increases which may be completed pursuant to Resolutions
25, 26, 28 and 31 as well as Resolution 28 of the 2020 Annual General Meeting 28 cannot exceed 65% of the share capital on the date of the Annual General Meeting ; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the global nominal amount of the debt securities that may be issued pursuant to the delegations granted in
Resolutions&nbsp;25, 26, 28&nbsp;and&nbsp;31 shall not exceed&nbsp;EUR 150,000,000. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our board of directors will
continue to use these authorizations in accordance with our corporate and strategic needs, and, in any case,&nbsp;does not intend to use these authorizations in the context of an unsolicited tender offer by a third party our shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under French law, in the case of issuance of additional shares or other securities for cash or <FONT STYLE="white-space:nowrap">set-off</FONT>
against cash debts, our existing shareholders have preferential subscription rights to these securities on <FONT STYLE="white-space:nowrap">a&nbsp;pro-rata&nbsp;basis,</FONT> unless such rights are waived by a
<FONT STYLE="white-space:nowrap">two-thirds</FONT> majority of the votes held by the shareholders present at the extraordinary meeting deciding or authorizing the capital increase, represented by proxy or voting by mail. In case such rights are not
waived by the extraordinary general meeting, each shareholder may individually either exercise, assign or not exercise its preferential rights. Such rights would be waived pursuant to all of resolutions&nbsp;25,&nbsp;26, 28, if approved, but not
pursuant to Resolution&nbsp;24. Accordingly, the issuance of additional Ordinary Shares or other securities pursuant to such resolutions might, under certain circumstances, dilute the ownership and voting rights of shareholders. </P>
<P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">62 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PROPOSAL NO. 24: </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>DELEGATION OF POWERS TO THE BOARD OF DIRECTORS TO ISSUE ORDINARY SHARES, GIVING, AS NECESSARY, ACCESS TO ORDINARY SHARES OR TO THE
ALLOCATION OF DEBT SECURITIES (OF THE COMPANY OR OF A GROUP COMPANY) AND/OR SECURITIES GIVING ACCESS TO ORDINARY SHARES (OF THE COMPANY OR OF A GROUP COMPANY) WITH <FONT STYLE="white-space:nowrap">PRE-EMPTIVE</FONT> RIGHTS SUSPENSION DURING A PUBLIC
OFFERING PERIOD </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The purpose of this delegation of authority is to enable the Company to obtain financing any time through the issuance of ordinary
shares and any type of securities giving, by any means, immediately and/or in the future, access to ordinary shares, by calling on the Company&#146;s shareholders. The Company&#146;s shareholders will be awarded, under the applicable legal provision
and in proportion to their ownership interest in the Company&#146;s share capital, a preferential right to subscribed for new shares or securities. This detachable and negotiable right will make it possible, if the holder does not wish to subscribe
to the capital increase, to financially offset the dilution resulting from the <FONT STYLE="white-space:nowrap">non-subscription</FONT> to the capital increase. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company intends to use this delegation of authority to raise the funds and have the financial flexibility necessary to enable it to execute its strategic
objectives, including, but not limited to, with respect to financing potential external growth. As a result of maintaining shareholders&#146; preferential rights, we believe that a share capital increase in amount not to exceed 40% of the capital
existing on the date of the decision to increase the share capital by the Board will provide sufficient flexibility in pursuing our strategic objectives. In particular, the implementation of this authorization could provide us quick access to a
source of financing and allow us to respond quickly to changes in market conditions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The share capital increases carried out pursuant to this
authorization cannot exceed 40% of the Company&#146;s share capital existing on the date of the decision to increase the share capital by the Board. In the case of issuances of debt securities, the nominal amount of any issuances will be limited to
EUR 150,000,000. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The terms of the securities to be authorized, including dividend or interest rates, conversion prices, voting rights, redemption prices,
maturity dates and similar matters would be determined by the board of directors. Any transaction where the Company sells such securities will be reviewed and approved by the board of directors at the time of issuance. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the case of issuances of debt securities, the nominal amount of any issuances will be limited to EUR 150,000,000. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This delegation of authority would be granted for a <FONT STYLE="white-space:nowrap">26-month</FONT> period. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Board of Directors shall be granted, within the limits set above, the powers required to set the terms for the issues and determine the issue price, and
if applicable, record the execution of the resulting capital increases, amend the Bylaws accordingly, impute, as it sees fit, the costs of the capital increase to the amount of the related premiums and deduct the necessary sums from this amount to
bring the statutory reserve to one tenth of the new share capital after each increase and more generally, perform all tasks required in similar matters. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Board cannot, unless authorized in advance by the General Meeting, make use of this delegation in a period public offering initiated by a third party
targeting the securities of the Company until the end of the offering period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This delegation, for the part not used, if applicable, supersedes any and
all relevant prior delegations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the full text of Proposal No.&nbsp;24, please see Annex A. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">63 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Vote Required </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Proposal No.&nbsp;24 requires the affirmative vote of a 2/3 majority of the votes cast by the shareholders present in person, represented by
proxy, or voting by mail at the Annual General Meeting and entitled to vote thereon. The votes cast will not include those attached to shares for which the shareholder did not participate in the vote, abstained or voted blank or void. Abstentions
will not be counted as votes cast and will have no effect on the outcome of the votes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>THE BOARD OF DIRECTORS RECOMMENDS A VOTE
&#147;FOR&#148; </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PROPOSAL 24. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">64 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc140648_9_14"></A>PROPOSAL NO.&nbsp;25: </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>DELEGATION OF POWERS TO BE GRANTED TO THE BOARD OF DIRECTORS TO ISSUE ORDINARY SHARES GIVING ACCESS, AS THE CASE MAY BE, TO ORDINARY SHARES
OR TO THE ALLOCATION OF DEBT SECURITIES (OF THE COMPANY OR A GROUP COMPANY), AND/OR SECURITIES GIVING ACCESS TO ORDINARY SHARES (OF THE COMPANY OR A GROUP COMPANY), WITHOUT <FONT STYLE="white-space:nowrap">PRE-EMPTIVE</FONT> RIGHTS, BY MEANS OF A
PUBLIC OFFER (EXCLUDING THE OFFERS SET OUT IN SECTION 1 OF ARTICLE <FONT STYLE="white-space:nowrap">L.411-2</FONT> OF THE FRENCH MONETARY AND FINANCIAL CODE), AND/OR AS CONSIDERATION FOR SECURITIES IN THE CONTEXT OF A PUBLIC EXCHANGE OFFER
SUSPENSION DURING A PUBLIC OFFERING PERIOD </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The board of directors is requesting the necessary authority to issue through a public offering ordinary
shares and/or any type of securities giving access, by any means, immediately or in the future, to ordinary shares. Resolution&nbsp;25&nbsp;is intended: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">To&nbsp;comply with the approach currently promoted by French regulatory authorities, pursuant to which,
irrespective of whether a public offering is underwritten, this Resolution should be used to complete any such public offering because it is grounded on provisions of the French commerce code meant precisely for public offerings. In particular, if
the end result of the planned transaction is a public offering of securities in France, Resolution&nbsp;25&nbsp;should be approved in order to ensure that the French regulatory authorities would view the financial delegations being granted at the
Annual General Meeting as sufficient for all potential market participants; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">To&nbsp;allow for a direct public offering, without the involvement of underwriters. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Any issuance pursuant to this delegation would be carried out without shareholders&#146; preferential subscription rights. However, shareholders could be
granted a priority subscription period in accordance with applicable French law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the French Commercial Code, the issue price to be determined
by the Board pursuant to this Resolution 25 shall be at least equal to the weighted average of the prices of the last three trading sessions preceding the beginning of the public offering, possibly reduced by a maximum discount of 10%. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company intends to use this delegation of authority to raise the funds and have the financial flexibility necessary to enable it to execute its strategic
objectives.&nbsp;We&nbsp;do not intend to use it in the context of an unsolicited tender offer by a third party for DBV shares. As a result,&nbsp;we believe that a share capital increase in an amount not to exceed 30% of the Company&#146;s the share
capital on the date of the decision to increase the share capital by the Board, will provide us with sufficient flexibility in pursuing our strategic objectives. In particular, the implementation of this authorization could provide us quick access
to sources of financing, in a similar manner to U.S. companies, and allow us to respond quickly to changes in market conditions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the case of issuances
of debt securities, the nominal amount of any issuances will be limited to EUR 150,000,000. The amount of any debt securities issued will be subject to (and deducted from) the global limit of 150,000,000, and the amount of any share capital increase
will be subject to the global limit of&nbsp;65% of the share capital existing at the date of the General Meeting, in each case as approved pursuant to Resolution&nbsp;32. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This delegation of authority would be granted for a <FONT STYLE="white-space:nowrap">26-month</FONT> period. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Board shall be granted, within the limits set above, the powers required to set the terms for the issue(s), and if applicable, record the execution of the
resulting capital increases, proceed to amend the <FONT STYLE="white-space:nowrap">by-laws</FONT> accordingly, levy, as it sees fit, the costs of the capital increase on the amount of related premiums and deduct the necessary sums from this amount
to bring the statutory reserve to <FONT STYLE="white-space:nowrap">one-tenth</FONT> of the new share capital after each increase and, more generally, perform all tasks required in similar matters. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">65 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Board cannot, unless authorized in advance by the General Meeting, make use of this delegation in a
period public offering initiated by a third party targeting the securities of the Company until the end of the offering period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This delegation, for the
part not used, if applicable, supersedes any and all relevant prior delegations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the full text of Proposal No.&nbsp;25, please see
Annex A. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Vote Required </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Proposal
No.&nbsp;25 requires the affirmative vote of a 2/3 majority of the votes cast by the shareholders present in person, represented by proxy, or voting by mail at the Annual General Meeting and entitled to vote thereon. The votes cast will not include
those attached to shares for which the shareholder did not participate in the vote, abstained or voted blank or void. Abstentions will not be counted as votes cast and will have no effect on the outcome of the votes. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>THE BOARD OF DIRECTORS RECOMMENDS A VOTE &#147;FOR&#148; </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PROPOSAL 25. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">66 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc140648_9_15"></A>PROPOSAL NO.&nbsp;26: </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>DELEGATION OF POWERS TO BE GRANTED TO THE BOARD OF DIRECTORS TO ISSUE ORDINARY SHARES GIVING ACCESS, AS THE CASE MAY BE, TO ORDINARY SHARES
OR TO THE ALLOCATION OF DEBT SECURITIES (OF THE COMPANY OR A GROUP COMPANY), AND/OR SECURITIES GIVING ACCESS TO ORDINARY SHARES (OF THE COMPANY OR A GROUP COMPANY), WITHOUT <FONT STYLE="white-space:nowrap">PRE-EMPTIVE</FONT> RIGHTS, BY MEANS OF A
PUBLIC OFFER REFERRED TO IN PARAGRAPH 1 OF ARTICLE <FONT STYLE="white-space:nowrap">L.411-2</FONT> OF THE FRENCH MONETARY AND FINANCIAL CODE SUSPENSION DURING A PUBLIC OFFERING PERIOD </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The goal of this delegation of authority is to allow the Company to issue ordinary shares and any type of securities giving access, by any means, immediately
and/or in the future, to ordinary shares, in one or more private placements to qualified investors or to a limited circle or investors (less than 150) as described in paragraph 1&deg; of Article L. <FONT STYLE="white-space:nowrap">411-2</FONT> of
the French Monetary and Financial Code. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Furthermore, the terms of this Resolution 26 set important limits on the amount of potential dilution. While our
stock may vary, we believe that a share capital increase in an amount not to exceed 20% of the Company&#146;s the share capital on the date of the decision to increase the share capital by the Board (as such cap is provided under French laws), which
would be subject to and deducted from the global limit provided in Resolution 32, will provide us with sufficient flexibility in pursuing our plan. In the case of issuances of debt securities, the nominal amount of any issuances will be limited to
EUR 150,000,000. The amount of any securities issued under Resolution 26 will be subject to (and deducted from) the global limits pursuant to Resolution 32. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the French Commercial Code, the issue price to be determined by the Board under this Resolution 26 shall be at least equal to the weighted average
of the prices of the last three trading sessions preceding the beginning of the private placement, possibly reduced by a maximum discount of 10%. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This
delegation of authority would be granted for a <FONT STYLE="white-space:nowrap">26-month</FONT> period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Board shall be granted, within the limits set
above, the powers required to set the terms for the issue(s), and if applicable, record the execution of the resulting capital increases, amend the <FONT STYLE="white-space:nowrap">by-laws</FONT> accordingly, charge, as it sees fit, the costs of the
capital increase against the amount of the related premiums and deduct the necessary sums from this amount to bring the statutory reserve to one tenth of the new share capital after each increase and more generally, perform all tasks required in
this regard. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Board cannot, unless authorized in advance by the General Meeting, make use of this delegation in a period public offering initiated by
a third party targeting the securities of the Company until the end of the offering period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This delegation, for the part not used, if applicable,
supersedes any and all relevant prior delegations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the full text of Proposal No.&nbsp;26, please see Annex A. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Vote Required </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Proposal No.&nbsp;26
requires the affirmative vote of a 2/3 majority of the votes cast by the shareholders present in person, represented by proxy, or voting by mail at the Annual General Meeting and entitled to vote thereon. The votes cast will not include those
attached to shares for which the shareholder did not participate in the vote, abstained or voted blank or void. Abstentions will not be counted as votes cast and will have no effect on the outcome of the votes. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>THE BOARD OF DIRECTORS RECOMMENDS A VOTE &#147;FOR&#148; </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PROPOSAL 26. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">67 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc140648_9_16"></A>PROPOSAL NO. 27: </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AUTHORIZATION, IN THE EVENT OF AN ISSUE WITHOUT <FONT STYLE="white-space:nowrap">PRE-EMPTIVE</FONT> RIGHTS, TO SET THE ISSUE PRICE ACCORDING
TO THE TERMS SET BY THE GENERAL MEETING, WITHIN A LIMIT OF 10% OF THE CAPITAL PER YEAR </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Board proposes the shareholders authorize the Board of
Directors to, pursuant to Article L. <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">22-10-52</FONT></FONT> of the French Commercial Code, authorizes the Board of Directors, when deciding to issue ordinary shares or securities
giving access to the capital, pursuant to the 25<SUP STYLE="font-size:85%; vertical-align:top">st</SUP> and 26st Resolutions<I>, </I>subject to the provisions of Article L.
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">22-10-52</FONT></FONT> of the French Commercial Code, deviate from the price-setting conditions set out in the above-mentioned resolutions, up to a maximum of 10% of the share capital
per year, and to set the issue price of equity equivalents to be issued as follows: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In accordance with the provisions of Article L. <FONT
STYLE="white-space:nowrap">225-138</FONT> of the French Commercial Code, the issue price of the ordinary shares that may be issued pursuant to this delegation of authority will be set by the Board of Directors and must be at least equal to: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">either the weighted average trading price of the company&#146;s share on the trading day prior to the date on
which the issue price is set, possibly reduced by a maximum discount of 15%, </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">or the average of five consecutive share trading prices selected from the last thirty trading days prior to the
date on which the issue price is set, possibly reduced by a maximum discount of 15%. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the full text of Proposal
No.&nbsp;27, please see Annex A. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Vote Required </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Proposal No.&nbsp;27 requires the affirmative vote of a 2/3 majority of the votes cast by the shareholders present in person, represented by
proxy, or voting by mail at the Annual General Meeting and entitled to vote thereon. The votes cast will not include those attached to shares for which the shareholder did not participate in the vote, abstained or voted blank or void. Abstentions
will not be counted as votes cast and will have no effect on the outcome of the votes. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>THE BOARD OF DIRECTORS RECOMMENDS A VOTE
&#147;FOR&#148; </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PROPOSAL 27. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">68 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc140648_9_17"></A>PROPOSAL NO.&nbsp;28: </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>DELEGATION OF POWERS TO BE GRANTED TO THE BOARD OF DIRECTORS TO ISSUE ORDINARY SHARES, GIVING, IF APPLICABLE, ACCESS TO ORDINARY SHARES OR
THE ALLOCATION OF DEBT SECURITIES (OF THE COMPANY OR A GROUP COMPANY) AND/OR SECURITIES GIVING ACCESS TO ORDINARY SHARES (OF THE COMPANY OR A GROUP COMPANY), WITH <FONT STYLE="white-space:nowrap">PRE-EMPTIVE</FONT> SUBSCRIPTION RIGHTS WAIVED IN
FAVOR OF CATEGORIES OF PERSONS WITH CERTAIN CHARACTERISTICS, SUSPENSION DURING A PUBLIC OFFERING PERIOD </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition to
Resolution&nbsp;25 and Resolution 26, which are intended to enable the board of directors to increase the Company&#146;s share capital through a public offering or a private placement, the board of directors also is requesting the necessary
authority to issue through an reserved offering Ordinary Shares or any type of securities giving access, by any means, immediately and/or in the future, to our share capital (including, without limitation, any bonds redeemable or convertible for
ordinary shares and any warrants attached or not to ordinary shares or other types of securities).</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company intends to use this
delegation of authority to raise the funds and have the financial flexibility necessary to enable it to execute its strategic objectives.&nbsp;We&nbsp;do not intend to use it in the context of an unsolicited tender offer by a third party for DBV
shares. As a result,&nbsp;we believe that a share capital increase in an amount not to exceed 30% of the Company&#146;s the share capital on the date of the decision to increase the share capital by the Board, will provide us with sufficient
flexibility in pursuing our strategic objectives. In particular, the implementation of this authorization could provide us quick access to sources of financing, in a similar manner to our U.S. competitors, and allow us to respond quickly to changes
in market conditions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The issue price of ordinary shares that may be issued under the scope of this delegation of powers will be set by
the Board of Directors and must be at least equal to at the discretion of the Board of Directors or the Chief Executive Officer: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the closing price of the Company&#146;s shares on the regulated market Euronext Paris during the last trading
session prior to the date on which the issue price is set, possibly reduced by a maximum discount of 15%, or, </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the volume-weighted average (in the central order book and <FONT STYLE="white-space:nowrap">off-market</FONT>
blocks) of the Company&#146;s share price on the Euronext Paris regulated market during the last three trading days prior to the date on which the issue price is set, possibly reduced by a maximum discount of 15%, or, </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">at the weighted average trading price of the company&#146;s shares on the trading day prior to the date on which
the issue price is set, possibly reduced by a maximum discount of 15%, or, </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the average of 5 consecutive share trading prices selected from the last 30 trading days prior to the date on
which the issue price is set, possibly reduced by a maximum discount of 15%. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The shareholders are asked to waive
shareholders&#146; preferential subscription rights to the ordinary shares and securities that would be issued by virtue of this delegation, and to reserve this subscription for the following category of persons: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">i.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">natural person(s) or legal entity(ies), including companies, trusts, investment funds or other investment
vehicle(s), regardless of their form, under French or foreign law, investing on a regular basis in the pharmaceutical, biotechnological or medical technology sector, and/or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">ii.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">French or foreign companies, institutions or entities of any form, carrying out a significant portion of their
business in these sectors or in the cosmetics or chemical sector or in the field of medical devices or research in these areas; and/or </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">69 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">iii.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any individual(s) or legal entity(ies), including any company(ies), institution(s), entity(ies), trust(ies),
investment fund(s) or other investment vehicle(ies) in any form whatsoever, under French or foreign law, when entering into an industrial, commercial, licensing, research or partnership agreement with the Company; and/or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">iv.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any credit institution, any French or foreign investment service provider or member of a banking syndicate or
any company or investment fund that undertakes to subscribe to any issue likely to result in a future capital increase that may be carried out pursuant to this delegation in connection with the implementation of an equity or bond financing line;
and/or. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">v.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">French or foreign investment service provider(s), or any foreign establishment(s) with equivalent status,
likely to guarantee the completion of an issue intended to be placed with the persons referred to in (i)&nbsp;and/or (ii)&nbsp;above and, in this context, to subscribe for the securities issued. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the case of issuances of debt securities, the nominal amount of any issuances will be limited to EUR&nbsp;150,000,000. The amount of any
debt securities issued will be subject to (and deducted from) the global limit of EUR 150,000,000, and the amount of any share capital increase will be subject to the global limit of&nbsp;65% of the share capital existing at the date of the General
Meeting, in each case as approved pursuant to Resolution&nbsp;32. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This delegation of authority would be granted for
<FONT STYLE="white-space:nowrap">a18-month</FONT> period </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Board cannot, unless authorized in advance by the General Meeting, make use of this
delegation in a period public offering initiated by a third party targeting the securities of the Company until the end of the offering period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This
delegation, for the part not used, if applicable, supersedes, as from today&#146;s date, any and all relevant prior delegations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the
full text of Proposal No.&nbsp;28, please see Annex A. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Vote Required </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Proposal No.&nbsp;28 requires the affirmative vote of a 2/3 majority of the votes cast by the shareholders present in person, represented by
proxy, or voting by mail at the Annual General Meeting and entitled to vote thereon. The votes cast will not include those attached to shares for which the shareholder did not participate in the vote, abstained or voted blank or void. Abstentions
will not be counted as votes cast and will have no effect on the outcome of the votes. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>THE BOARD OF DIRECTORS RECOMMENDS A VOTE
&#147;FOR&#148; </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PROPOSAL 28. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">70 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc140648_9_18"></A>PROPOSAL NO. 29: </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AUTHORIZATION TO INCREASE THE TOTAL AMOUNT OF ISSUES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The purpose of this Resolution 29 is to allow the Board of Directors to grant a customary over-allotment option for any issuance pursuant to Resolutions 24<SUP
STYLE="font-size:85%; vertical-align:top">th</SUP>, 25<SUP STYLE="font-size:85%; vertical-align:top">th</SUP>, 26<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> and 28<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> above. Any share
capital increase pursuant to this delegation would be at the same price as, and limited to a maximum of 15% of, the initial issuance, which is a standard level for over-allotment options, as per market practice. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the full text of Proposal No.&nbsp;29, please see Annex A. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Vote Required </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Proposal No.&nbsp;29
requires the affirmative vote of a 2/3 majority of the votes cast by the shareholders present in person, represented by proxy, or voting by mail at the Annual General Meeting and entitled to vote thereon. The votes cast will not include those
attached to shares for which the shareholder did not participate in the vote, abstained or voted blank or void. Abstentions will not be counted as votes cast and will have no effect on the outcome of the votes. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>THE BOARD OF DIRECTORS RECOMMENDS A VOTE &#147;FOR&#148; </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PROPOSAL 29. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">71 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc140648_9_19"></A>PROPOSAL NO. 30: </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>DELEGATION OF POWERS TO BE GRANTED TO THE BOARD OF DIRECTORS FOR THE PURPOSE OF DECIDING ON ANY MERGER-ABSORPTION, DEMERGER, OR PARTIAL
CONTRIBUTION OF ASSETS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Article L. <FONT STYLE="white-space:nowrap">236-9</FONT> of the French Commercial Code provides that (i)&nbsp;the
extraordinary shareholders meeting of the acquiring company may delegate to the board of directors its competence in making decisions relating to a merger for a period that cannot exceed 26 months and (ii)&nbsp;the extraordinary shareholders meeting
of the acquiring company may determine the merger and grant to the board of directors the power to set definitive terms and conditions of such merger for a period that cannot exceed five years. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to Resolution&nbsp;30&nbsp;and in accordance with the amended Article L. <FONT STYLE="white-space:nowrap">236-9</FONT> of the French
Commercial Code, we are asking shareholders to (i)&nbsp;delegate authority to the board of directors of the Company to decide on any merger-absorption, split or partial contribution of assets and (ii)&nbsp;grant to the board of directors full powers
to implement this delegation, in accordance with the provisions set forth in French Laws and the <FONT STYLE="white-space:nowrap">by-laws</FONT> of the Company, for the purpose of deciding all terms of any transaction that would be decided under
this delegation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If an operation by the board of directors pursuant to this delegation requires an increase in the Company&#146;s share
capital, it must be carried out within the limits set forth in Resolution 31 (i.e., the maximum nominal amount of share capital increases to be completed pursuant to Resolution 31, immediately or in the future, may not exceed 10% of the share
capital of the Company on the date of the decision to increase the share capital by the Board). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are asking shareholders to approve
Resolution&nbsp;30&nbsp;because this authorization granted to the Board would facilitate any potential external growth by paying all or part of the price with our securities, and we believe that shareholders&#146; approval in these circumstances is
often a cumbersome process, and could create uncertainty with respect to the ability to consummate such a transaction. Additionally, we believe that the process of submitting such a transaction for shareholders&#146; approval could prevent us from
seizing opportunities in a timely manner. The delegation provided for in Resolution&nbsp;30&nbsp;is intended to simplify the merger-absorption process. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This delegation of authority would be granted for a <FONT STYLE="white-space:nowrap">26-month</FONT> period. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the full text of Proposal No.&nbsp;30, please see Annex A. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Vote Required </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Proposal No.&nbsp;30
requires the affirmative vote of a 2/3 majority of the votes cast by the shareholders present in person, represented by proxy, or voting by mail at the Annual General Meeting and entitled to vote thereon. The votes cast will not include those
attached to shares for which the shareholder did not participate in the vote, abstained or voted blank or void. Abstentions will not be counted as votes cast and will have no effect on the outcome of the votes. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>THE BOARD OF DIRECTORS RECOMMENDS A VOTE &#147;FOR&#148; </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PROPOSAL 30. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">72 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc140648_9_20"></A>PROPOSAL NO.&nbsp;31: </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>DELEGATION OF POWERS TO BE GRANTED TO THE BOARD OF DIRECTORS TO ISSUE ORDINARY SHARES GIVING ACCESS TO ORDINARY SHARES OR TO THE ALLOCATION
OF DEBT SECURITIES (OF THE COMPANY OR OF A GROUP COMPANY), AND/OR SECURITIES GIVING ACCESS TO ORDINARY SHARES (OF THE COMPANY OR OF A GROUP COMPANY), IN THE CONTEXT OF A MERGER, DEMERGER OR PARTIAL CONTRIBUTION OF ASSETS DECIDED BY THE BOARD OF
DIRECTORS PURSUANT TO THE DELEGATION REFERRED TO IN THE TWENTY-SEVENTH RESOLUTION, SUSPENSION DURING A PUBLIC OFFERING PERIOD </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject
to the adoption by shareholders of Resolution&nbsp;30, we are asking our shareholders to adopt Resolution&nbsp;31&nbsp;and in accordance with&nbsp;Articles <FONT STYLE="white-space:nowrap">L.&nbsp;225-129</FONT> to L.
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">225-129-5</FONT></FONT> and L. <FONT STYLE="white-space:nowrap">228-91</FONT> of the French Commercial Code, we are asking our shareholders to delegate to the Board of Directors the
authority to decide to issue, on one or more occasions, ordinary shares of the Company and/or any type of securities giving access, by any means, immediately and/or in the future, to ordinary shares of the Company, in compensation for contributions
in kind granted to the Company as part of any merger, demerger or partial contribution of assets decided by the board of directors pursuant of the delegation granted under Resolution 30, such shares conferring the same rights as existing shares said
shares conferring the same rights as old shares subject to their date of use. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The securities issued pursuant to this delegation may
consist of debt securities or be related to the issue of such debt securities or permit the issue as intermediate securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are also
asking our shareholders to waive, to the benefit of the shareholders of the absorbed company or the contributing company, any preferential subscription right attached to the ordinary shares or securities to be issued. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The maximum nominal amount of share capital increases to be completed, immediately or in the future, may not exceed may not exceed 10% of the
share capital of the Company on the date of the decision to increase the share capital by the Board. This limit is set without taking into account the par value of the ordinary shares to be issued, if applicable, in relation to adjustments carried
out in order to protect the rights of holders of securities and other rights giving access to capital, in accordance with legal and regulatory requirements as well as applicable contractual provisions. The nominal amount of any share capital
increase that may be carried out in application of this resolution will be deducted from the overall limit set forth in Resolution 32 below. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The nominal amount of all issuances of debt securities to be completed giving access to the Company&#146;s share capital will not
exceed&nbsp;EUR 150,000,000&nbsp;(or the corresponding value of this amount for an issuance in a foreign currency). This amount will be increased, if applicable, for any redemption premium above nominal value and will be deducted from the overall
limit set forth in Resolution 32 below. This limit does not apply to securities the issuance of which is decided or authorized by the board of directors in accordance with Article L. <FONT STYLE="white-space:nowrap">228-40</FONT> of the French
Commercial Code. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are asking that the board of directors be granted all powers to decide and acknowledge completion of the share
capital remunerating the transaction, charge on the premium, as the case may be, the fees and charges generated by the share capital increase, to deduct on the premium, if it deems it useful, the necessary amounts for the allocation of the legal
reserve, to amend the Company&#146;s <FONT STYLE="white-space:nowrap">by-laws,</FONT> to take any decision in relation to the admission of the securities issued hereby to trading to Euronext, and, do everything that is required. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the full text of Proposal No.&nbsp;31, please see Annex A. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Vote Required </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Proposal No.&nbsp;31
requires the affirmative vote of a 2/3 majority of the votes cast by the shareholders present in person, represented by proxy, or voting by mail at the Annual General Meeting and entitled to vote thereon.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">73 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
The votes cast will not include those attached to shares for which the shareholder did not participate in the vote, abstained or voted blank or void. Abstentions will not be counted as votes cast
and will have no effect on the outcome of the votes. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>THE BOARD OF DIRECTORS RECOMMENDS A VOTE &#147;FOR&#148; </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PROPOSAL 31. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">74 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc140648_9_21"></A>PROPOSAL NO. 32 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>OVERALL LIMIT ON THE MAXIMUM AUTHORIZED AMOUNTS SET UNDER THE 25<SUP STYLE="font-size:85%; vertical-align:top">TH</SUP>, 26<SUP
STYLE="font-size:85%; vertical-align:top">TH</SUP>, 28<SUP STYLE="font-size:85%; vertical-align:top">TH</SUP> AND 31<SUP STYLE="font-size:85%; vertical-align:top">ST</SUP> RESOLUTIONS OF THIS GENERAL MEETING AND THE 28<SUP
STYLE="font-size:85%; vertical-align:top">TH</SUP> RESOLUTION OF THE GENERAL MEETING OF APRIL&nbsp;20, 2020 </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Board proposes that the shareholders
set the total par value of any shares that may be issued under the 25<SUP STYLE="font-size:85%; vertical-align:top">th</SUP>, 26<SUP STYLE="font-size:85%; vertical-align:top">th</SUP>, 28<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> and 31<SUP
STYLE="font-size:85%; vertical-align:top">st</SUP> resolutions of this Annual General Meeting and the 28<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> resolution of the General Meeting of April&nbsp;20, 2020, at 65% of the share capital on
the date of this General Meeting. To this limit will be added, if applicable, the par value of any capital increase required to preserve, in accordance with the law and, if applicable, any contractual stipulations providing for other adjustments,
the rights of the holders of rights or transferable securities giving access to the Company&#146;s capital. The maximum nominal amount of debt securities that may be issued pursuant to this authorization is 150,000,000 euros (or the equivalent of
this amount in the event of an issue in another currency). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We believe that this amount&nbsp;strikes the correct balance between protecting our existing
shareholders and providing the Company with the financial flexibility necessary to accomplish its strategic goals, and in line with the flexibility available to comparable U.S. companies. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the full text of Proposal No.&nbsp;32 please see Annex A. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Vote Required </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Proposal No.&nbsp;32
requires the affirmative vote of a 2/3 majority of the votes cast by the shareholders present in person, represented by proxy, or voting by mail at the Annual General Meeting and entitled to vote thereon. The votes cast will not include those
attached to shares for which the shareholder did not participate in the vote, abstained or voted blank or void. Abstentions will not be counted as votes cast and will have no effect on the outcome of the votes. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>THE BOARD OF DIRECTORS RECOMMENDS A VOTE &#147;FOR&#148; </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PROPOSAL 32. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">75 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc140648_9_22"></A>RESOLUTIONS&nbsp;33&nbsp;TO&nbsp;36: </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EQUITY RESOLUTIONS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
following is an overview of the equity plan-related proposals being submitted for the approval of our shareholders, which are described in more detail below. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to Resolutions 30 and 31 of the Annual General Meeting of April&nbsp;20, 2020, our shareholders authorized the board of directors to
grant, respectively, (i)&nbsp;stock options to subscribe for or purchase ordinary shares, (ii)&nbsp;free ordinary shares. As such authorizations will expire on October&nbsp;20, 2021, in order to continue our equity compensation program beyond such
date, pursuant to Resolution&nbsp;35 and 36&nbsp;below, we are requesting that our shareholders renew their prior authorization to the board of directors to grant, respectively, stock options, and free ordinary shares for the <FONT
STYLE="white-space:nowrap">18-month</FONT> period following the date of the 2021 Annual General Meeting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to Resolution 25 of the
Annual General Meeting of May&nbsp;24, 2019, our shareholders authorized the board of directors to grant share warrants. As such authorization expired on November&nbsp;24, 2020, in order to continue our equity compensation program beyond such date,
pursuant to Resolution&nbsp;33 below, we are requesting that our shareholders renew their prior authorization to the board of directors to grant, share warrants for the <FONT STYLE="white-space:nowrap">18-month</FONT> period following the date of
the 2021 Annual General Meeting. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">76 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc140648_9_23"></A>PROPOSAL NO. 33 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>DELEGATION OF POWERS TO THE BOARD OF DIRECTORS TO ISSUE STOCK WARRANTS (BSA), SUBSCRIPTION AND/OR ACQUISITION OF NEW AND/OR EXISTING STOCK
WARRANTS (BSAANE) AND/OR SUBSCRIPTION AND/OR ACQUISITION OF NEW AND/OR EXISTING REDEEMABLE STOCK WARRANTS (BSAAR) WITH CANCELLATION OF PREFERENTIAL SUBSCRIPTION RIGHTS, RESERVED FOR CATEGORIES OF PERSONS, SUSPENSION DURING A PUBLIC OFFERING PERIOD
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our board of directors recommends the approval of this delegation of authority to grant warrants in order to ensure the Company can
attract, recruit and compensate independent directors and consultants competitively by providing for customary compensatory grants to our existing and future <FONT STYLE="white-space:nowrap">non-employee</FONT> directors. To continue to attract and
retain highly talented directors with deep industry knowledge and experience, we must be able to offer our directors compensation in line with market standards, which include an equity-based component. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">However, pursuant to French law, <FONT STYLE="white-space:nowrap">non-employee</FONT> directors may not be granted stock options or free
shares. As a result, the right to subscribe for BSAs is a key element of our current <FONT STYLE="white-space:nowrap">non-employee</FONT> director compensation. This delegation of authority is critical to our business strategy because it enables us
to continue issuing BSAs, which is vital to our ability to attract and retain highly talented directors, compete with compensation arrangements provided by our U.S.-based peers and strengthen the alignment of our directors&#146; interests with those
of our shareholders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are also seeking authorization to grant BSAs to persons bound to the Company or one of its subsidiaries by a
consultancy agreement who, pursuant to French law, cannot be granted stock options or free shares. In certain circumstances, it is important for the Company to be able to offer a long-term compensation element to such persons in order to engender
loyalty in our highly competitive industry and align their incentives with the long-term interests of our shareholders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board
proposes the shareholders delegate to the Board of Directors, for a period of eighteen months its competence to proceed, on one or more occasions, in the proportions and at the time it deems appropriate, both in France and abroad, with the issue of
new stock warrants (BSA), subscription and/or acquisition of new and/or existing stock warrants (BSAANE) and/or subscription and/or acquisition of new and/or existing redeemable stock warrants (BSAAR) with cancellation of preferential subscription
rights reserved for the categories of persons defined below. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The total nominal amount of shares to which the warrants issued pursuant to
this delegation give entitlement may not exceed 0.5% of the capital existing on the day of the General Meeting. To this maximum amount will be added, as necessary, the nominal amount of the capital increase necessary to preserve the rights of the
holders of rights or securities giving access to the Company&#146;s capital, pursuant to the law, and where applicable, the contractual stipulations providing for other forms of preservation. This maximum amount is separate from all maximum amounts
set by the other resolutions of this General Meeting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The issue price of the warrant will be fixed by the Board of Directors. In the
event of assignment to <FONT STYLE="white-space:nowrap">non-executive</FONT> directors, the warrant issue price will coincide with its market value. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The subscription and/or acquisition price of the shares acquired by exercising the warrants shall be at least equal to the average closing
price of DBV TECHNOLOGIES shares for the 20 trading days preceding the decision to issue the warrants, if applicable, less the warrant issue price. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Approval of this proposal eliminates the preferential subscription rights of shareholders to the BSAs, BSAANEs and BSAARs to be issued, to the
benefit of the following categories of persons: corporate officers, scientific committee members, employees of the company and persons associated with the company and the French or foreign companies related to the company, via a service agreement or
as a consultant, in accordance with Article <FONT STYLE="white-space:nowrap">L.225-180</FONT> of the French Commercial Code. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">77 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This delegation means that the shareholders waive their
<FONT STYLE="white-space:nowrap">pre-emptive</FONT> rights to shares that may be issued by the exercising of warrants to the holders of BSAs, BSAANEs and/or BSAARs. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board cannot, unless authorized in advance by the General Meeting, make use of this delegation in a period public offering initiated by a
third party targeting the securities of the Company until the end of the offering period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board of Directors shall be granted all
necessary powers, under the terms set by the law and stipulated above, to issue BSAs, BSAANEs and/or BSAARs and in particular to: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">set the specific list of beneficiaries within the categories of persons defined above, the nature and number of
warrants to be allocated to each beneficiary, the number of shares to which each warrant shall give entitlement, the issue price of the warrants and the subscription and/or acquisition price of the shares to which the warrants give entitlement under
the terms outlined above, the terms and deadlines for the subscription and exercise of the warrants, the associated adjustment mechanisms and more generally, all terms and conditions with respect to the issue </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">prepare an additional report describing the final terms and conditions of the transaction; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">conduct the necessary share acquisitions within the framework of the share buyback program and to allocate them
via the allocation plan; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">record the completion of the capital increase resulting from the exercising of the BSAs, BSAANEs and/or BSAARs
and to amend the Bylaws accordingly; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">at its sole discretion, impute the cost of the capital increase to the amount of the associated premiums and
deduct the necessary sums from this amount to bring the statutory reserve to one tenth of the new share capital after each increase; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">delegate, under the conditions provided for by law, the powers required to enact the capital increase, and to
delay the capital increase, within the limits and according to the terms and conditions previously set by the Board of Directors; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">and more generally, perform all tasks required in similar matters. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The validity of his delegation is set at eighteen months from the date of the General Meeting. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Description of Principle Features of the BSAs </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to SEC rules, we are providing the following description of the material terms of the BSA awards we expect to be included in our BSA
award agreement letters. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I></I><I></I><I></I><I>Type of Awards.</I> BSAs are granted at fair market value and entitle a holder to
exercise the warrant for the underlying vested ordinary shares at an exercise price per share determined by the board of directors based and shall be at least equal to the average closing price of our ordinary shares for the 20 trading days
preceding the decision to issue the warrants, if applicable, less the warrant issue price. We use BSAs as part of our compensation for <FONT STYLE="white-space:nowrap">non-employee</FONT> directors and consultants. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I></I><I></I><I></I><I>Administration.</I> Subject to shareholder approval of this Proposal No.&nbsp;33, the board of directors will
determine the recipients, dates of grant and exercise price of BSAs, the number of BSAs to be granted and the terms and conditions of the BSAs, including the period of their exercisability and their vesting schedule. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I></I><I></I><I></I><I>Governing Law.</I> The BSAs are governed by the laws of France. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I></I><I></I><I></I><I>Certain Federal Income Tax Consequences for U.S. holders.</I> In general, no taxable income is realized by a
participant upon the grant of a BSA. Rather, at the time of exercise of the BSA, the participant will recognize </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">78 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
ordinary income for income tax purposes in an amount equal to the excess, if any, of the fair market value of the ordinary shares purchased over the sum of (a)&nbsp;the exercise price and
(b)&nbsp;the subscription price paid at grant. The participant&#146;s tax basis in any ordinary shares received upon exercise of a BSA will be the fair market value of the ordinary share on the date of exercise, and if the shares are later sold or
exchanged, then the difference between the amount received upon such sale or exchange and the fair market value of such shares on the date of exercise will generally be taxable as long-term or short-term capital gain or loss (if the shares are a
capital asset of the participant) depending upon the length of time such shares were held by the participant. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>New Plan Benefits </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The benefits or amounts that will be awarded or allocated under the delegation of authority to grant BSAs are not determinable at this time
because the number of shares underlying BSA awards depends on the Company&#146;s stock price, which cannot be predicted, the fair market value, the decision of directors of whether to subscribe for the BSA awards and the exercise of discretion by
our board of directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This delegation, for the part not used, if applicable, supersedes any and all relevant prior delegations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the full text of Proposal No.&nbsp;33 please see Annex A. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Vote Required </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Proposal No.&nbsp;33
requires the affirmative vote of a 2/3 majority of the votes cast by the shareholders present in person, represented by proxy, or voting by mail at the Annual General Meeting and entitled to vote thereon. The votes cast will not include those
attached to shares for which the shareholder did not participate in the vote, abstained or voted blank or void. Abstentions will not be counted as votes cast and will have no effect on the outcome of the votes. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>THE BOARD OF DIRECTORS RECOMMENDS A VOTE &#147;FOR&#148; </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PROPOSAL 33. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">79 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc140648_9_24"></A>PROPOSAL NO.&nbsp;34: </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>DELEGATION OF POWERS TO BE GRANTED TO THE BOARD OF DIRECTORS TO INCREASE THE SHARE CAPITAL BY THE ISSUE OF ORDINARY SHARES AND/OR SECURITIES
GRANTING ACCESS TO THE CAPITAL, WITH <FONT STYLE="white-space:nowrap">PRE-EMPTIVE</FONT> SUBSCRIPTION RIGHTS WAIVED IN FAVOR OF THE MEMBERS OF A COMPANY SAVINGS PLAN PURSUANT TO ARTICLES L. <FONT STYLE="white-space:nowrap">3332-18</FONT> ET SEQ. OF
THE FRENCH LABOR CODE </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the provisions of Articles L. <FONT STYLE="white-space:nowrap">225-129&nbsp;et</FONT> seq.&nbsp;and L. <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">225-138-1</FONT></FONT> of the French Commercial Code and the provisions of Articles L. <FONT STYLE="white-space:nowrap">3332-1&nbsp;et</FONT> seq.&nbsp;of the French Labor Code, the board
of directors is required to submit for approval by the shareholders a resolution to authorize the board of directors to increase the share capital through the issuance of shares and securities for the benefit of employees who are members of a
Company savings plan (<I>plan d&#146;&eacute;pargne groupe</I>). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The aggregate nominal amount of share capital increases that would be
carried out pursuant to this delegation of authority&nbsp;would not exceed 2% of the share capital at the date of this General Meeting (this amount is separate to any other maximum amounts set by other authorizations relating to capital increases).
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The price of any shares to be issued under this delegation may not more than 30% (or 40% lower if the vesting period stipulated by the
scheme pursuant to Articles L. <FONT STYLE="white-space:nowrap">3332-25</FONT> and L. <FONT STYLE="white-space:nowrap">3332-26</FONT> of the French Labor Code is greater than or equal to ten years) below the average opening price of our ordinary
shares for the 20 trading days prior to the decision setting the date for the opening of subscriptions, nor may it be higher than this average. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the conditions set forth in Articles L. <FONT STYLE="white-space:nowrap">3332-18</FONT> to L.
<FONT STYLE="white-space:nowrap">3332-23</FONT> of the French Labor Code, the board of directors would determine the issue price of the newly created shares or securities granting access to the share capital. For the benefit of the members of a
company savings plan (<I>plan d&#146;&eacute;pargne entreprise</I>), the shareholders&#146; preferential subscription right to the shares or securities would be eliminated. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">However, approving this resolution will enable our board of directors to adopt such a company savings plan if it determines in the future that
such a plan is appropriate to strengthen employee retention and further align employee and shareholder interests. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This delegation of
authority would be granted for a <FONT STYLE="white-space:nowrap">26-month</FONT> period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the full text of Proposal No.&nbsp;34,
please see Annex A. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Vote Required </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Proposal No.&nbsp;34 requires the affirmative vote of a 2/3 majority of the votes cast by the shareholders present in person, represented by
proxy, or voting by mail at the Annual General Meeting and entitled to vote thereon. The votes cast will not include those attached to shares for which the shareholder did not participate in the vote, abstained or voted blank or void. Abstentions
will not be counted as votes cast and will have no effect on the outcome of the votes. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>THE BOARD OF DIRECTORS RECOMMENDS A VOTE
&#147;FOR&#148; </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PROPOSAL 34. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">80 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc140648_9_25"></A>PROPOSAL NO.&nbsp;35: </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AUTHORIZATION TO BE GRANTED TO THE BOARD OF DIRECTORS TO ALLOCATE FREE SHARES TO MEMBERS OF STAFF AND/OR CERTAIN CORPORATE OFFICERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under French law, our board of directors must have a specific delegation of authority from shareholders to increase the Company&#146;s share
capital by issuing free ordinary shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If approved, the new authorization to grant free shares options will supersede the authorization
to grant free shares. The renewal of this authority is fundamental to our business strategy because it enables us to continue issuing free shares as necessary to attract and retain the high-quality executives and key employees that are critical to
our success, while aligning employee interests with those of shareholders. For a detailed discussion of our executive compensation policy and objectives, see &#147;Executive Compensation&#148; elsewhere in this proxy statement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Because we are a Nasdaq-listed company and considered a U.S. domestic registrant under SEC rules, our shareholders continue to benefit from
the protections afforded to them under the rules and regulations of the Nasdaq and SEC, including those rules that limit our ability to issue shares in specified circumstances. In addition, we follow U.S. capital markets and governance standards to
the extent permitted by French law and emphasize that this authorization is required as a matter of French law and is not otherwise required for other U.S. companies listed on the Nasdaq with which we compete. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board then proposes the shareholders authorize the Board of Directors, for a period of eighteen months, to allocate existing or future
ordinary shares in the Company, reserved for: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">members of staff of the company or companies or economic interest groups that are directly or indirectly related
to it as defined by Article L. <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">225-197-2</FONT></FONT> of the French Commercial Code; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">and/or corporate officers who meet the conditions set out in Article L. <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">225-197-1</FONT></FONT> of the French Commercial Code. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The total number of shares that can
be assigned free of charge pursuant to this authorization will not exceed 2% of the share capital on the date of the allocation decision. This limit will exclude, if applicable, the par value of any capital increase required to preserve the rights
of the beneficiaries of bonus share awards in the event of transactions involving the Company&#146;s capital during the vesting period. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The allocation of shares to beneficiaries will become definitive after a vesting period to be determined by the Board of Directors, which may
not be less than one year. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Beneficiaries shall, where applicable, be required to hold these shares for a period, set by the Board of
Directors, at least equal to that necessary to ensure that the cumulative duration of the vesting and, where applicable, holding periods cannot be less than two years. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">By way of exception, final allocation will take place before the end of the vesting period in the event that the beneficiary is classified as
disabled under the second and third categories set out in Article <FONT STYLE="white-space:nowrap">L.&nbsp;341-4</FONT> of the French Social Security Code. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All powers are granted to the Board of Directors to: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">set the terms and, if applicable, the award criteria and performance criteria for the shares;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">determine the identity of the beneficiaries and the number of shares allocated to each; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if applicable: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">record the existence of sufficient reserves and, upon each allocation of shares, transfer to a reserve account
the sums required to pay up the new shares to be granted; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">81 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">at the appropriate time, determine the capital increases by means of incorporation of reserves, premiums or
profits relating to the issue of new free shares granted; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">conduct the necessary share acquisitions within the framework of the share buyback program and allocate them via
the allocation plan; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">determine the impact on beneficiaries&#146; rights of transactions affecting the share capital or likely to
affect the value of shares allocated and enacted during the vesting period and as a result, to modify or adjust, if necessary, the number of shares granted to preserve the beneficiaries&#146; rights; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">decide whether or not to establish a holding obligation at the end of the vesting period and, if applicable,
determine its duration and take all necessary measures to ensure that the beneficiaries comply with it; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">and generally, in connection with the legislation in effect, perform all duties that the implementation of this
authorization may require. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This authorization shall imply that shareholders waive their
<FONT STYLE="white-space:nowrap">pre-emptive</FONT> rights to subscribe to newly issued shares through the capitalization of reserves, share premium and profits. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Description of Principle Features of the Free Shares </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to SEC rules, we are providing the following description of the material terms of the free shares awards we expect to be included in
our free shares award agreement letters. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Type of Awards.</I> The 2021 free share Plan is expected to provide for the grant of free
shares to our employees and employees of any company or group in which we hold, directly or indirectly, 10% or more of the share capital or voting rights as of the date of grant. Participants in the 2021 free share plan are determined at the
discretion of the board of directors subject to the terms of the 2021 free share plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Shares available.</I> The maximum number of
free shares that may be acquired and issued upon the vesting of award of free shares granted under the 2021 free share plan will not exceed 2% of our share capital on the date of the allocation decision. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Administration.</I> Subject to shareholder approval of this Proposal No. 35, the board of directors is expected to have the authority, in
its discretion, to determine (i) the terms, conditions and restrictions applicable to free shares (which need not be identical) to any participant and any shares acquired pursuant to such grant and (ii) whether, to what extent, and under what
circumstances an award of free shares may be settled, canceled, forfeited, exchanged or surrendered. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Vesting; Holding Period.</I> Free
shares are expected to vest at the times and upon the conditions that our board of directors may determine, as reflected in an applicable award grant letters and the 2021 free share plan, subject to waiver and release by our board of directors in
its sole discretion. Awards of free shares granted under the 2020 free share plan generally are expected to vest on the basis of continued employment through the end of the vesting period, and may require the satisfaction of performance conditions
to be determined by the board of directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Equitable Adjustments.</I> In the event certain changes occur our capitalization such as
(i) an amortization or reduction of our share capital, (ii) a change to the allocation of our profits, (iii) a distribution of our free shares, (iv) the capitalization of reserves, profits, issuance premiums or (v) an issuance of shares or
securities giving right to shares to be subscribed for in cash or by set-off of existing indebtedness offered exclusively to all our then-existing shareholders, the board of directors is expected to have the ability to adjust the maximum number of
shares or take other such action as may be provided in Article L. 228-99 of the French Commercial Code. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Governing Law.</I> The free
shares are governed by the laws of France. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">82 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Certain Federal Income Tax Consequences For U.S. Taxpayers </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following is a summary of certain U.S. federal income tax consequences of an award of free shares granted under the 2021 free share plan,
the material terms of which is discussed above. It does not purport to be a complete description of all applicable rules, and those rules (including those summarized here) are subject to change. The summary discusses only federal income tax laws and
does not discuss any state or local or non-U.S. tax laws that may be applicable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In general, the grant of an award of free shares will
not result in U.S. taxable income for the participant being a U.S. taxpayer or in a U.S. tax deduction for DBV Technologies. Upon the settlement of the grant in shares, the U.S. participant will recognize ordinary income equal to the aggregate value
of the payment received, and DBV Technologies or the surviving corporation following a change in control generally will be entitled to a tax deduction at the same time and in the same amount. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>New Plan Benefits </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Awards of free shares
are within the discretion of our board of directors. As a result, the benefits or amounts that will be awarded or allocated thereunder are not determinable at this time. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the part not used, if applicable, it supersedes any and all relevant prior authorizations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the full text of Proposal No.&nbsp;35, please see Annex A. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Vote Required </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Proposal No.&nbsp;35
requires the affirmative vote of a 2/3 majority of the votes cast by the shareholders present in person, represented by proxy, or voting by mail at the Annual General Meeting and entitled to vote thereon. The votes cast will not include those
attached to shares for which the shareholder did not participate in the vote, abstained or voted blank or void. Abstentions will not be counted as votes cast and will have no effect on the outcome of the votes. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>THE BOARD OF DIRECTORS RECOMMENDS A VOTE &#147;FOR&#148; </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PROPOSAL 35. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">83 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc140648_9_26"></A>PROPOSAL NO.&nbsp;36: </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AUTHORIZATION TO BE GRANTED TO THE BOARD OF DIRECTORS TO GRANT SHARE SUBSCRIPTION AND/OR PURCHASE OPTIONS (STOCK OPTIONS) TO MEMBERS OF
STAFF (AND/OR CERTAIN CORPORATE OFFICERS) </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under French law, our board of directors must have a specific delegation of authority from
shareholders to increase the Company&#146;s share capital by issuing Ordinary Shares in the form of stock options. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As a result, the
shareholders are asked to grant the Board of Directors the authority to issue and grant stock options, each representing a right to receive one ordinary share. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The renewal of this authority is fundamental to our business strategy because it enables us to continue granting options as necessary to
attract and retain the high-quality executives and key employees that are critical to our success, while aligning executive and employee interests with those of shareholders. For a detailed discussion of our executive compensation policy and
objectives, see &#147;Executive Compensation&#148; elsewhere in this proxy statement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Because we are a Nasdaq-listed company and
considered a U.S. domestic registrant under SEC rules, our shareholders continue to benefit from the protections afforded to them under the rules and regulations of the Nasdaq and SEC, including those rules that limit our ability to issue shares in
specified circumstances. In addition, we follow U.S. capital markets and governance standards to the extent permitted by French law and emphasize that this authorization is required as a matter of French law and is not otherwise required for other
U.S. companies listed on the Nasdaq with which we compete. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board then proposes the shareholders authorize the Board of Directors, for
a period of eighteen months, to grant the beneficiaries indicated below, on one or more occasions, options giving access to new shares in the company to be issued in respect of a capital increase or to the purchase of existing shares in the company
as a result of buybacks carried out under the terms set by law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The beneficiaries of these options may only be: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">firstly, some or all members of staff, or certain categories of staff and where appropriate, those companies or
economic interest groups related to it under the conditions of Article L. <FONT STYLE="white-space:nowrap">225-180</FONT> of the French Commercial Code; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">secondly, corporate officers who meet the conditions set out in Articles <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">L22-10-58</FONT></FONT> and <FONT STYLE="white-space:nowrap">L.&nbsp;225-185</FONT> of the French Commercial Code. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The total number of options that may be granted by the Board of Directors under this authorization may not grant entitlement to subscribe to
or purchase more than 7.5% of the share capital on the date of the allocation decision. To this amount will be added, as necessary, the par value of any capital increase necessary to preserve the rights of the beneficiaries of the options in the
event of transactions involving the Company&#146;s capital, pursuant to the law and, if applicable, any contractual stipulations providing for other forms of preservation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The subscription and/or acquisition price of the shares to be paid by the beneficiaries will be set on the day the options are granted by the
Board of Directors in accordance with the regulations in effect and must not be less than the average opening price of the shares for the twenty trading days prior to the grant decision. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">No options may be granted during the blackout periods set out in the regulations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This authorization includes, in favor of the beneficiaries of options giving access to shares, an express waiver by shareholders of their <FONT
STYLE="white-space:nowrap">pre-emptive</FONT> rights to subscribe to the shares that will be issued as and when the options are exercised. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">84 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Approval of this proposal delegates all powers to the Board of Directors to set the other
terms and conditions for the granting of options and their exercise, in particular to: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">determine the conditions under which the options shall be granted and to draft the list or categories of
beneficiaries as scheduled above; to determine, where appropriate, the seniority and performance conditions that must be met by these beneficiaries; to determine the conditions under which the price and number of shares must be adjusted,
particularly in the presumptions set out under Articles R. <FONT STYLE="white-space:nowrap">225-137</FONT> to R. <FONT STYLE="white-space:nowrap">225-142</FONT> of the French Commercial Code; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">define the exercise period(s) for the options granted, with the understanding that the term of the options may
not exceed a period of ten years from the grant date; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">provide the option to temporarily suspend the exercise of options for a maximum period of three months in the
event that financial transactions are performed involving the exercise of a right attached to shares; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if applicable, conduct the necessary share acquisitions within the framework of the share buyback program and to
allocate them via the option plan; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">proceed with all acts and formalities required to make final those capital increases that may, if necessary, be
performed pursuant to the authorization granted by this resolution; amend the <FONT STYLE="white-space:nowrap">by-laws</FONT> accordingly and generally to do whatever is necessary; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">at its own discretion and if it sees fit, impute the cost of increases in share capital to the amount of the
associated premiums and deduct the necessary sums from this amount to bring the statutory reserve to one tenth of the new share capital after each increase. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Description of Principle Features of the Stock Options </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to SEC rules, we are providing the following description of the material terms of the stock option awards we expect to be included in
our stock options award agreement letters. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Type of Awards</I>. Stock options may be granted to any individual employed by us or by any
affiliated company under the terms and conditions of an employment contract. Employee share options may also be granted to the chairman of our board of directors, our chief executive officer and our deputy chief executive officers, if any.
Participants in the 2021 stock option plan are determined at the discretion of the board of directors subject to the terms of the 2021 Stock option plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Stock Options are granted at fair market value and entitle a holder to exercise the warrant for the underlying vested ordinary shares at an
exercise price per share determined by the board of directors based and shall be not less than the average opening price of DBV TECHNOLOGIES shares for the 20 trading days preceding the decision to issue the stock options. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Shares available</I>. The maximum number of free shares that may be acquired and issued upon the vesting of award of stock options granted
under the 2021 stock option plan will not exceed 7.5% of our share capital on the date of the allocation decision. Under French law, the maximum number of shares issuable upon the exercise of outstanding stock options may not exceed <FONT
STYLE="white-space:nowrap">one-third</FONT> of the outstanding share capital on a <FONT STYLE="white-space:nowrap">non-diluted</FONT> basis as of the date of grant.</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Administration</I>. Our board of directors has the authority to administer the 2021 stock option plans. Subject to the expected terms and
conditions of the 2021 stock option plan, our board of directors determines the recipients, dates of grant, exercise prices, number of ordinary shares underlying and the terms and conditions of the stock options, including their periods of
exercisability and their vesting schedules. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The board of directors has the authority to amend or modify employee share options
outstanding under the delegation under this Proposal No.&nbsp;36, including in particular the authority to extend the post-termination </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">85 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
exercise period of the options, subject to the written consent of the optionees holding such options, if such amendments or modifications impair the rights of the optionees. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Vesting; Holding Period</I>. Stock options are expected to vest at the times and upon the conditions that our board of directors may
determine, as reflected in an applicable award grant letters and the 2021 stock option plan, subject to waiver and release by our board of directors in its sole discretion. Awards of free shares granted under the 2021 stock options plan generally
are expected to vest on the basis of continued employment or presence through the end of the vesting period, and may require the satisfaction of performance conditions to be determined by the board of directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Equitable Adjustments</I>. In the event of the carrying out by the company of any of the financial operations pursuant to Article&nbsp;L. <FONT
STYLE="white-space:nowrap">225-181</FONT> of the French Commercial Code as follows: (i)&nbsp;amortization or reduction of share capital, (ii)&nbsp;a change to the allocation of profits, (iii)&nbsp;a distribution of free shares,
(iv)&nbsp;capitalization of reserves, profits or issuance premiums, (v)&nbsp;a distribution of reserves, or (vi)&nbsp;an issuance of shares or securities giving right to shares to be subscribed for in cash or by
<FONT STYLE="white-space:nowrap">set-off</FONT> of existing indebtedness offered exclusively to shareholders, the board of directors will take the required measures to protect the interest of the optionees in the conditions set forth in
Article&nbsp;L. <FONT STYLE="white-space:nowrap">228-99</FONT> of the French Commercial Code. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Governing Law</I>. The stock options are
governed by the laws of France. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>U.S. Tax Limitations on incentive stock options.</I> The aggregate fair market value, determined at
the time of grant, of our ordinary shares issuable under incentive stock options that are exercisable for the first time by an optionee during any calendar year under all of our Stock Option Plans may not exceed $100,000. Stock options, or portions
thereof, that exceed such limit will generally be treated as <FONT STYLE="white-space:nowrap">non-statutory</FONT> share options. No incentive stock option may be granted to any person who, at the time of the grant, owns or is deemed to own shares
possessing more than 10% of our total combined voting power or that of any of our affiliates unless (1)&nbsp;the exercise price is at least 110% of the fair market value of the shares subject to the stock options on the date of grant and
(2)&nbsp;the term of the incentive stock option does not exceed five years from the date of grant. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Certain Federal Income Tax Consequences for U.S.
Taxpayers </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following is a summary of certain U.S. federal income tax consequences of an award of employee share options granted
under the delegation under this Proposal No.&nbsp;36, the material terms of which is discussed above. It does not purport to be a complete description of all applicable rules, and those rules (including those summarized here) are subject to change.
The summary discusses only federal income tax laws and does not discuss any state or local or <FONT STYLE="white-space:nowrap">non-U.S.</FONT> tax laws that may be applicable. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Incentive stock options </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">An optionee recognizes no taxable income for regular income tax purposes as a result of the grant or exercise of an stock option that qualifies
as an incentive stock option under Section&nbsp;422 of the Code. If an optionee exercises the option and then later sells or otherwise disposes of the ordinary Shares acquired through the exercise of the option after both the <FONT
STYLE="white-space:nowrap">two-year</FONT> anniversary of the date the option was granted and the <FONT STYLE="white-space:nowrap">one-year</FONT> anniversary of the exercise, the optionee will recognize a capital gain or loss equal to the
difference between the sale price of the ordinary Shares and the exercise price, and we will not be entitled to any deduction for federal income tax purposes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">However, if the optionee disposes of such ordinary Shares either on or before the <FONT STYLE="white-space:nowrap">two-year</FONT> anniversary
of the date of grant or on or before the <FONT STYLE="white-space:nowrap">one-year</FONT> anniversary of the date of exercise (a &#147;disqualifying disposition&#148;), any gain up to the excess of the fair market value of the ordinary shares on the
date of exercise over the exercise price generally will be taxed as ordinary income, unless the ordinary shares are disposed of in a transaction in which the participant would not recognize a loss (such as a gift). Any gain in excess of that amount
will be a </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">86 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
capital gain. If a loss is recognized, there will be no ordinary income, and such loss will be a capital loss. Any ordinary income recognized by the optionee upon the disqualifying disposition of
the ordinary shares generally should be deductible by us for federal income tax purposes, except to the extent such deduction is limited by applicable provisions of the Code. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For purposes of the alternative minimum tax, the difference between the option exercise price and the fair market value of the ordinary Shares
on the exercise date is treated as an adjustment item in computing the optionee&#146;s alternative minimum taxable income in the year of exercise. In addition, special alternative minimum tax rules may apply to certain subsequent disqualifying
dispositions of the Ordinary Shares or provide certain basis adjustments or tax credits. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I><FONT STYLE="white-space:nowrap">Non-statutory</FONT> Stock Options </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">An optionee generally recognizes no taxable income as the result of the grant of such an employee share option. However, upon exercising the
option, the optionee normally recognizes ordinary income equal to the amount that the fair market value of the ordinary Shares on such date exceeds the exercise price. If the optionee is an employee, such ordinary income generally is subject to
withholding of income and employment taxes. Upon the sale of the ordinary shares acquired by the exercise of a <FONT STYLE="white-space:nowrap">non-statutory</FONT> stock option, any gain or loss (based on the difference between the sale price and
the fair market value on the exercise date) will be taxed as capital gain or loss. No tax deduction is available to us with respect to the grant of a <FONT STYLE="white-space:nowrap">non-statutory</FONT> stock option or the sale of the ordinary
shares acquired through the exercise of the <FONT STYLE="white-space:nowrap">non-statutory</FONT> stock option. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>New Plan Benefits </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Awards of stock options are within the discretion of our board of directors. As a result, the benefits or amounts that will be awarded or
allocated thereunder are not determinable at this time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This authorization, for the part not used, if applicable, supersedes any and all relevant prior
authorizations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the full text of Proposal No.&nbsp;36, please see Annex A. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Vote Required </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Proposal No.&nbsp;36
requires the affirmative vote of a 2/3 majority of the votes cast by the shareholders present in person, represented by proxy, or voting by mail at the Annual General Meeting and entitled to vote thereon. The votes cast will not include those
attached to shares for which the shareholder did not participate in the vote, abstained or voted blank or void. Abstentions will not be counted as votes cast and will have no effect on the outcome of the votes. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>THE BOARD OF DIRECTORS RECOMMENDS A VOTE &#147;FOR&#148; </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PROPOSAL 36. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">87 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc140648_9_27"></A>PROPOSAL NO.&nbsp;37: </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AMENDMENT OF ARTICLE 13 OF THE <FONT STYLE="white-space:nowrap">BY-LAWS</FONT> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board proposes the shareholders approve an amendment to Article 13 of the bylaws: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">To raise the age limit for the Chairman of the Board of Directors from seventy to seventy-five.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">To amend<I> </I>paragraph 2 of Article 13 of the <FONT STYLE="white-space:nowrap">by-laws</FONT> of the Company
accordingly and as follows: </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">&#147;<I>No one may be appointed Chairman if he has reached the age of 75. If the Chairman
in office reaches this age during a fiscal year, his duties automatically terminate at the end of the annual Ordinary Shareholders&#146; Meeting called to approve the financial statements for that fiscal year</I>.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The other provisions of Article 13 of the Company&#146;s bylaws remain unchanged. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board believes that increasing the mandatory retirement age is important to attract and retain talent on the Board, including the Chairman
of the Board, and to maintain continuity of informed, engaged directors with the level of experience and expertise to serve the best interests of the company and its stockholders. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the full text of Proposal No.&nbsp;37, please see Annex A. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Vote Required </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Proposal No.&nbsp;37
requires the affirmative vote of a 2/3 majority of the votes cast by the shareholders present in person, represented by proxy, or voting by mail at the Annual General Meeting and entitled to vote thereon. The votes cast will not include those
attached to shares for which the shareholder did not participate in the vote, abstained or voted blank or void. Abstentions will not be counted as votes cast and will have no effect on the outcome of the votes. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>THE BOARD OF DIRECTORS RECOMMENDS A VOTE &#147;FOR&#148; </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PROPOSAL 37. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">88 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc140648_9_28"></A>PROPOSAL NO.&nbsp;38: </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>POWERS TO COMPLETE FORMALITIES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board proposes the shareholders grant all powers to the bearer of an original, a copy or an excerpt of the minutes of the Annual General
Meeting to carry out all mandatory formalities with respect to registration and publication. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the full text of Proposal No.&nbsp;38
please see Annex A. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Vote Required </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Proposal No.&nbsp;38 requires the affirmative vote of a majority of the votes cast by the shareholders present in person, represented by proxy,
or voting by mail at the Annual General Meeting and entitled to vote thereon. The votes cast will not include those attached to shares for which the shareholder did not participate in the vote, abstained or voted blank or void. Abstentions will not
be counted as votes cast and will have no effect on the outcome of the votes. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>THE BOARD OF DIRECTORS RECOMMENDS A VOTE &#147;FOR&#148;
</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PROPOSAL 38. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">89 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc140648_10"></A>CODE OF BUSINESS CONDUCT AND ETHICS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have adopted a Code of Business Conduct and Ethics, or the Code of Conduct, that is applicable to all of our employees, executive officers
and directors. A copy of the Code of Conduct is available on our website at <I><FONT STYLE="white-space:nowrap">www.dbv-technologies.com</FONT></I>. Disclosure regarding any amendments to, or waivers from, provisions of the code of business conduct
and ethics that apply to our directors, principal executive officer or principal financial officer will be included in a Current Report on Form <FONT STYLE="white-space:nowrap">8-K</FONT> within four business days following the date of the amendment
or waiver, unless website posting or the issuance of a press release of such amendments or waivers is then permitted by the rules of the Nasdaq Stock Market. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc140648_11"></A>OTHER MATTERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Fiscal Year 2020 Annual Report and SEC Filings </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our financial statements prepared in accordance with generally accepted accounting principles in the United States for our fiscal year ended
December&nbsp;31, 2020 are included in our Annual Report on <FONT STYLE="white-space:nowrap">Form&nbsp;10-K,</FONT> which we will mail to shareholders at the same time as this proxy statement. This proxy statement and our annual report are posted on
the Investors and Media section of our website at<I> <FONT STYLE="white-space:nowrap">https://www.dbv-technologies.com/investor-relations</FONT></I>&nbsp;and are available from the SEC at its website at<I> www.sec.gov</I>. You may also obtain a copy
of our annual report without charge by sending a written request to DBV Technologies&nbsp;S.A., Attention: Legal Department, <FONT STYLE="white-space:nowrap">177-181</FONT> avenue Pierre Brossolette, 92120 Montrouge, France. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">*&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;*&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;* </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our board of directors knows of no other business which will be presented to the
annual meeting. If any other business is properly brought before the annual meeting, proxies will be voted in accordance with the judgment of the persons named therein. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc140648_12"></A>SHAREHOLDER PROPOSALS AND NOMINATIONS FOR DIRECTOR </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Shareholders who requested that items or draft resolutions be included on the agenda must send to the Company, marked for the attention of
Legal Department, a new certificate of ownership for the same accounts, by midnight, Paris time, of the second business day preceding Shareholders&#146; Meeting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The preparatory documents for the General Meeting specified in Article R.
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">225-73-1</FONT></FONT> of the French Commercial Code are available online on the Company&#146;s website
<I>(</I><I><FONT STYLE="white-space:nowrap">www.dbv-technologies.com</FONT></I><I>)</I> since the twenty-first day prior to the Meeting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, shareholders may ask the company to send them the documents and information mentioned in Articles R. <FONT
STYLE="white-space:nowrap">225-81</FONT> and R. <FONT STYLE="white-space:nowrap">225-83</FONT> of the French Commercial Code, up to and including the fifth day before the General Meeting, preferably by <FONT STYLE="white-space:nowrap">e-mail</FONT>
to the following address: <FONT STYLE="white-space:nowrap">investors@dbv-technologies.com.</FONT> The shareholders are invited to indicate in their request the <FONT STYLE="white-space:nowrap">e-mail</FONT> address to which these documents may be
sent to them so that the company may validly send the said documents by <FONT STYLE="white-space:nowrap">e-mail</FONT> in accordance with Article 3 of the aforementioned Order. Holders of bearer shares must provide proof of such status by sending a
certificate of registration in an account. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In accordance with Article R. <FONT STYLE="white-space:nowrap">225-84</FONT> of the French
Commercial Code, any shareholder may submit, to the Chairman of the Company&#146;s Board of Directors, questions in writing until the fourth business day preceding the date of the Shareholders&#146; Meeting, in this case until 11:59 p.m. Paris time
on Monday, May&nbsp;17, 2021. Such written questions must be preferably sent by electronic telecommunication to investors@dbv-technologies.com or by fax to 01.43.26.10.83 (or by registered mail including a receipt confirmation form, addressed to the
registered office). They must be accompanied by a certificate of account registration. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">THE BOARD OF DIRECTORS </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Montrouge, France </P>  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">April 26, 2021
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">90 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="toc140648_13"></A>Annex A </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ENGLISH TRANSLATION OF FULL TEXT OF RESOLUTIONS TO BE </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>VOTED ON AT THE ANNUAL GENERAL MEETING </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Please note that because we are a French company, the full text of the resolutions included in this Annex A has been translated from French. In the case
of any discrepancy between this version and the French version, the French version will prevail. </I></B></P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I>RESOLUTIONS SUBMITTED
TO THE COMBINED SHAREHOLDERS&#146; MEETING OF MAY&nbsp;19, 2021 </I></B></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Ordinary resolutions: </I></B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Approval of the annual financial statements for the year ended on December&nbsp;31, 2020,
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Approval of the consolidated financial statements for the year ended on December&nbsp;31, 2020,
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Allocation of income for the year ended on December&nbsp;31, 2020, </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">4.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Allocation of the accumulated deficit to the &#147;Additional <FONT STYLE="white-space:nowrap">paid-in</FONT>
capital&#148;, </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">5.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Statutory auditors&#146; special report on regulated agreements and acknowledgement of the absence of new
regulated agreements, </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">6.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Renewal of the term of office of Julie O&#146;Neill as director, </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">7.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Renewal of the term of office of Viviane Monges as director, </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">8.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Appointment of Ms.&nbsp;Adora Ndu to replace Mr.&nbsp;Torbjorn Bjerke as director, </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">9.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Appointment of Mr.&nbsp;Ravi Rao as director, </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">10.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Ratification of the provisional appointment of Timothy E. Morris as director, </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">11.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Determination of the annual fixed sum to be allocated to the members of the Board of Directors,
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">12.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Approval of the compensation policy for the Chairman of the Board of Directors and for the Board members,<B><SUP
STYLE="font-size:85%; vertical-align:top"> </SUP></B> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">13.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Approval of the compensation policy for the Chief Executive Officer and/or any other executive corporate
officer, </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">14.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Advisory opinion on the compensation of named executive officers other than the Chief Executive Officer,
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">15.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Advisory opinion on the opportunity to consult shareholders each year on the compensation paid by the Company
to named executive officers other than the Chief Executive Officer, </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">16.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Advisory opinion on the opportunity to consult shareholders every two years on the compensation paid by the
Company to named executive officers other than the Chief Executive Officer, </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">17.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Advisory opinion on the opportunity to consult shareholders every three years on the compensation paid by the
Company to named executive officers other than the Chief Executive Officer, </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">18.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Approval of the information set out in section I of Article <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">L.22-10-9</FONT></FONT> of the French Commercial Code,<B><SUP STYLE="font-size:85%; vertical-align:top"> </SUP></B> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">19.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Approval of the fixed, variable and <FONT STYLE="white-space:nowrap">non-recurring</FONT> components of overall
compensation and benefits of all types paid or assigned during the year ended to Michel de Rosen, Chairman of the Board of Directors, </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">20.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Approval of the fixed, variable and <FONT STYLE="white-space:nowrap">non-recurring</FONT> components of overall
compensation and benefits of all types paid or assigned during the year ended to Daniel Tass&eacute;, Chief Executive Officer, </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">91 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">21.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Approval of the fixed, variable and <FONT STYLE="white-space:nowrap">non-recurring</FONT> components of overall
compensation and benefits of all types paid or assigned during the year ended to Marie-Catherine Th&eacute;r&eacute;n&eacute;, Deputy Chief Executive Officer until September&nbsp;17, 2020, </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">22.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Authorization to be granted to the Board of Directors to buy back company shares on the Company&#146;s behalf
pursuant to Article L. <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">22-10-62</FONT></FONT> of the French Commercial Code, length of authorization, purpose, terms, and maximum amount, suspension during a public offering period,
</P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Extraordinary resolutions: </I></B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">23.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Authorization to be granted to the Board of Directors for the company to cancel the shares bought back pursuant
to Article L. <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">22-10-62</FONT></FONT> of the French Commercial Code, length of authorization, maximum amount, suspension during a public offering period, </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">24.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Delegation of powers to the Board of Directors to issue ordinary shares, giving, as necessary, access to
ordinary shares or to the allocation of debt securities (of the Company or of a Group company) and/or securities giving access to ordinary shares (of the Company or of a Group company) with <FONT STYLE="white-space:nowrap">pre-emptive</FONT> rights,
suspension during a public offering period, </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">25.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Delegation of powers to be granted to the Board of Directors to issue ordinary shares giving access, as the
case may be, to ordinary shares or to the allocation of debt securities (of the Company or a group company), and/or securities giving access to ordinary shares (of the Company or a group company), without
<FONT STYLE="white-space:nowrap">pre-emptive</FONT> rights, by means of a public offer (excluding the offers set out in section 1 of Article <FONT STYLE="white-space:nowrap">L.411-2</FONT> of the French Monetary and Financial Code), and/or as
consideration for securities in the context of a public exchange offer, suspension during a public offering period, </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">26.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Delegation of powers to be granted to the Board of Directors to issue ordinary shares giving access, as the
case may be, to ordinary shares or to the allocation of debt securities (of the Company or a group company), and/or securities giving access to ordinary shares (of the Company or a group company), without
<FONT STYLE="white-space:nowrap">pre-emptive</FONT> rights, by means of a public offer referred to in paragraph 1 of Article <FONT STYLE="white-space:nowrap">L.411-2</FONT> of the French Monetary and Financial Code, suspension during a public
offering period, </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">27.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Authorization, in the event of an issue without <FONT STYLE="white-space:nowrap">pre-emptive</FONT> rights, to
set the issue price according to the terms set by the General Meeting, within a limit of 10% of the capital per year, </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">28.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Delegation of powers to be granted to the Board of Directors to issue ordinary shares, giving, if applicable,
access to ordinary shares or the allocation of debt securities (of the Company or a group company) and/or securities giving access to ordinary shares (of the Company or a group company), with <FONT STYLE="white-space:nowrap">pre-emptive</FONT>
subscription rights waived in favor of categories of persons with certain characteristics, suspension during a public offering period, </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">29.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Authorization to increase the total amount of issues, </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">30.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Delegation of powers to be granted to the Board of Directors for the purpose of deciding on any
merger-absorption, demerger, or partial contribution of assets, </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">31.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Delegation of powers to be granted to the Board of Directors to issue ordinary shares giving access to ordinary
shares or to the allocation of debt securities (of the Company or of a Group company), and/or securities giving access to ordinary shares (of the Company or of a Group company), in the context of a merger, demerger or partial contribution of assets
decided by the Board of Directors pursuant to the delegation referred to in the thirtieth resolution, suspension during a public offering period, </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">32.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Overall limit on the maximum authorized amounts set under the
25<SUP STYLE="font-size:85%; vertical-align:top">th</SUP>, 26<SUP STYLE="font-size:85%; vertical-align:top">th</SUP>, 28<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> and 31<SUP STYLE="font-size:85%; vertical-align:top">st</SUP> resolutions
of this Meeting and the 28<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> resolution of the General Meeting of April&nbsp;20, 2020, </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">33.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Delegation of powers to the Board of Directors to issue stock warrants (BSA), subscription and/or acquisition
of new and/or existing stock warrants (BSAANE) and/or subscription and/or acquisition of new and/or existing redeemable stock warrants (BSAAR) with cancellation of preferential subscription rights, reserved for a category of persons, suspension
during a public offering period, </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">92 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">34.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Delegation of powers to be granted to the Board of Directors to increase the share capital by means of the
issue of ordinary shares and/or securities giving access to capital, with <FONT STYLE="white-space:nowrap">pre-emptive</FONT> subscription rights waived in favor of members of a company savings plan pursuant to Articles <FONT
STYLE="white-space:nowrap">L.3332-18</FONT> et seq. of the French Labor Code, </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">35.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Authorization to be granted to the Board of Directors to allocate free existing and/or future shares to members
of staff and/or certain corporate officers of the Company or related companies or economic interest groups, with shareholders waiving their <FONT STYLE="white-space:nowrap">pre-emptive</FONT> rights, length of authorization, maximum amount, duration
of vesting periods specifically in respect of disability and, if applicable, holding periods, </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">36.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Authorization to be granted to the Board of Directors to grant share subscription and/or purchase options
(stock options) to members of staff and/or certain corporate officers of the company or related companies or economic interest groups, with shareholders waiving their <FONT STYLE="white-space:nowrap">pre-emptive</FONT> rights, length of
authorization, maximum amount, strike price, maximum term of the option, </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">37.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Amendment of Article 13 of the <FONT STYLE="white-space:nowrap">by-laws</FONT> in order to set the age limit
for the Chairman of the Board of Directors at 75 years of age, and, </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">38.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Powers to complete formalities. </P></TD></TR></TABLE>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Text of draft resolutions </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Ordinary resolutions: </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>First Resolution &#150;
Approval of the annual financial statements for the year ended December&nbsp;31, 2020 </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The General Meeting, acting in accordance with the quorum and
majority requirements for ordinary shareholders&#146; meetings and having reviewed the report of the Board of Directors and the Statutory Auditors&#146; special report on the financial year ended December&nbsp;31, 2020, approves the annual financial
statements for the financial year ended on that date, as they were presented, as well as the transactions reflected in these accounts and summarized in these reports showing a loss (group part) of (139,397,433.28) euros. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Second Resolution &#150; Approval of the consolidated financial statements for the year ended December&nbsp;31, 2020 </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The General Meeting acting in accordance with the quorum and majority requirements for ordinary shareholders&#146; meetings and having reviewed the report of
the Board of Directors and the Statutory Auditors&#146; special report on the consolidated financial statements as of December&nbsp;31, 2020, approves these financial statements, as they were presented, which record a loss (group share) of
(159,373,630)&nbsp;dollars. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Third Resolution &#150; Allocation of income for the year ended on December&nbsp;31, 2020. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The General Meeting, acting in accordance with the quorum and majority requirements for ordinary shareholders&#146; meetings on the proposal of the Board of
Directors, decides to fully allocate the whole of the loss for the financial year ended December&nbsp;31, 2020, totaling of (139,397,433.28) euros, to the &#147;losses brought forward&#148; line, which would consequently change from a negative
balance of (556,177,697.08) euros to a negative balance of (695,575,130.36) euros. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to Article 243 of the French General Tax Code, the Meeting
notes that it was reminded that no distribution of dividends or income has occurred in the past three financial years. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">93 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Fourth Resolution &#150; Allocation of the accumulated deficit to the &#147;Additional <FONT
STYLE="white-space:nowrap">paid-in</FONT> capital&#148; </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The General Meeting, acting in accordance with the quorum and majority requirements for
ordinary meetings, and having considered the report of the Board of Directors, notes that the retained earnings account is in debit by 695,575,130.36 euros after appropriation of the net result for the year ended December&nbsp;31, 2020, decides to
charge the entirety of the aforementioned retained earnings account to the share premium account, which, before this charge, amounts to 860,890,979.55 euros, and notes that, as a result of this charge, the share premium account shows a credit
balance of 165,315,849.19 euros, and that the retained earnings account is thus completely cleared. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Fifth Resolution &#150; Statutory auditors&#146;
special report on regulated agreements and acknowledgement of the absence of new regulated agreements. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The General Meeting acting in accordance with
the quorum and majority requirements for ordinary shareholders&#146; meetings and having reviewed the report of the Board of Directors and the Statutory Auditors&#146; special report on related-party agreements presented to it, notes the absence of
any new regulated agreements. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Sixth Resolution &#150; Renewal of Mrs.&nbsp;Julie O&#146;NEILL, as director </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The General Meeting acting in accordance with the quorum and majority requirements for ordinary shareholders&#146; meetings and having reviewed the report of
the Board of Directors, decides to renew the term as Director of Julie O&#146;Neill, for a period of three years, to expire at the end of the General Meeting to be held in 2024 to approve the financial statements for the previous financial year.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Seventh Resolution &#150; Renewal of Mrs.&nbsp;Viviane MONGES, as director </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The General Meeting acting in accordance with the quorum and majority requirements for ordinary shareholders&#146; meetings and having reviewed the report of
the Board of Directors, decides to renew the term as Director of Viviane Monges, for a period of three years, to expire at the end of the General Meeting to be held in 2024 to approve the financial statements for the previous financial year. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Eighth Resolution &#150; Appointment of Mrs.&nbsp;Adora Ndu to replace Mr.&nbsp;Torbjorn Bjerke as director </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The General Meeting acting in accordance with the quorum and majority requirements for ordinary shareholders&#146; meetings and having reviewed the report of
the Board of Directors, decides to appoint Mrs.&nbsp;Adora Ndu as Board Member, in replacement of Mr.&nbsp;Torbjorn Bjerke whose mandate has expired, for a period of three years, to expire at the end of the General Meeting to be held in 2024 to
approve the financial statements for the previous financial year. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Ninth Resolution &#150; Appointment of Mr.&nbsp;Ravi Rao as director </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The General Meeting acting in accordance with the quorum and majority requirements for ordinary shareholders&#146; meetings and having reviewed the report of
the Board of Directors, decides, subject to the adoption of the 8<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> Ordinary Resolution of this General Meeting, to appoint Mr.&nbsp;Ravi Rao as Board Member, for a period of three years, to
expire at the end of the General Meeting to be held in 2024 to approve the financial statements for the previous financial year. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Tenth resolution
&#150; Ratification of the provisional appointment of Mr.&nbsp;Timothy&nbsp;E. Morris as director, </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The General Meeting acting in accordance with the
quorum and majority requirements for ordinary shareholders&#146; meetings and having reviewed the report of the Board of Directors, ratifies the appointment of Mr.&nbsp;Timothy&nbsp;E. Morris as Board Member, made provisionally by the Board of
Directors to replace Mrs.&nbsp;Claire Giraut following her resignation. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">94 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Consequently, Mr.&nbsp;Timothy&nbsp;E. Morris will go about his duties for the remaining term of the
appointment of his predecessor, namely until the Meeting to be held in 2022 to approve the financial statements for the previous financial year. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Eleventh resolution &#150; Determination of the annual fixed amount to be allocated to the members of the Board of directors, </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The General Meeting acting in accordance with the quorum and majority requirements for ordinary shareholders&#146; meetings and having reviewed the report of
the Board of Directors, sets the total annual amount of the Board members&#146; fees to be allocated to the Board of Directors from &#128;600,000&nbsp;to &#128;800,000 for the current financial year and for future financial years until otherwise
decided by a new General Meeting. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Twelfth Resolution &#150; Approval of the compensation policy for the Chairman of the Board of Directors and for the
directors </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The General Meeting, acting in accordance with the quorum and majority requirements for ordinary shareholders&#146; meetings, having
reviewed the report of the Board of Directors and acting pursuant to Article L. <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">22-10-8</FONT></FONT> of the French Commercial Code, approves the compensation policy for the Chairman
of the Board of Directors, as detailed in paragraph 4.1.3.1 of the report on corporate governance in the Universal Registration Document 2020. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Thirteenth Resolution &#150; Approval of the compensation policy for the Chief Executive Officer and/or any other executive corporate officer </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The General Meeting, acting in accordance with the quorum and majority requirements for ordinary shareholders&#146; meetings, having reviewed the report of the
Board of Directors and acting pursuant to Article L. <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">22-10-8</FONT></FONT> of the French Commercial Code, approves the compensation policy for the Chief Executive Officer and/or any
other executive corporate officer, as detailed in paragraph 4.1.3.1 of the report on corporate governance in the Universal Registration Document 2020. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Fourteenth Resolution &#150; Advisory opinion on the compensation of named executive officers other than the Chief Executive Officer </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The General Meeting, acting in accordance with the quorum and majority requirements for ordinary shareholders&#146; meetings, having reviewed the report of the
Board of Directors and acting pursuant to the Dodd-Frank Wall Street Reform and Consumer Protection Act&#151;Section&nbsp;951, approves, on a <FONT STYLE="white-space:nowrap">non-binding</FONT> advisory basis, the compensation policy applicable to
S&eacute;bastien Robitaille and Pharis Mohideen, named executive officers and members of the Company&#146;s executive committee, as presented in the report of the Board of Directors to this General Meeting in paragraph 8 and in the Company&#146;s
Proxy Statement. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Fifteenth resolution &#150; Advisory opinion on the opportunity to consult shareholders each year on the compensation paid by the
Company to named executive officers other than the Chief Executive Officer </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The General Meeting, acting in accordance with the quorum and majority
requirements for ordinary shareholders&#146; meetings, having reviewed the report of the Board of Directors, pursuant to U.S. regulations under the U.S. Securities Exchange Act declares that it is in the best interests of the shareholders of the
Company that the shareholders be consulted every year to approve, on a <FONT STYLE="white-space:nowrap">non-binding</FONT> advisory basis, the compensation paid by the Company to the named executive officers other than the Chief Executive Officer,
as detailed in paragraph 8 of the Board of Directors&#146; report and in the Company&#146;s Proxy Statement.. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Sixteenth resolution &#150; Advisory
opinion on the opportunity to consult shareholders every two years on the compensation paid by the Company to named executive officers other than the Chief Executive Officer, </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The General Meeting, acting in accordance with the quorum and majority requirements for ordinary shareholders&#146; meetings, having reviewed the report of the
Board of Directors, pursuant to U.S. regulations under </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">95 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the U.S. Securities Exchange Act, declares that it is in the best interests of the shareholders of the Company that the shareholders be consulted every two years to approve, on a <FONT
STYLE="white-space:nowrap">non-binding</FONT> advisory basis, the compensation paid by the Company to the named executive officers other than the Chief Executive Officer, as detailed in paragraph 8 of the Board of Directors&#146; report and in the
Company&#146;s Proxy Statement. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Seventeenth resolution &#150; Advisory opinion on the opportunity to consult shareholders every three years on the
compensation paid by the Company to named executive officers other than the Chief Executive Officer </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The General Meeting, acting in accordance with the
quorum and majority requirements for ordinary shareholders&#146; meetings, having reviewed the report of the Board of Directors, pursuant to U.S. regulations under the U.S. Securities Exchange Act declares that it is in the best interest of the
shareholders of the Company that the Shareholders be consulted every three years to approve, on a <FONT STYLE="white-space:nowrap">non-binding</FONT> advisory basis, the compensation paid by the Company to the named executive officers other than the
Chief Executive Officer, as detailed in paragraph 8 of the Board of Directors&#146; report and in the Company&#146;s Proxy Statement. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Eighteenth
Resolution &#150; Approval of the information set out in section I of Article <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">L.22-10-9</FONT></FONT> of the French Commercial Code </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The General Meeting, acting in accordance with the quorum and majority requirements for ordinary shareholders&#146; meetings, having reviewed the report of the
Board of Directors and acting pursuant to Article <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">L.22-10-34</FONT></FONT> of the French Commercial Code, approves the information set out in section I of Article <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">L.22-10-9</FONT></FONT> of the French Commercial Code, as detailed in paragraph 4.1.3.4 of the report on corporate governance in the Universal Registration Document 2020. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Nineteenth Resolution &#150; Approval of the fixed, variable and <FONT STYLE="white-space:nowrap">non-recurring</FONT> components of overall compensation
and benefits of all types paid or assigned during the year ended to Michel de Rosen, Chairman of the Board of Directors </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The General Meeting, acting in
accordance with the quorum and majority requirements for ordinary shareholders&#146; meetings, having reviewed the report of the Board of Directors and acting pursuant to Article L.
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">22-10-34</FONT></FONT> II of the French Commercial Code, approves the fixed, variable and <FONT STYLE="white-space:nowrap">non-recurring</FONT> components of overall compensation and
benefits of all types paid or assigned during the year ended to Michel de Rosen, Chairman of the Board of Directors, as detailed in paragraph 10 of the Board of Directors&#146; report. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Twentieth Resolution &#150; Approval of the fixed, variable and <FONT STYLE="white-space:nowrap">non-recurring</FONT> components of overall compensation
and benefits of all types paid or assigned during the year ended to Daniel Tass&eacute;, Chief Executive Officer<SUP STYLE="font-size:85%; vertical-align:top"> </SUP> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The General Meeting, acting in accordance with the quorum and majority requirements for ordinary shareholders&#146; meetings, having reviewed the report of the
Board of Directors and acting pursuant to Article L. <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">22-10-34</FONT></FONT> II of the French Commercial Code, approves the fixed, variable and
<FONT STYLE="white-space:nowrap">non-recurring</FONT> components of overall compensation and benefits of all types paid or assigned during the year ended to Daniel Tass&eacute;, Chief Executive Officer, as detailed in paragraph 10 of the Board of
Directors&#146; report. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Twenty-first Resolution &#150; Approval of the fixed, variable and <FONT STYLE="white-space:nowrap">non-recurring</FONT>
components of overall compensation and benefits of all types paid or assigned during the year ended to Marie-Catherine Th&eacute;r&eacute;n&eacute;, Deputy Chief Executive Officer until September&nbsp;17, 2020, </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The General Meeting, acting in accordance with the quorum and majority requirements for ordinary shareholders&#146; meetings, having reviewed the report of the
Board of Directors and acting pursuant to Article L. <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">22-10-34</FONT></FONT> II of the French Commercial Code, approves the fixed, variable and
<FONT STYLE="white-space:nowrap">non-recurring</FONT> components of overall compensation and benefits of all types paid or assigned during the year ended to Marie-Catherine Th&eacute;r&eacute;n&eacute;, Deputy Chief Executive Officer until
September&nbsp;17, 2020, as detailed in paragraph 10 of the Board of Directors&#146; report. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">96 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Twenty-second Resolution &#150; Authorization to be granted to the Board of Directors to buy back company
shares on the Company&#146;s behalf pursuant to Article L. <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">22-10-62</FONT></FONT> of the French Commercial Code, suspension during a public offering period, </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The General Meeting, acting in accordance with the quorum and majority requirements for ordinary shareholders&#146; meetings and having reviewed the report of
the Board of Directors, empowers it, for a period of eighteen months from the date of this General Meeting, pursuant to Articles L. <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">22-10-62</FONT></FONT> et seq. of the French
Commercial Code and Regulation (EU) No.&nbsp;596/2014 of the European Parliament and of the Council of 16&nbsp;April 2014, to buy back, on one or more occasions and at the times of its choosing, company shares up to the limit of 5% of the share
capital, adjusted, if necessary, to take into account any increase or reduction in capital that may have taken place during the course of the program. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This authorization cancels, up to the amount of the unused part, the authorization granted to the Board of Directors under the twenty-first ordinary
resolution of the General Meeting of April&nbsp;20, 2020. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The shares may be bought back in order to: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">support the secondary market for or the liquidity of DBV TECHNOLOGIES shares through a liquidity agreement with
an investment service provider, in accordance with the standard practice accepted by the regulations, in which context, the number of shares taken into account for the calculation of the aforementioned limit corresponds to the number of shares
purchased, after deduction of the number of shares resold; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">hold the purchased shares and ultimately return them for future exchange or as payment under external growth
transactions; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">provide coverage to meet obligations arising from stock option plans and/or free share allocation plans (or
similar plans) for the group&#146;s employees and/or corporate officers, as well as all share allocations arising under company or group employee savings plans (or similar plans), employee profit-sharing plans and/or any other form of share
allocation arrangement for the group&#146;s employees and/or corporate officers; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">hedge the securities giving access to the company&#146;s shares, pursuant to current regulations;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">where applicable, cancel the shares acquired, subject to the authorization granted under the twenty-third
extraordinary resolution of this General Meeting. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The acquisition, sale, exchange or transfer of these shares may be executed by any
means, including through the purchase of share blocks, at the time deemed appropriate by the Board of Directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Board may not, without the prior
authorization of the Shareholders&#146; Meeting, use this authorization during a public offer period initiated by a third party for the shares of the Company until the end of the offer period. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The company does not intend to use options or derivatives. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
maximum purchase price is set at &#128;100 per share (excluding charges). In the event of a capital transaction, in particular a stock split or reverse split, or the allocation of free shares to shareholders, the abovementioned amount will be
adjusted in the same proportions (multiplier coefficient equal to the ratio between the number of shares comprising the capital before the transaction and the number of shares after the transaction). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The maximum transaction amount is set at &#128;150,000,000 (excluding charges). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The General Meeting hereby authorizes the Board of Directors to carry out these transactions, set the terms and methods thereof, finalize all agreements and
complete all formalities when necessary. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">97 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Extraordinary resolutions: </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Twenty-third resolution &#150; Authorization to be granted to the Board of Directors for the company to cancel the shares bought back pursuant to Article L.
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">22-10-62</FONT></FONT> of the French Commercial Code, length of authorization, maximum amount, suspension during a public offering period, </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The General Meeting, acting in accordance with the quorum and majority requirements for extraordinary shareholders&#146; meetings and having reviewed the Board
of Directors&#146; report and the Statutory Auditors&#146; report: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Authorizes the Board of Directors to cancel, at its discretion, on one or more occasions, up to 5% of the
capital calculated on the date of the decision to cancel, less any shares canceled during the last 24 months, shares the company holds or may hold following <FONT STYLE="white-space:nowrap">buy-backs</FONT> performed pursuant to Article L. <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">22-10-62</FONT></FONT> of the French Commercial Code and to reduce the share capital accordingly in compliance with legal and regulatory provisions in force; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Sets the validity of this authorization at eighteen months from the date of this General Meeting;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Board may not, without the prior authorization of the Shareholders&#146; Meeting, use this authorization
during a public offer period initiated by a third party for the shares of the Company until the end of the offer period. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Empowers the Board of Directors to carry out all necessary operations to perform such cancellations and the
resulting reductions of the share capital, accordingly amending the company&#146;s Bylaws and fulfilling all formalities required. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Twenty-fourth resolution &#150; Delegation of powers to the Board of Directors to issue ordinary shares, giving, as necessary, access to ordinary shares or
to the allocation of debt securities (of the Company or of a Group company) and/or securities giving access to ordinary shares (of the Company or of a Group company) with <FONT STYLE="white-space:nowrap">pre-emptive</FONT> rights, suspension during
a public offering period, </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The General Meeting, acting in accordance with the quorum and majority requirements for extraordinary shareholders&#146;
meetings and having reviewed the Board of Directors&#146; report and the Statutory Auditors&#146; special report and pursuant to the French Commercial Code, in particular Articles
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">L.&nbsp;225-129-2,</FONT></FONT> L. <FONT STYLE="white-space:nowrap">228-92</FONT> and L. <FONT STYLE="white-space:nowrap">225-132</FONT> et seq. thereof: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Delegates authority to the Board of Directors to issue, on one or more occasions, in the proportions and at the
times of its choosing, on the French and/or international market either in euros or in foreign currencies or in any other accounting unit set with reference to a basket of currencies: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">ordinary shares; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">and/or ordinary shares giving access to the allocation of ordinary shares to be issued or debt securities;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">and/or securities giving access to ordinary shares to be issued. </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Pursuant to Article <FONT STYLE="white-space:nowrap">L.&nbsp;228-93</FONT> of the French Commercial Code, the securities to be issued may give
rights to ordinary shares of any and all companies that directly or indirectly own over half of its capital or of which the Company directly or indirectly owns over half of the capital. </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Sets the term of validity of this authorization at <FONT STYLE="white-space:nowrap">twenty-six</FONT> months
from the date of this General Meeting. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Decides to fix the limits to the amounts of authorized issues if the Board of Directors should use this
delegation of competence: </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The total par value of the ordinary shares that may be issued subject to this authorization
may not exceed 40% of the capital existing on the date of the decision to increase the share capital by the Board of Directors. This maximum amount is separate from all maximum amounts set by the other resolutions of this General Meeting. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">98 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">To this maximum amount will be added, as necessary, the par value of the capital increase
necessary to preserve the rights of the holders of rights or securities giving access to the Company&#146;s capital, pursuant to the law, and where applicable, the contractual stipulations providing for other adjustments. </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The maximum nominal amount of the debt securities that may be issued pursuant to this authorization may not
exceed 150,000,000 euros (or the equivalent of this amount in the event of an issue in another currency), it being specified that: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">this amount will be increased, if applicable, by any redemption premium above par, </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">this amount will be deducted from the overall ceiling referred to in the thirty-second resolution below,
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">this ceiling does not apply to the debt securities referred to in articles L.
<FONT STYLE="white-space:nowrap">228-40,</FONT> L. <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">228-36-A</FONT></FONT> and L. <FONT STYLE="white-space:nowrap">228-92</FONT> paragraph 3 of the French Commercial Code, the issue of
which would be decided or authorized by the Board of Directors under the conditions provided for in article L. <FONT STYLE="white-space:nowrap">228-40</FONT> of the French Commercial Code, or in other cases, under the conditions determined by the
Company in accordance with the provisions of article L. <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">228-36-A</FONT></FONT> of the French Commercial Code. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">If the Board of Directors needs to use this delegation of competence under the scope of the issues envisaged in
point 1) above, it: </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">a/ decides that the issue(s) of ordinary shares or securities giving access to the capital shall be
preferentially reserved to shareholders, who may subscribe them on an irrevocable basis; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">b/ decides that if subscriptions, on an
irreducible basis and, if applicable, on a reducible basis , have not absorbed the entire issue mentioned in 1), the Board of Directors may use the following options: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">limit the amount of the issue to the amount of subscriptions, if applicable within the limits established by the
regulation. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">freely allocate all or part of the unsubscribed securities. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">offer to the public all or part of the unsubscribed securities. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">6)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Decides that the issue of Company&#146;s warrants (BSA) may be made by subscription offer, but also by
allocation to the owners of the existing shares, it being specified that the Board of Directors may decide that the rights of allotment forming odd lots shall not be negotiable and the corresponding securities will be sold. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">7)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Decides that the Board of Directors shall be granted, within the limits set above, the powers required to set
the terms for the issues and determine the issue price, and if applicable, record the execution of the resulting capital increases, amend the Bylaws accordingly, impute, as it sees fit, the costs of the capital increase to the amount of the related
premiums and deduct the necessary sums from this amount to bring the statutory reserve to one tenth of the new share capital after each increase and more generally, perform all tasks required in similar matters. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">8)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Decides that the Board cannot, unless authorized in advance by the General Meeting, make use of this delegation
in a period public offering initiated by a third party targeting the securities of the Company until the end of the offering period. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">9)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Notes that this delegation, for the part not used, if applicable, supersedes any and all relevant prior
delegations. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Twenty-fifth Resolution &#150; Delegation of powers to be granted to the Board of Directors to issue ordinary shares
giving access, as the case may be, to ordinary shares or to the allocation of debt securities (of the Company or a group company), and/or securities giving access to ordinary shares (of the Company or a group company), without <FONT
STYLE="white-space:nowrap">pre-emptive</FONT> rights, by means of a public offer (excluding the offers set out in section 1 of Article <FONT STYLE="white-space:nowrap">L.411-2</FONT> of the French Monetary and Financial Code), and/or as
consideration for securities in the context of a public exchange offer, suspension during a public offering period, </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The General Meeting, acting in
accordance with the quorum and majority requirements for extraordinary shareholders&#146; meetings and having reviewed the Board of Directors&#146; report and the Statutory Auditors&#146; special </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">99 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
report and pursuant to the French Commercial Code, in particular Articles L. <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">225-129-2,</FONT></FONT> L <FONT
STYLE="white-space:nowrap">225-136</FONT> L. <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">22-10-52,</FONT></FONT> <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">L.22-10-54</FONT></FONT> and L. <FONT
STYLE="white-space:nowrap">228-92</FONT> thereof: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Delegates to the Board of Directors the power to issue, on one or more occasions, in the proportions and at the
times of its choosing, on the French and/or international market, by means of a public offer (excluding the offers set out in section 1 of Article <FONT STYLE="white-space:nowrap">L.411-2</FONT> of the French Monetary and Financial Code), in euros,
in foreign currencies or in any other unit determined by reference to a basket of currencies: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">ordinary shares; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">and/or ordinary shares giving access to the allocation of ordinary shares to be issued or debt securities;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">and/or securities giving access to ordinary shares to be issued. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">These securities may be issued for the purpose of paying for securities contributed to the Company in a public exchange offer, pursuant to the conditions of
Article <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">L.&nbsp;22-10-54</FONT></FONT> of the French Commercial Code. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to
Article L. <FONT STYLE="white-space:nowrap">228-93</FONT> of the French Commercial Code, the securities to be issued may give rights to ordinary shares of any and all companies that directly or indirectly own more than half of its capital or of
which the Company directly or indirectly owns more than half of the capital. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Sets the term of validity of this authorization at <FONT STYLE="white-space:nowrap">twenty-six</FONT> months
from the date of this General Meeting. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The total par value of the ordinary shares that may be issued subject to this authorization may not exceed 30%
of the share capital on the date of the decision to increase the share capital by the Board of Directors. </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">To this
maximum amount will be added, as necessary, the par value of any capital increase necessary to preserve the rights of the holders of rights or securities giving access to the Company&#146;s capital, in accordance with the law and, if applicable, any
contractual stipulations providing for other methods of preservation. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">This maximum amount counts toward the overall limit on the maximum
par value of shares that may be issued as envisaged under the thirty-second resolution of this Meeting. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The maximum nominal amount of the debt securities that may be issued pursuant to this authorization may not
exceed 150,000,000 euros (or the equivalent of this amount in the event of an issue in another currency), it being specified that: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">this amount will be increased, if applicable, by any redemption premium above par, </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">this amount will be deducted from the overall ceiling referred to in the thirty-second resolution below,
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">this ceiling does not apply to the debt securities referred to in articles L.
<FONT STYLE="white-space:nowrap">228-40,</FONT> L. <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">228-36-A</FONT></FONT> and L. <FONT STYLE="white-space:nowrap">228-92</FONT> paragraph 3 of the French Commercial Code, the issue of
which would be decided or authorized by the Board of Directors under the conditions provided for in article L. <FONT STYLE="white-space:nowrap">228-40</FONT> of the French Commercial Code, or in other cases, under the conditions determined by the
Company in accordance with the provisions of article L. <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">228-36-A</FONT></FONT> of the French Commercial Code. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Decides to cancel shareholders&#146; <FONT STYLE="white-space:nowrap">pre-emptive</FONT> rights to ordinary
shares and securities giving access to capital and/or to debt securities covered by this resolution, while retaining the Board of Directors&#146; option to grant preferential rights to shareholders, pursuant to the law. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">6)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Decides that the amount received, or to be received, by the Company for each of the ordinary shares issued
under this delegation of powers, after taking into account the warrant issue price for issues of detachable share subscription warrants, will be determined in accordance with the applicable legal and regulatory provisions at the time that the Board
of Directors exercises the delegation. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">7)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Decides, in the event that securities are issued in consideration of securities tendered in a public exchange
offer, pursuant to the conditions of Article L. <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">22-10-54</FONT></FONT> of the French Commercial Code, and within the
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">100 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
limits set out above, to grant the Board of Directors the powers required to draft the list of securities included in the exchange, and to set the issue conditions and terms, the <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">share-for-share</FONT></FONT> basis, and, if applicable, the amount of the equalization payment in cash. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">8)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Decides that if subscriptions have not absorbed the entire issue mentioned at 1), the Board of Directors may
use the following options: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">limit the amount of the issue to the amount of subscriptions, if applicable within the limits established by the
regulations; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">freely allocate some or all of the unsubscribed shares. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">9)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Decides that the Board of Directors shall be granted, within the limits set above, the powers required to set
the terms for the issue(s), and if applicable, record the execution of the resulting capital increases, proceed to amend the <FONT STYLE="white-space:nowrap">by-laws</FONT> accordingly, levy, as it sees fit, the costs of the capital increase on the
amount of related premiums and deduct the necessary sums from this amount to bring the statutory reserve to <FONT STYLE="white-space:nowrap">one-tenth</FONT> of the new share capital after each increase and, more generally, perform all tasks
required in similar matters. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">10)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Decides that the Board cannot, unless authorized in advance by the General Meeting, make use of this delegation
in a period public offering initiated by a third party targeting the securities of the Company until the end of the offering period. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">11)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Notes that this delegation, for the part not used, if applicable, supersedes any and all relevant prior
delegations. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Twenty-sixth Resolution &#150; Delegation of powers to be granted to the Board of Directors to issue ordinary shares
giving access, as the case may be, to ordinary shares or to the allocation of debt securities (of the Company or a group company), and/or securities giving access to ordinary shares (of the Company or a group company), without <FONT
STYLE="white-space:nowrap">pre-emptive</FONT> rights, by means of a public offer referred to in paragraph 1 of Article <FONT STYLE="white-space:nowrap">L.411-2</FONT> of the French Monetary and Financial Code, suspension during a public offering
period, </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The General Meeting, acting in accordance with the quorum and majority requirements for extraordinary shareholders&#146; meetings and having
reviewed the Board of Directors&#146; report and the Statutory Auditors&#146; special report and pursuant to the French Commercial Code, in particular Articles
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">L.225-129-2,</FONT></FONT> <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">L.22-10-52,</FONT></FONT> L. <FONT STYLE="white-space:nowrap">225-136,</FONT> <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">L.22-10-54</FONT></FONT> and L. <FONT STYLE="white-space:nowrap">228-92</FONT> thereof: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Delegates to the Board of Directors the power to issue, on one or more occasions, in the proportions and at the
times of its choosing, on the French and/or international market, by means of a public offer referred to in paragraph 1 of Article <FONT STYLE="white-space:nowrap">L.411-2</FONT> of the French Monetary and Financial Code, in euros, in foreign
currencies or in any other unit determined by reference to a basket of currencies: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">ordinary shares; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">and/or ordinary shares giving access to the allocation of ordinary shares to be issued or debt securities;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">and/or securities giving access to ordinary shares to be issued. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to Article L <FONT STYLE="white-space:nowrap">228-93</FONT> of the French Commercial Code, the securities to be issued may give rights to ordinary
shares of any and all companies that directly or indirectly own over half of its capital or of which the company directly or indirectly owns over half of the capital. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Sets the term of validity of this authorization at <FONT STYLE="white-space:nowrap">twenty-six</FONT> months
from the date of this General Meeting. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The total par value of the ordinary shares that may be issued subject to this authorization may not exceed 20%
of the share capital on the date of the decision to increase the share capital by the Board of Directors. </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">To this
maximum amount will be added, as necessary, the par value of any capital increase necessary to preserve the rights of the holders of rights or securities giving access to the Company&#146;s capital, in
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">101 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
accordance with the law and, if applicable, any contractual stipulations providing for other methods of preservation. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">This maximum amount counts toward the overall limit on the maximum par value of shares that may be issued as envisaged under the thirty-second
Resolution of this Meeting. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The maximum nominal amount of the debt securities that may be issued pursuant to this authorization may not
exceed 150,000,000 euros (or the equivalent of this amount in the event of an issue in another currency), it being specified that: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">this amount will be increased, if applicable, by any redemption premium above par, </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">this amount will be deducted from the overall ceiling referred to in the thirty-second resolution below,
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">this ceiling does not apply to the debt securities referred to in articles L.
<FONT STYLE="white-space:nowrap">228-40,</FONT> L. <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">228-36-A</FONT></FONT> and L. 228-92 paragraph 3 of the French Commercial Code, the issue of which would be decided or authorized by
the Board of Directors under the conditions provided for in article L. <FONT STYLE="white-space:nowrap">228-40</FONT> of the French Commercial Code, or in other cases, under the conditions determined by the Company in accordance with the provisions
of article L. <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">228-36-A</FONT></FONT> of the French Commercial Code. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Decides to cancel shareholders&#146; <FONT STYLE="white-space:nowrap">pre-emptive</FONT> rights to ordinary
shares and to securities giving access to capital and/or to debt securities covered by this resolution. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">6)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Decides that the amount received, or to be received, by the Company for each of the ordinary shares issued
under this delegation of powers, after taking into account the warrant issue price for issues of detachable share subscription warrants, will be determined in accordance with the applicable legal and regulatory provisions at the time that the Board
of Directors exercises the delegation. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">7)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Decides that if subscriptions have not absorbed the entire issue mentioned at 1), the Board of Directors may
use the following options: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">limit the amount of the issue to the amount of subscriptions, if applicable within the limits established by the
regulations; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">freely allocate some or all of the unsubscribed shares. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">8)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Decides that the Board of Directors will be granted, within the limits set above, the powers required to set
the terms for the issue(s), and if applicable, record the execution of the resulting capital increases, amend the <FONT STYLE="white-space:nowrap">by-laws</FONT> accordingly, charge, as it sees fit, the costs of the capital increase against the
amount of the related premiums and deduct the necessary sums from this amount to bring the statutory reserve to one tenth of the new share capital after each increase and more generally, perform all tasks required in this regard.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">9)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Decides that the Board cannot, unless authorized in advance by the General Meeting, make use of this delegation
in a period public offering initiated by a third party targeting the securities of the Company until the end of the offering period. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">10)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Notes that this delegation, for the part not used, if applicable, supersedes any and all relevant prior
delegations. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Twenty-seventh Resolution &#150; Authorization, in the event of an issue without
<FONT STYLE="white-space:nowrap">pre-emptive</FONT> rights, to set the issue price according to the terms set by the General Meeting, within a limit of 10% of the capital per year </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The General Meeting acting in accordance with the quorum and majority requirements for extraordinary shareholders&#146; meetings and having reviewed the Board
of Directors&#146; report and the Statutory Auditors&#146; special report and pursuant to Article L. <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">22-10-52</FONT></FONT> of the French Commercial Code, authorizes the Board of
Directors, when deciding to issue ordinary shares or securities giving access to the capital, pursuant to the 25<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> and 26<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> resolutions<I>,
</I>subject to the provisions of Article L. <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">22-10-52</FONT></FONT> of the French Commercial Code, to deviate from the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">102 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
price-setting conditions set out in the above-mentioned resolutions, up to a maximum of 10% of the share capital per year, and to set the issue price of equity equivalents to be issued as
follows: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The issue price of the ordinary shares that may be issued pursuant to this delegation of authority will be set by the Board of Directors and
must be at least equal to: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">either the weighted average trading price of the company&#146;s share on the trading day prior to the date on
which the issue price is set, possibly reduced by a maximum discount of 15%, </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">or the average of five consecutive share trading prices selected from the last thirty trading days prior to the
date on which the issue price is set, possibly reduced by a maximum discount of 15%. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Twenty-eighth Resolution &#150; Delegation of
powers to be granted to the Board of Directors to issue ordinary shares, giving, if applicable, access to ordinary shares or the allocation of debt securities (of the Company or a group company) and/or securities giving access to ordinary shares (of
the Company or a group company), with <FONT STYLE="white-space:nowrap">pre-emptive</FONT> subscription rights waived in favor of categories of persons with certain characteristics, suspension during a public offering period, </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The General Meeting, acting in accordance with the quorum and majority requirements for extraordinary shareholders&#146; meetings and having reviewed the Board
of Directors&#146; report and the Statutory Auditors&#146; special report and pursuant to the provisions of the French Commercial Code, specifically Articles L.
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">225-129-2,</FONT></FONT> L. <FONT STYLE="white-space:nowrap">225-138</FONT> and L. <FONT STYLE="white-space:nowrap">228-92:</FONT> </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Delegates to the Board of Directors its power to issue the following (on one or more occasions, in the
proportions and at the times of its choosing, in France and abroad, with <FONT STYLE="white-space:nowrap">pre-emptive</FONT> subscription rights waived in favor of the categories of persons defined below): </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">ordinary shares; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">and/or ordinary shares giving access to the allocation of ordinary shares to be issued or debt securities;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">and/or securities giving access to ordinary shares to be issued. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to Article L. <FONT STYLE="white-space:nowrap">228-93</FONT> of the French Commercial Code, the securities to be issued may give rights to ordinary
shares of any and all companies that directly or indirectly own over half of its capital or of which the company directly or indirectly owns over half of the capital. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Sets the term of validity of this delegation at eighteen months from the date of this General Meeting.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The maximum total par value of the capital increases that may be made subject to this delegation may not exceed
30% of the share capital on the date of the decision to increase the share capital by the Board of Directors. </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">To this
maximum amount will be added, as necessary, the par value of any capital increase necessary to preserve the rights of the holders of rights or securities giving access to the Company&#146;s capital, in accordance with the law and, if applicable, any
contractual stipulations providing for other methods of preservation. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">This maximum amount counts toward the overall limit on the maximum
par value of shares that may be issued as envisaged under the thirty-second Resolution of this General meeting. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The maximum nominal amount of the debt securities that may be issued pursuant to this authorization may not
exceed 150,000,000 euros (or the equivalent of this amount in the event of an issue in another currency), it being specified that: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">this amount will be increased, if applicable, by any redemption premium above par, </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">this amount will be deducted from the overall ceiling referred to in the thirty-second resolution below,
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">103 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">this ceiling does not apply to the debt securities referred to in articles L.
<FONT STYLE="white-space:nowrap">228-40,</FONT> L. <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">228-36-A</FONT></FONT> and L. <FONT STYLE="white-space:nowrap">228-92</FONT> paragraph 3 of the French Commercial Code, the issue of
which would be decided or authorized by the Board of Directors under the conditions provided for in article L. <FONT STYLE="white-space:nowrap">228-40</FONT> of the French Commercial Code, or in other cases, under the conditions determined by the
Company in accordance with the provisions of article L. <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">228-36-A</FONT></FONT> of the French Commercial Code. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Decides, in accordance with the provisions of Article L. <FONT STYLE="white-space:nowrap">225-138</FONT> of the
French Commercial Code, that the issue price of ordinary shares that may be issued under the scope of this delegation of powers will be set by the Board of Directors and must be at least equal to at the discretion of the Board of Directors or the
Chief Executive Officer: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the closing price of the Company&#146;s shares on the regulated market Euronext Paris during the last trading
session prior to the date on which the issue price is set, possibly reduced by a maximum discount of 15%, or, </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the volume-weighted average (in the central order book and <FONT STYLE="white-space:nowrap">off-market</FONT>
blocks) of the Company&#146;s share price on the Euronext Paris regulated market during the last three trading days prior to the date on which the issue price is set, possibly reduced by a maximum discount of 15%, or, </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">at the weighted average trading price of the company&#146;s shares on the trading day prior to the date on which
the issue price is set, possibly reduced by a maximum discount of 15%, or, </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the average of 5 consecutive share trading prices selected from the last 30 trading days prior to the date on
which the issue price is set, possibly reduced by a maximum discount of 15%, </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">it being specified that the Board of
Directors (or the Chief Executive Officer in the event of <FONT STYLE="white-space:nowrap">sub-delegation)</FONT> may decide to set the offer price on the date of issue of the ordinary shares by immediate issue or by issue following the exercise or
conversion of the securities giving access to the share capital. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">6)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Decides to eliminate the preferential subscription rights by shareholders of ordinary shares and other
securities giving access to the capital to be issued in accordance with Article L. <FONT STYLE="white-space:nowrap">228-91</FONT> of the French Commercial Code, reserved for the following categories of persons: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">vi.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">natural person(s) or legal entity(ies), including companies, trusts, investment funds or other investment
vehicle(s), regardless of their form, under French or foreign law, investing on a regular basis in the pharmaceutical, biotechnological or medical technology sector, and/or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">vii.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">French or foreign companies, institutions or entities of any form, carrying out a significant portion of their
business in these sectors or in the cosmetics or chemical sector or in the field of medical devices or research in these areas; and/or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">viii.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any individual(s) or legal entity(ies), including any company(ies), institution(s), entity(ies), trust(ies),
investment fund(s) or other investment vehicle(ies) in any form whatsoever, under French or foreign law, when entering into an industrial, commercial, licensing, research or partnership agreement with the Company; and/or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">ix.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any credit institution, any French or foreign investment service provider or member of a banking syndicate or
any company or investment fund that undertakes to subscribe to any issue likely to result in a future capital increase that may be carried out pursuant to this delegation in connection with the implementation of an equity or bond financing line;
and/or. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">x.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">French or foreign investment service provider(s), or any foreign establishment(s) with equivalent status,
likely to guarantee the completion of an issue intended to be placed with the persons referred to in (i)&nbsp;and/or (ii)&nbsp;above and, in this context, to subscribe for the securities issued. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">7)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Decides Resolves that these subscriptions may be made either in cash or by way of compensation of debts,
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">104 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">8)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Decides that the Board of Directors will have full powers to implement this delegation, and therefore to:
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">a.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">draw up the terms for the issue(s); </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">b.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">draw up the list of beneficiaries within the above categories; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">c.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">determine the number of shares to be allocated to each of the beneficiaries; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">d.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">determine the amount to be issued, the issue price and the amount of the premium that can, if applicable, be
demanded at issue; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">e.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">determine the dates and terms of the issue, and the nature, form and characteristics of the shares to be
created, which can take the form of subordinated or unsubordinated shares, with fixed or unlimited terms; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">f.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">determine the method by which the shares and/or securities issued or to be issued can be paid up;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">g.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">determine, if applicable, the methods by which the rights attached to the securities issued or to be issued can
be exercised and, in particular, to determine the date, which may be retroactive, from which rights will attach to the new shares, as well as all other terms and conditions applicable to the execution of the issue; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">h.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">if applicable, suspend the exercise of rights attached to the securities issued, for up to three months;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">i.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">at its sole discretion, charge the costs of the capital increase against the amount of the related premiums and
deduct the necessary sums from this amount to bring the statutory reserve to one tenth of the new share capital after each increase; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">j.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">record each share capital increase and make the corresponding amendments to the
<FONT STYLE="white-space:nowrap">by-laws;</FONT> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">k.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">make all adjustments required in compliance with legal provisions and determine the methods by which the rights
of holders of securities giving access to capital will be preserved, if applicable; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">l.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">generally, enter into any agreements, take all measures and complete any formalities required for the issue and
for the financial administration of the securities issued pursuant to this delegation and for the exercise of any attached rights and, more generally, perform all tasks required in this regard. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">9)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">back at the next Ordinary General Meeting, in compliance with the law and the regulations, on the use of the
delegation granted under this resolution. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">10)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Decides that the Board cannot, unless authorized in advance by the General Meeting, make use of this delegation
in a period public offering initiated by a third party targeting the securities of the Company until the end of the offering period. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">11)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Notes that this delegation, for the part not used, if applicable, supersedes, as from today&#146;s date, any
and all relevant prior delegations. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Twenty-ninth Resolution &#150; Authorization to increase the total amount of issues. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Acting in accordance with the quorum and majority requirements for extraordinary shareholders&#146; meetings and having reviewed the report by the Board of
Directors, the General Meeting decides that for each of the issues of ordinary shares or securities giving access to the capital determined pursuant to 24<SUP STYLE="font-size:85%; vertical-align:top">th</SUP>, 25<SUP
STYLE="font-size:85%; vertical-align:top">th</SUP>, 26<SUP STYLE="font-size:85%; vertical-align:top">th</SUP>, and 28<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> Resolution of this General Meeting, the number of securities to be issued
may be increased under the conditions set out in Articles L <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">225-135-1</FONT></FONT> and R <FONT STYLE="white-space:nowrap">225-118</FONT> of the French Commercial Code, up to the
maximum amount determined by the General Meeting. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">105 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Thirtieth Resolution &#150; - Delegation of powers to be granted to the Board of Directors for the
purpose of deciding on any merger-absorption, demerger, or partial contribution of assets. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The General Meeting, acting in accordance with the quorum
and majority requirements for extraordinary shareholders&#146; meetings, having reviewed the Board of Directors&#146; report and in accordance with the provisions of Article L. <FONT STYLE="white-space:nowrap">236-9</FONT> II of the French
Commercial Code </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1) Delegates to the Board of Directors all powers to decide, at the times it deems appropriate, on one or more mergers, absorptions,
demergers or partial contributions of assets carried out in accordance with the provisions of Articles L. <FONT STYLE="white-space:nowrap">236-1</FONT> et seq. of the French Commercial Code, </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2) Decides that the Board of Directors shall have full powers to implement, in accordance with the conditions set by law and the bylaws, this delegation of
authority to determine all the terms and conditions of any transaction that may be decided pursuant to this delegation, it being specified that if this transaction requires a capital increase by the Company, such increase must be carried out within
the limits set forth in the thirty-first resolution below, </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">3) Sets the term of validity of this delegation of authority at
<FONT STYLE="white-space:nowrap">twenty-six</FONT> months, with effect from the date of this General Meeting, </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">4) Decides that this delegation may not be
implemented during a public offering period. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Thirty-first resolution &#150; Delegation of powers to be granted to the Board of Directors to issue
ordinary shares giving access to ordinary shares or to the allocation of debt securities (of the Company or of a Group company), and/or securities giving access to ordinary shares (of the Company or of a Group company), in the context of a merger,
demerger or partial contribution of assets decided by the Board of Directors pursuant to the delegation referred to in the thirtieth resolution, suspension during a public offering period, </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The General Meeting, acting in accordance with the quorum and majority requirements for extraordinary shareholders&#146; meetings, having reviewed the Board
of Directors&#146; report and the report of the Statutory Auditors, subject to the adoption of the thirtieth resolution above, and in accordance with the French Commercial Code and in particular the provisions of Articles L. <FONT
STYLE="white-space:nowrap">225-129</FONT> to L. <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">225-129-3,</FONT></FONT> L. <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">225-129-5</FONT></FONT> and L. <FONT
STYLE="white-space:nowrap">228-91</FONT> et seq., </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1) Delegates to the Board of Directors its power to decide on the issue, on one or more occasions and
at the times it deems appropriate, on the French and/or international market, either in euros, or in a foreign currency or any other unit of account established by reference to a set of currencies: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">ordinary shares, </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">and/or ordinary shares giving right to the allocation of other ordinary shares to be issued or debt securities,
</P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">and/or securities giving access to common shares to be issued, </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">in consideration for contributions in kind granted to the Company in connection with any merger, demerger or partial asset contribution decided by the Board
of Directors pursuant to the delegation granted under the thirtieth resolution above, said shares confer the same rights as existing shares, subject to their dividend entitlement date, </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2) Sets the period of validity of this delegation of authority at <FONT STYLE="white-space:nowrap">twenty-six</FONT> months, with effect from the date of this
Meeting, </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">3) Resolves, as necessary, to cancel, in favor of the shareholders of the absorbed or transferring company, the shareholders&#146; preferential
subscription right to these ordinary shares and securities to be issued, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">106 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">4) Acknowledged, as necessary, that this authorization automatically entails the express waiver by
shareholders of their <FONT STYLE="white-space:nowrap">pre-emptive</FONT> right to subscribe for the shares to which the securities issued under this authorization will entitle their holders, </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5) The total nominal amount of the ordinary shares that may be issued pursuant to this delegation may not exceed 10% of the share capital on the date of the
decision to increase the share capital by the Board of Directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">6) This maximum amount counts toward the overall limit on the maximum par value of
shares that may be issued as envisaged under the thirty-second Resolution of this General meeting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To this ceiling shall be added, where applicable, the
amount of additional shares to be issued to preserve, in accordance with legal or regulatory provisions and, where applicable, applicable contractual stipulations, the rights of holders of securities and other rights giving access to the share
capital, </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">7) The maximum nominal amount of issues of debt securities giving access to the capital and debt securities that may be issued pursuant to this
delegation may not exceed 150,000,000 euros (or the equivalent value of this amount in the event of an issue in another currency), it being specified that : </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">this amount will be increased, if applicable, by any redemption premium above par, </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">this amount will be deducted from the overall ceiling referred to in the thirty-second resolution below,
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">this ceiling does not apply to the debt securities referred to in articles L.
<FONT STYLE="white-space:nowrap">228-40,</FONT> L. <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">228-36-A</FONT></FONT> and L. <FONT STYLE="white-space:nowrap">228-92</FONT> paragraph 3 of the French Commercial Code, the issue of
which would be decided or authorized by the Board of Directors under the conditions provided for in article L. <FONT STYLE="white-space:nowrap">228-40</FONT> of the French Commercial Code, or in other cases, under the conditions determined by the
Company in accordance with the provisions of article L. <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">228-36-A</FONT></FONT> of the French Commercial Code. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">8) Decides that the Board cannot, unless authorized in advance by the General Meeting, make use of this delegation in a period public offering initiated by a
third party targeting the securities of the Company until the end of the offering period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">9) Acknowledges that the Board will have full powers to decide
and record the completion of the capital increase in consideration for the transaction, to charge all costs and duties incurred in connection with the capital increase against the premium, if any, and to deduct them from the premium, if it deems
appropriate, the sums required to fund the legal reserve, to make the corresponding amendments to the bylaws, to take any decision with a view to admitting the shares and securities thus issued to trading on Euronext, and, more generally, to do
whatever is necessary, </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Thirty-second resolution &#150; Overall limit on the maximum authorized amounts set under the 25<SUP
STYLE="font-size:85%; vertical-align:top">th</SUP>, 26<SUP STYLE="font-size:85%; vertical-align:top">th</SUP>, 28<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> and 31<SUP STYLE="font-size:85%; vertical-align:top">st</SUP> Resolutions of
this General Meeting and the 28<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> resolution of the General Meeting of April&nbsp;20, 2020. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
General Meeting, acting in accordance with the quorum and majority requirements for extraordinary shareholders&#146; meetings and having reviewed the Board of Directors&#146; report, decides to set </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">at 65% of the share capital on the date of this General Meeting the total par value of any shares that may be
issued under the 25<SUP STYLE="font-size:85%; vertical-align:top">th</SUP>, 26<SUP STYLE="font-size:85%; vertical-align:top">th</SUP>, 28<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> and
31<SUP STYLE="font-size:85%; vertical-align:top">st</SUP> resolutions of this General Meeting and the 28<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> resolution of the General Meeting of April&nbsp;20, 2020,. To this limit will be added,
if applicable, the par value of any capital increase required to preserve, in accordance with the law and, if applicable, any contractual stipulations providing for other adjustments, the rights of the holders of rights or transferable securities
giving access to the Company&#146;s capital. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">150,000,000 euros (or the equivalent of this amount in the event of an issue in another currency) the maximum
nominal amount of debt securities that may be issued pursuant to the aforementioned resolutions. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">107 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Thirty-third resolution- Delegation of powers to the Board of Directors to issue stock warrants (BSA),
subscription and/or acquisition of new and/or existing stock warrants (BSAANE) and/or subscription and/or acquisition of new and/or existing redeemable stock warrants (BSAAR) with cancellation of preferential subscription rights, reserved for
categories of persons, suspension during a public offering period, </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The General Meeting, acting in accordance with the quorum and majority requirements
for extraordinary shareholders&#146; meetings and having reviewed the Board of Directors&#146; report and the Statutory Auditors&#146; special report and pursuant to the provisions of Articles L. <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">225-129-2,</FONT></FONT> L. <FONT STYLE="white-space:nowrap">225-138</FONT> and L. <FONT STYLE="white-space:nowrap">228-91</FONT> and seq of the French Commercial Code: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Delegates its competence to the Board of Directors to proceed, on one or more occasions, in the proportions and
at the time it deems appropriate, both in France and abroad, with the issue of new stock warrants (BSA), subscription and/or acquisition of new and/or existing stock warrants (BSAANE) and/or subscription and/or acquisition of new and/or existing
redeemable stock warrants (BSAAR) with cancellation of preferential subscription rights reserved for the categories of persons defined below. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Sets the term of validity of this delegation at eighteen months from the date of this General Meeting.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Decides that the total nominal amount of shares to which the warrants issued pursuant to this delegation give
entitlement may not exceed 0.5% of the capital existing on the day of this Meeting. To this maximum amount will be added, as necessary, the nominal amount of the capital increase necessary to preserve the rights of the holders of rights or
securities giving access to the Company&#146;s capital, pursuant to the law, and where applicable, the contractual stipulations providing for other forms of preservation. This maximum amount is separate from all maximum amounts set by the other
resolutions of this General Meeting. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Decides that the issue price of the warrant will be fixed by the Board of Directors. In the event of assignment
to <FONT STYLE="white-space:nowrap">non-executive</FONT> directors, the warrant issue price will coincide with its market value. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Decides that the subscription and/or acquisition price of the shares acquired by exercising the warrants shall
be at least equal to the average closing price of DBV TECHNOLOGIES shares for the 20 trading days preceding the decision to issue the warrants, if applicable, less the warrant issue price. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">6)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Decides to eliminate the preferential subscription rights of shareholders to the BSAs, BSAANEs and BSAARs to be
issued, to the benefit of the following categories of persons: corporate officers, scientific committee members, employees of the company and persons associated with the company and the French or foreign companies related to the company, via a
service agreement or as a consultant, in accordance with Article <FONT STYLE="white-space:nowrap">L.225-180</FONT> of the French Commercial Code. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">7)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Stipulates that this delegation means that the shareholders waive their
<FONT STYLE="white-space:nowrap">pre-emptive</FONT> rights to shares that may be issued by the exercising of warrants to the holders of BSAs, BSAANEs and/or BSAARs. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">8)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Decides that the Board cannot, unless authorized in advance by the General Meeting, make use of this delegation
in a period public offering initiated by a third party targeting the securities of the Company until the end of the offering period. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">9)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Decides that if subscriptions have not absorbed the entire BSA, BSAANE and/or BSAAR issue, the Board of
Directors may exercise the following options: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">limit the amount of the issue to the amount of subscriptions, if applicable within the limits established by the
regulation; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">freely allocate all or part of the <FONT STYLE="white-space:nowrap">non-subscribed</FONT> BSAs, BSAANEs and/or
BSAARs to persons covered by the categories defined above. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">10)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Decides that the Board of Directors shall be granted all necessary powers, under the terms set by the law and
stipulated above, to issue BSAs, BSAANEs and/or BSAARs and in particular to: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B></B>set the specific list of beneficiaries within the categories of persons defined above, the nature and
number of warrants to be allocated to each beneficiary, the number of shares to which each warrant </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">108 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
shall give entitlement, the issue price of the warrants and the subscription and/or acquisition price of the shares to which the warrants give entitlement under the terms outlined above, the
terms and deadlines for the subscription and exercise of the warrants, the associated adjustment mechanisms and more generally, all terms and conditions with respect to the issue </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B></B>prepare an additional report describing the final terms and conditions of the transaction;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B></B>conduct the necessary share acquisitions within the framework of the share buyback program and to allocate
them via the allocation plan; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B></B>record the completion of the capital increase resulting from the exercising of the BSAs, BSAANEs and/or
BSAARs and to amend the Bylaws accordingly; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B></B>at its sole discretion, impute the cost of the capital increase to the amount of the associated premiums
and deduct the necessary sums from this amount to bring the statutory reserve to one tenth of the new share capital after each increase; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B></B>delegate, under the conditions provided for by law, the powers required to enact the capital increase, and
to delay the capital increase, within the limits and according to the terms and conditions previously set by the Board of Directors; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B></B>and more generally, perform all tasks required in similar matters. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The General Meeting notes that this delegation, for the part not used, if applicable, supersedes any and all relevant prior delegations. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Thirty-fourth resolution &#150; Delegation of powers to be granted to the Board of Directors to increase the share capital by the issue of ordinary shares
and/or securities granting access to the capital, with <FONT STYLE="white-space:nowrap">pre-emptive</FONT> subscription rights waived in favor of the members of a company savings plan pursuant to Articles L.
<FONT STYLE="white-space:nowrap">3332-18</FONT> et seq. of the French Labor Code </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The General Meeting, acting in accordance with the quorum and
majority requirements for extraordinary shareholders&#146; meetings and having reviewed the Board of Directors&#146; report and the Statutory Auditors&#146; special report, voting pursuant to Articles L. <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">225-129-6,</FONT></FONT> L. <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">225-138-1</FONT></FONT> and L. <FONT STYLE="white-space:nowrap">228-92</FONT> of the French Commercial Code and L. <FONT
STYLE="white-space:nowrap">3332-18</FONT> and seq. of the French Labor Code: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Delegates its powers to the Board of Directors to enact, at its own discretion, a capital increase on one or
more occasions through the issue of ordinary shares or securities giving access to the equity securities to be issued by the Company, reserved for members of one or more group or company employee savings plans established by the Company and/or
affiliated French or international companies under the conditions of Article <FONT STYLE="white-space:nowrap">L.225-180</FONT> of the French Commercial Code and of Article <FONT STYLE="white-space:nowrap">L.3344-1</FONT> of the French Labor Code.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Withdraws, in favor of these individuals, any <FONT STYLE="white-space:nowrap">pre-emptive</FONT> subscription
rights to shares issued pursuant to this delegation. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Sets the validity of this delegation at <FONT STYLE="white-space:nowrap">twenty-six</FONT> months from the date
of this General Meeting. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><I>4)</I></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><I></I>Limits the maximum par value of the increases that may be enacted under this delegation at 2% of the
share capital at the date of this General Meeting to carry out this increase, with the understanding that this amount is separate to any other maximum amounts set by other authorizations relating to capital increases. T </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To this amount will be added, as necessary, the par value of any capital increase necessary to preserve the rights of the holders of rights or securities
giving access to the Company&#146;s capital, pursuant to the law and, if applicable, any contractual stipulations providing for other forms of preservation; </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Decides that the price of any shares to be issued under point 1) of this delegation may not more than 30% (or
40% lower if the vesting period stipulated by the scheme pursuant to Articles L. <FONT STYLE="white-space:nowrap">3332-25</FONT> and L. <FONT STYLE="white-space:nowrap">3332-26</FONT>
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">109 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
of the French Labor Code is greater than or equal to ten years) below the average opening price of the shares for the 20 trading days prior to the decision setting the date for the opening of
subscriptions, nor may it be higher than this average. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">6)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Decides, pursuant to the provisions of Article <FONT STYLE="white-space:nowrap">L.3332-21</FONT> of the French
Labor Code, that the Board of Directors may allocate to the beneficiaries defined in the first paragraph above, free shares already issued or to be issued, or other securities giving access to the Company&#146;s capital that have already been issued
or are to be issued in respect of (i)&nbsp;any employer contribution that may be paid pursuant to the regulations governing group or company savings plans and/or (ii)&nbsp;if applicable, any discount and, in the event that any new shares are issued
in respect of the discount or the employer contribution, may decide to capitalize any reserves, profits or issue premiums required to pay up these shares; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">7)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Notes that this delegation, for the part not used, if applicable, supersedes any and all relevant prior
delegations. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">8)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Board of Directors shall have the discretion to implement or not implement this authorization, take all
measures and conduct all necessary formalities. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Thirty-fifth Resolution &#150; Authorization to be granted to the Board of Directors
to allocate free shares to members of staff and/or certain corporate officers </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The General Meeting, acting in accordance with the quorum and majority
requirements for extraordinary shareholders&#146; meetings and having reviewed the Board of Directors&#146; report and the Statutory Auditors&#146; special report, authorizes the Board of Directors, on one or more occasions, in accordance with
Articles L. <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">225-197-1,</FONT></FONT> <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">L22-10-59</FONT></FONT> and L. <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">225-197-2</FONT></FONT> of the French Commercial Code, to allocate existing or future ordinary shares in the Company, reserved for: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">members of staff of the company or companies or economic interest groups that are directly or indirectly related
to it as defined by Article L. <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">225-197-2</FONT></FONT> of the French Commercial Code; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">and/or corporate officers who meet the conditions set out in Article L. <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">225-197-1</FONT></FONT> of the French Commercial Code. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Sets the term of validity of this authorization at
eighteen months from the date of this General Meeting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The total number of shares that can be assigned free of charge pursuant to this authorization will
not exceed 2% of the share capital on the date of the allocation decision. This limit will exclude, if applicable, the par value of any capital increase required to preserve the rights of the beneficiaries of bonus share awards in the event of
transactions involving the Company&#146;s capital during the vesting period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The allocation of shares to beneficiaries will become definitive after a
vesting period to be determined by the Board of Directors, which may not be less than one year. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Beneficiaries shall, where applicable, be required to
hold these shares for a period, set by the Board of Directors, at least equal to that necessary to ensure that the cumulative duration of the vesting and, where applicable, holding periods cannot be less than two years. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">By way of exception, final allocation will take place before the end of the vesting period in the event that the beneficiary is classified as disabled under
the second and third categories set out in Article <FONT STYLE="white-space:nowrap">L.&nbsp;341-4</FONT> of the French Social Security Code. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">All powers
are granted to the Board of Directors to: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">set the terms and, if applicable, the award criteria and performance criteria for the shares;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">determine the identity of the beneficiaries and the number of shares allocated to each; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">110 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if applicable: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">record the existence of sufficient reserves and, upon each allocation of shares, transfer to a reserve account
the sums required to pay up the new shares to be granted; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">at the appropriate time, determine the capital increases by means of incorporation of reserves, premiums or
profits relating to the issue of new free shares granted; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">conduct the necessary share acquisitions within the framework of the share buyback program and allocate them via
the allocation plan; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">determine the impact on beneficiaries&#146; rights of transactions affecting the share capital or likely to
affect the value of shares allocated and enacted during the vesting period and as a result, to modify or adjust, if necessary, the number of shares granted to preserve the beneficiaries&#146; rights; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">decide whether or not to establish a holding obligation at the end of the vesting period and, if applicable,
determine its duration and take all necessary measures to ensure that the beneficiaries comply with it; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">and generally, in connection with the legislation in effect, perform all duties that the implementation of this
authorization may require. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This authorization shall imply that shareholders waive their
<FONT STYLE="white-space:nowrap">pre-emptive</FONT> rights to subscribe to newly issued shares through the capitalization of reserves, share premium and profits. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For the part not used, if applicable, it supersedes any and all relevant prior authorizations. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Thirty-sixth Resolution &#150; Authorization to be granted to the Board of Directors to grant share subscription and/or purchase options (stock options) to
members of staff (and/or certain corporate officers) </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The General Meeting, acting in accordance with the quorum and majority requirements for
extraordinary shareholders&#146; meetings and having reviewed the Board of Directors&#146; report and the Statutory Auditors&#146; special report: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Authorizes the Board of Directors, under the provisions of Articles L. <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">22-10-56</FONT></FONT> to L <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">22-10-58</FONT></FONT> and L. <FONT STYLE="white-space:nowrap">225-177</FONT> to L.
<FONT STYLE="white-space:nowrap">225-185</FONT> of the French Commercial Code, to grant the beneficiaries indicated below, on one or more occasions, options giving access to new shares in the company to be issued in respect of a capital increase or
to the purchase of existing shares in the company as a result of buybacks carried out under the terms set by law. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Sets the term of validity of this authorization at eighteen months from the date of this General Meeting.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Decides that the beneficiaries of these options may only be: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">firstly, some or all members of staff, or certain categories of staff and where appropriate, those companies or
economic interest groups related to it under the conditions of Article L. <FONT STYLE="white-space:nowrap">225-180</FONT> of the French Commercial Code; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">secondly, corporate officers who meet the conditions set out in Articles <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">L22-10-58</FONT></FONT> and L. <FONT STYLE="white-space:nowrap">225-185</FONT> of the French Commercial Code. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The total number of options that may be granted by the Board of Directors under this authorization may not
grant entitlement to subscribe to or purchase more than 7.5% of the share capital on the date of the allocation decision. To this amount will be added, as necessary, the par value of any capital increase necessary to preserve the rights of the
beneficiaries of the options in the event of transactions involving the Company&#146;s capital, pursuant to the law and, if applicable, any contractual stipulations providing for other forms of preservation. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">111 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Decides that the subscription and/or acquisition price of the shares to be paid by the beneficiaries will be
set on the day the options are granted by the Board of Directors in accordance with the regulations in effect and must not be less than the average opening price of the shares for the twenty trading days prior to the grant decision.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">6)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Decides that no options may be granted during the blackout periods set out in the regulations.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">7)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Notes that this authorization includes, in favor of the beneficiaries of options giving access to shares, an
express waiver by shareholders of their <FONT STYLE="white-space:nowrap">pre-emptive</FONT> rights to subscribe to the shares that will be issued as and when the options are exercised. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">8)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Delegates all powers to the Board of Directors to set the other terms and conditions for the granting of
options and their exercise, in particular to: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">determine the conditions under which the options shall be granted and to draft the list or categories of
beneficiaries as scheduled above; to determine, where appropriate, the seniority and performance conditions that must be met by these beneficiaries; to determine the conditions under which the price and number of shares must be adjusted,
particularly in the presumptions set out under Articles R. <FONT STYLE="white-space:nowrap">225-137</FONT> to R. <FONT STYLE="white-space:nowrap">225-142</FONT> of the French Commercial Code; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">define the exercise period(s) for the options granted, with the understanding that the term of the options may
not exceed a period of ten years from the grant date; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">provide the option to temporarily suspend the exercise of options for a maximum period of three months in the
event that financial transactions are performed involving the exercise of a right attached to shares; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if applicable, conduct the necessary share acquisitions within the framework of the share buyback program and to
allocate them via the option plan; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">proceed with all acts and formalities required to make final those capital increases that may, if necessary, be
performed pursuant to the authorization granted by this resolution; amend the <FONT STYLE="white-space:nowrap">by-laws</FONT> accordingly and generally to do whatever is necessary; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">at its own discretion and if it sees fit, impute the cost of increases in share capital to the amount of the
associated premiums and deduct the necessary sums from this amount to bring the statutory reserve to one tenth of the new share capital after each increase. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">9)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Notes that this authorization, for the part not used, if applicable, supersedes any and all relevant prior
authorizations. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Thirty-seventh Resolution &#150; Amendment of Article 13 of the <FONT STYLE="white-space:nowrap">by-laws</FONT> in
order to </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Acting in accordance with the quorum and majority requirements for extraordinary shareholders&#146; meetings and having reviewed the Board of
Directors&#146; report, the General Meeting decides: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">To raise the age limit for the Chairman of the Board of Directors from seventy to seventy-five.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">To amend<I> p</I>aragraph 2 of Article 13 of the <FONT STYLE="white-space:nowrap">by-laws</FONT> of the Company
accordingly and as follows: </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>No one may be appointed Chairman if he has reached the age of 75. If the Chairman in office
reaches this age during a fiscal year, his duties automatically terminate at the end of the annual Ordinary Shareholders&#146; Meeting called to approve the financial statements for that fiscal year</I>.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The other provisions of Article 13 of the Company&#146;s bylaws remain unchanged. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Thirty-eighth Resolution &#150; Powers to complete formalities </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The General Meeting grants all powers to the bearer of an original, a copy or an excerpt of these minutes to carry out all mandatory formalities with respect
to registration and publication. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">112 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="toc140648_14"></A>Annex B </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>COMPENSATION POLICY FOR CORPORATE OFFICERS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(SAY ON PAY EX ANTE) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I>(resolutions twelve and thirteen presented to the Combined General Shareholders&#146; Meeting of May&nbsp;19, 2021) </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Based on the recommendations of the Compensation Committee and taking into account the recommendations of the Middlenext Code, the Board of Directors (the
&#147;<B>Board</B>&#148;) has established a compensation policy for the following corporate officers of DBV Technologies (the &#147;<B><I>Company</I></B>&#148;): Chairman of the Board, Board members, Chief Executive Officer and Deputy Chief
Executive Officers (if any). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This compensation policy is in line with the Company&#146;s corporate interest, contributes to its sustainability and is in
line with its business strategy as described in Chapter 1 of the 2020 Universal Registration Document. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">No compensation component, of any nature
whatsoever, may be determined, allocated or paid by the Company, nor any commitment made by the Company if it is not in accordance with the approved compensation policy or, in its absence, with the compensation or practices existing within the
Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The determination, review and implementation of the compensation policy for each of the corporate officers is carried out by the Board on the
recommendation of the Compensation Committee. When the Board decides on a compensation component or a commitment in favor of the Chairman of the Board or the Chief Executive Officer, the interested party may not take part in the deliberations or
vote on the component or commitment concerned. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As part of the decision-making process followed for the determination and review of the compensation
policy, the conditions of compensation and employment of the Company&#146;s employees were taken into account by the Compensation Committee and the Board. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In proposing the structure of this compensation, the Compensation Committee also relies on studies indicating market practices for comparable companies. These
studies are based on a sample of companies with common characteristics in terms of size, workforce, market capitalization, clinical stage or geographic footprint. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Compensation Committee ensures that none of the components of remuneration is disproportionate and analyses the remuneration as a whole, taking into
account all of its components. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the event of a change in governance, the compensation policy will be applied to the Company&#146;s new corporate
officers, with necessary adjustments where applicable. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>1/ Compensation policy for the Chairman of the Board and for Board members </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The compensation policy mentioned below is applicable to Board members and to the Chairman of the Board, when he/she does not hold the position of Chief
Executive Officer. The components of the total compensation and benefits of any kind that may be granted to the Chairman and Board members in respect of their mandates, as well as their respective importance, are as follows: </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>Fixed compensation</I></B> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Chairman of the Board may receive an annual fixed compensation, which is determined in respect of practices noted in comparable companies, and which takes
into account his specific functions as well as his </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">113 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
membership of one or more committees, if applicable. For information purposes, as of the date of this report, the annual fixed compensation is set at 150,000 euros. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>Compensation paid in respect of Board Member duties</I></B> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In its eighth ordinary resolution, the General Meeting of June&nbsp;15, 2017 set the remuneration of the Board members at the maximum annual sum of 600,000
euros valid for the current financial year and until further decision of the General Meeting. It should be proposed, at the General Meeting of May&nbsp;19, 2021, that the maximum annual sum be raised to 800,000 euros. This new amount will remain
valid for the current financial year and until further decision of the General Meeting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The criteria for allocating the fixed annual sum allocated by the
General Meeting to the Board members were set by the Board on the proposal of the Compensation Committee and take into account committee membership and committee chairmanship. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of the date of this report, and for information purposes, the allocation of Board members&#146; compensation is the following: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I></I></B>each Board member, with the exception of the Chairman of the Board and the CEO, is entitled to
receive 70,000 euros. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I></I></B>the Chairman of the Audit Committee is entitled to receive an additional compensation of 20,000
euros. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I></I></B>the Chairman of the Compensation Committee is entitled to receive an additional compensation of
10,000 euros. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I></I></B>the Chairman of the Nominating and Governance Committee is entitled to receive an additional
compensation of 10,000 euros. </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The members of the above-mentioned committees are entitled to receive an additional compensation of 5,000
euros. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>Long-term compensation</I></B> </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company bases its long-term compensation policy on a global strategy of retention and motivation that is competitive in terms of market practices in the
pharmaceutical industry </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to this compensation policy, the Company may decide to grant share subscription warrants (BSA), at fair market value, to
the Chairman of the Board and/or Board members. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>Benefits of any kind</I></B> </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Chairman of the Board and Board members may be entitled to be reimbursed for reasonable travel, accommodation and other expenses incurred in the interest
of the Company, including attendance at meetings of the Board. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Board members may also receive additional compensation for exceptional missions carried
out pursuant to a specific agreement. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>2/ Compensation policy for the Chief Executive Officer</B><B><I> </I></B><B>and/or for any other Executive
Corporate Officer </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The compensation policy mentioned below is applicable to the Chief Executive Officer, whether or not he or she simultaneously holds
the position of Chairman of the Board. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">114 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The fixed, variable and exceptional items constituting the total compensation and benefits of any kind that
may be granted to the Chief Executive Officer pursuant to his mandate, as well as their respective importance, are as follows: </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>Fixed compensation </I></B> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The fixed compensation of the Chief Executive Officer is determined by taking into account the level and difficulty of the responsibilities, experience in the
role and practices noted in comparable companies. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Board, in its meeting held on November&nbsp;14, 2018, decided to set the fixed annual compensation
of the Chief Executive Officer at US$ 600,000. This amount remains unchanged as of the date of this report. This compensation is payable monthly. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>Annual variable compensation </I></B> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Chief Executive Officer receives annual variable compensation for which the Board, on the recommendations of the Compensation Committee, defines each year
financial and <FONT STYLE="white-space:nowrap">non-financial</FONT> performance criteria that are diversified and demanding, precise and <FONT STYLE="white-space:nowrap">pre-established,</FONT> allowing a complete analysis of performance. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">These criteria are aligned with the Company&#146;s short and medium-term strategy and represent important value inflection points such as building of the
commercial pipeline, regulatory progress of product candidates in the United States and in Europe, building of the future pipeline in line with the scientific strategy, culture transformation and the preservation of a certain level of cash (control
and drive capital management). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each year, the Board determines the rate of achievement of each objective, according to a predefined scale, of the annual
variable compensation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The maximum amount of annual variable compensation for the Chief Executive Officer corresponds to 150% of the annual fixed
compensation, it being specified that if the overall rate of achievement of the objectives predefined by the Board is less than 50% (interpreted strictly), no annual variable compensation would be due. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">These criteria for variable compensation contribute to the objectives of the compensation policy in the following manner: they are in line with the
Company&#146;s corporate interest, contribute to its sustainability and are in line with the Company&#146;s business strategy. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In order to determine the
extent to which the performance criteria for variable compensation were met, the Board relied in particular on the Company&#146;s cash position, the success of financing transactions and the regulatory progress of product candidates. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>Exceptional Compensation </I></B> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Board may decide on the proposal of the Compensation Committee, to grant exceptional compensation to the Chief Executive Officer in view of very special
circumstances, and unrelated to the fixed and variable remuneration components. The payment of this type of compensation must be justified by an event such as the completion of a major event for the Company. The amount of the exceptional
compensation may not exceed a maximum of 25% of the annual fixed compensation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The payment of the variable and, where applicable, exceptional
compensation components allocated to the Chief Executive Officer for the past financial year is subject to the approval by the Ordinary General Meeting of the compensation components paid to him during or allocated to him for the said financial year
(ex post vote). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">115 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>Long-term compensation</I></B> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s long-term compensation policy is part of an overall strategy to retain and motivate its managers and employees and to be competitive with
market practices in the pharmaceutical industry. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The long-term compensation policy implemented for the Chief Executive Officer is mainly based on the
granting of stock options based on the recommendations of the Compensation Committee. Where applicable, these grants may be subject to the satisfaction of performance conditions that may be set by the Board at the time of grant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The stock options vest progressively as follows: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">25% of the stock options will be eligible to vest at the end of a
<FONT STYLE="white-space:nowrap">12-month</FONT> period from the date of grant. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Then, after expiration of the aforementioned <FONT STYLE="white-space:nowrap">12-month</FONT> period, 12.5% of
the<B> </B>stock options will be eligible to vest<B> </B>at the end of each subsequent <FONT STYLE="white-space:nowrap">6-month</FONT> period. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The vesting and exercise of the stock options are subject to the fulfillment of a presence condition. Stock-options have a term of ten years. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Share-based compensation is in line with Company&#146;s corporate interest, contributes to its sustainability and is in line with Company&#146;s business
strategy. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Additionally, the Chief Executive Officer is, in accordance with the law and methods adopted by the Board, required to retain a significant
number of shares. With regard to stock options, the Board has set at 10% the number of shares to be held by the Chief Executive Officer until the end of his term of office. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>Benefits of any kind</I></B> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition to the reimbursement of expenses incurred in the performance of his duties, the Chief Executive Officer may be reimbursed for the cost of his tax
consultations and will benefit from a tax equalization clause with respect to his status as a US resident. He may also be reimbursed for the costs of legal advice incurred in the performance of his duties. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Chief Executive Officer may also benefit from the coverage by the Company of his residence expenses in France. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>Welcome bonus </I></B> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">When a new Chief Executive Officer is appointed, the Board may decide, on the recommendation of the Compensation Committee, to grant compensation, indemnity or
benefit on taking up his/her duties. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>Compensation policy for any other Executive Corporate Officer </I></B> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The principles and criteria for compensation mentioned above also apply to any other executive corporate officer of the Company (such as Deputy Chief Executive
Officers). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For instance, Deputy Chief Executive Officers may therefore receive, pursuant to their mandate, fixed, variable and exceptional compensation
as well as long-term compensation, benefits in kind and a welcome bonus under the same conditions as those described for the Chief Executive Officer. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">They may also be granted with free shares. With respect to the allocation of free shares, vesting and, where applicable, holding periods are defined by the
Board at the time of the grant and comply with the authorization of the General Meeting. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">116 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">These levels of compensation will be determined taking into account the difficulty and degree of
responsibility, experience in the position, seniority in the company, and practices observed in comparable companies. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>Commitments</I></B> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Chief Executive Officer benefits from the following commitment: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="29%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="24%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="24%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="18%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Commitments made by the<BR>company</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Main characteristics</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Criteria for award</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Termination&nbsp;Conditions</B></P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Severance indemnity</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On December&nbsp;12, 2018, the Board decided, in accordance with the recommendations of the Compensation Committee and in accordance with
Article <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">L.225-42-1</FONT></FONT> of the French Commercial Code, that in the event of termination of Mr.&nbsp;Daniel Tass&eacute;&#146;s duties as Chief Executive Officer, for any
reason whatsoever, he would be paid a severance payment provided that all criteria have been met.</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">This commitment was approved by the Shareholders&#146; Meeting of May&nbsp;24, 2019 in its fifth ordinary resolution.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Severance package will therefore be paid to the Chief Executive Officer if all the following criteria are met:</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;Viaskin Peanut approved on a major market;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;Construction of an EPIT pipeline with 3 trials in progress;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;6 months&#146; cash flow as determined by the expenses of the last quarter prior to the date on
which he leaves his post.</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Compliance with these performance conditions will be
established by the Board prior to any payment.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the event of termination without cause or for good reason outside of a change of control, the severance benefits get paid out over 12
months.</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">In the event of termination without cause or for good in connection with a change of control, those same amounts get paid in a lump
sum.</P></TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>3/ Agreement(s) between the Company or a subsidiary and the Deputy Chief Executive Officers </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Employment Contract </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Deputy Chief Executive
Officers may benefit from an employment contract. The variable and fixed portions of the compensation received by the Deputy Chief Executive Officers under their employment contract, distinct from their corporate mandate, are subject to the same
rules and criteria for determination, distribution and allocation as those set for the Company&#146;s employees. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>4/ Information on the mandates and
employment and/or service contracts of corporate officers entered into with the Company </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The table below indicates the duration of the term(s) of the
mandate(s) of the Company&#146;s corporate officers and, as the case may be, the employment or service contracts entered into with the Company, the notice periods and the conditions of revocation or termination applicable to them. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">117 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="20%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="14%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="13%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="10%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="12%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Corporate Officers<BR>of the Company</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Mandate(s) held</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Term(s) of<BR>office</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Employment<BR>contract&nbsp;with<BR>the company<BR>(specify
its<BR>term)</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Service<BR>agreement&nbsp;with<BR>the Company<BR>(specify
its<BR>term)</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Notice<BR>Period</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Conditions&nbsp;for<BR>revocation
or<BR>termination</B></P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Michel de Rosen</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Chairman of the Board</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">At the end of the General Meeting held in 2022 to approve the financial statements for the year ended.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">No</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">No</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">NA</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Revocation of the mandate in accordance with the law and case law</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Daniel Tass&eacute;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">CEO and Director</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>CEO:</B> Indeterminate Term</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Director:</B></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">At the end of the General Meeting held in 2023
to approve the financial statements for the year ended</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">No</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">No</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">NA</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Revocation of the mandate in accordance with the law and case law&#151;severance payments (see section B/ commitments, of this report).</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Dr Torbj&oslash;rn BJERKE</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Director</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">At the end of the General Meeting held in 2021 to approve the financial statements for the year ended.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">No</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">No</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">NA</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Revocation of the mandate in accordance with the law and case law</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Michael J. GOLLER</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Director</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">At the end of the General Meeting held in 2023 to approve the financial statements for the year ended.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">No</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">No</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">NA</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Revocation of the mandate in accordance with the law and case law</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Daniel B Soland</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Director</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">At the end of the General Meeting held in 2022 to approve the financial statements for the year ended.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">No</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">No</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">NA</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Revocation of the mandate in accordance with the law and case law</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">118 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="20%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="14%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="13%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="10%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="12%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Corporate Officers<BR>of the Company</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Mandate(s) held</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Term(s) of<BR>office</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Employment<BR>contract&nbsp;with<BR>the company<BR>(specify
its<BR>term)</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Service<BR>agreement&nbsp;with<BR>the Company<BR>(specify
its<BR>term)</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Notice<BR>Period</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Conditions&nbsp;for<BR>revocation
or<BR>termination</B></P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Ma&iuml;lys FERR&Egrave;RE</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Director</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">At the end of the General Meeting held in 2023 to approve the financial statements for the year ended.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">No</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">No</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">NA</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Revocation of the mandate in accordance with the law and case law</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Claire GIRAUT</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Director</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">At the end of the General Meeting held in 2022 to approve the financial statements for the year ended.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">No</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">No</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">NA</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Revocation of the mandate in accordance with the law and case law</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Julie O&#146;NEILL</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Director</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">At the end of the General Meeting held in 2021 to approve the financial statements for the year ended.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">No</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">No</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">NA</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Revocation of the mandate in accordance with the law and case law</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Viviane MONGES</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Director</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">At the end of the General Meeting held in 2021 to approve the financial statements for the year ended.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">No</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">No</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">NA</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Revocation of the mandate in accordance with the law and case law</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">119 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>A<SMALL>NNEX</SMALL> 1&nbsp;<SMALL>TO</SMALL> <SMALL>THE</SMALL>
<SMALL>COMPENSATION</SMALL> <SMALL>POLICY</SMALL> </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><SMALL>RECOMMENDATIONS</SMALL> <SMALL>OF</SMALL> <SMALL>THE</SMALL> R13
<SMALL>OF</SMALL> <SMALL>THE</SMALL> S<SMALL>EPTEMBER</SMALL> 2016 M<SMALL>IDDLENEXT</SMALL> C<SMALL>ODE</SMALL> <SMALL>OF</SMALL> <SMALL>CORPORATE</SMALL> <SMALL>GOVERNANCE</SMALL> </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Completeness</B>: the determination of the compensation of officers must be complete: fixed part, variable
part (bonus), stock options, free shares, Board members&#146; fees, pension conditions and special benefits must be considered in the overall appreciation of the compensation. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Balance </B>between the elements of the remuneration: each element of compensation must be explained and must
be in the company&#146;s general interests. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Benchmark</B>: this compensation must be considered, as far as possible, within the context of a role and
reference market and proportional to the company&#146;s situation, whilst paying attention to inflation effects. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Consistent</B>: the compensation of a corporate officer must be determined consistently with that of other
company officers and employees. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Readability </B>of rules: rules must be simple and transparent; the performance criteria used to establish the
variable part of the compensation or, if applicable, for the assignment of free shares or options, must be connected with the company&#146;s performance, coincide with its objectives, be demanding, explainable and, where possible, long-term. They
must be detailed yet without breaching the confidentiality that may be justified for certain elements. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Measurement</B>: determination of the compensation and the award of options or free shares must strike a fair
balance and take into account the general interests of the company, market practices and officer performance. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Transparency</B>: the annual information to &#147;shareholders&#148; about the full compensation and benefits
received by officers is provided in compliance with applicable regulations. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">120 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="toc140648_14a"></A>Annex C </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Part 1 </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Approval of
information referred to in Article</B><B></B><B><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">&nbsp;L.22-10-9</FONT></FONT> of the French Commercial Code </B><I>(eighteenth resolution)</I> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth information regarding the compensation earned by our non-employee directors for 2020. These amounts were earned
in Euro per the above policy and paid in Euro. The amounts below were converted using an exchange rate of &#128;1.00=$1.1422 for Mr. Michel de Rosen and &#128;1.00=$1.2143 for all other nonemployee directors, which represent respectively the average
exchange rate for the year ended December 31, 2020 and the exchange rates on the date of payment.. Mr. Tass&eacute;, our Chief Executive Officer, and Ms. Ferr&eacute;re are each directors but do not receive any additional compensation for their
services as a director. Ms. Giraut resigned from our board of directors effective March 22, 2021, and Dr. Bjerke&#146;s service as a director will terminate immediately following the Annual General Meeting. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="70%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Fees&nbsp;earned<BR>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total ($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Michel de Rosen</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">177,040</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">177,040</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Torbj&ouml;rn Bjerke</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">103,215</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">103,215</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Michael Goller</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">103,215</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">103,215</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Ma&iuml;lys Ferr&eacute;re&nbsp;(2)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Claire Giraut&nbsp;(1)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">109,287</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">109,287</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Viviane Monges</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 91,072</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 91,072</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Julie O&#146;Neill</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 85,001</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 85,001</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Daniel Soland</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 97,144</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 97,144</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Ms. Giraut served as a director and a member of our Audit Committee until her resignation in March 2021.
</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">No remuneration as non-executive director is accepted by Ms. Ma&iuml;lys Ferr&eacute;re as representative of
BPI France. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth information regarding the aggregate number of non-employee warrant awards
held by our non-employee directors as of December 31, 2020. None of our non-employee directors were granted warrants during financial year ended December 31, 2020. None of our non-employee directors held stock awards or options as of December 31,
2020. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="79%"></TD>

<TD VALIGN="bottom" WIDTH="12%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B><FONT STYLE="white-space:nowrap">Non-employee</FONT><BR>warrants<BR>awards (#)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Michel de Rosen</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Torbj&ouml;rn Bjerke</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Michael Goller</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">21,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Ma&iuml;lys Ferr&eacute;re</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Claire Giraut</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">17,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Viviane Monges</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Julie O&#146;Neill</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Daniel Soland</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">31,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">121 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><A NAME="toc140648_15"></A>Annex C </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Part 2 </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Approval of
fixed, variable and exceptional items comprising the total compensation and benefits of any kind paid during the previous financial year or awarded for said financial year to the corporate officers (French &#147;</B><B><I>mandataires
sociaux</I></B><B>&#148;) </B><B><I>(nineteenth to Twenty-first resolutions)</I></B><B></B><B><I>&#151;(Excerpt from the French board of directors&#146; report on the resolutions)</I></B><B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In accordance with the provisions of Article L. <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">22-10-34</FONT></FONT> II of the French
Commercial Code, you are requested to approve the fixed, variable and exceptional components of the total remuneration and benefits of any kind, paid during the past financial year or granted in respect of the same financial year, as described in
detail in section 4.1.3.4 of the company&#146;s universal registration document, to the following corporate officers: </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Mr.&nbsp;Michel de Rosen</B>, Chairman of the Board of Directors <I>(nineteenth resolution)</I>:
</P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="35%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="31%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Elements of compensation paid or assigned<BR>for FY 2020</B></P></TD>

<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Amounts or accounting value to be put<BR>to the
vote</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Introduction</B></P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Fixed compensation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#128;150,000</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">(amount attributed in respect of
FY 2020 and paid during the same year)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Fixed compensation for the position of Chairman of the Board</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Annual variable compensation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">None</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Extraordinary compensation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">None</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Free share allocation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">None</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Stock option allocation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">None</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Board Member compensation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&#128;16,890 paid in 2020 in respect of FY 2019, and &#128;5,000 attributed for FY 2020</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Fixed remuneration in respect of the director&#146;s term of office including remuneration of &#128;16,890 paid in 2020 in his capacity as Director and member of the Nominating and Governance Committee in 2019 and &#128;5,000
attributed in 2020 in his capacity as a member of the Nominating and Governance Committee</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Elements of compensation due to the termination or change of duties, pension commitments and <FONT STYLE="white-space:nowrap">non-competition</FONT> clauses</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">None</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Mr.</B><B></B><B>&nbsp;Daniel Tass&eacute;,</B> Chief Executive Officer <I>(twentieth resolution)</I>:
</P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="35%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="31%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Elements of compensation paid or assigned<BR>for FY 2020</B></P></TD>

<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Amounts or accounting value to be put<BR>to the
vote</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Introduction</B></P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Fixed compensation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#128;525,302</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">(amount attributed in respect of
FY 2020 and paid during the same year)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Fixed compensation for the position of Chief Executive Officer for 2020 corresponding to USD 600,000.</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">122 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="35%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="31%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Elements of compensation paid or assigned<BR>for FY 2020</B></P></TD>

<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Amounts or accounting value to be put<BR>to the
vote</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Introduction</B></P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Annual variable compensation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#128;288,916</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(amount to be paid after approval
of the general meeting 2020)</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#128;694,321</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">(amount paid in FY
2020 for FY 2019)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">On January&nbsp;14, 2021, the Board of Directors noted that the Chief Executive Officer had achieved 55% of his objectives, equivalent to a variable compensation of US$330,000. The variable compensation targets were set by the Board
of Directors on January&nbsp;7, 2020 and are linked to the achievement of qualitative and quantitative objectives (see &#167;&nbsp;4.1.3.1 of the 2020 universal registration document).</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Extraordinary compensation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#128;57,783</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">(amount to be paid after approval
of the 2021 General Meeting)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">The Board approved a supplemental incentive award to the CEO equal to 11% (US$66,000) of his base salary for his work in reorganizing our company and significantly reducing our expenses while advancing our Viaskin Peanut program and
other core capabilities. At the time the annual variable scheme for 2020 was designed, the aforementioned plan and related needs were not on the agenda as explained in the Chairman&#146;s letter, and therefore not included.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Free share allocation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">None</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Stock option allocation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Options: &#128;839,718</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">(accounting
value)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On November&nbsp;24, 2020, the Board of Directors, on the basis of the authorization granted by the General Meeting of April&nbsp;20, 2020 in
its 32<SUP STYLE="font-size:85%; vertical-align:top">nd</SUP> resolution, granted 274,000 stock options. exercisable at the price of 4.16 euros.</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The stock options will be definitively granted:</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#149; after a period of 12 months from 11/24/2020, up to 25%,</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#149; at the end of this period, up to 12.5% at the end of each <FONT STYLE="white-space:nowrap">6-month</FONT> period.</P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">They will be exercisable as of their definitive attribution and until November&nbsp;24,
2030</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">123 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="35%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="31%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Elements of compensation paid or assigned<BR>for FY 2020</B></P></TD>

<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Amounts or accounting value to be put<BR>to the
vote</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Introduction</B></P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Other compensation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#128;29,753</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">(amount granted in respect of FY
2020 and paid in the same year)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">In accordance with the compensation policy approved by the Shareholders&#146; Meeting of April&nbsp;20, 2020, the Chief Executive Officer received tax equalization in respect of his status as a US resident.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Elements of compensation due to the termination or change of duties, pension commitments and <FONT STYLE="white-space:nowrap">non-competition</FONT> clauses</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">No amount is subject to the vote</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">The detailed description of this commitment is contained in paragraph 4.1.3.1 of the 2020 Universal Registration Document.</TD></TR>
</TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Ms.</B><B></B><B>&nbsp;Marie-Catherine Th&eacute;r&eacute;n&eacute;</B>, Deputy CEO until September&nbsp;17,
2021 <I>(Twenty-first resolution):</I> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="35%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="31%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Elements of compensation paid or assigned<BR>for FY
2019&nbsp;(1)</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Amounts or accounting value to be put<BR>to the
vote</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Introduction</B></P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Fixed compensation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">107 814 &#128;&nbsp;(1)</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">(amount allocated in
respect of FY 2020 and paid during the same year)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Fixed compensation under the employment contract between Marie-Catherine Th&eacute;r&eacute;n&eacute; and the Company. No fixed remuneration was paid in respect of her position as Deputy Chief Executive Officer</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Annual variable compensation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#128;4,400&nbsp;(1)</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">(amount allocated for the
year 2020)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Variable compensation under the employment contract between Marie-Catherine Th&eacute;r&eacute;n&eacute; and the Company. No variable remuneration was paid in respect of her position as Deputy Chief Executive Officer.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Extraordinary compensation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">None</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Free share allocation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">None</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Stock option allocation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">None</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Elements of compensation due to the termination or change of duties, pension commitments and <FONT STYLE="white-space:nowrap">non-competition</FONT> clauses</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">None</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><I>(1)</I></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><I>the compensation elements described above were paid pursuant to the employment contract between
Ms.&nbsp;Th&eacute;r&eacute;n&eacute; and the Company, it being specified that no compensation was paid by the Company in respect of her mandate as Deputy Chief Executive Officer</I> </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">124 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc140648_16"></A>Annex D </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Achievement against Annual Corporate Objectives </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Viaskin<SUP STYLE="font-size:85%; vertical-align:top">&#153;</SUP> Peanut (VP) FDA approval and launch &#150; weighting 40&nbsp;points; achieved 0&nbsp;points
</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Details on objective: Objectives were set for US FDA approval of VP, as well as speed and uptake of subsequent
launch. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Achievement: DBV received a Complete Response Letter on August 3rd. No points were attributed against this
objective </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Progress on clinical trials &#150; weighting 20&nbsp;points; achieved 25&nbsp;points. </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Details on objective: DBV has studies ongoing, to expand the label for VP, to support scientific claims, and to
advance the clinical development of other products. Targets are set for enrollment, completion and publication of individual studies. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Achievement: Several important studies completed earlier, enrolled better or published faster than planned. In
total, the objective was surpassed and 25&nbsp;points were attributed. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Quality and Compliance &#150; weighting 10&nbsp;points; achieved
6&nbsp;points </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Details on objective: Quality control and quality assurance is critical in the pharmaceutical industry. Systems
and training must be developed and implemented to best ensure compliance with legal and regulatory expectations. Pre-Approval Inspections (PAI) for VP were expected as part of the FDA approval process </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Achievement: Points were earned for training and systems. No points were earned for PAI, following the VP CRL
received in August &#145;20. 6&nbsp;points were attributed. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">VP Manufacturing and Supply &#150; weighting 10&nbsp;points; achieved
8&nbsp;points </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Details on objective: VP is a unique product, with a complex manufacturing process. Objectives were set for
building manufacturing capacity and scalability in preparation for the US launch of VP, as well as manufacturing lots for timely release post approval. Objectives were also set for cost management. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Achievement: points were earned for building capacity and scale, and for cost management. Partial points were
earned for lot manufacturing following the receipt of the CRL. 8&nbsp;points were attributed </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Capital management &#150; weighting of
10&nbsp;points; achieved 10&nbsp;points. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Details on objective: as a biotech company, we need to manage the risk of product development and launch
planning, DBV had objectives to incent thoughtful investment, prudent spending, contingency planning and good overall stewardship of our investor&#146;s money. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Achievement: DBV&#146;s management achieved their capital management goals despite the uncertainty that followed
the cancellation of the VP Adcom in March and the regulatory risk leading up to our August target action date. The receipt of the CRL added to the need for fiscal prudence. 10&nbsp;points were attributed. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Positioning DBV for the future &#150; weighting of 10&nbsp;points; achieved 6&nbsp;points. </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Details on objective: these objectives are to incent management to complement the shorter-term imperatives of VP
approval and late-stage pipeline advancement, with the development of capabilities and assets that will pay-off in the longer term. Points are earned for building better technical skills and management capabilities, to build a robust biotech
culture, to pursue business development opportunities, to expand geographically and to advance our pre-clinical pipeline. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Achievement: The regulatory exchanges with FDA and the CRL response consumed a lot of management attention in
2020. We continued to build a strong biotech culture, made good progress on our pre-clinical pipeline and filed VP in Europe (with EMA) in September. 6&nbsp;points were attributed. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Total achievement in 2020: 55&nbsp;points </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">125 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g140648dsp001.jpg" ALT="LOGO">

 </P> <P STYLE="font-family:Times New Roman; font-size:0.5pt"><FONT COLOR="#FFFFFF">Important: Avant d&#146;exercer votre choix, veuillez prendre connaissance des instructions situ&eacute;es au
verso-important: Before selecting please refer to instructions on reverse side Quelle que soit l&#146;option choisie, noircir comme ceca ou les cases correspondantes, dater et signer au bas du formulaire-Whichever option is used, shade beajes) like
this, date and sign at the bottom of the form DJE DESIRE ASSISTER A CETTE ASSEMBLEE WISH TO ATTEND THE SHAREHOLDERS MEETING DBV TECHNOLOGIES <FONT STYLE="white-space:nowrap">177-181</FONT> AVENUE PIERRE BROSSOLETTE 92120 MONTROUGE SA AU CAPITAL DE
EUR 5 493 608 70 441 772 522 RCS NANTERRE ASSEMBLEE GENERALE MIXTE Convoqu&eacute;e le 19 mai 2021 &agrave; 14h00 Tenue hors pr&eacute;sence physique des actionnaires Au si&egrave;ge social COMBINED GENERAL MEETING To be held on May&nbsp;19, 2021 at
02.00 pm Held without the physical presence of shareholders At headquarters correspondent i D F H D JE DONNE POUVOIR AU PRESIDENT DE L&#146;ASSEMBLEE GENERALE THEREBY GIVE MY PROXY TO THE CHAIRMAN OF THE GENERAL MEETING ATTENTION: &Icirc;&#151;
&Icirc;&#161;&Icirc;&ordm;&Icirc;&plusmn;&Icirc;&sup1; &Iuml;&#132;&Icirc;&iquest; 1 uporturi pri CAUTION:hearinty they are diretty De change can be made lang the pray to eve CADRE RESERVE A LA <FONT STYLE="white-space:nowrap">SOCIETE-FOR</FONT>
COMPANY&#146;S USE ONLY Number of shares JE VOTE PAR CORRESPONDANCE VOTE BY POST projects de r&eacute;sus prate agres par le Comt if A Die&nbsp;&amp; TEXCEPTION de que je igrale of D, EXCEPT those ind by On the det the bes E Mas Neo Cl G Al CT 1 2 3
4 AND D 11 12 21 Ale 22 13 23 14 5 6 15 16 24 25 26 7 17 27 18 10 19 29 39 28 31 32 33 34 35 36 37 38 Ale 00 D JE DONNE POUVOIR AC HEREBY APPOINT: 40 41 42 43 44 45 46 a D a a Che You Ale D 47 40 45 50 Duis&nbsp;&amp; Marofice </FONT></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g140648dsp002.jpg" ALT="LOGO">

 </P> <P STYLE="font-family:Times New Roman; font-size:0.5pt"><FONT COLOR="#FFFFFF">CONDITIONS D&#146;UTILISATION DU FORMULAIRE (1)&nbsp;GENERALITES : II s&#146;agit d&#146;un formulaire unique
prevu par I&#146; article R. <FONT STYLE="white-space:nowrap">225-76</FONT> du Code de Commerce. (3)&nbsp;POUVOIR AU PRESIDENT DE L&#146;ASSEMBLEE GENERALE Cette information porte notamment sur le fait que le mandataire ou, le cas &euro;ch&euro;ant,
Ia personne pour lecompte de laquelle il QUELLE QUE SOIT l &#145; OPTION CHOISIE : Article L <FONT STYLE="white-space:nowrap">225-106</FONT> du Code de Commerce (extraitl : agit: Le signataire est pri&euro;&nbsp;d&#146;inscrire tres exactement, dans
Ia zone reservee a cet effet, ses nom (en majuscules), prenom usuel et adresse &#147;Pour toute procuration d&#146;un actionnaire sans indication de mandataire, le president de l&#146;assembh~e generale emet un vote favorable a 1&#149; Contr61e, au
sens de !&#145;article l. <FONT STYLE="white-space:nowrap">233-3,</FONT> Ia societe dont l&#146;assemblee est appelee a se reunir; (les modifications de ces informations doivent ere adressees a l&#146;etablissement conceme et ne prevent ere
effectuates a laid de cue I&#146; adoption de projects de resolutions presents ou agrees par le conseil d&#146;administration ou le directoire, selon le cas, et un vote 2&#148; Est membre de l&#146;organe de gestion, d&#146;administration ou de
surveillance de cette societe ou d&#146;une personne qui Ia contr61e au formulaire). d&euro;favorableill&#146;adoptiondetouslesautresprojets de resolution. Pouremettre tout autre vote, l&#146;actionnaire doit fa ire choix d&#146;un
sensdel&#146;articlel. <FONT STYLE="white-space:nowrap">233-3</FONT> ; Pour les personnes morales, le signataire doit renseigner ses nom, pr&euro;nom et qualit&euro;. mandataire qui accepte de voter dans le sensindique parle mandant&#148;. 3&deg;
Est employe parcette societe ou par une personne qui Ia contr61e au sens de !&#145;article L. <FONT STYLE="white-space:nowrap">233-3;</FONT> Si lesignataire n&#146;est pas l&#146;actionnaire (exemple: Administrateurl&euro;gal, Tuteur, etc.) il doit
mentionnerses nom, pr&euro;nom et Ia <FONT STYLE="white-space:nowrap">qualit&euro;&nbsp;1-&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;&#151;-&#146;</FONT> 4&deg; Est contrOl&euro;&nbsp;ou
exerce l&#146;une des fonctions mentionnees au 2&#148; ou au 3&#149; dans une personne ou une entit&euro;&nbsp;contr61&euro;e par une en laquelle il signe le formulaire de vote. personne qui contr61e Ia societe, au sens de !&#145;article l. <FONT
STYLE="white-space:nowrap">233-3.</FONT> Leformulaire adresse pour une assembl&euro;evaut pour les assembl&euro;es successives convoqu&euro;es avec le meme ordre du jour (article R. (4)&nbsp;POUVOIR AUNE PERSONNE DENOMMEE Article L. <FONT
STYLE="white-space:nowrap">225-106</FONT> du Code de Commerce (extra it): <FONT STYLE="white-space:nowrap">225-77</FONT> alinea 3 du Code de Commerce). Cette information est egalement d&euro;1ivree lorsqu&#146;il existe un lien familial entre le
mandataire ou, le cas echeant, Ia personne <FONT STYLE="white-space:nowrap">&#147;1-</FONT> Un actionnaire peut se fa ire repr&euro;senter par un autre actionnaire, par son conjoint au par le partenaire avec lequel il a conclu un
pourlecomptedelaquelleilagit,etunepersonnephysiqueplaceedansl&#146;unedessituationsenumereesaux1&middot; a4&middot;. Letexte des resolutions figure dans le dossier de convocation joint au presentformulaire (article R.
<FONT STYLE="white-space:nowrap">225-81</FONT> du Code de Commerce). pacte civil desolidarit&euro;. Ne pas utiliser a Ia fois &laquo;Jevote par correspondance &gt;&gt; et &laquo;Je donne pouvoir &raquo;(article R.
<FONT STYLE="white-space:nowrap">225-81</FONT> paragraphe 8 du Code de Commerce). Lorsqu&#146;en cours de mandat, survient l&#146;un des faits mentionnes aux alin&euro;as precedents, le mandataire en informe sans d&euro;1ai son <FONT
STYLE="white-space:nowrap">11-Le</FONT> mandat ainsi que, le cas echeant, sa revocation sont ecrits et communiques a Ia societe. Les conditions d&#146;application du present Un guide methodologique de traitement des assembl&euro;es generales,
incluant une grille de lecture de cue formulaire de vote par alinea sont pr&euro;cis&euro;es pard&euro;cret enConseil d&#146;Etat. mandant. A d&euro;faut par cue dernier de confirmation expresse du mandat,
<FONT STYLE="white-space:nowrap">celui-ci</FONT> est caduc. correspondance est disponible sur le site de I&#146; AFTI : www.afti.asso.fr La caducit&euro;&nbsp;du mandat est notifi&euro;e sans delai par le mandataire a Ia societe. La version
fran~aise de cue document fait foi. <FONT STYLE="white-space:nowrap">Ill-</FONT> Avant chaque reunion de l&#146;assemblee generale des actionnaires, le president du conseil d&#146;administration ou le directoire, selon le Les conditions
d&#146;application du present article sont pr&euro;cis&euro;es par dec ret en Conseil d&#146;Etat.&#148; cas, peut organiser Ia consultation des actionnaires mentionnes a !&#145;article L. <FONT STYLE="white-space:nowrap">225-102</FONT> afin de leur
permettre de designer un ou plusieurs (2)&nbsp;VOTE PAR CORRESPONDANCE mandataires pour les representer a l&#146;assemblee generale conformement aux dispositions du present article. Article L. <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">22-10-41</FONT></FONT> du Code de commerce: Article l. <FONT STYLE="white-space:nowrap">225-107</FONT> du Code de Commerce (extraitl : Cette consultation est obligatoire lorsque, les statuts ayant ete modifies en
application de !&#145;article L. <FONT STYLE="white-space:nowrap">225-23</FONT> ou de !&#145;article L. <FONT STYLE="white-space:nowrap">225-71,</FONT> l&#146;assemblee generale ordinaire doit nom mer au conseil d&#146;administration ou au conseil
de surveillance, selon le cas, un ou des salaries &#147;Toute personne qui procede a une sollicitation active de mandats, en proposant directement ou indirectement a un ou &#147;Tout actionnaire peut voter par correspondance, au moyen d&#146;un
formulaire dont les mentions sont fixees par d&euro;cret en Conseil actionnaires ou membres des conseils de surveillance des fonds communs de placement d&#146;entreprise d&euro;tenant des actions de Ia societe. plusieurs actionnaires, sous quelque
forme et par quelque moyen que cue soit, de recevoir procuration pour les representer a d&#146;Etat.Les dispositions contraires des statuts sont reputees non &euro;crites. Cette consultation est egalement obligatoire lorsque l&#146;assemblee
generale extraordinaire doit se prononcer sur une modification des l&#146;assemblee d&#146;une societe mention nee au premier alinea de !&#145;article l. <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">22-10-39,</FONT></FONT> rend
publique sa politique de vote. Pour le calcul du quorum, il n&#146;est tenu compte que des formulaires qui ant ete re~us par Ia societe avant Ia reunion de l&#146;assemblee, statuts en application de !&#145;article L.
<FONT STYLE="white-space:nowrap">225-23</FONT> ou de !&#145;article L. <FONT STYLE="white-space:nowrap">225-71.</FONT> Elle peut E!galement rendre publiques ses intentions de vote sur les projects de resolution presents a l&#146;assembl&euro;e. Elle
exerce dans les conditions de delais ftxees par decret en Conseil d&#146;Etat. Les formulaires ne donnant aucun sens de vote ou exprimant une Les clausescontraires aux dispositions des alin&euro;as precedents sont r&euro;putees non ecrites.&#148;
alors, pourtoute procuration re~ue sans instructions de vote, un vote conforme aux intentions de vote ainsi rendues publiques. abstention ne sont pas consideres comme des votes exprim&euro;s&#148;. Les conditions d&#146;application du present
article sont pr&euro;cis&euro;es par dec ret en Conseil d&#146;Etat.&#148; La majorit&euro;&nbsp;requise pour I&#146; adoption des decisions est determinee en fonction des voix exprim&euro;es par les actionnaires presents ou representes.Les voix
exprimees ne comprennent pas celles attachees aux actions pour lesquelles l&#146;actionnaire n&#146;a pas pris part au Article l. <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">22-10-39</FONT></FONT> du Code de Commerce : Article
L. <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">22-10-42</FONT></FONT> du Code de commerce: &#147;Outre les personnes mentionnees au I de !&#145;article l. <FONT STYLE="white-space:nowrap">225-106,</FONT> un actionnaire peut se
faire representer par toute autre personne vote, s&#146;est abstenu ou a vote blanc ou nul. (articles L. <FONT STYLE="white-space:nowrap">225-96</FONT> et l. <FONT STYLE="white-space:nowrap">225-98</FONT> du Code de Commerce et, s&#146;agissant des
societes ayant physique ou morale de son choix lorsque les actions de Ia societe sont admises aux negociations sur un march&euro;&nbsp;reglemente ou sur un &#147;Le tribunal de commerce dans le ressort duquella societe a son siege social peut, a Ia
demande du mandant et pour une duree adopt&euro;&nbsp;le statut de Ia societe europeenne, et articles 57 et 58 du R&euro;glement du Conseil (CE) W2157/2001 relatif au statut de Ia systeme multilateral de negociation soumis aux dispositions du II de
!&#145;article l. <FONT STYLE="white-space:nowrap">433-3</FONT> du code monetaire et financier dans les conditions qui nesauraitexc&euro;dertroisans, priverlemandatairedudroitdeparticiperencettequaliteatouteassembl&euro;edelasociete societe
europeenne). prevues par le reglement general de I&#146;Autorit&euro;&nbsp;des marches financiers, figurant sur une liste arretee par l&#146;autorite dans des conditions concernee en cas de <FONT STYLE="white-space:nowrap">non-respect</FONT> de
!&#145;obligation d&#146;information prevue aux troisiE!me a septi&euro;me alineas de !&#145;article L. <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">22-10-40</FONT></FONT> Si vous votez par correspondance : vous devez
obligatoirement noircir Ia case &#147;Je vote par correspondance&#148; au recto. ou des dispositions de !&#145;article L. <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">22-10-41.</FONT></FONT> Le tribunal peut decider Ia
publication de cette decision aux frais du mandataire. Le fixees par son reglement general, a condition dans cette seconde hypothese, que les statuts le prevoient. <FONT STYLE="white-space:nowrap">1-</FONT> il vous est demand&euro;&nbsp;pourchaque
resolution en noircissant individuellement les cases correspondantes : tribunal peut prononcer les memes sanctions a I&#146;E!gard du mandataire sur demande de Ia societe en cas de <FONT STYLE="white-space:nowrap">non-respect</FONT> des Les
clausescontraires aux dispositions du precedentalineasontreputees non ecrites.&#148; dispositionsdel&#146;article L. <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">22-10-41.&#148;&#151;soit</FONT></FONT> de voter&#147;Oui&#148;
(vote exprim&euro;&nbsp;pard&euro;faut pour les projects de resolutions pr&euro;sentes ou agrees, en I&#146; absence d&#146;un autre choix);&#151;soit de voter &#147;Non&#148;; Article l. <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">22-10-40</FONT></FONT> du Code de Commerce :&#151;soit de vous &#147;Abstenir&#148; en noircissant individuellement les cases correspondantes. &#147;Lorsque, dans les cas pr&euro;vus au premier alin&euro;a du I de
!&#145;article l. <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">22-10-39,</FONT></FONT> l&#146;actionnaire se fait repr&euro;senter par une personne autre <FONT STYLE="white-space:nowrap">2-</FONT> Pour le cas oU des amendements
aux resolutions presentees au des resolutions nouvelles seraient d&euro;posees Iars de l&#146;assemblee, que son conjoint au le partenaire avec lequel il a conclu un pacte civil de solidarit&euro;, il est inform&euro;&nbsp;par son mandataire de tout
fait lui il vous est demand&euro;&nbsp;d&#146;opter entre vote contre (vote exprim&euro;&nbsp;par defaut en I&#146; absence d&#146;un autre choix), pouvoir au president de permettantde mesurerle risque quecedernier poursuive un inten~tautre
quelesien. l&#146;assembl&euro;e generale, abstention ou pouvoira personne d&euro;nommee en noircissant Ia case correspondant a votre choix. Les informations a caractere personnel recueillies dans le cadre du present document sont necessaires a
I&#146; execution de vas instructions de vote. Vous disposez d&#146;un certain nombre de droits concernant vas donnees (acces, rectification, etc.). Ces droits prevent ere exerces au pres de votre teneur de compte aux coordonnees indiquees par cue
dernier. FORM TERMS AND CONDITIONS (1)&nbsp;GENERAL INFORMATION: This is th e sole form pursuant to article R. <FONT STYLE="white-space:nowrap">225-76</FONT> du Cod e de Comm erce (3)&nbsp;PROXY TO THE CHAIRMAN OF THE GENERAL MEETING This
information relates in pa rticular to the event that the proxy or, as the case may be, the person on behalf of WHICHEVER OPTION IS USEO: Article l. <FONT STYLE="white-space:nowrap">225-106</FONT> du Code de Commerce (extract): whom it acts: The
signatorv should write his/her exact name and address in capital letters in the space provided e.g. a legal guardian: (Change &#147;In case of any power of representation given by a shareholder without naming a proxy, the chairman of the general
1&#149; Controls, within the meaning of article L. <FONT STYLE="white-space:nowrap">233-3,</FONT> the company whose general meeting has to meet; regarding this information have to be notified to relevant institution, no change can be made using this
proxy form). meeting shal l issue a vote in favor of adopting a draft resolutions submitted or approved by the Board of Di rectors or the 2&#148; Is member of the management board, administration or su pervisory board of the company or a person
which If the signatorv is a legal entity, the signatorv should indicate his/her full name and the capacity in which he is entitled to sign on Management Board, as the case may be, and a vote against adopting any other draft resolutions.
Toissueanyother vote, controls it within the meaning of the article L. <FONT STYLE="white-space:nowrap">233-3;</FONT> the legal entity&#146;s behalf. the shareholder must appoint a proxywhoagreestovote in the manner indicated by his principal.&#148;
r Is employed by the company or a person which controls it within the meaning of article l. <FONT STYLE="white-space:nowrap">233-3;</FONT> If the signatorv is not the shareholder (e.g. a legal guardian), please specify your full name and the
capacity in which you are signing 4&deg; Is controlled or ca rries out one of the functions mentioned with the 2o or the r in a person or an entity the proxy. (4)&nbsp;PROXY TO A MENTIONED PERSON (INDIVIDUAL OR LEGAL ENTITY) controlled by a person
who controls the company, within the meaning of the article l. <FONT STYLE="white-space:nowrap">233-3.</FONT> The form sent for one meeting will be valid for all meetings subsequently convened with the same agenda (art. R. <FONT
STYLE="white-space:nowrap">225-77</FONT> alinea 3 Article l. <FONT STYLE="white-space:nowrap">225-106</FONT> du Code de Commerce (extract): du Code de Commerce). <FONT STYLE="white-space:nowrap">&#147;I-</FONT> A shareholder may be represented by
another shareholder, by his or her spouse, or by his or her partner who he or This information is also delivered when a family tie exits between the proxy or, as the case may be, the person The text of the resolutions is in the notification of the
meeting which is sent with this proxy (article R. <FONT STYLE="white-space:nowrap">225-81</FONT> du Code de she has entered into a civil union with. on behalf of whom it acts, and a natural person placed in one of the situations enumerated from
1&deg; to 4&#149; above. Commerce). Please do not use both &#147;I vote by post&#148; and &#147;I hereby appoint&#148; (article R. <FONT STYLE="white-space:nowrap">225-81</FONT> du Code de Commerce). <FONT STYLE="white-space:nowrap">II-</FONT> The
proxy as well as its dismissal, as the case may be, must be written and made known to the company. A Conseil When during the proxy, one of the events mentioned in the preceding subparagraphs occurs, the proxy informs A guide relating to the general
meetings processing, including an interpretation grid of this proxy form, is available on the AFTI d&#146;Etat decree specifies the implementation of the present pa ragraph. without delay his constituent. Failing by the latter to confirm explicitly
the proxy, this one is null and void. website at: www.afti.asso.fr <FONT STYLE="white-space:nowrap">Ill-</FONT> Before every general meeting, the chai rman of the board of directors or the management board, as the case may The termination of the
proxy is notified without delay by the proxy to the company. The French version of this document governs; The English translation is for convenience only. be, may organise a consultation with the shareholders mentioned in article L. <FONT
STYLE="white-space:nowrap">225-102</FONT> to enable them to appoint one or The conditions of application of this article are determined by a Conseil d&#146;Etat decree.&#148; more proxies to represent them at the meeting in accordance with the
provisions of this Article. (2)&nbsp;POSTAL VOTING FORM Such a consultation shall be obligatory where, following the amendment of the memorandum and articles of association pursuant to article l. <FONT STYLE="white-space:nowrap">225-23</FONT> or
article L. <FONT STYLE="white-space:nowrap">225-71,</FONT> the ordinary general meeting is required to appoint to the board of Article L. <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">22-10-41</FONT></FONT> du Code de commerce:
Article l. <FONT STYLE="white-space:nowrap">225-107</FONT> du Code de Commerce (extract): directors or the su pervisory board, as the case may be, one or more shareholder employees or members of the &#147;Any person who proceeds to an active request
of proxy, while proposing directly or indirectly to one or more &#147;Any shareholder may vote by post, using a form the wording of which shall be fixed by a decree approved by the shareholders, under any form and by any means, to receive proxy to
represent them at the general meeting of a Conseil d&#146;Etat. Any provisions to the contrary contained in the memorandum and articles of association shall be supervisory board of the company investment funds that holds company&#146;s shares. Such
a consultation shall also be company mentioned in the fi rst pa ragraph of the article L. <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">22-10-39,</FONT></FONT> shall release its voting policy. deemed <FONT
STYLE="white-space:nowrap">non-</FONT> existent. obligatory where a special shareholders&#146; meeting is required to take a decision on an amendment to the memorandum and articles of association pursuant to article l.
<FONT STYLE="white-space:nowrap">225-23</FONT> or article L. <FONT STYLE="white-space:nowrap">225-71.</FONT> It can also release its voting intentions on the draft resolutions submitted to the general meeting. It exercises When calculating the
quorum, only forms received by the company before the meeting shall be taken into account, then, for any proxy received without voting instructions, a vote in conformity with the released voting intentions. on conditions to be laid down by a decree
approved by the Conseil d&#146;Etat. The forms giving no voting direction or Any clauses that conflict with the provisions of the preceding <FONT STYLE="white-space:nowrap">sub-paragraphs</FONT> shall be deemed
<FONT STYLE="white-space:nowrap">non-existent.&#148;</FONT> The conditions of application of this article are determined by a Conseil d&#146;Etat decree.&#148; indicating abstention shall not be considered as votes cast.&#148; Article L. <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">22-10-39</FONT></FONT> du Code de commerce: The majority required for the adoption of the general meeting&#146;s decisions shall be determined on the basis of the Article L. <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">22-10-42</FONT></FONT> du Code de commerce: votes cast by the shareholders present or represented. The votes cast shall not include votes attaching to shares in &#147;He or she can also be
represented by an individual or legal entity of his or her choice: &#147;The commercial court of which the company&#146;s head office falls under can, at the request of the constituent and respect of which the shareholder has not taken part in the
vote or has abstained or has returned a blank or spoilt 1o When the shares are admitted to trading on a regulated market; ballot paper (articles l. <FONT STYLE="white-space:nowrap">225-96</FONT> and l. <FONT STYLE="white-space:nowrap">225-98</FONT>
du Code de Commerce and, for the companies which have adopted the for a duration which cannot exceed three yea rs, deprive the proxy of the right to take part in this capacity to any 2o When the shares are admitted to trading on a multilateral
trading facil ity which is subject to the provisions of the general meeting of the relevant company in the event of <FONT STYLE="white-space:nowrap">non-compliance</FONT> with mandatory information envisaged statute of European company, articles 57
and 58 of the Council Regulation (EC) no2157/2001 on the statute for a paragraph II of the article l. <FONT STYLE="white-space:nowrap">433-3</FONT> of the Code monetaire et financier as provided by the general regulation of the European company).
from the third to seventh paragraphs of article L. <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">22-10-40</FONT></FONT> or with the provisions of article L.
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">22-10-41.</FONT></FONT> The court Autorit&euro;&nbsp;des marches financiers (French Financial Markets Regulatory Authority), included on a list issued by the AMF can decide the
publication of this decision at the expenses of the proxy. If you wish to use the postal voting form, you have to shade the box on the front of the document: &#147;I vote by post&#148;. subject to the conditions provided by its general regulation,
and stated in the company memorandum and articles of association.&#148; The court can impose the same sanctions towards the proxy on request of the company in the event of <FONT STYLE="white-space:nowrap">non-</FONT>
<FONT STYLE="white-space:nowrap">1-</FONT> In such event, please comply for each resolution the following instructions by shading boxes of yo ur choice: compliance of the provisions of the article L. <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">22-10-41.&#148;</FONT></FONT> -either vote &#147;Yes&#148; (in absence of choice, vote expressed by default for the approved draft resolutions), <FONT STYLE="white-space:nowrap">-or</FONT> vote &#147;No&#148;, Article L. <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">22-10-40</FONT></FONT> du Code de commerce: <FONT STYLE="white-space:nowrap">-or</FONT> vote &#147;Abstention&#148; by shading boxes of your choice. &#147;When, in the events envisaged by
the fi rst paragraph of the article L. <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">22-10-39,</FONT></FONT> the shareholder is represented by a person other than his or her spouse or his or her pa rtner who he or she has entered
into a civil union with, he or she is <FONT STYLE="white-space:nowrap">2-</FONT> In case of amendments or new resolutions during the general meeting, you are req uested to choose between informed by the proxy of any event enabling him or her to
measure the risk that the latter pursue an interest other than vote &#147;No&#148; (vote expressed by default in absence of choice), proxy to the chairman of the general meeting, his or hers. &#147;Abstention&#148; or proxy to a mentioned person
individual or legal entity by shading the appropriate box. Personal data included in this form are necessary for the execution of your voting instructions. You have certain minimum rights rega rding your data (access, correction .). These rights may
be exercised using the contact details provided by your custodian. </FONT></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g140648dsp003.jpg" ALT="LOGO">
 </P> <P STYLE="font-family:Times New Roman; font-size:0.5pt"><FONT COLOR="#FFFFFF">Annexe 1 / Appendix 1 Le formulaire de vote par correspondance est sollicit&eacute; pour le compte du Conseil d&#146;Administration de
DBV Technologies S.A. / The proxy card is solicited on behalf of the Board of Directors of DBV Technologies S.A. Ordre du jour &Agrave; caract&egrave;re ordinaire : 1. Approbation des comptes annuels de l&#146;exercice clos le 31 d&eacute;cembre
2020, 2. Approbation des comptes consolid&eacute;s de l&#146;exercice clos le 31 d&eacute;cembre 2020, 3. Affectation du r&eacute;sultat de l&#146;exercice clos le 31 d&eacute;cembre 2020, 4. Imputation du report &agrave; nouveau d&eacute;biteur sur
leposte &laquo; Prime d&#146;&eacute;mission &raquo;, 5. Rapport sp&eacute;cial des commissaires aux comptes surles conventions r&eacute;glement&eacute;es et constat de l&#146;absence de convention nouvelle, 6. Renouvellement de Madame Julie
O&#146;Neill, en qualit&eacute; d&#146;administrateur, 7. Renouvellement de Madame Viviane Monges, en qualit&eacute; d&#146;administrateur, 8. Nomination de Madame Adora Ndu, en remplacement de Monsieur Torbjorn Bjerke, en qualit&eacute;
d&#146;administrateur, 9. Nomination de Monsieur Ravi Rao, en qualit&eacute; d&#146;administrateur, 10. Ratification de la nomination provisoire de Monsieur Timothy E. Morris en qualit&eacute;d&#146;administrateur, 11. Fixation de la somme fixe
annuelle &agrave; allouer aux membres du conseil d&#146;administration, 12. Approbation de la politique de r&eacute;mun&eacute;ration du Pr&eacute;sident du Conseil d&#146;administration et des administrateurs, 13. Approbation de la politique de
r&eacute;mun&eacute;ration du Directeur G&eacute;n&eacute;ral et/ou tout autre dirigeant mandataire social ex&eacute;cutif, 14. Avis consultatif sur la r&eacute;mun&eacute;ration des cadres dirigeants &laquo; named executive officers &raquo; autres
que le Directeur G&eacute;n&eacute;ral, 15. Avis consultatif sur l&#146;opportunit&eacute; de consulter les actionnaires chaque ann&eacute;e sur la r&eacute;mun&eacute;rationvers&eacute;e par la Soci&eacute;t&eacute; aux dirigeants &laquo; named
executive officers &raquo; autres que le Directeur G&eacute;n&eacute;ral, 16. Avis consultatif sur l&#146;opportunit&eacute; de consulter les actionnaires tous les deux ans sur la r&eacute;mun&eacute;ration vers&eacute;e par la Soci&eacute;t&eacute;
aux dirigeants &laquo; named executive officers &raquo; autres que le Directeur G&eacute;n&eacute;ral, 17. Avis consultatif sur l&#146;opportunit&eacute; de consulter les actionnaires tous les trois ans sur la r&eacute;mun&eacute;ration Agenda
Ordinary resolutions: 1. Approval of the annual financial statements for theyear ended on December&nbsp;31, 2020, 2. Approval of the consolidated financial statements for the year ended on December&nbsp;31, 2020, 3. Allocation of income for the year
ended on December&nbsp;31, 2020, 4. Allocation of the accumulated deficit to the &#147;Additional <FONT STYLE="white-space:nowrap">paid-in</FONT> capital&#148;, 5. Statutory auditors&#146; special report on regulated agreements and acknowledgement
of the absence of new regulated agreements, 6. Renewal of the term of office of Julie O&#146;Neill as director, 7. Renewal of the term of office of Viviane Monges as director, 8. Appointment of Ms.&nbsp;Adora Ndu to replace Mr.&nbsp;Torbjorn Bjerke
as director, 9. Appointment of Mr.&nbsp;Ravi Rao as director, 10. Ratification of the provisional appointment of Timothy E. Morris as director, 11. Determination of the annual fixed sum to be allocated to the members of the Board of Directors, 12.
Approval of the compensation policy for the Chairman of the Board of Directors and for the Board members, 13. Approval of the compensation policy for the Chief Executive Officer and/or any other executive corporate officer, 14. Advisory opinion on
the compensation of named executive officers other than the Chief Executive Officer, 15. Advisory opinion on the opportunity to consult shareholders each year on the compensation paid by the Company to named executive officers other than the Chief
Executive Officer, 16. Advisory opinion on the opportunity to consult shareholders every two years on the compensation paid by the Company to named executive officers other than the Chief Executive Officer, 17. Advisory opinion on the opportunity to
consult shareholders every three years on the compensation paid by the Company to named executive officers other than the Chief Executive Officer, </FONT></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g140648dsp004.jpg" ALT="LOGO">
 </P> <P STYLE="font-family:Times New Roman; font-size:0.5pt"><FONT COLOR="#FFFFFF">vers&eacute;e par la Soci&eacute;t&eacute; aux dirigeants &laquo; named executive officers &raquo; autres que le Directeur
G&eacute;n&eacute;ral, 18. Approbation des informations vis&eacute;es au I de l&#146;article <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">L.22-10-9</FONT></FONT> du Code de commerce, 19. Approbation des &eacute;l&eacute;ments
fixes, variables et exceptionnels composant la r&eacute;mun&eacute;ration totale et les avantages de toute nature, vers&eacute;s au cours de l&#146;exercice &eacute;coul&eacute; ou attribu&eacute;s au titre du m&ecirc;me exercice &agrave; Monsieur
Michel de Rosen, Pr&eacute;sident du Conseil d&#146;administration, 20. Approbation des &eacute;l&eacute;ments fixes, variables et exceptionnels composant la r&eacute;mun&eacute;ration totale et les avantages de toute nature, vers&eacute;s au cours
de l&#146;exercice &eacute;coul&eacute; ou attribu&eacute;s au titre du m&ecirc;me exercice &agrave; Monsieur Daniel Tass&eacute;, Directeur G&eacute;n&eacute;ral, 21. Approbation des &eacute;l&eacute;ments fixes, variables et exceptionnels
composant la r&eacute;mun&eacute;ration totale et les avantages de toute nature, vers&eacute;s au cours de l&#146;exercice &eacute;coul&eacute; ou attribu&eacute;s au titre du m&ecirc;me exercice &agrave; Madame Marie Catherine
Th&eacute;r&eacute;n&eacute;, Directrice G&eacute;n&eacute;rale D&eacute;l&eacute;gu&eacute;e jusqu&#146;au 17 septembre 2020, 22. Autorisation &agrave; donner au Conseil d&#146;Administration &agrave; l&#146;effet de faire racheter par la
soci&eacute;t&eacute; ses propres actions dans le cadre du dispositif de l&#146;article L. <FONT STYLE="white-space:nowrap">22-</FONT> <FONT STYLE="white-space:nowrap">10-62</FONT> du Code de commerce, dur&eacute;e de l&#146;autorisation,
finalit&eacute;s, modalit&eacute;s, plafond, suspension en p&eacute;riode d&#146;offre publique, &Agrave; caract&egrave;re extraordinaire 23. Autorisation &agrave; donner au Conseil d&#146;Administration en vue d&#146;annuler les actions
rachet&eacute;es par la soci&eacute;t&eacute; dans le cadre du dispositif de l&#146;article L. <FONT STYLE="white-space:nowrap">22-</FONT> <FONT STYLE="white-space:nowrap">10-62</FONT> du Code de commerce, dur&eacute;e de l&#146;autorisation,
plafond, suspension en p&eacute;riode d&#146;offre publique, 24. D&eacute;l&eacute;gation de comp&eacute;tence &agrave; donner au Conseil d&#146;Administration pour &eacute;mettre des actions ordinaires donnant, le cas &eacute;ch&eacute;ant,
acc&egrave;s &agrave; des actions ordinaires ou &agrave; l&#146;attribution de titres de cr&eacute;ance (de la soci&eacute;t&eacute; ou d&#146;une soci&eacute;t&eacute; du groupe) et/ou des valeurs mobili&egrave;res donnant acc&egrave;s &agrave; des
actions ordinaires (de la soci&eacute;t&eacute; ou d&#146;une soci&eacute;t&eacute; du groupe), avec maintien du droit pr&eacute;f&eacute;rentiel de souscription, suspension en p&eacute;riode d&#146;offre publique, 25. D&eacute;l&eacute;gation de
comp&eacute;tence &agrave; donner au Conseil d&#146;Administration pour &eacute;mettre des actions ordinaires donnant, le cas &eacute;ch&eacute;ant, acc&egrave;s &agrave; des actions ordinaires ou &agrave; l&#146;attribution de titres de
cr&eacute;ance (de la soci&eacute;t&eacute; ou d&#146;une soci&eacute;t&eacute; du groupe), 18. Approval of the information set out in section I of Article <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">L.22-10-9</FONT></FONT> of
the French Commercial Code, 19. Approval of the fixed, variable and <FONT STYLE="white-space:nowrap">non-recurring</FONT> components of overall compensation and benefits of all types paid or assigned during the year ended to Michel de Rosen,
Chairman of the Board of Directors, 20. Approval of the fixed, variable and <FONT STYLE="white-space:nowrap">non-recurring</FONT> components of overall compensation and benefits of all types paid or assigned during the year ended to Daniel
Tass&eacute;, Chief Executive Officer, 21. Approval of the fixed, variable and <FONT STYLE="white-space:nowrap">non-recurring</FONT> components of overall compensation and benefits of all types paid or assigned during the year ended to
Marie-Catherine Th&eacute;r&eacute;n&eacute;, Deputy Chief Executive Officer until September&nbsp;17, 2020, 22. Authorization to be granted to the Board of Directors to buy back company shares on the Company&#146;s behalf pursuant to Article L. <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">22-10-62</FONT></FONT> of the French Commercial Code, length of authorization, purpose, terms, and maximum amount, suspension during a public offering period, Extraordinary resolutions: 23.
Authorization to be granted to the Board of Directors for the company to cancel the shares bought back pursuant to Article L. <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">22-10-62</FONT></FONT> of the French Commercial Code,
length of authorization, maximum amount, suspension during a public offering period, 24. Delegation of powers to the Board of Directors to issue ordinary shares, giving, as necessary, access to ordinary shares or to the allocation of debt securities
(of the Company or of a Group company) and/or securities giving access to ordinary shares (of the Company or of a Group company) with <FONT STYLE="white-space:nowrap">pre-</FONT> emptive rights, suspension during a public offering period, 25.
Delegation of powers to be granted to the Board of Directors to issue ordinary shares giving access, as the case may be, to ordinary shares or to the allocation of debt securities (of the Company or a group company), and/or securities giving access
to ordinary shares (of the Company or a group company), without <FONT STYLE="white-space:nowrap">pre-emptive</FONT> rights, by means of a public offer (excluding the offers set out in section 1 of Article
<FONT STYLE="white-space:nowrap">L.411-2</FONT> of the French Monetary and Financial Code), and/or as consideration for securities in the context of a public exchange offer, suspension during a public offering period, 26. Delegation of powers to be
granted to the Board of Directors to issue ordinary shares giving access, as </FONT></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g140648dsp005.jpg" ALT="LOGO">
 </P> <P STYLE="font-family:Times New Roman; font-size:0.5pt"><FONT COLOR="#FFFFFF">et/ou des valeurs mobili&egrave;res donnant acc&egrave;s &agrave; des actions ordinaires (de la soci&eacute;t&eacute; ou d&#146;une
soci&eacute;t&eacute; du groupe), avec suppression du droit pr&eacute;f&eacute;rentiel de souscription par offre au public (&agrave; l&#146;exclusion des offres vis&eacute;es au 1 de l&#146;article <FONT STYLE="white-space:nowrap">L.411-2</FONT> du
Code mon&eacute;taire et financier), et/ou en r&eacute;mun&eacute;ration de titres dans le cadre d&#146;une offre publique d&#146;&eacute;change, suspension en p&eacute;riode d&#146;offre publique, 26. D&eacute;l&eacute;gation de comp&eacute;tence
&agrave; donner au Conseil d&#146;Administration pour &eacute;mettre des actions ordinaires donnant, le cas &eacute;ch&eacute;ant, acc&egrave;s &agrave; des actions ordinaires ou &agrave; l&#146;attribution de titres de cr&eacute;ance (de la
soci&eacute;t&eacute; ou d&#146;une soci&eacute;t&eacute; du groupe), et/ou des valeurs mobili&egrave;res donnant acc&egrave;s &agrave; des actions ordinaires (de la soci&eacute;t&eacute; ou d&#146;une soci&eacute;t&eacute; du groupe), avec
suppression du droit pr&eacute;f&eacute;rentiel de souscription par une offre vis&eacute;e au 1 de l&#146;article <FONT STYLE="white-space:nowrap">L.411-2</FONT> du Code mon&eacute;taire et financier, suspension en p&eacute;riode d&#146;offre
publique, 27. Autorisation, en cas d&#146;&eacute;mission avec suppression du droit pr&eacute;f&eacute;rentiel de souscription, de fixer, dans la limite de 10% du capital par an, le prix d&#146;&eacute;mission dans les conditions
d&eacute;termin&eacute;es par l&#146;assembl&eacute;e, 28. D&eacute;l&eacute;gation de comp&eacute;tence &agrave; donner au Conseil d&#146;Administration en vue d&#146;&eacute;mettre des actions ordinaires donnant, le cas &eacute;ch&eacute;ant,
acc&egrave;s &agrave; des actions ordinaires ou &agrave; l&#146;attribution de titres de cr&eacute;ance (de la soci&eacute;t&eacute; ou d&#146;une soci&eacute;t&eacute; du groupe), et/ou des valeurs mobili&egrave;res donnant acc&egrave;s &agrave;
des actions ordinaires (de la soci&eacute;t&eacute; ou d&#146;une soci&eacute;t&eacute; du groupe), avec suppression du droit pr&eacute;f&eacute;rentiel de souscription au profit d&#146;une cat&eacute;gorie de personnes r&eacute;pondant &agrave; des
caract&eacute;ristiques d&eacute;termin&eacute;es, suspension en p&eacute;riode d&#146;offre publique, 29. Autorisation d&#146;augmenter le montant des &eacute;missions, 30. D&eacute;l&eacute;gation de comp&eacute;tence &agrave; consentir au Conseil
d&#146;administration &agrave; l&#146;effet de d&eacute;cider toute op&eacute;ration de fusion-absorption, scission ou apport partiel d&#146;actifs, 31. D&eacute;l&eacute;gation de comp&eacute;tence &agrave; donner au Conseil d&#146;Administration
en vue d&#146;&eacute;mettre des actions ordinaires donnant, le cas &eacute;ch&eacute;ant, acc&egrave;s &agrave; des actions ordinaires ou &agrave; l&#146;attribution de titres de cr&eacute;ance (de la soci&eacute;t&eacute; ou d&#146;une
soci&eacute;t&eacute; du groupe), et/ou des valeurs mobili&egrave;res donnant acc&egrave;s &agrave; actions ordinaires (de la soci&eacute;t&eacute; ou d&#146;une soci&eacute;t&eacute; du groupe), dans le cadre d&#146;une op&eacute;ration de
fusion-absorption, scission ou apport partiel d&#146;actifs d&eacute;cid&eacute;e par le Conseil d&#146;administration vertu de la d&eacute;l&eacute;gation vis&eacute;e &agrave; la trenti&egrave;me r&eacute;solution, suspension en p&eacute;riode
d&#146;offre publique, 32. Limitation globale des plafonds des d&eacute;l&eacute;gations the case may be, to ordinary shares or to the allocation of debt securities (of the Company or a group company), and/or securities giving access to ordinary
shares (of the Company or a group company), without <FONT STYLE="white-space:nowrap">pre-emptive</FONT> rights, by means of a public offer referred to in paragraph 1 of Article <FONT STYLE="white-space:nowrap">L.411-2</FONT> of the French Monetary
and Financial Code, suspension during a public offering period, 27. Authorization, in the event of an issue without <FONT STYLE="white-space:nowrap">pre-</FONT> emptive rights, to set the issue price according to the terms set by the General
Meeting, within a limit of 10% of the capital per year, 28. Delegation of powers to be granted to the Board of Directors to issue ordinary shares, giving, if applicable, access to ordinary shares or the allocation of debt securities (of the Company
or a group company) and/or securities giving access to ordinary shares (of the Company or a group company), with <FONT STYLE="white-space:nowrap">pre-emptive</FONT> subscription rights waived in favor of categories of persons with certain
characteristics, suspension during a public offering period, 29. Authorization to increase the total amount of issues, 30. Delegation of powers to be granted to the Board of Directors for the purpose of deciding on any merger-absorption, demerger,
or partial contribution of assets, 31. Delegation of powers to be granted to the Board of Directors to issue ordinary shares giving access to ordinary shares or to the allocation of debt securities (of the Company or of a Group company), and/or
securities giving access to ordinary shares (of the Company or of a Group company), in the context of a merger, demerger or partial contribution of assets decided by the Board of Directors pursuant to the delegation referred to in the thirtieth
resolution, suspension during a public offering period, 32. Overall limit on the maximum authorized amounts set under the 25th, 26th, 28th and 31st resolutions of this Meeting and the 28th resolution of the General Meeting of April&nbsp;20, 2020,
33. Delegation of powers to the Board of Directors to issue stock warrants (BSA), subscription and/or acquisition of new and/or existing stock warrants (BSAANE) and/or subscription and/or acquisition of new and/or existing redeemable stock warrants
(BSAAR) with cancellation of preferential subscription rights, reserved for a category of persons, suspension during a public offering period, 34. Delegation of powers to be granted to the Board of Directors to increase the share capital by means of
</FONT></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g140648dsp006.jpg" ALT="LOGO">
 </P> <P STYLE="font-family:Times New Roman; font-size:0.5pt"><FONT COLOR="#FFFFFF">pr&eacute;vues aux 25e, 26e, 28e et 31e r&eacute;solutions de la pr&eacute;sente Assembl&eacute;e et &agrave; la 28e r&eacute;solution
de l&#146;Assembl&eacute;e G&eacute;n&eacute;rale Mixte du 20 avril 2020, 33. D&eacute;l&eacute;gation de comp&eacute;tence &agrave; conf&eacute;rer au conseil d&#146;administration en vue d&#146;&eacute;mettre des bons de souscription
d&#146;actions (BSA), bons de souscription et/ou d&#146;acquisition d&#146;actions nouvelles et/ou existantes (BSAANE) et/ou des bons de souscription et/ou d&#146;acquisition d&#146;actions nouvelles et/ou existantes remboursables (BSAAR) avec
suppression du droit pr&eacute;f&eacute;rentiel de souscription au profit d&#146;une cat&eacute;gorie de personnes, suspension en p&eacute;riode d&#146;offre publique, 34. D&eacute;l&eacute;gation de comp&eacute;tence &agrave; donner au Conseil
d&#146;Administration pour augmenter le capital par &eacute;mission d&#146;actions ordinaires et/ou de valeurs mobili&egrave;res donnant acc&egrave;s au capital avec suppression du droit pr&eacute;f&eacute;rentiel de souscription au profit des
adh&eacute;rents d&#146;un plan d&#146;&eacute;pargne d&#146;entreprise en application des articles L. <FONT STYLE="white-space:nowrap">3332-18</FONT> et suivants du Code du travail, 35. Autorisation &agrave; donner au Conseil d&#146;Administration
en vue d&#146;attribuer gratuitement des actions existantes et/ou &agrave; &eacute;mettre aux membres du personnel salari&eacute; et/ou certains mandataires sociaux de la soci&eacute;t&eacute; ou des soci&eacute;t&eacute;s ou groupements
d&#146;int&eacute;r&ecirc;t &eacute;conomique li&eacute;s, renonciation des actionnaires &agrave; leur droit pr&eacute;f&eacute;rentiel de souscription, dur&eacute;e de l&#146;autorisation, plafond, dur&eacute;e des p&eacute;riodes
d&#146;acquisition notamment en cas d&#146;invalidit&eacute; et le cas &eacute;ch&eacute;ant de conservation, 36. Autorisation &agrave; donner au Conseil d&#146;Administration en vue d&#146;octroyer des options de souscription et/ou d&#146;achat
d&#146;actions (stock-options) aux membres du personnel salari&eacute; et/ou certains mandataires sociaux de la soci&eacute;t&eacute; ou des soci&eacute;t&eacute;s ou groupements d&#146;int&eacute;r&ecirc;t &eacute;conomique li&eacute;s,
renonciation des actionnaires &agrave; leur droit pr&eacute;f&eacute;rentiel de souscription, dur&eacute;e de l&#146;autorisation, plafond, prix d&#146;exercice, dur&eacute;e maximale de l&#146;option, 37. Modification de l&#146;article 13 des
statuts afin de fixer l&#146;&acirc;ge limite du Pr&eacute;sident du Conseil d&#146;administration &agrave; 75 ans, 38. Pouvoirs pour les formalit&eacute;s. the issue of ordinary shares and/or securities giving access to capital, with <FONT
STYLE="white-space:nowrap">pre-emptive</FONT> subscription rights waived in favor of members of a company savings plan pursuant to Articles <FONT STYLE="white-space:nowrap">L.3332-18</FONT> et seq. of the French Labor Code, 35. Authorization to be
granted to the Board of Directors to allocate free existing and/or future shares to members of staff and/or certain corporate officers of the Company or related companies or economic interest groups, with shareholders waiving their <FONT
STYLE="white-space:nowrap">pre-emptive</FONT> rights, length of authorization, maximum amount, duration of vesting periods specifically in respect of disability and, if applicable, holding periods, 36. Authorization to be granted to the Board of
Directors to grant share subscription and/or purchase options (stock options) to members of staff and/or certain corporate officers of the company or related companies or economic interest groups, with shareholders waiving their <FONT
STYLE="white-space:nowrap">pre-emptive</FONT> rights, length of authorization, maximum amount, strike price, maximum term of the option, 37. Amendment of Article 13 of the <FONT STYLE="white-space:nowrap">by-laws</FONT> in order to set the age limit
for the Chairman of the Board of Directors at 75 years of age, 38. Powers to complete formalities.&nbsp;&nbsp;&nbsp;&nbsp; </FONT></P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g140648dsp001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g140648dsp001.jpg
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M4K?2U:0Y:R5;KRHE<XGMOA,=N\MQLR 5MTNI A( B+3GE1B_%$A:=*,MKI%
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M9*OF%1U$5[@@HTU\7S)3MJ2@D[3S?<E^<47,8P$B(R^ZW-<!6C,^J2L(HB1
M'AL/35=2)Q55H-;>Z.Z+[2/L[>; 0$%*,^*MN.&H,H8B2NV!!<-U=2HMQ'^&
M@F,[@W\6#Q4E[$@$Z3(-N< -&?3:2_37I$XV0=2R(I*2H/.RT%8QN/NQ+CN&
M6(;@(TZ!75DC=<:\Q'0@$%>5$5&G'KKQOIX4$O[0]R7-IR);F'"/F?,JRVRV
MV3JMLJW?J(T1AU%%WP70K*GCY<*#7,SG<O'+ CQL6N2ZL$9$^0ZV-VI)@:D
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MN3+R)0&((08W6CM.SA;0E!M39)UULS<47$-OK);1X+#>ZKP"N]_=W&!=FIC
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MY#N3]-8KZM?^>T#R'<GZ:Q7U:_\ /:!Y#N3]-8KZM?\ GM \AW)^FL5]6O\
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MG,>6T=3KZ86C1:^O5YJVFW&]!L3>\U414VIFE1>**C<-47_W5 ^VT_[J9O\
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MHA7IK>W'E0?1X"O+!CJ\!@]TPZ@.JVKB%I2Z&K7Q>KUZ>'JH-] H% H% H%
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M/IH$O'=GH<=)$F8#;!!'=%SS\M44):$L<DL\MT=Z9:;<[+02$V_VI6)CI:2
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MT(6#D\6W $T16&C,25+*B<+T$O;^ [-[AZR8C$P)!1Q;-YLHI-&@/(JMGH=
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MMAB=DFF6Q]D0#(/B(C\ HEDH.JH% H.4V&^4?MCAI (BDSBVG!1>2J+5TO\
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M"R<-J:VTR,IL1:CO.MK>SB(T"")>$E%+BJI05#O;WM0]#.$>01HR,FG#<DM
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MQ!93K";(H$8 ;%$$5XDT GQ]/B]-!"9VEVB>R$:&&5(I$#)/1XD=UT4$)C!
MZ_&13;34O4=$^)*5^ K;A07R0MBGNG&9N5N ).;Q4-&FS.2RC9 .N,;QBG#4
M1R%%;*B:K<.%!#EX/MM'F88AS2,3,,P6-QZ,O,O.H+6DB!4('B1P;(JJ-BH/
M8.SNW>,&..-S;L5H>JPD:/.0ED #G6=CJB:G3TO*;A""ZKF2+P+302-L=O\
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M$^EV_P"8[^;04VY]\;4RL?&P<?D0?EN9?%*VT(FBKIGLD7,43@B*M!<]NO\
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MN/E0]?3\RT;/4M?3K%1O;A>UZK:,Q,--G<T7BW\LQ*)#QT],B$V9+:?5MDV
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M"($CKCK(NW4_"WU&#'Q67X.- R/=;"0,Q*QSD:0X,5'$)\.GXW&E7J  $0\
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M#7J(KQ-HXVWUEX@*(?34KFGI&@R=RW<Z+!Q;GE%D2'(KCN3%(XN:'GI =,4
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M7N,+B1G'M3Z-JX;J=$&4ZBJ&C4H%<]5B"RI9$LM!*>Q6_'@C"Y-0B1!<?L8
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M5>"4%%M[-;Q7<FPV<AG8V2@Y7"RW)B00!67Y<<(ZE(ZXK8Q4G5T:!%.:\;\
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MYO?W^40?VOB?]08H.DH% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H%!S?;7_M_M[_ 1_\
MAI0=)0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0<UL
M+_+<G^V<K_SSM!TM!\HR?:7=LS*9+)>_VED9:0Q)?T@^P3"Q1D!'1DVG-7Q
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M4S68YOJ52AS.Q# ,9DU(D%/?.52ZK9+K/=1*#IE5$M=;7X)0>*8)S)$_"O\
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M:=C>5:RF?8D1YC9.MHLJ88#*;$2%%>8$21O5P\:\J"YP6Q]VPLBQ)R&>\ZS
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MINE!DSV]G,2FY 98W.DZR\@$A(A*UJ6Q6+UK?^%:"R';4Z1N!_*29)-LDV;
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MX< W DAUS("05!HW"%OP+=2+0'&WIH("]S$<%OHX\@(A$S)PTL@EJ7PV1-7
M>'*_%/106V(WD$^>,-V+Y4E;-PR-T%4=)"*>'@JHNM$U?E<*"^\Y$541'V[K
MR\0\>*IZ_6E!YYV':_7;MZ]8^J_K]5![YN)>W6;OZM2?@]?PT'GG(B_[]OU>
MV/IO\/P+0/.P_P"O;Y7]L>5M5^?JXT'OG(B?[]OU>T/HM\/PT#SD2]NNW?\
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M"HIHKBD0HJ.)P,5TDJ\>"?#01)DO9;V0G36]Y8\2E$^33?50='F$%"34)_\
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M)%8155X"BJM!W] H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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M2B-U(E+4K1*"J*I_*&:]I4(G!//SCC/&JO12,E;,#,C<%1U652(M6KUJO._
M+"1VZ;>S,K))E930S74?D1VR4$)45$4+B2> FP$%3GP3BE![&[=BQCYL,<Q.
M))J,BXZ3IJ8]$U/PJI>'7=-5O_UT$1>V4KIDR&X\@+'51QL-9*0IK R'4I>)
M/BT1+\KKSO093>V OM1 CYF5"*)#2&+K%Q,O&1N$1:KV=U^,?@2RI0;LOVX]
MXN-E[[GLB#705M'342 6$:#5XDU+J0C)5]K4J+Z+!@';15:)I_-S7&T108 3
M)L6PU(2"B"7&UK7]5 QW;8HN2C3)&<FSQC2"E(S*-3%7+*C:^U9-/"_#C9.7
MI#;C^WKD*4KPYR<Z'1<;%MPR)$<<:5LG.)*G&^M15/:1%X6M05P=I%$@)-P3
MAZ9>! )0TM?%IT@TDFD;,CR]*7^"@L,CVVB3A@"YD9*>08Z0.:B5PG553)]3
M4KZE.Q?A1/1PH/</V]=@2_-O9N9->4R,A=,D;5#+48H"'9$7C_#0=A0*!0*!
M0*!0*!0*!0*!0*!0*!0*!0*!04F<_P ZV]_BWO\ E'JRW/JK[?=+N[7_ (MW
M_+'^NJ[K5PE H% H% H% H% H% H% H% H*/:WM9G]IO_P#Y(5EM>/M=_??^
M/_UU]Z\K5P% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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M'VK=_B)I&8G%(B<3GKT7M:N H% H% H% H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% M0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*#3+=D-
M1S<CL+)>2VEE"$%*ZV7Q%PX)QH*1S);C'<9Q1BJYC5MH=1M4$$Z2%<C5;$JN
M73P_PHG,@A1]P;U=QBONX5(TEF2C;C2J1JXPC1*3@H*</&@\!U<."<:#+[0[
MTTH[[A'IZ=2M]4NHOB4;)X;7L.K\"^N@T'NK>:RU;9V\X3#BDK+IZ@L**B"A
MW1;:D127DJ<K4$A=R[O&$#OV=59"SCC&RCJV2.(W1^^A?:7ARM\-!XWN/>)8
M4YBX*\U#6T)2(%1M&1*]U1=2JXJIP3E\- '<F\>FA.;?T=05)%%U3Z>E51=8
MH.HELFI$!+KRYT"!NC=$S)Q6/<:M0U-UN9(5R^DVVT)$3PI^,2#Q]**GHH("
M;NWZBFB;<5RR$8%9P$6W)M-2<_\ :7^*UJ"Q#/[N63BF%PMFY++#F0E*1*C1
MFYH=! 04XB/BXKZ?@6@AR-Y[I8DHR6!)">>-B**D=G-)JB$BH"JG@L2J2(G!
M;4$N+G]Y.!DNKA$;<C$R$(5<72]J54<.^GV>&I/XEH(LC=F]FW'0';9GT114
M(2)1<*ZH2#X?P*/_ (VH)[^X\Z.==Q@8H^@NA&9:(9(*&0CK+PZ%%$4BX%PM
M9>*T$5K=NZB0P<V\\V:/* N+K(.BBK\:J"*K^3X1NO'AP2@EQ=P[E?=-2P9M
M,MMK[9J)D\C1'I&XHFG6&C5Z;HJ<*")]H]YB)%[E1T'%_LZAU *R"/ A,;BI
M$JJBE9$1++QM06#>7W*\Q&TXOH..O&T^IDJ]-M#$!=1+)?4A]32J\$2R\:"!
MCMS;RDSHK,G;ZPV''+/O$1.: 1S3Z!%+V7X4X7Y4&2[GW2ABGN(D%5L96=70
MFI;JM@\6GV?#SOJ3PHM!Y"W!O19!M3L,C;;4$WUD 2J)R$%"$$&UT_)5+\^7
M"@Q/=&[R?;8CX)7$=UCYHU,6P5%L"EX>*6\2V6W*RT!-R[S/$27EP71G \++
M *IFA"K:EU-")JLIHB<[)JXKP6@PD;FWL,UR(Q@E(&9'2"4>M >:3PJXEDL'
M'Q<57AP3C0']T;W9Y[>5TE ELV1*.I U#Q0;\5\*_#RH),3<6[7I#;9X-6VU
M-%=-PE11;4D]2*)$HKPLO"W'FE!-R67S\46UC8Q9*.]4B<153HB!H(ZP%",E
M("U(@\>"I05<?=>[49F'.P*QT891QDT(R0W">0$;TB)$M@*ZZ>*VY65*#?C-
MR;KE.3$D8 HP1F3=94S6[QB*:&Q\-KD5_P "?#0>!N+=SAJ+6#141$769.-(
MMU0>"&"+XM6K_91+%QH((;UWFBL"]M@P<>%% $,UN:(9*WJT(@J2 EE+PI>Z
MK0;Y&YMZI'(V<%Q+4+9KU%74*(J$K6D31#5=*7Y+Q7PT&4;=.\7 %QW;Q,@K
MBMDBD:DG%50]*!?226'X%6Z^%%H)D;<&X"P3F2F8E8DEEF2\<)2(U564^*!%
M046YW]"+RX<TH(S.Z-U$JB6 /47A:5%,14M2()%J#PB8W/\ V?9+Q4&R-N'=
M<B=':+!E'8=(.J3A+\4!HA>-42Q$B>@>2\%H,XFYL\<V4Q*P;K##3CR,R+KI
M-IH"(37PV34HBG\-!7_:S>[C49YK;VIIQ24EU."JBC6H5T*&L44BMQ3\5?6E
M!@>[=^";)!MHC OZ1HB(2'4H*A:T0AMQ(-//\9;)076*RFY9+CH3L>,2Q,(T
MHJ1)I/43JJ2V3PHFGAZ:"NB[PW*[9TL ZL95OK#J:E!5XJ@D">QRM^->X\$6
M@R=W+O% '1MXD<X^#J7NHK8EU(.E!X<+^)4*Z)P6@F/YG<K>3G16\7U666&2
MB2+D+;CQ$*.I>R^$4._K\*T$#[3[V\PC'V<NO25PG>H73UI<M"+I]*6%+_C?
M!0:!W;OGKJ);>)6^)H:(XEA2WQ=E3B7--7+THEJ#-K=>]BCM.N[>5D7#T.D1
ME=H4%5(U'3=114X<K\O2E!8YC<.?C167<?ASF..,D9M+K%1=$D%0X"MM/$N/
MM)[-Z"/!W+NTQF^:V^X)QFD>8 2MU25SQ-"JIIU"VJ6X\53T4&(;HW:;KK!8
M VG!D"V#RZS:5E"1''. IZ/9]=![+W1NH),^.Q@'"Z+JA"D+K)MP!5$4RLB6
MX75./'A0/M+O%4)Q,!=IM%51UDCAKZ@%13V;VX\[73@J4$-O>.] ;;>E;>($
M<,!Z8]2Z*1(.F^E>/BU:EL/"W-:"2&Z-ZOR'@:VYT60).BZ^X2*8+9+Z4#@O
M&]O1:R\:#V+N7>T@DZFWDB-^8!LU<<)PD:)RQ'I$1OI!%Y+;BE!E]K-QK+>$
M,&X[$:?<;1X>I<@;<)M51%#F@AK]17TC=46@\=W/N_0BAMXQ)>""IW4N"%=+
M#8402MXO2A(G*@WSMR;EB3&64P3DEHHHNNO,J2H,A47XI/#Q2]DO_#0>9'([
MVBOSWXL%J9$;(PAQKJ#JH+*.(:*B*BHIZ@_#;^$*XMU;\5@D';Q"\(HB$JD0
MD:@)6LB"MU+4/Y*>E:"=B]P[QEO0_-X-(+#KNB0I&3A %E759!&W&R?_ (4&
MG';DWM)D3F7\%Y=L([CL.0JE974 =+*@2#J77<56Z7YIPXT'DO=6\8\F3':V
M^<@&#<!J2FL4=0 50.R"5D,QY(J\T^&@]:W/OAY'53;?01LBTBZZJD0HETLB
M#INMO7;C\"T$-=V=P@T*FW%D#TU(B%2;12%OBB"2$2>->2IQMX;W2@E97>&Y
MV)$>'"PBOS'8[,A]I")>EK4>I<M&E4154/7?Q6M09#N7?"SP9+;R#'Z2&;J.
MJJ:BL6E/#S!+C;TEQY4&W!;DW?,GL,S\"42*\+A./J:ITR 4L-E3CJ-.:V]K
MX%H.GB.ONQ@<D,+&>)/&PI":BM_RAX+0;:!0*!0*!0*!0*!0*!0*!0*!0*!0
M*!0*!0*!0*!0*!0*!0*!0*!0*!04V1P,B5F&,@W+)H& *T>YZ2<42$2)$)!L
M*J*VMS2@K,5M/<,&;$<7.O.Q&[G)C&I'U'+*B>(U(M-E1%3X+\Z#7&V=N-IE
M6/M \+8CI;T:M2K>^LE(E6]O#9%_VN=!-';^>"=C7!RYG&B7\T!HJD\BF96(
MK\>!"/'U>F@AEM;=PRTD!GS<0" VV7$) 54'QH2#^*I*5D]2I^2E ?VGNPF@
MZ6Y7@>6R/FHI94545=(\4%47E_%Z5H/'=J;H."+0YI4DF^K\AU5<LJBC2 B6
M)%T_%%<?9\?+@E!H;VAO4!1?M(9%;XP5UV);(/.^H?"G,;+=+_C+02Y&UMT&
M\@Q\\<:(U&;8CB(J1]1L$%'3NMB\=R5/QN2T&$G:^ZE@-MQLRK<B\AR22ZG-
M9NV1H4UK[("-DOP^#U!I#:N]CCMFNX7(L@C(G6QN\  JHH")&GB4%YJJ>+DO
M"@DN[9W2K,16LRH26%>)TU5PD)77 (0LJ^(4 -'B3A>Z>B@V'MO<JP= 9QQN
M;U7'R?1%42(E#0.DE6P" DFGEQOSH$K;.X)+4=DLPXVVVV*&0$:'U1,G$XHJ
M*2>PERXV'_:6@C+M;>7B+[0KU%!11=*H@N6_I.?'5;V%\(WX<DH)[6!W $_'
M/+ER-B*PC4H"%55XT$DUE:U_$:<_5Z5XH%>>T-V$B.M[B=8DGI%]1U&*@-E3
M2AJJ(6M2+EZ=/LT'A;2WBJDX&XS:<=Z:.(@:T'IW74"E^49:E%4MPTIPO0;G
MML[G]VI'8RRA,<)YQV41.%I-P@0-%UOX6Q5/5QY>H-36S]T:G77=PNH^XHJF
MC5HN(H*JHJ5O$J:M*<$Y)PH,0VIO-$02S^H XH"B7&SFM!545-/A33J1.'H3
MTJ$YO;NY&H9M+FS??<-M2,T(4004[H&E=0W0@Y+QT\?:6@C1]J;I4FEG9TWP
MZXN/M#K >D+@N:!LJ*NJQ M^%E^"@D9+ [F?E L3)^6C@ JXB*:*ZZ1FKR*B
M>R*B0H)(MQMPH()[3WLJ*J;B+JJ7!U4-+ A(OL(J!==*>CX/PA-R.V=QNHK4
M+-G'C( -LMV5"#2T(*>M%U$JD%[+PXK0;H&"W!%QK[3V36;)UN.QB<N@HJ!I
M8!5YZ4+Q%SX_PW"O^RN]5:TAN0F7.8GH5U$14NH*AJE[$E]7-46WH2@EPMN;
MF8:F*]G7)3[HD,36FD N274M-N*@*(EO9XJE!HE;3W(L!J-&S9@\;QO3Y*ZT
M-Q%$0 !5"\*" V_#QYT'C&TMS"B [GWD:&UD C4BXHO$R523@I#P^!?0E!MQ
M>W]W1I#GG,X4ME6G;*HH-W21!:5$1+B@IJ(D1>*VMR6X>)M//'BT@R,RZ2]8
M%)T3<0E9!L@4=6K5J+4E^-KI?G>@-;1S;T-Z'D\V[*:>?9/4@BA(TS<M":D)
M+D6G5>]T3UK0:2VCNMHQ&)N%T8X(V@-N(16$5NJ*M]2\K)XN*<_A#7'V;NP)
M0N.;C=1I1$'0!%12$.'"ZKHUHJ^S;2O*@LAP.>9POE@R*OY%$/3)=(TN3KOB
M._B4=+7 43DM!"^RN\UT(FYC:02^,5&D-3!%X>VOA5!73PYV0EXJM!(C;;W.
MUBW&7<XX_.=,+O%=!!M+J2!ILMU(KW]2(/*@T3MI;D<8BQHN;-EAILO,FBN"
MX\\XXKAFI"5T2Z\+<N7*@R;VIN?IJ)[A>%42S6C4ME051"+4MUXZ%T\N"_E+
M0>P]N;L2+-CS,V;JO,H#+J>%1=,U5UQ%'20H@:4!+\%OZ+4$EG![E'W:AY:Z
M1Y!/SN!*KH+:S:*OXO-5OZ^')*"O>VMO59=VMPGY<QNJDBW ]*>(01+$G44E
MTJMK61>24'KNU-YHXYT-R.(VJGTT<'4J"J6!%MZ;<%7_ .:U^0>2-H[O4$5G
M<;JO:%!7'-2(A*2+J015!]D43BGK]:T&0;3W8RT M;A<L)MFX"I<BTW0TZA:
MRXV"U_AOP7@$V=MS,S84".N2**41"ZILFXBN$FE6U544>2CZ:",&VMW!C)D8
M<[JDR'6R:DJ)(K8"BJ>E$5$12+C_ /WX!BNV-XF[U3SZ@X0 "Z$+2.C\9 5=
M)*7INGI_V4H,']H[K(P!K<+OE452-"4^HM[>'4A<N'#_ /&@UN[.W:\VTP[G
ME\L(*+PBAH3G%./M(@7TIP'@-!(FX#>KF*Q[4;,"W-952FFNH=>JPH"$*+P
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#?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g140648dsp002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g140648dsp002.jpg
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M'>"2++UZ*W^*C"$R)$F!E<,"WBM</?<W"A[^NYMJWF^LK*)CM+M($EF*B:S
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M[?\ Z6SOD#$Q,W'#3& C9XL %1.U[]&MPFT%8+98A';#=).B7MUTQ2%.C[:
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M\*+YD7,M!CE2\O/UKW[\!MK;FA_#%<%MN7=;BX B9RUH\EH6C5-4HAC(\O\
MU&(H?XLL"4^A>B='=PUOYK;=3GZ*??>]()6$T G$0 EZ,:Z6%%TM$2REB6+:
MP:4I\[-4"FRW60L+/B>OZ*)+SO=0%Z UHQC5D1&61@58,W-R1LKD$\0R^G#-
M404]UQ[NBTV<Q4Q7O?'P^\9K16O2\7N2T0#14F355@."4^4>H!*HQLM25+=<
M\?%X;<U_(MC>=W3P,(+<03=:-%,RKI"EY"[9%JJ$Z?RUQ7F5C9[M$VEPQNXA
M]77 MYWUFTT)61$=HTC12KL70A3Q%=&H G@>.JF,9JB]&SW34;'&O@/UY^!:
MKN'>QEY[<K&94$GU:<L9*9H06U$U?5EE08N:HL&ENK7ZCKUV]S+;;[CO5]37
MD:QM'%-1%1-,CB*-H3742M6=@1YKY8U$U-:Q5ANH\IO(Y Y?J'.HM;_N[IW3
M30,>G:Z[0&-5:20.?;4$@-IIRZO]$$IV\25*6[.&/YK;;@W5PJ^X7W=L5VXM
M;9I;,JACDT('+F0.R4+<HZ3:-3#BN?'%E*;V7*4:6[F/B+2Y<&?GMXBN3XEW
MTI#+:&3IZ6,915$H623J4)(T%D5 H)RKX\<9S5,%VV.Z>IGZ+ W':[_1+7<N
M_$E9;NT#J%TAXXUIU.BU".;V3+I]0P$JFL*5*.Z$>&73J<?1;VUWW8NVW.N.
M1IXQ;=$LBERK*IG8 @:F#:LC\WG09L5B=/=S,,0WB>WV\EW:L5O>^@QD2U+:
MY")(9 O(AZ0C*&J@TYRW\!B9JF"V:6Z7$ZK^=WZ&5+:^[\BC4>ZF<$0,"X0-
MRA7N :E*%LT7_1F$JF&FM:G2W0GS-?V1[2O8V2\WRXOG%_"\-NL":0R!09M;
M!\Q7PTTSQTA*1-J\6\TZ48> N<V.IK%[>.J\*8(F")@B8(F")@B8(F")@B8(
MF")@B8(F")@B\?NK_P# 6O\ U]C_ /G4>.56X<8ZU[=Q\\OW)_PE=6Z2[C'T
MVLT,E%<E!IH7 &A6U9A3G73GPQJ1.I<J$8%\Q:[OY5RP7/<7O"K-!&8F8ZF
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M:WBVCKK)U-H#\IRU5%*9G%J M866=TE$2\4<RTVFU:W5XVN1/(KZI0&+%24
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M[RK4&-M1',<N&?IQ<D1K6!O-29!$';@Q70=FVSJSS27A*7%05+J%4=4.0O\
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M0I$JNJ1NTJA6(YW&FOIIX5PV03YU1WX&6%G"D'=DL*5T1;9;(M34T6:4"IQ
M&GR!=*DC+=P3KJ2ZHKW<=5X$P1,$3!$P1,$7CW7^;MN_Z&\_YMOCD?..(_1>
MV']M/]^'5-5W#=4MKZ3K6'5BBTA+A0I8NRZM*ZJ5-!X82FQN5HT#* :3$ZEA
M+O=@R13C;S+"9&A1M"$DT',M<@IKQ)Q#,8+<=VFY&9BSZU6;?-H18HOA[.)4
M5PD:IRZRRT.8I[)%>!X#$,Q@K'=:A<YKCPK9>YX5I$ME*'&7271RY5\#2E/+
MAD.)QK:\"P=Q)MS!:0=S0RW*0&UFC+E!J<* .I[/ U/R8"K;<LSW(B).8'N5
M?Q0G*#93AWIH4Z*FIH*<WGQ\AGAM>!7X)]06<7=T#2$-;2K'44E- H6H4L22
M/$^&(*RU+_'D"\.NA^X4CGNHG@<BWTL)%II9&*@$5S/M>&-;2]<QN9(!>]<T
M?>%NT;2>ZRZ4.EF&GVOT:5KX'CC.V&"ZG_'R=G"+W?&:_P!SE+(@>4+0A216
MFHT&7 X;;@0_X\^H*]SW0L-R\(M9&TJA7A4LPK2@/A4?)4\!BFJQN68;B\0<
MP5V[E"]$&RF9YD5AI*E=3*K:=1(X:QAM>!0;D[^(6+&7O"V0%O=9M*^T2 .)
M( K7T>K$-88+<?\ '2.L+>W[D2>YCMULY@\E.8Z-(5LP:ZO+RQ15<LRYSW(Q
MB3F%BB#NBWF8JMM,**S5(7,JA<J,ZURI7AZ<!5?4K/<3'6-"RJ.Z4,A064Y*
MUZGL<M#0US^;S&>&UX%?@EGS!6O>YH8)I88H'G:-0W40J4HRA@2:Y#G'Y?+"
M55EFEN1D 20'53W3'4+[E/K.83D!I2H/M<*#/R-!XX;7@6O@GU!:GN%?>8H?
M=9>9 \CG2 M49J 5YCR4RQ=I;<L?$\).8:$=JY7[QM3"#%!(TK5"ID17/.JD
MU&6,[8+J/\=)[2&79M6^^_7#0- T#*M>8C,ZB*#_ ,HKPQJ%1RN-?==G%W=>
MKCHO(F")@B8(F")@B8(F")@B8(F"+P>V2P[98I&)7$MZ5B/!C[S+1?EQQI>7
MGZU]#??^>TM9#^&*SZ^XKIA^"Q&HYB!]71::173Y>&#G!:R0OVA^JHE[NC2M
MKVE0K:M;&(UT9T0?I$DGT?(<3,<%33IM9/IZ5I;7&XUC+;,B*YJV0# JM1]'
MT  G%!."S.$+?ZA41[A>20,%VCE"N[*(SI9EKI&EE!KK'KP$C@J:40?/TZ:E
M#2W#A"=ECKK4E"A&GG))+!:'30'UFO@<1S@@C$/_ %#H./1DM+W<)'20[/&(
MW4LC!2I"Z2U,U^DWJ_*,!(X)4I0%FT*FVNMR,,DDFSHTI:F2Z"XD!+,0R\,@
M#7/SQ03@DX0< 5+.Q(9]Q>95;9X0&:JRE"H4$H=1JM<V);P^? $X)*, /^0Z
M/^"CWK<C-(OP=&#LX#,FD! %%":<VJA'^C$<X)D@P_J8+:VEO#=QAMK2.*56
M,CZ=.AAJ!STU.H*O$#+&@2]RQ.,<I\=HTZ+5@MQ?L1*-DC5HEY=0(-610=("
MGU>=!C+G!=#" LVAMTQ2YEW%3+)%M*%W-$D*U.9)J4 IGKI7Y\"3@D(P+ ST
MT[E#;C?]%X4V<-)$Q,:Z.57TUU4TTKGX<> PS'!!1@X)J7K3W^^>3H)M*O&C
M&-7*G0ND$<2O $^ X'%S'!9V4 ',^%%DW,"1!M,)9)1I=ETA@*T>@4\*"F#G
M!"(6'.;M JR7>Y!96AV94T@QQL4JWH.D#-1Z,1S@J*<+'J*ZW>[3"-#MB1H)
M%!>1"2M&TZP@_17T_DQ7)U*&G3BYSO9H'7KV]I +=(FB1NG2OU812RBFH+P&
M.@%B\<ZAS.]_"M#:VI-3"A/"I4<#\GHQ6"SM)8E!:6H%!"@&DK32/9;B.' X
M,$VDL2H%E9!@PMXPP)(.A:U)U'P\Q7#*$VLL2GN-E6ON\=<\]"^)U'P\\\,H
M5VLL2K&VMB"#$A#$L1I&9(TD^NF6#!9SRQ5?<K,%2((P4(*D*!2E*4I_X1AE
M"NUEB5+6=HQ#-!&Q  !*J31> X>&#!!4D-906=H*T@C%0 :*O <!PP8)M)8E
M!:6H8N(4#'BP45/RTP8)M)8E0;*R;36WC.D!5JBY*#4 9<*X90FUEB5)M+4J
M5,*%2:D%12N6?#^:,&";26)0VMJ0084(*E"-(S4YE>' X,$VDL2AL[0D$P1D
M@$ Z5R!X^'HP8)M)8E#:6IK6&,ZEZ;<HS3]$Y</1@P3:2Q*\GN:**/;[41HJ
M#W^QR4 ?_E4?ECG5%@XQUKU[E(F<G]$_X2NO=IY8S;1Q0QS23N8P)02 "I-<
MJFF6>6-3*X[O$%R20 -2XANU;UK5[)6U3-"6 %!&K  MDW$Y@&F,Y[69=]AX
M<PEJ?E61[CC]W,C[6Z0'B7T :F(XC/Q(KB;2RY;^&783M5#W)&(M;[6_6S*#
M0*A@"1J!S7D!-?(8FTX%?AEV$PVGU6DV_6T<W0&W-+( D5%5336@?0: @ :N
M%<4U!@LQW61#YV%_2IN=[2VFDC@VS6Z:@6Y46@;0<]).=!X<*>>!FUP2&[&0
M!,]-/JKIO\4<"S)8/'K9H@!0914I6@R7F-*C\^+M.!9.Z$ELSZ^=4;NF;6FB
MPE*M1FKD56H!!_GK7-?#\N)M>!:&XC7(:?3A6H[ETQP-+:2@RQB0Z1734D 9
M5XTIZR,7:\"Q\)R6D+"K)W()+X6D=I([&5HNH/8&A])8FE//^!PVEK,H=R:&
M8R%SJOXFJRZ+&=D9UCUY !B:&M:</SY8;7@5^%C(*OXH+2O'%8RR:"PZ@*A#
MH:AYCZL_+#:\"OP; 3(!2O<SN:16$SC( \!5N -14>9\A3SPVO AW("^00]T
MQK%#*]I+&LTCQ@-0, E,R/EX>@X;7@3X)<@2%@5T[A<R0AK273.C.@"G4-/4
M)!\.$8^?#:<"R=T#'Q"P]G:LV[FEYNG8N^@5+AN3_:I\O#A0X;7@6AN0UR&F
MG.JIW+<^]+&UA)H<JHIQ77IIK)HHXD_-B;4O<J=RCE?,%NO<D;&X MI:P:SF
M" RHP6HJ/3B[3@6#N9LM%JBW[C::6-38S1I(XC#M3(DTS J?X>C 5'U)/<V!
M\0++.U[AN[OJI'9M'(K+H=ZE"KR!/#FR!SIZL!4)U+53=(P8F3_@JKW1*VEU
ML9%@8LO48T)*D"M*9+S5+'YL3:\"IW$"S,'TZ>!;V?<#3!>O;M;CJB)W?(5*
M,P*CC2J@9^>+&HZQ4W1KB]C]*QN^X+N&698XDE6-I56@:IZ>F@(])++Z?#P!
MAJ$+=/=(R <L[=+_ (KOM=R>6\F@>/0J,BQDY$ZD+D$9YC3C8E:O/.B!$$'1
MUWXVO.F")@B8(F")@B8(O&B_SE<__70?\^;'(>?D7ME_;#_V2_ABO9QU7B3!
M$P1,$3!$P1>/=?YNV[_H;S_FV^.1\XXC]%[8?VT_WX=4U>\O]TBO)XH;<RQK
M#U(F5&IJ ]DL: L3PIBF1=9ITJ9B"2Q=<UWW%?VUM%/)M[*&75("6HI+% &.
MG+P.,FH0+EUI[G"4B!)0V^;HKJPVIAJ75*X#MRTJH!"9G.GHSPVAP0;K3]?5
MVK6VWG=Y/]YMCQ@QR.NHD&JBJH1I\2:8HG+!9GNU,73UA5FWG>HM2C;B[Z0R
MMSZ0Q!.F@4D@$<?R8&<L%8[M2/YU,W<%\MQ+'%MTDJ1NR=5=9'+Q^AQ] _EP
M-0O<I'=(&()F XTUJ;C=-UBE:$61G$AE*/I<(JJQ5 ^D/74%_+Y9X&9P2%"F
M0^9KL.7"Y43>]XH!\+=B 2QYU'HI5/&N7J-:8F>6"IW:EZ^KM6:[QND3S"'9
MV4+5I" 5#/\ 2(.CFX?*,,YP6CN],@/4TYUO-O6YQ7#1IMSSJ"M=!/+J5"1P
M-=.HD\,L4S+W+$=V@8N9MH5FV_[JD0EDVMD0Z5S9R=3$ 5 C)XFF)M#@M#=*
M9+">G.NG;MUW&:WEDNK%X7C)HF>I^5FR 'H X_R8U&9(M"Y5J$(R C)W7$NZ
M[W/2"?:@XT 3HX8)K!%2#ID4KY9G&<\C>%W-"E&T3UV<70K_ !O>Q&M-K8$J
M=(.K(TY=0"Y9CYL,\L%GXU)_.I??MX60!=K9EH"3S\6.5#H\!F<-I+!!NM)O
M/U=JO+O.[-;2RQ;<ZF,JH1@Q9BP.J@TC)#X^.*9EKEF.[4Q( S%NG2L++N&Z
MFF1!8F*+JF.XE4,P731,Z*!4G\F)&H3J72IND0"<SEK%O<;MO%N[1^Y-<MU&
M*LJ.HZ0) &6OF-!X^.*9R&I<X;O2D'S9;.E:VF\WDTRQS6+P+IJSMJH7/LHO
M* :C.OABB9.I8J;M$!Q)].-<\.];D8IC+8&U C>2(TD;FTZJ-1 M2U:YXR)G
M!=9;M!PTLUK:NU:76Z[O")"EDTE+C0@"MG$*$G(-QSH>&*9R&I9A0IEGDWAZ
M5$6[[R\<C';^8.HB0EUJI#:F)*'+E%,JYYTP$Y8)+=Z0(\75P<*JV][TRL4V
MMDHP!+EB:$YG2J>7\6)GE@J-UI:YZ<ZE-[WAAEM3^ )+,,Z$G+1X4IY5I3+/
M%SRP4.[4_7ISJZ[UNAM7G;;) 0P58027((8DTT^% /X9LY:Y0[M3S-G''JZT
M&\[F;82_#7UAB'C!;)0%HPY,ZZO+P/CAG+7)\:GF;/ISJUOO-\Q8W-B8(]#F
M-JL2S(":$%%TZ@I(Q1,ZPI/=H?EDYTX5SQ[[O,O39-L8(X)!+, ?9H<T! S\
ML9VDL%T.ZT@[STYUO:[QNDTR*VVM'$6 =V9@14^10>SXYT\L:$R=2Q/=Z<1Y
MW.G"LOC>\>[/<';F4JPTVX#L[*4<YG3ES@#*N,YY,[+7QJ69L_+RCZ*USW!>
M17$\*[=+(8J:"H<UK6E:)3P\#^7%-0O<I#=(D YP'XNU5LMWWN6[ABGL&CBD
M;FD(8:5HV1J*>7CA&<GN5J[O2$21)R%YW;?=';]GM?NUU?113QW%T'C8FH)N
M9#Y>G'.G5B Q./6O3OFXUIU,T8D@QC_"%ZGXT[5^\X?G/\F.FWABO+_K=X]!
M3\:=J_></SG^3#;PQ3_6[QZ"GXT[5^\X?G/\F&WABG^MWCT%/QIVK]YP_.?Y
M,-O#%/\ 6[QZ"GXT[5^\X?G/\F&WABG^MWCT%/QIVK]YP_.?Y,-O#%/];O'H
M*?C3M7[SA^<_R8;>&*?ZW>/04_&G:OWG#\Y_DPV\,4_UN\>@I^-.U?O.'YS_
M "8;>&*?ZW>/04_&G:OWG#\Y_DPV\,4_UN\>@I^-.U?O.'YS_)AMX8I_K=X]
M!3\:=J_></SG^3#;PQ3_ %N\>@I^-.U?O.'YS_)AMX8I_K=X]!3\:=J_></S
MG^3#;PQ3_6[QZ"GXT[5^\X?G/\F&WABG^MWCT%/QIVK]YP_.?Y,-O#%/];O'
MH*?C3M7[SA^<_P F&WABG^MWCT%/QIVK]YP_.?Y,-O#%/];O'H*?C3M7[SA^
M<_R8;>&*?ZW>/04_&G:OWG#\Y_DPV\,4_P!;O'H*?C3M7[SA^<_R8;>&*?ZW
M>/04_&G:OWG#\Y_DPV\,4_UN\>@I^-.U?O.'YS_)AMX8I_K=X]!3\:=J_></
MSG^3#;PQ3_6[QZ"GXT[5^\X?G/\ )AMX8I_K=X]!3\:=J_></SG^3#;PQ3_6
M[QZ"GXT[5^\X?G/\F&WABG^MWCT%/QIVK]YP_.?Y,-O#%/\ 6[QZ"GXT[5^\
MX?G/\F&WABG^MWCT%/QIVK]YP_.?Y,-O#%/];O'H*?C3M7[SA^<_R8;>&*?Z
MW>/04_&G:OWG#\Y_DPV\,4_UN\>@KSM[[DV+<(K.ULKR.XN&OK(K$E2Q"W,;
M,>'@!7&)U8E@#K'6O1NVYU:9E*42!DG_  E>[N<NY*UM'9(*2N5GF(#"-=)H
M=)9:\U,=9$ZEX*$86F>H6#%<IW#>5OC#[MJA,^GJ:'HL55%:@4-03G4XSFDZ
M[;*ED=[6Z;5G)NV^-58]MU$ L->L $9@9KF:Y9>5>!&!G+!:&[TM<UC/NG<8
M(=+#40IHH5LO:&JI%1YZ>/SXR92P6X4*&N6FFM=HW'<%OA ;!NB[(#,M: L%
MU$Y4IQS]'IQO,7N7#8P,'S6X+F&];^0!\)()SJ6:@]K(\O$4'HSQG/+!=?C4
M?7ISK:._WJ8R1>Z=!@$TS49AJ,H5LF"U"K4\<7-(ZE@TJ46.9^#D5!O&]EU
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M-6"@9K7B*F@\\7:!3XE1@6L*E^X-KC?IS2F*49-&R,2I&1J5#+D016M,CAM
M@W2H;0'"K^)=DR_O-">"E'!\N!6N)M8J_"JX=2VM]XL+BY%O"Y>2A+#25TY
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MCXK.2\9YD:/9@4BTJC-&VL*O@"5731LJYXF;@6A386U+^%:&]22VE8;*52!
M$5E.I@2JZ H6N8)XXN:RY9V1$A_4OTQ42M&#(J[-'2WFH[&)@#&W4S6BGAI6
MI%<CEY8'B5B#9_4-HQUV<*WM'MIETR;-TP\JK("@&E2"=39>%*4'\>*&.I<Z
M@E&ZH]F*YFEAG/OEQLKM/7I,*$*P8=0NZ4)T\3F#\^,N]I"ZB)CX14LO^BGX
MA$8)A<;*%0%&"D'2QUB*,4*5KI/@,7-B%-D7#5-&<ZUK!=P= R)LIB2%RD2E
M2&-5?40H0\0-/K. / LSIEVVCOW</+R+-[E&BC#;"&B#,(_ #56I 9!0-IR^
M3!_V51"T_P!6W3A5(K^VE8]'8M3:M*MI*YAL\^GRZ2*M\G'@()#TK4J4A?4T
MYU9=R+W(<[&6D2G1;0RLB1@$ L4I6M0 /5Z<7-;Y5#1:+;2S7PORKIM9H)'=
MQLVE@T0U!14B4U8\RK[%>;%!&"Y5(D!MICT=JSMO=IW97V-4CUQQ*-(J%)9"
MS#2 %0(,A_IQ Q_*M3S1%E2VT_7I=9-=JL4DD>R RQN$C/3/.KU-54*3FHH*
M^?AB/P+8IN0#4L;%62["ZYAL;2,69S)FS-G4D:D!S+<M:9>5,5_V5#3U;1M.
M/G427MJ957X()&1$/*-6DL!*$R2G%LL_.M/%F&"HI2;_ )&O['OTX5'OL*(W
M1V1S5VD#LK:G8DG4*K7@]<R*?DPS<";,F^H+ET3R06L.6U*BKTVH%U*S&-GT
MI1:U5E K3%-FI<X R/GQZVM6!OI3(\AV54>5"T;,C,U:5'4HG$L. ^4C$S<"
MZ;(,VTNTLM6D BNKN!IMGCBMYU;JN\>IU=6(0$@95IY?+PJ%IN69/"):H21P
M\ZRBN'DD1/<8VADT+*J021.5ZC,@ 8A?!6:IY<^. / M2@ 'S%[=8.H?@,56
M&YC6!VN-JB58:B&(1.A_WRHO-1OTJY"O'$!Q"LH$D-,VWV\#J9=YA@M7=MD9
M+='/*5*YG,M310>R*^G S87)'=C*3;2W3A5)]QM]08;*'FN59D8!F#ER32H0
M:M>BOI\<#+@5C1/W+!ICJ=;M>3,>J-G"72SQ+([*6#:PRNZT"F@7($^>*_ L
M"F+MIX6*K#/$8[F-=H6 Y ,8G*]-77F8!5+%"Q:@\LO/ '@5E$N#G?EUM]5G
M)>1Q3ITMC#:&-9%C92:&H924Y:-2N?E2OA'_ &5H4R1;4Z>];>]4NKV--G"U
M66DN@T?](.-(UU.=%\.&*]IL7/)X8DU,-.!%N41G2/91,H_WDRH4# "E0K(Q
MS&=*^(SK7!^!4P)OJ-IQJ3?.)8Z[#]:?984H!J'B4'CG2F&;]E39!C_5LTX5
MKMLUL]_&HV\6H4'0U&S;2E& TKD!E4C%B0]RQ6C(0/BS:%.VNN.V']WSGZE[
MTAE[?O,NGCEQPI>2SAZTWUMO;<T/X8K1;?NAC]9<1@#25TE:U&FNOZO,'/A3
M%::R9T-0.G*M&M^XBL&FXCZBHO58T"EZD/RA?(BF?R8K261.C;8=+EG+9=QB
M*%8+I0Z=1I&)K4LQIDRFM%.6=!B&,L5J-6BY<8*]W:]PRS.(KA$@U53.AH*&
MATK7C_.]?'(1)2G.B!:"ZR6R[G.I6ND534Z@06U$G@= H.&)EGBM&K0].G.N
M_:XMRB$HO9!*68&-@<P H%,@/+/TXW$'6O/7E MD#+NQM<$P1,$3!$P1,$3!
M$P1,$3!$P1,$3!$-/'!$P1,$3!$P1,$3!$P1,$3!$P1,$3!$P1>;N\VVPO$]
M["LNE)#'JT^.E6 #$#,-\V,3(%Z].[QF7$2URXEWS88S06O2ZM-58XUJHX,1
M6M.7U_-C&>."[G=:Q_,[<)5TW'9Y)XK=K+4QZ8B81H45).:/,T]>7#%S1N90
MT:@!.;'7A>LVW;MWJ]5[4=0( K:(SD3J"@!CF<C_ *C29XX+0W>LS ]>FG"I
MN=WV:%(9'LJD%X].B/6@AST@5/TJ4 ]>!G$:E(;O5DXS<.NUTO-PV!)I/>;+
M-&5C*8TYF:@\]1//G4>>!E'6$IT:Q RRZ2LGWS8TJ@L,M((0I$&+'(+IKY+Q
MX?,:3/'!;&ZU3;FZUU[C?;$%,-W"KB51+4!#J+ZER8'VLJ5&-2E'6N-&E5OB
M;K-.!<R[ML<-(A9/FAB*: 3R>TK5-#0@9UXXF>."ZFA5-N88WK?XEMI5+A[-
M$A02$R.$U(.H%R K[3,"<\7,+V7/8SN$K;,<%A<[KL:103O9$J3*BJ42JK0,
MY5:_3Y>'RTQ#.."Z0H522,V&G(KW&[;1'T[AK)3&=:F1D36KJP0+3CGK)]6!
MG&]EF&[U"XS6\O']%/Q;:7M6E:Q;4?JVC18]=)0U<PPR(4USPSQ:Y-A4$FS<
M.O4RS;=MC**L=@66,E%!1$0?0/$^1/AAGC@M#=ZNN5_">-0-S[>+LPL"S-DS
M".,CAI\_T>/HR.>6&:.";"LWFZ2KKNNPO%-=2VF;/&6U1J6;4QCC(#9Y"/#/
M&]E#0K B(ECKY3UJXWC8HX7G@MQ]2Z1J51!5I 5721X46APSQ6?CU26)O^BP
M3>=BCC4^X",,I+TC33I5"QH<O'+.F)GC@NAW:J3YGY2NE]XV5EMR;7679A"N
MB,L&72G G*H(^3CC6>."Y#=ZH?Q<=I6'QS97BC+6549V?28TR(4G70\.6F9R
M].1Q,\<%T^+5!/BZ2D6][/)'&!MY)++4:(] <A5)U,0#0&E?1ZL!.."2W:H"
M?%UK;WS8^I9E+-&%]DC+&A(8E<GIP].?ABO&RR]8V=5I>(^'A6?QO8T _N+*
MQ<F-.G&"S#G##F\_$^.)GC@M?&JG\W257XYLDDAB-FK!I,JK'P!4EVJ>6C/X
MYX9XX*_%J@/FU</,M;7>=GN)8=%H092%BDZ:T%06S\O9Q1.)U+%3=JL07E=P
MJ(MWV9H3/%9$+&$(K&BDA@5 7/C0TSIQQ!.."LMWJNQETJEON^T1N2-OZ4@K
MT^FD>K0H(J<Q3('\V G'!6>[U"/,_*5M#O.T-&%%HT:V:"55:- (QJT#30D#
MCX>&*)QPN6);M4?S>:R\VZU>U[@VN298X8G6K,BR!5"UJ2U*&N96OIP%0*3W
M2H Y*Q7N^T(+M"ZQ+FS9'Q( %#I)(IP.)M@MG_'RN>U=$O<ME$55HY#(55M"
MA23K4,*5*^=/]&-&J%SCN4CK#+&UE67NV:5:A9-LMV /&AFF.(#X^1;J1;=P
M/_Z2ZHKW,=5X$P1,$3!$P1,$7CW7^;MN_P"AO/\ FV^.1\XXC]%[8?VT_P!^
M'5-:W=SO"7;);0"2(4(+4"Z3IX&H.JH;%)D]BQ3A2,?$6.G<N=MUWAKBXB@L
MM:12E$;V>50#4ELN:N5,3/)[ N@H4P 3*\*UM>=PM9RF2U07*E!"&J P;-B0
M#E3RK@)2:Y2=.B)!I>&U9^^=SM*:6R*JD<O'4 %KS5%*YTX_DS//!:V=!KU#
M[AW*6.FR"C20N0]HG(YMEPI^7T8F:>"HHT/5IIV*IW?N 3]#W+G5#)P)K0T\
MZ9?E\*89Y8*_'HL^;7IIJ73:;CO4TJZ[$)"8F;6QH2]*JH&=*U\?XL:$I'4N
M52C2B+)6NJVUYW ]K*TULJS(T9C!!JX9N?EU947TX@,FN5G3HB08V6JCW_<H
M>2EFI5.5?)S3B*,2 #\^&:6"T*5!AXE8WW<H:GN41#$T-3110TKGGGZL,TL%
M-E0]14SWG<"6D;16JO<&5M: 4 09@9MX_I?DP,I-<I"G1,B\K&5WO][%HKK9
M!K@RE&05TA-%=69U<<N'\N+FDUR@I4LS9K&^JR^(=R.2$L43R9R?-O 'R \?
MR8F:6"UL: ODLO?NZ S'W,,H9J T7(!R!D3_ #17$S3P6]EN_JTL6MQNV\Q6
M\7]S!N993&% 8K01Z@?/-LL_].*9RP6(;O2)/B\('U1+SN0O$IM$"GVGKX9#
M,?.WAY89I8(:=!CXE6'<NX0VN:PI$3J8#-PNI5( !XZ:MF?S8"4L%94:-PE:
MNFZN]Y2Y(@M@]L2M)#FP# 5.FJ\,\L4F3KG"G2,;3XE@-P[AY(Q8@L 1)(]-
M-1IS%&\:G$S2P6]C1M.9;/>[VL, 2U5YW2LK$416!H1357U9XN:6"P*=)SXK
M%C+NN]*ELON:K<7$DJE3J8*J>S4BG'YL0SE@MQH4B3XK  K6=UW")V2XM@T1
M5V5B0""%&E1I\SYX R>U2I3HM8;56&\[A>SE:2U GC*-$OLEP22P()(6@RXU
MP!DURLJ=$2#2LMY%/O\ OU"7L5<,H7I 'VCXEBV:\/#\V&:6";*CJDK27>_>
MZ,1:H+A9E1%7,&.F;9G*IR]&*\FN613HYO-X6Z59K[?!#;L+-3+(JF9<Z*2]
M#GQ%%SX?FPS2P04J3GQ6:N95>Y[@2XE1+=98RSM&[9 (*Z1D?1^6N(\G5$*)
M )+%9R7_ '&J#^Y R*&9BE"K4!HN;5XTPS2P6A2HD^:Q;6UYOK2@36BK&5D:
MNK/4H&A:C+,G%$I8+G.G2:R6"K:7N_M;2M-9J95*=):Z"P=N8\2!I!\ZX@E)
MKEJI2HY@TK+=.539WN^O=(MQ:*D#L0SY@JH4^ELRW\,\42D]H4J4J0B6E:HV
M_<-[N9X1-9"&!UU/*P(H.;(#56N0XXD92.I6M1I1!:3E8]LIK[99-6C5+>C6
M?HUN917Y,2EY.?K6]]+5WX(?PQ6CR1>Y)'#N"*\&6MOYJ,C,HXM[8/B,75>L
M ',28FU5GM+@Q1LN[:'2'I59^5G'*S&A6IU-3UX$'%:C4BY\&M[ESO97+D%-
MZ0M$.9BU=+R'0#DU,Z$"O\N,Y3BN@JQ%]._Z<BTD@=^BB[LJ1PQ"-Z,2S/\
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M6%SIA2G5A"U#_6=4G,G,D <.&+LUS&]@ V6]S+:':Y[2QFAMI*.VLQE<M+%
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MLO+'&GY.?K7T=\_N!8]D/X8J$L;Y]+Q[DL2Y=&%'8(@TI0:<BU/YV&4XJFK
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M>JC-I! <+0\],J_2X9^G!XM<M9:HD!G#DZ:EM#>[*XN8H[:9HG@9YU8G01&
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MVF]D#I[BA0YEP0Q.8IQ3QI_%Z<0"6*LJE+7#3G5KBVWN22U6._C21%+.*BK
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M7S5_*/#$(C<MPG6+2 %HQ[[-,5:<]M2SM.TL\K$LPB525#/1S0::5K3QX^G
MY5([<!F TXU>ZB[>CEZ#/,\UN.BS**],*NJI;3I7^'EBD1682K$/8QMXTAA[
M?+,%>:,VZ]9ET"C*-.EF&BGH /A@!%64JW 7LZ^%1%:]MO<101M-(Y(1%T<H
MXZ372!2@J/GQ (NDIUQ$DL-.-5![;]XMI1+,[Q:%0%#_ .D"5KR5/AEZ1PKA
MX7"O]=B&%K]/*LYH>V =,DDP)5U8$59:Y?HDYZPH_P!=81!:C*OJ TY>!==T
M=AD2![FXD*+'2,:=*Z4<A:C3DRYT'HQHY=:Y4]L"<H%_TXUC>IVZ)TEE::MQ
M696H:#J/E2JDC(D@#PS\L265UJF:S$!K+.8<>G.K/%V\[6]KJGU$111QB.F0
MH%))3(?69T/\>*T;D$JP>5FLW]_ H%MVTVLP=20Q:CTPH56.O0*,R@>T<LZ>
M/AB-%#.OK8/V.GN_;432PZY87:-X)%531 S#50A=(S%*\,CY8K13/7+&PVNJ
MQG8.E<RH]Q+&L:KJ\2KL"%4:0?\ T^)\,3PJG;. 1$%].M4]W[>C+F>*:$1%
MDTE5*UU*I TCCJ6@P:*N>L68@NN^W[>VZ>A,<JPJB&(N4 :HK[(%1I_/Z<:%
M,%<)[Y..L/RKH?MG;W,)9I#T%54%5X*^L5Y?R<,:V07,;[,/=;V,HE[8VV1V
M=C)5BYXC(N230D5% U!@:02._3 :Q3)VSMTDBNYD(2-(E2HTA8^&5,-D%!OL
MP&#7OSJ3VUMS0+"Q=E1BRDD5%2AIPX?5@8;()\V;O9H_:J?A;;0U4:1,J44J
M,JU.>FN?C_+B;(+7SIZV3\+V(B2%7=8E=79>7,JA09TR/-F>.&R"?.F[V/WJ
M/PIMQU%I)69N+$I4FE*FBT/R_FPV03Y\\!IRHG:MB-#-+*TD8 5JJ*4H:J-.
M68PV00[_ #ML#*(01WC< FI&VP9GB?KYO+ >?D5E_;#_ -DOX8KVL=5X4P1,
M$3!$P1,$7CW7^;MN_P"AO/\ FV^.1\XXC]%[8?VT_P!^'5-:S[G$FXBT>W,C
MO(J*P4FBE"VLFE* U''%,K66(4289@=7U7"_<9BT&3;9(W?@ -65?.@S/"GJ
MQG:<"[C<WNF%#]QSQKU$VQ@A%%;S(- 1D.7B1PRSPVG J-S!L,].U;7V_BUG
ME1]N=EC&4N04JK4\O/AZ:>>+*HVI8I;IG (F%FW<2$F/X=(\;$*O+0<Q"M6N
M5*MQQ-IP+0W,WYPZL=_MXIWB6P?IP.T751:BB$H:4'T:9CP!'GAM.!3XA(!S
M6FWZZ<JO)NTL=N+@V!$&@.T&DF0DR=-0*"E:"N>+GULLC=P3ES6XZKG7,.YV
M4U.VL9&<B(#(G(TXKQ.FGK!'A7&=KP+K\+]NQ;VF]F:2*'X<PULNM@.10335
MFHJ,\CXT/#%$WU+G4W9@3GTT^BBW[A9[OW=MO=$,@C22F04D)F*5)!XTX?EP
M%2UF5GN;1?,+EF.XI3<21G;F"AF*.1E4  $Y<>*Y#C05\<-IP+7PPP.?33M5
MD[A8CIKMKG42 @%!^B?"A \3ZN.&TX%#NFO.%H^_(JP2C;Y"TVLUH 5T/HXT
MJ3G7EK\N+M.!9&Z$N,PL['6-QO<D<EJ4VS7(T2MRBNAI2*J&(6@R(KY^&(9W
M6+<-V!$GG8_5IS*Z=PS3+R[4[4(#5(I6E<JK7YQY8;1]2R=T _.%#=RSQZ*;
M9-I)(!"_145I3+/A3SSPVO J-R!_.%U#?I3<0PK8RGJ)$[/4442YGAQTXUM+
M;ER^*,I.86/T+#\1W:%TEV^1G0OJ,=:!0Q"G,>(I^7RQ-H<%OX<3=(::=2#N
M2YUE/<'=M6E A)4YT!U%1E2A.60\\3:G!/A19\R77<LT%T8Q8R21A%8,,B"4
MUD&N0R_CQ358W)#<A*+Y@[]RUN^X)(9.FEE*^2D/0A3J4-EE4T!S\J' U&U+
M-/=!(.9!5F[E:-86-A.1+$)6% "E7*D,/YM*MY# U>!6.Y._B%A;3Z+./N6Z
ME"M'MTC(_LFN1X9@TX<V(*IP6I;E$7S"FW[FDDG6-K"9%=PH=@!0%PF8S-17
M/^!Q15X%)[D 'S"[Z.M+?N,SWB6T=G(=;LG5^@ C4+%J4\_EP%1RS+,]SRQS
M&05;7N.219.K921M#$\C$@T8QA20  6%=65<!4X%9[F S2!<]:I^)YR5;W&0
M1L*T-=8-2"'&GEX#SXC$VO M?"'J#J7[FG2/4VW3+72%%"35J$"@'Z)^?+#:
M\"@W($^<+2W[BDDG6*6QEBJ*ZVI3V&<9<<].**G LSW, .) K!>ZIF$;C;Y>
MBX)U\00 N:Y"OM>6>)M>!=#N(#C,'4GNB?IB7X=*L7-4N:'E!/  Y\!3U_*V
MO I\$.V<.NSXU_\ (>YFVD%7"++0Z:D YY999^K&L]K,N/QO!F<+#M%E78%9
MC15GNR3Z!=2XE'R\_6NG^0#UN2/\,5UKO^SL0HNDKH60@FA"L-0+5X5'GC6T
MCBN)W2KZ3@MK?<K*XT]&57+'30<0Q770CP.G//%$@5B=&<;QI<@W&U-P;>K"
M4,R4*,!J50U*TI[+5'GAF#LFQEES:EF-YVXQ22B0].,(SG2V0D]D\/G\L3.%
MH[M-P&O^B+O6UL(3[PHZY<1:JK7I^T<_ 89PAW:I;9=]59]VVZ-V62=8])TZ
MGY5)TZR%8Y&B\:8N<*#=YFX*B[WM30+.+E#&SI&#7/7( RJ1X$@UQ,XQ5.ZU
M'9K>Q6^+[;16ZZ]-E1EE_P#3(D-$Y_9JW@*XN<*?'GAVV*J;[LSE M["3(Q1
M '&;"E0/G&)M(XJG=:H_*;%(WO:" 1>0D$ @ZQXTI_2&+GCBGQJGI*[%96!*
MD$ D&GF#0XTN)#*<%$P1,$3!$P1,$3!$P1,$3!$P1,$3!$P1,$3!$P1,$3!$
MP1,$3!%G-;6\U.M$DFFNG6H:E<C2N(0"M1G*-Q94:QLF #6\9"UT@HII4ZC3
M+]+/#*%H59XE#86))8V\18C2246M!X<,,H3:SQ*GW&RH1[O'0FIY%S/GPPRA
M-K+$JLNW6$R.DEO&RR$LX*C-F%&;UD>.(8@I&M,%P2H3;-N0,%MH@'.IN1<S
M\WHPRC!4UYG658;?8  "VBH*$#0O@:CPQ<H4VT\3SH]C8R4ZEO$]!I&I%-!7
M53,>>>&4(*LQ<2BV%DI<B!*R/U)"5!+,36IKZ1AE"&K/$V(+&R"E1;QA3D1H
M6G"GEAE";6>)4FSLR68P1EG;4QT+4MYG+CAE"FTEB46QLE4JMO&%92I 10"I
MSH<N&&4(:LL2BV=FE-,$:T.H4511JUKPXUPRA#4D=954VW;XX5A6VC$2@A4T
M@C,4/'S&)E"T:TR7<NI]PL<_[O%GD>1>&7H]&+E"FUGB55MMV]G#M;1E@ND5
M0$ %M1 '_BSQ,H5%:;,Y6C6=HS*[01EE 56*J2 #4 &G '%RA9%20UE0ME9J
M%"P1@)[%$44S!RR\U&&4(:LL2I]SM-++T8]+@AQI%"&S-<O'!@FTEB57W&QH
M1[O%1C4C0N9^;#*%=K/$J?<;+04]WCT-34NA:&AJ,J>!PRA3:R=W*AK&R9BS
M6\18MJ+%%)U>?#CEAE"HJS&LK6...- D:A$7@JB@'R#%6"22Y5L%$P1,$3!$
MP1,$3!$P1>-%_G*Y_P#KH/\ GS8Y#S\B]LO[8?\ LE_#%>SCJO$F")@B8(F"
M)@B\>Z_S=MW_ $-Y_P VWQR/G'$?HO;#^VG^_#JFFZ?B-9V>Q9#;Y 1T77X"
MM6R\3BRS:E*&Q(:;NN:2+NU0TCRV[44$@@!%(U&M3^B:>'RXRTUU$MW-@$E9
MH>["4(N(BK4)HJ@#FKPR)R'Z7GZ,&FH);O@=-,,%O,=^>WBZ/3Z^CIW%65E#
MZD).G*M5U98IS,L1V()=V>SI43+W08(NDT(DTMU2:5UAB%IE2A!!/E2@SSP.
M=(F@Y=V5.GW6MI$J-;B<&362*J10=.O#QKJIAXV5?=\Q?,UG?W*BIW;(-9EC
MA 8T5@I-.;,T%/*F)XULG=Q8Q*S?\4K(QZ]N0"=-=/T0%\31:DT;+(^?#$\:
MH^.1=+32Q=Y3N$7]5>(V9+D*1S#(A!X95H2>.-^)^!<'HY+CFT=<XC[K8_[V
M-% !HP1B3099#AYXC371]W&HK)&[K9%:2>"'(&1&"ED4CBWAQK3U#TXGC6B-
MWU GZZ::EH4[KZBJT\"HU:G2*@UX"O\ -%?GQ?&LON[7%5=^Z!%%T7B>D6J6
M9RF@L7;@0/!0OR>G$\:H%!R[WW6X*;R7N!8HHQ/!#,R#J%F09ZV4L!EYI2G#
M/B:8$R2G&B22Q(?3ZJEE-OT,9]XN8)(]$O1;6N91>4ZS6M#[666$3(7JU8T2
M?") N-7TZE"KW<@5FFC<-1I"3&%44);1R^D4J?##QJD[L=1Z>E5D/<UNZ!KN
M )0D&4KJ*E@6\4!TY >C$\8UJC82_++D6LUWOXCA:.6V(Z;+,6=!68$UTY4Y
M0*D8I,EB-.BY<2OPU*\A[E<6ZQR0@O 3.\94DR5]J,,#RBHX^'IQ3F4&P#N#
M?9Q<*R4]T%)-%Q#]574258ZLC1O(@$EODIEB>-:.P<.#:M9Y.YC<,83$D'((
M]97F;0I-#2I6NH>=:>%<4YW68"AEM=^_\.E0X[C<1A9H5NM3--!DVF%BH7ER
MU>R<SZ:8>)!L0]ARZCPJE>\!J15AKH72S%=(/C2@\AP\SY8GC6O_ )K[5:U@
M[KBG3JRQR0-(&E&5=)8:@*^S0< *_P > $U*DMW(L!!92UMW)&>C!*O2,;%I
M"RLXD8L1IU+0*,L&DH)T#:1:_(RK&O=)0GWB%47E+<K9UH<Z?1'G]+T8#.J3
MN^!TTYN%#'W@2["2%*4"#)J\!Y >9P\:/NUEA75.N]B<O'+&VJ5!#&2% BU5
MDRIS'2HIZSC1S+E$TFM!NZ=2PC/=+7(++&+4R'4K:=1CU@4R&7)7$\;KH?CB
M.O,W2W:J1MW*90[21)$DG^Y)4-T@Q#$TX9#+^7$&94B@S,7:_A1QW;,[B-XX
M86,NASH+@9].@H1G0<:Y8>,JCX\;W)L[UV*=^^(YB/W LH%2-8 6K'(#QQKQ
M/P+@=CDUYUQ]MQB3M=XRI</)>J46E36YER%<L\9I^3GZUVWPM7?@A_#%<@BV
MI$*-)/;](ZXXU1*DZRM4$8-"KJ0.%/#+&6"[&50EVB7X^E^!:Q)M$4,DD%[*
MB6\B22E5"%3(- 8DJ*C2:D8HRZBL2-0D Q%HZK<5=5VL [A[_-I,A!=DJ [A
M7)TE,LE!K3*F+9>ZA-3R91=U68K")-AZ+*M[*8Y%4%C&22J@9!BE>&;4^7&1
MEQ6Y&L_E'/W\W0HD7M^151[Z6G-I'3*DF1B3P05/$^BN!RXJ@UA;E'/ARK6\
MAV964W%[*!,@G6B<FDKD>5=*UT#Y0/'%(CK*Q3E5_+$6%M+5B(]AT>[K<S-$
M6ZC4BR+4TT)T5;5PIG4XGAN71ZSYF#\?>IE.P]( WTK(J!%4)I#!<E'L &NH
MCTBN!RXJ1VS^4:<JVC@V26&:9+MFBA75*W36FFI'BF? \,5HXK!E5! RVGA[
MU>/;-KDBB6.Z=HM6E2%0+5%$@+545H%Q<HQ637J EP'T"[+/>K-K>3IR27$L
M1&I672_UDFE<B%&?@/+&A,,N-3=I AP #] KMW%MBL5+M521(0C:4*MI(9J4
MK7#:!0;G45XMZL9>JJENI"0)(RI#"KZ!6OYN.*)A9ENTPV!_%:7NY):.JM$\
MFI2]4T\%95(S(->;+^7%E)EFE1,Q>%B=\MA"L@1RS%E,0TZU85HK@MREJ98F
M<+?Q9.RTM-XLKJS:[1BL"MH)89UR R%>-<!,$.LU-WE&64WJ#O>V"V%R9J0%
M^D'*L.:E>!%<,X9T^-4S96M9UF>X=M4L'9XRI((:-ZU!*\*5S(H//#:!:^)/
M4W.$;N':13ZXFI('*V>FE:5&?'PXX;0(-SJ8+0[YM8@$YFI"7:/7I:@9/:KE
MD!YX9PI\6H[-:D.];?,VF*0O]6TS$(U BD URXY\,!,%26[3C>-;*C;]M_2Z
ML;&2,2=)V5313H+DG+@ N&T"T-UF[&RQ_HK6V^;;<2)%%+5Y Q0:6H0HU$UI
M3@<!,%2>ZSB'(5!W%M!R$Q)R%.G)6I ('L^.H8;2*OPZF'2%"]R;05#&:FHG
M2-+$D"N8H/YN)M8JG<JF"O!OVV3RI#'(W5<T1"C@G,K7APY3BBH"LSW6<0Y%
MG&K)O>VO.L"RDRNQ14T/4D$ ^'#/CAG"AW:8#M8JMOVVJ'UNRL@<E2C5.@D&
MF6?#\H\\-H%H;I,_BK#>MMZ!G,M(ED$+$JPHY^B<L,X6?C3=FM9^15^/;9KT
M&1@2XC4E'HS&G T]/Y\-H%KXE1G93)OVUQSM \Q$JDJ4".22#3*@SSRRP-0*
M#=:A#M9R*I[AV@4^N.8J*(YJ*5\%^3UY<<-I%7X=3#I"Z;._M+Q7:VDZBQMI
M<T(H:5IF!C0D#<N52E*'F"YMWW26P,!CAZHD9NIG2BA<L_2Y7P.5<9G)EUW>
M@*CN6T[%Y\G<]S&I)MT9TJ65')! J**2!P/$GY <8VI7I&Y1.M=<N^Q+;7;!
MT6>%0T24+@U16'LD:N9B,CC1J6%<8[J<T<#VK!NX95@+@Q,PF>-2 V:JC$<M
M=63+QX$<,SC.T6QN@=K;M--2ANX;D/;J41%D2,M(W,I=I%5ARL2@T$GFX8;0
MJC=(VWV/U<5MN"D=R.7NH^BH:/J& U)!$:CCD*DMY?)7#:WJ'<@P+X/RK*?N
MJ6.@C@$P4\T@)4. E>52#IJ:',G+TY8&JMQW$&\MIIR\"W_$3?$EMNBI@;0#
M+K'*64LQ)(TFG#(XNTM9<_A^#,]MNI4_%$C$!+56R4L>J5 J*D9IQ'\ORS:\
M"U\$:Y='>GXFFU!?<Q5B0IZPI2F5>7(X;7@3X0]70NFPWU;J5D:-8J=/22]=
M1?B * \O#UXU&HZY5=UR!W>_4O5QT7D3!$P1,$3!$P1,$3!$P1,$3!$P1,$3
M!$P1,$3!$P1,$3!%XT7^<KG_ .N@_P"?-CD//R+VR_MA_P"R7\,5[..J\28(
MF")@B8(F"+Q[K_-VW?\ 0WG_ #;?'(^<<1^B]L/[:?[\.J:Y=^M]H>[?WN]D
MC9U0-;C-0K\A<"F5<M1\O7B5!%[2NNZSJ"/AB#PZ:<RQCGV6WM_=VW!I(Q*+
MCF5JU5^9&+<M#4+0\,_'&7B SK9C5E+-E:QM.M6MK/:H+R4F_?KVFMG63F9=
M6I=>>K_W?#YL4  WJ3J5)1'ALDVG0N2#;=CU)%\2E+.-='0BNFE"U13B,B?*
M@QD1CBNTJU6_(.=;Q1[-9>YS_$9E$A60,X:CHIJ->K,5*9?+3% B&M7.4JL\
MPR"S3Z]2U2SL(_?(CN,J'0Z2*P&6I@NL<:^7I)KBL+;5@U)G*<@TU+&^BV.6
MK2[C(R!5C93FM54 >T *OI!/F/0:XDA'%=*4JHN@-.SKX4]WV*:SC/Q%UCM&
M):9LFK<,'4'74CV,\O/!HD7W)GJQD?!;+5^ZKVT.R6<JGXF[N@(D)J?;6BD4
M'*PK1?73QQ0(C6LSE5F/(--+56W;85CF@;=#)&^D!/"JLK'2%KD3E3UX@RXJ
MS%8D'(RZ+"#;I%N;>WW,W$LJ*S:Z$JL3#2?#+\]:XU$#45SJRF&)@P'U7)#8
M;$8#=+N+LL3Z)+EUY27TLJ5(IH\P,L9$8WNNTJM5\N2_5]>-1!'LD*RLM_,8
MY%DB;6K459!HJ0PHH!'+D*\,\091K21JEO"+&/-:NR^:UO$MI?>S.LBR0JR1
MII8@AG%7*TU*NGCC<F.M<:0E D96N-YY.U8/MVS78L[1KN1;AQU8(0&U*'!D
M1=()"*NG@?GQG+$L'705JL,TLH:X]7*5$9V>XN;BY:XGUQP N)!J*J\9@H "
M>8G.E*UJ/4\)+H=I&(BP\WUS<RVW&>QFL[-Y;XE'K"KB-*:I$K4@GEI'49>?
MRXLB"!:L48SC*0$>&_ ]JXYH^V[B!(&W HE6D4BH1-5"(U%:#/,CT>&,D1.M
M=HFO$OE[^'3I6P&Q"X@F3=&1XHXXE2G,4CT@BE*T;3^?%\+WK']7*087DGGT
MZDNK3:9C"K7SI'<J\D*].@T,6<ZZ@<<^/&@\L" =:0J5 _A'A;7U:6<JBYV[
M:EMUM9[Z>)+:22EP]3K=@*T;,\N2GA6M/' Q#,ZL*U0RS"(.8"Q6NSLLNE$W
M!OK6C 2,#J%@!#4,W-X?(:G Y<5FGM1:8W/Q8K*6RVF-V59+L:)&A5TH L@#
M,P4DC/2M?FQ#$<*W&I4.J-S\BD6>V1W MXI[F6:'IRR*@-2JJ'!U%A1*,!QX
MT\L5@[*;29&8B(!<?3G6D;6$,UU<)).YN8Y6E#ISE"!)1"S*>42UH/# ,'*R
M1.0$2(^$CLMLX%R;C!9FYBK=7$<<2HLB],!65&,?4701F9//Q/EC,@'O7:C*
M64V1<\/*UO!U+H2PVPP^\7%_/';Q,(V21=%6**<Z5)R7U98UE%Y*YFK-\HB"
M3VK*XCV!HK<B^E5;9"(UC4U95=B6JO@WK%33QQ#EQ6H&L"?"/$=?$NUMOV^;
MW>V.X2Q3+"@$?LN0[$H?&C#70$>/&N-90;'7$59Q>64$.>+2Q<<MCL)+,^X2
M:B0BD(^D$@@B, 4I1\Z>G&3&.*[1JUM41S]:VNH-M6R&C<I42SD91(H;VY0&
M]HYMI7/CZ\4@-?<L0G//; >(=2TL++9X[RUE2]>:1W,MNSBJ-74N@>5.;%C&
M+BU9JU:AC(96U'H71VU/[OVP\^G5TI+U]/GIN933QQ:1:'/UKGOL<U=L1#^&
M*P%XY9FGV52\I:6,A3J(T@,2"FK41\_HQ'X%O9C54NLTM5QNKA)H_@Y:2BAX
MPI ;2HIK&B@IX<?GQ<_ IL X.TLTX5T,T)O$M7VNL0EC99 I*A]%-3<NGE7Q
MKX>&+K9ES .7,)VL>M8+/(W21]C4&M$!!*J*C.O3RI05_)7$?]E;,0'(J:<Z
MF"\DD=]>SZ$5'EC8II-8P H]FM6_A7 '@2=, 65,!SJ8KR5K$--M +1E81&$
M.::"U54K4*#E_"F E9<I*F!.R?#T\=Z-,TEH[G:$63V(U9"P(96-2-%?:6GR
MBM,'LN01:0&TLTX42ZD>:.*39J*S*DC!,EJ1S5*#)<SZO(X/P*FF "14TYU5
M;F0))&^SAEH%FHA&I=8R"Z#7-M5*X/P(8"PBIQ<W'R*]EN99X8XMJ,:R2GJ.
MJE40L2K/4HN>1!PC+@4JT+"3-[--:BQNY(UE0[3T>G&S51" [1 ,HTA<JELL
M(G@2K3!8YWMZUF+IRI/P95C/,8S&VH,Q;5J^KIY<*\<1^!;V8^Y;Q]ZT-U)[
MG=@;0(WZ:TC*EE<%B &"IGIK4@5_CQ7L-BSD&:/]1[=-:DS-*+22;:1S-T2A
M34T:K*NEJTY0,VIZ..#W6*96S 3X>.P_@JRW1;^[_!ZQQF0(2C%026!(&BG/
M_KH,R)X%8TVMVF&E^I19S3RR]&7:5B@N2W5!7E*J&90X*Z:ZOX<, >!*D0 X
MFYBH>^GEA"KLH**0])%;2K$ $Z>GQH?#P].6&;@5%( _\FG.ES</'>F*WV97
M6)V D*$!AI&:D(:9\3\WH$VV!(0>+RJ7C'O0W<@96;8P9/9!TT"@\>;1PJ,L
M'_939C[EFG"KW-U'U(T.T/*JJLT?(VD2S*=0II(KYG G@680+$[1M7(.51/>
M-:TECV?0K(AED  (4I5U;E\  O' EM2L:>:PU-?UL[5G;[CUK553: +>0!R%
M5G0U !  0 G2?F].6().+EJ=%I6SM&F.G2K0;A=*$==FT-2D2*K+I#+F"='J
MKZ!YY8"1P4E2B;-IISK1IXU*73;0>JC.M%4L5HJ'4 $\:4K3PIBOK99$3Y<]
MGX\*F241QPNNS!IY%8J@7) "11F"&F1K3TX/P*"+DC:6#3%6FNI+6XD>+:-2
MKIZ<L8YF+4KD$RIJ.=<4EC<D:8E$ U-.=<O7N+9NI;[,@=0<U5BZNY#:M105
M',:T_P!&,N1<%TRQE8:GX<ZG=;Q+2=V?:8VC+4$S 49RX"DG2?%F.$RVI*%,
MS%DR^')QJR7=R8EC;9 T:-K9:4YP*:E3214^O%<X*&G%WVENG"JB[N41.GLJ
MQK1"H )(8%0#[  T@G$<X*[.)-M1]#PKJB>%;^6,;70F21A<%20S :B2Q7+4
M0*9TX>.6-"^Y<I F .?4+-"J6L\3"0C9^DL<74<F,@EA2BJ-',:9X@/ M5(F
MS^H]N/>N_:96D24FS]S!:JK2FH$>T1I6ARQN!X&7GWB+$>+,K[C'.426+GZ3
M O"$5RZD@$#5PH,\62S1(=CK7G%MY:*-A90H[J^N/2#I*L=/,3Q(IX>G&/%@
MO2U($^(JD$V]:(U?;8RZT,CE5&H<#0!LF-/5B RP5E&DY:95&EWX6T4B[?&9
MF,C21%5H % 1:@Y9Y^)\,'DURT(T<Q&8M8M[B3=A*R0;?$14@,RC3P&==0KQ
M\OS9TO@N<!39S(JADWU17X=;L.44 IG4!FXG+CEB/+!:RTO7):1R;MU K[?#
M32Y8@4&H1AD4&IK5C0XKG!9(IM9(Z'L6$4^_=,ZMMB)1:DLJJ6)6M H8TS_A
MXX@,L%TE&B_G*Z =UZERGN,15&!MF8#F4L:UIEDN6+;;8N7]-AXCPK%;G>M(
MKM<6H@$T44J0N69'B2/1Z:8CRP6\E+UE79]ZC2-A9Q&7JU<(@%$"*U 2W'5J
M&KT</'%\6"@%(D^(LWUXE!W7N'ZQ5VZKBF@'( $5S.K/Y/5AGE@@H4;/&MA=
M;\CJ#;B0-&[,QI174,5&1!S.D<,5Y+&2B1?K[%E)?]QE'*605@"4&6>7B=1X
M?_M?)G#*6"W&E0>V6FG,K+>=Q*MP7M5D9%7HJN09C(0>)\$]/R8/+!0TZ)9I
M<?-VJ\M[OWO#I%9J8U9@KMP*ALC[7B,N'IX8IE)[EF-*BSF5JPO]TW^W,DJ6
M8:&,N >-0&HATKS<,\9E*0U+I2H49,#*U;&_W[H(XLEZC&0,HJ=(5@$)J5XB
MN+FE@L;*B_FLL[U"7N_M<1*]KHB8EIGRY0 .49FN=17QX^C#-+!#3HL6E;J6
M2;GW*\!86"JSH.D<ZAF!-64MD!Y5K\^)FE@MFA0!\RZI[O=3(3;V[&+I(X+
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MAHY5J3Y$T  \^.((\*W.J+1L[;=-.)=$MHTQFDAW55B9PQ <LJK)6E1JIS5
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M+3F/R\,,\\$%"@?SK9;WN&61(&M5@UDJ]P 6"#34.*U!J? ^7I&+FE@L&E1
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M>+X64>OF-@?CPY=+%DL/;I:=TEGDDA^M TAB472.4%*%3ED?:IB-%;,JU@(
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M0S1:@-<@:K:58-0-4C((OLU/Y\0&*W*G6!#D'3\;U>!^W9];16<G5BC=@*Y
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MAW^G8KNW;NF&012LDA,7(3I4(%#!N899BN+X5D"M:'%EO.H@W?9+=(O=EF1
MHA7F"(4J:GVJ$KJ)_A4!.(N5GN]61.9L=.-4@W#8NDL2I<$SJH2K:GT)15TG
M42NK+(TKB"45J5*J[^&SFM6SCMTV$5T8GZ59"DA8K*"J,<LZG)>4>K%\+.L#
M;9S%[;.+3%:;?TOQ0_24K%\*MM"MQ"]:6@-?'%CY_P#I"Q5?86W[275%>_CL
MOGI@B8(F")@B8(O'NO\ -VW?]#>?\VWQR/G'$?HO;#^VG^_#JFNZEZ+^0C.W
M*1Z-1&D,&;70#FKI(XXW:Z\_AR#U.>Y>=3NB.WB5.D\A#&5F-2&UG2!F.6A%
M?&@/CC'C7I_H$EWT"L).Z&C<]*%'U1Z*T8!<]>0;/P\1E@\U&W=[SK[M2QE'
M=AMDT:/>.H68'1I"A5TKD>%=7R^C/$.=EN/Q\UMS<.F'XJ[GNY5JH@D9CD*!
M0HKX\QK48OC4'QCB%$8[J%ZK2],VR^WIIS:0U" &KS5%?3Z,3QNA^/EL?,JQ
MS=X&($PPZF7(-I&DG@2 WAGJ'JIXX S5,=V>\Z<G,M;H=S+-(]N4=44K&C:0
MK5 H_&M0:UKBG/J6:9H,!)9+/W>Q*]"%:. SFE N1;2-7-QR]'IQ'FM&.[8F
M[34M)OQ2MS(T8B>$DB-<A1:M3BW$"GAGZ,\4YW68_'RAW?\ !94[OH%I'4,S
MEJKS:JZ4.=0 >-,3QK?_ ,W"ME;NGH.2(>J63I@@5"UYBU&H21Z?5B^-8(W=
M];*TGXG$<>CI,X%):  DDG-:M3(4P.=0;!R[K(?BM474(F<4.E:::9@@DM6O
M"F7YL3QK7_SOK4,>[W#@"**B\K<K,S<#05H//.N'C5'QAB5-ZG=+/(MN8Q"S
MGID$!PH8$5)/B*@^7AA+/J4IG=V&9W958]VB57T1,JM4HA%& !6AU'Q]H?EX
M8>-4?'9K=-&5 O>G4,OU&HC3T^*#,FH&K/UUX>&'C6GW5FM6].[0X75 4I_O
M-.9->%-66+XUS_\ G;6JL.ZD>(ITY%,:=;5IJ7!YJ4("@CQS]6'C5_\ G(+O
M?8KSR=TB9NA%$8P6IK*@'F.BE#6FG,X'.I ;NUI+HK]S^[C4B&;4U2H056BT
MR+4_2\>-. P\;*$4,VMM.#B_%4)[N 4GH,2"715&1RH 2P].?Y,/&M?_ #<*
MK%+W?(H8QPQU&JC@>50IHQH=67_A].(#-64=V&LG33EX%5!W@5=?JT%&*NVA
MFU%C0  T% ?&O##QJGXW"NW;VW\R-[\J"/Z.@+4<XX\QKR>KY<:CFUKC6%%O
M ^@[5ZF.B\B8(F")@B8(F"+P.VI$B[8>5U#I')>LRG@0+F4D9XXTCX.?K7T-
M]B37880_ABM!N.PN\ZK:J>EJJ^A KT=5.EB0#S,,SEXXN:."FQK "V_A*YUW
M7MR0ZI;5>JBZ2FE& U4E:E33(FK8SGC@MFA6%TK-!^"Z%W78[A.JUK41:%37
M&@.EF95TZCPY3_KRQK/$ZES-"K$L][ZUE)N^S70$!LG='&FNF,4K444AOY_A
MYXAG$ZEL;O5C;FZ^S@5;;>-@6-1%9LR5$:,(U8F@-*DG/@V> G'!6>[UGMEP
MWK63>NWX& ,(!").I5$/^\JZTH?:\<4SB%@;M6EKQ',L4W#8;*1;9+3ZG0CF
M1@K$"3F .HDT ;Q^3&<T18RV:-:8S&5K]2-O7;[1JRV=2HI'RH"/'2&4FE=(
M]?ST9XX*C=JP/FZU<[QLC@I)9:F=C(Z!(VYG%&8Y\:<3X^%<7/'!9^/5%TND
MK3XCL;7D,1M4K)&ACD*1_P#K4TJ!QS!Q<T7N6=C5$2<QL/#J68WS9(FUQ69!
M#Z&D6-,BH8\5)X!,3/'!:^+5-AETG36L_C.PPR%5L !J,9*QQUHOE3VN<TRR
M\:\,3/$:EKXU:0\W2=+EM\5V0Q33M9Z$@$:59(P6#U10 #6E!\V+GC@L;"JX
M&:]]9U6K-=[V;IHCV042,"ZZ%*552:UR]D#Q PSQP6CNU5WS=.EZN^Z[!&48
M6E7=$D0"--161 5XD>@?Z!7#/'!9%"L7\72=2M\3VJ&$2I8Z>JS)143/G0'5
MI)XEP<7,!J4V%218RNX3@>Q<QW7MNAF6SUL0Q8%4-%%7KQ/%AX?Q8SGC@NNP
MKW9NOB71%NFR2Q.19&L2L2AB4$T(1@M2/%Z8HE'!<Y4*H/FOX>7Z*!N6P3)-
M&+0F(*97Y%T_5 N* ')N-,J^>&:)U)L:P(.:V[GL4)N^SK$H2PHLI595"1@"
MI\17P)/$?Q59XX*G=ZA-LKN-=%G<[;?J!:V:,0R.Z2JJ$(XH9 .:N2TQ00;@
MN=2$Z?FES=2[QMFVC32UB&GV:(N7#AEZ,;RC!>?;S]1YU9MOLBFCH(!H,>2@
M'0PH5!'A3%RA059XG%%V^Q555;>,*@ 0!!D 01X>:@X90AJS.LJ%V^P6FFVB
M6E:411QS\O1AE"&M,ZRM8H88E*Q(L:DU(4 "I\<L %F4B;U?%64P1,$3!$P1
M,$3!%P[F=P#PBTB213J$FM:TK2A&8IEJQB3ZEZ*.1CF++SH;CN Q*DE@C2US
MD8*!I4\" W'R^?T8P#+!>B4*+N)%E8W.\]#6U@K32S:%A(%!&JD@E@>7,<23
M3%>6"F2D[9K +^%6@N-V55,EC'$D4))"K4%PE45>:H X<, 3@I*%,W2)<_6U
M52Y[@,:$6$2LZY@BE *>US^D\O\ )F>6"IA1?S'3D5EN=]+!FV^,*"!P!84.
M7TN X5_\WHP>6"AA1]1TY-+N%2TV^FR$WND7O.H!H1P*=//42:Y.> P>37((
MTLS9CEQX7[%=IMZZ<#QV<74)<SJ<LPU%TG5EJ7Q.*\L%D1I.09%K&7,DO<0@
M0/8024510BA!:FHFA_(!C+RP74QHO9(K>:[WE4A>/;T>9E'4&0TL'T\2W#0:
MC%)E@N<:=(D@RLT^JHUSW#J5S:1ZU!#:5&? @AB_#VN7\N#RP6A"CZCIR*]O
M-O',);&-%*.R=,"H95Y!FU*G^'G@#+!9G&EJD;_Q59Y=ZCA2X6V5GTQ-+#1<
MCH)EH15JU4+\N!,KU8QI$F+XV\MG:N=;O?KFUZB[?&N2.C%,]9"\RHS?1).9
MQEY$7+H:=&,FS'NYEW0R[F-RD1K11:E],<@"BBJ"=1-:G57R_EQL$O<N$HT\
M@.;Q+G6?N%>FON$.LUJX%%4"FGZ=:YG$>6"Z9:-OB.G(JQW7<*N?[BJI5B0%
M7V1DL8HXKGXXCRP6C3HMYM,;EK:/O#SPFYL(41@ZR-D644U4R)R9OS8HS:PL
M5!3 .61U*]O<;O(&ZE@D>F-G(('-+0%56C>?GB@RP69PIBZ3V]"Y[>?N/2FN
MQAY2-1( 8C2. #44YD>-,9!E@NDX4-4BC77<;*KC;XPQ9:#+5136AJV5?/PP
M>6""G0%F8Z<GXK2>;>P]L8K*-@\:FY%.4.S<V==7*"<J>.*3+!9C&DQ>1OL6
MAEW57N4]R61(\[=B%YP\IJHH?T*'.F?'%<X+.6F6.9GOYNU<[W'<#+RV$:L2
M%-0 -+,*DYMZ<OE\:8R\L%T$*(_,=-/HM4GWTVSM)9QO,)(U53D-!0=1J MX
M^DXKR:Y9,*6:R19CW*\ESO4<$6FS1Y2.=5 TANH!^ER\F?CBDRP68PI$GQ6=
MW%BLKB??![KT;&,JZ#WE"!0'52G&M!Q I^;$)E98MPC2M>1X%K<7&^),Z06<
M31EVZ3GA3S;F'K]/#TXI,L%B$*1#F1?3@59Y][71HL(2FFI7B0P2N68XDT_C
MQ"98*QC2-\BL4O-_<%DV^.,$'IN5YJU(6J:AED/'T^C$S2P6S3HB^1.G%I<K
MW,V^+=*D%G&]MH!8LH UE:DY$FM<J?RXI,GN4A&D8VR.919ESW7*73IN=LMB
MR?HGK2U&5>& \_($J-\<-]R75%>[CJO F")@B8(F")@B\>Z_S=MW_0WG_-M\
M<CYQQ'Z+VP_MI_OPZIKKW&#<Y%'N4ZQG54AA3ETD$5H^=>&67IQJ0.I<:,J8
M\P=>:VU]P>ZN@OUZSRJXD).E0OT0-/Z5*CQ]&,9)->O2*]',#EL;37^"UGV_
MN)XD1+]5^K"NU &ZF89JA. RH,L4QEBLQJT07,=?1SJ]KMVY].5=QO3)&P C
M"'3I(:H)8!&/ >/GBB)UE9G6@XR1M6,.T;QRQ37*FS9@9XQ([/DM&TN0&YSS
M<<N&,B$N1;EO%*\#Q:K!I9<KS66]O+*;2[6*W=JIP)]D*"#1LAXCQIZ:XIC+
M45(U:0 S1<JHV[N5;41KN"B4."'(#<@2@!)3/FS/GZ,,LVO5VU#,^6SOXU5-
MN[FDJ9;X1D,=(72<JD%O8\5I0>'YIEGBJ:U 71TYU8V'<B+*5O%DD<QK&W*N
ME5)+%N3T^ SX9<<7++%3:T"WA86Z7H^W=QO9LC7R"X,H96&2JBY@>Q4Y\1XC
MQPRR:]!6H"3Y;&TUK.':NXX/]U>HVL?6=0D\VE5%.3@NFOIQ!"0UK4J]"5\=
M.=7-CW-54CO%1(XT36Y#%G"YO[%?:S->/#+CBY9XK.UH7F.LZ7_@KR;?W"\:
M/[ZB7 E+'3FHB( TKRBI])&&66*@K40?+8W3SJ'LNY7>-5O%C5(P'<:3K>K^
M!3+Z-3\PPRRQ05* !\+V]G#QK%=M[H;4QO0E">FE10Y, 6(0UX@^'J!Q,L\5
MLUJ'ITYUT^X;]\0EG%XJP.&"Q\:<I"9%<@"V?GQKX8N63WKGM:.0#+;H^M8_
M#.Y5#A;]6#ECJ:@/DIR3RXCYJ5Q,LL5O;T/3ISJ!M?<@*GWU:1J$4!B 0N5<
MT/,:\<\,LL4V]#TZ<ZT]R[D2%U]\6:1P@5N5-+:U+D<A%-.KSQ<LL5G:4"1X
M6%O59K6?PSN<:F7<49V"@L0 ,ESH F7,33$RSQ6MO0]&G.DNU=R,P*[B#P)K
M09BIR&BG$X&$L4C7H>C3G74+;?Q=H_O,?N_)U(_0 NK3RUX@^/CX4QII.N6>
MCE9B^G"N!-O[ME::.>\5$  C==.E@3F/9U9"HKZL8RSQ7H-;=PQ$=.===M9=
MPQ1SQO=)*\J/TY3ETY"20P73P-?33&A&6*XSJ4200"&Z0I&V;PT0ZUV)9D+/
M$22H#%&5:Z%6H!H<QAEEBFWI/9%AWKGBVSNE%T_$$S8EC[7%M1*U3+U9_ER@
MC/%=)5]W/Y3IRK>&Q[B2=#)?*\2M5J@5*Z>!&@?2KX\*>6=$98KG*K1(+1MT
MX<-+51-KWY(41+P*\C,]S(6+M4L2-&I*4TT' 4IAEEBM&O1)<QXM'5KBR[DD
MEET7D:0,RE I*L H&5=!]HC/ QEBI"K0 #Q+Z<*-MN_/;O#)?:B[_P"\%$8)
MHID0G'5G3\OAAEDUZ"M1$G$=.=9OMW<I+%KQ'72RE!D6!!% =*Z3P^;TY3++
M%:%:AZ=.?3D7M6PF$"";_>TY\P<_6 ,=0O#-G+7+R>T #L* \.O=_P#YU+CG
M1\O/UKU_Y#_E_P"F/\(7L"*,5H@S%#D.&.K+QYBG3C/T1\PP1RIZ:9\HSS.7
MIK@CE B"E%&7#+A@CITXZ4TBGE3+!'*:$_1'S>7#!'*@QQM6J@UXU'E@R E%
MAB155450H 4  4 R &(R&1*G0GZ(X4X>&*CE-"?HC*E,O+A@CE52&%%"*BJH
MS"@ "O\  XC*F1-JGI1_H#YA_#PQ64S%244\0/F\L$="B'BH/R8(Y30G'2/F
M]%,$<H40BA4$'B*8(Y55AA1 BHJHHTA0!0 >&(RID3:ZL$0&H4 ^K%4<II7/
M(9\<$= B 4"@#U>6".45$7V5 ]0I@A)4X*)@B8(F")@B8(F")@B8(F")@B8(
MO/W;;KB]-OTK@PK$^MQF=7EP(X>G&)Q)7HW>L(.X=UQ#9M\.K5N3#,!*%^ 4
M"IYN-?Y>.,9)8KN=YI>CJTTP4C8MQ4G1N#+J:K%=0.8/#FRX\.'CQQ=F<4^5
M#TZ::,KS;-N4D"Q#<&#)(760ZB:: %^EG1A7/S\\# XK,=Y@"^74K2[->,%,
M5XT<I*=:45ULJQ!*5!'%N;%,#BI'>8ZXN-7.ZQ?8-PT,L=^R4SB:KEE(!7B6
M-2P/$YCPQ-F<5L;W![8KLGVZZDMKNW,B,EQ32SJ21DH:N?'E)!'CC1B6(7&-
M:(E&3&Q8/LERUOTQ,@8RR2D!6T4D#B@%:YZQJS_/C.0LN@WF(D[&X#F9/@ER
MLD,@NM9B2*,(Z\HZ3AZC21QI3/#(<4^5%B,MY/2%ZD$$<,>B-0H)+,%X%F-6
M/RG'0!EY)2,C:M,593!$P1,$3!$P1,$3!$P1,$3!$P1,$3!$P1,$3!$P1,$3
M!$P1>-%_G*Y_^N@_Y\V.0\_(O;+^V'_LE_#%>SCJO$F")@B8(F")@B\>Z_S=
MMW_0WG_-M\<CYQQ'Z+VP_MI_OPZIKKW';Y[I5$5T\!#:LN%-)4KRE#G7S]5,
M:E%]:XT:HA?%UY;;!_=98OB; M,CR3&M0XY5'MTK6E*^/&N,;.R]>H;WX@<F
MJ[0:<"WG[?N98DC^(S!%C$;"K9G,,]=0-2*4K7%-,XK$=[B"3D%^FI3!M-O:
M*XW"\]XCEHJ).QT @Z^568C*GY,! "\J3KF?DBS8+FMNW0D86'=)/=U("JI(
MIRA56JN 16A\^ X8@I\*ZSWQS; /IP+VHEM[.-P3'# M611RJJ*HJ<\AGY8Z
M!@O%(F9UDK=75U#*0RL 5(X$'&ES(9"R@@$@$\!Y^.",@=#6A!H:&GF,$9#(
M@-"P!RRKGGP_-@C%5,\(=D,BZT&IUJ*@'Q.(ZN4WLG6BT,^M="5UM44&GC7U
M8.IE+LK)(DB*Z,&1A56!J"#Y8J$$%BH>6.-2SN%4 DDFF0S)P=!$FY6J,%$J
M,$3!$P15:2-*:F"ZCI6II4GPP5 )4ZEU::C5QIXTP493@B8(F")@B8(F")@B
M8(F")@B8(F"+P>V96B[9:51J9);UE7S(N92!CC2/@Y^M?0WV+UVX(?PQ6$?<
M&Z!$,JQ5 57"@DZ@*.^1H17,*/GQ!4*Z'=*>I]+OQ6]GW!.53WL*M)-#:.9B
MO3KK-,AS^6**F*YU-T'Y</KV(F]R'<&7J_W;7( 70!= " 48<>;45\QAGM0[
ML,EWBL^NA7.F_;F;65ET--IBZ8?3'0T'4H"<_GR.)M"RZ'=:>886\/$I/<-_
M'' VE9361IA2C4&2KD:#/AYX;0J?$@2=5S+2?N"ZCEDZ:K*"W*M.4+H!R89D
MUK7U4\<4U"LQW2) >S33K6:]Q;E[D"8X_>1(BT_232"S$<%J<O1B;0LMG<X9
MKSE8J[=PW@"2!59VCC)A'L!B3KJQHP(R%/"M<\7:%9&Z1NX3;U(.X=SRU10&
MAYJ,14> %3D<-H4^)#&2@=R;ATT8PQ:VTU0%LJE0U3X4J?#$VA3X<'O*]ZVG
M2>/J(P9=3 $<,C3'8%UX)P,2Q6N*L)@B8(F")@B8(F")@B8(F")@B8(F")@B
M8(F")@B8(F")@B8(F")@B8(F")@B8(F")@B8(F")@B8(F")@B8(F")@B8(F"
M)@B8(F")@B8(F")@B8(F")@B8(F")@B\:+_.5S_]=!_SYL<AY^1>V7]L/_9+
M^&*]G'5>),$3!$P1,$3!%X]U_F[;O^AO/^;;XY'SCB/T7MA_;3_?AU36VX6=
MG?S>ZO+(DR4FH*T*T*9:P4IGS ?+C4H@V+G1J2IC, &N^O&O+AVGMZXM6BBO
M3H9Q*Y+(LE4!6O,H8"G ^'ACF(1(O7KEO%:,G,=3:VTT*U;:-BF54]]($$2K
ME(H&A5U&05!^BXYAPQ<D3K6!O%6-N6\X='<MX+#:8[2ZA:]$B3&L\C/&"I;E
M)J -.KABB(8VK$JM0RB<K-=85Q-L?;\6AGO642L5CUM'4Z!JXE?HA0=1]&>,
MY(XKN-ZK&Z-W'KTNXUO!LO;]JT%PUTI6.I77(FARM%J:\=)^8XHA$6NN<MYK
M2<9>@K5[+8GW!KYKU.LY5U'52@TJ/9]&E?FKBY8N[K J51#)ELXBN2/9^VGZ
M;+?#0X'3BZD:UJ 0*4!\B!X'UXR(1Q7:6\5P_AZ"C[3L+N$&YA7E&D!'A%:@
MC( 4%0> PR1Q0;Q6 ?)=P%="['L4:20^\@!RB2@O'J+1DFC&E<ZG4,7)%<SO
M54D%L<=:YQL7;ZSR*;]@X]L"5%H!7(D 5TE:YYB@\L39QQ73Y59AX>@Z?BJ?
M!>WBL8.X-H=W"1AT4,]:.0%4>7\?CB9(XJ_)K6^'5PZ:,M8=@[<);1>=1B-0
M82H64::U!'"@SK_)BBG'%9EO=;7%N0J;?:>W8W18[Q6D:-TU!XR2KH$.>=#1
MA3 0CBI/>*Q%L=>!XU";?L%O$T:[B.<B0<\;DE%;.A#5-'_CPRQ&M4U:TB^3
MH/ D&P[)$RRKN!/0*9F1"%(84] +%:9_Q8"G'%);U5-F6_@*M<;/L F0W-V#
MU2YC5FC /$DDTSI7B?'TG%,(ZRI#>*S'+&[C6,NP[&AB_P#D"D;5.G6A+9D!
M@QK2AR)Q#3CBMQWJJ7\-O*IEV3MX:E]_*-&K22N&BH/,^S1:5IE]'+A@81Q2
M.\UO3?QZ=ZD;)VV0C"] H!75(@+4!-6X-YG\N&2.*GR:_IZ"O:MI[*UBCM3=
MH[1!8QK= _"J@@4^CZ,=00+'7AG&<B99;^-6GW7;8$U27,=#2@#!B:MIR J>
M.!F D:$Y&P%7%_8LI87$14&A(=:5H33CY#%S!9V4\"J_$]N_>HCYD.IIE7//
M+$S#%783P/,JMNVV*LK&ZB*PKKE(<'2*D9T](IAG&*HW>H6\)M4KNFVM7^]1
M"AH074'VBOB?,89ABH:$\"I&Y[=J*^\Q @@9NHJ2 13//(X9@FPG@4^)[<&*
MM<QJP8H59@K:@2M*$UXJ<,P383P*A]UVY&F4W":[<$RH#5AI&ILAF:#CAG""
MA,M9>K+N-B:?WB,,?H,P5AE6A4Y@X9@H:,\"LWWC:D*@WD-6(  =3F14<#XX
M9QBM#=ZA_*>9:6^X65P=,,RNU*A 1JI0'AQ^E@) K,Z4HWA>9VFI?M\*&*%I
MKP!EXBMU+F*XQ2\O/UKU;^6K<D/X8J[+W"K"*$KTDU#K2Z79AJ)4Y%<]-!\_
MHP\2@-$VF_ ++K=UD2*L,2O]%FH0,APS&K\F>#S6LN[V6E;7\F_F2*6T15C$
M8+I(5 UEAJU9G@OEBRS:EBD*+$2O=5;\2&"508C<)H,1% #[6H,*GT8GB5&P
M<7M^"M+)W"MJ2%C,XZF?*HX#034F@XUS.*<S*1%'-K:SO1I.XF]V1%C5F,AG
MDH"H76 A&?'2<AGZ<'D@%&TE]3?59(>ZUA(986<\#E4%B2>+4(6@IZ_1B>-:
M/QR=:Z>KOOOR+TH_=2(M?,"P)_WA\,O#%>3KGEI9+SFM[ES1OW6Z*](DU$\K
M**@4:A-&\Z?PKB>-=2-W!:U64=SB5$9X:,.=Z"M >(6OA7#QJ'8,3:EP.X_?
M)I(S'':J:1:B#R"AJ1EZ<#F=(;#* 7,E$3]R&*X5ND9 AT%2I(D,A-!4^"<*
M^C 9DD*#B]GZ&[5TP?&^@.J$$T>L#,$.!'1"?6^-#,N<MD]EW?;T+"RCWZ2'
M3=2 %9%(*%0Q4*VH,1J%==!2F,Q$M:W4-$'PC5IT*B#NDK')(4#4YXETT'#.
MI.;<?1AXUH_'M ?33C6]I\>CC'O*B0I*H"H5!,?3()+$YG70^&*,VM<ZFQ)\
M-EG2_8DHW,;DSABEJK@U=TZ>GID9CV@&<_D].!=TCL\C?FXK;^SK6"Q;\1<
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M&D;G0S%::%!=57*NI'%:^5/#"(B5NM*O%G(=^OO6:3=H$:O=Y5.=&J"Q-5!
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MT#N^IJR JVDDAOT6R]&&48IM:C'P=RD;=M\I*_%V9KD$0+JI2B4\"#[*FO\
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MT=F,P82 4$6L!:E6I[)]GZ5/#$)E@M1IT;S+#GTYE9KCN6H3W&$LU.:G* ?
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M6WRJ%D@5@  *UX* !X_S1@8!6->8N*SM]DVR!E:.$:U% [$L:$:36ISJ,00
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MY?LUM^IADEZNI/D4?M#W2[4^#]P??\OV:V_4PR2]74GR*/VA[I=J?!^X/O\
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M'Z+W4P3N\V]<.J:];WFV_P#=3_:&.CA>/)+!/>;;_P!U/]H8.$R2P3WFV_\
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M0B[L%6M68-SM1J\2:#ERR'AZ\3*<515A?D62;/<Q B'=@FK46"D+5BI )S/
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M"G:_W/9?9HOU<-E# )\^O]R?N*?A3M?[GLOLT7ZN&RA@$^?7^Y/W%/PIVO\
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MHMYX3;3]6S:62,"[DN8I=<<J ,FI(5.KZ+BM#4X@W:0YNEUUE_F*<O4#F%K
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M,/9'L0=L6A) W#<20:'^^SY'C^EALAB>=/G2],/9'L0]KVH%3N&X@#Q-[/\
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MZ"$56RS51EX9>B@\,38<*H_R1 81BRB/L>TC>(B\N>G&VHQ:S0FJGS_F4P%
M8H?\G(@^&+\2]'9=C7;#,1<23F81@Z^ Z:Z<AP%>)QN$,J\V\[UM6L 9^E>G
MCHO*F")@B8(F")@B\#M^V]Y[:N+;5HZ\^X1ZAQ&NZF6OY<<:8>+<?65]#>YY
M:XE@('_\Q7#%L&UR&<R;BC+N,;JRQZ5-28E)C\:#H4_DQD4QC>N\M[J!FAY#
M^J_W*$[0V -+):WG3CD;2Z#0ZA6)CTIJ!(]H!6'CZSB;&.HJG_(5K!*-H_'0
M+HMNW]AVJ0K+.3)T9DK(H]BYD4N<A3E<FGZ(:G#&A3C'3%<Y[W5JBP6./_R.
MSG(>]4CV#8XH))#=GW:\M9+>(%%'*T2)(PY:MRP*5!R\L04XXWA:EO=4D#+X
MHR!Z21_$HCV#8EO(]UAO2HAN%D))K&6.NB*,@/\ ??1^7 4XN[H=[JF)IF-\
M>75;T:U6X[3V@.D<NX21MI?I%=*TB)?7K(&EC]81J?\ /@:4<58;_4O$1JY[
M.RX+)>Q=@E9X3>O+TE,#1L4-(^F$*$4IE'I%?#$V$<5L_P"4K"W*SVZ[W=^=
M4'9VP&WZS[E+-"VI)"2C]07 "RZ@%JQE*@_)B;&+7J_[&L[" !ZFN]JZ9NTM
MHEMXK5]Q9D2%H6+&,R-I:0AM=*@@RMJIQ\<:-&+,ZY1_R%02,A#6^MM78&P7
M7N7;NR;A5FN-"M%'"&C< Z8A*B\]=1_W^>>=!C4J<2N5'?*M/5K)NQ8W?]*Q
M/;6W+9PPIN#((KF2>.5=)/UWUC+X@9#)O+T8FR#7ZUOYLS(DQOB!S6:!<;=D
M[(IC'Q$K/'&J#F0!HXVK'J6M3I-<Z^)QG81Q78?Y.K;X+'X;S>IE[-V0N8AN
M;I*[RRHBM&2'N$TR$@@G2R9#P'RX&C'%(_Y&JSY++!K_ "W=*[MQ[)L]PO#>
M7%S)UVC1)-(4*S1KI5RM#F-3T\M1QJ5 $N5YZ/\ DY4XY8@,_7H.9$[)LQ&\
M<D[.'(-=*U!%JUKE75]%J^O#8#3B9#_DY.X&F;,J6W8ME:WBW5O=S1L)1*R<
MI7VQ(X7+EUL,_6?/ 4 "X*U/_*2E'+*(N;H8<W8OIL=U\M,$3!$P1,$3!$P1
M,$3!$P1,$3!$P1,$3!$P1>+WA_\ H&3_ (]I_P#G46.5;R\W6O;_ ([_ )A^
M[+^$KJWEMN$,:WTW01F(1CE5F4I3@?!\:FVM<MV$W.0/HZ\>V;M^*-I$NYHT
M='B,95JJ&((  7+V>0>(\\<AEQ7MF*Q+90=>GU1-JV&1[=89IO[W41LJ\0@:
MM:KJ3,-GZ_/%R10UZP!<#P]W/I@J2VO;;%GCN945W/5:)&TC03(48Z.6FCU\
M,0B.*L9UQ80+M?-BN].U[!XU'5D,04($HJBBY"@TB@RX</'&]D%P._3!N#K>
MX[=M9[D7#2R"3B2",R%50>'AHQ33!+KG#?)1CE8-^/:N=>T;,1A>O*3S:FR!
M)9=-30#@!EC.Q"Z'_(2>X+KDV.%YVN!*_7*%%8D4%8^GX <>)].-F&M<H[T0
M,K!G^KKDC[2LPA669Y04":6": 0&S"4IQ<T'AC.Q"ZG_ "$GL &G<M6[:MSE
M[Q*%+%F TU:H&1-*T!7+RX8;(+(WTX!3%VU:);R0F61VE=9#*VDL"CEQIRH,
MR<44@RDM]D9 L+!]&1NV;)XX4=F)A5E5J*#S-KRH.72W"F&R"#?9 DC6H/;-
MJ88HNM-2(RLK:CJK*/:K^DM,CAL@GS9.2PM;H5&[2V]T=&DD8.6-6(8\P /M
M CP^;+$V(6A_D)@NP6EWVU:7$DTO4:.64L2Z!01J0(WAXA<4T@5FGOLH@!G
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M0$#F[C"$ @ZN()(']$XF>.*U\6H[92I&][56ANHP:@ $BIJVD?.<,XQ3XU3
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M44E6D"@J""0!D?&F6&U"GP*G IN>YK&&YDMA'))- P6=0M-*D5U9Y'+/%-4
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MOQ#')[@#U6DTQFH81HR  BAYBK$_)AG."HW:#D9KFY[5<;W'T!,+!TYY$"L
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M16F6!@=12.\4V E!_P %I>[;NLDDLT&Y-#&]"%RTJH&=,C2M..$HG%9I5J8
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MK 4]9&&TBAW2H-2HW<FTC25D9E-*N$8*H-,V) _2Q-J%1N53!;2[UML6<DI
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M#<?1Q\>&>)M@M_Z^?!IIH5K#W+MTMPD*!^=B!)1=&D"NLM7V?+%%4$K$MRF
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MHF^FTE@DGC6]+:HYU"TTZLP%(;@/,>.+XFX5S)I9@0#EP6,MMW.R-&+J,"A
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M=>UVVXQ&5KV42LX730G(BM<N X^&-1!UKC7G ME#)O%KN-Q"@L)Q!,K58DD
MK0FF0/T@/DKA,$W)N\X1)SAPO/BM]^63IP;C$Z'4[!B'<&A&51[-:?ZLL8 E
MBO1*=%G,"MKBW[AZMN8KB,M'&=:LP4.]:$D!#X$>@>6*1)8A.BQ<&T\W2N>Y
M7N)8&DMKR.:9PQCC&CG/ Z:K3E'#\M<0YM172!HDM*) TZUI/!OO4$L=ZL4G
M3U"*8KI]A%>JJO@P)J#Q/EBD2Q682I,QBX?5RLMFB[A:>)5G5(EBCZLA"'5)
M4ZZ+I/H\:8K26!*BQLM<\VI8C\30.DDTT3PU&J.JAJ ,S58J@SHJCY<3QA;_
M *$@P!?\./A6\\6_R7+R6UU$EM4&($!@> H>6M.-<_FQ2)/85B,J(BT@<VG"
MLI[?>Y((4EO$C6-5:^<%4.3:FX+E512M1X^>4(EBM1G2!)$?W5G-'O22/-!N
M,:I.QZ(D96&@R%UT<HST-3$.;%:B:1#&!LOYM?*MKR/N)7G>*[@CB+'I:U'*
MI7ESIQUY9XIS8K%,T6 ,23I]%G+#W#$1*]]&% ]EM"+6H)KR'+2OGXX$2Q6H
MRHFP1.G*M+R'N 3LT-[$D<C@11N%R6I-%Y:EM(\3YX$2Q6:<J+6Q+@+/W;N(
MR.RWJ2$ <H*K3V@PH$.=30$UX9@X-+%:ST6\I&G&I,'=-0HO86(!+@!0:D9
M<N0RRJ#GYC!IXIGW?TG3E71;VF\QRVVJY4Q)'&LZDZB[!0K&I7SSRIB@27.=
M2D0;+7++EVZ#?=<+K?QW%OK7WG-7/(H5PK!5XD9XS$2Q76M*E:,I!:S5]59(
M.Z734;F.-B^4;*K42IK6BCT4SX>-<\5IJ&6[@W$K*:+N*35%[[$ND1EU#*&6
M@JQ+! :$^@98A$L5J,J(MRG7I>KP-OXOE1KE);,)(9)$Z9"/IY U0#09'\^
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MXA]4K?V\&]4_^Q>UCJO"F")@B8(F")@B\7<_\T[)_P *\_HQXY2\XY5[J/\
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MPQ-N%T_UDW%HRR(#\? JW/?6V0]2,12-<15ZB4HH"NJ,VORJV66>(:X"L/\
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M8ZB!2E*G P!6H;S4B;"JIL>THK*MLE'))J,^8UR/A3PIPQ,@0[U4.M6&S;4
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MOWT@5@_IA_!%0D'=#0B%W2-=!7J(U7U%31B6#'+QSK7T8C30RH N'-JZ&7N
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MX R'Z(-U-S?)CC3\O/UE?0WL_P!<6/9#^&*X(H=C,&F7<)53F1%E70%<@IJ
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M*GU^)Q0SWKE/:"!&6QFZ7=<\4>RQVUY ;V1)9@T,CNO,@C+5(%".;S^D?3B
M18VKI*54RB<H86\^G(D%ALTUTD5M=2/-(-3.%U!^FY;ZQB*,#JI3T8",2;"D
MJM6,7D W;@NBUL-NCFFL8+US==2.32PU%3!I-*$::8HB+G7.=69 F8^%B.=9
M7%WM6X2H6OFC)5(%22+3KZA5R1J%>< *?+T8$@ZUJ%.I3'E?7?A9T+=EVBU0
MQ3W;!%G+E"&Z>M/K BBA7+VLO'YL7PC6L U)EQ'\O+@ZS>':7V<13W@DM;*3
MI=54]D],Q%2 #G1SF,1AEON6A*H*CB+2D'OX7^BI;VVRZ)[2*_8M>=(HKU)
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M.YQM*K+U"*9#F++IT>.1]67IQ&EBM&=$6Y"VG#I>IT;O;JLLFXQM Z,ELO*
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M<2EY>?K73?6VP>[+#^"*Q:#NA"\SS(0I#HA8"IH%5,@HSIF.!/#$::Z"5 V
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M;B60O;J5%0Q)"TXU]/C3T89 ]ZUMYB((A8 +43:=NN Z0[FV@, 41DH"SZU
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MZTU1 :J5 )YAR\JD$YX&H K'<Y2NN2;N7;(H()R7,4^HJVALE6HJ:CQ(H//
MU0D=RJ$D:PM9=]VZ*FMF HI+:&H-:ZL\O!2"?7BFH%B.ZS-RR'<VUD#.45)%
M#$]13B3ED,3:A;^%4X.<*4[DVIP65W**&8OTWTA5#$M4CA1:X;0*'<J@_%=]
MK=17,*S1:M# $:E*G,5X'&P77"<#$L5KBK"8(F")@B8(F")@B8(F")@B8(F"
M)@B8(F")@B8(F")@B8(F")@B5&")@B8(F")@B8(F")@B8(F")@B8(F")@B8(
MF")@B8(F")@B8(F")@B8(F")@B8(F")@B8(O'LO\V;K_ -)9?T[G'*/G/$/J
MO;5_MX?O3ZH+V,=5XDP1,$3!$P1,$7B[G_FG9/\ A7G]&/'*7G'*O=1_MZG'
M#ZJ=Y.R23M'>RLLNA28U!)"KJ(?)6X5)KX4]&$\NM3=MJ \!9I8N*WMNV[J&
MWLNI(Q0ET612&!E42\Q9::M(QD")L7><Z\29L/PL7/);; CR-)>3N&7KB/0=
M9#!GJ*KXA<J '_:QDB.*Z"=8LT8X=7#IR+LBM]E@WA$61X9XY0!$R460LE54
M, ,E,@R\*8V!$27&4ZLJ;LX(YM&Z5PFV[<D8H)IK=V>)5#H>;2 .4:?'Q/$<
M?'&&BN^>N+6!OUZ:6+::W[=CDDAN+B9GCYGF8951SJ7E4?H</$9C%(CK6(SK
M$ Q MU<G>C#MI8$M>O(VF1FZG3!TZQFS5325^KSRSXG#PW(-N3F878]_"DTG
M;(AC@<R&* FKLE:B5@[,Y9:TY5S\:CC@3"Y(QKN2&<_2RSI6L-ML+V;VT=S/
MTD?WR1Z,&(C KS%<Z5'#/% BS/PK$IUA+,0'\O/RKD-EVT>FJWDJT)J#%2M#
MS#_=C3FWR&OTL\9RQQ7;:5[?".?O_'B6J6_;$CQ1)/+*&*Q)&J54\P1<]%-/
MGX'B>&*T%DSKAR0!KOY<=+EV!-B]_,YFD>:T3604) $ T%JZ*GAEGQK3QQKP
MOQ+@35R,P:7UY=-:Y$M^UUEB=)Y-<,@H%1@"T= J,%05I3+TUQEH+L9UV((%
MHQQY5G'!V[)<37%Q>F7WB9F10C*")6X9@ZO8X^6(T7<E:,JPB(B+,,</QYT6
M#M<H\?O,ZZR0)&5M7T68 LE<M 'Y/+!H(95W=AIR\*Z;ZVVF2RM;MX;ADZ9A
MC92BR(L2N]3JH0:*>&-2 8%<J4Z@E*(,;WX+6"RM[/MDJ\J7,@$ C$C,""A*
ME O,O*3X@<#Z\01ABMSJ5[B!:_+KQ644';\=S<J+IU@GCCB1>DU4).M=#:?'
M3J]GTX@$7O6Y2K&(\(<$F_KZEU7UIL$TYO)[F5>N(I:J"  X*)4A:U.=*G+&
MI")M7&E4K 90!8X^IUJCV^QFVDN>M/H6D>2*JNPCZ@ 70%II;A2GAB-%G6A.
MKF$6'/PMCWI:+V_#=PK:R3/+*#&RD ?[WEJ^H _ZL!E!L2H:QB<P##Z8+/W3
MMLM$B7-PS]1(V"H:N_L)JY/(Y?S1@T5K:5[21&X]IUZ%:7UOV_-*(Y)INM;1
M]$1(M2PA9C34%S\2PK3@3A(1*S2G6 < -(OSJNX#MJ6Y]ZGGE)F*EU5>50J$
M ,0M37@ 2<^'CA+*[JT=N(Y0!9VZ?56DLNV(%D269W+*'9=))"L$<&@7(44?
M)EBY8!05:\F(&EO"HAV_MJ[^ICFE$E"0I!4J NIES6E,\U]&((Q*2K5X6D#3
M2]0A[<:WF03SK;M)UWF*47E"J1J*9TZHS/,#XY8>%E3MA(%@[,S]_!Q<ZEU[
M;,:6SF7HQ5>/5'4.L@#'35<ZE <LS7TX>&Y0&NYD&<\.'*IZ/;K63Q)<3/"+
ME7>4*6(<QDYEE/!:Y\1BM%DS5LSD!\OUX_Q56M-AMUCK<W!ZI#5TYK1V.MAH
MRTL"#^CB-$*BI6D]D;.P</XK8R=M&ZGN'G=Y)C)$PT$@%PRNH(3/@?DIX4Q?
M"[K %?* !<QTM5K:SV*'<K5TE?KM1XA3D<R T8A5 4YTS]6*!$$*3J590((#
M=BV[937L$J:0^JYOQI)H#6[FRJ.&+2\O/UKGOI:L#^S#^"*Y1<6(O([6ZLIA
M,\FCJ++(Z&1J D,6'RG&7#L0NV2>4RC(,V N5UEV33<JEK-T[:-Q+1SI**0"
MGM^/Z)^7!XVV*&-6QY"TC5TW=*RBFV2X=8)K*:JK*5YF=!&G-5>;Z8\*<< 8
MG4M2C5B'$AJY^;4KI<['<W21>[3225B3J=0NJAB"G,'.2L1P]>#Q)63"K&)+
M@"W5W+/XELAGDDZ$W*Y FZK F1-2UU%Q]$9-7(5K3$S16MC58!QQ-JYE/O>R
MQ707W.8.X1HG1VU4G 9M7."O'/SP>+W)LZICYAKU8<GX)<3[!;2/$]E,!%2C
M:Z*=$AC6A+@>U6G^G%)B-20C6D'S"WL?!&O=AHJR6=R$1:KJ9CI62N0&LGFI
MP'RXF:.""G6U2C^')J59+_9B5E>QN" H;6TAJ B%E"\YK3@/GX89HX*BE5N$
MH\W<I;<-LTO(+28QI*D1!F8/SJS'EU\:K2E:FOJPS#!04JEV8.SW<7 M)+G8
MEBMV6VGD]XUM#&'8'4A*DT+@"I)%<5XK(A5<VBQGT9=";U86"&..WEZ159 :
MU U1JRAB[999>0\<:S@+F=VG4M)#]_ H7NN'H*[V[A](=QD% :H7G) S92*G
MR.)M53N!=@0K1]U6LA@C2)C<3%59,J*21JJ?1B[4*'<)!R38%O\ 'XW:Y2*!
MV>V5V9C32=!TTR)-2?"F+M+US^(0Q)'B7,>\;#.D,H("D!@H/,VE<JU].,[8
M+K_KIXA;OW'#&=#6\K2!8V?0!I'437D216@QK:+F-S)M<-;T6*+3N2.::.)[
M=XS,8UC(*L-4@8Z30_1"$UX8@J.K4W,Q!(-S]"JO<32+-+!:N\,(CK4J&9GD
M"4&=,ES-3QR.&TX%3N;,";2_0-.M77N2U-N\QC>B,HTY D/4@YD>"^/CEY8N
MU#+)W*68!PHG[CC@$<DEK+TI8A*A&DL"Q8!6%<JA:^CQP-1M2L=S,G (<%E:
M?N!$@BD2VD9YBW3C8HI(214/%N/-4#YZ8&HI'=')!(L['68[ILR]!%)I\R%!
M\_/(Y'E.?#+/$VH6O@R:\::7W<R]';[Z.]MEG1&16H=+TKF*^!.-QDX7FJTC
M"3%=.-+DF")@B8(F")@B8(F")@B\KN&*22&W*SK;]*42!F94!= 2HJWAYC'.
MH%Z]TD 38[AEYL6V;A+&6@EZL$@(8]<R:JII)+5SSSIP]&,")7IE7@#:&(_9
M;3K79:VN^0-"S4G>,RAVEDJ660J<J4I31C0$@N-2I2D^JZX8+--MW07YNC#$
MM99)1TR%<%U"+F0P]D<V69S\!B92[K1K4\F5S<!]?PP6<&U;G#<&3EC9UD5.
MDZA@'<O0:P_*M?GSQ! @K4Z\"&ONO6<&S[D+&6&+01+%#"DR/I)2*OM%"-5:
MG,'AE@(%EJ6\0S@E["2W&MAMV\].))=,KQ2,T3.P-%*!00#]-:5!_)BY9+&V
MI.2+'&G(5@FU[V;E6]Y8R0Z=:+,=05F#:<RQ"G3E7,^)IC.23WKH:]++=8>!
M:Q6FZ)N,EZ9OJF:1WB$PII%0*UJ.3AY?+C0!=UB52F8"+6V:M+U7X=O1*K)<
M.*A0%2X=2Q5?2Q/@6R]/D*3+)7;4M0__ "K-M.^TJMS,&--1ZYH0"#D,Z9#P
MPR20;Q2P',K+MN^JZ$2R,J,&*F9JMR4()\M6>7GZL7+)9-:D1<.9?0 T2K\M
M!5JG(>>>.R^?K4=2.BG4*/[!KQJ*Y>>6#HQ4LRHI9B%514L<@!@@#JDUS;P4
MZTJ1ZO9UL%KZJ^O$) 5C"4K@ZL\D<:-([!4459B:  >).*H 26""6(R=,.O4
MIJT5%:>=,'3*6?4K$@"IR XG!1%964,I!4BH(S!!P0A,$4%E'$@?Z<$9%964
M,I#*PJK#,$'Q&"I#*<%$) XFF"*IEB#],NH>FK22*TK2M/6<1U<I9U*LK*&4
MAE85!&8(.*A#*<%%"NC$A6!(X@&N"I!4D@<33!1"0H+,: 9DG@!@B\:Q(/=>
MZD&H-I8D$?\ CN,<H^<\0^J]M7^WA^]/_L7LXZKQ)@B8(F")@B8(O%W/_-.R
M?\*\_HQXY2\XY5[J/]O4XX?57W69TN@/A:W:G0.L?-=3 >RV2GAZ\69MN=9H
M1!CY\O!S<*X8MS(;7!LA^K8T<*5TE$(I31[5/*N7IRQ@2X%WE0U&IISZ=*O+
M]7::X]GB>=WDC5%C;31:B,FJ5S5JYT%/&N6*;KE(VR8U"UFOGUJUU+<I=HL>
MTB6Z412^^4I&7 T$$A:U"LP'E@27N4IQB8VS:-H;7I<D-Q/)/"/A*QIU09=2
M$,H=A1P=.G(\<_ \, >!)0 !\>K'HO5)9[GJ2";9HYTDDH2%/M!RI9RR9U6A
MK_%GB$G!6,8L&J$,/IQK2ZNI8;B8IM(EAB#(2J$EM(!0K134<Q!\L4EC<LTX
M"40\V)T.M8R2S'2L>Q1B@Z@UKX%BK+DF3$5^<8C_ +*V(C74.G*JW%Y<NKHN
MS$QL.C30VHHQ^L6H49E13]'^<<"3@K"G$?\ DMO[-+^!=&N9[))5VB-=+*GN
MY%28V34].04S  ]/'%U7+FP$FVAX^%[-:FWN3)'-IV?0T5&@5E*ZCU2 :Z.6
MGM8 \"3@Q']2^_FX^1(;NX>2XT;2L.J&5V+JU7EH"$:B"NKQX^'C48 G!)4P
M 'F]HY!C>N9KN1;QYEV0OTU8)+H(!<LI)%5RKJ)K3P^3$>VY=!3&4#:7]^G*
MNA[A(H4E?:%64SB**,"ITT:34*)Z#Z/3BOP+F($EA4L9_IBEO-)</K;:$AC*
MRC4Z'6653IY= R8$\3@"^I6<1$>=S9I>K-<7B[?2':TC99"B0LI*Z3$U&TA<
MJFBGU\<'+7*"$3.V;V7\O'RJ8;J0PW+-LVDJ\2M$ "9"3[5"HJ%;.OEGB@WV
M*2@'']3'DZ=:QBN7,Z@[*JJTB ,%((+,Q=R2@]G(>OT9X@/ MR@&_P"35V-K
MTXUJWUKSQKM* 6L<@MY'2H)B/U:JI0<3GD:?EQ>18%C'.?$0_+?K46EQU+A+
M279Q%$67J/H)0.%;,50 CEX^G$!M9E:D&&85'/3UK"*_G%R\B;*%U$:7Z;*]
M0Y743HS\#YX@E;<NDJ0RMM.G@XU87<KOJ^"!G15J^@J"2JN=)*5R(H,O+A@_
M L[, ?\ )T]ZNEU+<2UEV<(HCEF9734[.IY0#IH":9^/R8KOJ4-,1%E36!I:
MC O:^\+LT6OJD-&4YG1DJ[BJ C5D!4>NF&IV062R[0W?6P7K2&Z-VLKR;326
M/I]+J*1JI(R*22F6D'5ZCB@OJ690R,!.RV[B?'7<L(;V1 9#LFBH BC526JP
M9&#42@Y5IC(EP+<J8-FTTYTDE,;=%MA0HH-&452B#_A^:>7#TY8/^RJ(O;M=
M.=:K(ZP(@VQ.N;1[G4(B$68<$H5K5CX<?1BOP:E@Q#GQV9FOU8KEMI7C,JIL
MI;WEC,RL'Z=5H![2GC5B,AZL9!X%UG$%OZGELU/UKI2YD6R@D?9ZS O"(=%"
MJ*<@.5J:@:^7IKEC3V7+F8#,0*EEA?3!+JYCM)(K==I5RVAU$:FFME8N%(2E
M1Z:>FF!+6,I"!F#+/S_BIL[JZDN[<';5AMZA-91AI55)4J=(-*@4J!A$E[DJ
M0B(GQN>/O6G:A(V1B.(NKZGC_P#EDW@,6EY>4]:QO_\ R_\ 3#^"*M+?[RFV
MQ74<"SS3:/J!&ZE*IS:@37)_R8&4F=(TJ1F8DL ]KC'L6:[SO",%EVUI!(0R
M%:K12FK2P(/,#EAGE@M'=J9NG=VJ\VZ;NO29;"N6J6.KELBX8*VFGT5*UXUP
M,Y8+,:%.WQ:6</&I?=MS-M"\6WLLTM28V+'3HD5:,0N55)_TX9RUR#=Z>8@R
ML'9VJ@WS<6!*[7)IUA.8E3S>-"O#SPSG!7XL!^<7::UJV\7I-JJ;?(S3IJDK
MJ"QD,!0DKZSBYS98LC=X6O(6=/2LIMYO3;6\AVQVDE5W*$,PB*-RZJ(3Z<A7
MRQ#,M<M1W:.8C/8.GI53O&]=,$[:0X%=1UD$@9U4+5?DKAGE@K\>D_GTYT^-
M;L2L7PXJVM$,E'*49J-0::\/$Y5PSG!/C4[\^.':MCNFY:KF,67/$LK1MSZ6
M,;D(/8^DH' UQ<YP6-A"PYKVPUWZUC-O&Y1(8H-L8,%!C8!R@U,0!0(,Z#^7
M&3,C4MQW>!+F?5VJT6_W?OT%G/9&-IPY5RQ%0BG@"OM$CA7AXXHJ%V926Z1R
M&0D[+2'>;]XII'VYT6.)G3VR79:<H4H#GJ_(<L43."S+=H @"8OTUJE[OM[:
MQB8[<YBZ8=V+$%3TP[*>7PK3Y#B2J$:EJGNL9%L]K_54'<%\R)+'M\CH54L%
M#,&9RNG2VD9:37$VAP5^) %C(*D>Y7[7*$[6([AVBBDN=+'E9@7^AJH,^)IE
MZJA(O<M&C#+Y[+2W5K6\N];E$SUVN1AKT1E"S%EKQ/)ED:XIF<%SCNT#^<7:
M:UD^[[N&*-M9,B,Q20ZM  4&H(4DY,1\AQ,\L%L;O3OSV:<*]N"02Q+(*485
M%*TS]8'YL=05X9!BRO08JRF")@B4&")PP1,$3!$P1,$3!$P1,$3!$P1<.Z75
ME"L272DB=FC1PFLJ2ASR!]0IC$R!>N]"$I.8ZEYEO8[(+FVN8;MQJE/3&821
MXU-3D #0>/HIC C%W=>J=6KE,3'5S.N6.SV&=%+WDI4?5*A726(.D$@+4U]K
MUU;QQD")UKJ:E:)LB,=-.!0+7MV4,4O)EU:5,O, P6C4X E0"*G@*>C!HXJY
MZPOB%>:UV'W<:=P>-+@'IY .Q7V@-2ZC[-?7GXX$1:]9C.MF\KLDIV26%)!=
M3".-85(5*N ITU-%JN<GSYC#PXJQVH+,->O1[N:];BUV6UE66:\=IDJ@F89T
M,3'2C!<CH>N6--$:USSU9AA&S#E[5RO!V\MC+&NX2QG6LTDL*E7JJD  !?9%
M>'GEZ,9:+7KJ)5LX.486_CI>M)K/MV*5HVO6A+<SPL,OK59LU*^UI-?/%,8X
MK,:E8A\K\/%]$EM^VBZ1->%)(0$5::9%*:W6G+J&GJD4\,AQP(CBD9UV?+?S
M:ATLJE-G]WMH&N9T4Q!0\D9( =VD!8L#2NDAAZJTRQ/"J]1R6%^. 90EEL$M
MQ&EON#B5I"SJ:EVTKJ\1DPXU\Z^.&6+V%4U:PB<T;&1+78$:/3N3.\;)U6.8
M9&>N@T%-+</EP:.*&=8OX-,5W74.T75M<WK3R&W+HQ"*05D1-*Z5*ZM7.*>F
MF-$1()7"G*I"0BP=CS.O-%GV_)&H^)2LA&C21KJ=6JC<K58UR].8QAHXKT[2
ML#Y!IIVKI:T[>N[LR-=E[B<L\<= 64U$AID<QI^:@\L::)-ZY"I6A%LM@_!5
MLX]AF<H;J1FN%]W6*92I;6W4#4(S)\21Z\\0")UJU)5@'RBRVSF46\&Q1R"5
M=PE>19!(6*G*K]0"@7('3\V> $<4G.J0V4,WT;%2]EL=Q%+/\1>130A@-0"/
M4A=.GF5AGZ0,7+$ZT%6K$@9 -.M4@CV.& J;BX47 9%EE4D*K.PU$T*Z3T/]
MGCEB#*%J9JDW1LPT_:YUM$NSV\R;@E^[M([RHY6J!!RR"@ H/#UTXXHRBUUS
MD:DAD,;K.Q90KL;/>/[Q+(\@:>0M#4A()!,".7A7@/'UX@RVK<C5&4,!JOQ#
M8Z<2U@LMBM^H%N96BD0V[)1RJA09&R R!"&OIKXXHC$+$JM636![_I]5SP6F
MS32Q^[;FZM64"O,QTU<D$U' U/GEXX@$3<5TE4JQ!S0&KL5TB[?@=9_?993&
MW7",CR.2'UBJE2<NF> &#1&M0RK2LR@/9AI>MC9[) UU').[3J!+)J0.P6%Q
M-D IJ>6I\3F<5HAUC:5992!9=SV+.RM-DZDEO!<RJTH]W6*09*8WU4"$4TMH
MSRH<\2(C<M5:E5@2!9;SCO4/9[$9*F_D$LM'C)4BBO6C4T\#Q+'C05RP:.*"
MI5;RA@JFVV)55X;R4 GI"2*.I%2!HR7TYT]9P:.*UGJF^(QM/?I<M(K+889;
M=S=N[1%)8Y&!=6'48CFH1Q1J^7'%$8C6L2J5B",HMLZ._P"BI/8;#U+B&;<9
M.NSN)"PR6IU%"-.G3G7/CB&,<5J-6LP(@&7=M>C\2[EH-4]RL-)/B-5Q3&X^
M8\0^JX5WV$']<_\ L7N8ZKP)@B8(F")@B8(O%W/_ #3LG_"O/Z,>.4O..5>Z
MC_;U..'U5]R@WKWQI+*ZCBCD5%"2-])222%TGZ/I_EQ9"3V%9HSI96D"2,/Q
M6-O9[S%)#JOD-M'(NL!\V.JA0EE)KGY^CTX@C+%;G4I$'P^(C0WK*1>Z8[?K
M27,2(%+259 5&I226Z>FBJ&/ Y99\<0YVO6XG=S)@#T]JW@CWAXYHYKQ+B="
MA,45$H#(&-<@PK&,L\4"6*YR-,$$1(%M_%VJ%LNXF5'DODZHJ- (Z8S#*31
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M"++#<K&?B(E G,>[#L6]Q;V]S>0R6^Z&.615C@"L6?4JEF)753V,S4>OPQ2
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MRS#=AFME8&Z5:??6@N)+<64DG1;2[(,B= ?EH#]%@?GQ348LRD-US 2S /\
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M3W?BM0B#@H'J'EBK+E.FE*:109 4\\$<IH7(T&7#+A@CJJ0PHBHB*J)32H
M%/+$94R)+E6*(>*@Y4X>!\,51RFA/T1QKP\?/!'*JL,2QB-44(,@H I\V(R&
M1)=5]TM>N9^DG6*A#)0:M(-0*X,%K:29GL6FA:UH*\*T\,59=-"4TZ1IX4IE
M@CK.*TM86=HHD1I&U.54 EO,X@ "U*I(WE7Z<=*:13U#SKBLLN4Z<=2= JP
M8T&8'"OSX,F8J=*UK05' ^O!'4=./]$<*<!PP9,Q4A$!J% .?AYYG!'*:5\A
MYX*.FA,^49TKEQIPP5<J&BB9&1D!1@0RD"A!XX,@D0701Q@4"@"E,AX#!D<H
MD:(JHBA50 *H%  . &"$DVJ0B 4"BGE3!'*:$RY1ED,L$=-"5KI%>-:>>".4
M*J:5 RX8(Z:$->4<W'+C@CE"B'BH/APP1R@1 VH*-7G3/!'*D*JB@  \A@HZ
MX-XFL(XHUO Q5BY4+Z(V#$YCZ).,3(UKT;O&9)RZ6KQ$NNVH1.(XITZ^@NP
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M$P1,$3!$P1,$3!$P1,$3!$P1,$3!$P1,$3!$P1,$3!$P1,$3!%X]E_FS=?\
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M5,2QF=4&>8RV=G%W:,HBVZ2=Y;>+>B2VI]*,S/H]G.KY<U0:?DP$7L=6581
M)I]G5IPK-;:T>2:5-WD*VRI+/*I8@1ZG(4MJ-<ZGYO#!ABM&<@ # >*P<=G
MM+>RL[BWMX+?<Q[PO7%06#,6D5WY>IJRT^> B"+"LSJRB290L\/59J5[I-NF
MG:4[NJ/&1H8/1D*@1M]+3F?YO$XI8ZU*9F VSOX.7#1EC[K H)&^D%:@Z6)T
M\4H 7;@3RUS])RI&_:6]H?MZ<W.M+RRMB+0-NQMI6@5%)8J\BUKG5P:&N?CZ
M<#$66K%.K+Q>#,,W(.A8O;62T$6^NL<BN%BC8M5I"[ZO:)KE^3PKB,/4N@G(
MWT[OHW NS;;6W-ZC1[LUU(K-((NH6JHY""-1&7#AC40'O7"M4EEMAEY%78 I
M[9N0REE,VX J.)'O4V0IA3\O/UE7>_\ G'%#^&*Y$N;**0I\)9+>1=#FK%V9
MN7SXLE?23C+C!=C"1#Y[=/KR+07]E:DM\'D7)2"*,*R+33F<@ 2/(8N8#4L[
M*4__ "#\%03V'3RVO5"\YM^D22Y 56!-<M6HT/JXY8CC!7+-_/:SK:2_M1#;
MB+;FDLW6.X%">II=74-I\3I0<3XXN886+ I2<O-I6C@U:<BK%>;7');O#MC"
MXNU$H4$:@5?2I.?"JUKX8"0P5E3J$$&=D;.A(=RVL3HR[9(KAE".!RZF/10<
M>//I(\,!(/<DJ-1O.-+?IRJZ75G$UW#'8:;2W61YF.HEWB90@''S/R4Q7 >R
MQ0TY'*3+Q%FY;TM+S;-!MAMDL,=RCT0#VD52["@.7CE@)"YDJ4ZGFS@D,N5)
M]G$<:G:9SU.8DFM X+#FU9^R=(\/"F,O'!=3"HY\8LT_'%=$-SM\,4DWPID=
MG%JT:G4Q5US+5H-.14?Z<4$#4N<H3) SZG6;[K8QQ+;#;'T$]2:-JG-@R'F^
MDS"GK]>)G%S+0H3)S9^+KYE1]QVZ."..YVPA99$SJ50R$!*'4> 0>.6&8:PJ
M*,R28SN'1^*WN;R%IG2;:FE>%RJ%<JJC41@QX9+BD\"Q"F0'$V<?BKS?#;J\
MMK>3;WDUPQHH8T2-&&K,5^B#2OGEBEB699CGC$R$A>>73O6<-Y:2M'!+M+=5
MU56&73H7%./ASU.66("+F6I4Y!R)V=-RN9=NDBGV^3;-<4/4?I5U!C$W24Y_
MI*!GBN+F4RS!$Q.TMTVK+XKM\4JSMM4L<R*'J!^DU !3VO:KZ#B9Q>RUL)D-
MG#*R7^U*)3%MDAD>-EG11QC5:_+[-!3Y,,PP4-*I8\Q?9QJTUU;)';QC;"]L
M EP44ZG!D#@D*,F((\\ZX$C!(TY$DY_%:.9E/OEC':K*FV,(;A1-.N7&C@<#
MQY/X'%<-<ILYF3&=HL'0L%EM%M08MJ!,YECEC)920LJ T!_3!U ^C&7#7+H8
MR,K9W-U'JN5TNMMN!,5VWDBT@,[,A:LP!/"O+757S^?%<'4LF$XMX[^SZW*(
MKBSG#A]J:.YBA65B:Z"4("@4-3DW\1P!!U)*$HW3\)+*DFZV$FN5MJ+(2[%J
MD.S,2I.D@9-3,UX8F<8+0H3%F==$]WM</0:3;VK+'-"!6KB%6HY(KG4MJ)^7
M&B0-2YQIU).T[B#RJ@O]J1Q,VVNM0&24C4S:6)!/$^VYI7C7$S#!795"&SZ?
M@$>[VKIK,=K=I+N:0&,BK%DSU-F0 2>'A@XPO04ZCMG'A 4S7%G;PLB;672:
M"LBFHY9%&I78ZJ\ #ZL"0-21A*1<SN/5@J)=[8JJ$VAQ'K,(II YB1F*@?0\
M?X\'&"IIU-<P]ZO)>V,UDDLNW-*5=(H59BTAI&)%-2 :U8@>>&8$7*"E.,F$
MVO)PO91'N\*7)N'VM_>90662,U!717(G3F:4RX\<,]KLJ=W)CE$_".U)Y[.R
MN:':P([0DK(A+,K!$93PX$L5^2N!(!NN2,93CY_-VE>ELTUM,T\D5HUJ6TDE
M^+C.GJH:Y8W @ZEY=YC(,#+,O3QT7E3!$P1,$3!$P1,$3!$P1,$3!$P1,$3!
M$P1,$3!$P1,$3!$P1,$3!$P1,$3!$P1,$3!$P1,$7CV7^;-U_P"DLOZ=SCE'
MSGB'U7MJ_P!O#]Z?5!>QCJO$F")@B8(F")@B\7<_\T[)_P *\_HQXY2\XY5[
MJ/\ ;U..'U4;XMM%.MS<68G5^G%K0OU-(9B]50>PJ%B?/@<L*C"TA-U,B,HD
MUYU-P<KMQ7KCL=]VZV0R0V3H[JIN-+!O81O9)8ZJ:0O^K&8U -2[5=UG(L9#
M@YU#7VTM="X^&R+(U'>4FA;2^KV58Z^9F-/1Y8F:+NRHI5,N7.&[NA=8NK?>
M)XD]U)6/-FE(T%0R,VDH6U$,J$>!QMQ+4N.0T03FYN7'E6$=QL:]:=;*119$
M2=1GRU!M""K/X5IG[(R.,@QPN724*M@S#Q:8?BLKV]V.;5--83AY^?6M!)72
M8M:J&_1J"?Y<24HG4MTJ=6-@D+.;%KM.17FGV);>*7W%S"ZS+J+Z6JCHCJ:M
MG5JYU\/3BDQ:Y9C&J21FML^I&I7F78HWN]-C)));F-I I8,QE#-Q+#@*ZAY9
M8'+;8I$U3E\08OT<BSNMQVN>X,[;?</<1-&Y-0!J2C#(M3B%!(&>!D";EJG1
MJ1#9HL727<-GFG,\UA))<$AR4:H&G+4!J ]@<0.;AG3 RB=2D:52(82 &G!C
MS*D5QL,DS2BP=%6*2YD9W()$60Y=?\WQR'KQ 8X+4H5@&S:P.?D6IW;:9X%5
MK&9HK92@+$45"H#9ZJD</6.&+GB=2Q\>I$^8/+3!3+=[/?W+S/92M*$8=4DA
M:(K,%.EO$ @BGH.!,2;DC3J4XL)!GTU:7A<YN=F5UACVQR9FI(KG-EID0-1U
M:JT]'CB/'!=,E5G,[M-.A:1[QM$195M)!;W:_7R.3J,>BB,=3:LQQ/AE7/#/
M'"]9.[U#^8/&[C=;1;GM9M;I$MI!;0.C,=15C+J #:RPI32*G5QQH2#&Q8E0
MJ9@21F+\RRN)=EC6&63;I.C." N=1H.@%EU:1R@TKGX>.(3'!;A&J7 F''XZ
M:E6RW+:9+A)K:WF0JC7,K!BQ/*3GFVICHX5\?/$C(/8E6C4$6D1AISH;S;6D
M9Q83-)='6TCO2FH"2B:6RY@*:?7@XP5V<P&S#P\'):K6U[M=KHOK>R>.12L,
MT884!N$$ITDFC-1$^>G'%$@+0%F=*I+P2DXO'(6^I6AOMK@@5[:RD<72,A0L
M:E$81R* 6-#3U5IZL,P%P4V521:4AX>N\:<*Q7=MG2^26WLG::-G5IB3JTYD
MZ035JD^/ XF>+V!:.[U# B4K"UBEKK9KJ&Z7W!R8&C6:.2331I7((!#')2Y.
M66>*\2]B"G5B8^*]]6 XE:&\V9K:42;>\7NT)FE0\ 6HA53JSK3C@)1:Y25.
MJ)!I YBRK9[QL5NX%K92!V+JH!4L:D:A1G.>HY^7$Y8"<1<%:F[U9>:0U:7+
M2'=-HBUV4-E*3/\ 5N@8$MGI&9?5E6A_1X>6 G&YEF5"H6D9"RW2S\5G#N^T
M0W)N([&3K1KI:53F6;0-(#'/V^)X?+B"<079:EN]246,@Q[^Q9Q-LMA<SVLE
MI)*Z.5$A8&JMS4XKG5CE2M*GA7 9069:D*M2(D) 6::<B]:RVS8[S;XVBMM,
M$FF01$L"I%6"L <BNKV?#'2,8D+R5:]6$RYM"[)MKL)PHEA#A5$8!K[(!%./
MI.-&(*X1KSC<5DNQ;4@HL  ( -&;,*"HKGY&F)LPMG>JAUJ(=BL8;_WV'7%)
MI",BM1"%X5''\N I@%U9;U.4,IM7%VXLS=NSK"=,S7&X"-N%&-W-0_/C-/R\
M_6NV^$"L'NRP_ABMH1W&@E$AC<]-NFV0JXTA33TBN7"N*,RQ(T"S/>H:/N4V
M\3B2(7*NQ:,BB%: *K4^<D8C294&@Y#'+TK2S^/B6(W>B2)@1*JA5(Y5H>+5
MYM51BC-K6:FQ8Y7?3N7J    "@&0 QT7D2@K6F?"OC3!$*J>(!H:BOF,$=,$
M32I() J.!\<\$=,$3!$P15DBCD $B!P"" P!%1P.>#*B1%RM@HF")@B8(F")
M@B8(F")@B8(F")@B4%=5,^%?&F")@B8(F")@B8(F")@B8(F")@B8(F")@B8(
MF")@B8(F")@B8(F")@B8(F")@B8(F")@B8(F")@B8(F")@B8(F")@B8(F"+Q
M[+_-FZ_])9?T[G'*/G/$/JO;5_MX?O3ZH+V,=5XDP1,$3!$P1,$7SO<+[@O<
M6R&PBBEGT7?)/(T2:=,=3J5)#7Y,<:CY@W"OI;H(&C4SD@/&X/CPA=7O'>'[
MCM_VN;_#8KSP'/W+EDW;U3]H_6HZ_>'[CM_VN;_#8// <_<F3=O5/VC]:=?O
M#]QV_P"US?X;!YX#G[DR;MZI^T?K4^\=X?N.W_:YO\-@\\!S]R9-V]4_:/UJ
MK2]VLNEK#;F4^!NIB//]VP>> Y^Y41W<?FG[1^M6]X[P_<=O^US?X;!YX#G[
ME,F[>J?M'ZU59>[472MAMRKY"ZF S_\ Y;!YX#G[E3'=S^:?M'ZU;WCO#]QV
M_P"US?X;!YX#G[E,F[>J?M'ZT]X[P_<=O^US?X;!YX#G[DR;MZI^T?K3WCO#
M]QV_[7-_AL'G@.?N3)NWJG[1^M5:7NYE*M8;<RMD5-U,00?_ .6P>> Y^Y41
MW<?FG[1^M3U^\/W';_M<W^&P>> Y^Y3)NWJG[1^M3[QWA^X[?]KF_P -@\\!
MS]R9-V]4_:/UI[QWA^X[?]KF_P -@\\!S]R9-V]4_:/UI[QWA^X[?]KF_P -
M@\\!S]R9-V]4_:/UI[QWA^X[?]KF_P -@\\!S]R9-V]4_:/UJ#-W>P(-AMY!
MR(-W-3_\VP>> Y^Y,N[>J?M'ZU6)NZXHQ'%MVW1QK[*+=3 #U 6V SC4.?N5
MD-W)<SJ>T?K5NOWA^X[?]KF_PV#SP'/W*9-V]4_:/UJ!+W<"2+#;P6-6(NIL
MS2E3_=O1@\\!S]R9=V]4_:/UHLO=J*%7;]N51P NI@/_ ,VP>> Y^Y4QW<_F
MG[1^M6]X[P_<=O\ M<W^&P>> Y^Y3)NWJG[1^M9J>ZED>5=MVU9)*:W%U*&:
MG"I]VSP\> Y^Y:/QR&SU&_='ZU?K]X?N.W_:YO\ #8// <_<LY-V]4_:/UJ
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M1![O')&\B+6-2Q"FI:O-X>S4^O$)F%N%.A(7D6'2Y'?NQXH:QQQN6^M5--0
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MD>N2:%6K&[=-2&I(%JH%#6A;*GY<4&2S*- V ZQS*!/W7TU?W>%GYCTS1<E
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M\ELKBTZ@22)8WJ)0 P(E5Q]$8Q.#D%V9>K=]Y%.,HF(D)->^KB(6'P;>OO\
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$8(O_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g140648dsp003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g140648dsp003.jpg
M_]C_X0 817AI9@  24DJ  @              /_L !%$=6-K>0 !  0    \
M  #_X0,I:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+P \/WAP86-K970@
M8F5G:6X](N^[OR(@:60](E<U33!-<$-E:&E(>G)E4WI.5&-Z:V,Y9"(_/B \
M>#IX;7!M971A('AM;&YS.G@](F%D;V)E.FYS.FUE=&$O(B!X.GAM<'1K/2)!
M9&]B92!835 @0V]R92 U+C,M8S Q,2 V-BXQ-#4V-C$L(#(P,3(O,#(O,#8M
M,30Z-38Z,C<@(" @(" @("(^(#QR9&8Z4D1&('AM;&YS.G)D9CTB:'1T<#HO
M+W=W=RYW,RYO<F<O,3DY.2\P,B\R,BUR9&8M<WEN=&%X+6YS(R(^(#QR9&8Z
M1&5S8W)I<'1I;VX@<F1F.F%B;W5T/2(B('AM;&YS.GAM<#TB:'1T<#HO+VYS
M+F%D;V)E+F-O;2]X87 O,2XP+R(@>&UL;G,Z>&UP34T](FAT=' Z+R]N<RYA
M9&]B92YC;VTO>&%P+S$N,"]M;2\B('AM;&YS.G-T4F5F/2)H='1P.B\O;G,N
M861O8F4N8V]M+WAA<"\Q+C O<U1Y<&4O4F5S;W5R8V52968C(B!X;7 Z0W)E
M871O<E1O;VP](D%D;V)E(%!H;W1O<VAO<"!#4S8@5VEN9&]W<R(@>&UP34TZ
M26YS=&%N8V5)1#TB>&UP+FEI9#I&-$(S,D5%1D$V03(Q,45".#(R1$)!-C$Q
M,C4S,# Q0R(@>&UP34TZ1&]C=6UE;G1)1#TB>&UP+F1I9#I&-$(S,D5&,$$V
M03(Q,45".#(R1$)!-C$Q,C4S,# Q0R(^(#QX;7!-33I$97)I=F5D1G)O;2!S
M=%)E9CII;G-T86YC94E$/2)X;7 N:6ED.D8T0C,R145$039!,C$Q14(X,C)$
M0D$V,3$R-3,P,#%#(B!S=%)E9CID;V-U;65N=$E$/2)X;7 N9&ED.D8T0C,R
M145%039!,C$Q14(X,C)$0D$V,3$R-3,P,#%#(B\^(#PO<F1F.D1E<V-R:7!T
M:6]N/B \+W)D9CI21$8^(#PO>#IX;7!M971A/B \/WAP86-K970@96YD/2)R
M(C\^_^X #D%D;V)E &3      ?_; (0 !@0$! 4$!@4%!@D&!08)"P@&!@@+
M# H*"PH*#! ,# P,# P0# X/$ \.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'
M!P<-# T8$! 8&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?_\  $0@#2 (J P$1  (1 0,1 ?_$ (T  0 "
M P$! 0             $!0(#!@$'" $!                     !   @(!
M P," P0## H! P + 0(#! 4 $1(A$P8Q!T$B%%$R(Q5A<9&Q0E)S-'24M#55
M%C:!T6+2,U,DQ'47<J&"0R62P52$\.'Q8T1E$0$
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M!>1MEBD4<5'3;IZ=-!-QW@?BF-RD>5I4!#DT>S(;@DE,LC76#S]YBQ,H9@"
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M8?9H&P^S0-A]F@;#[- V'V:!L/LT#8?9H&@:!H&@:!H&@PCFAD+K&ZNT3<)
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MT&1LUUF,)E03!0YC+#EQ8\0VWKL6Z:#Q;=5K3U%F0VHT622 ,#(J.2%9EWW
M8J=C^@Z#;H&@:#"6:&%0TKK&I95#,0HY,0JCK\23L-!GH&@:!H/&95&[$ ;@
M;GIU/0:#W08330PQ-+,ZQQ(-WD<A5 ^TD]-!GH-5JW5J5WLVYDKUXQO)-*P1
M%'VLS$ :#*"Q!8A2>O(LT,@#1RQL&5E/H58;@C09Z!H-,ERG%*(99XXY6XE8
MV=0Q#-P78$[]6/$?IT&[0:$R%!Q(4LQ,(EYRE74\5!9>3;'H-T8;_H/V:#;'
M)')&LL;AXW 9'4@J5(W!!'J#H$4T4T22PNLD3@,DB$,K ^A!'0C0>=^#O]CN
M+WRO<$6XY\ =N7'UVWZ;Z 9X1,L!D43.I=8B1R*J0&8+Z[ L-S^G09<E#!21
MR.Y ^) ]?W=![H-:V:[3&%94:8+S,88%N.Y7EMZ[<@1H-F@:#%)H7=T1U9XB
M%E4$$J2 P# >G0@Z#+0- T#0- T#0?-L9Y)%B<YYEB52=,YD,HTV(C:I9:"5
MGQU5(29UC, 4RQE26<;;==!K]I;OE%F[-^:6K4\?T,#78K45L=O(%CW0'M+&
M$?;<-%". ^4C;?J$#R''Y2GYSG\K&^0AQUJ;#PY.U5$C.E 13F7Z<HID4"81
MB0Q_,JLQZ>N@AI9\XG@RLD=S+"IC\/E+?C[LLB2SND\BTGG5D#R2=O[J.-V7
MBS MUT$V.GY92S,SQY'+V(:>0P2UTFDDDC>.ZR)D2X*[.FS$D'Y8S]WCH*NS
MF?*<QB<1C+,=^:Q6J5_SQ)JTJ+]?#FL>.K%%#,L0D;Y#MQ^;TT$:SG?,Y[=[
MZ9,F4GJWC8@M"Q8*3Q78.PK1/7BJPN(FD"I 6!7J2>C:"SRLWF<-*G<FNWUI
MW<IEDRLC-;7LQ5[,T>.1%IHTT431C[R+\Y"\B=^H=Q!8\N'M<9XFDL>4C%N\
M#20B&5[7:)C+0M]V0G;=6_?>H'IH/G$LN8@L9BYX[8RTV.L-A(LCD+\=Q9UK
MH+GU 1^V+.RR&/N&,;IR;;B!T#Z;[?/EK/B<?YG8FFE>2PL%B6.6&;Z?NL(3
M^.!*VR;<7=0S#9B-SH.&_,_/IJ9_,Y,A6H8BS5PV9L5HW$T\<3R-:R$(C7N<
M95^G'.,?*#)MMMN J;9\U2X^6QSY.:W^5YBKXY-.DIDDKI<@>(RHR;F;L=QH
MNX.3A5.Q/J'?^U]G+3P90VK4]J@L\8Q[3I:W'X0,H26Z%GE7G_"&RMNH/38!
MR,7D/D,F8RDV/MY>]DZ>7RL%BA%&S5EQL$$O;$ =/IS(LPC$9W+%SQ.Z[C00
ML)?\ROWX\<EK*18JU;Q(EL"2Y*_;EBNBYQM68*TB[M%%W.VH5&^[MOH/I'N!
M+E*N JBE)92L+E6/+6:@=[24.>T[IP#2;^G)D'(+N1UZZ#@;V4SX@M?37/(=
MHZ9/A;20RA[=P69Q_P!4$0\UV6%4^IVWB/,_-NP"THUO++N4QGUM_)Q1Y#.9
M:+(I%))'&E.I]4:B)L!VXRR)LXV+]-R1H.?QV1]PYJ.0-S)7J>1^CF;+JE2]
M8$%@6H@G!>*)&.'-1])RWCWD]5#$/?\ $>5D:C2R%S-T(#2RTE5:3VK3V+$,
M]=:LB2M!'::+\9EB$R_,>C%QMN%E7R7G7UT1ORY%/+/K*ROCHDD_+?RTUHS8
MD^537Z,9#SY<Q* HZ; AH2;S:G1QAFNY>6KD<5B;GD4Y$KSPN\X6ZU<*O*%N
MVVSI$-U4%@.0WT%/:N9VCA;L.)_.AWK.;MXZRWUD#32]U/IBRPUY9YI=MS&D
MI1'7JW(^@=32L^:2W*^8:S?:PV;KU!38.M7Z*;&1O)RA"A>/U#D]P]5/0$>F
M@I#E_+!B<?\ 3V\X]B05#YF]R.RD%:8K*94A>)!8CWGX*XK#@L>S;C?D0^G>
M!39F7P^K)D)9+-T]_M2V(Y(9&B$KB#FLH$G_  ^/S. S#YB-SH/EN+R/N!-B
M+C6\G?JW?HHWS"BKD)A#<^KBYJ#Q0P@IW$;Z3?:/\0?=!8+[PK\QL^8^/Y/(
M)D80<;E:<)GEGL0RLER%T/=EBAD*/%R:,S*KD*/O;;D)WG>0SU/S?'/4EO6*
MI6H$Q=;ZJ ,QLD2R1RQQS5I_D([L5CCQ0<E9=]]!RN8E\KO>/Y*JSY2WE)\;
ME5\GHSQ3&M%*.E1:H91'N6^6,0D\X]V;<]=!(=O*:-O()6BN5L?)<NR7IZT#
M]]*LOD![\D+*C/R^F)8<=SQW91OL=!KS*W[YC,<V:DP52;&V8KMF)UM-%%G#
MS?FJ&=XXX?F3G\_$!V'Q(6W@T_ES^=,^2>6.W-+>&:K=BR8NS$[+2^=U6LBJ
MG#M-$S%P6WWZD!(]R,QD(O+)<?!D,G688*2UBJV,21Q)DN^4A[G:1]]SLH63
MY&Z\O305\]_SM[4R1S9(>7-:MQV*")+^6IC_ *67L20DK]/]\1E'#<S(2IZ;
M@!Z?(/*,[=QM:I/E*]"5,'!D)E@FJN))#<^O =XT93\D2R,OW>FQ!T'<>X%.
M>3QRG!722P\>4Q#;;,[%8\C79F;;<[!5)8_Z=!RGME?\TL^0*,U9LF8U;#9J
MI+%:[4=H3*(PK3*D$6PY!%@W5T^8^@8A8>77LG%Y@R6;&7KU%KTFP,6)C9TG
MM-9D%M9OE,3;((P5F(4(68=>H#D[.4\Z_+'-*WE_SYZE@>2(\4IBJVC9B6'Z
M,/'VAL&<1B+<-'\S;]#H+*Y'Y7B;%ZU7R.5EBIYBS3KI8EDEB&/.':SS;D/G
M"VC\LK$E2.(.W304<4N6R^'Q-M;V:N8B)O'[^5LV4L+(EXVU-@Q QJW 1-SD
M6,=M=E(VZZ#I?;2_YK8\C49JQ8[QKV3FJ<L5KLQV!,HAXM,J5XMAR"" D.GS
M'T#:#5[O?F5A\S1L/DUK28V#\AK8^.:2&Q9,TGU2SB)75B%$723H$)9>NY 6
M-'R+R,^44\/,;O=7R&_]7O7D$(QAJV)*F\W#M]LMV^.S;[C;X'03?<>O6&:\
M;R.8H29+QBC):.0@2N]Q(K,D:BK9EK1K(SI'M(O+@>+,#^D!SCVJ41A-"CF/
M&O#+!R,T!Q\-F&6>^3#V917C1IH(I-Y6CB9%5V&[+\PW#W&S>X4@@R>4L9"+
M*09/#59:48(K=BQ2K?7;PJ.VX[LLA9COP8?*1UT%14S'G:86Q!%/D+2)/0.5
MS$GUZ?@L\HL;5Y(19JS;A.\M9G54.Z\-!(B/E5R7#+;^INUA8HS13O7F5NW%
MGX^V6>9>\P2 ;\I-BR;.1\=!]"]P+%R&'$[2VZ^'>Z!F[&/$AL)7[$ICZPAI
M51K C#LG7;[!OH.!HX+(#V\J4<31GESOD\\N,M2Y 2UC^6P7KEIVM,(W,/<@
ME=-^WN6D'3098Z;R3%UJ7C.=6[B\3AK-N"6;#?4S@PRQK-B8TG2)97BC1Y(3
M\@'.-5;H=B$/QZCYA^1XN);>6HI33QJG#7B#PA8;*)'D"\?'8MQ<\RW_  R-
MQQ.@FM+YLMOZ&*?(+''9>BEXHSV/I?\ $,4()G=&9O\ HF;YB?N_-^G0+\OF
M-=\C2CN9"&M2_-(:N1>">W,(%NX]HE:5 ;#*8Y)DYHQ<)NPW*:"JR-CREX*>
M7K'+5<BF-RU''S*]BVKN;U1T='F@CD96A[AC[Z<B$]6VW(7N:O>1X_S:K0Q\
MF5>&ID<97Y3RVID>E,R"S)P2!H)(SW6#S3S%U8;#CL-PHL"ODN+IQT8VR<.-
MKMV\U86*4VXHFR]HS]J0)W?N&(GM[[(Q=?MT%W%_B_(QO7%[+Q8F*IF[&*L
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M$UA/+5AEG4%RW7CZ[*3\VQ"SQV8\G:[2&?OY9+Y@QAQ->G49([BR[_5M9B=
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M:.OSB58SV9+ 9$W5556Z?>(7V!O9RI[DOBY;E_)U.[-"O-IXQ7@2N&C-B&6
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MS3R/^Y!_2H_]6@?FGD?]R#^E1_ZM _-/(_[D']*C_P!6@?FGD?\ <@_I4?\
MJT$>WY%G*LE6.7"'E<F^GAVLQ'Y^V\G7IT'&,Z"1^:>1_P!R#^E1_P"K0/S3
MR/\ N0?TJ/\ U:!^:>1_W(/Z5'_JT#\T\C_N0?TJ/_5H'YIY'_<@_I4?^K0/
MS3R/^Y!_2H_]6@?FGD?]R#^E1_ZM _-/(_[D']*C_P!6@?FGD?\ <@_I4?\
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M T#04OAG^5L;_$C]TZ"ZT#0- T#0- T#0- T#0- T#0- T#0- T#0- T#0-
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M7-.&45H@Z5F4J85/'<(58KQ]-CMH-:> >#(24\?QZDUA2)%6($UE  A^[]P
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M*^1I\@_T]J))DYKZ,%<$;C?UT&H>,>-K"\"XNH()*JT'A$$80U$+%:Y7;;M
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MW&8!!UY$]-!IH9"G?J06ZDHE@LQ)/ PW!:*0;JW$[,-Q]HT$>EG\3=GLP5K
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M^*YLB3?@WS#U)^8!T/AOMUD?'O*)\F;4,E26J('Z-)8E<+"H9I)0TB\>R?\
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MF!X"P).X)W'70*WL[;&2N37;4-RO9N1693+R<V8ER"762Q'P"DJJ=M>3/_\
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MC$BEMSW'C(4IR7X[\2#H(5WWBPB8JU;JTKO>BKR3P+9KO%&SBHUV%&8<B#-
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MQURRAY*JQRLLJ1U59Y/I(@R_)'SEW^+= -]@!H.DT#0- T#0- T#0- T#0-
MT#0- T#0- T#0- T%1A/[2S_ //T_J5;06^@:!H&@I?#/\K8W^)'[IT%UH&@
M$@;;G;?H- T D ;D[ >I.@:!H&@<EY<=QRVWV^.V@: 2!L"?7TT#0- T#0 R
MGT(.QV.WVC0- T#0- ) &Y.P^TZ#SFF^W(;@[$;_ !/70>A@20#N1T/Z/CH&
M@:!H!(! )ZGTT#0- T#04OD/\NP'_D?^TL:"ZT#0- !!WV/IZZ!H!(&VYVWZ
M#])T'@922 02/4#0>Z 64;;D#<[#?XG0- T'@96)"D$J=F /H?7KH/001N#N
M/M&@:!H&@:!N-]M^OKMH&@;@$#?J?0:!N-P-^I]!H,6DC5E5F 9ONJ2 3M]F
M@RY+RX[CEMOM\=M T#0 01N.H/H=!X74$ D GT!/KH/00?0[_#I]HT'AD0+R
M+ *>NY/3[=![R&_'?YAU(^.QT#0-QOMOU]=M!483^TL__/T_J5;06^@:!H&@
MI?#/\K8W^)'[IT%UH&@X7R_#>77/,?';U:""QA<==AD""Q)')&6BG2Q-)$(F
M1]D=5C^?IUZ?-N [:M/WX(YNV\7,!NW(.+KO\&'P.@I//J%S(>%YJE2B,]NQ
M4EC@A7;=G9=@!OMH.4N4?<GZVS:@R%[AW;LT-0+6[/X.11:<76/EPDJ,Y;YM
MS]H(T%9XSG?<&7Z'+!<GDL09@<C&\=7D_(V(U^C5.!:$;Q%^1W]#_#T%=:A]
MUZE"W+5CRIR]^.K9DE3Z>2-;"8R)!$$VVZV4</\ ,JC8;[@C06$-'SZFTA5,
MD*[V[DN2GB6![8AL6TE44V<'IP8?+\!RV'(#06F"B]S3DJ-S)3VQ$D]2&:DZ
MUNTU9X).]),$7?NANWSX-Q#[\1MH-/EU/SVSY)8DH)>:6FUJ7$&,5Q05&Q<L
M<+!F_$^H-IV4\NG4?O=CH+J2[YED/&O(;%6"W0NS6U&$CE2);$=8Q5PS!#S7
M[_=/S[Z#E,S=]SL5+FY)KEQ:,#K#4D2*!R\+VZ\59H9'V0SO$S\PRG=B=]OE
MT$VG)[GB]7#?F30]Z/\ *NZM3@U7ZE_J#E=@&605MNWPV^'[_EH+CP;%>34L
MQ+<S,]^Y8N87'M(UEHNR+B-,UF("-45'5I%V'V?$Z"+[:KYI&N?.7K6*XG6*
MU42PD2M]7(LHLA6C"<]F6/YN(4^J]#H*EXO=.I3KQ36<M:BDJ5YYYJR4FMKD
M9*QWBV9$05UF7YQMT)'7COH)SWO=,3&)JMDV:#6;D[1B'Z6T$$$L%2)R2WX@
M$L8].)]3Z:"++)[P196"3\>6,U5L+6C2'ML\D4LL\#R-\L<D<K)'&S;] O1O
MFT&BAD?=BMBKC2ULC;9TOPX_>. 3":6K7>I(X<J>"3B<<F_TKMQT%[[DT_*[
MT=>G3CN2T9ZP5HZ2PD-:[L9(M]WYA%V@VW#;KO\ 'CH.67%>XDK2V,I%>#)E
M(+=SZ"" 3JZI/$\E5W)$B=GM+]T]-MOFW&@W6<?[K<8<D([(S,<=J.,1BN$)
MEJ4=GG1=D:3:*8 [[=P #Y=M!8U[ONA7IP1O%=MM:1$K3"*)&BX9 %S9#MR!
M-1NA(W8#T#>H7-RMYK![;0=NW<D\CD%>:[($BDG4NRF>-47MA5 W7Y 6 Z@,
M=!329+W5-'Z84KL=^2-)TF_Z:6-%&)D4QM( @,AOJK;<!ZC][H+CS+%>71X/
M"G!-+>S>/-B06K';+]QZ,\89^B1\N<FRC;;?;X:#FK.1]Q(JN*I/9RC7;29.
M6HD$-9+#&$UA4^J$_+\-9)&Y-\IXD;].N@SNR>[9@L\7R$=D%CDNW%7>N&%D
M=A<=QVF[30<N;?,PZ=.7(:#3<K^Z<*VK%1<A6L7YZUB]MV;+1G\LB1%AXA%*
MBU&XEV4#[OHI)T'=^12^=1XW$_E*))9/$9AU5.X/D',Q)(QC]>1'S'YN(^Z6
M.@G^0_R[ ?\ D?\ M+&@NM T&NS]2*TOTH0V>#=@2DA"^WR\RH)X[^NV@XKV
MZQGDN'ES46>K V,AD4G%N"9["RR-1A[TI+QP]N/N1%5&W3[OH 2'<Z#Y][BX
M7S#,96K+A(HEC\?B&1J-.7'?OE_D2+B0-UAB>-N?3:;04<.,\QJ7LCD(:F0I
MT;]D/;-)83>%=[60F B67FNX>:'G\>).V@V1VO=>.I::]#DY,L:Z!4J_1+36
M%HX1W >,CFTKF0NJ;[]>/R\3H(.,H^Z1N)>ECN2Y)HNU7-Q8?IPM>7(=EI%^
M;A(5EK_-ON03O\=!.6#W.M5Y5K6LO6JQ0VIJLEI*:W'M1UHS''(%1D[1L\N'
M0;]1OPXZ#H?.)?-.QCGQ2W%9JTS.N/6NS_F.T?TJV!8W K[]SGM^C<Z"MC\3
MS=3VUR]11:_.;F2L7YV@:,67_P#TAW-XVV7ER@0<>77;I^C05,6,]S,3A>QC
M)+A@GY36(F2%I*ZMD)"ZU@JAN;0."02QVZCYM!TN4E\Y3V_QH'U,N=D>),A/
M62..=(B6)<Q?B;G8*&"$'<[[@;Z#GJ5GW;;&EK:9,9HTXMDC2B*@B$$?>8\M
MS]9WNYQ7?COQ_>:"7+D/<6*"2O2JY:9+ J''6;:5>[&D=J;ZGZGAQ"L\)BX@
MKR(_VN6@T3TO=BKCWGKW\A<N(8@L$BU &1\=WK!&T:?,+B\$Z[#?;TT"\?/;
M%S(9B&A?A:8-6J,!$MB&HUR-@> YD_A\CQ'S['U!&@IXJWN]#7>T3D8[MU:C
M9&0)#(RF*O+$G:C4E0>\JF4 _$'[I)T'4X>GYG/YUC[.:2VXJ?4]R3A N/6.
M2NBQ&'B6E[C-RY@L=CO\..@K?(:ON/)GKURA'=:[42^M-V6N::02R0"#Z7T=
MIC71]P_[_P!?WN@@IX_[C27XL\JS6LS%56O0DN10JJ)W+C+S5^3*_P#P>3;J
M2".0]=!-L4/,;J59"F:-2O-4F,MI:B7V[5^L\R_@*/PP@E;B?4#XCCH+?RZG
MY3#Y7;O8XY(T+-2A%8:CVG*Q13V#8%=9 0)OQ(C]I0MQ^8#8/,OCO+K_ (GX
MV]U;;9.O;+Y"* Q+*T3U[$47U"I\A_XD?="= =R.@T'.R4/=O%8JACL?8NM4
MBK5=YNU!+/'8^D5>T%41@PI,GS _'U;CH/HF?PM>Q4JYNU0.0SN%@DFH11$H
M6L%58HH#;?.\:^IZ:#AL5@O<'QNK)C)>]-4M6(,C=O88*T_.5'6XJ"UR^>2R
M(I6V'W6?;05E;">X28['59JE]K6.IR"K R5&I(IQ3Q1\O5FL&R[*ZG=?_MXZ
M"QI8_P ZQRV8>.5^@%MQ<L5UK27VB:YD)1],\@/*/\2L3]BD[;==!OK#W<AI
M29"T]RQD&$\+8V/Z18@@QR/%+&># 2_5@]=RN^X VVT%A[;U/,&SMJ]Y#%8*
MK6>M5LVE5'>(6.Y&& ).^SG[W7[>N@Z_"?VEG_Y^G]2K:"WT#0- T%+X9_E;
M&_Q(_=.@NM T#0-!6^29N+!8&]EY8FG2E$TQA0JK-Q^ +;*-_M.@Y^K[G8?:
MY#E$&.OU)!$*YECG25FA,XX2P<UZ("7Y <1U/3KH)<?N-X.DHJG*UXIPPC:$
M<ME<N(R-PO'978*Q]%W&^VXT%ICO)<#DK%JO1NQSS4R?J%&XX@,5+ D ,H92
MO)=QN"/705%/W'\>O3VS3D[V-H*CW<GN%AC22.217/+9BI[0 ('7D-MQH$'N
M9X>:U62YD(J=BT@?Z60DR1DNT?!]A\K]Q2FQ_??*.I&@W)[A>)L\>^1A[5CM
M_2.K%S()%Y;E%') O[XMT'QVT&UO.O&"S]O(0LD$[06I6?MI&425V8,X"N%^
MG<$J=NAZ]#H-$GN-X)]/!++EH!%8=UC#AP0T13GS4KNG#NH27 V# ^AT%])D
M:$=Q*4EB-+DHWCKLZB1@0QW52=S]QOV'02- T#0- T#0- T#0- T#0-!X54L
M&('(;@'X@'U_<T'N@:!H*7R'^78#_P C_P!I8T%UH&@:!H&@JLCY7X[C<G7Q
M=Z]'7OV@A@@??<B1^VA) V4-(.()/WNGJ=!#7SWQ:29HXLA"1"S+:9V,0C1(
MI9NY\X7FG&N_S+TZ'KTT'E#SC#Y'%Y')TVYU,=8%5I9#VE=BD3[_ #@%?^.!
MLPWW&@EXKR[QO+6+5?'Y"*Q-2!-E1N.(5VC9MV !"O&RDCH"-M!"'N-X0:@M
MC+1&L9#%W0'(!"JW)OE^6/BZMW#\NQ!WV.@\M^XGB<!M)'?BFFHN4M0J2'4I
M(8I FX_$9''$JN_78?$:#3)[F>*#%K>2P6EDH')PTV5DE>,5S9X;L @D[0Y<
M.6^W7TT%M@,W8RJ6FFQMG'?3S&)!9 '=4#?N)L3\IT%KH&@:!H&@:!H&@:!H
M&@:!H&@:!H&@:!H*C"?VEG_Y^G]2K:"WT#0- T%+X9_E;&_Q(_=.@NM T#0-
M!7^086KG,+<Q%MF6M=C,4Q7;?B?7[P8?M&@K\CX/@[<<,4,0H001VXUAJ)'$
MA^MA,,C%0NW(+Z:""/;7$"D:@LV.!AN0<MTWXWK$5F0_=]5: !?T:#+QSVUP
M.!ER!K[RQ7XWK]MHX49()'9VC[L:)*_5_5V)VV^/70:HO;/&G#93%7LA;OP9
M."O5:2;LAXHJ>_8"=N-%)7?<\P>1]= Q7MCAL<I,<\AD>2I-*R1UX%9Z=LW$
M/;ACC0<G/%NGW1]O701+?L_A+"["]:B/>[_-1 74\G;\-VC+Q-\_1T(8:!+[
M/X&>2^;%RT\5^9IY(4[42!F2=-]HXU#/_P!2WXC;L=EW)Z[A+/MI1F_,);V1
MM7+V4JV:EZXXA1F6TL$>X2.-(U*)40+LOVD[Z"WRGB6+RF;H9>X9'GQNQJQ!
M@L8(;GN0!R/S*A]?WH_3N%G0BMQ4H([DPLVD0":<*$#M\6"CH-!OT#0- T#0
M- T#0- T#0- T#0- T%+Y#_+L!_Y'_M+&@NM T#0- T')YOPB;,>4'(3W9(<
M4U2M7GIP\-YVK67L!9"R,RINR]48'U&@J:WLM@8YIY)\A<LFPABD+]A'([5B
M(,SI$KO)M;8EW))(&_V:"S'MKBY8+9R%NQ?R-R7O29*7MI*"5B0JJ1)'$%V@
M7]YH)E#P3$TRP[DLT;U+%&2-RH#16IVL2=5"G?DY _1H*+*>T%3*8Z*A?SN1
ML0PQM7C$@JNJPE$C0)&8>VKH(QM*%Y]6Z]>@;*?M>DK=W+Y&><PW;=JC6C[8
MBA2U=-I@I[:NQ<*@;D3QZ\=!IE]F<5/+%)9RMR8Q5C44LM;EQ-%J!V?M<U7M
M/RX*0O/YMNN@[HPVA<@=)@M2.)TE@*@EW)3MOR]1Q"MT^._Z-!(T#0- T#0-
M T#0- T#0- T#0- T#0- T%1A/[2S_\ /T_J5;06^@:!H&@I?#/\K8W^)'[I
MT%UH&@:!H&@:!H&@:!H&@:!H&@:!H&@:!H&@:!H&@:!H&@:!H&@:!H*7R'^7
M8#_R/_:6-!=:!H&@:!H&@:!H&@:!H&@:!H&@:!H&@:!H&@:!H&@:!H&@:!H&
M@:!H*C"?VEG_ .?I_4JV@M] T#0-!2^&?Y6QO\2/W3H+K0-!\^\OQ]QO/,7D
M*\$]JQ M2.K6>FTM3BUIC:E^J5N,$D<1#?.!OQ4#GN0 [VO/'/"DT88)(.2A
MT:-MC]J.%8?Z1H*+W#JWK?A&;K44>2Y-4DC@CC#,Q9AL  FS'_1H/G5F#S?Q
M5,S6Q=:6O:GL0FJV*J3/C^PM>5DD1'3(,LLLH[<JA/WJ=5#<]!C=\]]P%J9"
MW'-8CEK21PVJWY>#!55ZU5RZ2,H[D_U$[)V2Y.Q^Z-N6@M:WD/N/]?%&1=DK
MBQ$F*,F.X?7UVMLD[WF[:_2-%7 9/^'R^]L=^&@M?!?\8#(W;.=MW+%BYB<?
M9B@GKK%7BL-WC/'&$2,!T8J&1GY?;\-@Y6+S+W(%:K5MRWH<A+]:\<D6-[K6
M)(((&AC6%X(9(XN](R.Q38;[=T_? ;JN8]T$R>3LVZTE+OS1QY)JU6:S+5KQ
MV!&DE0-7[4_X#$D*\QZ\N(V*Z#W*>2^Y-2,R4*=WO22I,)6QY4V0E:H.,T<<
M5K@SDR;CG'ML1S!7CH+UIO)\?X3B(H?K*K26+"9&>&JURW%$3.T.T#+(Q#R=
MM2W$[*?A]X!S6,S7NY6HFF(I*RU,?"D,<E.>9@J5H>,P9:\@,QD+AU[LA'7\
M(E?F#KI,UY>W@V)N.ENI>FL+%EK*518MPU@\@,\=81#D6XI_^#<*W(QC;8!0
M6O(O=)@ZUDN+=<J@KR8U5ACJF&,I<[@YJ9VF8AX>ZW$;CB./+03FM>Y\=F*L
M+EB6*S;EK-9-*'E#!!DHH4GZ)Q+359'<EAQZ<E4 '<(+Y+W26M TPELV3#]0
MDKT ?IYQ#?CV"1JI._:@8@[G=NG1@N@SH>4>Y7U.#::K=FKR&1+D(J;/-M,Z
MB4R-6@54[?$@/],WQV??;00,?Y#[IVTL.]:SWXHV:C:FH,)(VFCCY)L]>L&X
M/RZ<#]G)AUT$R]G?=B#(9BO&T@AJEXZ\C4Y)6,*2Q+%81H:C1,\L9=GXF7B?
M2(<>)"ZS&>\S7P'$VZ\%R#-VF1+;+7$DL8"2'G)$D%@J'9%](/WPW"=>(5=+
MR_W#EHPQ6Z=VOD&22>=H\>[(B-C(Y(57DO L;I92G+D.H;B-CH+F7,>:_P""
MZ5JTD]3,27!%G&K5?J)*<)D;N?2PA9>^B;*J/Q?DAY[? !06_(_=(I(*J7!>
M8!$K28T+"M4UD9;A<<U^H,Y*M!W3L-QQ&W+09Y;.>XF(0/9OV7JSW7I?4"A&
M\D<29.O7AE1$C_$DGKS2';B0>.ZKT.X0K67]T()GN1/>;ZJ&K&7>FP$=:.Q=
M7ZD0QUK12Q(HK]V/ML0'WX #Y Z+P[.>?V/*OI<]#(:4E-'8QUG@KQ2B*$[\
MY8D)+NS^DS'X&-..Y")2\H\^KYFY^85[<V,@R2+))%1<A:CM83A'&(5E<@]D
MLT;2C;YN8W*@-4%GW$R6$^LNQV3;CL89ZN-:!8!SW@GL/(RJ'V[A9'^;BH!W
MT%5#Y3[O#&5[$T<\DG?3O0149A.S&(&2OO)31 BR=%/'B?0S]-R'TWR'^6X#
MX?\ Z1]/_P"$L:"ZT#083F00R&,$R!3P V)WVZ;;D#]IT' ^U56;%5[%)X+!
MJO\ 3B*]:HRT[,MKM.;*SH>6_#@OXOW2S<0S=-!]!T'S?W/I7)LK7L15+5PQ
M4W^CKK!:F@DL=S?C%+3=)*=GH )Y 4XG]!T%/?S?N-B[T\-%<E88Y6>9EEJ-
M-":[V(>$"2)7DW18&9@><8_VR1QT&ZEE?/J="QAM\G8MV)TCJ79*;,R!\E92
MTQF[8C"I7[+(S=-B"NXWV"-'GO<ZKAZ\5+Z^>]#1A2*"QCR5>,8[G):EF:-#
M]2MT&/M$C<#[AWYZ#L,%D?)SYI;\?M6S;I8N$6YKS1PJTRVU5:\+=L*JLCQ3
MLVP'R\/MT'86'>."21$,CHK,L:[%F(&X W(&Y_7H/D&+\T]S4BM2W:=Z: 1R
M&L1CY3-]1)49X8BHK5SLDZ<2>!4$[%V&QT&RY:\]O9VD\\=PSQ2-'+6^AVJP
M1/9IB.9)N'"1VBYR'<MP8'HO'J&FGG/<^EA:<%?\PLWZ]"!8H;% LLY%5S:F
ML3F-2LT-A>*)N.8"_*_/EH+NH/,;OE3>/YJ6W<PCP12-;2N*P22)8IPSRI"B
M'E,&3Y)3T^4QC;F0^DZ#Y5Y+Y7YYCLUFHPUF/&))6CI68J7-(4EMU83Q#Q?C
MR.DLG'A+)N?WB$=0UU/(_=ALU4A$#O0W_P"D>S4DB-R'NS+W+(2NRUY>VL9V
M:2';??B=^*AA'Y!Y\*QM&/(V+ I;26I<8*\D%F6:H)HHU$4K21Q;R'<0N=AT
M[O'?07_M?8\IN29*]Y##/%:FCKH&FB> .87G3DJ.L>Q9 C-LB^OH/30=+Y;)
MF4PC_DSM%?DGJQ),D8F:..6S''-($8%3PB9FZC8>N@^<6O*O<NG-DA>DDK5H
M[D-5)$I/-(D<F1BKQR5Q],D4S2UG9RJR2GEZ!=N.@DP>1^YW>0/';9P=J,+8
M_C':I_C<K5J3C_T]A55"(=UZ[#@>6RAT'@4?DZ9C)MG;ERT]BGCIHA8A6*!)
M&B?OK%PC101)T9-]QTW^TA?>7VLQ5\=MSX=&>^G;X&./O2+&TBK-)'%_^1XX
MBS*GQ(VV/IH.)QF5]RI[IG:6T<;4L4DK+-02*2]6L7Y()I9U**\3)7"OLH3;
M8,5 .V@^G:#Y9Y)F?=*K)))CVE[,U^]'$#49UBCKE133C#7LRLD^[EG('H '
M3U(16\[\Q7R9*RSS3B.>P^4QM>EW8X*U7(5H":TL:-).37E=G"EF#?!2..@C
M9'/>X\4-[)4JF0ANW540M]&[;+!)>,,;1=BR5+KV0?PQOTY.F^^@RFS/NG4N
M2_2?5<;=MK+FQ5FDC1WKU&AK((ZUAA 2TO+JNS+L9%/J'2^*6/)[?G$T^6^K
M"15+D4D$E8PU('^L3LI!/Q59^<"!N6[?'J/N@.HPG]I9_P#GZ?U*MH+?0- T
M#04OAG^5L;_$C]TZ"ZT#0- T&,TT4,3S3.L<4:EY)'(5551N68GH !H(,7D7
MC\S5%BR=21KZLU%4GC8SJOWC%LWS@;=>.@T5\IXC=AG%>WC[,+LTMD1R0R*7
MB"NSR;$C=%X$D^G30;V\B\?3ZCEDZB_2!#;WGC':$FW;,GS?)SW''?UT$6OY
MEXU:R7Y=3OPVK(2*9Q%(C*L4\<DD<G+ELRLL#?=W_9H,QY%XC*]2T,GCY'G+
M14)^_"Q<LRJZ0MR^8EN((7X[:"=4R>-N2V(:EN&S+4?MVHXI$=HG_@R!22K=
M/0Z"#)Y9X\MJI5COP3S7;#5(EBEB;:6-"[*WS>HZ#;UW(Z== ;R[QSZF"O%?
M@L233/7/8D20121Q2S-W2K'ALM=_7XC0;!Y/XT8J\PRU+LVR15D^HBXRD'B>
MV>6S;-TZ:#./R+Q^3Z7MY.H_UP9J7&>,]Y4^\8MF^<+MUXZ"-_C/Q0S4X8\M
M4E>_,]:J8IDD5IHHC.Z<E) (C7?K^C[=!E1\M\=N8^K?6_!%7NRM!4:66)>Y
M(K%>*?,0S-MN%'7]&@G5,GC;DD\5.W#9EJOV[4<,B2-$_P#!D"DE6Z>AT$&S
MY=XS7LPUI,G6-B>VN.2))4=A:=6=86"D\7(0]&T$Z;*8R"Y#2GMPQ7;"LU>J
M\B++(J#=BB$\F"_'8:")_BOQ;Z>*S^<4?IIW,4,WU,/!Y%(#(K<MBP+ $#08
M7/+_ !BI.D$V3K"=[<>/[2RJSK:FW[<3JI)1FXG8-H/!YCXLURI3CRM6:S>G
M>K6CBE23E/%&97C/ G9@B[['0;;_ ))AJ.2IXRQ:C&0O2"."HK*9=BKOS9-^
M03:)OFVVWT&9\@PYP]G+U[<5S'U(Y99IZKK,NT*EG *$@L /301T\@\>MFO#
M:EBAEGF HUKA2.29XR&5X$<[OL=BI7XZ#7CO-_%+V)CRL>4JQU'X*S331QF-
MY1R2.0%OD<C]Z>N@G2Y_!0RV89LC5CEIJKVXWFC5HE?8*T@+;H&W&Q.@\A\@
MP$SU4AR561[RL]%4GC8SJGWFB ;YPNW7CH-U#)XW(5S9H6X;=<,4,T$BRH&7
M[PY(2-Q\=!6U?-O%;4DZQ9.MVX)HZHL&:,1232H)%CBDY<7;8^@ZZ#WR'^78
M#_R/_:6-!=:!H&@:!H(MK+8JI:KU+5R""U;/&K7EE1))3]D:,0S?Z-!&'D_C
M1=T&6I<XY1!(OU$6ZRDE1&1RZ.64CCZZ#(^2^.+5>V<K3%2*7Z>2P;$7;6;T
M[;/RXA_]GUT'DODWC<5AZTN5IQV(W6-X6L1!U=VXJI4MN"S= /MT&M<OXG2?
M(3+=H5GCE7\UD$L,969AQ7Z@[C9RJ[#GUZ:#4GFWB+S6HAEZBFEV/J'>9%0?
M5)W(-G8A3W%ZKL>N@LLAE,9CJWU60MPTZVX7OV)$BCW;T')R!UT&D^08$69*
MIR57ZF*,SRP=^/N+$%#F1EY;A0K \O38Z#'#>08K,UI[6.G6>K!,\#3J08V:
M/8L4<$AEZ^N@\3R?QJ2".Q'EJ3UYIOIHIEL1%'G/_P")6#;%_P#9'70:(O,O
M&6I)<GR->G$^^PM2QP,-G=!N'8;;F-MOMVT$F?*^/RVCCI[E22TIBD--Y(S(
M"SJ86[9/+J_'@=O7;;0:I_)\'#=J4VMQM+=662)D960) I:1W8'Y5' C?[1H
M-60\R\8HXR+)29&O)5L':HT,L<AG(8*1#LWXA!/7CH-[^3^-1K8=\M21:;]N
MVS6(@(G+<>,A+?(>0VV/QT'MGR;QNK*\-G+4X)8U#21R6(D95;CQ+!F! /-=
MOUC[= N9KQH-/#<OT@U$QRVHII8MX&+ Q/(K'Y#RVXD_'TT'F-\FP&3OV*&/
MO0V[-:&&Q*D+AP(K/(Q.&7<$-P/4:")GO./&,)6LS6[\+RU)(89JD4D;3B6R
MXCA0H67B79NG+;[?309^0>9>/>/E$R=H0SR02VHJ_K(\5<H)64?[/=7_ .OV
M'02X_(<!**ICR=1Q>9DI%9XSWV0[,L6S?.5/KQT&Z]EL50:!+UR"HUE^W66>
M1(S(_P#!0,1R/7T&@KZ?F?B]JI9M#)5X8Z4CQ71/+'&T+)*T/XH9ODY/&>/+
MUT&4-GPZGD;4\,N.KY*>$6KLJ- D[P ;B:5AL[(!^^;IH-\?DGCLJUGCRE1U
MNR-#399XB)I5.S)$0WSL#ZA>N@VP9G#V(;,\%ZO-#39EMRQRHRPL@W<2,#LA
M4>N_IH(%7S/QZYG:^%H6DNVK%1KZR5WCDB%=9.T'+ANO)]P.._IUVT&S"?VE
MG_Y^G]2K:"WT#0- T%+X9_E;&_Q(_=.@NM T#0-!5^3X),]@;F)>4P"TH E"
MAPK*P=>2'8.O)1R7XCIH.4;VOMS7&LV,G7)N2UY\D(:*1'G4LO:B%1A(3 "T
MFTA?N,WKR!.@UR>S]-J56M%?^G[%;'TI'A@53)!4CE@M(0&]+4,[(?X/0]=M
M!Y![/U(\K8MO<62"2X+D,3QRNRJV0BR$D3\YVA*EH0J\(EV&Q/(CJ'ECV>AF
M:U&<D(Z=OOEXXX LBF87E 5^97BJY+[I7KP^P[ ,C[2_46,E=O7X'OY.M)7D
M->H(88BQK!7AC,DA4A::\OGZGKN-@-!=>(^$R>/9/*VQ=$U?(/RBII&T:1;R
MR2EOGDE^8F78B,(GQX;DZ"AL>S5263'D7_PZL78LQ\)D$BBVUP/'V9X@DG-S
MN7$@]#MN-!28CVFSF5K6J^>*8J!*M;'U172+NO'7K7*_-VAE<-_+%/,\2VQ'
M!-]!>1>SU4U94LVXI)K$<J3,(970M+8K3%A]3/9D]*BJ=W._K\-M!Y;]FZ\^
M8DOC(;1SS/+-79)@%_ZR6Y%VA%/%&"KSD'N(X.VX"G096O9VM-12G'?$$8JP
M4I3' %)CBH3T'9>+CB[+8# ]=N.W7X!$E]DXY8H3)D4,_*=;@"W>S+'86!6V
M4W3*' K*-VD9?]CH-!TWAG@[^-WLE.M[O5KS PU$C9$B DDD+?/)+\S=WJ(^
M"=-^&Y.@H\'[0)B+M>U#D%D>E:BFK/+',[F!'F9HY.=ATY$6&V:-$ /7B=R-
M!:^3>WIS>3NV/KD@JY.M'5OQM62:<"!9E0UIG.T._P!0>7R,?X)4DZ"N_P#4
M_P!0]RQD+T$MNY4M5&[%,0P)]15AJI)'$9)-F1(-V^;YM]OE  T"E[4ST[LM
MF'*JJ_60W:\ KL8U:*621V*O,X#N)F'X81-_F*,=]!CXS[46\+F:^5?+I:G@
MEA9@U>3YTBKSUVZO8E*NXL<OEV1=M@FQZ!-\A]M?SG+6K+7UAI7I._8C6N#:
M$GT,E#\*SS'!.W)RX\#\V_78D:#=X_[>#%>,Y?#O;62;+QO%+:C2;90:XK*W
M">>RQ(5?X8'P &@T^1>W%G+Y'%65R@A@QJTP8#$[<FI6%L!E*31+^)QXGN*_
M'U78[[A2R>RL\F/A@;+0K9J0Q5:=B*FT)2&,3?.W:L([3$V6^;D$(Z,C<FW"
M2/9NN;UR>7(]^.S+WU[T<CR!I+,%F97!F^G*N:^P"PKZC<GCH-\WM.&M9$QY
M%(Z>7:4W8_I4>9%>:Q,@JRLQ$)'U;!FX$G;=>)T%AXU[=PXGQ[*XB>UWFRT9
MAL6(1,A"?3BNI'U$UH\@@^#;?8 !H*"[[+2WI&L6\I UB0&&:.&K-7KF!J\-
M=AVH+4;<^-93NSE>I'';;8.USR!+7CR+Z+D !OU.PIV!H+O0- T#0-!QOF/M
M_9\BS5*^N3^E@JFLS5C'(Q+5;0L[JR30KN_'B>XC\?5=CON',^)>V>:?+QVL
MY#%2J8RO#2HQ1I#W94ABN0]QI(GD!8+<#"0JI)!_#70;(O8V./'0UUR:FS69
M%CE*7.#PI6>L%F47 Y;A(3\DB+\.&QVT%H/:'&K2DK)80%H,A DI@#,OUY@X
MMN7+$Q+6 '7K^C;0:\=[/U:F0^I:\)XX[D=J 2),\G!+9N&.0R3R1$\ST:.-
M/3?8G01['LVS4):=?*1Q!I(Y89?IG$D3HDT1*-%/"P';G  WVZ$,&5N(#I?+
M/#[6=PE+&Q9$UVJL#+*\;,)@(6B/(025G4_/R^1P-^A!7IH.?_\ 3=4X:+'M
MD%[\4L<WU8KKNQAQL=!$92YY)O"'92>H^7].@Z7">+6L?A,G0ENQM;RDUFQ)
M9KUQ#''):'7MPLTP^4]?F8[_ !T'*8OV=NT)Y+2YB"6U/RCF[U-K$0ADAABD
MX)9L3GN_],I5F8J-R.!78 )E'VCJU)4 O=ZKWK5N6&:'N%K-N":N[J[.>*]N
M9?D]!Q^78-MH-*^T#"):_P";*(:X>>E,M8"U'>>LD"S--W#RCC:,2)'Q'4 %
MB%&@3>R^/>G9J+D9$AF6:*+9/FBAF@X")2&!XB=Y9C]O,CIZZ#S_ -02"N4C
MR4*2V>0R+FM+.&4V([ : V+,LD4G*(!F9WWZ'8$#046.]IO(<C:,F2[6+3&1
M5ZN+V7?O+ ;2LT[4[$4DN\=KH_.,EO5!UW#I5]H<:M;L+838"948P!B%EQ<>
M, W9V;9%CYC<_'C^G01JGLQ5@R0M27Q/%':CMQ++',[[BU#:E1N<[0\6:#8<
M8@1TW+;=0Z+Q/PO_  [D+]B*TDM>\O6$0]MD86;$XV8.1Q"VN.W'][OOUVT%
M2?:P/E(K4N0C:M4N27:<0K 2[SWXK\RV)NX>[\T/!/E78'<\B-!:^:>%?XE,
M0^J2NBUK5.=7A[W*.T8F/'YTXD-77UWW!(T%'<]GZT_D+Y9;P$<]GOSU"DRH
M%6=;""/LSPJ&YJ=RZN#T/$$=0L_<'P"SY:($CR0I0QQ2Q21M$\@/<9&#CMRP
M=5[>W%^2==^.X!T%/<]H);0E[F2@Y)+9FH,M1XF0V[AN2&:2&Q'*[JVRQLCH
M1UWWW.@U2^R<<K6N]EC86U5:%Y9HI#()GHB@T@59TK\"@WX]G?X<MM!:6?;'
M?.V\G3O15X[\G_4UWJ1S!(=X&VKEFXQR\Z^_,JWJ/EW4'01L/[108_Q_)8@W
MQ(;L56"&SVY6*I1<R0]Y)YYUD^8_.J<%(W&PWT%SXMX.V%S%S+SVTL7,@C_5
M+#!V(A(\S2DQ+SD*KL0-BQ).[$]=!9X3^TL__/T_J5;06^@:!H&@I?#/\K8W
M^)'[IT%UH&@:!H*ORC.I@<!<RSQ=\54!$7(("S,$7DYW"+R8<FVZ#KH.3;W1
ML17&K3T:C&G+7@R9KWA*>Y;LO6C^D7M+WN+1[R!N#+Z;$@Z"-%[NW(J45K)X
M9*XLU:UFJL-HS<GR$$DE*!B8H]I)9(&BZ;@,5ZG?H'J>[.1EMVZL.!)>.T*-
M5Y)FCC><7X\?()',.RCG+R7AS^4=>)(&@AGW9RT-VW/?HQQT:2GE5K3"24S0
M19$S@F2)>41?'_*PXD="?B-!+G]V,I!;MU&Q%::7%Q/9RDL%XR0B%#7/_3OV
M!W7X6]RK!-BNV_4'07GD/F]W$YYJ*8U+%"NE"2[:[Y69?S&S)5C$4(C82%6B
MW.[KT/3KH*6E[P))-6CN48(%MT_S&&6*X)46!ZTUB-)6,:<)O^F8,G4#U#'0
M>6?>'LU9&7$F2W#%#-/724L$2ZU=*3$K&QXS&T?1=QVWZ$Z"LL>[>8KRODK%
M5X:5<#OXKB"Y9:]PD+(4#A6EKHVY4$+ZKZC0=_X?Y'/GL6]JS2:A9BFD@D@8
MLP)C(^=.:Q/Q._[Y%._PT%YH&@:!H&@:!H&@:!H&@:!H&@:!H*7R'^78#_R/
M_:6-!=:!H&@:!H.3\C\VNXC/+CXL<EFG%%3GNVFG,<B+=N&FHBB$;]PJWS'=
MUZ?IT'.TO>>U9JO;_P /RK!*H^@/=8&:6<2"I 0\2;232Q</EY*"P^8]=!?)
MY]+;\:BSF-HI/'>OPT<8LLQC259ID@[SN(W**)"W0*3L/TZ"DH>\%N_86O#A
M1"UJ<P8^Q:G:"N>#RI)WY&A^0_@-Q"!]S\I(.@CWO>22?Q*6]4K1U,E.D:U5
M[R3%&FQCWUE *;2*A3AZ;'U_1H-V0]U\F^?.'QM*O_+88HKDDTO"2!<C%1L=
M#"OS<I=@4+*#N-]QH/*/O'<R*JM;#"N]PEL=/<L-7@,02:0]V1H3QDXUSLJ!
MU).W+HV@EY?W,M8+PK 9>:LF0NY#'+?M1F1HB4BKQRSR+VXI4'60=6XJ-QUT
M&'_MB[+;2"IBH)!<9EQP>YQDW7(PX[_JHQ"QA^>?GTY]!MZZ"(WO59_%"X"4
MF2Q])0?E+P>19V@?N[0%EZQDKVUDW]#L=!,A]T,Y;>$4L!&!.880+-PQ,MB:
ME)=XLJPR_(J0L.7J=Q\OKL$,>]DTW=DIX"22 +$D+R2F/>>5('XNQB**G_4[
M!E9FZ;\0#OH,K?NEY'6OS XJM(E>)H9:<=AVD-N.^]1VC(AYRQ<$Y<4CY_[.
M@^@8'+P9C#4LI 5,=R".<!&+*.XH;8$JA/K\5'ZM!/T#0- T#0- T#0- T#0
M- T%1A/[2S_\_3^I5M!;Z!H&@:"E\,_RMC?XD?NG076@:!H&@QEBBFB>*5%D
MBD4K)&X#*RL-B"#T((T$*+Q_ Q-5:+&U8VHJR4BL$8,"M]Y8ME^0'X\=!M_*
M\9Q5?HX.*=H(.VFR_3GE#MTZ=L]4_@_#08KA<.MJ:VM"N+5AD:>P(D$DC1$-
M&7?;DQ0J"N_IH/1A\0+ L"C7%@!E$PB3F Y8L.6V_P QD8G_ .1^W085\#@Z
M]<5J^.JPUPK((8X8U3@[!G7B !LS $CXG029*=220R201O(W#D[*I8]IB\>Y
M(_>,>2_8>HT$,^->.F%X#BJ9AEF^IDB->+BT_P#S67CL7_VO70;WQ.*>.6-Z
M<#1SQ+!.AB0J\2;A(W!'S(O([*>@WT&$>$PL42Q14*R1(O;2-88PH3BR<0 -
MMN+LNWV$_;H/*6#P]&2.2C2AJF&)H(E@18U6-G[C*JJ H!;KZ:"=H&@:!H&@
M:!H&@:!H&@:!H&@:!H*7R'^78#_R/_:6-!=:!H&@:!H-,M*G,Y>6".1V"JS,
MBL2(VYH"2/WK_,/L/70:8,+AX&F>"A7B:Q*+$[)$BF293R61R!\S@]0QZZ#<
MM&DL,<"UXQ!$P>*((O!64\E*KML"#U&@I\WX1X]EJMB"2LM5K<J3V;%54BDE
MDCWXF4\2LOKZ2!A\?7;0;Z?B/C-2M6KQ8RLRU*Z5())8DDD$$:E50R."Q&Q/
MJ?B=!O;QSQYIIYFQ=0S63RLR&"+E(W)6W=N.['DBGK\0-!X_CGCSI81\749+
M<@GMJ8(B)95.XDD''YV!Z[GKH-EO!X6[##!<Q]:S!6_D\4T,<B1[#C\BL"%^
M7ITT%5B_ O',;FK>9BB:6[;)W,Y$BQ@R+-LFXW_XB*5Y$E=@%V VT%E)X]@)
M/J^YC*C_ %^WU_*",]_B=QWMU^?8_P +0;X\9C8PHCJ0H$X\ L:C;@AB7;8=
M-HSQ'Z.GIH-(P&"$YL#&U1.8TA,HACY]J,@HG+COQ7B-AZ#;0+6 P5L,+6-J
MV X<,)88W!$C!W!Y*?ONH9OM(WT&ZIC:%22:2M D+S\.[P&P(B01H-AT 50
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M?;]N@L8IHID$D3K(AWV=2&!V.QZC01:^8Q=EIU@M1NU:?Z2<!A\LX ;M'?\
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M%99'53)*5+\$!/S-Q1CL/@-!OT'CND:,[L%1069CT  ZDG08&U6%<6#*@KL
MPE+ )Q;T/(].N^@V:!H,4EBD+A'5C&W"0*0>+; [';T.Q&@TRY&A#<@HRV(T
MN6@[5JS.!)(L8!<HF^Y"[C?;TT$>/R' R5X+,>1K/7LV#3KRK,A22R&9#"C
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MQ;\LR%I94LR2Q11TE@1&>24F;X?';IUZ!/'N=XB9HHC/.I<(96:K8"0-)+)
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M=X:[5$OUIIHY(VDK$3-+.8W562"-81^*?E/(#UVW"PQOGGC>2Q%S+4YY)*U
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M0_IT'!^V/CV<PDMLWJ<E:O9BJ5*\/"K'P%**0--(M>21#W.2IS!Y,1N51=@
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M0Z@AZUJ6VG$A01^)88?;MMMUZZ"KI>S&!J13)'D+A:PABF?:JA:-JLE1@1'
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MC/)*B@-"ZQ2KN3ZI(ZJ1]I T$?.R)):\>D0AD?(!E8>A!IV"#H+S0- T#0-
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M_-(;)R<IHU;37*=#M1\8VEM06Y%+CYF!DK;+]@/QT%_Y#_+L!_Y'_M+&@NM
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M:M.6E<.TWU=KO<1&\0B$O<YB+MRNO;WX['TT$M?!/%EK-6%/:%XIX&3N2?\
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M&'BD&.K!X!Q@?LQ[H"W+9#M\OS=>GQT&;8?$NH1J5=E 90IB0@*ZA'&VWHR
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M*_R'^78#_P C_P!I8T%UH&@:!H&@:!H&@:!H&@:!H&@:!H&@:!H&@:!H&@:
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ML\QP3A+RVX'YM^OS'06'@7A7^%J5F%YTL367C+R1B=5(AB6)-Q//9._%.NS
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M,%9RS! H9N@ZM\=!QUGW;FIHXNX*6*9I):M1(YA/W;5>W'3D3:)&<)SG4JW
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MN5*QQJ25C395.PY'JQ9OT]-!!C]M/'T"Q&:X].$CZ&D]AF@J@2I-QA3X#E&
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MX<97BQ,>,W9JZ0"MN3\Q0)P]1\=M!RDGM/@+&$.(N6;-FN[QR2NQB5V,6/\
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M3MR/4@=-^N@]RF*Q^5HR4<A")ZLG$M&21\R,&5E92&5E8 JP.X/IH*F+V_\
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M!"/MWX8:RU3C$:!&Y+&7E(V*A.WU?_A<0!VON;?O=!)\AZ7<!_Y'_M+&@NM
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M8>N,A#+!E8(H5R,4P')9GA60_,BI&W1QOP &_38>F@N- T#0- T#0- T#0-
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M:XWAJQR6KRR%Q+;<D3??^<_=#<C]N@Z+0- T#0- T#0- T#0- T#0- T#0-
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M+&7;U)X+LJ_JT%%[@1WI,-76!;#T?K(#F(Z7<^H:CR/=$?:_%/S<>8C^8IR
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M"JLY]=]CH+4X_"9"NTAK5K=:XF[N4CD25'XG<G8APW!?V#0;X\?0CX]NM$G
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MH&@:!H&@:!H&@:!H*C"?VEG_ .?I_4JV@M] T#0-!2^&?Y6QO\2/W3H+K0-
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M-4[232"]W%D4R.^_)N0/7J-!]$P39#\JK1Y&,1WX(HXK10*(GE6->XT04_\
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M+DKTJ4XUC1)3!(VRQR1$+(\321H5F;Y(V"[[=.F@E#VKQ_ J<I<WL*8LFP[
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M=P-!26O=G,539CAAJVY($>.*M*98+O**&.1;=F K^%!.7V4;;KNOKOL ]O\
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MH8XYIH5WY(DN_;+ CY>6VX!ZZ";H&@TW+U2E")K<JPQ%TC#N=ASE8(B_K9F
M&@RK6(+->*S7<203HLD4B^C(XY*P_6#H-F@:#"O8@L0)/7D6:"50T<J$,K*>
MH*L.A!T&NQ>IUY(XYYEB:781\SQ!)=8P 3TW+R* /B3H,J]NM8:989!(U>3M
M3;?O9 H8J?T[,-!Y<N5:59[-N58:\>W.5SLHY$*-S^LZ#=H&@:!H(QRF.6Z:
M368UMCA^ 6 ?\4.R; ^O(0N1_P#$_9H).@TVKM2J(C9E6(3R+!%R.W*1SLJ#
M])T&[04OD/\ +L!_Y'_M+&@NM T#0- T$.YD,57F1+4\,<Y,:QJY7GO-((H]
MAZ_/)LH_3H)/9AYJ_!>:[A6V&XY=3L?TZ"KO>2^+P96'#W;]9<C(R&*I(R\N
M;_\ #WWZ*S_O-^I^&@EP7<7:CK6H'CFCR" UIE'(2IQ,@V8#TX]1OH(V57Q^
MS=HXS(&-KDDAN4JQ)#,U8AFDV7X*6&^_3KH-&,\H\4RV0>G0M16KD(=65$8[
M")^+@.5X_*_3H=!/MX;'6[=.U8BYRT',M4<F"+(4*<VC!",RJ2%+ \=^FV@F
M,B-MR4-Q.Z[C?8_:-!'I6L?.ICIO')&@!_"V*;$LO0CY3\R,.F@W-! P :-2
M!L0"H.Q7T_9H*:/RWP][MC'IDJAM5%E-B'FHXK#UFZGY3V]OG ^[\=!MQ6?\
M:S$DT>-L16V90TX120055AS)&V_%U.QZ['06W!0O'8<?3CMTT&*P0(H58U51
MML   ./5?V?#0>"O7"A1$@4-S XC;EOOR_7^G0>FO7/+>)#S.[_*.IZ>O[-!
M[VX]B.(V(XD;#JOV?JT'J(B*$10J*-E4#8 #X :#%8(%4*L:JHZ!0   3O\
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MDO=+1IVP>@&Y).@O_*:.3O\ C]ZAC)5@NW(_ITL,2.TLI"22+L#\R1LS+_M
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M#!]-CH88UKPVII@TU>!8DF(9(@27!?8^G3XZ#L?)\58RF/@KP%.4=ZC9?F2
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M((Z7":4Q]F:6VEF0CB.+F&VLBCK^(@Z[==!<>)^#9[$>97<E8MO+CG$Z5_\
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M3#8A+<5Q*-=;<*M'#8$2"1$8DLJN!R )8D@:"9H*63POQ:2S5G.,K**;3/!
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M:60<V,E1:6[%54=(D&VP^]UT%WXYX[2P&.^AJ,SH9&E>1Q&K,[[;GC"D48Z
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MBNM=V:L2EESQ9@5[VZ+_ /$GXZ"ZSV8K87"WLM9!,%&!YW1?O-P4D(OVLQZ
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M7>-26(,1!)V]=Z\7_P"HOV:#+&8/ XF6?\MI5Z4MQC+.(46-I"#ZG;;?8O\
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M^[H'^&?&_P"ZJ?\ 1XO]W0/\,^-_W53_ */%_NZ!_AGQO^ZJ?]'B_P!W0/\
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M&_[JI_T>+_=T#_#/C?\ =5/^CQ?[N@?X9\;_ +JI_P!'B_W= _PSXW_=5/\
MH\7^[H'^&?&_[JI_T>+_ '= _P ,^-_W53_H\7^[H'^&?&_[JI_T>+_=T#_#
M/C?]U4_Z/%_NZ"73HTJ41BIUXJT1;D8X46-2Q !.R@#?IH-^@:!H&@:!H&@:
M!H&@:!H&@:!H&@:!H&@:!H&@:!H&@:!H&@:!H&@:!H&@:!H&@:!H&@:!H&@:
F!H&@:!H&@:!H&@:!H&@:!H&@:!H&@:!H&@:!H&@:!H&@:!H/_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>g140648dsp004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g140648dsp004.jpg
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MV@ , P$  A$#$0 _ /U3H#0&@- : T!H#0&@- : T!H#0&@- : T!H#0&@-
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M  3XM_T _P"VS_>T!_@GQ;_H!_VV?[V@/\$^+?\ 0#_ML_WM ?X)\6_Z ?\
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MY>+MQ8-$"9QP8O=9S, Q?<$>XLI">)AN,[=)T'6<S]?#LQT6!CLWK!UV/(H
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M@*TK"3/E,0PQ'IM!26\0&P\'R=[)^*T+UYD-MN$Y:R!@8F180^@Q$1TC0/-
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M.TQ/\&@X3X?@%8@L4%<OMV0SN.EK)LD;3EC&39Y=[F1E)<N>^^@Y_P &>/\
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M=J)+EL&X^WW=>GUZZ"W2PV-HV#?40*"-2T2*XXA"U$9C$#'2/<XI_P!.@NZ
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M"Q>;?KIP[#%^2::RM1)CE><2PQF"7PC\LQ]0C??0($>#_)3AFQ<JW9<@N[1
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M(_"/\IXS^AC^.= \T!H#0&@- : T!H#0&@- : T!H#0&@- : T!H#0&@- :
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MMK@T138?5/FIK@$(CE$]-@XCMMTZ1L#3-_WYX]_6G_V-V@=: T!H#0(_"/\
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M%C"ZZ=]WS$>P.L>FV@8VOF#-A<RB:^&6:JKGU:K&/!4]RM:"J1&)D/+GSDP
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MMZ[Z"CCO+/'KZ@8FZH0=9;3K2PP'OM0? H3O/ZD;^G'UT'5OR'QT,D[#W+:
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M;N.JWH"5C92#H7/61A@P6W3UVWT"IWG?BBJZ[$WH8MR4V50E;7&2K'/M% +
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M;8D!$]IY1,?2=!:S?]^>/?UI_P#8W:!UH#0&@- C\(_RGC/Z&/XYT#S0&@-
M: T&*L_(48U>4R&6!2<1C;S<=$A.SF/F417&)80+CEW3Y24Q$;1.\1OH):?R
MIXM;C'=J7_\ [4%A4YX"0E%<S"W[Q(@_Y7M\FSRVXS$CRWT%/&_,_B&3E04
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M"6U9"S\-OKH+OEWEV-\7QP7\@MK$F?;B%2H9B>,EU)QI#T'TY;SZ1$Z#)?\
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M(I7$E$G"^L=(D9Z V\6\M\GM9+*V+K@M/1AH?6PR5$J'6:MRY78Q/(S*.Y*
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M?BVH55H,E-H1R7)[++30HT$I*UE,3"H^O&8G80^C9O\ OSQ[^M/_ +&[0.M
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MC@<?<\BDB">@^T=]RT%*E\RYF]V(1A4UQR%A2<>^[8)"H%I,#]:97,\X[<=
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MV@SC6V&.X9QQ]N\Z"F_PGY#+[IU=-I%TD5T9&V5^'E>D+9,L35&7JE ,"8F
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M2CZQ/6)T'S6S\O6DXG+/_=8EDJ&8+&UJG=GBZK#B#[J2X;C^FATR.T^X=M]
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MF1B(WF.Q[O3UZ>N@G\IMQ<\(NVH4U$.1!0IX2MH[E'0PGJ,_LG0:/0&@- :
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MHG(_^?C$^Z(@NN@K'\3>)057[<755TN85TJ(. 5V&+)K#!@<BJ#&2'CL0[S
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M1B;[HUCW*:8OV3#2J?9$WC(S/,D])WG;?K$;[[@Y\W_RIDOZ+_U1H'F@- :
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MU%Y);JV.W#[6:"PFK*B.52^#.NQI[0?#N%'3IOH,1B?CSR ,=XLYN J&ED5
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M$;Z#)8WY*Q]L:A6,;=QL9&L-S&S<^V +"2)<3(&#V )##@*0.1+:>D3H'/\
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M4G(5[-5Z6M^]6U1UOTFJ22R9!3',CL!$#]= WLVJ=&HRS::NK4KCR:YI"M8
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MYZ?Z=]![Y%X0>8SJ\C]V"Z\C1&Q6-/<DIQ]\;J^)\QB(+W 42,_2?IM((?\
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M&4E0PAF.VU\/*9V&/=RC:/V:!5/Q;B=B6.1OA6=R"Y6$U0%BO-EEL:[/TN7
M&/9$2,P<B4C)3H*T?#N C(4[LW[I%1:EM<#^V*!^WLE94 F2)8 01\2@#CG&
MW+>>N@L83XG\:PV7JY.F3.Y6!4<&+K')L37&L+"=*>_$RL(W$&0._7CH.\G\
M5^-Y#-WLLV6 W) <6U@%:>1G7^UDQ<:2L!/:V]HL@=XWV]=PO>452J>#6JI.
M.Q**P*E[.,&?#B/(N$ .\[;SL,1H-'H#0&@- :"&[:"I3?:,9(*ZS:0C&Y3
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MDDPXI,:QVW=:^S9>PMNUMN;6&73[=<>O\G0=Y+P3#Y3R>,[D()\A6KUU5.3
M7O7>QXDP0,1;'-@SP,9B)'?0&.^//$,==7=J49"RDA)!DY[(7P[G 5B9D( /
M?9L QQC?TT$<?&OAL1.U-D')K8#ONK7=7V88*P4WN]Q:Q%[!A83 [%,;==!!
M'Q/X#"Q4.-(:X#P"L-BS"8WK?:27:AG#G-?].3VY3'UT#F/%\&.9',C7D<E!
MFS[@6,'>6)6@H(8+B0RM"_;,;;C$^O70+W_&_AKV0;:$E^HUI!WWP!]]WW#%
ML"&<35+O?VBB0B9G:.LZ!E9\:P=D<J-BJ+8S:X3D^1%/=6*^U >OMB F=N.W
M69GUG04V^!^+-K5ZQTRE-4+"U##G1N%QD->)S![G!L&#]V^TQ$QH(E_''A:[
M1VHQHDPY;/%C&L6(V!8#@6LS):UG%AG(!&!F9WVWVT%I/AN 7AKF&[3FT,@$
MJM ^S8<9!(=OC#6L-@Q QM'$HV^F@L8OQ^CC8&*[;;.)&4?<W+5GJ<#$[]]C
M-X]D;1].NWK.@46OC+Q"U^\H<FU*LPPW9)$7KHJ<PYB2(EBZ _D1'2/3IZ=-
M \Q>(IXRL->O+C 9F1.R]MED;_3N/)A[?LWVT"NS\?\ B-D*JW4-UTY9V0%K
MAB1<V'L!L"<=U9-B"X,W'?Z:"UF_$O'\W*IR57NDF# 9!C$R2V[=U1RH@YK9
MPCF!;B6W6-!'A?#<%A;MFYCAL*9;8USUE:LL23'%S8?98PE04S'K ](Z1TT$
M%/X]\0IV8L5Z'%HL!J=VN,52IDM 4B1R*EPPN7 (@=_IZ:"QF_[\\>_K3_[&
M[0.M : T!H$?A'^4\9_0Q_'.@>: T!H#0&@56<-XM?;"K-&C;:MI6(!BDL(7
M1Q@V[3$S!_EB2]?306:>&Q%*S8M4Z->M9MERMO2H%L:7KNPAB)*>OUT%</%?
M%UE:->'I 5X3"Z0UE1+Q;.[!;L/O@YCW07KH"U@?&'9%=NUCJ3,D4<$V&I43
MY$(_*)E'/88_#02N\>P#X 78VJV%P$+@T+*!A0D"]MQZ<!80C^$3,?709_R'
MXQ\.R>,"D5<,5021-:NDNNE1;KX$3 -1KW@/0]H,?Y)1H'-?Q?Q88EJ<73(G
MUQJL?V5F;:T! "LV3$D8<!B-BF>F@M+PF&5C)Q2J%<,7(R$T!4$(D2ZD,JB.
M&T[]>F@I3X_X;VZ83C<=VZCB&@/91Q4^9W*$QQ]I\AZ\>N\:"[=PV'O')W:-
M>T9**N1.4#)E)S!&J9*)]A2,3(^G3001XOXS!52C$4N5$8&C/VZMT#!<XA7M
M]D04<O;]=!Z'C'C2W5GAB:8.I<IIM&NJ"3)E)EVB@=PY&4E/'ZSH++<?C7,,
MVUDL8R5]PB 2(I1/-7*9CKVRGD/X>L:!=5\;\,KD5:IB\<D^X#20I"!GNHGN
M <B(Q[E]SD,^L<M_KH+5#QSQ['R,T,74IR)=P90A:I@^)#RC@,=>+"C?\)G\
M=!!3\<\6CMV<?0J*B+'W@MJ+6N#? FON%*XCF6S"CKH&)T:3+,6F5UG9A9(A
MY ,LA1S!&OE,;\2D8F1])VT%2EXWX[15VJ6+J55;,CMI0I8[-B(9&PC'Y^ \
MOQVC00-\6\/5077;B,>NA4(K"DG71"5'MN3!&1XC/3J6@N5</AZUVQ?JTJZ;
MMK_]:M*4 -;M_P#I#&((O],Z"M_A+Q7E:+]S4>5Z"&Z7VR=W0901PWV^^"(8
MF>7K.@F_<^!BC.&^RJQ0:)26.[2^R0\HDI[.W&8Y%UZ>N@\7X[X^JS6M+QE0
M+5)?9IO%"X8E41,=M10.X#UGH/30>4?&_':!P='%TZAP4G!(0I<\I@HF=Q&.
MNQE'^F?QT'6'QV!I5VKPU:K6KDPN\%,%K"6Q/$^4+B(Y1,;3OUT%;_!OB'VI
MU/W'C_M&'#65_M4]LF#OQ,@X[24<IVG]N@B\T  \1R  ," IB!&(VB(@HB(B
M(T#W0&@- : T$%\7E1LC7.5OE1PE@Q!2)R,\9B)]=IT'Q?QS/>>TJ8Y>K9;E
MI)&(0ZC80<G9>VF0MGG,Q*B!L1!;#^:)Y>O0-O\ %GDODN=I76YJ4LA1*[+5
M :R@S"2<HQ( &.V6VT=2C?8NL=0W&@^08W&>28W&93R*M7KKR#<A912NG]V^
MU$/R\U^34&4*D!24S''Z1'TT'%OSOY)KW\[3&$RS'@]2 .N9,B$L!=>WVP&(
M(7P7.8Y[=?;^6=!>+S'S*IF_W5D+L*34M,2F\.-:Z<B<&F1KP"RXKF%NGW#/
M7\WH)1H+_P 57O* 73QN6>5JJW%*N()B26Q)]XU2HV$1=R>$#,R77?\ 9.T!
M]%T'RXWT \FR)9O]YGY2&4']R(J%8CE1_3[,)B)^V[$CR^XDOKSY=>.@IXOS
M/S_*7L?01<$"OFK]YV9QS _=M@DV#;2V840R0E0[$7IMO.\&,:"6EY1\D6IQ
M=4[2TNRE:I>;9&@6U?OTKKF($".8GBVHO:3G?W;3ZQH*5_S[Y'J4*TLE,?>+
MHVWWYK$I=3[NJQLU]B[L3'=5 P1=>O&?=(Z"X?F?GD5ON\E:7B*CKD57/"@V
MR%2 HA8W@9XL9W[!]N)(8VB./YYWT%#-_(GE^+K<Z:)18.S:?*CIM$7PLDQ"
M]BEK(.8,ID!C>(ZR4;3H/HWQ]-F?%J\V99+>_<WEO*3X_>-X[\NNW';;]F@L
M^9SF8\2S$X3E^]XIN^Q[>TL[O">/;WZ<_P";^W0?/OWWA<8B7>&V,@FJXJRL
MUD[2[=JM4$R+=QJLSSFU,Q L^@Q/)GI&@6W?-?-[Q4(=)C93:KLQ^,72>F<F
MD",AMRR9_0%L@,2LOR_7\PZ#6_&?F6;RM9T^0N1R:U*J)@)J,GFHVNKR)  [
MKA>\1U*.L%UCJ&_T'S7Y SWDN%S]RUB0*0.GC4ML'!$FN#+-SNNVV(.4<0&9
MF)VWB2Z1H%^/\T^2&2%]T)8E+*:)QRZQB-G[I)E+8>? @]T!/Y=HZQ.\;3H$
M3_-/+,J\$SFS=62H"LQ6HLJSW[N.OE]JSE,EL+4 (3]"VW]T:#Z'\;W?)"2_
M&YI\6_M*F/=7M=@D%_S*)DU3N1<NV0>OKUZZ#::#XI:SOF/DIT,99ML%+[M-
MF9K)I-1-%D6H&:#&%,=T2'W$7K[-_P IQ&@^HYO^_/'OZT_^QNT#K0&@- :!
M'X1_E/&?T,?QSH'F@- : T!H/FF7PGE-;$^07,/6-.5;F#)3PC=\XYTUYL2B
M((9W*$_28+I[>NV@KT@^3H/"[MN-K@N?WJ30!4E).;^[X@))A^SV_=SRY$OC
M_*Y1H*7C5#Y6LG25D[E]02\3O08PG9ZZCR,>[W&D5<[$)C9<0/\ -Z3.@YA?
MR:6,051>8_> K.<BR[-22BU*-K$4MN@COOVN4\.6VW3?0=O#Y-/)XR,<>6KX
MB)C[,KH+?8DON9[OWL Q,0N4\8#N[SQW_E[:#9?)R/(['C$HP8D<M>L,D"QY
ML*D6\.@ @@(M^G*!GEQWVZZ#$R'RR%;C$Y1N6BJ$8@TC513[?;9W/O083(^X
MB>/'>>L\-MO?H+!6?D2HBRZE6S5K&,5?1BTV>R5\7,JHE#'[D.P#8!W BG>-
M^OMD= N9AODM+\:-9;ZZAM6[:S!(OF+KKK)EKX[BX@#KLZ27MVDO0MM!](\]
MC-3BJW[M^[[/W:_WI&.XQ<^TXGR['+Z]SARX^[ARX]=!D,=:^2TNJ5;M?(M^
MZ;BS78GL3"JJKK/NHM$!0(M*KV^[ Q.\[\?KL#[Y1+RF<733@%W)8QI]]U$O
M>&RB[<$$2LR@F;>AB,?RNG30?/Y\>\\%9Y.4Y<<Z1OLP8''"+5K!+6LX#?AL
M-M9 4;;#.T>F@:^18'RRMF>Y7'-64U"NKQ]ZF:2LS+J5#L]UC./)965LWWC^
M3U]F@DN6?EV:C:*$6XRM<<B;KD0K[5G=-15AKS)1RD52R%Q.W$HVG05L96^3
M*3,"*8R#L>E_!=*%#4 :_>7$PXY8XHX+Y[0X.H](D3VG0;OY&//Q@TAAEVB:
MVR V64YGNK3Q*9+B,BPXYP(S $,]=]^,3H,GXQ<^3H+$5,O6R$O;:H/NVB%,
M)"L%*5V09(E.Q39#<AC?UY1.V@<?)F)SEB_CK^)7;:^O0RR%15*)7%E]:/M^
M\N9V(9()B-XVWVT&?7@OD&JC)*P[,BFQ6_?=FL+V#*77'W1.K,2<[&,UV$0#
M,P//?EZ:#9_&X>1CA'_OQMAI38*:?W:Y4X4\ ]I<V-87ZG/:3F)^GIM.@Q7V
MGGR\TS*'7RKLA3!D72GLD@ESEJC25CXB8F1.DHO;]=MI]^^@^@^'OS3\/9?E
M4O18;=NG619XPT*TV#FL,P$E$?I<=HWT&"1B/E&OC$649#)/RH5,2X$6C5*)
MNV"8O("T8&/TUA 3QWV'\T==]!1\9\>^0 QJZ?<OX^NZRQUR$*74=WHH.Y[G
MR;)"=F%=8B(W_+[9T$F1J_+2*2%+LY%B&Q5L7G0(LLC8;4GN@H52F84-B/<
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MJZXLJ78M=R:U8VK[K!44B1 (D7*/;OTT$F7RU#$8VQDL@WLTZP\VGM)3Z[1
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M58R5M19@8/MN0T7I.0F8Y0+%C,COUCIH,OGO#?.,]5",AEZ0FMP&--"&KKP
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M'F@- : T!H#0&@- : T!H#0&@- : T!H#0&@- : T!H#0&@- : T!H#0&@-
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M/YIW]-OQT!R'EQWCE/T^N@4H\L\>L95N)1<AE]+#2Y0@<P#%I6\A(^/"/TG
M7KUWZ:!M)A$;R4;;[;[_ %WVVT!W Y<>4<OYN_7IH/.XOC!<HXSZ3O&V@]DP
MB"F2B('\T[^GUZZ YCTC>/=^7KZ_P:"EA\[B,SC59+&6@LT7\NT\=X@N!RLN
MA1$]#&8T$5'R;!7[(5J-P++&18D)5R,/^4;"'QW!B0B09/&8F=] Q[B]HGE&
MTQO$[QUC0>]P-YCE&XQN4;^D?C.@]B=^L>F@- : T!H#0&@- : T!H#0&@-
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MMM8.0DQ4:UQ (L$39<<K5*!%<DX3,9$27!#,_707L_YCX]X_->,M9)!6@:Q
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MB#&2'IOR_ &_B_E^,\BFY]F<?\L<=N/U()E<]^S8B& OV-XEQD>0SM^;Z0$
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M,*7W:9!;*EQLA%P(YA)K]O2-Q+>1WB(G0:?-_P!^>/?UI_\ 8W:!UH#0&@-
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ML)@':::X(&$MA <#/N'FA9=?J.@I7/COQJU=*[(V$VF.:YS46&J)D/D)8LI
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M0;YL%/(=IGB70ID8$-GX!G\_GJ=S(952J@18E%;'BLQ:GMQ$G#F&4\RY%MT
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M/>G%UW]W'V%%]BI937IRH=H8\3_,:^NY1Z[Z!+8Q54<"W&.\;<]-RTY>,O\
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M+M0V)XK@QG> CM^XHT$MX_E2E4N-KW\A=<J2566=2O,%#<.=B6;+2,S*[\"
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M\10A#!RM9QW*Y6J"5M"3>L1*8[<;]>7"8'\9B8^F@G\:\OP'D>,C(8NXIZQ
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MJ9+T+L%9& Y\H4?)A1);%TGTWB)@$\_"G)E6#SC3KU%=I(&GD0[T3HS 3+.
MALR6;0'+EZE,=-!K<MXFRU5Q$TKTTLIA)B:-V5BT9B52E@-5,CR!@3UB"B8G
M:8GIH$UOXTO7"8=KR!SSR*@KYPF(64O2MYO!=?K_ ,M ]TPC;E[?_-'+04;O
MPY%L5J;F2*O0CCAU37&.R,6(?$.-9@;OJ'J$[=?S=9#6>+X"S@:BL8MB3QJ$
M[AP7*SFRQS&O/;D40!<XVC>9WWWF=!EB^&L?.01;*]W!'A%E;527/M6VVU2O
M9@B$B3YB9(3](F.,]=!SE_ ,OC$8>]X^PK>4PU;'T41,*'].DFT@F\&D(')C
M<F.$F/'U@OI(3>%_&=W$)PSK]^#?0FO9?5!8R/W2Z+J1\61(^V1?$] C:1_"
M>@-R\'8KQS XNCD9KW?'94="\:1:,FI!UI[B9(8F"6TND%$Q/6)Z:";PWPM/
MC VA5;.U]W"I9+!$/>$%S*('VQS,Y+:(VCTT&9J_#MFO;==C/L9?_P"7*M9;
M7[A0=6U]R!NYM+N2742@> [?E@=!=QGQ9-.Y5L,RYV8383;:)H 98]%BU8@H
MD2V&)^^*-HC^3$Z"*K\2#6B:R\N?[L=87>N5>POFRR@IE1"W?D 1L'(=IWX]
M)'E.@ZN?%MTEU%4<U"*Z*]"M:JOJPY-D<:M@JAHBU4\))O.0WVF8B)WCIH*^
M1^'[.0REK(VL\9O>%F%E*-Y K(C_ #FD/;681P 8'V]"DI]V@MG\6%-FXP<N
M85\LZ&YE'8"9<(7&7%BHY*93L3B&9]V\>FQ==!?Q'@UG"OQS\?=%C:=:*+8<
MO830=K[AQ1Q+H<QN(_3?KH&F;_OSQ[^M/_L;M ZT!H#0&@1^$?Y3QG]#'\<Z
M!YH#0&@- :#(Y/XO\;R>5NY.V=HK5Q1*@H;M*><@7))<><;$H2$2*1&?08T$
M1_%'CC?M_N+%VQV;97V2YT'WGDP&R1[A[9YKC:5\9V]N_'IH*.,^'<1&'K5\
MO;L7<C6$8KVNY!#5D3(YBJ# (1 I+W08EO'3TB-@=+^.O'@22HFQ,&5(S+NS
M!26/*347(8&8F2*9+;;]FV@7U_B#Q-"C&#MDXF$[[KNP#8=,*X-B5B$0Q<UP
M(2VWF>I<M!;#XR\>A%M;6VGMR"&U[UIK>37=Y@M,R+C$<]P&(VB(@8VB-!;R
MO@V$R6?1G72U=Y(J!G;D(%H(.6*%G(2*.)&7Y)&9B=IWCIH)L+X?B,,VNVGW
M>=6G&/5W#Y1V89+>O2-RY3ZZ#,8OX;PP87'ULI;LW,G1174B]+(9]OV (9"N
M+0,(67</VF)=-M_RCL#EGQKXPVJ=1X-=7::#<LV3,'->O-88+:(G8EE/+]N@
M@_[7X60DRR&2+(S,1^]9LS]WV87*NQSX\>WP*>G'??W;\NN@FP/QMX[@\H&0
MQ\N EA P@B$ER<*%,LF>/<DB >L<^._7COUT%G'>#XJAG/WNA]J2&;,HI&WE
M63-TQ;8E:]NG<8/+K,[==MHG;04Z/QEX[3LUGBVVW[$U3C5.?)A54D^X*$Q,
M=%\MM]]YV@8WVB-!X?Q=XN6,/'S#^V0U(6R3@C65&2E!CR&1Y1W)WY#,3Z3&
MV@ZS'@@V<'B,/0NNJ*QMU5N;0E$6)@.<E($(\(*29Z<>.W3;;IH(0^*?&EV$
MM6ZZ K)36HBQ,K?83)R-A\%$R;)[I<IWVG\.D:"-7Q'XR-9:76+UJ4I&JES[
M'-@5P2202)<8]@"PICZ[SO,SH([GQ5CWYE=E=ZVJ@ 6"76%T_P#*V76Z]P&U
M/;,!LZO)3!<O6(_+TT%A/Q3XRFU6M@RU-E!$;G&P3.QSLG;V<1@1='..=PD9
MVG:9VZ:#4XZM8K4EHLV2N.#?G8.!$BWF9C>!VCI$[:"SH#0&@- :!'YO_E3)
M?T7_ *HT#S0&@- : T$5NP-:HZR420H63"&/68")+_\ =H,'C_EP+#*\VL%:
MI5G?;$RPQU:16%U!/K240S^5 %!_S.F\[>@1)^:<86,LWWXNRM=2PBLR!-9[
ME<"9J2!;C!0UFRMXZ"4[[\=R@)+'RH=*Y;K%B;5Z:CI&T:BKA"8*R-40'D8]
MS]4XZ_AO.@O8[Y,JVEW(;CGUK./L4ZEQ!&LN+KE]F/V$AF8* -7+?ZQ/XZ"K
MC?E8KA5"/ 6Z]6U%!OW!MKS (R;YK5F2(G)3,N&8(8C>!]W[-!L,YED8C$6\
MF\>2JBR:0<P7RV](YL( C>>G6=!A%_-5=B"8O!7&S7AA7Q TQVA6Y2=Q[A+E
MG+[@)'I'3?\ TA<_[K+B'\\+:@\9S+/C#$3%-8/-'.)Y_K;]LCV#KQC\=HD)
M+?RG64K'37Q=BU8R9L75KB:@GFN\-'W$90,1)GRW_F_MT%OQ/S:]Y!G'U?W;
M-2@FBJQ+&, FC9FU9JN24!)#(B54N)1^&_UC0/O(,O&&PMS*36=<^T7+/MJX
M\VGM]!'09:I\KXRQCVW(IG,(K*LM%;5-B.[<*GP@A+;>"#EUVG;UB)Z:"&G\
ML1>+[>EA+#<D=R*:<<;D*=')+WP;A80DJ.-4M]X_#C)==@K(^<<%88S[?'7&
M(2@S<V C<'KJS:))Q&\1$#'"3Y<>?3TZZ"2Q\Q)J /WV#M5&PT!L0UJ.TI+4
M@Y;#?!RH2,6;0)%'6)]WI,A93\GH&S85]C8M5J-N:^3OQ*0&O#KS:=?8.?)L
M22MYD?0>OKTT##P[SR/(W]D\8_&RRHN_4EQJ9#:[3-?+],BX3!+])^DQ^V(#
MCSWS.[@JEJOBZ)WLF&/M9#E$K%:%5X@>Z<,(.?O./8/68B?V;A!;^3JE?'U[
M(8Y]AMJ;8)0!+&2.ID4XV8W(H&.;+ E$_0?704T?*;%VVUGXFRT:SQ#(V8-$
M#6AU]E !X\N3>+%^HQU'KZ]- W\9\\'.Y4:48Q]-%BH60Q]MIJ(7UH;"A+B!
M$0$7*"XE'I,?7>(#WSSSVIXA54]U0[G<!KC4HPAD*KC!,(0F>9SL7TC;\2'I
MH-$RXL:)78B96*I=$>DR,#RT&/POR@G(7<;2LXFS0LY5 7*@--+-ZK:[;"V%
M*R+:9^W()'UB=OIH$-GY>R@X?+Y(,::Z9 /[GO%VR!;W8E5]27K@^9>\R@C&
M-NL1^,Z#0T/D!EC*OQM?'6+TU+)KR-F"0H*RBMLJJ+8S&61)).?;UXQOZ[1H
M'6;_ +\\>_K3_P"QNT#K0&@- :!'X1_E/&?T,?QSH'F@- : T!H#0&@- : T
M!H#0&@- : T!H#0&@- : T!H#0&@- : T!H#0&@1^;_Y4R7]%_ZHT#S0&@-
M: T'+E+<HTM&#6P9 QGTD2C:8T"@O#?%R5V3QJ33Q0,K*)(9&LN5)B8F=I@
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M!WZ^D[Z!W^],9PKG]VGA;GC5+N!LV9^BYW]W^C05,IY/@L;0?>M7%=FORAD
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MKH*U+X)\@IQ-P,Q0?E)MV+/&W2;:IR%V@FDX32YY&1#V(("D]NLC,;3H#,?
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M3W&198H"7)%ZJB%#TGW=(Y:"A4^8W6JQ7T8$V8UL6!QYQ9#[ASJ]0;<+),A
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M&.JNA-ALK:4P*QD#_4*0-G!?3]0N"CGB.\]-!QC<[B\D^VBDV6LH&*K<<&#
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MDEDE;#<W2M9<U^V>/I^2/J%!_CWG94A%-#,KK0EX)JEF1*T.1)285;-W>_\
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M;38OI*?MUA6;9.33!+DF;)D1'EMOUZQ'4*S_ #VYA)=2RM>,O;QJRM9>[C.
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M?;RZ;Z#SR'(#D?C]V0 )6-RFJP*RG>1AL"<#,Q^&^@T^@- : T!H#0&@- :
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M2Q3E$ "W:53'*>2V"0[;[[Q]= IK?(HY'RC&8/'8^P)/BR>5*XEJ658K@HA
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MP#Q&RP12[[B9(PXG/$0F9T'3?E'R/&WLRC(X.&LQ_>M-KIM*V15JUJ1L@62
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M#8$CMM/KUT%7"^#XG%9&,H#K-O)R+A==M-[C&]^$C//H(^T:JQ':(B.OUF=
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M^2_(:,CF0Q_W4VDS>&OCXH<ZJZBJAG4MKL\/U6F\0B5\YWY2/"..^@7>9/\
M-/NFTS?>R%C'-L%4JSCA97>B,2_MV6.4F%D9V&2OM[[>D</Y4A?R>>^1J,VK
M8MMOKV'Y-"JRZ2]JBJUQ:ZKA(4L.8E)$1$0LW'J(3MU"IALS\C9!V.ATV*KW
MNFI9RD41AT5ANN@2W=75$<DB$[DH8Z\N,;Z")'E7RRS'Y1M@BK6%2OFJ*;S*
ML7W7$EJ**)!P)._OB+&W0ORST#=AE_*&?&W[S15=_B*:$L"N]0][O0/K*1X1
M)?RH#8=_3:/308 <WYI3=F'4+>4;5L->_&WSQ)2Z]<74IA7K-3*1A22F#CG
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M?N#,#!+@_P"5!'$;Q^,?CH)78W'.42G54L44'!+-8D,PPN1Q,3&WN*-R_&=
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M2/NP_C7"^XB^[([:>?<J2N((U.+;^:?J'T+-_P!^>/?UI_\ 8W:!UH#0&@-
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M<9ZCMH*3OB3QQZBJMM7BQN\N3CY?$J5:)/9FT!R/>[NWNCD<CRF2X[Z#J_\
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M.J74E3*9.S4:;QE,@SW^^$QL4B.^_P"70-?'OEZ[<^S+*TZM&O:=Q^\EX=J
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M:9/'?*B\[E44[E\::U-7CF* + E5BK JF#=86'W'?ZS,CSF?Y7&8F T6$CS
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M3<;B:C+59A-KO)*Y,&&V7$8E,;P4MF3W_G==!%F_[\\>_K3_ .QNT#K0&@-
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M1_&=!R/REXB4M$66I8!$M"_M+'*R8/FL8U8X?K2+HXSPWV]?3KH+X^;8(_'
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M9:,0>T?FT'9_'GB+'):=&2-)2<[N?Q;/?*U'?'GQ? O83!AD%M,]-!Z[X_\
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MKS)3V4A$#L/OVW+D6VT<MHB-!1QWQI@Z5BM8FS=M/IP"ZC++H.5(4AU=:!V
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M>0&!**)9 E,2LI(@GK^69Z:#4: T!H#0&@- : T!H#0&@- : T!H#0&@- :
MT!H#0&@- : T!H#0&@- : T"7-_WYX]_6G_V-V@=: T!H#0(_"/\IXS^AC^.
M= \T!H#0&@- :""Q?I5B$'O!9EM(@4QRF),5Q,#Z[<S$=_QF-!/H#0&@\,Q
M",Y@1&)DBGTB(]=!!1R%&^GO4W!83[9ABYW&8,!8,Q/UW Q*/X=!)8L(KK[K
MC@%\A'E/IR,H 8_TD41H)- :#A"$H4*D+%:AWX@,1$1O.\](_;H.]!#-RK%P
M:4M&+1K)P)F?=*P*!(HC\(DHB?X=!%?R^+QW'[ZTNMS%C![A0.XJCDPHW^@C
MUG06&O2D8)S!6)$(#)S Q)',"(QO]2*=HC01_?4^P-B' 2".%BT9@ADR/MP.
M\;]><\?X=![3N5;M55NHT7UGC!I<N8(#$NL$,QZQ.@\.]2&P-8G!]P10,*WB
M2W(2,=XCK&XK*8W_  T$CT)>J5/6+5%MR XB1G:=XWB?VQH.]!#6N5+,NBNT
M6S79*7P$Q/!@Q$R!;>DQ!1H.W/2A4M>P5*';DPY@1C>=HWF>GKH(ZUZG9(Q0
MX&&O\X#,<A]Q!UCUCW+*/]$Z"?0&@A7<JLLNJK:)6:\ 3TQ,20"S?A)1].7&
M=OX- I\W_P J9+^B_P#5&@>: T!H/GWF.6JAYIC<=4SS*V<(JK?L2M BHJK#
MI[DL3,C]PRW$2D GD6_N'CM,R"[XE\GNV[# R]Z77;=6L^Q$W9L+3;:;!.L:
MF O[:QN,_HA/'B/IO$D0?3+A$%-Y!.QBLY&8]=X&=M!\4I^;-PF&P^4P65=Y
M#9;A?N?(*;[I7E(=,5Q"PTF,G[?BUI\@YA$CR]..\!9L?*?E"NSDY6@C-)U>
M*VI.C$S=6J+AP-HDCL)<.,V=N7\O07I^7LZ(46V!QE.3F@+*C#)K;@W+A5F-
MHDAC D5@'/:.YUG:9Z1R!8GY:\CRXAV[=&JBO;I&UZXB!;7NUKA0@^%ETK.3
MK! S)">Y1N STD+<?+V?1BV/4N@QRJK^&),GE=5-:C]R%NP4G,S7:<0/Y8G8
MQGF4[QH-?_B[/TO'?*;5ZO7N9/QUIK"*HM6EL?:ILB4@1.,8&'['M,]!WC\-
M BP7DWD'D'GN.JGDZC\7CAO$RQB^\-6\8*J2$C,.,9[,VY$ADC'>-_S;< AM
M_+.;KV\HL(QMD:MB_6BNOO=ZD%.V-<+=_P!Q?HR)\RXB/[)GKQ GY<S547$]
M%/(54N/AE*,-^W?4H3#<D]<2;/\ A5V# #!3$L$HWG05+7S#Y?6MVDNQ=-9U
M:IOFJQ@ V>5$KJV#!6(<0#[5G HF-X*><;<= _Q'GGD'^.T^,Y::)0T(B#I@
M7,F36BS,D,O-BACJ,<U<)]>YRGAH$]OY&\CQ-G,(?D<;$HO9,T-OBP %5,$$
MBA$ R)[SA=) 7KQB9@"^@,/-O-\OB,CA[Z+%;'B_"WKK,9DI.(<Y9U3"NL0(
M/^8GF0#/68WG82]-!/XG\C9S->9V</8H)K4UE:7V98J+B9K&(B;5P\VD+=]_
M^ $1N.Q%OOH%5KY5\EG,KQU2<5]Q;>ZNNBR'%9IRO)UZ %;$61OW L2V-H#Z
M1&\>[006?F#R$,OD,;5''V#2+0K$0DN1<C(5Z)=U8V&NXE]P11R6OT]O..N@
MXO?)7F..R63;993=./KG6BDM<J4;PR8U2N;M</%:DM$F"1[1_/&)WT'C_D_R
M/(U:R&OH8IDV: Q(-@G7Q;D_MSFD27N7$"M?ZHP3/S;3,1[I![Y5YGG,)Y?>
MJC>IJI,K8P:XW *%5?N;%E;K;2%@22X[0A/Y8Y$'N'KN!D?,<[;\/P671;K4
M#LY==2Y;$2*LZN+VH[B9,@D5V. F$R7H4=9]= @K?)GF>(\;Q2KH5+=NU2Q#
M@R);B*@O(L24VIL6*X&SE4VY]U<21^G38@9^6>29*]@?#+S["<5.4>97@G*,
MQ]8MJ;C@?O:W<GC)C!!$;Q/3KH%^&^4,Y4Q.-4UU:P:4UI,+<FRWDY=>;5/]
MWL"1[HJ!4&+.V4LB1DH'??02X+Y;\DS5[["G&.)EBQ0&M:XD0@F[%HB[BE66
MGS&*L;09++W>X!T#7P;S/+9[RAQV;=9JHQ46)Q-.3YU6S9(939$R*.^,#QF=
MA^OMB-ID$4>>>3^26\%03>IUU7;5&S>G']^&5P;#R/'63AHD+H[,<ICCOL42
M$1ZA]+S?]^>/?UI_]C=H'6@- : T"/PC_*>,_H8_CG0/- : T!H#0?)<[XK\
MF6_+\G=QI'22]=Q->T%LH5*V5)&M[98PQ*'1&_%0P$^X>76= ?X'\DG+T,E2
MQ3\="X[*P;DRLMKJB]3>?,B842+5I?[ (_7K^;: CI>!>:6+M%-\;2:0.5_B
M!G[S:?[P8,LD[*A$X)*YB8B5QQW@H'CL$3H+?BGB?G^.\IQ5J]+G4TI[%MMB
MX3@%(*, %<"P2EG+A)0Q;!G\_."Z:#2?(.'S.1C'%3K.R%!!NF]C*UPJ#&$:
M]D,[T$OVJ/>9'E]>761B-!D?\ ^;!C^YDIL9FXUY#?0G(LK=X8I@NNT#Y@(@
MNQW"(.DSORVF8B-!R'QWYHRFU3S>!5<2Q>*!-YBA#(#2QZJY;+,(]CJ[YCE'
M'Z[>[02'XI\DL\Q=D(%J*;;$R\@N3VF*&_6:J1$FF?2NID%'$(C>1$9&=]!
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M86<!N(V:?*)9QW_6VC\W$O30*_!L5\D5?)ZUC.?=MJ-HJ&^=FR)*6Z*RAF%
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M?22GHKDI9E,I[(]PXGBT0V@Q%@%,%'YN/MT'(8G #E'9J/.%#G+PDC)W "M
MLK$*@[:E%R%1#%<=C]W69WB>D0%=?B'QZ&4JWO\ $=5L*E<V%M[1R?8LLLJD
M"DMES!-VF>)>D3'$NN@,;XGX+3R>-OM\GJ6CHKIK;#15,LG'>VL0SSF%E B$
M'TG>1W'C,Z"SG,'X=EK-T2\N4C%W6V+940[$D-FU4.H;!<6Y<8@^<#,>O[-H
M@)+T8D/&LTE?DM7)YS(W$9-;B8BJ,6*OV_;@!V8$"/V@E$'OOZ%/UT"O 87"
MLQ^2L9WR:JG,91G?DDG7+LL7=^]KG.VZRD3@>0=1^F\^N@L7/'/&+0V&SYJH
M+V2"RO,V!&OQ>%DE%LM<SLGA%<1CK,[;[^[KH*=7Q;QR_AAKY_RFKWZYO+&(
M42)76[M^+OO(9B7\I4N-IF-HWC\WNT#?'JP6*;2C&9W&+G&U;4(L%("#+60L
M+:XB2!=!$4]-RF9DNLS,;Z!_YAY;XQ8\9R"492LUIKV!8,$BF>4>D1H''^-?
M$?\ YBI_[P?^.@/\:^(__,5/_=#_ ,= ?XU\1_\ F*G_ +H?^.@/\:^(_P#S
M%3_W0_\ '0'^-?$?_F*G_NA_XZ _QKXC_P#,5/\ W0_\= ?XU\1_^8J?^Z'_
M (Z _P :^(__ #%3_P!T/_'0'^-?$?\ YBI_[H?^.@/\:^(__,5/_=#_ ,=
M?XU\1_\ F*G_ +H?^.@/\:^(_P#S%3_W0_\ '0'^-?$?_F*G_NA_XZ _QKXC
M_P#,5/\ W0_\= ?XU\1_^8J?^Z'_ (Z _P :^(__ #%3_P!T/_'0'^-?$?\
MYBI_[H?^.@/\:^(__,5/_=#_ ,= ?XT\0WW_ 'O4WCT_5#_QT!_C7Q'_ .8J
M?^Z'_CH#_&OB/_S%3_W0_P#'0'^-?$?_ )BI_P"Z'_CH#_&OB/\ \Q4_]T/_
M !T!'FGB$3,QEZD3/K/=#K_]= ?XU\1_^8J?^Z'_ (Z#R?,_$)VWR]2=NL;M
M#U_UZ#W_ !KXC_\ ,5/_ '0_\= ?XU\1_P#F*G_NA_XZ _QKXC_\Q4_]T/\
MQT!_C7Q'_P"8J?\ NA_XZ _QKXC_ /,5/_=#_P = ?XU\1_^8J?^Z'_CH%]K
M/X3)>0X!6/O)MM"P\S!)P<P/VCHY3MZ1O,1H-5H#0&@- : T!H#0&@- : T!
MH#0&@- : T!H#0&@- : T!H#0&@- : T!H#0&@- : T!H#0&@- : T!H#0&@
M- : T!H#0&@- : T!H#0&@- : T!H#0&@- : T!H#0&@- : T!H#0&@- : T
M!H#0&@- : T!H#0&@- : T!H#0&@- : T!H#0&@- : T!H#0&@- : T!H#0&
M@- : T!H#0&@- : T!H#0&@- : T!H#0&@- : T!H#0&@- : T!H#0&@-!__
!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g140648dsp005.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g140648dsp005.jpg
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MX!$CY3\=?-.!DT_<7'U718!JNRM#CK0\_P!,H@&. 0"2D8F9]=QF- \S_E>
MP JG+6OM^_!DL16QI<%1$L9(J$Y%:X*.9E[1WZSH.Z?DV"NO0BK<!S+)601
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M.*L[EQ]L\>A<>H;KPWQ\L!XY5Q1$,FF6&? C,()S2;(C+)DMHD]H]/V1$=-
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M<J8DE!#2YC[NG;,3B8F>DZ#+_P#.'#(=;/(5;-*L,U1H*>OLV'E86UTS -(
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M3,=L8,[)S,+4AU85Q'I =FR8S$1U]?7KH)2^*O$R%BR&R54P,5U)L,E"C<,
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MC!-'W+@(W$%GUB>7#0/L#\A^36[. I7JE3[OR1-:_0FOW86%.0)EV#DYGDQ
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M,#)3,[S,[>L[SH.^ <^YQCGMQY[==O7;?0<16K1OLH(WVW]L==BDH_Z"G?\
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MD2X;[[3N6\Z"5M#Y9LYBC8D[U.H;VL2D96Z4P62<R1M0-M*Y":<J$=Q;$1O
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MG0>Z T!Q'>"VCE'2)^O70&@- : T!H#0&@1^;_Y4R7]%_P"*- \T!H#0&@-
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M3*)8M9=O<($Y"7#S@9F1^N@M!Y]XQ%I5.Q>4JVYYH6H>9Q$C8*L'=/A JEC
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M:KAS80BI5@YVWB)F1@8W]Q1H,_FOE++EA\A>PF+3V42**MFW: "*SP2TPFO
MR?&%NG8AF9WC>1@?=H+$?)[T?<0>-*PC&M+^,6">L#2#,B^BKL+A8]_::Y3M
M[9X[=2/05/\ G#DAH)L,\;.&VJ]:[56NS+X^ULP[]1O90QHR$U^L L_S1,S$
M<M@T_DE].1\!?D$2))N5%O60%!C(LXE&Q#T*-I]8T&ET!H#0&@-!5RV2KXO%
M7,G8@IKT4-LN@(W*02$F7&/K.PZ#YV'S)D3J]P?&7B^$NMDMS65PFLBO%@C
MWH61EMN.T!QY;>Z1GE 6F_*N4%S*H>/Q-U(6+#U%>6 C616KVH*#E>TF2[<1
MPVV@H_-Q]V@@H_*.1^_<^_4$<5%A\*8MD# 4191"+%@37R@E??<BB#VX\M_2
M-!9H_+?WN8IT48.T:+,UI=9"&GVEWC**K)X*)?$E<&'S8,C!=.6TZ!GY7YG<
MQ>5+&UZ9&I2:=FS>%P 01;N?:@ *-;><S(SR].GIUVT&?R'RGG7_ &08W%"F
M;S*C\<P[*SFQ5;D54R!H</T",6;_ +W&/Q+>(#S_ )L9\;%YLX(6UJXUT_;J
M<QC%V9L7$6".5):9JB:,\2!<SMM,C$3/$/HF*R:\GAZF3J\#7<0%A/$X,)A@
M041#!WB8Z^L:#!>,_*67MT,<W)8I?NF@G*VD6(B%NRAP-;LI(()@>\).>4;;
MSMRXSH'ODOGT8+R*GBWT"FE8%9.R9&0K G,)8+CBLPY[CZ,,.6\0'*>F@SV/
M^5\SF2Q$X_"%45?O4QEESO+$Z5M;CY+(T+B7#V8F1'D'7H<_0+OF_F/E>+\E
M1C<560VJ2\>S<V<6&RUD@JFN>0$(@2YGW>L>L1.@B#Y?,K]:C&!LL?$P.5A$
MM?%>9NMH^PUI(&#!US+=A+]OIN7MT#?R_P TL8#(0I%)V0/[.7C55,;%,VDH
MY3 +:Z>$-Y3P@IVB=@F= B+YI0(&XL7M5&DVTNQWYX.>BL=@ZZC[/;DA[1 4
M$8LB>O;VC?07/(?E>,7DG8RKB'9"\IDB*DRP^2PJ)M,+]%+R@H^Y$1B1VGUD
MAC0/,UY7<J5<(>-QLW+>=;":U:PZ*G;WJLM;M*1;,3 ID9&!F=]!E'_,<?;!
ME?X8U6&3 DYHN5+6,/&,O]GM2$QQB!X\X9'7:?R[Z"YF?E3(8AJZ5KQ]CLO
MO=9I4G%<@$5X44D)H29<RBP/$6@N/Q*(D9('/FOG$^-XZK:12^^?:AAKJ2;
M9VU+[AE J589/&-M_9QC?W%&@3!\M2VF>13B.6-,PJ46';2MS;K)2(J))1N
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MQ%J(:ZT4'3L6.I1 3LF>)3MPCU$+?BI>47_'_)+V7JV!RM[#5H(32:2.P"+
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M9),=Q)D(0XS*)&8..4QRVVB 9YGP;&97*?Q!EJW7DRJE;JH8(ILS2;WD=X2
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M!IJKV*I612TY$9EWLF(F-HF-RV]NT@JH_+&:9C\M;;V&(LE:.MC_ +@AR-2
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M0&(&/PT%K%>'>-XG)NR>/I0BX\3 S@V$, UD-,0612"Q)D<I@!B-]!!3^/\
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M6R)@HDE 43$Q,3'X;Q((;/Q6JQ#4LS=UE2[V&953H4P[5BK/)3B;(\@]T#R
M-AV&(CC&^X<Y;XO2W#VT5+1G9E*!K@<"(DRG2944)3$=!/N;E^'TT%1WQ$V_
MC5!DLY8;D"%*[+)2B5$E*"2M4IXPLI7W#,3*)]T[[;;1 7:OQG3QF(574;,G
M]F;K U&R"AL2W'?P^4F41L(D'7?\?V:"Y@? P1\>1XKEK!O?;KL'*7 +=AV+
M&Y-8)S'61(O;,CZ1&\?3028;P3['.#GKF3;D,J7>^X<:UJ X:M*AB 7$0, %
M>/Y9F?V1 5\[\;IR_E=7R!N2<'VKJMA=206P1.H?.!69Q)+!G[\#UF?K]- X
MS?\ ?GCW]:?_ &-V@=: T!H#0(_"/\IXS^AC^>= \T!H#0&@-!G+GQYXE<R#
M[UFH;3L]Z7(E[OMY*PJ4..$0?:@V+G8B@=_KZZ"W7\4Q*<19Q4S9=6M[R\WV
MK#7S,Q$1,/-DM'C QQXE&W\N@6#\7^&0*Q^T;/$B)\S9L;V>;.\46Y[G_$#W
M/=LS>/\ 1,QH.I^,O$N^ZP";*G-EDB:[EH)5WG189".+(A4$V.4P&T=9^G30
M<3\6^$=L5#1,*\(^W*N%AXJ,862A-BX/B;1!A1#"B2Z^O2-@YS'QI@<IFUY%
M\M!4J>NY74YZI?+UUTQR-; GAV:O @]"WZ]=!9L?'7B;WO>=5@L>4L&5O<OM
M,DDGW$<#CLERJK+<-NL?MG02(\!\6178A=0N#A3#B)K2-DU[)W ,S(I(C^X:
M1D4SN6_70193P/%9;R8LUD2-Z_M:U8:,,:M136>U\2X0,0</)HS F,Q$C^W0
M>8WXV\2QMA5BK7=W$2C[?NV;#16-63E"UBQA0(+[I<1CIUT%S+>&>/Y;)JR=
MU+"M*['^[>Y2S^T=]Q7[JUF(,[39DAY1.V\Z"JWXZ\48FJJ*S%322NO2<E[E
M.2"2(@[;0.#$H[A1OOO,3,3TT%Z[XIAKF)JXMP.A%(A93<%AP6%,")&&#8$X
M=SV(HDN6\Q,[^N@K4_ _%J7:BK3[4(8IJXAC)V-*C0!3N4\IX./>9_-,[SO/
M70>K\%\<58HO2IR#H(154*;#U@Q-3_\ '!X <"[MS,\>Y$Z"QE/$O'\KD0R5
MZI#;JZKZ .Y$,Q7M1$-'89B-YB.A>L;SMZSH%Q_&?A[&L8RJTS,.VJ2LV)[$
M<P;O6_4_0*6) ^2]IY1OH)E^ ^.KLU[(Q:^X1 P;9N6I)\ PG!%F>Y^O L,B
MB&;[;[>G30=Y+P;QS)9@,O:2W[T3KL+MV'J69TV=VN3% 8K9*RF=N0SH._'_
M  OQ[ 6&6,8EBV,4%;]1[G0"%&9K2L6F<  2PN(CM$:!C5Q5"LRZ:E;%D6]^
MYRF2@V=H$[[%O$?IJ&-HZ:#/K^+_ !!0_I)LK:/:BO8&Y:AR 1#!4M#.YR4
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M0BV:Q"I%G(HZ1^0IB-YB)F- G\&=YI=RANS;[BZ%>H'VB75U(^XEEJT ML1
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MM:S>^Z?>9VV23T<[*.T.Y*D@EJ^6VVWM]P/R\.^2)K2]5^U&8B*::]E]OV"
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M?0ULXD!1O^,3H-'H#0&@- :"&[;53I6+CH*55EFYD ,F7%8R4\1CK,[1TB-
M@9\B^*#+H79.P:#[9@A+&EO]J-O<1 9F1[1C[HZ<IV]=!7Q_R7XWD+5(*[Y[
M-TC0/-318%@'0C@SV\!CN3 [S/K,;>N@X1\M^".L"J,A("0$SOL68*CBJ;'&
M3F/S2@>Y$?4=OQVT!3^0Z]RMF[0UF4Z^).L E=4Y+"^Y "W-,AW!CWQMM$Z"
MWB/D+Q_+S;&C%HV54,M"!UFKEZE&2S*OS$8;LP)'V_7;\8T"7$_,&%+$XZSG
M$NQUS(59NB@4/,("5'8%8F2PYGV DIXQMH'&0^2/%:+W(8YSBK24V2KUW/%:
MEK6UKS)8E$*6+PY'^,[?2=@F5YWX^S%W,J)/FA3L34[W8;/??#OM^%:('DZ9
M=[(X1.\Z!?1^1*^2\GIXJA59%,ZEFUD;EE;4E7.LR%2@@(/:R#G<N<QTVVWW
MC02,^4/%UXHLJ0W8I1(R#)I6!@U,"6 \)(!B5$ S,%O^SUVT%,?F#Q45VG6H
ML(0JT5>J?:,YLJ"NNP5A8P._;$'1,_Z/K,1H+9_*GA@.()LNE'!IJNC7<59O
M8&":*7",@PAY0/$=YDND;SH(K?RGXZM3%JBR%]:VL=6?5L 5>$\.4V1@))<?
MJAM_K<HVWT'3/EOP=?WF]TIFG/'HH_UI[XUOT.GZD0XQ"9CIUB?3KH&EWS/#
M5,;1OF-EG\3G:C356<=IDP$L*(1 ]R. #,EO'3_HT"G%?)6/O+\BRA*)7C6"
M!3 R/!LE8 ZPV38 <(]L P=AC<OQB-XT'5OY9\+ICM=L/JN$CBS5?7<MR 5
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MS+AIK(9@GE7@Y:*HG\TCVB__ )G0.!R%&9.)>L36(FU9&,$ G^63C?V[_MT
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MV64F%<<LYO5?LRF9&H<=(@X+?KML6_KOT!'B_A;)5,:JN5FJ-E;DQ]P,M/\
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MB"G:?29@2B9B)WB)C0>>0^1XS 5$6LB1"JQ:127(#)SW;+(6&\1](F=YG\-
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M2DHE<Q,2OW&4^S;UG\= RQF$Q^+EL45RE3!4 UQG92Q2N%@*P_*$<8^F@O:
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MT&)R'GWF64P&0/[_ /A-^:BWACJ]!Y.4B$HL%<BQ);0!29CM,?[/YQG0,/\
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M4I5YL6VBE$$ 2PYVCDPX6$?_ +1E$1H)] C\W_RIDOZ+_P 4:!YH#0&@^?\
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M8[-2Y2MH7(_J"UE>XJP.^PRQ8,),'L AM,R,<>N@ME/RL-!ZT?Q1>8BH\2&
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MV7 2XAO(KZQMH.\!'R=?O36O'EJ5"S9HF]AP(L5$Q:^[6+2&/;$BF"( $?\
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M><!!"D2X#T&)G8O:1:"##_'/F)+QM3*R4XY-@ILUIN%/_#?>.>"Y[4+B8A;
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M!RZ@6FF"!VB):[@;R@8CU(A64_MG]LZ#JGY/@+>*#*KOH&@4!R>;0$0)D1,
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M#_N%@ $4P(BSK^WZ[Z!GF_[\\>_K3_[&[0.M : T!H$?A'^4\9_0Q_/.@>:
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M8DB(>O'C/304\??^6+E;(Q-K)(''ULC9QS/LP@K3E*ILJ)/[BJDS$F&\8B%
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M>*JB)M/,8.6F':KVF<$)E8FU^R8[,!+PY272-_7UT#/%>:^.Y7+,Q5&P;+8
MUH[I<"F+KM%+34TP%;!%IP.X%/7057_)'B2+=JFZRX+57:.Q-6S!NF6BB(KC
MV]WSW3$/T]_7\- 1\D>(2P FX81*N\UIU[ +1'$SXV&$N!0?%1SP9,%T]/30
M0J^4O"VRD%VW%8<<K&K%6SWQXB!29I[?<%?%H3SF-MIT#7#>68/,VKE;'.-Q
MT3-;F=EHJDEG*CA;2& 9Q8$C/&9ZZ!+AOE3QC(UZC&_<4FVR@94ZN_9/<L'6
M1+V0';5WF+F%\YC?0-\W_?GCW]:?_8W:!UH#0&@- C\(_P IXS^AC^>= \T!
MH#0&@-!D\A\:>/7[MI]AMN:]O[DFX\7R-:&7$%7>T0B-Q,P.?WNA=8VF9W"P
MGPFG7P>;QH6776YP63<LY Y?)L.L-:). [/MX+'VC(_LVT"7Q?XR8@K=SR>V
M64O6S/D,M-H=IE0:9 9F($?(!F?RQMO]9W*0M%\48$A COY([B]EKR!6IFP-
M<5&F*T'QV[7!I?3EO/+ERZZ"I5^'\(7W]?)O?<Q3F1-/&]TH0L!HJHBPAVB9
M= ++W1.W7?;EUT#$/C]->O2J5+C(15LLO&]L!+BL]@D(D86"U0*^?/\ +UD8
M_&= PS_AU'/X^A5R5A\NQYBY5I4@)RV%$HB(2$U^X3+]WI/4=IZZ!9_RH\0E
M*4M4YRTXJ,&,,:4[U1F)$IVV_5';:&>NV@]3\7X)/9)5R^IX08/L)?"#>EA
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M3YJ[3X19.T@&;+Y\5,9,1Q*)(=H.2T#G-_WYX]_6G_V-V@=: T!H#0(_"/\
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MKMGVKY1(LC\.L>H.<UB4X?XY9BD[2JC377"1B8C9?$8V@B.8CIZ24_RZ#5:
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MOL_<@-A8]XTR,$!"M9,G]3>.(SU_9H%%7Y!NY+R_'8&EC'U-QM,S470"&HA
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M^DR7ILWNV)*;"@-!M>=4 :$LYD7>40SVA.(]9F!ZZ!_F_P"_/'OZT_\ L;M
MZT!H#0&@1^$?Y3QG]#'\\Z!YH#0&@- :#*5_C7QS[_+7<@J;[<LZPU@-)D*
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MWI&.7X[== QT!H#0&@- : T!H#0&@- : T!H#0(_-_\ *F2_HO\ Q1H'F@-
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M,V(7/;LU>PNLP!K2[@L^L?K\8V@H'EH)<E\3719>/#+KU"?9M]B88P>--],
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M==4V'O6YCAGNN%:X7]N763VG]V2W'<&7_.+QO;[@JEX,5 K)F5)00@"=3^]
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MG\)Y=/IH%G_+/PV97)TVL,2DG,.S9([&YPSC:*63-@>0Q,"WE$?R:"V'A'C
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MHW0?&181<E^R(B>.TS,%H%Q?+GD!9O*4DS5^T3#>%AJ2@J0IR":9NLK![#D
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M"J5A^P5"9%N1M I,'+4(G> (IGMK'EM!1TWT$D>9^>SW]VO&)G_]9G^&G_\
MI'_%@O9&XS]U^@1EO[_R]S\L\=!KOC6_+,#%6S88[(P^[:.7J.NTT.R%B$ME
M1Q$A!P&\#](_9MH-=H#0&@- : T!H#0&@- : T!H#0&@- : T"7-_P!^>/?U
MI_\ 8W:!UH#0&@- C\(_RGC/Z&/YYT#S0&@- : T$3;=5+D):T =9*0KK*8@
MF$(R90,?781F?Y-!+MH*RLGCFY!^.596=ZL ,L5A*)8L6;\),8_+RVZ;Z"6Q
M81623WG"U!MR,ND1O.T?_6=!)M&@-!$-JJ5IE06A-E( UB(F.8@R2$"D?I!2
MLHC^2=!+M&@-!!-ZE%B*W?#[B2D85!1)<H'G,3$>D\)Y?R:"?;0&V@-M!&-A
M!O- G$N4(FP/J(GO S/\O&= 6+"*ZNZ\X6N)$>9=(W,H$8_TE,1H)-H_Z?70
M&@-M : VC_H]- ;1H#04\/3Q=3&IK8L0B@'+LPLN8>XIDMBF2W]TS]=!<VT'
M#G)2$L<8K")B),Y@8B2F(B-Y_&9VT'*;59R.^I@DF)+=D>FX3(E_T3$Z!)Y=
M9KVO"[MJLP75GUQ:EP3!"8'(D)#,>L3$[QH-!H#0&@- : T!H#0&@6U_&O'Z
MV6=F*^/0K*6(F'7!6,,+EM!3)?B7&.4_7:-]!<JTJE06!62*1:PW,@(V@F-*
M3,YV^I%.\Z";0&@\@ @Y9 QSF(&3VZS$;S$;_LWG0>Z T!H#0&@- : T!H#0
M&@- : T!H#0&@- ES?\ ?GCW]:?_ &-V@=: T!H#0(_"/\IXS^AC^>= \T!H
M#0&@-!\H\A\.\[MY^[:HBU=[G?.AFRNS]N"GTC354NKR_3-9EM)P'^UO/*=@
MU7QMA\]B\193ESL1++$G6KVC!AJ7VPB1&0;9]I'!%M+2]?IOM (,MXGY31\H
MRN<PM-EC^(66<TA<[7<!F,6A;9%A\(A5@"^G+;K$3MMH%2?#_DQ5VP0E8*'4
M:ZC>V[,P+%KKQ(HXN&/SK9R@U?69AD\MM!-7\*\Z>Y:;/W:4RZM&;?\ Q(RB
M\0W@8RQ7@605=?VXF,A'"9@H#CL,3H&=OQSY 5X>>-0Z+0"\UKHR;/O(JQ=(
MEE%R;2>[M5XQ"SD=_0BGTD$&,\)^0UMIML5[,9,:]:NC)_Q&(&M",E:=/?6)
MSWX^S< 1$P?^K^):"3&^(?(2*D)R%6Y?QH6NY8HCDR3=LS*##N2\;';D ;P+
MVDJ3_-*XD8B0+OC'E=->,/-1>R^1MY*I6>FID6HA]96&+O")=Q(!'W2B(M^$
MG,>O6-!S4\"^1:OWAH)JLI<3!V,E%Z9AIQCHK@HIDN?<6P./=[?U@_IT"<_!
M?-+4Y!J@NX^F%.X7CV-+*,-M:[(UNQ+6 XH/=JFF,$9B,3^W: ^JT+AV0=)H
M8B4M-/ZL1'/MSMW VF?87TT'S+(^*_(19[/MJQ89CKI=SWWB6;4C92R:U4P;
M$+YUQ:N)-(2O?:&%$R6@J9OP_P"0;%2?L$7:R![$T\=_$Y>00$W/8XY<@B@>
MZG?@_<>G&6<-!8GQ;Y+_ (YD7@3!7;^W,GE<(@$@L5CD*\=T=UB -B18D2B.
MD&?*=!Q1\(\W>RI7NC<KT^[3C.%.38<W'+-DV+29!G-2F#,1(1PDHF(X1QT'
MT+PNAE<?XU3I94C.[7[BR)C)<?;AI=KDR9*2GM<>LSO^/70?/JWC'R/4MU[@
MIM-=2>#LO!9&#'*&-J"@ZRS/@@11R]A<(G> VGC$Z#?^$U,S5\;K)S0R&2[E
MAC@)O?D8988Q8]S][BLAC0?)\I@_D2IE&6K]:Y-&_=0I]2KD"&'D60$A%1S8
M,Q$J_*.1=N/W>(QM.@NIP'G;,R=!'WBLA6K46T;AY S1C@9?N,X/"3VN'%2!
M44['RVVF=O=H+^)\)\R<ZBB^%RKC8;3_ (PH\FQQV7J59BS: P9S!33-7LB1
MY;=0';J&S^.,%9P/A]'$V:TU75):!KEO>B=VE,&)\C]IQ/*(GK'IM&@^=5L)
MYUD*=VSC:]O@VUD$W3?D&3]VK^*SV?MDR]/:E"%G$#)+$HGCN43H)(^.O,+_
M (ZQ.<39N6*M=(TJ9Y H@B5E7V)&>#87)_9]H!(YZ>F_3?066>'?)3,M0:5J
MT%5?^[@+ %"/^->QL.YNB#AM<UAT6SI''V[;Z#5VL?:QWQ37Q]L(7:IXNK7L
M!$P4"Q2P X@HZ3M,>N@V6@- :!/D?*\/CLK7QEJ7"ZQ*QAPH:5<"><K2+'B,
MK F''$8DO7^6-!S@?,,)G+#J]$G0Y2Q? /0U'<0R9$'J[HAW%E(3$$/_ %:!
MU,Q$3,SM$=9F=!G<7Y_XSD[:JU=S0BU!%0L/0Y%>T*^I%6<P16V(CK[9ZQ[H
MWCKH'QVJP% FT!(CA8C)1$R<QR@8W^NW7;0<%?HC/$K*A+G"]I,8GF7H/K^:
M?PT%+$>2XC+V;=:BTF.I3M8&0(>/ZSJ_J41O^I59'3\/VQH#%^2X?)5(N5W<
M:I;2#FQ*A+?_ %>>V^@ZRGDF&Q:)L7K(IJA)"VS/5:R&1&1,HWXSR.(VT%YM
MBND(8UH+64Q F10,3)>D1,_CH +-8W$D&@3AC<EP4241OMO,>OKH%;?+_'%9
M;^$G>7%Z&$EBM_R,%(OXF7H.ZSB8W]?3UT#7OI[W8[@]_CS[6\<^.^W+CZ[;
M_70<,NTU$0M>L" 9(Q(QB8&-MYG>>D>Z-!Z5RH#)63UBP0[I!)#!0$?OS&_Y
M?VZ#AF0JKL=@S@2XD9'/Y!XR,;$7I!3W(F(^N@["Y4.=@>LI]OY2&?\ >1N'
MI/[T>GXZ#DKU$9V*PH9B"*8DQCH'4I]?IMUT$AO0"9>;!%$#RELE$!Q]=^7I
MMH.?NJO#N=X.'$3Y\HVXE^4M]_2?IH%N&\N\=S327C+H69A:FC([Q!@X.X$A
MOMR]OKMZ?70,"R%$5DR;"^ %*RGF.T''J'K^;]F@CK9;'6)6 /"'L 3BL10+
MH@AY^Y<SRB>.@CR.>Q&/Q;<I9LA%)0&R6A,'R%<21<('?E.PSTC06WV:Z @W
MM!03,#!&4#$E/I&\_6=!R=ZDLB$["@(-I.",8F(F>,;[STZSMH/9M5182Y<$
M,"((PDHY#!3M$S&_3?0!W*@&(&]8F1<!&2&)DO3C$;^O[-!6Q^<P^14#:5Q3
MP8QJ5R)1[CKG*VB,3UG@0S$Z"GF_[\\>_K3_ .QNT#K0&@- :!'X1_E/&?T,
M?SSH'F@- : T!H,UE?/L)2RXX2L7\1S)0W?'UB"6C*JY6.)1,QU(1B(C_:C?
MI.@M3YMXD++JSRU8#QHD=V"9$=L0* *9F>D\3F G;T+IZZ!5:^5_#$L<*KH6
M KUUW'-7,<)2SO?DG]]@S6*"7'7_ .NP7O&?.\!GE4P586C)7*XVHQI, W !
MC!C!<)D>7 A*1B=XB=!HM : T!H#0&@- : T!H#0&@- : T!H#0&@- : T!H
M$?F_^5,E_1?^*- \T!H#09/ROQG.9K+8XU,J!0I6*]M5@^Z-NNU+.3>UQW6R
M'K_3]^W&)F?=OM <>*8?S*I>N9'/!C[&2NFL6VZ[WS UP(I%"E&D86"^72.4
MR13)%.@U5RJJW4?5;OVK"R4SC.T\3&1G:?Y)T&"GX]SN3QV,P&?LTSP>&2:J
MS*HLBQ8+[5E-+&"?L3(+=)3 26Y[3'&.F@2W_AW/Y :%F_D$6\D8OG,L@F("
M;%AP,^XK[ P]P6L5P.X3L(['&V@[\H^'LMD<45.@S'K:]F5;:>P.#);D+,N0
MZ6BHV'*USQ(8(>NWNVC;0:SPGP^_@;V3LVWJ=%Z(X0OEO$Q<N69WY1'[MP8_
MEB=!ET_#=LT@F^VG:6 MV!@$8]PZ+*H%L0[>TV<O_P".@XN_#%HZS452H DD
M! US67:*P%:NJ3.(&?\ >,K;D6TEMUZSH-1YSX?>ST8UM=&/LE3784S'9(3.
MI/W*Q#NCPB9YIX;#[>HD4;COOH%GB?Q:S Y3'Y"7(?;K6+;+E_A,6;*7UQ4L
M6'MO,P2X*8F=M!YF/BV,IY7=R5E&/=CK3&6.#5\FDUF/BE$,&0D9@"#F,[_O
M3T_$*_C/Q7E<5Y74S%NXNU%>%'+X8R&\PHC3)/#A[E[C)1),V_V-XY:!ED?C
M.ED/)G9FW7I6>_D@N'WE0PRK!BYI=DN0S$QWMF<?R_Z=!G*/Q)Y/5RN-N,=C
M;8X] IV;!C#AC%S1[+1%7(P[D\B(S+D/3B.V@M5OAZZI.,I6+5:_3Q[N;G6
M(G6P*[2MEWXF"$B&*A*'>9CCPCZ3H.E_$E^A]I8Q,T$VJ;)?V^!K6XPR?WB0
M80#R@01,K&=IX_2..@XQWPV[[@+67C'W+,W:UII=HBCM*?9<U0\XF>)_=1&W
MI.W70.[7@F7_ .7-+Q>LZJ5BH2><,']$U*=W.V$FMW;]NT"7;+CMTC0(L9\5
M^44<?7Q\6<>RLV*89#EWID5T<L[("*8F-B@UV.W[]N,Q]8GH!BOANU6K*[A4
M:]^N>/"M=J@4,4FD!K82RD!D#:)\IB.F\SO,Z#O#?$-Q-_'6;Z\6%?'@I4TJ
MBB[+B15LH"XP3';OD=D9GUXP/YBG;05B^(_(+(,KVHQ8<,2&)H95'<&TC:H*
M6MD>S'<-QAP(I;'%7M'U+D$+?A?,3CK"@C&L;<5805>V37JJ$^%;6*I"I40W
M]'W1"P^D[[Q/(-7\H^#Y;RVC5JT6516L; .&U&T\G+@ 8!PMI1PZ[@/'EO\
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M*>(#,E,1&\[;1H/GZ_EVVRU0J?:U%M9$,N/-S_MC4=QE-3:[@08PMLIDQ-W
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MQ(%3 G:BW+I=-_N!+YY+A1#.X<)B0&-YD>4S'+ERZZ!X'AF%&GF:,]XZ.<&
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M;3TWVT&6GSU>!WMX?(V_)"/&38>;KJK">]S4).L5YD3I]J63N,2 ;;Q,1MO
M7P^4_,&TYL+K8V!I5+=ZX<EW1>NK84K9,UGO6J2%A;[L/B4?7?0<4_EKRS(7
MF4Z]&E7-UP*E?OD)G6DKL59BPE5@G$4C/+J"NL<>N_+01!\J9?*YHL2MJ 2-
MNF:7U?TW< S%>FU30ES6;,!D[\UKGUCC,==!]'S?]^>/?UI_]C=H'6@- : T
M"/PC_*>,_H8_GG0/- :"*W3J7$RBVA=A$S$RIHB83,3O$\2B8Z3H/65J[?\
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M8+A,+]WN]_MZ?7IZZ"I:^1/":ZI;_&:CA"RBFV$.6V0;:9VEP<"4\?=OOO\
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MK!&?3019;Y HXW*6*;*-IM6FU-:[DEPOL*LV0AB4S!'#9DH,/<(2,20[SZ[
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MW3.W7;IH+7AO@M#Q8KQ5++7S>(",3%*@CM\MIA: 4ON%S]Y\>1=-_30+<?\
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MF%@1$*P[A'VUB1E, &PQOZ:".WX;XU;S(YFS2%E\9 I*39VR-8R*S8F"[1F
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MVT$=;Y%SU[(+DE+H5;U/'WJ"5,"TS[9IV+%AA^P)%DU:LCP]T07Y2G07,?\
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MXXX<-;EC=H$92QX0?*QM/;,NF_ N'0%.4/SRZNOD75<BEX5"B4Q46R7O/'7
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M9:-:OTBBJA1CQE<%OO$%OM 6SL^?8U]=%8;H66#4M5Z:JHMJ6'77F[)_=V)
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M!"8+E]9Z:!%COB"XFYCF668^58IB(6:D%#;@*L]\GVY+>)?M&T;;]2.=_=M
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M]1Y FM?+.1O80W8?$FJZF-\@;S$1JQ%XJ<3 -A9MY$HYVXC,#_M;#H)2^98
MZHG@;139&;/!$D\QI]Z4"WBI9QS(P.>$S'MC\V\\=!M_(\VK"8:SDV*)_9X"
MM 2,$QC3%:P@BF!'D9Q&\](]=!E<7YEGX)]S+(%*@RXX6<<! 9 =DZP)9WH_
M,(=PYGI$SO'2)C0<J^5N[DFH##MG'U+*JEV]WU_IE8NOHJD5;<CCN5^1;>@S
M]9C;0,/!?D)/EI.E6-LTDPE5JJ]P' -0Z9X>X@ 89''<A&2C:8V*=!)Y'YW&
M&R;:L8YEJK056L9>V+ #L*N.-*9!9>YL\E%)1&VT1TWGIH,Y;^871AQ,\0ZC
MD<I72W!C!C:YQ:YB+&0D3D>WVY*1XSO&VW7>("PKY::=-K@PKH&N-91?=-A#
M3M68WA,)A9-G81(ID0F9C;B/KL%1'R\]SU7K%$Z>"*O6L\AD3L01KO&]; (?
MRQ]A/'CL73_:V@+ECY6R2+ 8\O&V3ES25S[3[M'"*O9)PLET1(\I[9#PV_-]
M9&>6@V<9ZC_AV,^4&-'[/[^8VW.%=KN_EB?S<?IH,"?RSEJ5UXY##&+;/V<8
MK'+.'%LY#[#&,:@&S^141MPG8O\ 9]V@T^?R:\I\?.R2U-0%RHMXH>$K:$,X
MEQ8$]1(=]IC0:C0&@- : T$=E"[%=M=F\K<!+.(G:>)1M/7_ $Z#,VOC3QFP
MI \7J;53515LK;,-4-);5*D9G>-Y78,2WB>6_P"R-!(WXX\3:]=AM8S<N:,P
M9-,IF<:1$B2F9GE/OV/?\\;06^V@;9_!4,[BFXR_!_;M)9\EE(&)J8+5D,_B
M)A$]>GXZ!'5^,?%ZU2S6&++!MK8IYM>9F0ML?<G/*?K+9W_^GIH),?\ '/CM
M'(KO*FT9(F/M:[;#&(2 E)BM2RG80$RY1'TZ?2(V#FA\:^,TGI<O[EA5#25$
M76&,&NNN4FI"8*9XJ$B_+^R(](C8'>=P>/SF,;C<@!%7;(%N!2!B:CABS HZ
MP0&,%&@3*^.O'@96<9676Z<?\+:8\B:N9,C;(3Z#WN7%D1&Q#L.VT1H*MCXE
M\1L<(<-DP34BE7";!S"AA$5^:I]1/MC'I/'?W;<NN@N#\>>.#]Y,BXBOR$VC
M)I3)$NT5R)_9^L<S/_1H%OA7Q[?P.?M92W?&PJ*YTL?55WH6I!O[_M!K&0O;
M81@ Z?MVV@0?9GP_"9@KI75F1WDUD-(#()'[-IOKFO;\I@UDEOH%C_C+QURD
M+-MW=0P#S&RP9LB+I> V.,Q!B#9F1C:(C>8_+.V@Y'XL\5&H^J,610PP96"'
MEM5)9RP/M_\ 4V*?KOT]OY>F@N5/ /'ZQK,(>;5MK6.XQQ&1-J<^V13/K_O2
MW^F@7A\2>(KM)L+BT'9)9PJ+!]LF*$@ S']Z8 Y';T^NV_70=5_BCQ%=<4."
MS= 434&;5EK2BMV#KBB"F=X  :7';KRGEOOH'WC_ (_4P=,ZU9KWPPY8QMED
ML.9V@?7I$1$#'2(_^N^@3W_C3QN]D;F1L%:FW< @%D//=')BW%*)GJ'ZB0*(
MWF(VZ1'701E\6>+S)%RMP2RD\?,66_\  E+8<4T^NRN3!B9_9[?R^W07<=X#
MX_C[B+U:'_?(.#^[-QL:?Z4J(6&<R1B<3R(2Z26T^L1H&69P.,S(5 R"NZ-*
MRJY7B)D=G)F>,SMZQUG>)Z3H,V?Q%X=*J25!90JDH$ "K!CS!=B;00R9WDN+
MC(O7KOM.\:"Z[XX\8=CRH&MO8*HNC&S2Y0I+IL+F)_UA;.^_^B>F@AJ_&'C%
M>K;KQ]RV+R;->RQKS,R"X0&[W3Z3)*B8V]/ITT'K_C+QI[4$XK1IKVSNA5)Y
MRGN'8^ZVX3Z0+IDAVVGKMOQZ:!EF_P"_/'OZT_\ L;M ZT!H#0&@1^$?Y3QG
M]#'\\Z!YH#0&@- :!+8\+\2LY-^2?BJS;]@#78>:XDC!JY2<%$])YK]A?C'2
M?306<+X_A,%797Q--=)+CAC17&W-G$0Y%,]2+B QO/X:#/9'XNP63\L+R#('
M-F"WF:)K3PDBK%5*"9 0P@E1S[9GU^NVT:!X[Q+QEV6G+NQE=F2D.W-DEQ)2
M,A*^N_29[<R&_KQ]OIH$COB3P-EFH8XI"ZM6&\J0A';:30 ()F_NG@"^,=?R
MSMZ:!I<\+\?<^W<1573R=M)(*^D8AHP:^U)A^[!\(X\MM]NGIH&&*PU'%K8J
MD)+2R0F%24R(0I(( 0B?RC *'I_IT%2[XAXM>RHY6YC*S\D(\8L,""*8@9#K
MOTGV'([S])V]-!#C? _#L:R64<370R8D98(^Z8()7.Y3,S/Z92/\G303T/$/
M&,?D(R-+&H1=%<)%X#M, ("N-OI$\ $=_7:(C06LCA<1DMOXA45:B%M1$.&"
MCMOB!:&T]-C@8WT'N(PV+P].*>-K!6KP4G(!OU(O4BF=Y*9_&9T"ZWX+X=<M
MV[EG$5FV[L<;3Y".93$C/+>/RENL9Y1U]L=>D:"+_EWX/VJROX)5[=,S96'M
MQL!L.&G/^ED<^O[WN]=!8?X7XI8BG#L77.,?O]G$A^2)*#D?VC)Q!<9Z;]=
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MNV]K#+;:87UF("[D/E7R.D=FRRI1+''9N4J,\VB:SJFL8?9/J/:@6$3.,;Q
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M:W&$H R]<BM5#D)-M.[:XYS,0,D9;=9G:(WG\-!3S?\ ?GCW]:?_ &-V@=:
MT!H#0(_"/\IXS^AC^>= \T!H#0&@-!5LY2A6NU*3FP-JZ1!67M,R1 LFSOMZ
M>Q93UT!1R=.[47;0<]AI$"B,27)2)2'2#@9ZR/3\8ZZ")^<QU>JJU8825O<%
M=<&!B<L:X4!'"8Y=6'$;[;==_302ULG3LC9)9S 56DAQF) ,&&W+:2B.41OM
MO'3?063, 'D90(QZS,[1H/.ZJ"@>8\BCD([QO,1]8T%+(7</4*M>MRON2T*5
M:QQYE#+; 7"Q(8F1@S@.7TZ1OZ:"\)@>_ H+C,B6T[[3'K$Z!%C?-_&LGD!Q
M]2P;&.EHUFDAP5[$HF8;%=YA"G<-NO I_P"B)T#H75X .+ X%M"]IC:?I$1H
M.NZKW^\?T_\ >=8]O3?W?ATT%)N<QJLE6QS&$-JW,Q6C@?!DPLFSQ/;CT!<S
M/7^?0>9GR#%8=0,ON[<,DA 1$F%,@ICI]H04_D2<_P"C;UT%V')F2CF.X1!'
M&\;Q$]=Y_#05J&7QU\&%5=#!4YE8_4?U4E(F,;[;[3$]8T$OWU;NROEM$+AO
M=F)A<B4S'1GY9GVSTWT%?LX=D7*1UEPIY?\ %K-40IYN'KORCBV2B-I]=!+2
MRV-NPR:EE;H4YE9G$O1R2D6!_*,Q.^@B?G<4FRJJ5B#M/7+DH7$L,EPP%$<"
M._M$VCO/T_T3H+" HU@8*(4D.X9M@.(QW&3S,BV_>*9Y3^.@F@PF!F"C8ORS
MOZ[QOTT'G=5O$<QWF)F(WC?8>D_]&@K5\MC+%VQ1196RW5@)L)$HD@[N\AO_
M -KA.@LRQ<!SDH@/]:9C;_IT%;&Y;'Y*FBY3;#$68DDE,2,E SQF>);%TG]F
M@\7F,<R];HBZ(LT85-D2B1@>_$ROW3L,\N,^DZ!?YO\ Y4R7]%_XHT#S0&@-
M : T$-P7%3>*)D7RLX5(\8*#D9X[<HD=]_QC;0?(\.GY5H8T"?5R=V0FVGB5
MA<6&,=4$5-8#;+A 5O">HMF-YY"(CTT$*?'?D5'\1BFO*U,C;(W6;86*Y5F*
M+&J7/:4;1_XJ;8;\IXSTGWQ$QH+E*E\E=G'_ 'E?*E"P,:0UKH*D7?=27=O]
M]CSE9(V@0(F\8@H_-(SH(+E+S#%)P2+SLS87>_AB[P5KD?>-L_9Y!MU8,)@\
M8@Q5,B)#&T>W01QXS\GUW/LU8MQF[M:M+[<V5DJ>U0M)[<[EVX>+)5[H#CSG
MEOMOH+C<!Y]<"U]L[-4L:NOD6X=#[HQ<BQ"*OVPV&"QDF,V(?*Q,RZ?F]LP.
M@^H1]Z6)]T3%V:_NB-HGNR'[.GYM!\>RY^2^-U<86=R&2#'/J4XO%%]:K;+\
M5K+'"#W, 1$&\9,(.(GIM$C$QH(ZOB'F^2\5?<@\@5[.)2%M)6>V#DM\=!)L
M:'(8[DW $9.?=O'T'?0/_&9\PPWD%J[?K91OCXU(X*LLAAJ]J12M:Q>X6E^;
ME/ #CKR(]XG0?0\Z-XL)D!H<OOBK.BIPF(+O2N>WQF=HB>6V@^8%@/E&OFJB
MD7LC-0*U?LN[@V/=*2FV-@W60#N2XIXR2&;>WAM$3&@7SB_E\L+51!Y%2UNL
M0389W+IL)*80PUE>'@L60W<9L&$SM/#AM$ ^;@_DA5.;*+=QV2R-ZW0O"=B(
M57I66\57D*YR"YKB$$(A[O=/KH*,8GY5C(9F66+YIDVQ*DD "VK]XLEC3<RT
M<+=]E!C$PE?NGWERV+0;/XXQE['X.T%RO9K$_(6["5W6"VSV6MDERTP)D24C
M^)3/X]=!D<IXOY12RN9MTT95E+)9*S88O&W 58-DTZP4VP36! I!D.$AW_U-
MQD!T&N^/\;Y+5IW;'DMASLM8L3!P;9- K"(@9KKB>"Q(I*>D1,_7Z:!)YBCS
MUGG&-;B$W!Q:&T)8U#8[!IFQ/WD-7+TC'%4_O*9)?N\=M!JO-%9IOC=I>&[O
MWLDG<:YBMY(AP38%)G,"+21S@)F8V+;K'KH/GMBI\C%E\/\ 95<Q7QR'UIWL
M7 L,FJ5XILQ:D7J&"&M,;08./;;8H*)G04L!XW\F8Q^'IUSO4\?16I:Q,HL*
M@EO;-O[B9MAR!@S$A,K9/&8X<2B8T%#QO*^2YJW'V=G-9'$UZU _(%U;Z3>R
MTP;?<*FT'#VPEL*(E\P+CM[8'I(.K4^>8#!O\AR]RRS-TSQRZ&,9:'[>Z1(6
MMU:%!,+-K&&76!ZF.X]-!]1P=*W1PU&G<LG<MH0M=FVR9(FM@8YG,S_K%O.@
M^4CXIYSE;>,5EE9,E5KE2QF2L6PE#;:K/*74A6S<$"KE/'88_)[>0S.@^E9O
M^_/'OZT_^QNT#K0&@- :!'X1_E/&?T,?SSH'F@- : T!H/EV>^*\WD<OD7H;
M2KS<*^Q>;B6_Q&(NU"KK040/'MI*>GO_ "^D1.^X5:/Q'FJO;9*<;:B9?'\/
MNL-U:L;8KP-NOV:]6.Z/V\^T5K]?]Y$[S(2G\3YR75]RQ[CAM9D9%DM^ZI17
MOMM%]IL$QNT&QON0^Z.O*-M@75OA//IP\52M)-JW53<COCV+D5E.7)MB:4@L
MR)\'[U.G<8W*>DP&B\D\0R0>%^+X)--67;C[U/[BO:)C:Y+2)\N\S@1=N.D0
M4K_#<=NF@2)^(?*%Y;%VON*':H&LP)<DLDJV;SJK_0)IK#O<5S+A'A&W;^N@
MUL^!L5X+AO'*)(I.QYT#>Y,2(R=4P-S0VB)DRD)*)+UGUT%?XP^/[_BB+@7F
M 9V%5TS*6\Q9*(."=(PBM &SGUWYE^)EM&@JSX5YP?B8^(1;H5\33J'4KW0[
MQ6+*P#MUUN7Q 4Q(]'$!E)?3COH%;/AV[;/)V;%?%U"M4[:\7CJ\&5;'V7Q6
MA;4%*E\9Y5I81@ S!%TCUF0XR'Q#Y#8M9LT6:B*V1L19[,%R*Q,7(L\&L.N9
MK"1WB1.7CRVV@1CCH&GB?QGEL-F\;?983->G'O1##:0[KMCP NTD>(S:'CL(
MQM'08Z1H+A^!9&?.UYR5T6UQR$WYR#.Y]_"IH%4^T&.$AVA.><>_;_9W]TAG
M\E\2^3W/)KV5EF/E+SL$:ID@"VL[2;"D65K0,\)!';9),;OOO$;>W0=_\FK-
MA#?NT8U3)YS4KI[DJK=W*?>F*9E82/Z/LW&(Z]-H'06E?$)3F:YV%T6X)%TK
M$8V0F5PCO7F@J%2';V'[T/;^7I/[- KN?#7D;,=62JQ2.S66A2#:1D"Y36A'
M/MM2];('C'MD(+;\IA/J#!OQ-DIL9=ZU8L7V%Y&,<XE<OU<A8!TL8!+D0+AR
M5O[^FWK&XZ"EB?AW/4WJ<?\ #Q*+)LB1,B-"9MT;4"LAKI&9_P"$:,P( /OW
MVZS&@L5/B#)2VLNZ&-^UKLJQ<[<,(LG"+<62LW1,.,ND1V@9D^I%N6VT:#2?
MX(R2/! PM%M=.6Q]EMS"NF#FNE@6SL50F(CE"X64*.!C\N\1H,K9^%LK&2!M
M>ZMB1J*4NP;96U35US6W880PS![3)A[."/>6XEH&"/BW)8K(U[N#KXQ159QK
MA7/-'<930^N\#):CGB46.X)]9DHVF/KH&4^"9;_!.!P[AHY"WB7@^W2L]R*-
MK86C(%/!A1 DV&!R O<,;Q]= APOQ!FZ.:PEVQ90Q6.73B>RTE_;S4(Y)2()
M#&&IG+K'>7ZSR@M!?\^^-<]Y!D;SZC*1U;O:W39Z%$JKL3!P9(LP/$F[[",$
M4>AC]0T&8HV:'QM]A:.&VJE!"'L&9*"8L0 BB2]TQ,Q]=!J] : T!H#0>&8
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MZVO'TID!AMUJ4QR;$R(SN<\9G:>A;;_3>-!H(F)B)B=XGK$QZ;:#.YOS?Q#
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MBF(';>1Z3/X:"M9\1\=LY2<FZBDK+$NKV8E8<'K?*I+OCQ_4F.P/'EZ:"U_
ML'O6+^'5N5(I.G/97NDBG<B5T]DS/6>.@GH4*>/J+J4U0FLK?MK'TCE,E/\
M]9T$^@- : T!H$?F_P#E3)?T7_BC0/- : T%.QFL/6R",;8O5TY&U$E6IL:
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M0M"7]N8W@^W$\N.T^NV@NZ""<A0A5ALV50JI,C:/F/%4B,$4,G?VS E$SO\
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M0&@- : T!H#0&@- : T!H#0&@- : T!H#0&@- : T!H#0&@- : T!H#0&@-
I: T!H#0&@- : T!H#0&@- : T!H#0&@- : T!H#0&@- : T!H#0?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>g140648dsp006.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g140648dsp006.jpg
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ML9_@7_\ -Z![7SC_ *EC/\"__F] ]KYQ_P!2QG^!?_S>@>U\X_ZEC/\  O\
M^;T#VOG'_4L9_@7_ /-Z![7SC_J6,_P+_P#F] ]KYQ_U+&?X%_\ S>@>U\X_
MZEC/\"__ )O0/:^<?]2QG^!?_P WH'M?./\ J6,_P+_^;T#VOG'_ %+&?X%_
M_-Z![7SC_J6,_P "_P#YO0/:^<?]2QG^!?\ \WH'M?./^I8S_ O_ .;T#VOG
M'_4L9_@7_P#-Z![7SC_J6,_P+_\ F] ]KYQ_U+&?X%__ #>@>U\X_P"I8S_
MO_YO0/:^<?\ 4L9_@7_\WH/OM?./^I8S_ O_ .;T$CQ?)V<IX[CLC:$!LVD
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MT)=:S=3N2&0RM:A6IN#@P*S%*KK;S4/W2QT#RY1$=2G?TT%PSY)\B#*J\?\
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MB'TVY24Z"]QOG&3N^-9GR",*1UJ!6PQM5#N[9N>S:U)?L^V$+YDK[(W*>O\
MJD,X7S</Y?4E6-4_*VK%A,U5/LFM85EK89-XTRM+.>^(P!UH_3OQZR%E1^4L
MAD4NR%+Q]@XBD*QR+K=@*ME-AM4;7;]LP-R@(: %/."WG[1+;0>KORC84JC%
M3$18MY&EB;==)6(4,'E[!5P61]L]A5(\I+CUCZ:#/V?D;R9>6LI-$CC$C:BQ
MPLA-@;*LNJELHYK<>U'/:(*-^,]9WC06$?-3&VL@%/QZW>KUO>!3*N-@F-;1
M(@*&1->% +)67"0:PNFW'E.V@N\7\E5+/@^2\IL(7$8KO18JU'2Z9)0P4!^U
M768LBY1]K5C,?7IUT%)D/D[R&IE&4+V ).3Q^[9IU;H.59$J%JW \IKB4[15
MD8C8?O\ _KZAURWRQ66VQ?HUF6L903?;7:IX"NW-/'!=.)&5E,1$LA<3!="@
MM]]MM!W7\F9\LK& +QY0^1-8N45??1->:S*YV)8=B$[B0PN0D(7/W;;3QZP&
MI\-\B+R/QJCFBJS2*X)$54CADKD#()&3&(@OP_30<O OY+PW\(O^KH+[0- T
M#04='^=<Q_ 8[][<T%YH&@:!H&@:#+>2?'N&\C\@J9/+Q-BK5I6*<4X)B^4V
M&*,I(U&$R'%,B2YW$HGKH)]OPOQBW4M5'4![%MZ[;8 C646$K!2VK,"$E$ )
M 1E<CMMH/B?"?%E%BC&@),PC&OQC6$QAJ;8$A<?,R(C(X.=Y.9Z]?700U_&?
M@P6K-F,2LF6PLK<)FTU\+I05D!41RL!:4<B@1B-^OKH/A_&?A9U1K'2:4"PF
MP^;=N;&YA"B&;$M[\A(1 R$GQV^F@MK_ (W@[^&'"V:@SC%PH4UUR2H7V)$D
MRHER!+E<@,C(S$QMTT%-/Q9X'-4:LXO]D+VVM^_8[A-L *WD;.YW#AH@,,$B
MF"V^Z)T$W'^"^*8\JQT\>*65&@ZLT39)@2J\50B#DI+A"(X<-^.WTT'G->!>
M,9G+!E[Z'_F0(BJ-FO;MU2[,')]O^SM5&W*=Y_\ [:#I5\(\6JYLLVB@(9(C
M-O<YLD(:P>#&BF2E0M,>A,$>1==YZZ"Q''#&7/)=YO(ZXUO;\Y[,0)D?/AOM
MSGEMO^C05+_ ?%W9]OD!(>&6>23>]5RVD637C94&I;040C']&1V]?TSH.^#\
M+\8P=Q]S%41K/>,@10;#@%R<LE:A,B%*Y.>7!<"._P!-!;O2MZ6)9$RMHR!Q
M$R,\2C:=B&8F/],:#,4?B[PBCC3QE>BW\N-8*BHRY<:M8J.#7*18XX40&,2)
M+XE$^DZ"[PF"Q6$HQ1QB.Q7YDTHDC89L9.YL8QDF9F4^I$4SH(N>\/\ '<\U
M+LI5EKD":UM6UJ#E3-I-1$DUR:RXQR MQG]&@E8S XG&6+MB@CL,R#!=;@2.
M0)@A"X*%S,@$\1B)XQ&_UT$+#^$^+8;(-R&-H#7M-@Q@H-A"L6GW&"E9D0)$
MSCD0K$8F?706>.QE'&UIK450E!-:^0B9G]H]A.:7W3/XF&1:#Q<PV+NVZ]RW
M7%UBJ#E((]YB L1 M&1WXE!P,1.\:"D3\:>%II,I+H%"&2HHWL69-7MYDDPA
MDL[B(7)3QA1#$;Z#XWXQ\%;%6#Q(2-0> #W&Q# ALOXV(@_[1'=*3V=R^Z9G
MUF= R7QEX-DE JYBQ8L!L!QAK@@@N-E[P9P,>X!-*3XGO$3UC;0=W?'WASCL
MF[& WWA/.P##80$5L!6^>!%(#W!6.^T>O7UZZ#WBO!?%<4Q#J5'@^LX[*[#&
MN<V7,3[<C-C3,V3VOLCG,[1Z:#C5^./"ZMNK;KXV%MI]N4##7=KDG?M&:I/M
ML->_V&8R0_2>F@F>1>(>.^1"D<Q3BS[?G"B@V**!;$0P))1 4@<1',)GB6W6
M-!'J^ >(U<@C(5J':L5H5"H!KH5NA<)49)Y]HV L8&#(9+:/702\YXK@,[QG
M*U!LD"C0LI(P(08:VEQD"&1+N5UE!1]PR,;3&@>/^+X/QY-E6(KS7&XZ;-J2
M8UQ,=("$L,VD924B [SOUT$3Q+^\>0?YLW]RG0:#0- T#0- T%/8\/\ '+.7
MG+NIP60(T-)W-D1+*G+L'(04!R"#F-^.^W3TT$2W\=>&VFPUN/\ VG-S#);G
MJ[GN'38:+>V8]U9-*2X'N.\^F@FYKQ3Q_-%!Y.F-@Q25<#Y&! LF+=/ @(9$
MH8A9"4?=$CTF-!6Q\8^#Q*"_+-R3/*9ESYET]WO;VMV?VG]K/+]MSZZ!/QCX
M*5JS9/$@;+<6!=!FTE[7"@[$ LCD%]PXYEP&/N^[UZZ"RQ_BF H8RUC$5>Y2
MN\O>KLL9:)T&$+*&G8)IG'"..Q3Z=-!$Q7Q_XCBB4=*A -2\+2W,:YS8:M)H
M7NQIF<B"G&(A,\1WZ1H.N3\(\6RF67EKU 77U=K]IS8(GV#YI[RQ(5M[9SR#
MN"7&?30<+WQUX9>Q]3'V<:)5*0M76 6."16^=W+DP,3);)_$!3(S]8Z:#O5\
M(\5JL-E?'BLV*;7.8)D[JL E;1ZE_2"JJ/\ ]G_3H(4_&'@TVTVORS9M<TL2
M,/L0L6UEBI3>U#.WW!6L0Y\>4C&TS.@^VO!:;\OXVT94O#^+!)8S'PJ29#X3
M-=92\CG]FM1=!X[R6Q27303LSX9XUFKR;V2I0^RD17!=QH":P/N"MP 0@X!/
M[H%D%$3H.5OP+Q&Y372LXX&5DS9)2Y-GVE=9W7E$P6\$3)Y;[[C/X=M Q'@7
MBF(LC:HTI"R+RM]]CGN9+V)]N;"-IF1$2OMF2WT$</C/P@%/2.-XJ?M]D/L<
M5<60X?;1W/[-LP8*.SQZQH)O_9OC7Y 6 ]E$XHR[IJDV<Y;W.]W9=R[W=[OW
M]SGRY==]]!'Q?Q[X?BV,;2Q_;:Z+ N:37-,_=BH;$D3#.2)D5U\BGKT_TZ#A
M9^+O!++%,;BAF4+2I8BUX#M6"%)(@$X$C!<<!,HDN/3?;02LKX%XCEK%:Q?Q
MH.956"%Q!, "2HN:U- "$'+$NL R"&/T:"='CF$C$6,/-0"QEN7S9JEN0'-I
MA-=ORF9^\V%/_P"K054_&OADU!K>Q/[739BU[FU[ONRN%27N^[[B=UC ;=S;
MC&WIH.G_ *[\+_,:^0_*E>YJBL%1N?:_8!*E$:>7:,UA/$3,9*(])T'+&?&G
MA&,(2I8R%D$UI"2:]DC%)DMK"/,RV%1S,@,?;'IMMH.UKX^\0M/A[L?!-@WL
MDH8X>167C9;R@3B"@G+$]IZ1,=-M!Y9\=>&-L7'LQL'-^&Q94372G>Q.[C!,
MGVEFR>I& P4SUWWT'2?#,0CQS)83&A[5>36T7O=O<,F.7VY8Z;,MEVPQ$;',
M](V]-!2>#_%E#QZV_)76+NY1KEN4Q0O!:I57.L/'OOM-*96TXGFR8VG88C:-
M!;J^._"U8E.)5BUACJZ[:4UA)D"(9""BT/0M_P!I!S]>GTVT$#S+XYK9R0LT
M#32R$-4;G.6YL,%"F*6/)+JSE2(N+[EL'?\ "7*)T%WXAXW6\9\9QV!K,EJ<
M>F%"V8@>4]9(N,=!B2F=H^F@X>!?R7AOX1?]707V@:!H&@HZ/\ZYC^ QW[VY
MH+S0- T#0- T&3\K\RR^(RZ<9B\,.5<="SDG$=H:L JH:@(8Y+9R,^]]OI'Z
M9B.N@S>7^8'SC+EFCC273<VOCL5D):1-*U=I+N@95P0\@!26R13L<R0[0,Q.
M^@4?F!P3A:MG$.0FUP18R.18RN)-AY5I[1E6!9E/"&_M>SR$HXQO]L!S'YT6
MROD[B<&]M*I6MV:38EP]WVA\>#B- )3+NLKXL9^O:=!WN?)GDJ/(Z="WBT4%
M4K5@,\$6?<;UPQTWEF@X2$R4#OR&8C[AVWVG?06_Q_\ ))>6V&I/%-HQ%==N
MN[9Y*);)V[9FU%<8</29$.8[3T*=!Y^6/*+>'P].CC;TXW+9BQV*UX4':E"U
M#+FN[( XBC8(7^'I)QH*Q'S,#%>.._+874S-=#+-VRTZRDV&.E#JHD2C7WD,
M N0-8O?T'>>F@\'\V+KCE_?8@JK\>0KJT3<<6VDRT-1<L22!D0,F"?-/='C/
MKRVB0\_^Y<D=5AU_&S8^I5OWKXL>RNJ$8[L$9URL5U,;W!L_9NL?NB8G;UT'
MVU\B^6VLUBZ%'$ B_P"^ &X\K82JQ5M8VS923']HI5*R3N8@)=8Z243H*[)?
M+EV)N&L'5VY&K3IX^GT/VE\V9%=MDL4FR1POV/286<%QC[>LZ"6WYO&K6HK7
M@[EBU%3W5]#!L0^ !S*\0D0K%W39-<S#F*A(=NL3.T!^FV;]>MCVWV[Q72HG
MLZ3R@ 'G/V_IVCTT'Y4/S+GLO7HSB,-%9MJYC>#+!/A)U+E@5&LF,K (OV(=
MX#F.TR4%.V@_5[MH*E-]IFT+KK-IR1"$; ,E.Y',",=/69VT&(^,_.K?D%O*
M4+:CAE>%WZSN9,7->X;(!0&5>IS[1)*.0B0S&WWEH)GEWE=O!>0URYC./7A\
MA<=688)!CD6*:TR33B>'^_*/]?I,[:"1X%YL?E-;(DVE[&SC;,5FA!-)9\DK
M>)KEZ:K=I%L?B5'ZMXZZ"N^0;'D56W7/#YMB<D_MJPF 0E)Q9?#-WLM$P6'[
M<5S',AD.$;SO)2,:#(A\GYW#Y.UFLHVW9P+2R@U5DNO%2R5:R*J:\?*Q]R)\
M.7=E_0MI(-^F@_0O!O,F>35;ANQYT'TFPH]X?*60008FECTU3*.O$MUQM,?Z
M]!"\P^1#\<R=BN6-FS2H8P\OD+<.X$*A,EBM2N!=PS,8VW(8V^OZ0RU3Y@RM
M'#L9:Q%BW9"V4/NOFPJDM+A-P?MHI P8#CV>J-HG:2/KOH- OY/<Y\6:^)AW
MCZK=+'W,H%M9&%G( @E]I("0N4$VU"1PR/69&"B-! \2^3+S/$U/OUYMWJ@X
M95BQ)B'>9ES6'/80V'MRW?:/7]6@@X3Y1SX) \M1]QE7\TTZE>P UF,;EF4$
M04DD27,<?N/>8XQOQDIVT$ZW\M9Q-J[CU^-@S*XBO<M9A$WA%2PI0AG[%O9G
MN]U5H"#<0VGH6WKH/T2A<5=HU[BHF%65 Y<%TGBP8*-_]4Z#\MR7R[E:K\?G
M'8PD>.6:=UU!0.%K;A18JUZO="%\D3).Y;#)_:77[HXZ#;>#^7L\FH67MHG0
M?4?V&#,.[3/L$X8DWIK&8['M.ZXV*)C]>@]^)?WCR#_-F_N4Z#0:!H&@:!H&
M@PN>^3HQ/E]?!10"S799J4WV5N,FJ9=(1 C4"34 C+!W[K@*8ZB,]-PCJ^4L
MHS%ULG_V_M4S)I7XW/O5<K)6'PE<6 X<J_VE#)D>Y$#T_%L,A%O_ #):Q^4_
M*K7C[)OU(66717:RU*X:TUA[::Z&BV9!?<V;*IVVC\6\0'T?F*U/YR$X$XN8
MS<DX[NL]V:XLC7EK$=CGVX$X;)H[T<?_ +;1(;#P[R5?DF!3E0%029L6P$.]
MP DLY"=CXJ+Z;\3 2CTD8G09D_._)ZWDN:Q7Y:BZ<Y2OC< F+'9B>6.B\XK#
M)47 16)'O$',S/&(Z;Z#5>*^0?GN)]Z=8J=E3[%2Y4(X9V[%5Q(:,,':#'FN
M>);=8^D>F@S[/D:\)92Y&'"/'\<VY4C)MNI21V:,%!P2F0, LF+(!*#(NF\A
MQZZ"IQGR_E\I;7C*/CP-RS+1UA [;45^ U/=BWN/JJ=QF/M_W/KZ;QUT'%'R
M9F,IG,+&(JRNKD+-$,BFVX-E+=6NL:"H!1?<!TYY%SF"XQMQB9G0<9^7KV4N
MU\?4JQ1)EO',3=0TK*FU6Y)%5RY,T*7)$#O5)L':>A>F@_6=!@<M\MTL1D'4
MK] UG5==7<.&1,*&LF'U3G[8W]X!1"X_VMXZ[:#+9KY(\T&OFO:)BF%3%YJR
M[N.!ST7*)5X"$_L  @ G<8@O7>9F?MC</T7Q7R?(96[E,;D\=&-R.*)/<6M\
M65FNRON+*&0"ONZ3!#QZ3'29C05OE7R!D<)E<A6KX7WU##X].5RMSW(I(*[6
M. H4J0+N& UB/:2&)]-]]MPJ<G\P6J1''Y*,B[(6\=C#*PTN[^7F8V'-%%:P
MQ0_:,!$"<S,]>,1OH)5SYF\>K^.KR'9;&88%>?R)H,78!EI@* 6;+,H&"9$S
M,!,\>L#/IH(<_,&3.BMM7QPVV01D;-Q;7LK+%6,A!&:3?7!C1:%F.&ZQ^Z)B
M=O70=U_*6;;91CT^.#.5NOJA3KG=&%RB[4LVUM:V%%P((IF+ $2V_HR6@KZG
MR;G\AG" Z45,:+,75["[ =Y=U]^S3L 9=DQ8KN5BC<9B>(Q,;24\0EV_FJLB
M@NP&+,W]JL%FO+"GL7[5AE>*A]M33_9S6<1D(3.PQL,\HT&M\,\G+R3"QD#I
M-H-%K$-0T61$DLMN:B:M)FLXVD2D!_T:#-9CY8+%^097%6,5"EX]%AU9CWDE
MEN:U2;4R@"3VC N,A]C2.)B9D(C0<O*//\V-_%TL+3WMF_$N-1. !>K)!<W2
M9D!]L0FK!2<1,S](_2'C_P!QM#)4J5O#12$WE3OVK%F10NRNT=9BD/A,I80\
M.?[0U20E'&)+>(#N/RAFSQ-7*AXY$U<NRJ.!DKRQ)XV[ H"7AVY)$Q#!9/&#
MB!Z;\NDAR5\CYX&MITL).1NA.5?:%MY:@4&,L@E@*/L#R@I;^R@ACT^XOKH*
MQ'R[=4FWFLE7(L.&0L1C0JL&&'5#$1> 'K-<?=/*/0XV(NL\1^X+E_R5Y(C,
MUO'&^-J'R.TP.W6B_$UH0VO8>+9L0CEN,TV 0=OUVF-XT&L\3\@#R'QRAF10
M57WB^9UC*#E9Q,B8<HZ%L0S&_P!=!'\"_DO#?PB_ZN@OM T#0-!1T?YUS'\!
MCOWMS07F@:!H&@:!H,MY)\>X?R/R"ID\M$OJU:5BG[.":KE-ABC*2-1A,A(I
MD27.XEOUT$ZWX7XQ:J6:C:(PBW87;;"S8HAL)6"E-4:R$U$ ) 1E<CMMH(A?
M&WA9%6(L?)36@8'=]B8; MEX^YB6?VC9I2<=[EUG?0>I^.?#2*[OC]PR M"R
MB7/E/&P<&[M*[G;5W"C<I6([_702K?AOC=O(_F5BG!7N^%J7P;!F6K3->)F!
M*(D>R4@03]I1ZQ.@^X#P_P >\?)A8FL2)8 JV)SG0"@F9!2H:9PI8[] #8?U
M:"<>)QYY966-/+((0RJE\R7VI:8&P8'?C]Q*'>=M^F@I&_&OA3;IW#QL=]KR
MLO@7/%;6&WOSWE"<+:/=W. ,9&"F9B-YG0(^-O"?[7OC!,;HF#0-KC !8V'G
M"!(Y&ONT1/\ 8P/W1$^L1H.Z/ O%$(:D:4G#Z]FH\W.>YC$W.'N!-K#-A<^R
M'62WC;I,:#QD_CWQ#),AMNA).$E&#EN>I@E74:%$!J,"&16XQB8GZZ#X?QWX
M:=4:L8T5*6NNE/98U)K&G+"1*F+,3602]GWC,%/*=YG0?'_'/ASUU090+:HL
MDK('V (U&?<);R%@D\".9*1;)1,S,_6=!HR ""0(8D)CC(S&\3$]-MM!F4_&
MGA::C*BZ!BADI(0]S9GM>V9W4C7F6;H%;(W$52,?JT&BMU:URJZI:6+JU@"4
M])QN)K.)$A*/K$Q.TZ"G\?\ "/&O'K3[>*JFJS94M#WM>^P9*3)2H))[&3L'
M.>/Z/302,UXM@,W,SE*@V9E#*N\D8S"FL6TXCC([3W$+*"C[HD8VF-!\\?\
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M,\ND_P!&1WG0>(^73I7L7C+-(;??"HFU<6Z98+[-8701J!)*6/(HC8VB?7>
MF-MPNO"//KWD5E5>_A_RH[>,K9BCM9&SSK69D=F<07P8,Q'3K&T^OK&@IW?,
M-NKCG9.Y@"3CR#)3C6C: R>S%$<, PA<=J&"DB ON]-IB.FX6V4^0[E?RO\
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M]L[>F@[C\:>$#8IO#&PN:((6E0-<*2BJ4G7ERH/MN)13) 3!*8GKOOH(F?\
MB_Q_)8['4:Z_:KQ_LD!,&V2]E2L!8A E!B0E,KC9F_*)Z[Z"4WXS\,;213.D
M<I0-H=_<6.;(O;39[[.YS=W9 2*6276(GZ1H/MOXT\*MW+=JQCY8=Z']]<N?
MV>=M<I>T$0?:6UBRD28 P4[SUZSH+JIAL;4OV;]=/"W;6E-AG(IY!6@H5&TS
M,1Q[A>F@K,;X%XKC,Q^<4J9*O1W^U/><2EQ:*#?"DD<J7##'D4 ,;SUT$17Q
M9X,MQL_+B8)JLUNPVQ8:@$7.MA2T&PE+!D]9$!B-_30>9^*O!Y5*SI-81PX7
M/.U:-SAL+%+ <TFRQH]M01 G,P/&-MMM!)=\<^'.R-C(,H23[4N)H=Y_9AEE
M<I<X$<^T#6+*1)@C!3O/7K.@]W? ?%KDK)E9BW(37KU["+#T.6NIW(3"VJ,#
M"1AYQ,Q.\Q.T[QH.E[P_$N\29XS3#V-&%0NIV]YE)@4,4V.4[D0-&#ZSUGUT
M$-OQOXS<NLR&02UUJTU5J]7&U;&DZRH0&&%4[O8+;M#T(9](WT'UWQIX:VVZ
MT=)D2\VN- V;(UQ>\2%CPKPR$@TN93W!""WG???KH+&UXSBSK8T*U<%.P<3.
M$+[X&N<(*N/02&2#MG(R,SM,?KVT'+Q?Q9/C]8:Z+3GJBNE,@PIX<U29,= ;
MS FXVR1[>O300X^,?!_=6[+,;#BO3:*PIS7-3)WIF;)BDS)0&WE,$0C$[=/3
M0=\7X#XMC&I?5JG-E%B+86GO?8=+H0=89-KC89P*6D B4S$;](T'%7QKX:JS
M7L+HF,US!@JBQ8[)L4TGJ-J>YVFDMIR028S(_3TC02_)/"?&O)" LO5)Q IE
M>26YR)-#MNXEDI-<L67&)D"W'?Z:#S3\'\;IY6,I6KL58@NYVQL6/;]WM]J7
M>V[G8[LATD^'*?TZ#WEO"_',MDEY&_6-EE<*@H%SEJ;"&2U,/2!BIT+9/(>X
M,[3H($_%W@L^[@L;S"X#5&HG/):@>R'-BL$LXU^;!@Y[,#UB)^F@\%\4^#R@
MT^S=$.-AV61<MPU_?!:W"]L-YM!@I#F!S(SMZ:#K:^,O"+5JS9=C8DK8,!R8
M:X4;N3[=C 0)PH&DG[)8(P6WUT'#R+XUPV:S5')')H[+YL7>RUZFM(:C*J>#
M5,6:I"&>H^L=)T$Q7QWX>EJ6)Q\*A"ZJEJ!C15QH,EE:97!<"("*?NF-YWF)
MF8T'*E\9>%4H**^/F(F4=N#>]G:"H\;*%)[C"[2@< EVU[#T]-M!>X_$T,>=
MLZBNT5ZP5NU.Y3S<8B!%]TSM]H#TCIH*KQ+^\>0?YLW]RG0:#0- T%%;\'\8
MMYN,T^G)7^:G'LUPI8U$1"6M0)PEC%Q$<#,)F-HV](T'''_'OBF.8UE&JVN;
M1E82%FS'963(:2ZT=S:NLC&)(%<8GZ]-!H]!63XSA)1ET'5@U9TC++"9$7?[
MB1KE!;ST'M! [1M$:"J'XR\+&\%WV)D]9"P8.Q8)?="O[7NRHF2N6$C[".1Y
M%'K,Z#M4^/\ Q2K19154*:[1J R#<YA2.//G5B3,R+]F7IU_5/30<%_&'A"Y
ML<<=/&R)+E9/>0*6;1>:ZX$R10!- 2(50,3M&@]97XV\3R>5_-K";*LCW#;[
MFK<MU2@VJ6@RCL-7^)2 '_1'ZYT'D?C+PR+R[TU&F];?<A!VK1J[Y*E)NE)-
ME4L8N9$SD=R^N\Z#X'QAX8%$::ZC0!9J8EPVK0V%G73-=4KL0R'!Q3/;Z%U'
MI.@DK^/_ !!=!]!6.%=.S531<D#9$%7KL8U8]"WW@W&4E^(IGK,Z#0Z#,W_C
M?Q"]8L67U&C8LO*RQJ;5E!PUBX4V0)3 D(: ##!':#VB2B9C07]&C3H4D4:2
M0KTZJQ370N.( L(XB(Q'I$1&@ILEX#XKDLU^<W:9-OEV.Z7>>*F15*31#4B<
M*9"S+D,&,]>N@ZXWPWQ[&Y1F2I(8JPPFG"_</*N!V"YN)5<CE*R874I (WT$
M_,X^,EB+N.DA"+B&U^9K%P1W0D-R6?VG'7J,])T&-\'^*J^"O-RF3>%W)2Q!
MUB5-K@KVR75PF)LV+32F5VCC:3XQ&T#'3?06"_BCP5<GM09(FEE45G:M&M==
MS ::4K)L@I<L6)<0B(C;IH+*WX5XU;R4Y*Q4YW"?[DV=QD03/;Q5F"&"@2 D
MC $$QQGZQH(:_C/P\*14HK/).ZB21W+9,1[?EV8K-)LLKPOF7&%$/2=O307.
M#P6+P6-7C,6GV])1,,%<C/8FL)IS)')%/(SF>LZ#AF?%<#FK*K&3JQ88E%BI
M$29P!U[8P+U, 2@& 7 9V.)VF(F.L:#YX_XI@_'QL?EB3%ELA*S8>YUES.V/
M%<$YYL9(@/01Y;1]-!(S.#QN9K+K9!9,6ERK*9 S48.27-9B:R HF)_7^K05
MQ> >(G110/'B52M3/'H5)LV&LQBVD,3RWW[B0(2WY#,=)C06&%P6/PU8Z]+O
M2+3EK6V'NM-,YB!W-KS8PN@Q'4M!Q\@\7Q&?75#(BZ"I-E]5M:P^JU;)62ID
M65S6?4&$,QO]=!5-^+/!VTU52H' *[_)HV;(.;%J8*P-AXLAKQ;(QS%A%$[1
MH/;_ (R\*?>BZ5 A9#1L@E=BPNN+P7"8:-8&"B#[40$E ;S&@^Y/XU\,R:*R
M+E B34JA06 />J"JJ_W:6]M@=T0GJ,,Y;3UT&GT&?GP+Q2<X6:FE/OB;-B8[
MKNQ[@E]HK$5^?9ATKGCW(#E^O06^,QU/&8ZKCJ2^U3I)77K*WDN*E#  .Y3,
MSL,?6=!5>!?R7AOX1?\ 5T%]H&@:!H*.C_.N8_@,=^]N:"\T#0- T#0-!B?/
M?DZKXG?JX\:17KEA#+9+@R7$)40A,#(K;R89%L [1$_4HT%97\_SUV]D%2L*
M5+\TIKQ[_5T4?R]>3M]U1!$B?9B8^NTGQ]1WD.U7Y9?+<2-_!-I!G_:MPQ^X
M6WN5K5A2)-L#'[)B_<K.5_=$Q/0MXG0:WQ[/AF0R!"F4>POV,?,24%SFL7&3
MC:(VY?HT$K,Y6KB,/>RMOE[7'UVVGP$;EP2$F7&.F\[#TT&-Q/D/F.4\@OIO
MH_(44*N.R'L^ZBS!I8=OO1W>(Q$F*@$MYCC([P6W60KL;\VQ?:=)&&[N3<54
M,6E-J#0^;9-B.=B5@ ]L4$1RON#M^&2G03,G\J96BJR<^--(\4I#,ZN;:8FL
M5EQ*6*Y&#AT?LY9,_;L,QTY;C >O(OD]=3!':&F]<L=EZHFEBX8$X@G#+![B
MV!^T]OTW&=M^N^@CY?Y:A-OR/&,HMHLQ%>TU3.^M=QL5MOVJD/5(RMD3R68=
MR-OQ0.@CU/E#,56W&YJD1&E^510JU&K('^VR5:C6 ^:P(62RR(<N?';<ICTV
M"8[Y3S@93\B#QF6>0J[Y6J?O5B@%I2IXL&Q*_OA@OXQ]D3!1M,;?=H-O@LNC
M,X3'Y>N!+1D:R;:EGMS$7!#(@MMXWB"ZZ"+Y5Y#."QJ["ZI7;EJPFG1J"<+[
MC[!P 03"B8 8_$1;3TCTF>F@R.+\P\C5B,QY#EY%2\5<O4V8AC4+#EW4#7CW
M,B,<5QSVG\107X9+:-!XQ/R_=S Q6Q/CQW,NLK16J<614N$5(3),4YZU2<L]
MT$+$@'>=]Y&.LA#_ /:N3HMO6\U4,:E7)WZU--1BBEJ:U06K!L$'XY(HB.+(
MCE/6>,=0M7?)F<3>5A6>-S'DC;2JXT(NKE';?6?96_W/;_#_ &1@$/#E$QTY
M1MN'#&_,B;N7PU \25)>5!<2ZU8!7[8V&DU5YD>U8E3%[%$,$NL<1+0?H^@Q
MWF?GM_Q_(32I88LI*L;9R]HXL!7@*]0P%D#!B7(YY_;'2/TS'KH(!_+.V]X,
M,TO'F/?2J9.7!!LM5U,9(E7VD@61I-<'RF>7]'CUT$LODVNN_BDNH$NID*N/
MMV+DM'C6C)RY:8.-NL0U(A);Q^.-!23\YTO=4E#B'$-A5>R^((B<"+K"BN2U
M@L^X4I@6F,D/&)VCE.@@T_E;)XK\QLY<YO+#A7HUH@51-AN7R549(P B@!14
M#E/$N@](DIZA8#\VIDL9SPYUU76$I]JT[VU>& [LR-=S5@MLS'[0><KW';;[
MOM@/T[097SWSZMXDJ@)5_=7,DTU5E$9*7$*"6,-C 6XAB(VB-@G>9CZ==!EJ
M7R5Y%F[=Y-.M^75K8XA>(-L?VE;;QG%GN)(-OV:U,*.NVP;_ -+H$MGS&2:U
M:^_!M7B\KN6#L^X7)6!%ZTS+5P.Z9(&]P(W+>(VGB730;3#YT<ED,S3A,JG#
MVQID<E$]R2K)L\XC;IT?QV_5H(?B7]X\@_S9O[E.@T&@:!H&@:!H/SO*N\KO
M9_RSV'D3L6O!)KG1K0FJRK)'6EQ38[BB:0R4=>+!Z>F@X87Y4NW%T27C&/LY
M1RX-37K4JL$8JMD'$,PJ3D!%\[#/(I+ZQ$_:'#%_.U/)+B:V&<QMSL?DRQ9,
M"\K3A4L'L-8!7/\ :0<Q$G]N^TS,;:#O<^2O*:/D/MKN"%2/8J@: V5&XLC8
MR'LD"+(CAVF3(SR+:8&=Y'?[=!.'Y,RI9).&_P"W3G- ZRK(U!L@0)&JE%B6
M*9P_;=Q-L)".(SR^V=O703_C[Y 7Y>BX<U!HOJ2ON59?#'!#8F8%ZB!34L'C
M,$)!M_LD7701/,//,EXWY0"F5!L8)6'LW[$K.(L%86]*5 L2C;[B:(]2B/NW
MG\/4+GQCR>[E+F1QF3QLXO+8SLF^N+ALJ)5D2E3 :(AOU68E$C&TQ]8VG04_
MR#\G)\/L*6=$;H]B;5@1? .A0EQGMI$&F4])G<^ ?_???8*"O\DYRGEH!\%D
MHL,R-6C0&%)[E@<V5*I!-X_8()C8BZ](WVDM!<!\G95]B<52\<98\CK3:G)8
MSW2@!2ZG9DB78*.+9;%I?;CB/K/+AMH*[R+YD?4NY#&8_&K.RM%N*5B; LXV
M:U-EN(L L#6L=E%&W=D]_48]=![K_,O:R=#$7<89W)"@&5-!DR5OO+ X[*Q5
MLP %HDPI(.,3T@MM!J?DG,Y?"^"9O*X<0G)5*ILK2R8@1+TY_<)Q/"/N@9CK
MMMH,M8^5+^#I.3D<8;SHVTX8;KK03-B^58+3).$5QXK!1%,L%?68V@.N@CL^
M?,:,UQ7B+)LA4/R*?VD-6)/8B(K!"B]Q,]@C'?A$CMMUG;0?IF3R-;'8RUDK
M,S%6FEEE\C&\]M029;1^G:-!^>8SYLK6\3D,H[$-34QB4WKC!81B%%I3#6<B
M4N)<@8YFD=]X_"13TT'K(_*UF@KWYXFQ,/I4;8UB:,UT)NNM0#WL2EK%_LZX
M]R8YC$D(_I*0\(^2LO<SB(BN"\):7A#K-JV4..&Y*RY1B10#5FN>S,3P*)V'
MI,27V@I?,MQ]6DY_CC$,S2%NP"8M*.;!,LKJP#9XC"/N>![_ '?9O_2CCH-?
MX?Y-:SU?(3;Q\XRWC;K*%BM+1?$FH .3$Q@8D2[G3IO^G;TT%+Y-\GIP7E-;
M"%1&PMK:B'N6^)<LKK84!=@ 9L D<<I:8=/P\M!6T/F*TZBFW;\>;7C(U(M8
M1865-*R16DTQ4?0(3)-M+F)G>.,S,[3&V@Y#\@9^N_)GF5E0C%WK5F]35*K$
MKQM#%HL,%;($.?<L6 XE,07W;=-!-=\GYRO?K8:SXR2O(+IU_:4O>J)1(LKL
M'##>(3QE<U#$PX3].,EH-AY'?NT/'<E?I*!MVK5<]"C+B$L6N2B"+:>F\?HT
M&'\/^0\I'BZ)RZ&7,LFSBZ5IY-5LQN7%#!9':4D!%<6QCCPWVCUF>N@Y>.?+
M&5+Q6[?S>-&<ACL667<-=T2MBYM6$ L=PCC.U;UZZ#OEOF$L<=@68?8/S&QB
M\<UEG87,I\YL,.%J:2EC 1QZ%,E.VT1UT&U\8SRL_@:684AM4+8<_;O&08!1
M,B0E$_H(9VGZQUT$3P+^2\-_"+_JZ"^T#0- T%'1_G7,?P&._>W-!>:!H&@:
M!H&@I\]XC@\ZU#[ZVQ8KB:EOK6'U6]INW<43*YJ(EGQC<)G;IH/-7PWQVKFV
MYI%61O.7"CF6-)6T+!/*$D4J@Y4H DH'>1C;05B_BKP5==U<*!PMHK6N9LV9
M*N"&P]05#EG*L(-&#$4R,1,1^B-!=X'QW$8"F=/%)E%=KF6603&-(G.GDPR-
MI&4R1=9WG03K-:O:KMK6%BZN\"6Y1Q!"8''$A*)]8F)VG04>&\"\6PX70I5#
MD<@@*MSW#WV>:%0<+5N\V3  +2&!CIMH("OB?P=:V#%1Y&:TJ%S+MQCEA5.6
M5X2TVD:NR4SPX3&V\Q]=!#\A^'_%LAA2I8Y,X^T*Q6NP+;$P?!\V(*R$,'W)
M0TB.);RGD4SH+"S\6^$6K=FT^@9MM%9)@S8L=N"NC(V96KN=M<NY3)\!C>>O
MKH.MKXW\/M6;=BQ3-I71>+5%8L2D9M1M8)*>YVU&W^F2QB9_USH/3?COP]S+
MQNH]V,C%B+2S:X@_MAK:_@$GQ7)L0![AML4<HVG0>\9X#XMC; 6:U4YMCW^5
MMSWO<R;(+6V6M:9FR9! #'*9XQ&T;:"XQF.IXS'5<;27VJ=)(5ZRMY+BM0P
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MJ%)H6(N8<0I9SR%<?;O$=.D:#X7QOXA*H6%1J>$ *&(LV$L2*F.:L4L6P35
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M6M^7O)KF-QS:/CPT[65C&7* V+:S%E.[=369!R 3VV?MAB.D]"Y>HR.@E?\
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M7]/ZHT'=_A/C;\(O"G5**"7E;KP#6K:JP32=W5. A:!]QA3$B7UV].F@K_\
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MH ?+N<]D%QGC,FNY7MOQ2ZUHGM9[*VNJWNK%'((V=#([<,+C$QQY;1H+RO\
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MUT')_P =^&OS'YP[&B=_O^ZYRQO;[_#MRWL\^US(/M(N.Y1TG?0<Z7QIX/1
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M[(\V S?N!O$1'X2+TT'KQ?Y&RF4&NJEBIM5*PUOS>[:NJ6Y4W&$(=L94L'<
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MC+)PF.P015,R$!/?>('KH/D?*&9/R 5A2_M)JG'1A"<,)C)CD"K&<VH7,]J
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MTT'-_P QO0BS99@Y%&,I-M9C^TP1J<JV^C[=(BLN])6*W0]QCC._K]N@CO\
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M@"M8)CGN2-QB9CB/J4S'4-QH,5Y3\@9+"9;(UT8:+N.PU&OD\K=]T*3!#V.
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M0%>NX39"ZT]&$N.D?=,SH+.]\P6<>5NW>P<AA4V\C0KVUVA-[7XX&'U1*P@
M;"2&)EG0O6-NN@\/^0O-3\KQ^ /#UL<X+BUY/^V>X$T6*-JR,J*$!.X36F9W
MB-YCC^&>6@F?%_G&=S%/$8_/485=MX6OE$7Q>#9L!/%;":L5KA)R904",E&T
M^L3&V@_0-!@\K\DY*M<O13PX/Q5*^&&+(,LPL_?N .W^PA9SV.ZX (^?+K,P
M$Q&@M/C&SF[G@>%R&;L39R>0K+N/;) <?V@88,#P4@1'B4;#Q^WTY%MO(2O
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MQ85/<<$+;M*V!(BT1CN!'VGZE$SH+;$X>MBXL!6(H0Y@FJO,SVT""5I%21]
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MP[[%@N_5J&$S"RY2<6^D[=/UZ#DGY5S&$'*6<]CRLXA64RM2M>4Y?>@J0-L
MF*_ /LX))<,D]^7K&W706UCY(\AJWEX:UXZM?D+WU%)J#>@Z\INKLF#2L0GE
M' J3!,>W^L>6@X8_Y$\A8S#5:.(7D9RMFPJ8;>VMJ57ML38>:PJPOL)@8V*2
MB9W$.I3U"HS/S/FFIO5L+C4#; 1=C[DV#:@UA?KU&B1^WA7.1LQ,=DVC'UGI
M&X6W_LS)KL96I0Q!Y*QBBNVLC#[:TPNM6=*H%$PG[R*0/@!;;1'W'UC02L;\
MI6+V70"\/M@K.1#%)R<V8[LN;3&XL_;=N-@D2X%^TWB?I,:#?:"B\O\ )+.!
MI4FU:/YA9O7:]!%>6PB.=@I&#(Y%FPCMO/3TT&41\MWA1+\C@UTDG7R!UV%>
M7(E8Q5@:UA9E*P@%DP_V9]2*(_!$S$:"./S62\6V]:PA#*;\8D@6XQ@K;T+=
M2X>Z159VW2W@1D \)^[:1^Z [7_D[+8Z]E*E?#ED7T??V;<,N M:E8ZO3:T4
MSV.107O-@@HWY1UF(G[0L,1\EV[>:J8F[A_9V+EA"U2-@71%>U2L7%,+8!^_
M^R$!A'2-]X(HT%8[YCOQ6*W5\>FS5KH19N%[L ,1L9"QCP!8DO8RY5N?4AC:
M?7>.H;'Q/R*WFD7XNTAH7\9<.C;0#O<+Y@ -@EMX*DA('#ZA&T[QH)^;RB\3
MA[N3; R%-)N*#8"1G@,SM+#F!")_3.@_/L=\PY7(V0QU/Q\&94[)5@ K34UY
M#V96Q;W'U5-VV7(3^Q]?29C0=*?S!>LKJ#_V_*[F811LX&N5L)APWR,8BP<+
MF$2N%$1<>>\>GW=-!-J_*1,G((LXJ47L51R5N^F'P80[&&L24#(".0M%PD)[
M1MZ2.^@J[ORWG3QURS3P:TU^Y;H4;K+<%/O44#NA)IA7^ZF%R,SRWW_H[==!
MOO%[N0O>-XN[D0 +UFJEMD5ER#F804\9XA^G]&@LC(0&2+H(Q,S/ZHT'Y87R
MEGQNTLN_%>WP5S%S=H5HLK85@;%ZE72UNR]TL!=KE(1)1]VV^_H%Y;^1[8>4
MNP-7% V:KK VK;K0H6"*M>I9:WJLNNUZ!$9F(^WJ41/0,[_[@S^33*<5BT)N
MA:Q$BPWM*NVID;OMB@6,K*W/<>,DN##8N0E.VV@GU?E*^.+?9J8AN0KXFJS(
MYM[[:EM56]U94,)&%"+CX5&'QGA&T1'*2G067COR1=RV:IU78:*N,R=C(U<;
M?BS#3,\:PP(F([8=L6"LB'[YGZ3'UT&YT&#ROR3D:UR]%/#"_%TKX8<\@RS"
MR]^T [?["%E/8[K@61\N4;S,!,1H+3XQM9N[X'ALAG'S9R>0K+N/9) <?MQA
M@P/;4@1'B4;#Q^WTY%MO(2O OY+PW\(O^KH+[0- T#04='^=<Q_ 8[][<T%Y
MH&@:!H&@:#+>2?'N'\C\@J9/+1+ZM6E8I^S@FJY388HRDC483(2*9$ESN);]
M=!.N>$^+W*=FH^@/8MV%W&PLF*(;"5@I35&LA-1 M(",KD=HC_3H."OCWPY-
M;VR\: I[0H(>;=R ;'NON+ER(I?/<(IGD4^LSH)0^(>.1BK^(FG!XW)M=8N5
M3-A@3+!]QI#!%/;W/[]@VB"ZQM.@Y4O!_%J6(R&(31@L?E9.<DES&OE\L6*C
M)AM(S*9 (C?EH/&*\!\3Q5A=FE1D+*G>Z&PQSW,EW8*KW"-IF1SV3D/NF>F@
MY+^./#%OK.5C^T=6 %8K<\ *%,EJX<L60#N!G)#W(+;Z:"5G/"O%\[=1=RM
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MJJLOE3B8".7U/D<_=)#MQT&M/Y;LU_)1P5O"'%A+JU7)S68^S*G6X Q[7"M
M,!8. FD1A,==H+;J%GY9Y]DL'EK=.IA?S&KC<:.8R5KW((D*_<:!BM9 7<9
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M[+&NX9'ZD,1O]V@H*7S:^WB+=]7CMDB4JM8KP'N25*;+(7,O9[6" DQ,&P5
MW[>HR770>*_R=F<C=:\$I#"35Q+%G2M@UHV;F5.D<<Y20D$\)Y1,"41&VPD7
MVA)J_,5TJ*KESQ^4*R%5EC#"NV#3L&%M-(5,B5KA/-EI<P6Y1QWWVF-M!JO$
M_)<CF'Y>GDL:.,O8>R%5ZP?%E9RRNNP)@< K[>+HCJ,3H,G9^:&4,?\ FF4P
M1U\;9*XG%M58%['V*;Y1VS5"QE4-F.0EN7ZXB=MPDXSY5R63;0IU<#/YA<N-
MJ%#'M16@%5XLD];75EL8/'<=NU'WQMZ?=H(^%^5[+\55OABFOPM?\OKY;)OL
MK]PM^0!)#Q2"@AT+BRON%'#UGB,[:"/:^4?)1M4LNO!MG"6L;;N4*JG"YMH8
MLU%*:X%J-B>VMY,(0AGVS]2C;0;CP_R=?D?CZ\L *&2)@&NNZ+ 02BD9B#D5
M%UVWXF E'I,1H,;0^9;=RL<+P4#E)MTZBL4RW*K 3=,PB;(-0LE=N0^Z1$PG
M^B93&@Y7OG+VE@Z)8)K,I1AOYQ34QKNW*G$J K&E#8>;.W)!S[<;=)F)Z0$[
M(_)61;A\AE$XAJ<"L["*>47;2%DVU+$(.)KM64K$C$^,_?/V_<([Z"GQ?R'Y
M'C6V;>=6VY9N7,JC&8Y%A/M]ZN3KXVNGK748;L?$<R,NG(I]8$0MO)OE?*>.
MT8+(8)49)0676Z"[W>+M5H$N:.PAS"@Q+>):M0QZ%,=-!75_D;-ULDZZ\CN8
MNN>8:ZK$ !#5JV\> 'O S,^W198>V_W?I])T'Z#XUY .=K6[BD=NHFY8J5'<
MX.'A6/M$X=HC89:)P/KO$;_708;!_+.0=6JG&&8_&*_*EW\DZVOOB66D 7,*
M!("SMDP>?X.G6-_30;+ROR.]AYQ2*&/'(W<M<]DA1O\ ;@$PAMB6&?!L\8%$
M^@[Z#%5?G+WBK;Z7CUNV@5,=1),/,C%3A5^W_L_%?(3[D=HFSQ&>G+[9#LKY
MBO6:Q/H8--X*M!V3R1HOCP6JNXU&"^:1(V2(<A!@KGZ%Q^H?'_.>+5DKHQC+
M#</2EX,OJ%Q,Y5D$XS)?9A0JW"0@I?ORVW&(ZZ"<?FGFYYKQNF["5\:.2O=N
MV!70L<JI4G6(D)!<$)@29Y1(Q$R.PE,%,B%_Y-Y-D<;D,=BL3C1R>5R(6'+2
MU\55 BK =TR;(-G?DX!$8"=]^NT1H,[\=^79SRKR?,9%G)& 55I?EU&37,B=
MA4.9+1A7+N06X[PV1V](GUT'/-^?9UF4K#0HS7P:<K:QS\C#ERUYTZ=DVAV"
M NV'>5L!\IG<>H\9ZASPWR]#+M?'W*'M5%1"RJW>M"EMC^Q#;(PYJ378'J!$
M#=XF)F0$8W@*X/EOR#+W\=3Q6*$+T9"N#*\6"BO:K6J=U@_VA]91#"V5>1$M
M91.WVR7IH)C/D;(Y#-8A%8'8YC;55&2J$:FK$HLWZMA0S ;S^TI_[R"ZCML(
M]=PX^)_*.98_OY>L ^.LC%+3>-XD]'YA1[\,L\4J N3N(3,;1$E'3;0?H?C&
M99F_'Z&795*G[](V%UC+D0K9]R^4[#U()B9CZ>F@B>!?R7AOX1?]707V@:!H
M&@HZ/\ZYC^ QW[VYH+S0- T#0- T&6\D^/<1Y'Y!4R66W=5JTK%/V8FU4E-A
MBC*28HUS(2*9$ESN);]=!*;X%XHW)3D)H\7E \P6URT%(+[(&5<#%)&*X@1.
M0Y1$1M/2- L^!^)V:L578\22-6M27$,:) BD<LK0!B4$!*,I(3&>6_UT$.S\
M5^!6:2Z;L7!(6+@+9U@3:-DN;AL,%D,?##^XNZ1=>N@GJ\*\:5F?SE50@O<X
M;/%SH3+87VN\5?GV9;P^WN2'+]>@\9;P/Q3+Y0,I?H]VZ$I*6"UJQ,JQ]Q!,
M6LQ!A*/J$F,S'TT'K,^#>*YG(KR.2H0^VN%@1=QH T$GW%@]8$*W"!SR$6"4
M1/IH#_!_%K%::SJ FDEW%2$FS\&2=#[<;P6_[5HP7ZOIMH/=KPSQRUFHS3JI
M?F$$HS,'.6MAH_W1N2!BII+_ *,F,S'TT%;FOCG"9SRHLWEP]TGV*:04^35C
M/;>QQ=SMF(M6?<'=9C(_;H.COC'P9URU<;C(-UR+,/B7/[?]N62K7!7/MK[P
MG//@,;SU]>N@]5/C;PJJN5IQW22(I,W/8?WUSJ\>9F1\!0XP$-^(Q/VQ&@B7
M_B[QQF6Q>4H*BE9Q]M-ED0336T4URK<>U+.U#"7(C+>,E,1M.@Z5_BGP*NEB
M4XR1$UJ5!>XLR:UH9W4BDY9)IA1]5]N1X_3:-!;8WQC'XQ]4J)N2BJIZXKRY
MK!85E@,)KI81DQD$'0BF9ZSUT%OH&@:!H&@:!H&@:!H&@:!H&@:!H,_XE_>/
M(/\ -F_N4Z#0:!H&@:!H&@K;'C>"L9M6<?36W*IK,I+M%O,Q7<4$:^._&8F1
M^L?I_3.@JD_&OAB:3:2Z+(KM[4",V;4DF*Y<TQ6.6R5>%EU&$R,1H/:?CKPU
M)K-6/XDL #?O/GGV[7O0)NY_M3BS^TYGN6\SUZSN''-?'>#N8"<512NF:JCJ
M-%K *P"E6&+:P969QS@C2/7E!1_1(9ZZ#[\?^$?]JT\@++ V;>4M>\M&$.@(
M*%+3$#-AMEQ?:J)DC84S/ZMHT$/ ?$WBN/HV$WJPY&S;]X-ES9;(2N[8)YBM
M1&8*F=Q@B7$24C$Z"ZQWA?CF/;7=7KF3ZK&.38>]]AO<<J$F1,<QAGNN('[I
MG:/301$_&GA";5.RK&"#* H&N,-=V_[)TKDQ7/MM-/\ 0-@D0_2>F@YQ\6^"
M0U[8Q<05@3"=G6(A8L:#RA PS9'[98LCM<=BC>-!=X; XK#49HX]';KD9M;S
M,VFQC)W,VL;)L813ZD13.@RN3^(?%;%9%:DDJBPM57NW;8:4HJ&3 K((F\JX
M01;C"I&!GK$:"R/XT\*)-=48^5C6%@"2[%A9L!K.ZP;!@P3L";)DBALEO,S,
M^N@^N^-?"'W+5QN+$G7.Y+H[CNW!.D2::U0?;4;)".9 ,27UF=!(M>"^)VTF
MFSC@:ID6Q("(YC^WO&U9F/NZ2;UB<3'49C[=M!7O^)O 'UO;MQA$LA:NP7N;
M4,L ^8)@V60V#L04Q'^]DM!WO>"XT,=97A%(I9)J;*$VK MLK"+TJ]S)*E@<
M^<(#U+UC]&\2%MXY@J/C^ QV#H1,4\;7763O^*14,#R+;^D6V\_KT$*KX'XG
M5J'3KX\0K&50C7S9.\X^1*KUDM_V<K'_ $_7?06ES&4;CZ;[*H8W'NFQ3*9F
M.#96:9+I,;_LVE'7].@H_P#UMX7_ &J/R^>W;Y\T]^QVERQD.*:Z^YPKE+1@
M^28&>4;Z"K/X>\29FXN-1+*$5"K%3)MB3:QCY<UEATMYV(9T@P;RB=HWT%X?
M@GBAY1V2.C!6+,D5A4L;[8S8OLF95>?MY,ESQD^'*8^N@CT/C;PRAV)J4"6R
MM95<0^7V"<+4 2E1W283.V"V$$+WX<9F./706'D'BN"\@! Y6O+2JD1UW+:V
MNU<F/$X%J"6R(,>A1RVGZZ#KA_',)AI;^5U J0X$K,%[P/"LN%)&!WXC !$1
M&T:"N?\ 'WB#\P>89CXF^9DXCAKA7W6)E!M[,'"H8:BD2/CRF/6=!RCXR\'A
MG.<8)AVNS[<VN.OM[?VO+L$<J[DH_9RSCSX_701__4O@7W%-!IN(TLFR=RX;
MX.L# 04.)TLB5@\X&8+IO_HT%A6\"\1JE3*OC@45 4C5D29]GMR::Y_%]TP=
MAA3);R4E,SOH*?R#XJP5_"NP^-!>/J7U5*&4B>Z[N4*?X%+&6B -@1@1=(D4
M1^GIL&V  6 @ P(!$"(Q&T1$=(B(T%%X%_)>&_A%_P!707V@:!H&@HZ/\ZYC
M^ QW[VYH+S0- T#0- T#0- T#0- T#0- T#0- T#0- T#0- T#0- T#0- T#
M0- T#0- T#09_P 2_O'D'^;-_<IT&@T#0- T#0-!AL[\G#B?,*V ]@-E+;-2
MFZRM\DU3+I" $2048 ,2P=^ZT"GU$9Z;A5U/F/(-K4GV/'93.95SP*QN <O9
M[M5.%N_9C"(D[(%!?=]N_3>..@TG@69SF4'.SF517LT\HRLNJ)BT5+&N@X$6
M"*^8S)R420Q/7KMZ:#/9[R?R5WG]'Q_%,8BG^;*3DG2Y(E*1QTW.VD2KMV$M
MMSW+E,QM!#!;P%CY7\G!@/)*^(]@-M1LJ+LM6^9<OWKH2)=E:FC C)1,RYB]
MX_#RT%7/S'?3B!R=OQPE)N5G6L0L+:V'8]O86@P/[!A4EWA,/6)CUXSTT$;.
M_)6<3DK56U5/&6,30R;LE1K.4[N2M-5]5B;!JVB>+BC[E])WWB8VG07A?)-V
M*N0RDX80P%:;BJ>2;=0J6OI.E!"Q3(&5 Q@' %$G/3J,;QH*&G\J>49G.8]&
M'P\,<LL@B]C2L2E+92BI82X7V*ZG0,#9XQ'9C<I_V?NT',?F@TVGV KG;5E#
MJ'AZ3N2A0H\>NT_NFA-D]X-FW0"ZSZP/70?I?CF:#-X*EE@KNJ1<4+9K6!D&
MKF?4#&=IWB=!^<>.?+.:J>.U'^08P[#;56R_'6U.5W+;$W5U!6:H!8HYG:7Q
M+E,<=Y+:>F@[Y+Y2RM'/=C)42HLQ%:\W*XQ#0L@^85694E+R!4_=+B'J([3Z
M]-IT$6_\F^28;+9=N<QYK]@)-3B:UE3%3"<8RV4=^4B90P@VCH/$OTCZA>C\
MDYKWQ80_'Q'R2;2ZZ*/O1FN2V52M]TK,*^WB"R&1A<_=MMO'W:"4/R'99X+3
M\F5AS*W<MJHKQ,O""AS;WL8B7;<.A_=.@HLG\VGCK)XQ^".<[3EWYE16YC0
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MU'ZQ,3&@\Y#Y,S6,KY"P>"=;?6NKI-Q_NJPL"PZM7:JO6XCO8)DO_P!.^_\
M1] ^9OY?_+\PS"1BXG)2LP4'NZ[)&V-0K0@U:R(@7]DAS+:=_P"CMUT'/ _*
M&3LU:RF8QUWR&^-,4XM;*ZTP;<>-UIBZ=N*X#K/.2GE,#&@ZM^94\2>C W&T
MZE=%K,.EB *I#;3J;%DN3W8:FU3W@-XF.L3Z;A^C:#\ZH_)7D3,GDL7_ -OE
M?R*\C=1CJ]=Z5P5*B*>XUAM*!$N5@(B/K)?2(F=!ML!FJ6<PM',4N7M+Z0>F
M&1Q.!.-^)CUV*/2=!D,IY_EL/Y?FJUC'MN>/X]6.8^VF4C[2+9- SD2F&-ZB
M)% _A&-_U:#WXU\NX//^4%@JJ#B"*P%6S#%LYE4*19W5!,FF"XS*Y/\ %$?2
M=HT&NS>7IX7#7LO=DHJ8]#++^$<BX*&2F!CIO,[=-!BY^4LJ&3##/\6M)S36
M5EIIE8K2)1:59<)]T2D8$ I'S^N_2-_7017?.&,38RZ2QC&EC*S[:QKV:SR:
M-9ZT&LNV9 IDDX9$9*>GKM/30>K7RKED9ZI2M8:<?7JMN!Y!#7*::55Z075L
M42I*#B5LWF(Z[QM^O0>,/\WX_,1%?'8EUG+6#4..HK>@X:+A8S]HX2E:26M!
M$P"ZQTVY;Z#5^!9K)9GQV+^262;96[R30<!!+%%QR067"9&9  @9F)Z^N@K?
M+?.[?CGDB$OI]W AB;N2NV%D,O@ZS$@ +7,QRY2Z!V^LE'6(&=!:>,^4V<K<
MO8W(8MN(RN/%+75&L4X239Y]I@-5)#.\J,9CZ3'Z-ID./G/D68PBL,6+J!;/
M(92K1L"9P'%+IGD0[_TNFT:#'8#YF?5\4K7_ "C'/6T\=%ZO=$D0%S:PJJ7$
M!*.SNVPOCSVCC.\[;3&@V7@WF]+RW'6;5=79;3?-:P$,!R^7 602G+^Q@R)Q
MUCTG>)CIH*WY-SF<QOY"C$NMH+(WC19G'UTV[4K"H]T0M;XD/QJ'E/Z-!2>/
M?*69G&>U;C;.<S=0KS;Z1%-*PBG4?VPFRIA"N+)@0S"U_:7KN,:";9^:,(K-
M4Z"JI/JW@45>R#T2W^T5O<J(JT%+0"1V'D>T[_T=NN@@YGY8SS?%K5W$X"PB
MX&,7E#:;:S(JU[<%[1C DOO(NV9$L=^(Q^F8C0?J6@Q%OY+)=]Z:^&L.QX7&
MXFODY8H%LR*A+]C(27<%9,"5=V8VY?3;KH+'XTR.=RG@V(RN<.3R61KA;;T5
M Q#HYA 0J('CQF.._P!VWXIF=!(\"_DO#?PB_P"KH+[0- T#04='^=<Q_ 8[
M][<T%YH&@:!H&@:"A\E\)P/D9 >1%XL%+:I-JV'5C96?MW4,))!S6?&)D2_1
MH):/',4G(4L@"RFSCZ94*<D92*T'*R.(&9VY%V0W+UZ:"BO_ !1X;="P#$V5
M!:*U[D:]JPB&+O'+7I.%F/)1-(CX3T@IG;UG<+2MX7@*SZ[U).&5;%JVF98<
M[.O04/F8F>O*#G:/I]-!PQ7Q]XQBW4G4ZY@R@2SK3+3+:4TOR\-]YZ[5_MZ_
M7KZZ")'Q;XFM':K1;J%';XOK6WI:,+A@Q$&!Q.TBXH*)Z3_JC0=ZWQOXG5LU
MW5:QH&K[/L5P<R$C./&0K%VY*8Y"!<9GZQZZ"*SXF\,8YK&*M&IL7!&H5NQ-
M=8Y$3&W"D\^"^[W2*>,=)]-M!Z?\6>*/7,'[R'G+)?;7=LKL.%X+6Y;6K,3,
M&0@)(9GUC?UT%@OP7QI0\$U94OWE;(BH#(0%])2T(XC$[0(K0$<?3IH+'/XY
MF3P61QRCA;+M5U<&%&XB35D$3,1](Y:#,XSXH\9K89=&Q[E]H5U1]_-NS-A)
M4HGL^U<1RQ(+(SD1&8_%.^^^@6_B'PBU6BLQ%D0)+J]L@N61.T%ADN9[HX9R
M?,M*3W/?K/Z.F@T^+P]'&#:&F$A%RRVX_<I+=SYY',;^D3/TT$'R/P["^0-K
M/O>X6^J+5+=4L.JLE+^/>21)()D&=L=X_5&@JH^)_#1.H0)L -,*0+1%E\).
M<;(^T-JN?!IJ@('D<3O'KH*#Q?X=94R++&=M+LUU5ETZ5:LRW "";:K@$(O:
MV$"+*X<4J^V(WZS&T0&OL>!^,688-BK+EMMV+S5&92!NMUSJNY#OU$DL*./I
M]=!XQO@6"HNJ/%EVT^B_W%1MRY8M$LH2RN(CWC/[(6\XV_3.\]=!&CXO\1A9
MK%+P!B01,!9<&TJM'<2T9$HD6J>TR!D?=&^WIH+'$>'XC%6U74%9?=4EM?W5
MJPZRP@<P&'R)I%,SR4.WZ(Z1H)^8Q-+,8JWBKPR=.ZHT6 $I"9!D<2B"':8Z
M?HT%=0\+PM#,,RE6;2S8QC_9Q:?[,7/W[K1J\^S!')3,_;ZS,^LZ"RR^)QV8
MQEG&9),6*-L)6],S,;C/Z)&8*)CUB8G>)ZQH,PSXF\1:/(YOS99#0MWO?VXL
MV5/$!8JPZ&0;%R*5QQF>G&-M!'\?^)\+C,E9N/-KUQ;78QM7OO["Q333423$
MR7;-RQ46S)'?K'UB)T$LOBOQ*%+6D;5;LA4%!HMO4:SHIFLEJR$HD6=@I61?
MTA]=!8^->$>/^-FP\4IH&U?:,G.:\I'ONL]2:1E,]VRPMYG?KH.7F7B$>2EA
M@.PRLG&WINM-#&)=.U5Z1[352) 4&Z"_T1,:"O=\1>$L& !-I"9!(/2FY96#
MRKLERF6!%G[9@L*2Y'O,SZ[Z#48K%4L75*M3&02;GV2B2DI[EEQO;.\_I8PI
MV^F@JO$O[QY!_FS?W*=!H- T#09^YX+X]<S?YP];IL2Q5AU<;#AJM?7V[#FU
MX*%&:^ \2D?I'Z(T'&A\=^-X][7THM(,Q)=>!M/D:JV-%S5U1DY% ,,(DH"(
MWVV].F@TV@J"\4P;$9M#42U?D,E.6AA$4M@T#6D=YG[1A00,1'IH*D?B[Q*+
MP7#7988,%_:9:L$DGC6FI+R5)\)8:)XF6V\^OKH.U3XY\8JT&T06YB7!26V6
MO8PY'&GW*L293,_9,1_ICI.@X+^*O#0%X=AY*:!)2@[+S764;0>:ZH$<BD"8
MH9F B/2(].F@]9;XS\=R>7_-S;>JY#O'8AU.X^OLUB%UC.( HB)E2!'_ $;_
M *9T'D?BSQ.+X72BXPP?[OLG<L$B;)*E#'DF3[9,8LI@RF.N\SZSH/BOBSQ-
M-(*R8MJ-1)97NA;>-I15T>V7*WP<''[">W,;]1]=!)7\;^(JQ]G'JJ$NI;J)
MHO7#6;DFNUC@W*2DN<L>9$>_(IGK.@TV@RM[XT\8N7+%R?=U[5EYV2?5MV*Y
M@;EBM\+)9C("X5CW!CI,Q$^L1.@T6.QU+&X^MCZ"1KTJBP160'X06N($1C_1
M$:"CR?Q]XUD\T>8N+>5EWMXLI&PX*[XIE)H%R!*%LA9E)1!1ZZ#OBO"\+BLF
MS(4IM!)DTPIS:>511O*3:2JQ'*@DRF9G8>F\[;;SH+#.8V,GA;^-F5Q[VNVO
MNX.ZO]J$A]Z]QYCUZCO&_P"G08KP?XM9B<DW,9NS[S)]RN=7MOMN%?M4/KC,
MLM,8PN06SCC^$>GK.Y2$Y?Q#X6N#"%VR3*&U%5SN634FN]BVFE*R.16/-(S]
ML?3;TT%I>\#\;O9,\G8096V/]RV8:<"<S6BF8&$3Q)9I&!()C:?700P^,?&0
MHS3[E\@ U'3:=^V;:LH@H5%5A,DDP(F0_;ZQ.Q;QH+S 8'&X'%KQF- PJ+-K
M!AC#:<DYA.9)&R2,I(SF>LZ"-G?$,%G;*K&323I57LTR7##!;*]P1ARF@,Q!
MC,@)1O\ A*(F-IT#QWQ/$X";)TY>ZS<D)M7+CVVGLA42*Q)KB,N(1,\1].L_
M69T$C.8''YNJJO=AG%#U6D,2PU,!R"Y@0F$Q/ZI_3&@JB^.?$CH5J!U3*K3I
M'CJX=UD2"#:IWVG!04&+*X$)Q/(9CI.@ML'@ZN&JE7KNLV)8<L:^Y8;:<13$
M#U8XCG:(&(B(Z:"/Y'XMCL^%2+;;-=M!TV*MBF]E9H&2S46QKD9VD&%$QH*=
MGQ3X>=4$=NVLX[_N+:[ED+-D;4B5@++Q9#'"V0'>"GIMTVT'IWQ7X<R[[J$V
M$A#@M!23:>NH+UJA$-BN)PKEVA@/P^GZ]!ZR?QAXCDJU:L]5@$UZ:\=((M/3
M#JJ/]TI\+,>["YF9'GOUF?TSH-9H,Y/Q]XQ.;+,=EW?)Q6_;>X=[6+9!*BLQ
M6Y=J'2$S'/C^OUZZ"YQ6,J8K%T\92&0IT4KK5@*9*86H( (DIZS]H^LZ"K\"
M_DO#?PB_ZN@OM T#0-!1T?YUS'\!COWMS07F@:!H&@:!H,'\E_)53Q9]''B<
MC=L1[UL02 GVE=@]T FP0B3&[\ &-Y]9Z=)T'-GRR1W83C_'[EVLVVO'U;8L
M0H66GT@OJ&088F ]H_O*8^V8])T$)_S-3KU2R14;/;8JGO6>==->LQ[+:V2Z
MSU%<0=(@DR*1F>/'UG06*?EG'.\CQN$BB:BR5=%A;VV*H;^X"3CL1W)BS ;;
M&22+:?3?0<,)\KA:HT;,8RY9Q?\ 8*V2S1E7'LVL@M)*$DB0D>WN5=PECQ'E
MTWVG8+#P[Y'GR*[5KMPUG&+R%1UW&O<Q+(<NLT$NW%9$03!-&1Y1UB?IZ:"_
M\ESZ\'BBNDAEMIM36JU%2,&ZQ9:*4K@CD1'D9QN13M$==!DL/YCY'-7/YS+I
M]K2PMBU69AS*L#((5U33_:"(%<1YLGG)Q$P4=.F@XXOYD7EU0C$X.QD<Q#;
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M84C(GO$<9Y3MZ:"8/R?8F\C%?]O6_P Y[UA-^@+$E->*JD/)D'!3#1--H""
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M@JI*F1:55=52C?E/,6F5H1'[H'K/+Z:"P;\IY ,DO!QXQ:+R,C9#,9[BM B
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M?>>H]D=I'T^N@A8WXJ\3H6:]E?O'.J17&M-FY8?"UTV=RNL(890(+*9VB/\
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M(4Z*@17 BDIA:XXC$E/6>D:"#Y%XAB,^VHZZ5A-BEW(KV*EAU5L Z!AJY-)
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M(*M7DI8L"4)P9?WE<&0#Q&2_1$[!.\+^1(\EL)0W$6L45S'JRU";!I.'56S
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MPTF>YEO9'C$P)#,\N?3:8ZZ"#?\ F*[<Q\VO&,$ZVH&8L66;+$I"/S-R@A4
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M!9!\T>/'Y.K ^V<MIM74:3#2+EVFJ%L+.MSEW$>< ;('C!?JB9T$=7S37_\
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M'Q@AMIWN12M\YG'Q;?[54M9#F$E'+@$DR-^D=.O';?03C\*PQ9\LV#+:+#6
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MZEN$?=ZZ"BCX>\,XFLAN'7[+ZU>L5RQ*JZ;# :8UPY[*V8H#$A^Z)B.N@O\
MQOQ;&>/JMA1)[#OO]U<?:<RPUCNT">9&R2GJ"A_5H(WB7]X\@_S9O[E.@T&@
M:!H&@:!H,]=\%P-W.KS-GW#'+:%B*DV&S4]PL.V#_;\NWW!#IO$?K]=!4%\.
M^'E655YWQKK0FJ:ANV!%JJAD=471!1W.QRV#E].D[Z"_QOB6%QMY=ZJLQL*"
MXL"(R*.-^U%Q_2?TNC>/T1TT%K:K(M5G5; 0RN\"4Y<^A <<2&?],3H,ECOB
MGQ6BU;1*Z\TQ4!,V;;G\%X]\6:JP@RF!!;(](]8]=]![R?Q9XGD2M&T;2CO%
M9FZ5>TY$N7<VER6]LAY*F8W@9]/IZSN$FU\>^//Q].F,V:QX]KG5+M:PU-H#
MLD1/_;!,%,,YSRB>GI^B-@F^.^)8+QT7!B*\UUO%(&OF1C$5UPI>W*9G\,=9
M]9GK/706.0H4\C1L4+JA?3MJ-%E!_A-;!D3&?U3$Z#+!\5^,@J.#LA%X&0Q6
M5]]8FZ$"N50L7R<EV^W,CP])]9^[KH)9_'WCI4+M.(LB-^:AN?%ETOAE#A-=
M@N(I9!@2A+EOO,^N@KX^(O#]V1/O"2:K===8K;R2E60_O()7)2(<Y^[>(WB?
M3IH+JKX=@ZKZCTK.&4KEO(5YEA3$/O\ <[\S$SUB>^6T?307<Q$QM/6)]8T&
M-7\2>'+2:@"W$#PB@7N[$E1%1]P!I3)[H@3^@_3[?P]-!RRGQ9AB\=S./Q7)
M5_*XZQCSN66M=)S9,VFUQ%,F9DQDR1>OTCI$:"5'QAXS[<AYWINR\+(9:;EB
M;RS6LDA 6)+G "IA!P_#M,[Q,S,Z#V'QCXBO&VL<JNU=>VNL#2%[>[!4W'82
MX6<N?=A[29)[[D76=]!R5\5^)BJ5LBU9YV6V[#+%ISC<=FL-1XM(RF36U(1!
M!/3]&V@N/'O%Z."6T*UFY9EL"/.]:=:(07O  '=(N(CO/IUGZS.@DYO"X[-X
MQV,R*Y94?QY0)$LQ("@P,#"1(# Q@A(9WB8WT%)5^-O&$<BD;-BRP+06+EBP
MUKW>]4M+2:PYF2GM( 1_V8CIH.=CXO\ %G#$A%JK8 @E=NK9<AX0%9=.1%@%
M!<32D!*/K,;^O70=Z7QUXU0O+M4(M4TKX3./1:>%,S4J$@PT0? CA8#&\^NT
M3.\]=!RN_&7BURC0Q[8M10H5548J!:<"GUD;2M5@!*!;$3'K/7UZ]=!J]!FK
M/QYXU9S199@/[AN&XRF-AL5#M@$+&R5>"[<M$1C8MO6(GUC?07>)QE3%8NGB
MZ8R-2@A=:N)3)3"TA !$E/69XCZZ"K\F\)P?DAJ/)0[=2'U9[+C5!HM<.ZMD
M#/W#)* HW])B)T'+*^ X#(V[%YDV:^0L/79B[5L,0Y;5(]M$J,)CC!)^TA]"
M^L:"[QU!&/HII(EA)0, !.8;F3^LV,DC(I^LS.@J? OY+PW\(O\ JZ"^T#0-
M T%'1_G7,?P&._>W-!>:!H&@:!H&@ROE?FF2P^53C<=A3R[V4K&1;Q>NO )J
MFL#C]I'W&7>^R/T^LQ'705 _*S[32C%8-ERN^S7HXMQ6%I]Q9M4UY"((2&94
ML*QD1G._4=H&=]!07_DWR2SGS(4.QF*Q=28R5-+:INF]^811())B702QGJ,A
M([Q.\_H@-Y\?YS-9OQ\[V8KJK6HNWJX@D^X,KKVF)"=]AVF.'']>V_UV@-)H
M/RK)_+]ZK9I9AV-;6\7;6O.JES4QEV5.0BO,CMR1R-N\;S^&=RZQMH.K_G!*
ML,&0_)SY1;.I9:3I717Q4+A/WAJ@=F0?$>0#'."B9C;>0_2J5H+=-%I>W;L+
M!H;$)QL8P4?<$D)>OJ,S&@X9S*+Q.'NY-HP:Z:3<0$Q:8GA&^TL:0+'?])3M
MH,'AOF!^99[#&X(K6:AYK]JNR(HE"T@XWC8:M6_^^$('M]2GUX_=H*KQCY1\
MH"%V<K3+(8WV6"9>LB24E6;D^2C.%C&[9[DC)#$Q Q'V_HT'O'_.%9QYG(!4
MLW*8H]UBJP2N(A26 B0.>V/;8XF]P>9E$CT^V8G<+-GS,BOY!.%MXH@L5VKJ
MW^TZ72JTQ0M@1$5QS4'<&#9O&TS^&8C?01+'RUY)9Q%=M/ 12OW Q%ZDNQ:6
M8,I9.XNL7(@&>VR.?';:=N7+Z2.@T/B'R,OR'/Y+#'0G'V*'<F%.<'N>*F]K
M=E8H!@070@(>83']*)Z:#9:# _(7GF9QBLK3P- W/QE9%B_D>:A&M%IA"KBI
MD3WIXK(C]-H]-YZ:"9D/,['CT9>ID%ED+&)Q;\X3QD%\TS8="Z\1 Q$$"UP/
M+;KH.6$^2+.2SR*#L*RKC[ER_CJ61EZV<WXZ6=SDF(@@ Q24B6_K&TQZ3(;?
M09+RSSC(87*CCJ&%9EF10=D[! ]:(!%<P XCN1]QES^R/K]9CUT&7?\ ,+<=
M5R-TDADD'>;.-43@K'%,*56Q @ @QK#F;$_T-H_I$/306U?Y699RBEIPCIPQ
MVL?29DR>J"%N4K)L(_L_XI@?<B)_=T]8WZ[!O]!0^3>36<59QU#'X\LGE,F;
M?;UH:" A: YM8;#@HC;<8B-NLS'I&\P&%9\AYK'^!8O,9&Y,Y'R.NFKCPD%+
MBO;A;V/>PH6P=H 1^WB<<AZ1UG03U_+[CI1;J8"U:HT\:O)Y>PQJE,0GO/0W
MBLH'O&/M#,>.T&/6-ND2'RU\UTJV3RE2<=WE4*N0M)=7L@Z6?EH<S6<"/;63
M!B>,=PIC^E SH);_ ).R]=IB[QLX53L4J>6:-M117?D6+%(C'&); KL+-DQZ
M<MHY;3,!!5\UBK%3E,K@G4:EBC-_%S#U.)XQ954X' Q':F6V5S&^_P!L[SM,
M;:#4^#>:)\JQ]FR-4JKJCYKN&")BBG@+(-+2!7<"8/;?C&Q1,?30=/$O[QY!
M_FS?W*=!H- T#0- T#092_\ ("JF9O4QQ5NQC<20AF,POM=FL9HBQU7)PTQ%
M1"1D(SQY1^O8*N?EJ%I7[GQ^_7MW(IMQ=,BK2=E%ZP%99Q(LD%D!M#N 91(Q
M,>N@C/\ F=56N3[GCN02(S90,<JQR=RB\46*X0+)WV(OL.=A+;02LE\L)QM)
MY7L0VIDZEH:EFA9M4TP$FF+"SAY-[;(8N?M@-RY;Q,1MOH/"/F&E9FN^MAKC
M<4:<78M9"20(H#,%PK\EDSF4B?X^$3M'7KH+OQSSJGG;R:->HY5CVC+5X6<?
M[*:[)5>PS:9^^6I;MMT^R?U:"\RN2J8O%W,G<*0J44,LV#B)F86D),YB(]?M
M'08IGRNY+:]%_C5].9O$C\OQILJ\FIM"V0;+!:2PXS7*&"4[CT]=!OAF9&)*
M.)3'4?7:?T:#$>1_*M# W\LBUCW35Q,UDNO2Q"U'9NP,H2/<,=M^>YF6PC$;
M[Z"KK?+Z+K49&JO_ /1B:.19?J=VM_>JEBFL)"T3!K]OC:F>?/;:?TQMH. ?
M-H6"Q]U&/X88"R<9Y_=4V4QCJH6>2"6<BX2!L3N/KZ:"=B?FC&991)Q^,=:S
M!/2BKC4/JNAG?6UHE-A;22'!==DL@BW';Z[QN&D\"S>1S7C89#(K)-L[5Y1I
M,1$UBBXY( 4!)#R$%Q$S$]9ZZ#IY/Y26&;0IU<>[*Y7)FP:=%!*7,B@.XTS8
MX@ 1$=OKUF8C04A_*5<7$PL+?7BZ[J]/(9!O9"*URT"R!#$]R6SQEZP,AB1$
MB^L1,P%>CYF@ZRK3?&L@BL=6GDS:1U9@*%XY6#RB&S/*#B=UQ'+;K^K03ZWR
MFDVG-G"W*M(BR"J-TSK=NP[%DV'+'=L=OD*#("9Q&8B=YCZA7XWYIKY0UU,9
MA'WLFVU-0*U>S48J9BJ5N#BS#.S(\%E$[3O!=-!XL_->#JI"\8.XY!% Z%.P
M=:L G:"RPX-[#$1D!JESY%,;Q$#OOH)6,^:,%DLOB,?5INB,JL#!SFUD_<;#
M3(I%C!]SVS5/.4\MHVF-]]!^A:#'V/D>LK,LJQC+1XI-X<2[-1*NR-YD#Q5V
MY/O2'(Q7+.&W.=O3>=!;>'^1M\CP-;-%CVXU%T!=44\UDPT, 3!DPLC@>7+\
M,SOH(OG/G.,\0Q]:S=&&-NOBK45+5($F<"9,FYQ L!$%E.\S^J.LZ"HP_P L
M4\V5<L-A[M^M )/*O5*-J??::1B1EF[N))(BE7*(#[HWWC01W?,=5&._,7X*
M^NI:K>]PA;UY*]7[R4[@,,W44^Y68BS;<9_3$Q 2 ^4+#;3,4CQN\[R*NQT6
M\0#:O):4 EDN[TMA100VU0 Q.\E,QTVF=!&1\QU[IJ+%X&]>I6K"J-.V)5UB
MRU8I!>4OBQ@F,=L]C*8V&8^N@]5?E>M8B'UZ-RQ:N+HKI8?9 E[JRVVLU]WE
MQCA[)DF1%QXCN.^^@VV'R#\AC4VWTG8Y[.4-I6>/=60E(S$R!&$QO&XD,[3&
MTZ"M\"_DO#?PB_ZN@OM T#0-!1T?YUS'\!COWMS07F@:!H&@:!H,IY+\?X[R
M/R*IDLD;"IUJ-FD55+7US/W+4F7)B#7)+D$R)!/2=]!,M>"^+V:=BH=25JL6
M57=TL:DUV$*!"FH-9 :2!:A&.$QT_P!,Z#@KXX\/56*N%&86:H2R9<XB,8L^
M\DC,CDB,GSS(YGE,^LZ"WP^$Q^'2]% 36FQ8=;-9,-@BVP<L;P@Y+@)',EQ'
M8=YGIH)^@RD_%O@Y/>TZ!'#P>OL%8L2E86C%KH0J6<$\F!!_LX'8HWCKH.CO
MCGQEU,*SO>LD&&SW99"[-HI:$+8)6.]W2 @ 1D)+CT]-!H:5.K1IHI5%"BI5
M6":Z0C806L8$!&/T0,;:#CF,1CLQC+&,R28L4;82MZIDAW&>O0AF"&8GK$Q.
M\3H,\/Q9X;'</LVBLM<-AETKUR;4M%79F?<2WN[$K["'EM,;;QTC02ZWQ]XG
M6HG012D*K%TDDN&-_P!WC2@JHQ,EO^SF/]?UWT'(/C?Q(%6417?-6U$C-0K5
MDJZA)HN(4))DK3!,""F%C'Z/302;/@_CMG+MRK%.&R\H.PM=FPNNU@A"Q8VN
M#!29B$1$$0;](_1&@Y6/C[Q5]-50ZIBI%.MCD$M[EF"*;1=7@# X*"6P!*#B
M>6\>N@[8CPGQW$9,\E20R+1"Q:^Z][@2#CAC00MIF"188P10$1OMH+W09[R'
MP'Q?R"W[K*5F,<2P2[M/>@6K4<L6+@48"V%G,D'.)VGTT#R7P'Q;R5_?R]9C
M637.FR5O>B&USGE*FPDPA@07W1![[3H)-7Q+ 56U6HK2+*5JS>K3S.>-B[W(
M>?6>O+O'TGI&_307&@R?DGQ[C?(O):^3R9F=)-!U JBFN01]]JS*#-)KYK(5
M\266\3H/=_XS\.O-:UM1JC?+>_-:S9K=Q;UJ4U)]AB]U$-=>Z_P_;Z:"56\%
M\8K5QKIJS"AL4[<1+&3/>QZU*K%O)?T KA&WUVZ[Z"_T%7GO&<1G5UQR"V2=
M1DMJO0YM=RRD9 N#4DMD00%(E&^TQZZ"(SP7QH\%0P8UV(HXN1G&RA[DNKD
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MTFNN4[+:[9AB5(8KFLAGMF%9>X_ICE&T]=!WH^ ^,4!0NG6)":MU>1KI R@
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M;3(P7W;0#%E'+8A8 SO'UCKH.O@.6OY;Q:O?OLAMICK8&<"([BJVU0=!B(Z
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MUC09ZU\2^"6<?7QTTFIHUZ48R*]>U90+*<3)"EW:8'=&",BCGOUF?TSH)[_
M?%'D@WTNX=;(QF$D3&3,71" AOXNO2(^V?M^NV@^EX%XL4Y&9J3OE46JU[]J
MS[U76DYX_B^WD9S.\>GTT&;5\66(\Y3G6751C:MTLE6JJBP!RXJQ5H$UR^:N
M^Q[DT5<RVB)GUF0VN<P>/S>/*A?$R01J:,J8:6 Q#!:HP8N1,2 P@HF)T%;8
M\ \3LU5U+%'O5EG=8*C8R8Y9&3*S,_=_3EI3'^S_ $=M!Q/XX\6;2FG:79N
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MF8GUT%+9^(_!+%)5(Z;AK*0ZK*UV[0=U%AI/-;Y%D2X>Z<G'<WVG06WD/AN
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M6UVS$L2SA/W 7&/UQ])CKH(P_'7C@915Y7N%J2Q;U8P'G%(;"%BI3XK[\>8
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MT^7K!DS,)&0 .TO>9V#[.6WZ9G02] T#0- T#0- T#0- T#0- T#0- T#0-
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M[B8$<J$H""ZSTG8/T'08'(_,>"Q^<R&(LTWPZBBX^)!M1A'[!)/9$I!Q.5R
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M=/&"C\O>MI!92=;;M-!L=8,=O7Z^DQM.@B4_C+Q6NNT!K=;]_5=3R!V7$P[
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MYRO/W4%MM.T]TN.WIH)WCGC-?!+<*[MV\;N,2V\\GD(+B8 !Z",1&_KMO/\
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M^<*HP-AZ)?A:V,[US)B5:)G(#<BEVHXO)7$VS&Q"4A]T3SX]=!KOCKS!'D^
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M99&N$6-K 5#6/[:8 A>X!W9(CM/*)X]=!X3\VX2TCGCL5>R3U*MONHIE3=V
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M\2_O'D'^;-_<IT&@T#0-!F\GX%ALEEBOVGVR0YB7VL5#R]D]U?CV6,3._4>
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MW;7A)\ZJFH$.(K%<+)-DP(1&(F.O0NN@4_B?QFH=04.NA2K>T)N.BQ/MK#:
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M$;:#2TODG 7?$C\EK"Y]<'^S]FGMM>5N717% 2LR29&TQ@2%G"=]^6V@S_\
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M6X6@-N@2U0[\N4P,<1F(Z:"OR'Q/7N>2MN#?M5<7:KW NKK/E;FMO6 :Y93
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M2P4K1$C$_AC@D>F@K/$O[QY!_FS?W*=!H- T#0- T#0- T#0- T#0- T#0-
MT#0- T#0- T#0- T#0- T#0- T#0- T#0-!0^!?R7AOX1?\ 5T%]H&@:!H*.
MC_.N8_@,=^]N:"\T#0- T#0-!E/+_/)\=O!35A[65;-&SDW>U) 0NM3)8MDN
M\Q>Y?M8XC'KH(%OY5JC+6TL3;M8P&KIQE8E((]\]0L2B0)D-@2)H+EG'C!3M
M])F K5?,ZJ6(\<L9S&DFWF:=.S9%=BK'";A0L24@G=]H[SRGB,\1GUF=XT'=
MGS$(I8\/&\BU4(NVTF)U(AE?&.[-QD<G1(\)D9""C<]^F@DS\K0R_-2CX_?N
MBRVS'4["SK #K:ZT6^$=QH$ =G>>91M$QMZZ"%'SOXE-S'5^TT8NKJ,?W&5P
M8B;TQ"@[!,[KI'?=G:$H&.O70<,W\RW4X2W;Q_C]D'RJV>*;:.OV;$T+0U;/
M0&\PX\^8\HCE&@TGFGR+C?$ZN.+()_MN3DH15-]= CV@@V\WO8M,<.41^+K,
MQMH*M7S#C+!K=3Q-VQB>&.;:R42@00.5/M(Y+)D,*19T. &=HZ]=!>>0^9SB
M\LK%4\3;S%WV\WK2J?:W35@^WS_:FOF1%OQ6&Y3M.@H<A\T82AFK^+?0L&RD
MJTT8KLK6&G-(.;!*NIIM5R&)D.Y$?KVT%QA_D/$W_#KGE+%RFA0%QOA3J]N"
MA(\Y[3*S&@>\3M$;Q._28C04J?,/++EW/$^HS!U\)7K7&TGBASY2Q%HF<#6;
M%E,DM>VY1M(S$Z#HGY6B'!7'"WK2 94IGDHFL %;NTU6D+X=R#^_OB!3 \1*
M?T==!VM?+F&#'%?K53?7&K1LDTW5JRP+(B9K4QEABP$P!>YQO_2&(WWT%52^
M6TY!\9$395PC QDB'!1L!C[5Y%F&%R(97_8X^X)GIU'UT'L?DO,6,NN3QMK&
MXZQ6QKZ*6C6-SYOY :ZRY0PQ"# X@Q+8@WW]=!5'\Y^WPF L9A48[(V4QD\K
M76=6?[##&*B$PYPR9L)>\"OD?$9Z1,QH-IYM\E87Q1>.]P/??E(8=1<N16&5
MI@28<MLFE<?[P8$=]YF?],P'CP7SJSY5D<P2Z?:PU:*;,7;F1@VKMU5V/V@<
MB(2CN?HC]'KOH,S@/G/$]G!T,O\ M<G;KT?S*PLZZX"Q?$97 5R9#V#^T&3E
M83 Q/^G8-GY%YE.*RB<73Q5O,7RKG>L(I]J"556<+D_VIKYD1%L"QW(MIT&=
MN?-F#J93(T'8^P3*";+Q%+*SVG[21A@FE338C?ERCNP/VQ,SMMH+_#^?8F_X
M?:\J:/ML=26]MF0<BT/"N,F9+96-JSCC'3KO])B-!E?'/F:KD09536=E<[9M
M;4,;692*)2\&N6,N4\TCV4US[G,^7+Z?<.@DT_D_*!Y'?3>P]L,0#<4GF0H6
MRBS)#"X"P,LYLGOG$%VX*!'KUC01<7\W82WE,O(&5BHM)NQB 92&9"H4+>32
ME_),L(^0]_A'"/T[Z"90^9:V316C%82UD+]FQ:J^UKOJ$$'32JP918[L)("6
M\>)"7KTT%GX/YY9\GR.7**4UL-651L8VT9!##7<JA8F&A!%(D//04;_F'V]H
M,K=QUFAXP>*=D*K'0CG;Y6JJ*IKF&?LN?N/PMX[043.W78-7X/YQC/+J%FS2
M'MLIOFM:5#5/"#X"R)!R"8I@R)QU$O7>)ZQH/?B7]X\@_P V;^Y3H-!H&@:!
MH&@:!H&@:!H&@:!H&@:!H&@:!H&@:!H&@:!H&@:!H&@:!H&@:!H&@:!H*'P+
M^2\-_"+_ *N@OM T#0-!1T?YUS'\!COWMS07F@:!H&@:!H*G)^,8K)7#N6A.
M7,H6,84B<C'M[9 38VC^ENH=I^F@J5_&/BR[Z;4#9E234Z:$V&^T.PA0I788
MC?@31 !Z_IB"VY1OH(4_#GB?MU5X?D10M%>LQ8W&C#ETCDZL.VG[^QRV'?Z;
M06^@M1^/O'(K#6@&]H:E^A$=PM^SDVPVS&_Z9,8XS]-!UH^#X"DVLU ,@ZMT
M\BG=A3^W96FH4S^D>T7I^GKH(-+XQ\<HNJ,HMNU!K E;$HMM6NP-:9)/N!&8
M[G#?;]<?:6\=-![M?&?BUK&*QK5N]LA5Y*N+B$H'(LAKYY1UY<XB1G^CH)V:
M\/QV711&Q8MIMXW?V>2K/)-H>00#-V#^*&#'WQ,;3Z^L1H.!?'_CI)MI(7D-
MT:(V"-[#,ORTX97F3.2*9Y1]TS.Y?70>_(_!L'Y!;5;NS92\$E5<=2PRO+ZK
M"@CKN[<CS64QZ>OKM,;SH*N/B/Q.+/>$[PK K1UJ@7'@BO-V"[\H "'MR1')
M1,3N,_AF(Z:"TQG@V H8C)8L@9=1F),LLVVPFMLRQ<)*6'T__)@(]-O3].@Y
MXKP#"XZOE50^Y;+,H&M??<LLL-)2P, &#.9D>(MF.G^GUZZ#TGP+QY*H6 -X
MQ<IY#JPI_;T$J0B?]$!7#>/KH(?_ *M\4"DRM5&Q2D\DS,KLUGFMRK;1)9$H
M^O$.V9! ?A@9Z:#Y0^*_$:212M;V+%B6[/>QTE->Q8LAS(Y(CB67&<N4SO$]
M= Q_Q;XQ2:+ .XZ5^T&O%BTUT*50LC:K)7SF>(+8$=/K'2=]!\7\6>-I77"M
M8R%7VP'7@J]QRB.J32;%9A!,$2@(RX?TAB9VGK.@MO(/$L;FRJ-<VS3N4><5
M;M)YUW@#8B&!S&>H'Q'>)_1$^L1H/>'\6QF(OVKM(GP=U:%V%L<;0F:RX4#/
MVDD7<E8B)%ON6T;]=!54/C+QS'OJ-HMNU0JKKJ.NFVY:;$5!@4%8 9CN$ C$
M;_THB(+>.F@F^2>$83R"RJS<*PFPM1U3;4>RN3:K9@F5VRN8YK*1CIZQ])C>
M=!4)^(/$4L&4G?6E(V I5@N/!54;<\VQ7$2CM_?L43'6)CI.W307.*\*P..P
MU_$PL[=;*DT\H=HY:RR3PA3):4[>JQ@>FW2-!7?^LL'-,4'=R;7I:#:5]EYY
M6:TK UC"&27VQVVF)=/NB?NWT':I\;^+TZCJE=;A3892<WDXS*3QQBQ!2121
M3/,(DYF?NZ[Z".?Q7XP=>S4EMZ*+YY(I1<="*I]X;$'67RX@0M""'UX^D;1T
MT$C#?'7C^*O!?4RW8NBY]DK%JPQYFVTA5=I%)S/J%<-H](^D1H)7CGA6%\=8
M98SO #*U:H:6-(UR--?:4?$OZ?;B!(OK$:"J5\2^(+AP3%MJ&5RIUZ[+;B75
M035O$*L<MT]MJ ()&=QVC:=HC8-%@L&C#U#0NS:N$PY8VQ=>=AI%,0/XCG88
MB!B($8B/]>^@@>)?WCR#_-F_N4Z#0:!H&@:!H&@:!H&@:!H&@:!H&@:!H&@:
M!H&@:!H&@:!H&@:!H&@:!H&@:!H&@:"A\"_DO#?PB_ZN@OM T#0-!1T?YUS'
M\!COWMS07F@:!H&@:!H,YY'YC^49%&-J8JWF<@RNRZVM3[4$NJDA V?MC5!%
M)'$  [D7705-GY7H5Y>]F)NQB .Y6K9683"GVJ"VL<D5RSO!_=F")&$#)#M^
MC<(5KYHHTJ1/R&$N4'S[0TIM,J+7*+P--+FV)=V$C/MS&8843RVCZZ#I<^;/
M%JN7IXUJS$[ 5#L$3JL$F;^W9&%=Z3?MSB3E,&(Q.^\Z#JKY<Q\5[EJWBK=.
MFFO=LT7,E!>\G'/BNY21!A%!RPA@(.(Y1.^@XY3Y?JU,O<P:\<<Y52+155S8
MJ'RL5:QV9!BUN)J@(5S F8QO_KC0<L'\IW;0(KEBK5[/W%UVCB$366*Q*DFR
MXQ<;1#MQWQ_$6_(H&/TZ"2KYAQEAH,JXF\[&"./*YD?V #7_ #-DI4)K)D-D
M@;'%D ,\?7KH-_H&@:!H&@:!H&@:!H&@:!H&@:!H&@:!H&@:!H&@S_B7]X\@
M_P V;^Y3H-!H&@:!H&@:!H&@:!H&@:!H&@:!H&@:!H&@:!H&@:!H&@:!H&@:
M!H&@:!H&@:!H*'P+^2\-_"+_ *N@OM T#0-!1T?YUS'\!COWMS07F@:!H&@:
M!H*#R7PC"^0N2^X=FO84IE8G4WLK&RLZ1EM=A+F.2SD(G],?28T%<?Q5XF;G
ME(V8J-BQ*\=%AGM$-MJ-+W)3OQ!A@T^OTDIF(B9G02;_ ,>8.V?>%URI9&O6
MJKLU;!J8*JD-%<=/M+<;!P4%$Q/Z.D:#C3^,/&:#ZAXTKE!55:%'5K6FK38&
MK.Z?<#$_M)'ZSO\ ='0MXZ:#N_X[\8?1Q5)R6&C#7YR=+=A<H?+3=,',?B"3
M9,R$]/3]&@CQ\7>,_FTY*3N%'N+5L*,V6>T%UY;%VB%._']K#SF=_29^W;0<
M5?$WC24*%%C((MHE?9R*K1A:$5H&MPAH[;B25B)1,==HGUB)T$Q'QOXI7I/I
M5T,54L#0 U"PIB!QAPROM,S,_BC<YF=R^N@O<53L4Z0HL6CN-@VG+V?BV8PC
M$/\ 0 E 1^J-!+T#0- T#0- T#0- T#0- T#0- T#0- T#0- T&?\2_O'D'^
M;-_<IT&@T#0- T#0- T#0- T#0- T#0- T#0- T#0- T#0- T#0- T#0- T#
M0- T#0- T%#X%_)>&_A%_P!707V@:!H&@HZ/\ZYC^ QW[VYH+S0- T#0- T#
M0- T#0- T#0- T#0- T#0- T#0- T#0- T#0- T#0- T#0- T#09_P 2_O'D
M'^;-_<IT&@T#0- T#0- T#0- T#0- T#0- T#0- T#0- T#0- T#0- T#0-
MT#0- T#0- T%#X%_)>&_A%_U=!?:!H&@:"CH_P ZYC^ QW[VYH+S0- T&0^1
M_)?(?',2>7QP4YI5%,;:]T%AK&L';MH6*(V7S^[DXYD0Z;CMO,!4U?DVW=\U
MG%(.BG')N!CF+>%J6L:=87R2[:Q*H)<CXK27W,B)*)C>(T'Z+H,A\E>:V_%\
M56/'*19RMQTC6K66=L"5765BQ.^X_=VE2(?_ '(=!);\B>-+IONPUC*M?%(S
MA-6'*"IV9.%D/7J4]HNF@JJ'RO4;6:5K$9&+L7<A51CZU>7O.OCG=IEGB,]
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M&1%.\C _[7TT&)H_!F"J)<H,I<V.H--!B%-1*A5A5I+=U(#NN!M<9DV\I/\
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MC!;E5X"!CKW#;8 1'ZZ";C?._';_ (_>SL.*O2Q<M')B\9%M<DA##$P'EO/
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MR%IQO(%"3@ONCC/I$S/30?5_*.%.*H?EV5"W=?%>K2928MQR2I?#($MH[?:
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M2@E%"_NE=I?(>?+I/&=XT'>C\9T:]ZSDK.2MWLI>KVZ]ZX[M03?>#77)<%@
M!V@J (",1'KOO/70<<1\48C&^0X_-1=L/;BU"JFM@5X*.-?VVQ/!0V"7P^[M
M$SA!=8CI&P2\Q\>5<CEW7HR=RK5MV:EW(8Q4JFO8L427*C.363!B12 F('$%
M$1]=!X\,^-,1XG;-U!Y,5"IKU4DBHN5*DH+B3DI4YTQQB()IE.WZ^N@K6_#.
M%;EK66/)7(R+#[M.V U@<AD/&P!DP4P5F0-<0'N.>P[C]9T'=OQ16.(>.<R*
M\JZ;?YCE!]OW;(7P4MP$,IE:X@:RH7VQ&1X_Z=!'_P#2?C;+:FW+=FU733FB
M"#% GVRJ33(?<@H;,KE<R4*EG"#ZQ'2-@M\7X#-7)4,E>S>0RUO',(ZY6R5Q
M@)KG6@.VI:PC[621%$<B+\4[1$:"@H_$C5Y*Q39D[2_&XHXVC-59)WNA2-QF
M-C=<D$;L&)E9#R&9C03X^),7'>F,G<ADE+*#1[,'5.+TY!9+_9[%VWG.W."W
M&=IWT'>I\7XY3;]JQD;=S(96G<IY&XWM0;?>]J"9Q   )6%<  1'C$?29ZZ"
M3Y)\<XG.8K$TG-);L+$11M$JO8Z=KLG#$V5N2<$/Z0Z3M,;:#EC/C3&X_-4\
MDF[8-=1:!*D0H%3'5EN6IY0M8<2@;1_:&P;[3QZ:" WX=Q#JOL796^S'U5M5
MA*O),1C^\P6\E%"N3) EQ =V2XCTT&D\7\7C!1D3._8R5O*68N6[5J%P4MA"
MT;"*@6 CQ3&T1'30<O$O[QY!_FS?W*=!H- T#0- T#0- T#0- T#0- T#0-
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M2Q65AW8@#!C!89@SH<*$^/K/30*WR_XVU37NIY"I6%%FQ5>Y$<;45'C6:%>
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M^(1O/6=YT'SQ+^\>0?YLW]RG0:#0- T#0- T#0- T#0- T#0- T#0- T#0-
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M!P$N7 &PAC<A^UD"76/MT&K,I$"*/6(F=!^?X?Y<QTU/&UYBNY-_.UZ)384
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MQ9JUJKJ[) ES[09!;=X"#YR,[%]W&?T:"\T#093(?&^%N>2GG^^Y+K!I9>K
M-<EO.O$"N9-JF.7]@P)0I@P41UT$)7Q/BUU4UQS&4X4.U^1;O7,8Z$%)!%<>
MWP/I/#=T,F0^W?;0=$?%6"57RBRMW'.S-)]')6V&N6M]RPV,=T"!AF[-HV'C
M$1$0/30>'_$V$>+Z[+]^<8?O#JXON+]O6?D%,58<K]GW.6UADC!F0C)3M'Z
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MJ%NBER'V9L)AL^R&8C=5>!$05);1)\>,SR+>>OK.@KO$O[QY!_FS?W*=!H-
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M-!1T?YUS'\!COWMS07F@:!H&@:!H,WY/YWC?'KR:+Z5Z[9=6==X442^0KUB
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M=Q*(D9CZQ.@H/$O[QY!_FS?W*=!H- T#0- T#0- T#0- T#0- T#0- T#0-
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MZ31(-?4@I<N%BTK <>V6Q,4(EQG:9Z;AL]!F/,O-!P(%6K4;.1R9U+%P$50
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M*1X%4QZ<;^47'U;.+HHQ59Y2#/[(IZFG!#([29BGA,_HF=!J= T#0- T#0-
MT#0- T#0- T#0- T#0- T#0- T#0- T&?\2_O'D'^;-_<IT&@T#0- T#0- T
M#0- T#0- T#0- T#0- T#0- T#0- T#0- T#0- T#0- T#0- T%#X%_)>&_A
M%_U=!?:!H&@:"CH_SKF/X#'?O;F@O- T#0- T#0- T#0- T#0- T#0- T#0-
M T#0- T#0- T#0- T#0- T#0- T#0-!G_$O[QY!_FS?W*=!H- T#0- T#0-
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MS(WZ#O.@L?D#XPJ^96%-??*L(U74S42$6@@'[3+4C8$Q2^-MNX,;[=-!'O\
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M- T#0- T#0- T#0- T#0- T#0- T#0- T#0- T#0- T#0-!0^!?R7AOX1?\
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M_P#'U?X\?^%H'YMYC_X^K_'C_P +0/S;S'_Q]7^/'_A:!^;>8_\ CZO\>/\
MPM _-O,?_'U?X\?^%H'YMYC_ ./J_P >/_"T#\V\Q_\ 'U?X\?\ A:!^;>8_
M^/J_QX_\+0/S;S'_ ,?5_CQ_X6@?FWF/_CZO\>/_  M _-O,?_'U?X\?^%H'
MYMYC_P"/J_QX_P#"T#\V\Q_\?5_CQ_X6@?FWF/\ X^K_ !X_\+0/S;S'_P ?
M5_CQ_P"%H'YMYC_X^K_'C_PM _-O,?\ Q]7^/'_A:!^;>8_^/J_QX_\ "T#\
MV\Q_\?5_CQ_X6@?FWF/_ (^K_'C_ ,+0/S;S'_Q]7^/'_A:!^;>8_P#CZO\
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<- T#0- T#0- T#0- T#0- T#0- T#0- T'__V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
